data_2k2e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k2e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.457 HD13 ' HG2' ' A' ' 134' ' ' MET . 3.9 mm? . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.798 0.332 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -70.06 104.08 2.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.357 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.4 m -126.14 151.71 46.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.231 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.01 122.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.183 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.2 p -89.54 -20.3 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.315 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.44 140.59 10.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.657 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.43 -79.82 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.5 162.68 38.53 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.839 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -107.99 111.25 23.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.857 0.36 . . . . 0.0 110.674 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.2 4.32 57.53 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.238 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -162.14 172.41 15.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.73 124.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 28.9 tt0 -94.53 109.5 21.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.002 0.43 . . . . 0.0 111.169 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -117.05 124.01 72.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 62.85 29.55 16.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.604 0.716 . . . . 0.0 109.506 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.404 ' HA ' ' CG ' ' A' ' 23' ' ' GLU . 34.8 mt-30 65.64 13.98 9.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.723 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.2 110.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 92.1 mtt180 -86.41 96.8 10.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.993 -174.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.78 115.43 22.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.7 p -90.47 28.71 1.41 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.261 0.553 . . . . 0.0 111.064 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -154.1 171.39 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.785 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.23 138.05 58.24 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.286 0.366 . . . . 0.0 111.2 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.19 147.69 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . . . -123.1 116.52 23.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 175.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -135.83 157.82 45.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.957 0.408 . . . . 0.0 111.057 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.488 ' HB3' HG23 ' A' ' 141' ' ' VAL . . . -139.5 160.16 62.73 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.65 -57.04 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.456 2.104 . . . . 0.0 110.492 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.79 103.11 12.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.35 178.73 32.65 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.902 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -88.61 176.02 3.6 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 112.919 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.14 104.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.344 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . . . -85.99 126.62 34.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.559 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -91.26 118.62 30.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.794 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' A' ' 60' ' ' ALA . 1.3 m0 -98.32 130.23 28.78 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.42 23.48 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.937 2.425 . . . . 0.0 111.178 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.514 HG12 ' HB2' ' A' ' 51' ' ' ASP . 73.2 t -85.71 136.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.771 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -117.85 -24.26 7.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.068 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HG2' ' OD2' ' A' ' 51' ' ' ASP . 8.0 ptt180 -139.03 155.66 72.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.02 -176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 1.88 2.41 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.538 2.159 . . . . 0.0 112.897 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.73 -14.74 24.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.33 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.514 ' HB2' HG12 ' A' ' 46' ' ' VAL . 65.1 m-20 -77.32 -19.34 56.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.12 117.53 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.006 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 30.7 p -121.57 175.45 6.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.852 175.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.9 71.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -62.31 -45.39 93.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.133 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.53 -30.71 68.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.003 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 53' ' ' THR . 90.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.356 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -65.27 -38.3 89.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -68.46 -42.58 78.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.376 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.4 ' HB2' ' CZ2' ' A' ' 44' ' ' TRP . . . -65.38 -26.39 67.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.562 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' A' ' 63' ' ' LEU . . . -73.74 -12.88 60.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.022 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.57 28.41 73.17 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.603 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 61' ' ' ALA . 91.4 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 120.495 0.188 . . . . 0.0 111.268 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.482 ' HB3' HG22 ' A' ' 141' ' ' VAL . 9.1 Cg_endo -51.29 111.7 0.63 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.841 2.361 . . . . 0.0 111.985 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 3.9 tt0 -69.5 -32.47 71.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.69 HG12 HD11 ' A' ' 133' ' ' LEU . 3.3 p -136.01 131.31 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.456 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -112.96 121.19 43.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.866 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.5 mt -101.2 104.55 15.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.284 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.865 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -105.69 114.31 4.5 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -76.11 -20.97 57.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 -58.4 4.79 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.402 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -81.17 -55.31 4.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.744 0.307 . . . . 0.0 110.565 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -159.89 143.45 14.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -52.66 114.61 1.45 Allowed 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.118 0.886 . . . . 0.0 112.113 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -96.85 111.85 23.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.21 98.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.814 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.07 134.26 40.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 108' ' ' VAL . . . -106.04 175.27 21.26 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.735 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 74.3 Cg_exo -49.63 -34.61 35.25 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.351 2.7 . . . . 0.0 112.542 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -49.47 -43.66 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.283 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -96.01 -37.9 10.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.185 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 104' ' ' GLY . 35.0 m -91.42 -14.36 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -171.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 1.1 tmt_? -57.33 -44.7 99.78 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -47.45 -32.08 14.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.3 2.0 . . . . 0.0 113.188 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 93.7 mt -92.33 -36.24 13.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.679 0.276 . . . . 0.0 110.785 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 87.2 mt -58.49 -36.7 74.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.02 68.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.16 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.87 -12.18 45.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.65 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.14 14.69 38.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.029 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.1 t -86.99 107.82 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 0.0 110.659 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.77 111.33 3.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.605 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.12 124.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 111.487 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -102.86 129.11 49.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.193 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.01 102.5 13.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 0.0 110.495 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.536 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.8 mtm -140.43 -171.77 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -105.42 172.13 6.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.508 HG23 HD21 ' A' ' 144' ' ' LEU . 88.5 m -52.29 -48.52 65.3 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.586 0.554 . . . . 0.0 112.345 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -62.37 -50.01 73.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.99 85.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.711 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.91 75.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.41 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.408 ' O ' HG13 ' A' ' 132' ' ' ILE . 47.0 mtt180 -59.82 -48.07 83.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.835 0.35 . . . . 0.0 111.117 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -66.25 -36.73 83.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -60.45 -45.39 93.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.528 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -58.56 -40.32 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.4 mt -62.11 -54.63 31.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.723 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.69 HD11 HG12 ' A' ' 91' ' ' VAL . 74.3 mt -66.95 -32.28 73.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.365 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.457 ' HG2' HD13 ' A' ' 11' ' ' LEU . 54.2 ttp -72.74 -36.88 67.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.36 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.48 80.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.073 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.51 -36.97 74.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.32 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.04 41.79 5.79 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.482 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -111.77 153.62 26.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 90' ' ' GLU . 19.9 mmt180 -63.52 97.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 111.307 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.66 136.25 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.305 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 36' ' ' ALA . 37.5 t -123.83 133.51 69.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.4 p -116.43 130.53 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.254 0.55 . . . . 0.0 111.068 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.16 112.41 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.508 HD21 HG23 ' A' ' 123' ' ' THR . 77.2 mt -103.31 139.55 38.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.556 HD21 ' HD2' ' A' ' 146' ' ' PRO . 2.2 tt -122.86 132.41 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.556 ' HD2' HD21 ' A' ' 145' ' ' LEU . 56.0 Cg_exo . . . . . 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.479 . . . . 0.0 112.216 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.566 0.222 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 61.62 87.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.417 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.3 m -107.32 118.79 37.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.088 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -69.16 100.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.701 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.44 -25.32 42.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.507 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 23' ' ' GLU . . . -155.88 149.67 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.741 176.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -87.0 -15.14 39.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.54 -161.87 48.13 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.294 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.05 87.03 2.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.29 60.89 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.673 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.53 148.36 17.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.8 mt -97.08 138.75 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 4.2 tm-20 -110.22 109.7 20.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 109.932 -175.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.67 111.22 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 m120 53.39 52.64 13.06 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.722 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 73.3 -0.02 3.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.172 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.14 122.64 64.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.476 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 53.7 mtm180 -97.0 111.26 23.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.498 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -93.53 117.75 30.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 m -88.35 -7.64 56.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.177 0.513 . . . . 0.0 110.008 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -116.07 161.62 18.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.181 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 145.5 55.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 110.733 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.03 147.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.919 0.39 . . . . 0.0 111.671 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -129.08 112.5 14.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.682 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.513 ' HB3' HG12 ' A' ' 41' ' ' VAL . 32.5 p90 -139.4 162.27 35.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.994 0.426 . . . . 0.0 111.813 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.51 ' HB3' HG21 ' A' ' 141' ' ' VAL . . . -139.36 156.56 71.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.136 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HD3' ' HE1' ' A' ' 130' ' ' TYR . 6.2 Cg_exo -78.66 9.56 3.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.121 2.547 . . . . 0.0 112.068 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -152.32 21.31 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.781 0.8 . . . . 0.0 108.997 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.14 -169.69 12.6 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.915 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -86.75 176.56 4.58 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.787 2.325 . . . . 0.0 112.612 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 35' ' ' PHE . 34.2 t -112.58 104.5 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.649 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.85 152.36 21.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.701 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 m -108.87 132.69 53.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.533 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -113.05 126.65 27.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.534 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 2.0 Cg_endo -83.37 9.74 3.97 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.218 2.612 . . . . 0.0 111.302 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 51' ' ' ASP . 41.5 t -86.8 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.508 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -120.98 -33.75 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.815 0.34 . . . . 0.0 111.383 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' HB2' ' OD2' ' A' ' 51' ' ' ASP . 69.6 mtp85 -108.03 147.66 35.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.973 0.416 . . . . 0.0 110.818 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HG3' ' O ' ' A' ' 96' ' ' THR . 12.7 Cg_exo -70.21 -6.01 17.82 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.047 2.498 . . . . 0.0 112.212 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.75 -19.68 24.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.321 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.552 ' HB2' HG12 ' A' ' 46' ' ' VAL . 30.1 m-20 -82.91 -20.21 35.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.13 116.94 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.825 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.1 p -113.48 169.51 8.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.371 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -60.27 -34.62 73.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m -59.1 -46.87 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.504 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.434 HD12 HG23 ' A' ' 46' ' ' VAL . 97.9 mt -66.93 -33.78 76.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.627 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.22 -40.9 97.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.8 mt-30 -62.95 -33.77 76.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.06 -43.74 56.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.32 66.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.746 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -21.98 66.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.86 94.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.331 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 111.309 -177.034 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.477 ' O ' HG21 ' A' ' 116' ' ' VAL . 53.9 Cg_exo -53.44 139.04 65.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.473 2.115 . . . . 0.0 112.06 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' OE1' ' HG3' ' A' ' 138' ' ' ARG . 37.3 tt0 -88.22 -36.89 16.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.036 0.446 . . . . 0.0 110.134 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.73 138.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.237 0.541 . . . . 0.0 111.258 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -114.92 118.77 34.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.661 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.07 119.46 39.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.202 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.58 121.74 59.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.838 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -96.81 106.31 3.33 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.507 ' HA ' HD13 ' A' ' 145' ' ' LEU . 12.6 p -83.5 13.35 4.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -171.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.09 -102.4 1.15 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.213 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 72.3 mtt-85 -62.99 -45.73 91.03 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -142.49 140.23 31.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.842 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.9 tt0 -66.17 96.73 0.35 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.144 0.497 . . . . 0.0 110.241 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -99.42 99.65 10.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.743 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.5 mt -60.57 137.83 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.05 -178.69 5.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.474 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 147.79 16.32 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.872 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.645 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 11.4 Cg_endo -55.17 -40.77 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.852 2.368 . . . . 0.0 112.113 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.17 -27.79 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.182 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -74.82 -37.51 62.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.986 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 34.5 m -92.13 -7.68 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 42.7 mtm180 -53.95 -49.18 91.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 66.6 Cg_exo -53.7 -39.36 83.75 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.103 1.869 . . . . 0.0 112.704 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 94.0 mt -78.13 -39.1 42.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.62 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 85.5 mt -62.39 -32.63 73.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.642 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.15 78.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.747 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 60.3 mtt -77.83 -38.86 45.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.041 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.09 3.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 31.0 t -90.43 115.8 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.53 0.205 . . . . 0.0 110.539 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.03 132.26 10.96 Favored Glycine 0 C--O 1.224 -0.531 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.02 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.63 123.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 117.318 0.559 . . . . 0.0 111.115 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.69 131.75 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.501 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.15 128.68 51.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.842 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 71.7 mtm -144.96 -171.82 3.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.3 156.25 34.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.447 HG22 HD23 ' A' ' 144' ' ' LEU . 40.4 m -57.91 -43.75 86.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.916 0.389 . . . . 0.0 110.927 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.51 -40.65 80.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.71 89.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 110.966 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.4 -47.36 76.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.51 96.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' HG13 ' A' ' 132' ' ' ILE . 42.4 ttm180 -63.4 -50.15 70.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.69 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -63.32 -35.85 81.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.432 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.592 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 50.9 t80 -57.73 -44.99 86.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.761 175.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -64.14 -39.26 93.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.2 mt -64.18 -50.23 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.747 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.85 -26.04 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.799 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 36.8 ttm -61.88 -50.42 72.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.068 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.491 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.88 -44.37 97.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.59 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 105.42 33.33 3.67 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.061 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 138' ' ' ARG . 17.0 ttm180 -100.05 144.98 28.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -70.46 79.62 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.987 0.422 . . . . 0.0 110.879 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.31 128.54 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.924 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 36' ' ' ALA . 25.9 t -113.11 131.57 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.8 p -115.67 131.64 67.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.57 111.34 22.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.395 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 123' ' ' THR . 98.9 mt -107.05 120.83 43.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.738 0.304 . . . . 0.0 111.672 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 96' ' ' THR . 94.8 mt -93.93 126.0 50.84 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.699 172.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.234 0.303 0 C-N-CA 122.611 2.208 . . . . 0.0 112.426 179.084 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--O 1.235 0.308 0 CA-C-O 120.972 0.415 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 34.8 t30 -74.6 125.6 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.018 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -154.48 142.77 20.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.831 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.98 112.5 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.231 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 p -74.23 -32.8 63.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.296 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 23' ' ' GLU . . . -131.19 92.13 3.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.761 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' HE2' ' HG2' ' A' ' 124' ' ' GLN . 71.0 t80 -104.61 -3.22 24.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.377 0.608 . . . . 0.0 109.904 175.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.32 -23.71 70.24 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.927 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.98 -175.58 4.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 111.152 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.48 14.69 60.57 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.523 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.445 ' CE1' ' HD2' ' A' ' 28' ' ' ARG . 27.4 p90 -148.97 173.35 13.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.75 108.19 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 0.0 111.091 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 45.7 tt0 -93.5 112.5 24.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.133 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.4 95.92 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.887 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 m120 64.63 -77.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.757 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -119.09 -28.11 5.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.074 -176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.39 127.7 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -173.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 23.3 mtm180 -98.52 109.68 22.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.277 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -91.2 131.71 36.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -101.9 14.51 31.75 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.561 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -148.98 179.06 8.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.821 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.81 139.9 58.36 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.551 0.532 . . . . 0.0 111.25 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 pt -145.1 156.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.305 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.56 130.6 50.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.251 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.56 ' HB3' HG11 ' A' ' 41' ' ' VAL . 36.5 p90 -150.43 154.86 38.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.367 0.603 . . . . 0.0 112.06 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -119.17 164.56 20.68 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.531 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 26.4 Cg_exo -63.32 -42.37 22.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.413 2.075 . . . . 0.0 111.607 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.75 101.55 7.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.23 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.78 -157.55 27.67 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.297 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -93.39 163.81 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.285 2.656 . . . . 0.0 113.197 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.56 HG11 ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -114.15 116.67 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.46 145.92 41.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.341 . . . . 0.0 111.419 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -79.07 128.73 33.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.606 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.445 ' C ' ' H ' ' A' ' 46' ' ' VAL . 1.7 t90 -98.32 116.97 65.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 12.8 Cg_exo -71.56 33.93 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.503 2.802 . . . . 0.0 112.888 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 51' ' ' ASP . 94.2 t -114.68 125.44 72.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.534 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.12 -49.42 4.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.176 0.512 . . . . 0.0 110.894 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -107.88 150.91 40.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 14.7 Cg_endo -59.63 -19.78 54.68 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.336 2.024 . . . . 0.0 111.796 174.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.26 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.296 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.537 ' HB2' HG13 ' A' ' 46' ' ' VAL . 11.8 m-20 -68.73 -28.4 66.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.805 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -54.44 115.06 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.608 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -121.95 159.77 26.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.874 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 107' ' ' GLN . . . -52.84 -44.32 66.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -63.16 -35.8 81.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.226 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.445 HD13 HG23 ' A' ' 46' ' ' VAL . 49.9 mt -69.57 -31.83 70.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.36 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.79 -35.46 80.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.182 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.342 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -70.66 -39.37 73.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.452 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.44 ' HB1' ' CE2' ' A' ' 44' ' ' TRP . . . -69.68 -23.85 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.853 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -81.43 -7.36 59.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.957 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.55 37.83 85.67 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.388 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' A' ' 61' ' ' ALA . 97.1 mt . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 111.527 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.437 ' HG2' ' HB1' ' A' ' 61' ' ' ALA . 50.2 Cg_exo -56.4 127.8 27.46 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.884 2.39 . . . . 0.0 112.686 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -64.24 -46.87 81.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.448 0.642 . . . . 0.0 109.528 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.79 132.07 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.876 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.493 ' HB3' HG23 ' A' ' 118' ' ' VAL . 57.3 tp -114.26 117.38 30.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.96 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.1 mt -101.51 117.03 34.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.336 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.2 t -104.05 110.32 29.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.444 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.08 96.84 2.17 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.597 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 33.4 p -80.87 -13.63 58.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.776 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.69 -101.52 1.42 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.751 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -62.85 -58.49 7.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.345 . . . . 0.0 111.336 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.4 mmt-85 -109.2 122.33 47.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.992 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.597 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 53.3 tt0 -74.51 97.19 3.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.441 ' HB3' HG21 ' A' ' 96' ' ' THR . 40.1 t-80 -73.6 104.82 4.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.862 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.63 142.26 53.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.442 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -93.16 160.22 14.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.852 0.358 . . . . 0.0 110.617 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.79 162.36 14.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.609 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.27 -49.52 16.06 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.74 2.293 . . . . 0.0 112.253 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -62.48 -25.79 68.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.568 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 93.7 mt-30 -76.78 -34.35 57.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.775 0.322 . . . . 0.0 111.316 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.8 -11.57 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.609 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 68.0 mtm180 -52.34 -55.26 33.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 23.0 Cg_endo -61.19 -35.4 85.85 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.038 1.826 . . . . 0.0 113.006 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.4 mt -80.77 -37.85 29.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.0 111.179 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.6 mt -69.26 -23.89 63.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.318 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.72 68.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.445 175.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 62.4 mtt -88.46 -35.85 16.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.29 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.55 14.51 5.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.289 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.1 t -85.32 108.44 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.694 0.283 . . . . 0.0 110.568 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.46 94.72 1.73 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.969 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 92' ' ' LEU . 39.9 t -88.6 129.88 38.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 0.0 111.213 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -126.73 139.89 52.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.124 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.4 128.23 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.7 mtt -140.31 -173.38 3.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.224 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -91.84 168.31 11.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.4 m -59.49 -35.76 74.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 111.761 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.579 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 7.1 tm0? -75.84 -52.46 10.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.62 98.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.535 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.43 87.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.83 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.11 78.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -73.66 -45.49 52.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.639 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -63.04 -35.75 81.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.128 0.49 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -54.01 -46.25 71.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.948 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -63.34 -41.57 98.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.836 0.35 . . . . 0.0 110.814 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.0 mt -64.02 -47.4 90.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.793 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.94 -27.62 66.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.004 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 56.3 ttp -65.58 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.041 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.01 -26.66 61.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.34 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -67.31 -35.8 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.452 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.2 9.72 55.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.91 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -87.85 155.5 19.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -82.78 87.13 6.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.473 0.654 . . . . 0.0 111.09 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -103.66 132.88 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.757 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.412 HG21 ' HB1' ' A' ' 36' ' ' ALA . 57.6 t -120.3 136.13 58.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.1 p -121.57 135.81 60.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.313 0.577 . . . . 0.0 111.232 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.08 119.85 36.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.115 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.7 mt -110.17 125.31 52.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.971 0.415 . . . . 0.0 111.616 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 96' ' ' THR . 95.5 mt -104.09 153.63 38.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.073 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 122.922 2.415 . . . . 0.0 112.011 176.623 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -64.75 102.12 0.55 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 0.0 110.365 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -110.03 146.09 35.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.764 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 17' ' ' TYR . 47.9 t -68.32 109.73 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -44.49 61.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.573 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -139.35 116.87 11.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.244 0.545 . . . . 0.0 111.377 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' HB2' HG11 ' A' ' 14' ' ' VAL . 89.5 t80 -136.5 142.29 43.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.072 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.81 -90.02 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -144.41 137.14 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.02 -91.17 0.79 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.341 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -111.81 177.71 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.701 0.286 . . . . 0.0 110.951 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.5 mt -128.92 136.31 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -114.82 120.56 40.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.144 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.72 117.62 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 64.36 49.72 2.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.507 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 68.25 18.55 9.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.173 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -128.61 121.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.4 mtm-85 -88.42 110.87 21.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.639 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -90.91 114.7 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.017 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.2 m -92.99 29.01 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.304 0.573 . . . . 0.0 110.179 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -152.51 167.97 27.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.533 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.43 147.53 52.49 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.384 0.428 . . . . 0.0 111.233 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -140.74 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.074 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.72 123.08 25.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.46 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 45.2 p90 -152.36 162.19 41.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.35 0.595 . . . . 0.0 111.956 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.94 155.05 58.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.571 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.91 -57.65 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.678 2.252 . . . . 0.0 111.987 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.35 27.68 3.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.5 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.65 -172.57 13.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.273 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -87.05 173.39 5.85 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.823 2.349 . . . . 0.0 112.593 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.502 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -109.1 113.79 45.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.983 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.5 133.57 50.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.036 0.446 . . . . 0.0 111.158 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m -76.44 124.16 27.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.165 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.46 126.27 40.03 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 0.9 OUTLIER -83.43 8.63 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.46 2.773 . . . . 0.0 113.111 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.09 135.82 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -120.69 -48.83 2.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.106 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.553 HH11 ' HG2' ' A' ' 48' ' ' ARG . 24.3 mtt-85 -93.37 139.89 23.06 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.449 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.85 -10.29 27.8 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.185 2.59 . . . . 0.0 112.494 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.21 5.0 52.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.443 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 1.2 m-20 -109.7 0.24 18.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.36 127.01 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -135.14 156.9 48.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.25 62.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -57.56 -37.73 73.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.272 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.464 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.31 -34.79 63.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.541 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.17 -41.82 98.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.95 -41.48 86.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.82 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.66 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.347 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.492 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -79.88 -4.57 52.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.141 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.52 17.7 77.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.55 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 88' ' ' ALA . 96.4 mt . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.967 0.413 . . . . 0.0 110.697 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.408 ' HA ' HD23 ' A' ' 63' ' ' LEU . . . . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.492 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 70.0 Cg_exo -52.28 137.37 55.68 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.559 2.173 . . . . 0.0 112.159 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -68.91 -41.47 78.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.78 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.466 HG13 HD11 ' A' ' 133' ' ' LEU . 3.6 p -140.71 137.75 35.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 118' ' ' VAL . 58.9 tp -122.16 118.62 29.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.58 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.416 HD13 HD12 ' A' ' 133' ' ' LEU . 89.3 mt -98.49 119.04 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.388 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.1 t -109.85 114.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.385 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.51 106.69 3.08 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.0 p -76.16 -30.88 58.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.53 -61.84 2.36 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.164 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -73.18 -75.14 0.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.326 0.584 . . . . 0.0 110.89 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -134.36 137.05 43.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.084 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -73.73 109.32 7.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.881 0.372 . . . . 0.0 111.218 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -72.7 108.01 5.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.5 108.79 3.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.04 141.41 58.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.404 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.36 150.78 16.91 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.7 -19.34 60.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.013 2.475 . . . . 0.0 112.699 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 mt-10 -94.91 -14.43 24.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.231 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -86.27 -40.76 15.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 111' ' ' LEU . 3.7 t -96.21 13.61 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.638 0.732 . . . . 0.0 109.654 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.44 ' HB2' ' HA ' ' A' ' 106' ' ' GLU . 56.1 ttt85 -49.83 -54.81 28.34 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.16 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.17 -33.51 49.31 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.692 1.595 . . . . 0.0 112.325 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.429 ' HB2' HG11 ' A' ' 108' ' ' VAL . 88.9 mt -73.34 -46.44 49.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.66 -33.98 76.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.17 -32.67 74.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 73.8 mtm -81.75 -25.07 35.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.659 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.23 22.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.449 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.53 107.73 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 110.697 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.67 96.15 1.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.781 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 92' ' ' LEU . 46.5 t -89.33 118.83 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.811 0.339 . . . . 0.0 110.717 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -107.07 108.4 19.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.66 106.01 17.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 110.267 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.2 mtm -136.34 -171.68 2.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.032 0.444 . . . . 0.0 110.791 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 125' ' ' ALA . 1.9 m-20 -66.76 158.92 29.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.399 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -63.07 -42.44 99.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.221 0.534 . . . . 0.0 109.917 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.535 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 53.1 tt0 -66.23 -42.7 88.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.441 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.401 ' H ' ' HB2' ' A' ' 122' ' ' ASP . . . -63.68 -44.15 94.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.99 96.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.938 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.37 93.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 124' ' ' GLN . 63.0 mtm180 -62.77 -48.38 79.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.9 m -62.99 -34.01 76.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.787 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -62.69 -44.74 95.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.369 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.406 ' HA ' ' HG2' ' A' ' 134' ' ' MET . 90.6 m-20 -65.84 -28.15 68.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.714 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 128' ' ' ARG . 81.3 mt -72.16 -50.74 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.516 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.466 HD11 HG13 ' A' ' 91' ' ' VAL . 98.0 mt -67.51 -34.97 78.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.804 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.406 ' HG2' ' HA ' ' A' ' 131' ' ' ASN . 19.0 ptp -67.84 -29.94 69.21 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.418 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.71 -26.69 40.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.59 -39.79 57.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.532 . . . . 0.0 109.903 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 30.84 5.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.821 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -100.92 148.26 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -71.11 99.83 1.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.031 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.56 140.56 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.107 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.67 142.64 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 7.2 p -120.83 139.52 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.187 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -126.55 115.04 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -116.24 135.39 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.2 mt -109.21 99.67 37.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--O 1.233 0.257 0 C-N-CA 122.337 2.025 . . . . 0.0 111.496 176.805 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.866 0.365 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.95 113.97 24.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.13 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -116.3 143.13 45.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.646 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.91 115.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -87.26 -46.31 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.147 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.71 138.54 19.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.721 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -156.69 104.61 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.88 -29.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.841 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 23.1 m-20 -73.45 -29.26 62.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.018 0.437 . . . . 0.0 111.057 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.59 -12.53 4.28 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.5 p90 -111.92 154.9 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.35 111.37 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -94.17 112.94 24.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.038 0.447 . . . . 0.0 110.387 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.72 110.61 28.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.462 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 62.54 45.33 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.546 . . . . 0.0 109.965 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 73.73 -6.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.047 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.05 117.86 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -91.25 102.36 15.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.368 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.89 127.19 35.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.771 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -104.97 17.36 24.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -116.62 172.39 7.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HB3' HD22 ' A' ' 145' ' ' LEU . . . -74.31 137.35 42.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 164.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 pt -134.99 144.87 33.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.413 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.74 125.67 38.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 44.7 p90 -149.08 162.58 39.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.075 0.464 . . . . 0.0 111.326 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.491 ' HB3' HG23 ' A' ' 141' ' ' VAL . . . -139.75 163.28 45.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.699 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.72 -36.93 34.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.72 2.28 . . . . 0.0 112.946 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -124.85 32.7 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.053 0.454 . . . . 0.0 110.521 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.31 16.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.873 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.83 147.32 80.63 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.687 2.258 . . . . 0.0 111.502 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 26.1 t -80.24 88.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.1 124.57 29.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.377 -174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.7 m -82.05 121.89 27.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.6 ' HZ2' ' HB3' ' A' ' 56' ' ' LEU . 1.2 t90 -103.79 121.76 46.97 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.57 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.66 13.98 1.54 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.821 2.347 . . . . 0.0 112.951 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.442 HG22 HD12 ' A' ' 56' ' ' LEU . 48.5 t -95.79 112.82 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.47 -29.34 18.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -113.54 126.33 28.29 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.463 -173.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.16 -1.53 4.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.995 2.463 . . . . 0.0 113.209 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.14 -15.09 23.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -84.32 -7.81 59.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.015 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 56' ' ' LEU . 60.1 mt -69.62 130.44 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.501 -175.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.2 p -111.25 179.77 3.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.702 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -68.33 -35.08 77.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 m -65.11 -41.72 94.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.49 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.6 ' HB3' ' HZ2' ' A' ' 44' ' ' TRP . 61.7 mt -65.17 -36.57 84.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.071 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.49 ' HB3' HD13 ' A' ' 111' ' ' LEU . 72.1 mt -63.09 -37.32 86.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.709 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 96.6 mt-30 -65.97 -40.69 91.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.83 -40.66 88.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.813 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.34 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.45 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HB3' HD22 ' A' ' 92' ' ' LEU . . . -82.33 -2.02 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.87 72.74 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.349 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.431 HD12 ' SD ' ' A' ' 114' ' ' MET . 96.4 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 121.82 0.819 . . . . 0.0 110.758 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.224 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.59 123.77 14.66 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.746 2.297 . . . . 0.0 112.296 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 50.6 mt-10 -65.11 -50.62 65.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.63 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.474 HG12 HG21 ' A' ' 140' ' ' VAL . 4.2 p -135.02 130.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.382 0.611 . . . . 0.0 111.47 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 61' ' ' ALA . 65.2 tp -107.52 113.28 26.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.521 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 119' ' ' GLU . 95.9 mt -93.19 98.11 11.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.539 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -91.6 105.72 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -84.27 108.82 3.15 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 175.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.0 p -62.62 -17.44 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.614 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 65.5 -92.2 0.15 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.853 171.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.22 -51.25 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.711 0.405 . . . . 0.0 111.638 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -144.66 134.26 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -70.04 112.03 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.813 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -113.06 147.43 37.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.255 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.68 106.86 18.84 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.7 169.79 12.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.14 147.96 16.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.728 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.525 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 51.1 Cg_exo -57.15 -24.59 59.5 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.354 2.703 . . . . 0.0 112.601 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -56.16 -31.97 63.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.223 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -89.28 -23.43 22.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.825 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 105' ' ' PRO . 20.2 m -93.68 -21.57 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.536 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 57.5 mtm-85 -53.94 -49.36 90.0 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 11.7 Cg_endo -55.72 -34.52 91.03 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.982 1.788 . . . . 0.0 112.754 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 62.5 mt -81.57 -37.5 27.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.736 0.303 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.1 mt -64.69 -32.67 74.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.924 0.392 . . . . 0.0 110.584 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.72 -10.26 59.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.431 ' SD ' HD12 ' A' ' 63' ' ' LEU . 67.1 mtt -97.05 -43.82 7.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.257 0.551 . . . . 0.0 109.737 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.02 10.71 2.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.208 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.66 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 39.7 t -98.5 125.99 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 110.475 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.23 124.51 8.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.71 115.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.646 0.26 . . . . 0.0 110.994 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.442 ' HB2' HD22 ' A' ' 93' ' ' LEU . 27.1 mm-40 -112.35 127.97 56.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.856 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.29 104.91 14.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.502 ' HB3' ' HB3' ' A' ' 126' ' ' ALA . 36.9 ttm -129.78 168.73 16.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.323 -169.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.13 155.67 27.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.915 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.614 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -54.37 -52.4 61.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.861 -177.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -77.65 -37.96 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.426 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.26 91.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.091 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 121' ' ' MET . . . -65.92 -44.29 85.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.729 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.05 93.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.702 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -64.5 -51.86 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.6 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.9 m -59.0 -36.97 75.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.92 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -57.99 -46.35 85.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.958 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -64.12 -37.24 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 110.592 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.65 -46.74 85.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.02 -24.11 64.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.4 ttm -64.97 -47.22 78.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.87 62.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.57 -11.76 59.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.061 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 70.14 32.64 69.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.815 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -100.78 150.38 22.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.745 0.307 . . . . 0.0 110.641 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.4 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 49.8 mtm180 -78.69 90.7 4.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.474 0.654 . . . . 0.0 110.94 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.474 HG21 HG12 ' A' ' 91' ' ' VAL . 6.0 p -123.4 137.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.587 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 36' ' ' ALA . 39.5 t -116.41 133.2 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.3 p -110.72 134.92 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.28 113.53 16.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.643 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -110.41 129.36 55.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.782 0.325 . . . . 0.0 111.197 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.553 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 69.6 mt -103.67 98.84 13.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.393 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.459 -0.516 0 C-N-CA 122.555 2.17 . . . . 0.0 112.225 179.466 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 37' ' ' PRO . 88.0 mt . . . . . 0 C--O 1.234 0.283 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -152.94 127.25 9.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.747 0.308 . . . . 0.0 110.355 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.679 ' HG1' ' HE2' ' A' ' 134' ' ' MET . 23.4 m -110.9 141.01 44.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -175.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -68.19 115.59 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -49.09 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.94 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -134.66 129.48 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.234 0.54 . . . . 0.0 111.817 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HE1' HG21 ' A' ' 123' ' ' THR . 85.0 t80 -104.14 102.57 12.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.49 175.2 47.38 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.784 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -81.19 -21.46 39.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.042 0.449 . . . . 0.0 110.64 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.63 -39.68 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.35 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -124.23 170.5 10.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.98 133.42 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -113.99 120.88 42.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.924 0.393 . . . . 0.0 110.035 -177.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -124.58 110.73 25.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.436 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 61.6 51.27 4.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.63 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 68.85 14.25 8.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.283 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.0 108.89 26.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -83.05 119.37 24.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.188 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -98.6 107.61 20.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.401 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -89.61 14.08 12.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.865 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -140.9 161.5 37.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.589 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -58.72 142.79 48.89 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.586 0.554 . . . . 0.0 111.097 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 pt -136.41 139.78 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.362 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -133.19 109.72 9.64 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.495 ' HB3' HG13 ' A' ' 41' ' ' VAL . 42.8 p90 -146.83 161.01 41.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.486 0.66 . . . . 0.0 112.24 -170.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.501 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -109.48 154.81 42.1 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.565 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 11' ' ' LEU . 54.0 Cg_endo -70.14 -5.71 17.09 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.145 1.896 . . . . 0.0 111.891 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -92.15 17.14 9.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.004 -170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.95 -99.74 0.34 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.298 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.82 134.59 65.46 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.681 2.921 . . . . 0.0 114.658 -170.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 35' ' ' PHE . 96.3 t -113.69 119.95 62.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 157.61 16.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 m -124.52 148.14 47.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -115.92 139.54 25.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.983 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.11 23.98 0.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.195 2.597 . . . . 0.0 110.499 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 51' ' ' ASP . 93.3 t -85.9 130.25 36.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.572 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -113.14 -40.98 3.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -106.01 145.62 31.29 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 28.1 Cg_endo -64.32 -8.82 17.83 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.791 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.12 -12.71 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.56 ' HB2' HG13 ' A' ' 46' ' ' VAL . 73.4 m-20 -81.13 -16.42 53.07 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.46 114.57 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.758 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -111.47 155.44 23.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.846 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 107' ' ' GLN . . . -52.17 -38.96 59.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.758 0.313 . . . . 0.0 111.318 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m -57.46 -43.82 84.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.997 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.67 -32.8 72.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.21 -35.77 81.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -69.65 -33.16 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 110.394 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.23 -44.78 78.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.886 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 141' ' ' VAL . . . -64.01 -35.22 80.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.276 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.98 62.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.316 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.53 40.4 59.58 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.364 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.714 0.769 . . . . 0.0 110.668 -179.113 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.959 0.409 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.83 173.56 14.22 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.61 2.206 . . . . 0.0 111.715 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' OE2' ' HD2' ' A' ' 138' ' ' ARG . 34.1 tt0 -90.58 -38.71 12.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.347 0.594 . . . . 0.0 109.762 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.8 HG12 HD23 ' A' ' 133' ' ' LEU . 3.3 p -139.59 142.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.284 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.3 tp -118.84 118.12 30.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.487 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.56 115.07 29.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.383 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.8 t -107.0 115.05 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.808 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.66 105.25 3.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 49' ' ' PRO . 19.8 p -77.08 4.42 10.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -171.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 74.07 -91.12 0.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.338 -0.458 . . . . 0.0 114.228 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.527 ' C ' ' HD2' ' A' ' 99' ' ' ARG . 52.9 mtt-85 -67.83 -60.93 2.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.967 0.413 . . . . 0.0 111.077 -171.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.527 ' HD2' ' C ' ' A' ' 98' ' ' ARG . 3.4 mpt_? -129.41 148.34 51.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.9 99.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 109.841 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.741 ' HD2' HD22 ' A' ' 103' ' ' LEU . 47.8 t60 -92.34 118.43 30.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.606 -174.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.71 110.59 4.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.231 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.741 HD22 ' HD2' ' A' ' 101' ' ' HIS . 67.1 mt -77.48 151.98 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 161.84 14.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.23 -170.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.73 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 46.9 Cg_endo -68.41 -1.24 6.99 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.238 2.625 . . . . 0.0 112.721 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -89.09 -23.0 22.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.39 0.614 . . . . 0.0 109.871 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 77.5 mt-30 -94.63 -47.89 6.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.507 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 m -86.13 -1.02 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.739 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 18.3 ttm180 -56.19 -56.02 35.65 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 41.9 Cg_exo -57.82 -39.72 84.71 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.923 1.749 . . . . 0.0 112.365 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.8 mt -74.09 -40.98 62.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.7 tp -60.86 -36.47 79.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.531 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.24 -27.67 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.998 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.04 -9.38 59.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.15 0.5 . . . . 0.0 110.102 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.83 -0.44 55.21 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.273 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 40.8 t -79.63 103.3 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.817 0.342 . . . . 0.0 110.361 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.45 101.74 1.3 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.921 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -88.74 110.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.701 0.286 . . . . 0.0 110.588 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -110.76 135.82 50.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.18 124.9 50.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.071 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.02 -171.83 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.72 164.88 19.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.468 HG21 ' HE1' ' A' ' 17' ' ' TYR . 21.1 m -64.19 -34.09 77.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.066 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.41 -47.38 27.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.589 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.28 86.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.695 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.801 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.89 -45.58 93.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.919 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.06 -51.29 70.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.716 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.5 m -62.19 -39.28 92.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.725 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -57.1 -49.74 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.242 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.51 -44.9 95.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -68.33 -44.28 83.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 110.925 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.8 HD23 HG12 ' A' ' 91' ' ' VAL . 23.5 tp -66.63 -37.32 84.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.866 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.679 ' HE2' ' HG1' ' A' ' 13' ' ' THR . 33.4 ttp -63.35 -37.18 86.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.446 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.49 -29.1 69.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.46 -34.95 78.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 0.0 110.26 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.05 29.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.445 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.497 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 55.8 mtm180 -97.86 137.03 37.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 122.763 -0.257 . . . . 0.0 110.452 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -65.38 110.51 2.67 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.429 0.633 . . . . 0.0 111.319 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG23 HD21 ' A' ' 133' ' ' LEU . 5.4 p -130.03 135.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 60' ' ' ALA . 47.0 t -109.52 140.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -122.23 132.93 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.129 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.42 113.97 24.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.343 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.466 HD22 HG23 ' A' ' 123' ' ' THR . 94.2 mt -114.95 125.19 53.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.942 0.401 . . . . 0.0 111.503 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 96' ' ' THR . 97.8 mt -97.76 119.55 62.22 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.213 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 27.6 Cg_endo . . . . . 0 N--CA 1.453 -0.869 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.961 0.41 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.27 108.22 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.261 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -111.79 146.7 37.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.186 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.93 125.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -84.15 -46.15 12.22 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 153.09 30.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.516 . . . . 0.0 112.257 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.43 123.54 35.81 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.77 -8.68 60.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.601 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.92 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.636 0.731 . . . . 0.0 110.11 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.9 -19.3 28.1 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -153.21 157.23 39.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.84 133.08 58.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -101.53 122.05 43.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.894 0.378 . . . . 0.0 110.352 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -121.83 96.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.65 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.39 56.12 2.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.087 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 71.26 -8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.079 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.89 117.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -98.14 103.07 14.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.823 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -89.32 114.01 25.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.461 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -89.91 25.44 2.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.22 0.533 . . . . 0.0 110.517 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -147.22 166.48 26.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.057 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB3' HD21 ' A' ' 145' ' ' LEU . . . -66.82 140.3 57.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.314 0.384 . . . . 0.0 110.696 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 pt -135.93 144.85 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.997 0.427 . . . . 0.0 111.516 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.63 112.05 17.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.29 176.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.466 ' HB3' HG13 ' A' ' 41' ' ' VAL . 41.5 p90 -138.28 156.64 47.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.228 0.537 . . . . 0.0 111.797 -173.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.519 ' HA ' ' HH ' ' A' ' 130' ' ' TYR . . . -139.47 157.18 70.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.816 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HD3' ' OH ' ' A' ' 130' ' ' TYR . 24.0 Cg_exo -64.12 -42.33 18.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.383 2.056 . . . . 0.0 110.881 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -106.52 82.45 1.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.546 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.41 -171.17 38.21 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.247 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -92.4 178.62 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.151 2.568 . . . . 0.0 112.934 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 35' ' ' PHE . 47.0 t -114.21 105.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 145.4 24.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.962 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -101.6 129.34 47.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.18 114.15 64.81 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.456 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 39.87 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.387 2.725 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.15 132.0 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.119 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -114.19 -25.41 8.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 110.645 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -114.64 128.37 25.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.731 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.1 -9.37 25.55 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.934 2.423 . . . . 0.0 112.954 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -3.89 55.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.603 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -86.75 -14.69 41.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.544 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.489 HD13 HD13 ' A' ' 145' ' ' LEU . 67.3 mt -58.82 110.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.968 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -133.54 179.18 6.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.29 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -41.98 71.97 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.208 0.317 . . . . 0.0 111.611 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -56.3 -46.0 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.08 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 52' ' ' ILE . 90.8 mt -73.15 -37.15 66.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.91 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -40.46 96.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -66.97 -37.52 84.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.585 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.88 -42.34 99.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.91 -26.98 66.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.242 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.41 -6.38 55.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.244 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.26 59.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.525 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 -177.157 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.618 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 88' ' ' ALA . 15.1 Cg_endo -57.67 142.25 95.76 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.563 2.175 . . . . 0.0 112.476 176.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.673 ' HG3' ' HB3' ' A' ' 139' ' ' ARG . 34.4 mt-10 -71.05 -40.45 71.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.409 0.624 . . . . 0.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 140' ' ' VAL . 4.8 p -138.63 136.63 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.688 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.493 ' HB3' HG21 ' A' ' 118' ' ' VAL . 54.8 tp -116.05 116.66 28.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.577 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.44 124.07 47.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.687 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.84 126.19 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.742 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' A' ' 144' ' ' LEU . . . -108.88 112.95 3.61 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.528 ' HA ' HD12 ' A' ' 145' ' ' LEU . 21.2 p -81.62 -61.38 1.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 122' ' ' ASP . . . 84.92 -22.01 10.32 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.498 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.402 HH21 ' HB2' ' A' ' 146' ' ' PRO . 52.1 mtt180 -113.09 -64.86 1.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 110.084 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -139.73 126.41 20.57 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.485 ' HA ' HG21 ' A' ' 96' ' ' THR . 27.9 mt-30 -70.37 94.98 0.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.165 0.507 . . . . 0.0 110.898 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -73.18 120.12 18.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.553 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.66 119.52 15.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.693 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.9 mt -73.49 139.74 45.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.99 159.01 15.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.205 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.671 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 58.3 Cg_exo -51.86 -41.11 64.72 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.185 2.59 . . . . 0.0 112.04 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.425 ' CD ' HH22 ' A' ' 109' ' ' ARG . 31.1 tp10 -52.51 -28.67 21.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.42 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.23 -42.76 8.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.512 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -87.26 -11.34 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.671 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 27.7 mtm-85 -50.9 -53.99 41.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.542 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.01 -37.47 93.82 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.991 1.794 . . . . 0.0 112.781 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 118' ' ' VAL . 98.1 mt -79.73 -34.84 39.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.879 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.72 -34.09 75.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.32 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.88 78.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.43 -41.42 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.367 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.03 15.68 7.72 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.371 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.93 117.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.18 102.9 1.86 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.826 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 92' ' ' LEU . 41.3 t -102.89 121.73 54.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.18 140.29 52.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.449 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -114.39 125.89 54.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 111.437 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.463 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.8 mtm -144.61 177.31 8.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.429 ' HA ' ' H ' ' A' ' 97' ' ' GLY . 19.9 m-20 -72.38 154.46 40.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.746 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.494 HG22 HD22 ' A' ' 144' ' ' LEU . 28.7 m -47.65 -53.31 15.24 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.846 0.717 . . . . 0.0 112.61 -174.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.48 -46.27 89.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 0.0 111.605 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.45 79.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.272 -177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.03 76.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.35 84.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.324 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -59.35 -51.06 71.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 109.958 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 -36.29 83.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.499 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' HH ' ' HA ' ' A' ' 36' ' ' ALA . 87.7 t80 -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.748 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -60.06 -41.24 91.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.319 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.94 -48.28 89.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.73 -31.19 72.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.025 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.7 ttp -64.59 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.265 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.91 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.822 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.417 ' OE1' ' HD2' ' A' ' 138' ' ' ARG . 38.4 tt0 -74.71 -22.07 59.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.911 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.05 27.48 49.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.34 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.417 ' HD2' ' OE1' ' A' ' 136' ' ' GLU . 15.7 ttt180 -87.33 149.14 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.249 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.673 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 48.3 ttt85 -79.9 85.15 5.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.483 0.658 . . . . 0.0 109.285 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.448 HG23 HG13 ' A' ' 91' ' ' VAL . 4.8 p -120.46 132.98 68.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.009 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 36' ' ' ALA . 40.0 t -115.24 134.21 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 9.9 p -117.71 130.82 72.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.35 106.06 14.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.562 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.494 HD22 HG22 ' A' ' 123' ' ' THR . 92.5 mt -106.4 128.5 54.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.639 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 96' ' ' THR . 78.2 mt -87.5 151.29 50.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.861 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.402 ' HB2' HH21 ' A' ' 98' ' ' ARG . 27.5 Cg_exo . . . . . 0 C--N 1.345 0.348 0 C-N-CA 122.557 2.171 . . . . 0.0 112.075 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -77.84 86.83 4.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.279 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 m -116.25 140.44 49.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 ' HA ' HG22 ' A' ' 24' ' ' VAL . 48.6 t -60.62 112.91 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -74.9 -53.33 9.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.517 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -140.34 157.12 46.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.153 0.501 . . . . 0.0 111.258 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -110.01 118.41 36.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.74 156.95 15.65 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.322 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.9 92.49 0.51 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.64 11.43 55.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.105 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -161.13 150.23 16.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.135 0.467 . . . . 0.0 111.159 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.6 mt -96.94 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -118.08 114.83 23.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.037 0.446 . . . . 0.0 110.151 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 14' ' ' VAL . 40.4 t -129.77 113.04 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.669 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 60.14 38.53 20.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.362 0.601 . . . . 0.0 110.298 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 68.59 17.43 8.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.014 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.91 112.85 36.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 28' ' ' ARG . 24.0 ttt85 -72.81 110.79 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.131 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -102.51 98.08 8.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.198 0.523 . . . . 0.0 110.638 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -99.83 28.9 4.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.269 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -148.03 156.4 42.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.45 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 44' ' ' TRP . . . -60.63 136.86 58.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.433 0.458 . . . . 0.0 111.386 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.2 pt -138.04 150.16 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.309 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -135.28 125.8 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.843 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -147.89 157.46 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.234 0.54 . . . . 0.0 111.789 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.482 ' HB3' HG23 ' A' ' 141' ' ' VAL . . . -132.19 155.35 81.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.244 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.58 -22.73 57.93 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.74 2.293 . . . . 0.0 112.538 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -116.53 22.71 12.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.59 0.71 . . . . 0.0 109.284 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.71 17.45 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.039 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -89.83 -171.41 0.5 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.083 2.522 . . . . 0.0 112.297 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -111.29 114.79 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.01 151.97 22.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.907 0.384 . . . . 0.0 111.191 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -91.41 126.3 36.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.245 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -101.34 119.78 56.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.113 -176.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.6 Cg_exo -78.79 22.63 0.65 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.439 2.759 . . . . 0.0 113.248 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 56' ' ' LEU . 88.5 t -91.77 132.18 36.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -105.53 -51.22 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.255 0.55 . . . . 0.0 110.939 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -116.89 138.92 25.11 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.148 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HB2' ' HB3' ' A' ' 101' ' ' HIS . 43.9 Cg_endo -67.19 -11.14 31.11 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.939 2.426 . . . . 0.0 112.832 -176.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.73 -15.42 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 63.9 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.654 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.96 100.21 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.974 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -89.04 159.42 17.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.51 68.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.93 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 m -60.06 -36.82 78.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.452 HD12 HG21 ' A' ' 46' ' ' VAL . 81.9 mt -67.75 -36.15 80.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.097 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.42 ' HB3' HD11 ' A' ' 111' ' ' LEU . 97.2 mt -68.2 -37.9 81.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.852 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.26 -39.62 91.04 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.023 0.439 . . . . 0.0 110.492 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -64.65 -40.72 95.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.722 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.86 -20.62 63.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.27 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.508 ' HB2' ' HG2' ' A' ' 89' ' ' PRO . . . -82.11 -5.82 58.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.5 15.29 81.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.699 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.947 0.403 . . . . 0.0 111.442 -177.121 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.536 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 88' ' ' ALA . 80.8 Cg_exo -47.46 124.9 10.03 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.497 2.132 . . . . 0.0 112.07 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 39.2 mt-10 -66.16 -45.47 80.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 140' ' ' VAL . 4.0 p -134.72 133.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.248 0.547 . . . . 0.0 111.278 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.38 121.97 42.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.618 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.2 mt -105.58 109.87 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.891 0.377 . . . . 0.0 110.495 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.49 121.74 45.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.18 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -93.3 106.76 3.45 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 24.8 p -59.98 -49.82 76.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.735 0.414 . . . . 0.0 111.915 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.28 -78.03 0.57 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.255 -0.497 . . . . 0.0 113.146 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -69.65 -38.19 77.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.589 ' O ' ' HB ' ' A' ' 96' ' ' THR . 44.7 ttm-85 -166.77 140.73 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.63 0.253 . . . . 0.0 110.81 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.52 ' HA ' HG21 ' A' ' 96' ' ' THR . 90.0 mt-30 -70.73 105.32 3.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . 51.3 t-80 -117.98 111.25 18.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.85 130.34 40.8 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.61 151.88 40.71 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.97 165.31 13.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.264 -176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.6 Cg_endo -56.46 -31.19 84.98 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.173 2.582 . . . . 0.0 112.709 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -67.09 -25.76 66.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.155 0.502 . . . . 0.0 110.705 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -96.36 -23.27 16.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.738 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 26.7 m -106.7 -7.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.725 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 39.9 ttp-105 -53.62 -55.2 37.62 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 38.5 Cg_exo -58.07 -32.99 96.82 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.987 1.791 . . . . 0.0 112.333 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.741 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.3 mt -78.09 -33.91 50.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 90.0 mt -61.08 -38.34 85.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 109.932 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.13 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.198 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 64.4 mtt -89.53 -33.07 16.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.659 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.04 18.48 5.5 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.268 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.741 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 t -93.14 114.48 29.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.727 0.299 . . . . 0.0 111.098 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.44 102.37 2.71 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.1 t -95.69 122.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.814 0.34 . . . . 0.0 111.489 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -120.6 146.33 46.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.061 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.24 119.6 32.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.988 0.423 . . . . 0.0 110.682 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.458 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 64.9 mtm -142.74 175.05 10.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.47 163.29 25.65 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.832 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.2 m -50.77 -52.79 37.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.399 -173.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.46 -43.89 96.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.639 0.257 . . . . 0.0 111.284 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.79 99.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.971 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.91 71.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.96 89.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.793 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttp-105 -67.63 -46.52 72.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 0.0 110.653 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.6 m -65.89 -31.49 72.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.292 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.482 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 75.6 t80 -59.0 -45.59 90.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.387 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -64.15 -41.63 97.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.53 -47.11 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.654 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.98 -28.26 66.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.989 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.33 -47.43 70.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.218 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.59 -25.41 66.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.553 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.43 -12.32 60.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.276 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.86 57.24 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.122 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.453 ' HE ' ' CD ' ' A' ' 90' ' ' GLU . 6.8 tpt180 -105.58 153.11 22.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.694 0.283 . . . . 0.0 110.323 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -82.6 91.12 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.789 0.804 . . . . 0.0 111.144 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.452 HG21 HG11 ' A' ' 91' ' ' VAL . 7.2 p -118.1 142.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.705 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 36' ' ' ALA . 39.4 t -122.31 141.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.4 p -120.39 138.45 50.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 110.855 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.76 107.76 10.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.434 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.6 mt -104.13 129.89 51.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.689 0.281 . . . . 0.0 111.694 -172.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -101.74 105.94 44.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 N--CA 1.45 -1.035 0 C-N-CA 123.311 2.674 . . . . 0.0 111.328 174.232 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.0 tp . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.868 0.366 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -69.2 107.01 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.104 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.435 HG23 ' HE3' ' A' ' 134' ' ' MET . 14.5 m -133.22 135.64 45.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 -175.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.468 HG23 HG21 ' A' ' 24' ' ' VAL . 49.2 t -73.02 118.89 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -93.02 -75.14 0.5 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.894 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.64 98.25 11.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 0.0 110.66 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -86.14 114.98 23.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.196 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.87 168.52 19.0 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.29 -21.41 36.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.121 0.486 . . . . 0.0 110.134 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.56 -38.21 5.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.53 155.6 46.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 110.817 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -114.57 114.16 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.613 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.515 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 42.5 tt0 -99.33 116.21 30.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.468 HG21 HG23 ' A' ' 14' ' ' VAL . 61.3 t -116.06 121.95 68.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.688 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 60.03 31.03 20.45 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.355 0.409 . . . . 0.0 110.506 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 71.16 14.47 6.66 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.57 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -104.8 116.75 49.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 99.0 mtt180 -93.31 116.49 29.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.86 0.362 . . . . 0.0 111.333 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.07 143.08 32.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.331 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.2 p -106.13 1.29 26.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.542 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -128.98 170.65 13.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.065 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.5 143.04 54.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 112.355 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.99 144.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.702 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 120.03 26.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.465 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.8 162.19 36.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.19 0.519 . . . . 0.0 111.709 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.493 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -137.81 151.91 71.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.288 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.46 -45.09 36.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.731 2.287 . . . . 0.0 112.57 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE2' ' HG2' ' A' ' 139' ' ' ARG . 39.0 mt-10 -97.59 23.34 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.823 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.91 -170.84 11.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.22 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -90.05 -168.37 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.89 2.393 . . . . 0.0 112.316 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.34 117.72 56.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.658 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.07 123.21 35.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.233 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.1 t -77.52 113.13 15.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.718 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.19 117.94 64.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.85 25.47 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.903 2.402 . . . . 0.0 111.603 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.548 HG11 ' HB2' ' A' ' 51' ' ' ASP . 83.9 t -86.16 122.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.272 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.74 -39.89 11.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.646 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 96.1 mtt180 -139.64 157.38 70.19 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.961 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 16.5 Cg_endo -58.44 -11.72 11.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.23 2.62 . . . . 0.0 113.393 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.4 -21.47 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.548 ' HB2' HG11 ' A' ' 46' ' ' VAL . 63.1 m-20 -86.25 -5.12 59.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 145' ' ' LEU . 71.0 mt -74.41 125.46 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.035 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -141.25 175.34 9.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.036 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.488 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -57.63 -45.65 85.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 m -56.4 -44.41 80.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.929 0.395 . . . . 0.0 111.425 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.62 -39.06 84.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.762 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.503 ' HB3' HD11 ' A' ' 111' ' ' LEU . 96.0 mt -66.09 -40.17 90.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.161 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -61.45 -46.91 88.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.453 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -63.19 -36.78 84.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.915 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.68 -32.44 73.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.047 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.63 5.7 8.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.18 -7.67 54.73 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.42 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.011 0.434 . . . . 0.0 111.148 -176.713 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.454 0.169 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.3 162.45 7.75 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.095 2.53 . . . . 0.0 112.734 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 139' ' ' ARG . 9.5 mm-40 -72.87 -49.71 28.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 -175.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 12.8 p -148.22 145.52 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.227 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 117' ' ' GLY . 2.0 pt? -119.04 132.01 56.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.128 0.49 . . . . 0.0 110.107 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.77 123.44 41.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.108 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.6 109.13 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.513 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -85.34 108.71 3.23 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.603 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.8 p -69.09 -12.14 61.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.23 -85.31 0.71 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.286 -0.483 . . . . 0.0 114.001 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -61.6 -41.0 96.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.899 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -172.5 158.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.603 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 52.9 tt0 -62.52 137.7 58.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.577 . . . . 0.0 111.718 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -136.19 164.14 28.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.487 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.18 110.13 22.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.885 0.374 . . . . 0.0 110.423 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.14 131.89 38.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.45 -176.78 23.32 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.103 -1.046 . . . . 0.0 114.172 -167.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.605 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 60.4 Cg_endo -72.18 3.75 3.81 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.774 2.982 . . . . 0.0 113.473 -173.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -96.94 -26.6 14.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -96.02 -50.94 4.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.505 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.675 ' HB ' HG12 ' A' ' 118' ' ' VAL . 33.5 m -91.56 5.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.638 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 42.0 ttp-105 -59.85 -52.32 74.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 76.7 Cg_exo -54.8 -29.77 64.31 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.166 1.91 . . . . 0.0 113.075 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 57' ' ' LEU . 58.7 mt -70.04 -49.0 55.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 109.86 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.8 mt -64.19 -32.54 74.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.36 -26.89 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.368 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.445 ' HE1' ' HA ' ' A' ' 111' ' ' LEU . 65.7 mtm -87.34 -33.48 19.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.857 0.361 . . . . 0.0 110.665 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.43 4.25 9.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.408 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.0 131.2 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -82.33 141.3 21.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.736 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.675 HG12 ' HB ' ' A' ' 108' ' ' VAL . 11.7 p -127.33 145.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 122.689 -0.301 . . . . 0.0 110.227 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.86 136.65 27.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.791 0.329 . . . . 0.0 110.632 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.48 127.52 46.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.796 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.497 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 32.8 ttm -147.2 161.75 40.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -174.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.97 159.97 31.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 m -50.5 -63.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.44 -44.19 95.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.723 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.35 89.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.89 94.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.573 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.71 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 132' ' ' ILE . 53.4 ttp180 -60.2 -55.84 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 15.8 m -60.51 -38.03 83.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.04 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.22 -49.6 76.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.994 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.15 -40.85 95.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.627 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 79.5 mt -60.56 -56.4 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.76 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.74 -31.69 72.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.435 ' HE3' HG23 ' A' ' 13' ' ' THR . 58.8 ttp -66.22 -40.83 90.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.213 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.69 -35.45 72.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.66 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 9.1 mm-40 -61.69 -29.71 70.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.79 32.69 7.06 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.829 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -107.28 135.8 48.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.458 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 28.6 mtm180 -67.44 97.65 0.59 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.516 0.674 . . . . 0.0 110.869 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 7.4 p -123.78 139.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.333 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.493 HG22 ' HB1' ' A' ' 36' ' ' ALA . 30.8 t -109.46 150.42 12.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.91 130.98 55.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.006 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.31 120.71 39.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.237 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.76 127.37 53.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.897 0.38 . . . . 0.0 111.55 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.403 HD11 HD11 ' A' ' 52' ' ' ILE . 68.5 mt -99.64 116.64 64.69 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.575 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 C--O 1.233 0.253 0 C-N-CA 122.616 2.211 . . . . 0.0 112.815 -177.706 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -114.02 112.35 23.13 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m -130.6 143.6 50.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.999 0.428 . . . . 0.0 111.618 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.3 139.35 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.606 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 p -99.1 -40.02 8.21 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.731 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -140.23 116.71 10.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 111.715 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -105.47 104.33 14.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.04 -169.68 14.44 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.124 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.19 94.03 3.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.992 0.425 . . . . 0.0 110.809 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.81 60.35 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.261 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -125.56 152.16 45.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.038 0.419 . . . . 0.0 110.992 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.28 124.6 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.891 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 36.9 tt0 -111.59 122.56 48.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 111.339 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.42 115.19 49.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.051 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.39 -78.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.467 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -138.42 -1.1 1.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.458 0.17 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.58 121.89 68.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.792 0.329 . . . . 0.0 111.198 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.2 ptp180 -97.84 123.37 41.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.292 0.568 . . . . 0.0 110.334 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.43 137.35 37.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.198 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -94.73 17.31 13.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.37 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -147.25 167.78 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.929 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.56 146.95 47.13 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.483 0.489 . . . . 0.0 111.466 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 pt -141.78 147.08 22.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.084 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.76 124.97 40.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.821 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -147.95 161.33 41.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.498 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -136.56 160.74 65.47 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.619 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.541 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 11.3 Cg_endo -56.03 -48.67 18.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.728 2.285 . . . . 0.0 111.941 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -111.71 86.97 2.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.97 178.8 41.76 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.058 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -90.22 143.2 3.85 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.025 2.483 . . . . 0.0 113.076 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.86 114.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.58 154.47 30.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.556 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.1 m -87.25 143.14 27.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 t90 -111.88 121.63 39.16 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 9.8 Cg_exo -72.54 46.99 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.526 2.818 . . . . 0.0 113.409 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.436 HG23 HD13 ' A' ' 56' ' ' LEU . 92.0 t -122.19 115.96 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.17 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -82.98 -32.1 27.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.0 110.159 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -160.3 158.57 25.94 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.036 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 17.5 Cg_exo -68.44 33.94 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.964 3.109 . . . . 0.0 114.414 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.68 -27.48 15.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.634 0.254 . . . . 0.0 110.934 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -111.96 7.18 19.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.477 HG13 ' HA ' ' A' ' 49' ' ' PRO . 54.6 mt -61.74 109.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.157 0.504 . . . . 0.0 110.822 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 p -127.89 175.99 7.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.788 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -59.4 -43.69 92.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.82 -175.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -58.21 -42.72 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.786 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.436 HD13 HG23 ' A' ' 46' ' ' VAL . 93.8 mt -67.93 -36.56 80.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.735 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.0 -37.38 85.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.319 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 98.2 mt-30 -58.08 -42.69 86.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.999 0.428 . . . . 0.0 110.443 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.72 -39.76 84.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.271 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.6 -18.0 52.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.11 -20.39 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.33 45.3 30.96 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.056 0.455 . . . . 0.0 110.555 -177.352 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.708 0.29 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.19 154.39 74.44 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.792 2.328 . . . . 0.0 112.516 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.48 -42.7 58.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.476 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.33 139.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.327 0.584 . . . . 0.0 111.899 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 141' ' ' VAL . 51.1 tp -118.11 122.49 43.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.5 mt -104.27 121.72 43.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.741 0.305 . . . . 0.0 110.619 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.37 113.36 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.26 89.76 1.01 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.237 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.52 31.96 4.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.872 0.368 . . . . 0.0 111.234 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.435 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -72.37 -15.08 77.08 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.225 -175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -83.14 -21.96 33.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.41 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.5 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 10.8 tpt180 -168.77 90.95 0.25 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -56.99 106.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.281 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -115.05 99.71 7.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.73 111.7 1.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.6 mt -68.38 133.19 48.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.255 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.05 21.53 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.631 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.9 Cg_endo -55.12 -47.16 27.87 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.509 2.806 . . . . 0.0 112.938 -174.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.67 -25.4 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.769 0.319 . . . . 0.0 111.634 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -78.13 -40.98 36.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 29.0 m -101.24 4.19 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.577 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.506 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 32.8 ttp180 -54.26 -48.9 93.13 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 53.6 Cg_exo -53.49 -34.27 71.4 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.098 1.865 . . . . 0.0 112.59 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.6 mt -86.55 -34.32 19.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.878 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 80.2 mt -63.78 -34.25 77.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.908 0.385 . . . . 0.0 110.157 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.29 -13.11 62.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.115 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -100.82 -25.33 14.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.971 0.415 . . . . 0.0 110.509 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.03 18.64 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.05 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.7 t -94.78 118.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.99 111.24 3.63 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.672 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.71 119.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -108.45 118.67 37.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.998 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.58 106.93 17.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.689 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 40.5 ttm -134.49 163.68 29.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.103 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.96 149.64 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.435 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 9.7 m -60.21 -47.0 87.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.76 0.315 . . . . 0.0 111.376 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -69.93 -40.56 75.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 110.576 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.46 95.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.971 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.4 83.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.97 88.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -64.03 -41.14 97.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.542 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.464 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.9 m -63.52 -43.79 96.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.447 ' CE1' ' HD3' ' A' ' 37' ' ' PRO . 73.2 t80 -57.08 -41.86 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -58.48 -47.13 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.05 -45.6 90.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.704 HD22 ' HD2' ' A' ' 138' ' ' ARG . 87.0 mt -64.21 -34.58 78.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.541 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 50.8 ttp -67.52 -34.28 76.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.345 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.76 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.07 -23.1 61.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.033 0.444 . . . . 0.0 110.415 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.55 31.58 15.64 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.149 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.704 ' HD2' HD22 ' A' ' 133' ' ' LEU . 45.8 mtt180 -83.43 152.46 24.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.797 0.332 . . . . 0.0 110.922 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -83.18 93.02 7.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.891 0.853 . . . . 0.0 109.494 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.7 p -125.77 133.87 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.33 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 36' ' ' ALA . 33.5 t -111.96 133.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.2 p -116.65 130.15 71.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.906 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -109.95 109.49 20.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.453 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.65 129.87 46.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.478 HD13 ' HG3' ' A' ' 49' ' ' PRO . 87.8 mt -103.65 117.34 60.12 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.439 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo . . . . . 0 N--CA 1.458 -0.571 0 C-N-CA 123.02 2.48 . . . . 0.0 111.856 177.307 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -64.35 109.38 1.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.033 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 m -117.6 133.09 56.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -66.17 110.32 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.552 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 m -82.77 -44.74 15.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.41 150.59 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.042 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -128.36 128.58 44.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.03 -169.02 12.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.857 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.49 -61.2 1.91 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.277 0.561 . . . . 0.0 110.94 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.75 25.08 15.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.737 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -155.13 138.88 16.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.602 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -120.79 120.96 63.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -96.03 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.267 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.51 128.31 66.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 61.27 30.16 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.213 -177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 69.22 15.53 8.58 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.732 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.26 121.72 62.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -87.36 111.76 21.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.004 0.43 . . . . 0.0 111.581 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.58 124.0 45.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.042 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -97.98 22.55 9.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.978 0.418 . . . . 0.0 111.332 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -151.39 171.82 16.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.473 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.85 135.91 57.67 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.604 0.565 . . . . 0.0 111.623 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.67 144.81 26.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.107 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.07 122.18 35.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.519 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 37.7 p90 -143.78 153.51 42.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.102 0.477 . . . . 0.0 111.708 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB3' HG22 ' A' ' 141' ' ' VAL . . . -139.48 158.53 68.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.052 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -58.68 135.22 65.82 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.255 1.97 . . . . 0.0 111.62 173.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 70.02 16.86 7.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.162 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.18 169.46 22.98 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.5 177.24 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.129 . . . . 0.0 112.221 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.406 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 43.1 t -102.81 102.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.35 134.42 35.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.09 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -77.7 118.89 20.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.035 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -98.18 120.31 59.99 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.673 -175.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.3 Cg_exo -77.19 26.56 0.45 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.348 2.699 . . . . 0.0 112.99 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.522 HG13 ' HB3' ' A' ' 51' ' ' ASP . 79.5 t -103.19 110.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.673 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -113.72 -13.88 12.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.318 0.58 . . . . 0.0 109.566 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.035 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 37.2 mtp-105 -101.83 135.25 19.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.44 -33.57 93.92 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.596 2.198 . . . . 0.0 112.319 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.11 9.54 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.456 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 1.035 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 3.6 t70 -85.09 -25.88 27.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.206 0.527 . . . . 0.0 110.13 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.9 109.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.565 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.0 m -112.35 155.53 23.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.168 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -56.68 -38.18 71.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 t -57.34 -42.79 82.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.712 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.82 -27.48 64.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.469 ' HB3' HD11 ' A' ' 111' ' ' LEU . 95.8 mt -71.3 -35.07 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.386 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.102 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -66.34 -43.93 84.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.367 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 -19.33 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.913 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.3 -5.93 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.38 82.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.127 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.358 0.599 . . . . 0.0 110.97 -176.674 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.521 0.201 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 18.5 Cg_endo -57.77 134.43 62.73 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 123.052 2.502 . . . . 0.0 113.013 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -67.29 -36.82 82.32 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.494 HG12 HG22 ' A' ' 140' ' ' VAL . 6.0 p -139.76 135.78 39.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.993 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.6 tp -111.67 120.6 42.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.193 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 119' ' ' GLU . 94.9 mt -102.08 112.2 24.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.864 0.364 . . . . 0.0 110.895 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.85 113.61 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.959 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -97.77 97.07 1.89 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 p -106.67 56.17 0.65 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.155 0.502 . . . . 0.0 110.931 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.706 ' HA3' HG21 ' A' ' 123' ' ' THR . . . -64.07 -28.54 72.99 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.536 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -63.0 -38.72 92.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.249 0.547 . . . . 0.0 110.768 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -170.44 95.06 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -61.23 128.09 34.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.798 -168.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -107.77 120.93 43.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.833 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.8 tp -80.1 103.18 9.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.91 145.92 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.031 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 173.77 20.1 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.747 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.615 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 54.2 Cg_exo -52.29 -49.34 17.71 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.543 2.829 . . . . 0.0 113.155 -175.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.09 -34.51 73.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.863 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -68.52 -30.27 69.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.88 -8.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 85.7 mtt180 -54.22 -52.49 68.4 Favored Pre-proline 0 N--CA 1.466 0.344 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.514 ' HG2' ' HB1' ' A' ' 54' ' ' ALA . 79.1 Cg_exo -50.96 -34.11 44.8 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.387 2.058 . . . . 0.0 113.173 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.559 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 80.0 mt -89.73 -37.99 14.16 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.146 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.3 mt -60.89 -34.44 74.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.776 0.322 . . . . 0.0 110.694 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.16 -24.06 65.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.092 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.4 mtt -90.67 -9.85 45.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.382 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.19 10.68 54.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.252 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.6 t -94.59 113.55 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.674 0.273 . . . . 0.0 110.537 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.12 118.78 4.78 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.618 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.56 117.18 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HB2' HD22 ' A' ' 93' ' ' LEU . 27.6 mm-40 -114.33 110.1 19.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.195 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.18 110.73 22.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 67.4 mtm -138.56 -171.85 3.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.813 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.06 154.33 39.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.941 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.706 HG21 ' HA3' ' A' ' 97' ' ' GLY . 5.0 t -62.94 -45.79 90.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.777 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -74.7 -38.05 62.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.71 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.696 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.96 78.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.727 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.23 88.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -63.74 -48.27 77.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.374 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -66.13 -39.32 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.11 -44.23 91.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.801 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.61 -50.1 71.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.138 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.35 -48.85 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 91' ' ' VAL . 96.9 mt -65.52 -35.37 80.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.344 -177.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.67 -33.78 74.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.809 0.338 . . . . 0.0 110.097 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.76 -26.17 65.99 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.67 -24.97 58.89 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.133 0.492 . . . . 0.0 110.413 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.13 18.69 53.07 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 40.4 ttm-85 -81.42 154.17 26.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.395 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 89' ' ' PRO . 37.4 mmt180 -79.23 99.07 6.88 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.674 0.75 . . . . 0.0 110.742 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.494 HG22 HG12 ' A' ' 91' ' ' VAL . 4.1 p -134.49 134.7 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.532 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 36' ' ' ALA . 26.4 t -116.66 137.33 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.23 136.23 58.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.071 0.463 . . . . 0.0 111.178 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.12 112.33 18.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.756 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -105.2 138.68 41.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 -175.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.448 HD11 HG11 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -119.45 91.12 43.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 123.186 2.59 . . . . 0.0 113.213 178.81 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 121.184 0.516 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -64.62 107.11 1.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.4 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 m -131.24 150.16 52.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.745 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -71.56 129.84 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 p -85.67 -33.73 21.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.711 0.291 . . . . 0.0 111.54 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 23' ' ' GLU . . . -145.26 112.34 6.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.58 0.229 . . . . 0.0 110.476 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -70.38 -38.22 74.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.869 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.9 -163.6 44.33 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.781 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.01 -74.84 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.202 0.525 . . . . 0.0 110.277 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.93 31.99 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.469 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.45 119.25 2.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.4 110.07 26.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 36.7 tt0 -97.95 112.62 24.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 110.543 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.07 109.65 29.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.81 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 62.97 43.57 6.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.654 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 70.48 12.04 7.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.819 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -106.04 113.04 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttm105 -90.72 112.84 24.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.346 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.45 117.56 33.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.686 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 55.5 m -93.9 10.53 32.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -148.2 -179.34 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.362 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.74 146.33 46.3 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.22 148.46 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.573 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.3 131.14 48.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.599 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.04 158.2 38.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.312 0.577 . . . . 0.0 111.789 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' A' ' 141' ' ' VAL . . . -131.51 161.87 59.54 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.547 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.83 -46.36 33.9 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.374 2.049 . . . . 0.0 110.981 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -118.27 96.05 5.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.022 172.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.83 178.64 41.03 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.67 138.97 7.43 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.568 2.178 . . . . 0.0 112.718 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.26 103.02 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.2 121.85 42.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.481 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -66.94 120.74 14.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -97.88 127.21 37.93 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -170.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.4 Cg_exo -70.09 3.99 2.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.408 2.739 . . . . 0.0 113.033 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 51' ' ' ASP . 84.7 t -86.14 134.96 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.682 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 50.0 tp60 -107.16 -41.48 5.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.146 0.498 . . . . 0.0 110.155 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.682 ' HG3' ' HG3' ' A' ' 47' ' ' GLN . 63.5 mtt180 -129.5 156.09 79.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.607 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.64 0.11 2.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.16 2.574 . . . . 0.0 113.172 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.6 -17.23 27.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.148 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.529 ' HB2' HG11 ' A' ' 46' ' ' VAL . 43.5 m-20 -88.15 -16.29 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.048 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.67 114.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.667 -174.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 p -124.27 173.62 8.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.402 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.24 91.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.616 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -60.96 -42.25 97.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.417 0.627 . . . . 0.0 110.797 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD13 HG22 ' A' ' 46' ' ' VAL . 87.5 mt -71.56 -28.85 64.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.856 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.95 -39.14 87.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.488 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -63.67 -37.93 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.3 -44.84 74.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.27 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.529 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . -76.68 -9.21 58.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.28 23.61 71.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.724 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.455 HD22 ' HE3' ' A' ' 114' ' ' MET . 27.9 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.974 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 86.4 Cg_exo -47.6 132.44 20.57 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.247 2.631 . . . . 0.0 113.368 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.5 mt-10 -77.3 -43.03 34.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 7.1 p -140.66 137.45 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.158 -177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 61' ' ' ALA . 45.1 tp -110.0 118.22 35.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.301 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.3 mt -98.06 120.85 39.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.866 0.365 . . . . 0.0 110.747 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.15 122.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.093 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -100.39 113.09 4.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.189 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 22.2 p -83.76 -66.98 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.743 0.306 . . . . 0.0 111.678 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 -65.26 3.87 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.572 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -69.52 -37.6 77.2 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.769 -0.254 . . . . 0.0 111.217 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 96' ' ' THR . 13.7 ptt180 -161.19 138.47 8.95 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 170.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -81.08 91.5 6.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.391 0.615 . . . . 0.0 111.237 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -94.68 106.98 18.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.534 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.26 149.35 38.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.711 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.5 150.39 21.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -105.95 165.48 13.87 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.468 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.51 -26.34 82.6 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 123.397 2.731 . . . . 0.0 113.36 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.69 -11.68 44.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.003 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.54 -45.68 8.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.281 0.563 . . . . 0.0 109.995 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 104' ' ' GLY . 27.0 m -90.79 16.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.499 0.666 . . . . 0.0 109.979 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.629 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 33.2 ttt180 -54.25 -52.95 64.37 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.801 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.9 Cg_exo -59.28 -40.51 67.84 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.961 1.774 . . . . 0.0 112.465 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 91.8 mt -73.94 -42.11 61.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 -176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.6 mt -61.45 -38.17 86.23 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.573 0.225 . . . . 0.0 110.955 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -35.02 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.455 ' HE3' HD22 ' A' ' 63' ' ' LEU . 65.7 mtt -76.38 -29.83 57.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.646 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.95 10.82 13.42 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.99 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.7 t -92.12 113.27 27.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -80.33 130.01 9.48 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.567 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.2 124.04 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.988 0.394 . . . . 0.0 110.393 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -114.43 108.62 17.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.311 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.14 111.06 22.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 68.2 mtm -137.85 -171.65 3.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.56 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.25 152.14 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.873 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.526 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 7.7 t -63.77 -38.24 90.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.68 -37.25 42.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.234 0.54 . . . . 0.0 109.94 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.97 90.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.886 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.43 -40.75 70.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.008 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.0 84.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.424 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -72.76 -43.74 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.1 p -67.04 -32.22 73.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.48 ' HH ' ' HA ' ' A' ' 36' ' ' ALA . 79.7 t80 -57.56 -44.96 85.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.42 174.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.7 -36.39 84.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.54 -49.81 82.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.59 -30.46 71.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttm -65.72 -42.48 91.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.192 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.7 76.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.85 -16.75 60.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.775 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.39 51.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.206 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -93.25 167.63 11.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.803 0.335 . . . . 0.0 110.924 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.692 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 2.1 mmt180 -83.38 90.66 7.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.119 0.485 . . . . 0.0 109.872 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.4 135.84 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 36' ' ' ALA . 16.7 t -125.61 142.92 40.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.459 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 8.3 p -123.63 140.82 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.1 113.34 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.355 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 98.8 mt -104.11 133.94 48.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.338 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.69 103.99 51.32 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.058 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.462 -0.351 0 C-N-CA 122.969 2.446 . . . . 0.0 112.343 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -101.59 112.06 24.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.128 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 m -100.31 143.57 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.413 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.89 115.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.139 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -45.76 73.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.738 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -141.77 110.52 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.21 0.529 . . . . 0.0 111.439 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -99.21 129.31 45.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.769 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.5 ' HA3' ' CE1' ' A' ' 21' ' ' TYR . . . -132.3 -178.17 15.35 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.137 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -86.51 -20.47 27.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.031 0.443 . . . . 0.0 110.46 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.9 17.43 5.72 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.995 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.5 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 27.3 p90 -164.95 150.36 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.74 0.305 . . . . 0.0 110.76 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.44 106.35 15.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -105.6 118.26 36.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.954 0.407 . . . . 0.0 109.954 -177.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.29 139.18 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.83 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.26 -83.8 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.667 0.604 . . . . 0.0 110.176 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -152.71 13.27 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.466 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.56 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.003 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 48.0 ttp180 -83.45 107.4 15.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.82 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.74 129.83 35.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.099 0.476 . . . . 0.0 110.941 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 m -108.45 19.09 20.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.887 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -145.44 168.92 19.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . . . -65.8 142.77 57.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.108 0.48 . . . . 0.0 111.598 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.8 pt -137.98 138.82 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.7 118.68 25.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -146.52 163.61 35.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.79 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB3' HG21 ' A' ' 141' ' ' VAL . . . -139.23 152.73 70.18 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.1 -32.75 96.28 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.87 2.38 . . . . 0.0 112.959 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.587 ' OE2' ' HD2' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -100.75 19.27 17.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.835 0.35 . . . . 0.0 110.867 -178.016 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.11 -176.15 20.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.853 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.5 -170.28 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.069 2.513 . . . . 0.0 112.437 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.14 116.16 50.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.122 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.68 129.64 35.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.916 0.388 . . . . 0.0 110.74 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p -75.28 121.19 21.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -115.17 117.16 41.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.897 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.26 22.9 0.87 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.228 2.618 . . . . 0.0 113.048 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.34 123.87 41.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.796 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -106.17 -35.93 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.734 0.778 . . . . 0.0 109.389 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 48' ' ' ARG . 47.0 mtm180 -120.18 131.54 24.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.063 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.6 Cg_exo -67.14 8.24 0.39 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.292 2.662 . . . . 0.0 113.092 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 48' ' ' ARG . . . -95.22 -3.01 48.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -109.99 14.09 23.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.2 119.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 111.193 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 p -104.14 168.46 9.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.05 -30.04 70.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 p -66.26 -42.14 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.774 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.53 -34.77 79.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.624 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HB3' HD13 ' A' ' 111' ' ' LEU . 96.7 mt -63.53 -42.42 98.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.15 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.15 -36.63 83.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 110.96 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -71.24 -36.67 71.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.464 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.02 -27.37 67.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.938 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -73.79 -9.12 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.936 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.62 15.32 78.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.523 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.486 HD22 ' HD3' ' A' ' 89' ' ' PRO . 90.1 mt . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.101 0.477 . . . . 0.0 111.055 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.486 ' HD3' HD22 ' A' ' 63' ' ' LEU . 17.3 Cg_exo -66.51 121.48 8.74 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 111.735 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 109.878 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.672 HG13 HD11 ' A' ' 133' ' ' LEU . 6.4 p -134.12 135.29 54.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.731 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.49 104.72 12.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.414 HD12 HD12 ' A' ' 133' ' ' LEU . 93.9 mt -90.13 110.75 21.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.691 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.78 112.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.436 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.63 92.68 1.79 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.511 ' HA ' HD11 ' A' ' 145' ' ' LEU . 1.3 m -60.75 -24.84 66.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.712 0.405 . . . . 0.0 112.072 -171.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 79.61 -68.62 3.16 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.546 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -92.82 82.08 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.881 0.372 . . . . 0.0 110.578 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 63.25 -173.99 0.16 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.149 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -90.22 143.3 26.89 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.936 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -136.7 126.72 26.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.851 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -80.96 111.78 17.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.463 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.8 mt -76.85 170.18 16.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 159.53 15.1 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.774 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.27 -34.92 98.06 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.941 2.427 . . . . 0.0 111.91 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.42 -20.59 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -96.34 -63.19 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.814 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.3 -18.93 8.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.44 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 37.0 ttt180 -57.84 -46.51 99.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 73.2 Cg_exo -53.11 -34.3 67.74 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.165 1.91 . . . . 0.0 112.875 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 57' ' ' LEU . 92.3 mt -76.45 -42.09 45.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.641 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.28 -26.52 68.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 0.0 110.467 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.74 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 60.1 mtt -90.82 -7.46 52.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.883 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.48 51.17 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.091 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -91.83 117.16 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.799 0.333 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.65 93.94 1.7 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.961 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.81 120.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -125.29 127.15 46.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.415 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.67 116.67 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.3 mtm -142.34 -171.79 3.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.588 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.32 153.63 42.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.408 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 9.0 m -57.95 -42.96 86.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.261 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.47 -48.45 81.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.46 -50.16 68.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.791 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.69 91.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -60.12 -50.24 74.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.424 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.1 m -65.47 -36.01 82.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.47 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -59.01 -46.88 87.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -56.93 -42.9 80.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.712 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.65 -52.76 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.794 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.672 HD11 HG13 ' A' ' 91' ' ' VAL . 94.7 mt -64.4 -35.23 80.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.507 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 45.0 ttp -65.31 -41.3 94.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.77 73.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.671 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -73.11 -20.57 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.8 39.26 29.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.752 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -97.27 162.69 13.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.578 0.228 . . . . 0.0 110.89 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.587 ' HD2' ' OE2' ' A' ' 38' ' ' GLU . 16.7 mmm180 -75.25 80.84 2.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.0 120.51 64.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.18 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 36' ' ' ALA . 43.9 t -109.87 132.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -117.92 133.8 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.12 0.486 . . . . 0.0 111.122 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.86 110.0 17.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.347 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -100.57 120.97 40.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.944 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.511 HD11 ' HA ' ' A' ' 96' ' ' THR . 73.6 mt -104.21 107.04 56.23 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.629 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.452 -0.933 0 C-N-CA 122.236 1.957 . . . . 0.0 110.405 169.212 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.49 0.662 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -65.48 108.43 1.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.218 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 m -118.17 137.04 53.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.073 0.463 . . . . 0.0 111.816 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 24' ' ' VAL . 63.9 t -67.74 132.96 32.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 174.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 p -94.69 -45.67 7.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.736 0.303 . . . . 0.0 111.688 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.15 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 0.0 111.163 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -105.98 -76.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.838 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.77 -111.75 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.027 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -162.25 130.91 4.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -49.09 3.71 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.915 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -111.71 170.24 8.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 110.987 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.96 117.19 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.447 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 29.5 tt0 -96.87 117.81 31.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.053 0.454 . . . . 0.0 110.797 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 14' ' ' VAL . 25.6 t -113.54 124.37 70.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.639 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 66.67 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.728 0.642 . . . . 0.0 111.376 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -141.34 -3.97 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.11 122.3 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.117 -172.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 12.8 ptt180 -85.76 111.42 20.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.978 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.41 120.08 31.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.3 m -101.97 23.54 11.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.54 0.686 . . . . 0.0 109.572 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -141.7 163.59 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.398 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.72 57.76 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.396 0.435 . . . . 0.0 110.991 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -137.04 137.52 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.32 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.76 109.68 14.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.546 -0.752 . . . . 0.0 108.973 173.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.406 ' HB3' HG12 ' A' ' 41' ' ' VAL . 37.5 p90 -126.43 147.13 49.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 112.359 -173.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -101.95 157.64 33.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.932 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 26.5 Cg_endo -62.84 -17.53 60.0 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.625 2.217 . . . . 0.0 113.116 -176.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 43.1 mt-10 -89.31 9.23 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.3 -69.57 0.41 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.646 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HD2' ' C ' ' A' ' 38' ' ' GLU . 4.5 Cg_exo -37.99 119.85 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.592 3.528 . . . . 0.0 114.923 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 35' ' ' PHE . 41.9 t -113.25 113.56 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.925 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 135.77 33.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.664 0.268 . . . . 0.0 110.794 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 m -88.78 137.89 31.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 m0 -121.15 131.8 24.38 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.3 Cg_exo -81.52 20.5 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.487 2.791 . . . . 0.0 111.619 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.507 HG12 ' HB2' ' A' ' 51' ' ' ASP . 92.4 t -94.75 123.32 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.418 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 6.32 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.293 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.404 ' C ' ' H ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -152.16 152.83 30.26 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.39 14.48 0.38 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.934 2.423 . . . . 0.0 113.162 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 48' ' ' ARG . . . -93.67 -29.53 15.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.258 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' HB2' HG12 ' A' ' 46' ' ' VAL . 28.9 m-20 -77.79 -20.78 52.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.226 -175.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.431 HD11 HG12 ' A' ' 94' ' ' VAL . 23.0 mt -60.04 110.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.22 0.533 . . . . 0.0 111.194 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -131.44 165.6 23.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.482 -178.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.61 65.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.721 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 3.4 p -62.55 -50.74 70.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.856 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.51 -36.91 84.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.824 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.465 ' HB3' HD12 ' A' ' 111' ' ' LEU . 97.5 mt -61.46 -41.86 97.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.98 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.85 -33.17 74.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.86 0.362 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 55' ' ' SER . 87.9 mt-30 -71.38 -35.83 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.75 -26.53 40.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.04 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . . . -77.77 -10.68 59.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.135 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.57 35.17 67.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.623 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 0.0 111.283 -177.424 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 116' ' ' VAL . 26.0 Cg_endo -63.92 153.47 75.57 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.588 2.192 . . . . 0.0 112.531 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.35 -51.7 6.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.024 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.37 136.65 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 tp -115.33 119.01 34.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.79 119.91 39.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.431 HG12 HD11 ' A' ' 52' ' ' ILE . 58.9 t -111.84 117.87 56.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.363 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.83 102.29 2.9 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 101' ' ' HIS . 6.1 p -78.15 19.12 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.8 -85.03 1.09 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.234 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -79.19 -33.58 43.77 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -169.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -142.3 -173.72 3.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.487 ' HG2' ' H ' ' A' ' 122' ' ' ASP . 93.0 mt-30 -95.31 82.46 3.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.648 165.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.463 ' HB3' HG23 ' A' ' 96' ' ' THR . 58.5 t-80 -94.8 101.77 13.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.726 -174.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 48.0 tp -64.76 143.22 58.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.67 -165.71 1.03 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.324 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.95 150.51 16.92 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.765 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.69 -37.19 83.74 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.265 2.643 . . . . 0.0 112.758 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -72.96 -33.38 65.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.944 0.402 . . . . 0.0 110.761 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.05 -42.32 73.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.1 m -89.99 -6.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.35 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -50.5 87.83 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -54.02 -40.45 81.19 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.14 1.893 . . . . 0.0 112.615 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.668 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 64.7 mt -77.63 -38.08 48.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.129 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 73.8 mt -61.89 -34.34 75.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.11 63.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.6 mtt -91.11 -11.87 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.6 8.79 55.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.668 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.0 t -86.69 111.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.742 0.306 . . . . 0.0 110.44 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.69 104.28 2.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.146 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -91.04 120.19 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.738 0.304 . . . . 0.0 111.027 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -118.48 115.78 25.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.422 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.416 ' HB2' ' HA ' ' A' ' 102' ' ' LEU . . . -99.05 118.52 36.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.655 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.4 mtm -140.02 -171.82 3.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.221 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.487 ' H ' ' HG2' ' A' ' 100' ' ' GLN . 12.8 t70 -70.31 151.55 45.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.477 HG21 HD22 ' A' ' 144' ' ' LEU . 63.8 m -56.96 -37.99 72.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 111.002 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.72 -42.84 70.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.463 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.51 -41.6 84.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.944 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.43 -38.71 90.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.849 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -52.21 66.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.157 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -61.84 -40.18 94.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.999 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.527 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 41.0 m -64.8 -40.32 95.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.398 . . . . 0.0 110.474 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -60.93 -46.76 89.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.711 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -58.32 -37.68 75.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 79.4 mt -68.52 -53.86 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.608 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.658 HD22 ' HD2' ' A' ' 138' ' ' ARG . 61.9 mt -61.91 -41.63 98.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -64.93 -39.47 93.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.579 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.71 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 44.8 mt-10 -73.84 -26.31 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 22.82 12.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.256 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.658 ' HD2' HD22 ' A' ' 133' ' ' LEU . 56.1 mtt-85 -80.35 157.68 26.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.843 0.354 . . . . 0.0 110.204 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -90.0 83.38 6.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.248 0.547 . . . . 0.0 109.932 -178.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.32 134.72 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.529 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.35 136.83 53.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.6 p -120.69 134.46 64.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.048 0.451 . . . . 0.0 111.411 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.14 113.07 20.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.563 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 123' ' ' THR . 91.3 mt -108.4 133.97 51.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.671 -175.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.401 HD11 HD13 ' A' ' 52' ' ' ILE . 83.5 mt -111.0 105.65 57.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.918 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.457 -0.658 0 C-N-CA 123.212 2.608 . . . . 0.0 110.589 166.902 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 37' ' ' PRO . 54.7 mt . . . . . 0 C--O 1.236 0.392 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.67 95.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.452 . . . . 0.0 109.971 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -91.31 129.19 37.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.502 -173.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.37 107.32 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 m -79.84 -36.88 36.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.003 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.53 130.74 15.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.203 0.525 . . . . 0.0 111.375 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -100.4 106.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 -170.73 34.66 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.116 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.54 -58.68 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.226 0.536 . . . . 0.0 110.59 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.11 38.11 1.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.766 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -151.76 143.87 23.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.906 0.384 . . . . 0.0 110.294 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.28 118.62 59.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.82 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.77 112.0 23.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.733 0.301 . . . . 0.0 110.274 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.51 115.16 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.999 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.415 ' C ' HD21 ' A' ' 25' ' ' ASN . 0.2 OUTLIER 72.12 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.625 0.77 . . . . 0.0 110.428 -178.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -174.88 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.283 0.633 . . . . 0.0 109.364 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.09 126.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.367 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -95.06 121.1 36.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.604 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.7 113.2 26.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.604 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -92.78 19.91 7.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.568 0.699 . . . . 0.0 110.106 175.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -130.59 151.84 50.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.665 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 44' ' ' TRP . . . -58.56 136.8 57.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.7 pt -141.85 154.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.097 0.475 . . . . 0.0 111.723 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.31 124.04 28.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.327 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -146.24 163.13 36.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.032 0.444 . . . . 0.0 111.529 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.516 ' HB3' ' HD2' ' A' ' 37' ' ' PRO . . . -126.65 163.56 40.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -176.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 36' ' ' ALA . 63.7 Cg_endo -73.4 23.52 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.706 2.27 . . . . 0.0 112.914 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 36' ' ' ALA . 38.9 tt0 -173.49 90.3 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.04 -165.04 29.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.878 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.88 167.22 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.2 2.6 . . . . 0.0 113.034 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.84 122.9 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.148 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.12 140.72 29.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.1 p -84.41 119.73 25.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.069 0.461 . . . . 0.0 110.594 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 2.3 t90 -98.24 116.4 65.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.737 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.15 35.55 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.267 2.645 . . . . 0.0 114.043 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 51' ' ' ASP . 94.6 t -101.14 133.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.684 0.278 . . . . 0.0 110.577 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -113.84 -43.93 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.477 . . . . 0.0 110.554 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -116.92 151.99 48.09 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.24 -6.66 10.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.746 2.297 . . . . 0.0 112.539 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.39 -3.52 46.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.526 ' HB2' HG12 ' A' ' 46' ' ' VAL . 64.2 m-20 -84.19 -28.16 27.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.555 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.4 mt -55.45 113.73 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.759 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.1 p -128.95 175.14 8.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.392 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -58.29 -44.92 88.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.043 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 m -60.93 -42.43 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.47 HD13 HG21 ' A' ' 46' ' ' VAL . 80.7 mt -70.51 -28.26 64.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.435 ' HB3' HD12 ' A' ' 111' ' ' LEU . 83.7 mt -73.45 -30.06 62.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.79 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 95.2 mt-30 -63.75 -43.63 95.86 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 174.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.47 -42.29 92.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.706 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.77 76.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.637 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.48 0.66 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.35 82.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.427 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.1 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.303 -177.141 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.641 0.258 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 2.8 Cg_exo -75.54 151.21 36.9 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.041 2.494 . . . . 0.0 112.125 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -67.27 -44.83 78.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.934 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 p -132.4 136.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.484 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 141' ' ' VAL . 62.3 tp -118.07 121.94 41.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.184 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.19 120.85 42.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.5 t -103.31 119.84 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.941 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.492 ' HA3' HD23 ' A' ' 144' ' ' LEU . . . -98.26 98.81 2.1 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.587 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -126.49 93.0 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.45 -10.21 39.16 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.453 -0.88 . . . . 0.0 114.46 -170.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -89.51 -26.41 20.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.716 0.758 . . . . 0.0 110.168 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -159.53 94.24 1.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.902 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -65.23 109.5 2.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.29 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -106.13 122.41 46.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.891 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.7 134.07 39.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.134 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.4 mt -94.12 137.12 33.67 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.28 171.08 17.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.075 -171.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.42 -44.06 30.87 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.745 2.963 . . . . 0.0 113.351 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.24 -46.8 69.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.133 0.492 . . . . 0.0 111.404 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 92.8 mt-30 -75.98 -12.55 60.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.581 -173.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.03 14.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.2 mtm105 -55.84 -54.89 46.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 24.3 Cg_exo -64.15 -26.71 64.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.842 1.695 . . . . 0.0 111.907 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.435 HD12 ' HB3' ' A' ' 57' ' ' LEU . 75.3 mt -78.72 -46.6 18.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.08 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.73 -34.65 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.832 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.89 65.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.188 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.532 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 50.4 mtt -94.3 -7.83 40.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.006 0.432 . . . . 0.0 110.215 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.95 -8.51 55.98 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.13 122.0 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 0.0 111.004 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.67 109.63 3.78 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.74 110.33 24.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.84 0.352 . . . . 0.0 110.917 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -108.55 116.93 32.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.388 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.95 29.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.495 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.1 mtm -137.49 -172.78 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.304 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.9 159.02 29.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.691 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 p -59.02 -53.04 62.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.967 0.413 . . . . 0.0 110.973 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -65.33 -36.81 85.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.17 75.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 0.0 110.893 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.46 90.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.668 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.391 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -65.18 -42.69 93.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.979 0.418 . . . . 0.0 110.485 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.0 m -65.3 -34.39 78.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.979 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.404 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 60.6 t80 -61.69 -42.76 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.95 177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -57.2 -45.23 83.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.014 0.435 . . . . 0.0 110.586 175.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.72 -53.34 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.402 ' HB2' HG13 ' A' ' 140' ' ' VAL . 93.1 mt -62.43 -31.23 71.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 37.5 ttm -59.96 -50.23 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.493 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.69 72.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.076 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.78 -23.49 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.11 18.63 58.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.552 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -82.69 144.51 30.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -70.71 94.09 0.99 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.077 0.465 . . . . 0.0 110.894 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 133' ' ' LEU . 7.4 p -126.37 138.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.41 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 36' ' ' ALA . 44.9 t -118.89 134.92 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.1 p -115.9 128.69 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 0.0 111.002 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.8 109.82 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.521 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.492 HD23 ' HA3' ' A' ' 95' ' ' GLY . 96.1 mt -113.36 136.47 52.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.706 -173.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 91.7 mt -93.72 133.78 27.41 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.245 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 14.9 Cg_exo . . . . . 0 C--O 1.233 0.242 0 C-N-CA 122.762 2.308 . . . . 0.0 112.804 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 134' ' ' MET . 71.9 mt . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.634 0.254 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -78.87 98.97 6.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.1 m -108.32 137.05 46.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.091 0.472 . . . . 0.0 111.931 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.417 HG21 HG21 ' A' ' 24' ' ' VAL . 80.1 t -73.12 126.16 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.479 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.9 p -87.63 -34.65 18.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.61 0.243 . . . . 0.0 111.314 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.77 172.96 12.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.754 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.24 -33.33 6.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.95 -118.46 14.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.962 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -157.42 107.19 2.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.857 0.361 . . . . 0.0 110.475 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.09 18.96 48.49 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.213 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.932 ' HE1' ' HB2' ' A' ' 23' ' ' GLU . 44.3 p90 -160.34 176.25 11.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.873 0.337 . . . . 0.0 110.593 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.2 mt -123.85 122.13 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.932 ' HB2' ' HE1' ' A' ' 21' ' ' TYR . 28.5 tt0 -105.44 108.85 20.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -172.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.417 HG21 HG21 ' A' ' 14' ' ' VAL . 57.7 t -109.91 107.6 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.946 177.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 58.3 53.63 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.274 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 72.96 -17.97 0.38 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.619 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.72 123.14 29.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.145 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -93.27 102.76 15.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.29 118.05 30.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.563 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -95.14 20.3 9.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.217 0.532 . . . . 0.0 110.133 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -151.08 163.87 37.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.898 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.09 146.62 53.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.197 0.522 . . . . 0.0 112.408 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.73 151.0 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.871 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.47 127.3 40.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -148.31 153.46 38.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.041 0.448 . . . . 0.0 111.397 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.455 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -139.65 159.28 65.91 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.0 -41.36 79.66 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.608 2.205 . . . . 0.0 112.063 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -102.99 94.71 5.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.74 -175.0 23.92 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.815 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -97.89 -178.06 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.365 2.71 . . . . 0.0 112.746 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.21 111.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.14 36.94 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 t -79.2 119.01 21.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.505 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.1 126.0 41.75 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -175.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.5 Cg_exo -69.58 -7.46 21.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.27 2.647 . . . . 0.0 113.048 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.598 HG12 HG12 ' A' ' 52' ' ' ILE . 48.5 t -86.26 102.6 11.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.413 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -98.23 -7.98 28.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.199 0.523 . . . . 0.0 110.448 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.611 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 12.1 mtm180 -138.57 146.26 50.03 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.917 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.57 ' HG3' ' HB3' ' A' ' 98' ' ' ARG . 33.8 Cg_endo -64.74 -9.79 22.33 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.799 2.333 . . . . 0.0 113.259 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.4 -2.98 47.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.468 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.611 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 3.6 m-20 -103.39 9.88 37.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.207 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.598 HG12 HG12 ' A' ' 46' ' ' VAL . 58.2 mt -84.7 126.52 40.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.731 0.301 . . . . 0.0 111.578 -175.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.9 p -128.76 166.61 18.67 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.47 -39.38 83.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.473 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 m -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.247 0.546 . . . . 0.0 110.854 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 46' ' ' VAL . 71.1 mt -72.3 -28.86 63.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.75 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.33 -37.79 80.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.252 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.52 -39.62 94.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.231 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -66.21 -41.53 89.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.574 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -20.26 65.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.546 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.74 -7.42 55.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.21 76.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.485 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.042 0.448 . . . . 0.0 110.837 -177.715 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 CA-C-O 120.836 0.351 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.84 164.56 34.17 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.556 2.171 . . . . 0.0 112.414 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 42.0 mt-10 -92.29 -44.13 8.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 140' ' ' VAL . 7.5 p -139.37 136.87 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.073 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.9 tp -113.28 112.03 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.547 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.99 108.6 21.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.404 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.12 106.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.49 98.4 1.39 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 49' ' ' PRO . 5.3 m -65.96 -14.76 62.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -170.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.34 -72.9 2.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.974 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.57 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 39.6 ttm180 -85.81 70.35 10.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 0.0 110.074 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 66.28 154.46 0.08 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.726 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 53.7 tt0 -62.53 128.92 38.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.878 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -112.93 138.05 50.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.41 97.12 10.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.43 170.74 15.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.321 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.9 144.09 15.78 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.393 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.524 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 48.9 Cg_exo -55.78 -36.47 95.29 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.439 2.759 . . . . 0.0 113.296 -173.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 10.9 mm-40 -63.66 -28.87 70.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -88.26 -9.88 51.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.371 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.17 5.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 110.9 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.573 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.7 mmt180 -53.41 -52.79 63.29 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.292 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 61.7 Cg_exo -53.32 -39.68 80.45 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.153 1.902 . . . . 0.0 112.739 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.2 mt -78.72 -42.12 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.024 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.7 -37.06 80.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 110.617 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.75 70.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 65.1 mtt -83.61 -15.34 49.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.97 8.37 42.15 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.177 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 38.2 t -86.54 108.61 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.744 0.307 . . . . 0.0 110.576 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.75 107.23 2.32 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.828 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.5 t -87.09 111.74 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.783 0.325 . . . . 0.0 110.623 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -112.71 117.5 32.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.388 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 100' ' ' GLN . . . -101.98 115.95 31.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.319 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.478 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 65.4 mtm -139.51 -172.81 3.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.052 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.58 157.34 37.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 34.5 m -60.14 -45.83 91.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.241 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -64.39 -41.02 96.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 110.793 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.46 96.43 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.32 86.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.561 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.43 96.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.447 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -62.72 -48.62 78.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.277 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.0 m -62.73 -38.36 90.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.38 -44.04 95.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.75 -46.54 74.34 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 110.711 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.89 -52.25 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.84 -31.44 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.54 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.463 ' HG2' HD22 ' A' ' 11' ' ' LEU . 48.9 ttp -66.84 -43.23 84.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.825 0.345 . . . . 0.0 110.283 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.98 86.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.16 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.45 36.14 5.22 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.347 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -100.91 161.42 13.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.606 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 55.4 mtp85 -78.57 77.98 5.04 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.368 0.604 . . . . 0.0 111.024 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.483 HG21 HG11 ' A' ' 91' ' ' VAL . 5.7 p -112.04 132.96 59.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.372 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.455 HG21 ' HB1' ' A' ' 36' ' ' ALA . 38.5 t -115.65 134.04 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.5 p -119.04 135.45 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.248 0.546 . . . . 0.0 111.226 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 117.78 30.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.188 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.2 mt -107.37 120.44 42.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.173 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.43 HD23 ' CZ3' ' A' ' 44' ' ' TRP . 71.9 mt -100.96 130.09 25.87 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.278 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 1.9 Cg_endo . . . . . 0 N--CA 1.453 -0.899 0 C-N-CA 122.995 2.463 . . . . 0.0 110.995 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.539 HD22 ' HB2' ' A' ' 35' ' ' PHE . 56.8 t30 -75.05 109.75 8.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -147.06 146.14 29.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.934 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.87 118.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.16 17.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.33 -175.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 23' ' ' GLU . . . -147.44 119.31 8.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.083 0.468 . . . . 0.0 111.332 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -113.18 116.54 29.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.416 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.58 -164.1 9.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.831 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.67 109.05 18.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.748 0.309 . . . . 0.0 110.874 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.2 1.0 72.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.437 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -153.43 142.12 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.556 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.0 mt -126.36 111.95 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.254 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -93.69 117.99 30.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.024 0.44 . . . . 0.0 110.436 -176.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.49 113.05 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.741 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 62.32 39.41 12.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 72.19 9.53 5.95 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.773 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.68 107.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 31.0 ptt-85 -81.53 114.85 20.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.323 0.583 . . . . 0.0 110.394 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.39 128.03 43.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.907 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 p -104.55 14.37 30.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.462 0.649 . . . . 0.0 109.717 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -137.68 171.25 14.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.378 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 145' ' ' LEU . . . -62.27 141.71 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.555 0.534 . . . . 0.0 111.687 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 pt -142.11 136.41 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.26 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.3 120.87 37.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.308 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.539 ' HB2' HD22 ' A' ' 12' ' ' ASN . 40.2 p90 -149.88 162.78 39.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.165 0.507 . . . . 0.0 111.834 -173.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 141' ' ' VAL . . . -130.68 158.62 74.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.747 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.662 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 19.3 Cg_endo -60.1 -32.42 94.68 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.604 2.203 . . . . 0.0 111.702 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -130.44 103.44 6.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.171 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.58 -156.14 26.52 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.923 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.64 162.22 6.43 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.836 2.357 . . . . 0.0 113.091 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -114.27 101.6 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.68 118.99 38.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.954 0.407 . . . . 0.0 111.641 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 65.6 m -66.88 132.66 48.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 170.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.536 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -97.93 129.74 30.42 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -171.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.536 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.83 -0.93 6.0 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.884 2.389 . . . . 0.0 112.917 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.402 ' CG2' HD13 ' A' ' 56' ' ' LEU . 46.8 t -86.22 96.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -89.54 -20.96 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 109.734 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 50' ' ' ALA . 44.4 mtt-85 -129.04 130.85 23.44 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.46 12.06 0.26 Allowed 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.058 2.505 . . . . 0.0 113.669 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' ARG . . . -88.47 -2.59 58.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.998 0.428 . . . . 0.0 110.428 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.87 69.31 1.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.883 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.6 mt -115.26 107.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.159 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -113.85 174.9 5.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.952 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 107' ' ' GLN . . . -62.73 -44.0 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.7 m -59.6 -39.32 83.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.025 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.402 HD13 ' CG2' ' A' ' 46' ' ' VAL . 94.9 mt -70.48 -34.05 71.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.61 -35.59 77.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.1 mt-30 -62.1 -41.91 98.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.46 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -68.62 -38.59 80.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.396 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.8 65.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.57 0.14 35.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 0.0 111.112 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.7 0.1 87.9 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.471 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.814 -176.71 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.522 ' HB3' HG22 ' A' ' 141' ' ' VAL . 15.8 Cg_endo -58.34 132.22 47.49 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.795 2.33 . . . . 0.0 113.266 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -76.34 -33.98 58.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 p -134.78 134.08 53.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.016 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.3 tp -114.12 112.7 23.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.268 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.59 116.01 28.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.36 100.63 11.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -86.04 76.25 2.17 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.353 -174.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 90.48 4.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.041 0.448 . . . . 0.0 109.972 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.33 -30.78 21.28 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.168 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -64.09 -50.39 68.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.304 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -145.32 132.36 20.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -72.41 91.72 1.38 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.97 108.93 7.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.864 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.8 120.19 9.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.9 mt -80.13 149.02 30.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.54 147.36 16.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.277 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 51.6 Cg_exo -55.9 -32.43 85.29 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.182 2.588 . . . . 0.0 112.51 -177.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.15 -29.35 38.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 98.9 mt-30 -73.82 -41.64 62.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.77 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.07 2.69 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 66.9 ttt180 -59.27 -55.46 45.96 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.292 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 19.0 Cg_endo -57.99 -26.94 77.25 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.026 1.817 . . . . 0.0 112.333 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -83.25 -43.87 15.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.393 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.62 -35.16 77.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.76 68.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.227 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 66.0 mtt -83.97 -23.97 30.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.11 0.481 . . . . 0.0 110.175 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.22 3.37 22.88 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.694 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.77 102.94 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.338 . . . . 0.0 110.341 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.23 99.46 1.57 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.103 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.56 127.51 39.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.625 0.25 . . . . 0.0 110.546 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.92 136.63 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.996 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.12 123.46 35.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.054 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.457 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 38.6 ttm -142.52 160.09 40.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -174.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.62 145.4 54.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.457 HG22 HD23 ' A' ' 144' ' ' LEU . 8.8 m -52.33 -45.66 65.74 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.226 0.329 . . . . 0.0 111.711 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -60.13 -50.14 74.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.65 71.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.294 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.3 88.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.629 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.06 97.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.584 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 132' ' ' ILE . 21.0 ttt180 -58.93 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 28.1 m -62.2 -41.71 98.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.63 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 53.0 t80 -54.85 -51.6 65.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.103 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.46 -41.75 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.084 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 128' ' ' ARG . 80.1 mt -62.46 -54.6 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.62 -32.48 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.174 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.662 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 53.2 ttp -64.42 -43.32 94.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.36 175.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.45 -23.68 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.224 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 32.7 mt-10 -88.33 -3.41 58.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.006 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.7 44.17 82.21 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.228 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -117.65 157.31 26.65 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.576 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -73.16 100.39 3.06 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.114 0.483 . . . . 0.0 111.054 -173.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.69 135.24 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.738 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 89' ' ' PRO . 66.6 t -128.6 142.15 44.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.0 p -129.6 136.94 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.661 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 113.94 22.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.253 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.457 HD23 HG22 ' A' ' 123' ' ' THR . 97.1 mt -100.52 127.89 46.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -172.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 32' ' ' ALA . 18.0 mt -117.26 94.5 45.27 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.853 172.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 N--CA 1.455 -0.757 0 C-N-CA 123.272 2.648 . . . . 0.0 112.909 -177.725 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 CA--C 1.523 -0.09 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.402 HD21 ' HB2' ' A' ' 35' ' ' PHE . 3.3 m-20 63.74 23.79 13.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.216 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -61.75 139.7 58.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.204 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.402 HG11 HG23 ' A' ' 22' ' ' ILE . 58.3 t -65.78 103.13 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -70.32 -34.45 72.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.907 -176.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -154.46 149.05 26.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.199 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -120.07 132.22 55.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.02 178.91 17.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.677 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.87 99.26 1.02 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.384 0.274 . . . . 0.0 111.281 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.95 15.65 72.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.314 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -157.55 152.14 25.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.186 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.636 HG12 HD13 ' A' ' 144' ' ' LEU . 3.1 mp -113.41 120.64 63.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 40.1 tt0 -97.33 110.83 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 0.0 110.687 -176.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.455 ' HA ' ' OG1' ' A' ' 15' ' ' THR . 57.5 t -119.99 119.76 61.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.529 176.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 63.42 42.5 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.591 0.557 . . . . 0.0 110.22 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 66.79 10.85 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.319 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.5 115.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -82.02 101.99 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.83 89.33 6.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.083 0.468 . . . . 0.0 110.598 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -86.58 52.16 2.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -168.28 156.85 8.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 44' ' ' TRP . . . -56.73 130.5 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.493 0.495 . . . . 0.0 111.262 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.94 136.1 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.298 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -121.03 114.66 21.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.883 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 34.7 p90 -138.9 152.78 48.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.115 0.483 . . . . 0.0 111.785 -174.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.487 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.54 154.62 71.6 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.135 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 -13.7 27.98 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.731 2.287 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -122.45 22.47 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.72 168.91 29.91 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.335 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.62 172.1 15.69 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.581 2.187 . . . . 0.0 112.07 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.46 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 46.2 t -87.62 95.97 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.62 109.25 7.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.344 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -85.69 131.27 34.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 27.6 m0 -98.31 145.77 30.41 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.642 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.4 Cg_exo -81.71 37.01 0.65 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 110.225 168.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' A' ' 51' ' ' ASP . 54.3 t -108.85 123.04 64.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -171.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -119.02 -9.84 9.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 137.77 28.02 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 96' ' ' THR . 28.7 Cg_endo -65.3 -5.45 11.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.477 2.118 . . . . 0.0 112.143 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.31 4.5 53.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.469 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.535 ' HB2' HG13 ' A' ' 46' ' ' VAL . 60.5 m-20 -90.29 -11.24 41.39 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -62.98 105.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.046 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 67.4 p -111.17 166.13 11.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.34 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -62.88 -32.0 73.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.184 175.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -60.29 -47.97 83.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.604 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.58 -34.39 78.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.843 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.486 ' HB3' HD11 ' A' ' 111' ' ' LEU . 98.7 mt -65.06 -38.79 91.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.817 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 94.9 mt-30 -65.56 -39.08 91.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 110.43 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -71.83 -39.32 69.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.97 -17.71 63.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.878 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.402 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.53 -7.33 56.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.813 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.56 3.15 78.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.163 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.025 0.441 . . . . 0.0 110.922 -178.893 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HB3' ' CG2' ' A' ' 141' ' ' VAL . 6.7 Cg_endo -49.41 136.52 32.33 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 123.996 3.131 . . . . 0.0 113.736 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -77.75 -46.6 21.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.487 HG11 HD22 ' A' ' 133' ' ' LEU . 7.3 p -132.03 133.85 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.637 173.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.45 119.5 35.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.174 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.56 105.22 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.223 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.15 118.34 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -94.43 118.26 5.75 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.558 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -72.13 -5.21 33.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.238 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.23 -80.67 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.537 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.5 ttm-85 -55.54 -55.72 28.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 110.78 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -172.22 152.44 2.81 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.648 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.558 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 44.4 tt0 -58.4 128.41 37.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.775 0.672 . . . . 0.0 112.375 -168.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.49 ' HB2' HG21 ' A' ' 96' ' ' THR . 32.6 m170 -127.62 148.13 50.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.627 175.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 tp -88.42 126.35 35.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.81 171.54 14.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.423 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.19 156.46 16.33 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.753 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.52 -32.48 88.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.222 2.615 . . . . 0.0 112.973 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 tt0 -81.96 -25.14 35.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 110.709 -177.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.54 -44.73 73.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.492 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 35.5 m -97.83 10.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.881 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.628 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 13.5 ttt180 -54.69 -53.88 55.4 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.503 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.5 Cg_exo -59.62 -35.24 95.73 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.031 1.821 . . . . 0.0 112.552 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.661 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.7 mt -75.15 -36.62 61.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.08 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 89.9 mt -57.96 -42.91 85.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.839 0.352 . . . . 0.0 110.476 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.52 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.425 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -81.19 -22.53 38.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 110.715 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.25 17.47 10.74 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 46.7 t -93.3 108.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.426 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.11 86.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.177 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.28 126.02 39.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.736 0.303 . . . . 0.0 111.299 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -127.93 145.75 50.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.028 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.5 128.36 55.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.231 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.523 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.4 mtm -147.03 -175.13 4.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.918 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.99 163.03 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.663 0.268 . . . . 0.0 110.633 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.469 HG22 HD23 ' A' ' 144' ' ' LEU . 5.6 m -56.77 -39.12 73.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.667 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.1 -53.32 59.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.095 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.33 76.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.153 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.18 95.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.325 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.78 81.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.233 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.408 ' O ' HG13 ' A' ' 132' ' ' ILE . 78.4 mtp180 -63.39 -45.31 91.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.8 m -65.8 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.85 -49.73 76.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.449 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -58.98 -41.0 86.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.982 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 128' ' ' ARG . 73.2 mt -63.09 -53.3 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.487 HD22 HG11 ' A' ' 91' ' ' VAL . 10.8 mp -69.16 -23.78 63.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.237 -177.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.4 ttp -66.82 -43.2 84.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 109.889 174.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.28 64.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.739 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.03 -16.52 63.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.782 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.52 37.84 62.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -115.62 151.96 33.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -80.05 84.39 5.79 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.984 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.73 130.43 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.415 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.542 ' CG2' ' HB3' ' A' ' 89' ' ' PRO . 22.9 t -115.29 129.43 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -115.95 138.4 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.925 0.393 . . . . 0.0 110.843 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.24 105.75 12.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.636 HD13 HG12 ' A' ' 22' ' ' ILE . 77.6 mt -100.43 132.82 45.6 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.485 ' HG ' ' HB1' ' A' ' 32' ' ' ALA . 2.0 tt -119.17 86.95 33.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.228 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 N--CA 1.454 -0.853 0 C-N-CA 122.944 2.429 . . . . 0.0 111.439 172.292 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 35.9 t-20 -68.13 105.21 2.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.6 m -119.73 126.12 50.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.474 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.2 120.01 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 p -96.04 -23.36 16.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.738 0.304 . . . . 0.0 111.799 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.28 103.23 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.868 0.366 . . . . 0.0 111.309 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HD1' HG12 ' A' ' 22' ' ' ILE . 88.4 t80 -123.96 131.3 53.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.753 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.23 -4.72 33.5 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.29 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -91.34 17.34 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 0.0 110.916 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.01 -42.93 2.09 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 54.0 p90 -111.77 176.28 5.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.45 HG12 ' HD1' ' A' ' 17' ' ' TYR . 48.9 mt -119.49 113.29 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.96 0.409 . . . . 0.0 110.207 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 34.0 tt0 -89.35 118.8 29.28 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.8 t -105.03 104.18 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.161 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 65.69 -80.45 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.935 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -132.22 2.54 3.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.204 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.3 t -125.35 127.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 0.0 111.035 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 66.6 mtt85 -86.99 113.11 22.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 88.8 m-85 -99.24 148.84 23.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.873 0.368 . . . . 0.0 110.836 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -88.72 -67.66 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.067 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -115.7 -169.14 1.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.927 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.627 ' HA ' ' O ' ' A' ' 144' ' ' LEU . . . -36.24 128.29 0.74 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.417 HG23 ' HA ' ' A' ' 43' ' ' SER . 18.5 pt -143.71 162.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.32 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -137.15 133.64 35.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.812 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.636 ' HB3' HG11 ' A' ' 41' ' ' VAL . 37.1 p90 -157.2 163.01 39.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.291 0.567 . . . . 0.0 112.244 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.407 ' HA ' ' HH ' ' A' ' 130' ' ' TYR . . . -130.95 161.89 58.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 73.5 Cg_exo -49.45 -55.04 4.52 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.132 2.555 . . . . 0.0 112.347 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -131.93 95.12 3.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.09 -153.54 17.15 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.937 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.1 134.69 13.21 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.758 2.305 . . . . 0.0 113.321 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG11 ' HB3' ' A' ' 35' ' ' PHE . 53.9 t -114.14 121.39 66.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.78 168.16 20.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.127 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 33' ' ' ILE . 11.6 p -99.94 150.23 22.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.937 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.58 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -98.33 131.64 25.83 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.58 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 37.7 Cg_endo -67.01 -11.13 31.06 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.842 2.361 . . . . 0.0 112.592 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.432 ' CG2' HD12 ' A' ' 56' ' ' LEU . 10.9 t -86.1 146.1 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.94 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -129.11 -1.44 5.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.489 ' HD2' ' OD2' ' A' ' 51' ' ' ASP . 50.9 mtt85 -134.67 137.17 26.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.46 -7.02 19.08 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.954 2.436 . . . . 0.0 112.377 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.44 -13.94 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.376 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.489 ' OD2' ' HD2' ' A' ' 48' ' ' ARG . 27.4 m-20 -96.23 3.88 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.164 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.51 122.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.875 0.369 . . . . 0.0 111.257 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.1 p -121.57 176.3 5.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.373 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -64.29 -37.61 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 0.0 110.199 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -48.41 78.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.506 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.432 HD12 ' CG2' ' A' ' 46' ' ' VAL . 44.0 mt -70.63 -30.44 67.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.952 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 111' ' ' LEU . 81.0 mt -67.23 -39.1 86.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.454 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 24.6 mt-30 -58.18 -39.9 80.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.076 0.465 . . . . 0.0 110.214 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -68.41 -42.58 78.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.645 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.68 -13.15 62.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.88 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.1 -13.2 62.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.105 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.99 88.32 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.634 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.47 . . . . 0.0 110.809 -178.797 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 18.1 Cg_exo -66.42 155.73 68.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.947 2.431 . . . . 0.0 112.15 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.34 -44.9 13.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.0 0.429 . . . . 0.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.485 HG11 HG21 ' A' ' 140' ' ' VAL . 4.9 p -133.02 133.91 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.399 0.618 . . . . 0.0 111.245 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -111.79 110.7 21.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.337 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 119' ' ' GLU . 97.2 mt -90.35 113.12 24.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.58 118.45 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -92.9 101.49 2.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 p -76.33 56.68 1.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 145' ' ' LEU . . . 76.35 -103.38 1.71 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.614 171.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.59 -35.49 11.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.238 . . . . 0.0 111.262 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -142.55 159.71 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.653 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.747 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.7 tt0 -62.79 111.19 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.792 175.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -113.73 116.18 29.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.039 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 143.01 57.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.068 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.27 -164.92 1.16 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.03 147.44 16.24 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.763 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.57 -42.42 65.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.063 2.509 . . . . 0.0 112.658 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.914 0.388 . . . . 0.0 111.697 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 98.7 mt-30 -96.24 -39.98 9.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 109.858 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.82 -24.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.801 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.517 ' HA ' HD13 ' A' ' 112' ' ' LEU . 7.8 ttp180 -63.4 -38.29 38.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.84 -43.41 23.93 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.803 1.668 . . . . 0.0 112.264 170.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.72 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.4 mt -75.5 -36.21 60.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 109' ' ' ARG . 96.3 mt -61.08 -31.24 70.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.73 -22.49 63.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -87.9 -30.62 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 122.47 9.07 6.67 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.155 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.72 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 17.1 t -98.89 110.13 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 111.023 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.28 122.91 6.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.606 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.28 125.23 46.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.937 0.399 . . . . 0.0 111.491 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' HB2' HD21 ' A' ' 93' ' ' LEU . 51.8 mm-40 -110.01 103.24 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.682 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.43 109.8 21.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.614 0.245 . . . . 0.0 110.355 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.747 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 63.2 mtm -141.97 -177.24 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 -176.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.63 147.61 36.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.973 172.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.485 HG22 ' HB3' ' A' ' 144' ' ' LEU . 61.8 m -55.86 -44.46 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.691 0.281 . . . . 0.0 111.323 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -64.0 -44.01 93.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.568 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.07 99.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.003 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.02 79.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.98 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.6 94.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.97 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -61.11 -50.08 74.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.041 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.607 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.54 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 73.2 t80 -61.55 -46.74 88.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.691 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -56.0 -44.55 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.462 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 62.3 mt -69.29 -54.27 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.237 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -57.11 -40.31 76.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -175.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 46.7 ttp -58.95 -36.67 75.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.68 -13.11 54.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 27.1 mm-40 -88.5 -35.44 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 170.42 98.92 0.12 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.06 85.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.409 0.684 . . . . 0.0 112.84 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -144.45 33.79 1.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 133' ' ' LEU . 7.2 p -127.45 140.42 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.567 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.0 t -124.74 143.84 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.54 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 9.9 p -120.63 140.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.305 -176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -129.72 109.23 10.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.315 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 84.2 mt -116.58 138.9 51.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.78 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 5.0 mp -108.76 94.34 14.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 O-C-N 123.239 0.337 . . . . 0.0 110.171 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_endo . . . . . 0 N--CA 1.458 -0.575 0 C-N-CA 123.281 2.654 . . . . 0.0 111.566 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.235 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -76.69 94.69 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 m -109.44 137.76 46.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.658 -171.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.11 127.35 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 p -105.77 -56.33 2.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.657 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -114.89 135.57 54.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.1 0.476 . . . . 0.0 110.877 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.11 167.38 10.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.649 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.07 -172.43 35.05 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.75 -63.51 1.19 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.134 0.492 . . . . 0.0 110.763 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.12 -5.43 65.83 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.907 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 13.0 p90 -139.9 148.72 42.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.858 0.361 . . . . 0.0 110.045 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.66 120.41 58.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 32.5 tt0 -96.37 114.1 25.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.317 0.58 . . . . 0.0 110.566 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.34 125.23 59.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.679 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.04 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -141.54 16.04 2.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.606 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.58 129.73 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.369 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.3 mtp-105 -88.23 114.84 25.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.074 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.17 100.47 9.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.78 0.324 . . . . 0.0 111.123 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 36.2 m -83.81 36.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.439 0.637 . . . . 0.0 109.818 173.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.489 ' HB2' HG22 ' A' ' 33' ' ' ILE . 8.1 m170 -120.22 169.81 9.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.2 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.33 105.26 15.86 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 164.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 31' ' ' HIS . 19.4 pt -112.24 132.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.419 0.628 . . . . 0.0 112.625 -169.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -113.6 121.63 44.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.429 174.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -147.88 155.79 41.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.273 0.559 . . . . 0.0 111.773 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.487 ' HB1' HG23 ' A' ' 141' ' ' VAL . . . -129.23 159.88 66.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.628 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 23.0 Cg_endo -62.71 -25.68 75.08 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.447 2.098 . . . . 0.0 111.628 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -125.63 108.23 11.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.561 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.05 -170.3 23.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.323 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.93 -177.29 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.38 121.86 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.976 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.7 119.46 38.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.962 0.41 . . . . 0.0 110.789 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -94.06 131.8 39.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.345 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -98.28 137.1 20.74 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.037 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.53 0.05 9.91 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.017 2.478 . . . . 0.0 111.374 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.415 HG23 HD11 ' A' ' 56' ' ' LEU . 29.7 t -85.88 113.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.486 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -111.79 7.77 20.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 0.0 110.794 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.521 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 54.0 ttp180 -127.02 115.44 21.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 26.8 Cg_exo -63.44 -10.81 22.99 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.4 2.733 . . . . 0.0 113.883 -173.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.37 -2.0 58.35 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.269 -0.269 . . . . 0.0 111.38 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.521 ' OD2' ' HB3' ' A' ' 48' ' ' ARG . 42.5 m-20 -98.16 -2.83 39.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.89 118.55 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.206 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.7 m -129.4 169.16 15.27 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 107' ' ' GLN . . . -49.71 -54.33 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -173.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.7 -33.52 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.415 HD11 HG23 ' A' ' 46' ' ' VAL . 98.3 mt -65.23 -44.54 87.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.498 . . . . 0.0 110.224 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.99 -37.25 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.664 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.511 ' HA ' HD21 ' A' ' 111' ' ' LEU . 48.2 tt0 -62.09 -37.52 85.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.701 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -71.61 -41.3 69.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.58 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.11 -4.94 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.875 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.09 -4.42 38.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.531 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.42 35.52 52.01 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.096 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 110.661 -179.351 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 121.404 0.621 . . . . 0.0 112.625 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.45 165.86 26.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.695 2.264 . . . . 0.0 111.271 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.724 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.2 mt-10 -94.8 -38.01 10.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.769 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.496 HG12 HG22 ' A' ' 140' ' ' VAL . 6.0 p -144.08 137.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 111.179 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.6 tp -113.26 115.39 28.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.702 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.05 116.16 28.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.578 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.51 121.64 52.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.261 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.38 89.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.044 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.59 36.91 1.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.227 0.537 . . . . 0.0 109.832 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.552 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -79.78 63.3 4.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.009 -170.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -161.11 -52.62 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.54 90.3 2.4 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -71.24 93.12 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.7 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -76.09 107.46 8.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.207 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.64 126.04 26.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.16 165.7 15.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.68 157.91 15.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.93 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.94 -33.72 97.46 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.04 2.493 . . . . 0.0 112.594 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.79 -20.5 62.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.952 0.406 . . . . 0.0 111.005 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 87.9 mt-30 -88.02 -35.11 17.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.448 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 30.2 m -92.48 -21.03 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.741 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.547 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 7.5 tmm_? -59.07 -48.55 96.38 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 8.5 Cg_endo -51.14 -43.42 48.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.323 2.015 . . . . 0.0 112.626 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 58' ' ' GLN . 91.8 mt -75.04 -37.03 61.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.9 mt -66.02 -34.71 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.0 -31.22 72.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.213 0.53 . . . . 0.0 110.363 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -75.39 -38.28 60.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.79 -12.25 5.91 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.934 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.08 109.66 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.753 0.311 . . . . 0.0 110.871 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.34 115.98 4.79 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.003 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.55 123.53 43.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.621 0.248 . . . . 0.0 110.812 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -129.39 120.2 25.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.12 122.8 44.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.494 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 70.0 mtm -139.9 -171.82 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.36 150.04 49.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.715 0.293 . . . . 0.0 110.218 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.552 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 8.2 m -56.36 -42.53 77.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.337 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 52.3 tt0 -72.82 -35.98 67.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.18 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.34 -36.46 82.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.126 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.23 95.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.142 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.551 ' O ' HG12 ' A' ' 132' ' ' ILE . 69.5 mtm180 -64.59 -55.85 17.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.412 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -59.71 -32.95 70.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.261 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.431 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 81.7 t80 -59.03 -54.27 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -61.3 -34.22 74.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.472 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 128' ' ' ARG . 45.0 mm -59.76 -55.31 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.551 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 72.0 mt -71.89 -31.05 66.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.3 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 ttp -62.12 -49.97 73.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 110.48 178.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.18 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.736 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.42 -16.63 61.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.516 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.46 31.53 24.59 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -106.05 147.4 28.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.012 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.724 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 68.9 mtm180 -81.41 88.81 6.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.274 0.559 . . . . 0.0 110.6 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 91' ' ' VAL . 7.4 p -120.19 138.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.958 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.487 HG23 ' HB1' ' A' ' 36' ' ' ALA . 40.1 t -121.06 140.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -124.21 138.9 52.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.008 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.84 103.98 9.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.408 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.8 mt -100.63 122.59 43.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.879 0.371 . . . . 0.0 111.165 -173.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.08 109.02 54.89 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.461 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 C--N 1.342 0.221 0 C-N-CA 123.311 2.674 . . . . 0.0 110.904 174.152 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mmm . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.679 0.276 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -91.84 116.33 28.81 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.0 mt -73.01 117.74 15.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.988 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -76.43 124.95 28.35 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.4 m -91.34 104.39 16.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 20.1 m-20 -88.17 107.54 16.87 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.841 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 1.5 Cg_endo -82.48 120.7 3.25 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.091 2.527 . . . . 0.0 112.66 -174.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.647 ' HB1' HD22 ' A' ' 11' ' ' LEU . . . -95.26 122.94 38.48 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -2.46 17.32 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.83 -14.78 57.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.194 0.521 . . . . 0.0 110.422 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.647 HD22 ' HB1' ' A' ' 8' ' ' ALA . 3.9 mm? -88.84 84.82 6.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -70.06 104.08 2.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.357 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.4 m -126.14 151.71 46.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.231 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.01 122.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.183 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.2 p -89.54 -20.3 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.315 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.44 140.59 10.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.657 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.43 -79.82 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.5 162.68 38.53 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.839 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -107.99 111.25 23.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.857 0.36 . . . . 0.0 110.674 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.653 ' HA2' ' HB2' ' A' ' 149' ' ' ASP . . . 98.2 4.32 57.53 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.238 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -162.14 172.41 15.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.73 124.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 28.9 tt0 -94.53 109.5 21.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.002 0.43 . . . . 0.0 111.169 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -117.05 124.01 72.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 62.85 29.55 16.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.604 0.716 . . . . 0.0 109.506 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.404 ' HA ' ' CG ' ' A' ' 23' ' ' GLU . 34.8 mt-30 65.64 13.98 9.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.723 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.2 110.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 92.1 mtt180 -86.41 96.8 10.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.993 -174.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.78 115.43 22.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.486 ' OG ' ' HG ' ' A' ' 151' ' ' LEU . 2.7 p -90.47 28.71 1.41 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.261 0.553 . . . . 0.0 111.064 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -154.1 171.39 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.785 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.23 138.05 58.24 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.286 0.366 . . . . 0.0 111.2 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.19 147.69 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . . . -123.1 116.52 23.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 175.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -135.83 157.82 45.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.957 0.408 . . . . 0.0 111.057 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.488 ' HB3' HG23 ' A' ' 141' ' ' VAL . . . -139.5 160.16 62.73 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.65 -57.04 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.456 2.104 . . . . 0.0 110.492 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.79 103.11 12.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.35 178.73 32.65 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.902 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -88.61 176.02 3.6 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 112.919 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.14 104.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.344 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . . . -85.99 126.62 34.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.559 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -91.26 118.62 30.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.794 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' A' ' 60' ' ' ALA . 1.3 m0 -98.32 130.23 28.78 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.42 23.48 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.937 2.425 . . . . 0.0 111.178 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.514 HG12 ' HB2' ' A' ' 51' ' ' ASP . 73.2 t -85.71 136.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.771 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -117.85 -24.26 7.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.068 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HG2' ' OD2' ' A' ' 51' ' ' ASP . 8.0 ptt180 -139.03 155.66 72.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.02 -176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 1.88 2.41 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.538 2.159 . . . . 0.0 112.897 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.73 -14.74 24.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.33 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.514 ' HB2' HG12 ' A' ' 46' ' ' VAL . 65.1 m-20 -77.32 -19.34 56.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.12 117.53 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.006 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 30.7 p -121.57 175.45 6.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.852 175.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.9 71.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -62.31 -45.39 93.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.133 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.53 -30.71 68.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.003 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 53' ' ' THR . 90.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.356 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -65.27 -38.3 89.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -68.46 -42.58 78.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.376 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.4 ' HB2' ' CZ2' ' A' ' 44' ' ' TRP . . . -65.38 -26.39 67.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.562 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' A' ' 63' ' ' LEU . . . -73.74 -12.88 60.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.022 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.57 28.41 73.17 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.603 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 61' ' ' ALA . 91.4 mt -70.99 -75.83 0.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.495 0.188 . . . . 0.0 111.268 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 53.35 69.2 0.73 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.935 -176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.03 -43.19 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.866 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 p -90.38 115.09 29.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.648 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.13 125.23 42.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.718 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -65.2 -40.08 93.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.038 0.447 . . . . 0.0 110.068 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 70' ' ' PRO . 37.8 m-20 -122.57 94.25 47.8 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.932 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 69' ' ' ASP . 21.1 Cg_endo -61.32 121.53 9.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.734 2.289 . . . . 0.0 112.435 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.6 mt -81.49 -42.3 20.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.458 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.35 96.58 5.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.413 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -77.74 118.12 19.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.201 0.524 . . . . 0.0 110.997 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.97 128.44 36.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.584 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -82.17 -0.4 44.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.286 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.77 82.12 0.22 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.43 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -88.45 3.6 5.86 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.823 2.348 . . . . 0.0 111.591 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 80' ' ' GLY . 24.0 tt0 -141.77 156.89 45.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.55 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.15 19.76 3.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.097 0.475 . . . . 0.0 110.241 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.704 ' H ' ' HG2' ' A' ' 78' ' ' GLU . . . -81.69 -75.77 1.1 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.631 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.84 164.72 37.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.013 0.435 . . . . 0.0 111.154 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.52 153.76 16.7 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.27 121.19 41.43 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -81.01 155.6 72.56 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.773 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 87' ' ' ASN . 87.9 Cg_exo -47.57 -48.91 14.39 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.588 2.859 . . . . 0.0 114.3 -172.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.87 1.18 2.17 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.396 0.617 . . . . 0.0 110.849 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 85' ' ' PRO . 89.2 m-20 -100.56 13.49 34.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.562 177.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.24 158.53 87.31 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.144 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.482 ' HB3' HG22 ' A' ' 141' ' ' VAL . 9.1 Cg_endo -51.29 111.7 0.63 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.841 2.361 . . . . 0.0 111.985 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 3.9 tt0 -69.5 -32.47 71.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.69 HG12 HD11 ' A' ' 133' ' ' LEU . 3.3 p -136.01 131.31 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.456 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -112.96 121.19 43.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.866 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.5 mt -101.2 104.55 15.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.284 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.865 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -105.69 114.31 4.5 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -76.11 -20.97 57.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 -58.4 4.79 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.402 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -81.17 -55.31 4.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.744 0.307 . . . . 0.0 110.565 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -159.89 143.45 14.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -52.66 114.61 1.45 Allowed 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.118 0.886 . . . . 0.0 112.113 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -96.85 111.85 23.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.21 98.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.814 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.07 134.26 40.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 108' ' ' VAL . . . -106.04 175.27 21.26 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.735 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 74.3 Cg_exo -49.63 -34.61 35.25 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.351 2.7 . . . . 0.0 112.542 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -49.47 -43.66 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.283 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -96.01 -37.9 10.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.185 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 104' ' ' GLY . 35.0 m -91.42 -14.36 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -171.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 1.1 tmt_? -57.33 -44.7 99.78 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -47.45 -32.08 14.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.3 2.0 . . . . 0.0 113.188 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 93.7 mt -92.33 -36.24 13.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.679 0.276 . . . . 0.0 110.785 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 87.2 mt -58.49 -36.7 74.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.02 68.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.16 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.87 -12.18 45.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.65 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.14 14.69 38.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.029 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.1 t -86.99 107.82 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 0.0 110.659 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.77 111.33 3.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.605 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.12 124.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 111.487 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -102.86 129.11 49.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.193 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.01 102.5 13.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 0.0 110.495 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.536 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.8 mtm -140.43 -171.77 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -105.42 172.13 6.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.508 HG23 HD21 ' A' ' 144' ' ' LEU . 88.5 m -52.29 -48.52 65.3 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.586 0.554 . . . . 0.0 112.345 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -62.37 -50.01 73.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.99 85.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.711 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.91 75.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.41 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.408 ' O ' HG13 ' A' ' 132' ' ' ILE . 47.0 mtt180 -59.82 -48.07 83.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.835 0.35 . . . . 0.0 111.117 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -66.25 -36.73 83.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -60.45 -45.39 93.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.528 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -58.56 -40.32 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.4 mt -62.11 -54.63 31.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.723 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.69 HD11 HG12 ' A' ' 91' ' ' VAL . 74.3 mt -66.95 -32.28 73.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.365 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.457 ' HG2' HD13 ' A' ' 11' ' ' LEU . 54.2 ttp -72.74 -36.88 67.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.36 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.48 80.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.073 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.51 -36.97 74.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.32 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.04 41.79 5.79 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.482 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -111.77 153.62 26.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 90' ' ' GLU . 19.9 mmt180 -63.52 97.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 111.307 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.66 136.25 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.305 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 36' ' ' ALA . 37.5 t -123.83 133.51 69.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.4 p -116.43 130.53 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.254 0.55 . . . . 0.0 111.068 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.16 112.41 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.508 HD21 HG23 ' A' ' 123' ' ' THR . 77.2 mt -103.31 139.55 38.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.556 HD21 ' HD2' ' A' ' 146' ' ' PRO . 2.2 tt -122.86 132.41 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.556 ' HD2' HD21 ' A' ' 145' ' ' LEU . 56.0 Cg_exo -53.25 134.61 57.39 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.479 . . . . 0.0 112.216 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -93.91 14.26 20.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.08 -38.61 0.21 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.153 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.653 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 24.9 m-20 -110.68 176.36 5.07 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.628 -175.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 76.1 p -174.09 -171.19 0.6 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.847 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.539 HD11 ' H ' ' A' ' 151' ' ' LEU . 4.4 mp -60.55 -33.16 72.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.895 0.379 . . . . 0.0 110.77 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -59.79 -36.86 77.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.004 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -74.73 -10.49 59.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -75.91 -22.66 55.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.848 0.356 . . . . 0.0 110.336 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -101.51 173.81 6.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.508 ' HD2' ' HD2' ' A' ' 157' ' ' HIS . 26.5 p-80 -122.72 0.93 9.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.309 0.576 . . . . 0.0 109.725 173.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.508 ' HD2' ' HD2' ' A' ' 156' ' ' HIS . 2.9 m-70 -136.48 -172.63 3.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.397 174.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 53.2 m80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.569 178.082 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mmm . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -100.47 -57.66 2.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.844 0.354 . . . . 0.0 111.598 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.1 mt -81.08 67.9 7.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.476 0.655 . . . . 0.0 111.497 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -144.75 11.35 1.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.569 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -146.52 -178.99 6.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.968 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.82 144.44 52.9 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -54.53 -22.21 27.07 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.76 2.307 . . . . 0.0 112.653 174.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 73.87 -61.53 0.49 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.681 0.792 . . . . 0.0 111.788 176.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -74.04 104.35 4.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.713 0.292 . . . . 0.0 110.95 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . -77.39 130.42 37.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.51 -42.71 61.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.701 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 61.62 87.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.417 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.3 m -107.32 118.79 37.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.088 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -69.16 100.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.701 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.44 -25.32 42.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.507 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 23' ' ' GLU . . . -155.88 149.67 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.741 176.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -87.0 -15.14 39.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.54 -161.87 48.13 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.294 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.05 87.03 2.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.29 60.89 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.673 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.53 148.36 17.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.8 mt -97.08 138.75 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 4.2 tm-20 -110.22 109.7 20.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 109.932 -175.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.67 111.22 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 m120 53.39 52.64 13.06 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.722 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 73.3 -0.02 3.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.172 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.14 122.64 64.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.476 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 53.7 mtm180 -97.0 111.26 23.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.498 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -93.53 117.75 30.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 m -88.35 -7.64 56.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.177 0.513 . . . . 0.0 110.008 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -116.07 161.62 18.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.181 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 145.5 55.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 110.733 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.03 147.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.919 0.39 . . . . 0.0 111.671 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -129.08 112.5 14.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.682 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.513 ' HB3' HG12 ' A' ' 41' ' ' VAL . 32.5 p90 -139.4 162.27 35.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.994 0.426 . . . . 0.0 111.813 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.51 ' HB3' HG21 ' A' ' 141' ' ' VAL . . . -139.36 156.56 71.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.136 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HD3' ' HE1' ' A' ' 130' ' ' TYR . 6.2 Cg_exo -78.66 9.56 3.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.121 2.547 . . . . 0.0 112.068 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -152.32 21.31 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.781 0.8 . . . . 0.0 108.997 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.14 -169.69 12.6 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.915 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -86.75 176.56 4.58 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.787 2.325 . . . . 0.0 112.612 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 35' ' ' PHE . 34.2 t -112.58 104.5 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.649 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.85 152.36 21.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.701 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 m -108.87 132.69 53.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.533 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -113.05 126.65 27.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.534 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 2.0 Cg_endo -83.37 9.74 3.97 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.218 2.612 . . . . 0.0 111.302 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 51' ' ' ASP . 41.5 t -86.8 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.508 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -120.98 -33.75 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.815 0.34 . . . . 0.0 111.383 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' HB2' ' OD2' ' A' ' 51' ' ' ASP . 69.6 mtp85 -108.03 147.66 35.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.973 0.416 . . . . 0.0 110.818 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HG3' ' O ' ' A' ' 96' ' ' THR . 12.7 Cg_exo -70.21 -6.01 17.82 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.047 2.498 . . . . 0.0 112.212 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.75 -19.68 24.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.321 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.552 ' HB2' HG12 ' A' ' 46' ' ' VAL . 30.1 m-20 -82.91 -20.21 35.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.13 116.94 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.825 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.1 p -113.48 169.51 8.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.371 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -60.27 -34.62 73.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m -59.1 -46.87 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.504 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.434 HD12 HG23 ' A' ' 46' ' ' VAL . 97.9 mt -66.93 -33.78 76.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.627 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.22 -40.9 97.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.8 mt-30 -62.95 -33.77 76.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.06 -43.74 56.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.32 66.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.746 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -21.98 66.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.86 94.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.331 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.8 25.06 0.69 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 111.309 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.16 123.24 13.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.78 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.07 106.61 17.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.323 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.66 100.54 6.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 69' ' ' ASP . 11.5 p -120.43 159.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.256 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.6 mtm-85 -89.54 -6.43 56.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.931 0.396 . . . . 0.0 110.743 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 67' ' ' VAL . 35.4 t70 -121.48 101.09 43.89 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.914 0.388 . . . . 0.0 110.711 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -89.25 5.83 4.73 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.773 2.315 . . . . 0.0 112.208 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.1 mt -89.6 -42.66 11.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 46.55 72.92 0.2 Allowed 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.859 0.724 . . . . 0.0 111.93 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.22 -27.07 62.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.144 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.47 -12.96 60.02 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.883 0.373 . . . . 0.0 110.947 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.45 125.8 46.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.12 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -75.26 136.26 72.41 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.8 86.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.634 2.889 . . . . 0.0 114.193 -172.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.711 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 4.9 mm-40 -140.52 91.4 2.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.033 175.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.63 96.44 8.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.78 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.31 -55.88 5.04 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.484 173.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.49 -17.98 62.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.654 0.264 . . . . 0.0 111.68 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.711 ' HA3' ' HB3' ' A' ' 78' ' ' GLU . . . -89.8 39.17 3.13 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.45 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.76 171.53 20.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 86' ' ' ALA . 29.8 mmm180 -120.56 157.55 53.82 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.285 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.41 12.06 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.707 2.271 . . . . 0.0 112.79 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 84' ' ' ARG . . . -75.81 -17.87 59.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.075 0.464 . . . . 0.0 110.204 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -87.17 2.29 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.473 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.73 159.75 31.79 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.415 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.477 ' O ' HG21 ' A' ' 116' ' ' VAL . 53.9 Cg_exo -53.44 139.04 65.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.473 2.115 . . . . 0.0 112.06 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' OE1' ' HG3' ' A' ' 138' ' ' ARG . 37.3 tt0 -88.22 -36.89 16.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.036 0.446 . . . . 0.0 110.134 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.73 138.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.237 0.541 . . . . 0.0 111.258 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -114.92 118.77 34.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.661 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.07 119.46 39.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.202 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.58 121.74 59.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.838 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -96.81 106.31 3.33 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.507 ' HA ' HD13 ' A' ' 145' ' ' LEU . 12.6 p -83.5 13.35 4.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -171.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.09 -102.4 1.15 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.213 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 72.3 mtt-85 -62.99 -45.73 91.03 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -142.49 140.23 31.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.842 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.9 tt0 -66.17 96.73 0.35 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.144 0.497 . . . . 0.0 110.241 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -99.42 99.65 10.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.743 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.5 mt -60.57 137.83 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.05 -178.69 5.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.474 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 147.79 16.32 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.872 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.645 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 11.4 Cg_endo -55.17 -40.77 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.852 2.368 . . . . 0.0 112.113 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.17 -27.79 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.182 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -74.82 -37.51 62.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.986 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 34.5 m -92.13 -7.68 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 42.7 mtm180 -53.95 -49.18 91.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 66.6 Cg_exo -53.7 -39.36 83.75 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.103 1.869 . . . . 0.0 112.704 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 94.0 mt -78.13 -39.1 42.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.62 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 85.5 mt -62.39 -32.63 73.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.642 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.15 78.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.747 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 60.3 mtt -77.83 -38.86 45.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.041 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.09 3.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.625 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 31.0 t -90.43 115.8 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.53 0.205 . . . . 0.0 110.539 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.03 132.26 10.96 Favored Glycine 0 C--O 1.224 -0.531 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.02 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.63 123.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 117.318 0.559 . . . . 0.0 111.115 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.69 131.75 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.501 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.15 128.68 51.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.842 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 71.7 mtm -144.96 -171.82 3.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.3 156.25 34.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.447 HG22 HD23 ' A' ' 144' ' ' LEU . 40.4 m -57.91 -43.75 86.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.916 0.389 . . . . 0.0 110.927 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.51 -40.65 80.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.71 89.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 110.966 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.4 -47.36 76.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.51 96.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' HG13 ' A' ' 132' ' ' ILE . 42.4 ttm180 -63.4 -50.15 70.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.69 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -63.32 -35.85 81.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.432 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.592 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 50.9 t80 -57.73 -44.99 86.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.761 175.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -64.14 -39.26 93.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.2 mt -64.18 -50.23 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.747 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.85 -26.04 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.799 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 36.8 ttm -61.88 -50.42 72.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.068 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.491 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.88 -44.37 97.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.59 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 105.42 33.33 3.67 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.061 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 138' ' ' ARG . 17.0 ttm180 -100.05 144.98 28.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -70.46 79.62 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.987 0.422 . . . . 0.0 110.879 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.31 128.54 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.924 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 36' ' ' ALA . 25.9 t -113.11 131.57 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.8 p -115.67 131.64 67.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.57 111.34 22.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.395 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 123' ' ' THR . 98.9 mt -107.05 120.83 43.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.738 0.304 . . . . 0.0 111.672 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 96' ' ' THR . 94.8 mt -93.93 126.0 50.84 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.699 172.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 118.73 5.63 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.611 2.208 . . . . 0.0 112.426 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.8 115.31 6.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.751 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.11 -44.77 0.22 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.627 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 68.47 -176.37 0.2 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.054 0.542 . . . . 0.0 110.248 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.3 m -159.46 -24.64 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 122.876 0.47 . . . . 0.0 109.78 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.5 tp -86.71 -40.38 15.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.242 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -107.48 114.09 27.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.638 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -112.23 165.67 11.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -70.28 -49.26 51.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -82.45 134.83 35.23 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -95.69 -16.9 21.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.017 0.437 . . . . 0.0 110.797 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -120.7 -90.31 0.58 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.7 m80 . . . . . 0 C--O 1.246 0.879 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.612 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -66.48 -46.17 77.23 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.4 tp -79.09 125.35 29.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -57.0 -53.31 59.5 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.185 0.303 . . . . 0.0 111.594 -171.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.589 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 24.2 m -87.54 116.83 25.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.785 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.44 101.36 1.29 Allowed Pre-proline 0 C--O 1.234 0.268 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 5' ' ' THR . 83.7 Cg_endo -95.9 157.19 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.234 2.623 . . . . 0.0 113.006 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.83 103.9 15.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.608 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -11.39 60.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.754 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.38 -12.15 60.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 0.0 110.858 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.9 mt -104.9 93.54 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.94 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 34.8 t30 -74.6 125.6 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.018 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -154.48 142.77 20.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.831 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.98 112.5 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.231 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 p -74.23 -32.8 63.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.296 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 23' ' ' GLU . . . -131.19 92.13 3.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.761 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' HE2' ' HG2' ' A' ' 124' ' ' GLN . 71.0 t80 -104.61 -3.22 24.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.377 0.608 . . . . 0.0 109.904 175.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.32 -23.71 70.24 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.927 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.98 -175.58 4.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 111.152 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.48 14.69 60.57 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.523 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.475 ' HB3' HD21 ' A' ' 151' ' ' LEU . 27.4 p90 -148.97 173.35 13.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.75 108.19 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 0.0 111.091 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 45.7 tt0 -93.5 112.5 24.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.133 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.4 95.92 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.887 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 m120 64.63 -77.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.757 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -119.09 -28.11 5.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.074 -176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.39 127.7 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -173.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 23.3 mtm180 -98.52 109.68 22.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.277 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -91.2 131.71 36.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -101.9 14.51 31.75 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.561 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -148.98 179.06 8.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.821 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.81 139.9 58.36 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.551 0.532 . . . . 0.0 111.25 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 pt -145.1 156.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.305 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.56 130.6 50.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.251 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.56 ' HB3' HG11 ' A' ' 41' ' ' VAL . 36.5 p90 -150.43 154.86 38.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.367 0.603 . . . . 0.0 112.06 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -119.17 164.56 20.68 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.531 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 26.4 Cg_exo -63.32 -42.37 22.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.413 2.075 . . . . 0.0 111.607 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.75 101.55 7.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.23 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.78 -157.55 27.67 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.297 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -93.39 163.81 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.285 2.656 . . . . 0.0 113.197 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.56 HG11 ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -114.15 116.67 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.46 145.92 41.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.341 . . . . 0.0 111.419 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -79.07 128.73 33.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.606 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.445 ' C ' ' H ' ' A' ' 46' ' ' VAL . 1.7 t90 -98.32 116.97 65.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 12.8 Cg_exo -71.56 33.93 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.503 2.802 . . . . 0.0 112.888 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 51' ' ' ASP . 94.2 t -114.68 125.44 72.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.534 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.12 -49.42 4.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.176 0.512 . . . . 0.0 110.894 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -107.88 150.91 40.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 14.7 Cg_endo -59.63 -19.78 54.68 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.336 2.024 . . . . 0.0 111.796 174.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.26 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.296 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.537 ' HB2' HG13 ' A' ' 46' ' ' VAL . 11.8 m-20 -68.73 -28.4 66.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.805 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -54.44 115.06 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.608 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -121.95 159.77 26.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.874 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 107' ' ' GLN . . . -52.84 -44.32 66.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -63.16 -35.8 81.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.226 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.445 HD13 HG23 ' A' ' 46' ' ' VAL . 49.9 mt -69.57 -31.83 70.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.36 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.79 -35.46 80.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.182 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.342 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -70.66 -39.37 73.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.452 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.44 ' HB1' ' CE2' ' A' ' 44' ' ' TRP . . . -69.68 -23.85 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.853 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -81.43 -7.36 59.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.957 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.55 37.83 85.67 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.388 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' A' ' 61' ' ' ALA . 97.1 mt -83.02 13.43 4.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 111.527 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.8 82.27 5.21 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -81.53 143.55 31.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.199 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 21.8 t -138.43 166.37 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.443 ' N ' HG11 ' A' ' 66' ' ' VAL . 48.8 t -58.67 -24.45 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 110.051 172.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 66' ' ' VAL . 96.3 mtt180 72.75 -68.86 0.21 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.415 176.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.7 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 12.6 t70 -168.52 -57.65 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.668 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 69' ' ' ASP . 93.1 Cg_endo -90.37 142.0 3.5 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.894 1.729 . . . . 0.0 112.262 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.63 -19.88 61.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.232 0.539 . . . . 0.0 109.888 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.29 109.5 20.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.956 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -75.91 135.26 40.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.239 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.4 -42.72 5.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.24 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.59 -62.34 1.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.238 0.336 . . . . 0.0 110.153 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -81.98 108.92 12.76 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.53 -46.3 4.04 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.696 2.264 . . . . 0.0 112.82 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.74 166.96 23.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.385 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.18 -1.88 28.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.274 0.559 . . . . 0.0 109.753 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.77 -139.62 27.69 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.458 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.96 21.94 10.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.997 0.427 . . . . 0.0 110.755 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.97 -153.39 5.91 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.911 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.5 11.1 12.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.016 0.436 . . . . 0.0 110.557 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.492 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 8.8 ptp180 -124.26 123.61 25.93 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.791 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 2.7 Cg_endo -86.47 -157.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.469 2.779 . . . . 0.0 111.642 176.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.01 20.18 17.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.36 0.6 . . . . 0.0 110.104 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -69.08 -15.22 63.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.994 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.55 133.95 76.57 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.173 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.437 ' HG2' ' HB1' ' A' ' 61' ' ' ALA . 50.2 Cg_exo -56.4 127.8 27.46 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.884 2.39 . . . . 0.0 112.686 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -64.24 -46.87 81.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.448 0.642 . . . . 0.0 109.528 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.79 132.07 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.876 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.493 ' HB3' HG23 ' A' ' 118' ' ' VAL . 57.3 tp -114.26 117.38 30.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.96 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.1 mt -101.51 117.03 34.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.336 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.2 t -104.05 110.32 29.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.444 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.08 96.84 2.17 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.597 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 33.4 p -80.87 -13.63 58.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.776 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.69 -101.52 1.42 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.751 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -62.85 -58.49 7.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.345 . . . . 0.0 111.336 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.4 mmt-85 -109.2 122.33 47.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.992 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.597 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 53.3 tt0 -74.51 97.19 3.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.441 ' HB3' HG21 ' A' ' 96' ' ' THR . 40.1 t-80 -73.6 104.82 4.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.862 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.63 142.26 53.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.442 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -93.16 160.22 14.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.852 0.358 . . . . 0.0 110.617 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.79 162.36 14.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.609 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.27 -49.52 16.06 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.74 2.293 . . . . 0.0 112.253 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -62.48 -25.79 68.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.568 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 93.7 mt-30 -76.78 -34.35 57.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.775 0.322 . . . . 0.0 111.316 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.8 -11.57 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.609 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 68.0 mtm180 -52.34 -55.26 33.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 23.0 Cg_endo -61.19 -35.4 85.85 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.038 1.826 . . . . 0.0 113.006 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.4 mt -80.77 -37.85 29.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.0 111.179 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.6 mt -69.26 -23.89 63.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.318 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.72 68.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.445 175.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 62.4 mtt -88.46 -35.85 16.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.29 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.55 14.51 5.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.289 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.1 t -85.32 108.44 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.694 0.283 . . . . 0.0 110.568 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.46 94.72 1.73 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.969 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 92' ' ' LEU . 39.9 t -88.6 129.88 38.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 0.0 111.213 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -126.73 139.89 52.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.124 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.4 128.23 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.7 mtt -140.31 -173.38 3.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.224 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -91.84 168.31 11.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.4 m -59.49 -35.76 74.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 111.761 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.579 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 7.1 tm0? -75.84 -52.46 10.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.62 98.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.535 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.43 87.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.83 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.11 78.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -73.66 -45.49 52.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.639 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -63.04 -35.75 81.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.128 0.49 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -54.01 -46.25 71.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.948 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -63.34 -41.57 98.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.836 0.35 . . . . 0.0 110.814 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.0 mt -64.02 -47.4 90.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.793 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.94 -27.62 66.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.004 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 56.3 ttp -65.58 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.041 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.01 -26.66 61.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.34 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -67.31 -35.8 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.452 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.2 9.72 55.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.91 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -87.85 155.5 19.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -82.78 87.13 6.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.473 0.654 . . . . 0.0 111.09 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -103.66 132.88 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.757 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.412 HG21 ' HB1' ' A' ' 36' ' ' ALA . 57.6 t -120.3 136.13 58.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.1 p -121.57 135.81 60.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.313 0.577 . . . . 0.0 111.232 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.08 119.85 36.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.115 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.7 mt -110.17 125.31 52.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.971 0.415 . . . . 0.0 111.616 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 96' ' ' THR . 95.5 mt -104.09 153.63 38.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.073 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.02 172.81 12.59 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.922 2.415 . . . . 0.0 112.011 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.47 -34.26 60.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.616 0.722 . . . . 0.0 110.009 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.31 -41.62 0.48 Allowed Glycine 0 CA--C 1.502 -0.78 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -78.8 143.41 36.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.886 -0.657 . . . . 0.0 109.988 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.7 m -143.03 156.19 44.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.29 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 21' ' ' TYR . 4.5 mm? -70.01 -25.42 63.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.928 0.394 . . . . 0.0 110.446 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.82 105.89 7.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -62.38 -34.17 76.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.876 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -109.54 106.71 16.54 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -55.93 128.58 35.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.0 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -97.33 135.56 39.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.56 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -117.01 -35.91 3.96 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 167.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.2 t60 . . . . . 0 C--O 1.246 0.887 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.434 173.695 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.661 0.267 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -143.58 150.67 39.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.267 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -71.73 -21.67 61.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.237 0.541 . . . . 0.0 109.934 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -127.42 102.34 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.557 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 p -88.13 130.95 34.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.534 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 56.93 64.93 4.16 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.669 -173.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.48 5.3 5.65 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.787 2.324 . . . . 0.0 112.09 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.14 90.97 5.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.675 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -73.15 156.26 38.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.223 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.18 48.46 0.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 0.0 111.78 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.8 mt -147.72 80.58 1.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.984 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -64.75 102.12 0.55 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 0.0 110.365 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -110.03 146.09 35.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.764 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 17' ' ' TYR . 47.9 t -68.32 109.73 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -44.49 61.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.573 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -139.35 116.87 11.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.244 0.545 . . . . 0.0 111.377 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' HB2' HG11 ' A' ' 14' ' ' VAL . 89.5 t80 -136.5 142.29 43.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.072 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.81 -90.02 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -144.41 137.14 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.02 -91.17 0.79 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.341 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -111.81 177.71 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.701 0.286 . . . . 0.0 110.951 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.5 mt -128.92 136.31 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -114.82 120.56 40.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.144 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.72 117.62 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 64.36 49.72 2.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.507 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 68.25 18.55 9.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.173 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -128.61 121.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.4 mtm-85 -88.42 110.87 21.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.639 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -90.91 114.7 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.017 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.2 m -92.99 29.01 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.304 0.573 . . . . 0.0 110.179 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -152.51 167.97 27.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.533 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.43 147.53 52.49 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.384 0.428 . . . . 0.0 111.233 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -140.74 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.074 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.72 123.08 25.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.46 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 45.2 p90 -152.36 162.19 41.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.35 0.595 . . . . 0.0 111.956 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.94 155.05 58.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.571 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.91 -57.65 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.678 2.252 . . . . 0.0 111.987 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.35 27.68 3.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.5 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.65 -172.57 13.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.273 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -87.05 173.39 5.85 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.823 2.349 . . . . 0.0 112.593 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.502 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -109.1 113.79 45.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.983 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.5 133.57 50.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.036 0.446 . . . . 0.0 111.158 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m -76.44 124.16 27.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.165 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.46 126.27 40.03 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 0.9 OUTLIER -83.43 8.63 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.46 2.773 . . . . 0.0 113.111 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.09 135.82 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -120.69 -48.83 2.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.106 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.553 HH11 ' HG2' ' A' ' 48' ' ' ARG . 24.3 mtt-85 -93.37 139.89 23.06 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.449 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.85 -10.29 27.8 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.185 2.59 . . . . 0.0 112.494 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.21 5.0 52.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.443 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 1.2 m-20 -109.7 0.24 18.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.36 127.01 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -135.14 156.9 48.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.25 62.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -57.56 -37.73 73.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.272 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.464 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.31 -34.79 63.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.541 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.17 -41.82 98.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.95 -41.48 86.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.82 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.66 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.347 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.492 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -79.88 -4.57 52.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.141 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.52 17.7 77.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.55 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 88' ' ' ALA . 96.4 mt -86.69 -9.83 55.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.967 0.413 . . . . 0.0 110.697 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.69 -173.68 3.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.468 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.19 108.3 4.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.937 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.0 128.87 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.982 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 m -75.1 74.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.567 0.698 . . . . 0.0 112.497 -174.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -129.58 -88.63 0.51 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -175.88 99.52 0.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 170.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.37 98.94 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.887 2.391 . . . . 0.0 112.594 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.9 mt -90.33 -27.01 19.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.975 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.07 100.8 12.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.161 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -83.02 137.01 34.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.036 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.7 mt -80.14 3.13 21.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.721 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.39 -11.71 60.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.588 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -109.62 151.62 42.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.579 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.47 128.38 29.93 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.347 2.698 . . . . 0.0 112.953 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -88.73 146.08 25.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.08 -168.05 2.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.977 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.03 61.48 3.75 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.295 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.6 -66.14 0.97 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.813 0.339 . . . . 0.0 110.418 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 84' ' ' ARG . . . -97.66 -37.41 4.49 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 71.21 -17.58 0.31 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.789 0.836 . . . . 0.0 112.779 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 82' ' ' GLY . 65.7 mtt-85 -130.26 134.01 25.6 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.97 -16.45 29.09 Favored 'Trans proline' 0 N--CA 1.466 -0.093 0 C-N-CA 122.677 2.251 . . . . 0.0 112.143 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -120.08 76.32 1.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.871 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -110.73 71.4 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.444 0.64 . . . . 0.0 109.439 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.408 ' HA ' HD23 ' A' ' 63' ' ' LEU . . . -90.91 157.55 43.22 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.631 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.492 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 70.0 Cg_exo -52.28 137.37 55.68 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.559 2.173 . . . . 0.0 112.159 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -68.91 -41.47 78.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.78 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.466 HG13 HD11 ' A' ' 133' ' ' LEU . 3.6 p -140.71 137.75 35.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 118' ' ' VAL . 58.9 tp -122.16 118.62 29.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.58 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.416 HD13 HD12 ' A' ' 133' ' ' LEU . 89.3 mt -98.49 119.04 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.388 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.1 t -109.85 114.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.385 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.51 106.69 3.08 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.0 p -76.16 -30.88 58.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.53 -61.84 2.36 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.164 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.499 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 64.1 mtt85 -73.18 -75.14 0.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.326 0.584 . . . . 0.0 110.89 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -134.36 137.05 43.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.084 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -73.73 109.32 7.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.881 0.372 . . . . 0.0 111.218 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -72.7 108.01 5.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.5 108.79 3.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.04 141.41 58.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.404 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.36 150.78 16.91 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.7 -19.34 60.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.013 2.475 . . . . 0.0 112.699 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 mt-10 -94.91 -14.43 24.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.231 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -86.27 -40.76 15.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 111' ' ' LEU . 3.7 t -96.21 13.61 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.638 0.732 . . . . 0.0 109.654 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.44 ' HB2' ' HA ' ' A' ' 106' ' ' GLU . 56.1 ttt85 -49.83 -54.81 28.34 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.16 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.17 -33.51 49.31 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.692 1.595 . . . . 0.0 112.325 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.429 ' HB2' HG11 ' A' ' 108' ' ' VAL . 88.9 mt -73.34 -46.44 49.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.66 -33.98 76.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.17 -32.67 74.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 73.8 mtm -81.75 -25.07 35.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.659 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.23 22.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.449 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.53 107.73 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 110.697 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.67 96.15 1.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.781 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 92' ' ' LEU . 46.5 t -89.33 118.83 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.811 0.339 . . . . 0.0 110.717 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -107.07 108.4 19.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.66 106.01 17.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 110.267 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.2 mtm -136.34 -171.68 2.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.032 0.444 . . . . 0.0 110.791 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 125' ' ' ALA . 1.9 m-20 -66.76 158.92 29.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.399 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -63.07 -42.44 99.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.221 0.534 . . . . 0.0 109.917 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.535 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 53.1 tt0 -66.23 -42.7 88.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.441 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.401 ' H ' ' HB2' ' A' ' 122' ' ' ASP . . . -63.68 -44.15 94.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.99 96.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.938 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.37 93.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 124' ' ' GLN . 63.0 mtm180 -62.77 -48.38 79.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.9 m -62.99 -34.01 76.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.787 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -62.69 -44.74 95.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.369 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.406 ' HA ' ' HG2' ' A' ' 134' ' ' MET . 90.6 m-20 -65.84 -28.15 68.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.714 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 128' ' ' ARG . 81.3 mt -72.16 -50.74 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.516 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.466 HD11 HG13 ' A' ' 91' ' ' VAL . 98.0 mt -67.51 -34.97 78.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.804 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.406 ' HG2' ' HA ' ' A' ' 131' ' ' ASN . 19.0 ptp -67.84 -29.94 69.21 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.418 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.71 -26.69 40.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.59 -39.79 57.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.532 . . . . 0.0 109.903 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 30.84 5.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.821 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -100.92 148.26 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -71.11 99.83 1.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.031 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.56 140.56 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.107 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.67 142.64 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 7.2 p -120.83 139.52 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.187 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -126.55 115.04 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -116.24 135.39 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.2 mt -109.21 99.67 37.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.49 135.7 26.98 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.337 2.025 . . . . 0.0 111.496 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.499 ' OD1' ' HG2' ' A' ' 98' ' ' ARG . 30.4 t70 -88.27 158.31 18.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.44 -5.41 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.129 -0.558 . . . . 0.0 111.962 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.87 114.79 4.76 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.4 p -80.91 94.48 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.5 tp -75.39 112.96 12.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.629 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.73 156.37 39.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.304 177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -102.31 88.2 3.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -85.6 145.8 27.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.92 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -104.38 140.21 38.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -87.65 12.76 11.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.571 0.701 . . . . 0.0 110.448 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -75.38 -21.55 58.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.894 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.844 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.66 0.266 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -120.1 150.56 40.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.22 110.41 21.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.648 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -65.49 109.87 2.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.146 0.498 . . . . 0.0 110.065 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 135' ' ' ALA . 26.6 m -82.7 102.4 11.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.958 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.18 90.67 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.994 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.67 23.35 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.385 2.723 . . . . 0.0 113.004 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.67 -43.84 53.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.147 0.499 . . . . 0.0 110.229 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 38' ' ' GLU . 16.1 p -132.52 151.2 51.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.607 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 108.77 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.922 0.392 . . . . 0.0 110.227 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.16 117.91 14.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.222 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.95 113.97 24.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.13 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -116.3 143.13 45.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.646 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.91 115.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -87.26 -46.31 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.147 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.71 138.54 19.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.721 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -156.69 104.61 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.88 -29.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.841 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 23.1 m-20 -73.45 -29.26 62.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.018 0.437 . . . . 0.0 111.057 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.59 -12.53 4.28 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.5 p90 -111.92 154.9 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.35 111.37 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -94.17 112.94 24.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.038 0.447 . . . . 0.0 110.387 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.72 110.61 28.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.462 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 62.54 45.33 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.546 . . . . 0.0 109.965 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 73.73 -6.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.047 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.05 117.86 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -91.25 102.36 15.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.368 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.89 127.19 35.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.771 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -104.97 17.36 24.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -116.62 172.39 7.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HB3' HD22 ' A' ' 145' ' ' LEU . . . -74.31 137.35 42.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 164.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 pt -134.99 144.87 33.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.413 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.74 125.67 38.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 44.7 p90 -149.08 162.58 39.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.075 0.464 . . . . 0.0 111.326 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' HB3' HG23 ' A' ' 141' ' ' VAL . . . -139.75 163.28 45.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.699 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.72 -36.93 34.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.72 2.28 . . . . 0.0 112.946 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.47 ' HG2' HG21 ' A' ' 9' ' ' THR . 24.0 mt-10 -124.85 32.7 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.053 0.454 . . . . 0.0 110.521 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.31 16.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.873 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.83 147.32 80.63 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.687 2.258 . . . . 0.0 111.502 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 26.1 t -80.24 88.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.1 124.57 29.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.377 -174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.7 m -82.05 121.89 27.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.6 ' HZ2' ' HB3' ' A' ' 56' ' ' LEU . 1.2 t90 -103.79 121.76 46.97 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.57 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.66 13.98 1.54 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.821 2.347 . . . . 0.0 112.951 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.442 HG22 HD12 ' A' ' 56' ' ' LEU . 48.5 t -95.79 112.82 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.47 -29.34 18.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -113.54 126.33 28.29 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.463 -173.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.16 -1.53 4.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.995 2.463 . . . . 0.0 113.209 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.14 -15.09 23.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -84.32 -7.81 59.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.015 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 56' ' ' LEU . 60.1 mt -69.62 130.44 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.501 -175.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.2 p -111.25 179.77 3.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.702 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -68.33 -35.08 77.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 m -65.11 -41.72 94.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.49 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.6 ' HB3' ' HZ2' ' A' ' 44' ' ' TRP . 61.7 mt -65.17 -36.57 84.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.071 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.49 ' HB3' HD13 ' A' ' 111' ' ' LEU . 72.1 mt -63.09 -37.32 86.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.709 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 96.6 mt-30 -65.97 -40.69 91.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.83 -40.66 88.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.813 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.34 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.45 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HB3' HD22 ' A' ' 92' ' ' LEU . . . -82.33 -2.02 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.87 72.74 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.349 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.431 HD12 ' SD ' ' A' ' 114' ' ' MET . 96.4 mt -85.87 64.31 8.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.82 0.819 . . . . 0.0 110.758 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -135.57 126.49 27.65 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.273 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.74 105.05 2.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.979 0.419 . . . . 0.0 110.706 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.7 HG11 HG21 ' A' ' 67' ' ' VAL . 48.0 t -111.15 137.26 44.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.291 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.7 HG21 HG11 ' A' ' 66' ' ' VAL . 93.1 t 74.17 117.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 123.918 0.761 . . . . 0.0 111.575 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -79.38 96.58 6.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.711 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -84.35 117.62 69.15 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.134 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -85.37 -0.78 9.02 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.817 2.345 . . . . 0.0 113.388 -176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.8 mt -87.73 -4.02 58.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.36 . . . . 0.0 111.021 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.95 0.87 14.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.285 0.564 . . . . 0.0 110.581 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -69.3 -27.98 65.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.481 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 98.0 mt -133.42 166.15 23.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.118 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.807 ' HB3' ' HA2' ' A' ' 82' ' ' GLY . 4.1 p30 -142.94 151.22 40.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.002 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -70.99 120.18 77.88 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -14.06 75.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 126.355 4.703 . . . . 0.0 115.847 -163.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -120.74 -47.94 2.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.312 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.82 26.38 16.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.147 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.45 -75.82 0.75 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.48 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.7 -40.46 9.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.832 0.348 . . . . 0.0 111.268 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.807 ' HA2' ' HB3' ' A' ' 75' ' ' ASP . . . 83.5 28.5 35.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.341 -176.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -168.66 -167.53 0.78 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -89.68 110.81 42.08 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.31 153.98 51.02 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 123.046 2.497 . . . . 0.0 112.121 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 55.37 65.38 1.49 Allowed 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.8 0.687 . . . . 0.0 110.978 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.55 3.86 11.18 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.696 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.89 148.29 92.01 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.378 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.59 123.77 14.66 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.746 2.297 . . . . 0.0 112.296 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 50.6 mt-10 -65.11 -50.62 65.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.63 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.474 HG12 HG21 ' A' ' 140' ' ' VAL . 4.2 p -135.02 130.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.382 0.611 . . . . 0.0 111.47 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 61' ' ' ALA . 65.2 tp -107.52 113.28 26.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.521 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 119' ' ' GLU . 95.9 mt -93.19 98.11 11.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.539 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -91.6 105.72 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -84.27 108.82 3.15 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 175.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.0 p -62.62 -17.44 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.614 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 65.5 -92.2 0.15 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.853 171.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.22 -51.25 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.711 0.405 . . . . 0.0 111.638 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -144.66 134.26 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -70.04 112.03 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.813 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -113.06 147.43 37.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.255 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.68 106.86 18.84 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.7 169.79 12.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.14 147.96 16.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.728 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.525 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 51.1 Cg_exo -57.15 -24.59 59.5 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.354 2.703 . . . . 0.0 112.601 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -56.16 -31.97 63.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.223 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -89.28 -23.43 22.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.825 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 105' ' ' PRO . 20.2 m -93.68 -21.57 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.536 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 57.5 mtm-85 -53.94 -49.36 90.0 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 11.7 Cg_endo -55.72 -34.52 91.03 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.982 1.788 . . . . 0.0 112.754 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 62.5 mt -81.57 -37.5 27.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.736 0.303 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.1 mt -64.69 -32.67 74.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.924 0.392 . . . . 0.0 110.584 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.72 -10.26 59.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.431 ' SD ' HD12 ' A' ' 63' ' ' LEU . 67.1 mtt -97.05 -43.82 7.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.257 0.551 . . . . 0.0 109.737 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.02 10.71 2.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.208 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.66 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 39.7 t -98.5 125.99 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 110.475 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.23 124.51 8.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.71 115.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.646 0.26 . . . . 0.0 110.994 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.442 ' HB2' HD22 ' A' ' 93' ' ' LEU . 27.1 mm-40 -112.35 127.97 56.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.856 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.29 104.91 14.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.502 ' HB3' ' HB3' ' A' ' 126' ' ' ALA . 36.9 ttm -129.78 168.73 16.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.323 -169.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.13 155.67 27.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.915 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.614 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -54.37 -52.4 61.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.861 -177.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -77.65 -37.96 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.426 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.26 91.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.091 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 121' ' ' MET . . . -65.92 -44.29 85.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.729 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.05 93.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.702 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -64.5 -51.86 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.6 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.9 m -59.0 -36.97 75.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.92 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -57.99 -46.35 85.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.958 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -64.12 -37.24 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 110.592 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.65 -46.74 85.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.02 -24.11 64.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.4 ttm -64.97 -47.22 78.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.442 ' HA ' HG23 ' A' ' 5' ' ' THR . . . -70.52 -21.87 62.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.57 -11.76 59.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.061 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 70.14 32.64 69.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.815 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -100.78 150.38 22.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.745 0.307 . . . . 0.0 110.641 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.4 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 49.8 mtm180 -78.69 90.7 4.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.474 0.654 . . . . 0.0 110.94 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.474 HG21 HG12 ' A' ' 91' ' ' VAL . 6.0 p -123.4 137.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.587 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 36' ' ' ALA . 39.5 t -116.41 133.2 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.3 p -110.72 134.92 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.28 113.53 16.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.643 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -110.41 129.36 55.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.782 0.325 . . . . 0.0 111.197 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.553 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 69.6 mt -103.67 98.84 13.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.393 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.03 175.88 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.555 2.17 . . . . 0.0 112.225 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -98.36 -170.71 2.0 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.48 -15.08 0.22 Allowed Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -102.1 -29.57 11.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.208 -0.496 . . . . 0.0 111.101 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.9 m -73.03 -32.03 64.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 0.0 110.245 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.45 100.92 11.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.82 142.58 58.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.747 -172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -104.9 104.41 14.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.896 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -70.37 -44.41 68.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.99 110.59 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 164.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -82.27 -38.13 24.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -162.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -94.21 -10.64 32.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.515 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.065 177.407 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.807 0.337 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -134.44 -174.8 3.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.735 172.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 7' ' ' PRO . 87.8 mt -110.07 179.51 4.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.854 0.359 . . . . 0.0 110.975 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -95.76 -40.83 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.322 0.582 . . . . 0.0 109.572 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.618 HG22 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -99.06 -164.86 1.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.607 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.789 ' HB3' ' HA2' ' A' ' 82' ' ' GLY . 3.9 p-10 -65.47 147.78 98.45 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.729 0.3 . . . . 0.0 110.59 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.65 ' HA ' HD11 ' A' ' 3' ' ' LEU . 5.0 Cg_exo -76.42 33.71 0.42 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.401 2.734 . . . . 0.0 112.913 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 68.94 113.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.455 0.702 . . . . 0.0 112.282 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.414 ' HB ' ' H ' ' A' ' 10' ' ' ALA . 8.0 p -90.56 -153.59 0.31 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.744 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' H ' ' HB ' ' A' ' 9' ' ' THR . . . -120.45 166.67 13.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.554 0.216 . . . . 0.0 111.099 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 37' ' ' PRO . 88.0 mt -126.1 152.35 46.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -152.94 127.25 9.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.747 0.308 . . . . 0.0 110.355 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.679 ' HG1' ' HE2' ' A' ' 134' ' ' MET . 23.4 m -110.9 141.01 44.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -175.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -68.19 115.59 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -49.09 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.94 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -134.66 129.48 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.234 0.54 . . . . 0.0 111.817 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HE1' HG21 ' A' ' 123' ' ' THR . 85.0 t80 -104.14 102.57 12.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.49 175.2 47.38 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.784 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -81.19 -21.46 39.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.042 0.449 . . . . 0.0 110.64 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.63 -39.68 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.35 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -124.23 170.5 10.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.98 133.42 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -113.99 120.88 42.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.924 0.393 . . . . 0.0 110.035 -177.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -124.58 110.73 25.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.436 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 61.6 51.27 4.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.63 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 68.85 14.25 8.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.283 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.0 108.89 26.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -83.05 119.37 24.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.188 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -98.6 107.61 20.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.401 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -89.61 14.08 12.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.865 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -140.9 161.5 37.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.589 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -58.72 142.79 48.89 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.586 0.554 . . . . 0.0 111.097 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 pt -136.41 139.78 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.362 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -133.19 109.72 9.64 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.495 ' HB3' HG13 ' A' ' 41' ' ' VAL . 42.8 p90 -146.83 161.01 41.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.486 0.66 . . . . 0.0 112.24 -170.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.501 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -109.48 154.81 42.1 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.565 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 11' ' ' LEU . 54.0 Cg_endo -70.14 -5.71 17.09 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.145 1.896 . . . . 0.0 111.891 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -92.15 17.14 9.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.004 -170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.95 -99.74 0.34 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.298 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 16.7 Cg_endo -56.82 134.59 65.46 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.681 2.921 . . . . 0.0 114.658 -170.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 35' ' ' PHE . 96.3 t -113.69 119.95 62.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 157.61 16.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 m -124.52 148.14 47.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -115.92 139.54 25.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.983 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.11 23.98 0.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.195 2.597 . . . . 0.0 110.499 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 51' ' ' ASP . 93.3 t -85.9 130.25 36.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.572 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -113.14 -40.98 3.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -106.01 145.62 31.29 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 28.1 Cg_endo -64.32 -8.82 17.83 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.791 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.12 -12.71 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.56 ' HB2' HG13 ' A' ' 46' ' ' VAL . 73.4 m-20 -81.13 -16.42 53.07 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.46 114.57 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.758 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -111.47 155.44 23.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.846 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 107' ' ' GLN . . . -52.17 -38.96 59.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.758 0.313 . . . . 0.0 111.318 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m -57.46 -43.82 84.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.997 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.67 -32.8 72.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.21 -35.77 81.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -69.65 -33.16 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 110.394 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.23 -44.78 78.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.886 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 141' ' ' VAL . . . -64.01 -35.22 80.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.276 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.98 62.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.316 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.53 40.4 59.58 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.364 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt -82.35 62.23 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.714 0.769 . . . . 0.0 110.668 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.51 146.49 42.03 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.465 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -60.84 -52.76 63.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.321 0.581 . . . . 0.0 109.767 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.703 HG21 ' HB3' ' A' ' 77' ' ' PRO . 46.6 t -122.16 104.32 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.438 173.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.0 t -70.02 108.86 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.923 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -72.51 93.87 1.62 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.77 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 40' ' ' PRO . 25.5 t70 -69.62 123.43 88.49 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.726 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.01 2.88 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.044 2.496 . . . . 0.0 113.245 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -91.29 -42.22 10.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.02 0.438 . . . . 0.0 110.031 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.48 -171.13 3.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.364 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -130.35 28.7 4.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.082 0.468 . . . . 0.0 110.226 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.6 mt -127.73 -165.87 1.54 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 12.3 m-20 -125.74 84.91 2.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.412 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -102.36 106.77 50.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.79 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.703 ' HB3' HG21 ' A' ' 66' ' ' VAL . 91.6 Cg_endo -96.51 -164.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.367 2.711 . . . . 0.0 112.28 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.434 ' OE2' ' HA ' ' A' ' 87' ' ' ASN . 42.1 tt0 -78.95 127.7 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.97 111.27 13.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.805 0.336 . . . . 0.0 110.887 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.72 -100.06 1.42 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.983 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -162.0 127.48 3.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.789 ' HA2' ' HB3' ' A' ' 6' ' ' ASP . . . -79.08 -169.82 37.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.864 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.06 83.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.056 0.455 . . . . 0.0 110.894 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.69 HH12 ' HA3' ' A' ' 115' ' ' GLY . 53.7 mtt180 -113.15 125.73 29.29 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -51.73 -40.13 65.77 Favored 'Trans proline' 0 N--CA 1.477 0.54 0 C-N-CA 124.051 3.167 . . . . 0.0 115.318 -166.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.86 30.28 0.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.434 ' HA ' ' OE2' ' A' ' 78' ' ' GLU . 64.9 t30 58.8 28.39 17.34 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.965 0.888 . . . . 0.0 109.721 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . -88.87 130.65 44.05 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.766 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.83 173.56 14.22 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.61 2.206 . . . . 0.0 111.715 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' OE2' ' HD2' ' A' ' 138' ' ' ARG . 34.1 tt0 -90.58 -38.71 12.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.347 0.594 . . . . 0.0 109.762 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.8 HG12 HD23 ' A' ' 133' ' ' LEU . 3.3 p -139.59 142.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.284 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.3 tp -118.84 118.12 30.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.487 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.56 115.07 29.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.383 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.8 t -107.0 115.05 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.808 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.66 105.25 3.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 49' ' ' PRO . 19.8 p -77.08 4.42 10.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -171.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 74.07 -91.12 0.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.338 -0.458 . . . . 0.0 114.228 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.897 ' HG2' ' HA2' ' A' ' 148' ' ' GLY . 52.9 mtt-85 -67.83 -60.93 2.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.967 0.413 . . . . 0.0 111.077 -171.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.527 ' HD2' ' C ' ' A' ' 98' ' ' ARG . 3.4 mpt_? -129.41 148.34 51.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.9 99.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 109.841 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.741 ' HD2' HD22 ' A' ' 103' ' ' LEU . 47.8 t60 -92.34 118.43 30.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.606 -174.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.71 110.59 4.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.231 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.741 HD22 ' HD2' ' A' ' 101' ' ' HIS . 67.1 mt -77.48 151.98 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 161.84 14.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.23 -170.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.73 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 46.9 Cg_endo -68.41 -1.24 6.99 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.238 2.625 . . . . 0.0 112.721 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -89.09 -23.0 22.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.39 0.614 . . . . 0.0 109.871 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 77.5 mt-30 -94.63 -47.89 6.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.507 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 m -86.13 -1.02 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.739 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 18.3 ttm180 -56.19 -56.02 35.65 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 41.9 Cg_exo -57.82 -39.72 84.71 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.923 1.749 . . . . 0.0 112.365 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.8 mt -74.09 -40.98 62.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.7 tp -60.86 -36.47 79.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.531 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.24 -27.67 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.998 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.04 -9.38 59.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.15 0.5 . . . . 0.0 110.102 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.69 ' HA3' HH12 ' A' ' 84' ' ' ARG . . . 100.83 -0.44 55.21 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.273 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 40.8 t -79.63 103.3 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.817 0.342 . . . . 0.0 110.361 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.45 101.74 1.3 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.921 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -88.74 110.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.701 0.286 . . . . 0.0 110.588 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -110.76 135.82 50.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.18 124.9 50.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.071 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.02 -171.83 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.72 164.88 19.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.468 HG21 ' HE1' ' A' ' 17' ' ' TYR . 21.1 m -64.19 -34.09 77.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.066 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.41 -47.38 27.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.589 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.28 86.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.695 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.801 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.89 -45.58 93.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.919 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.06 -51.29 70.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.716 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.5 m -62.19 -39.28 92.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.725 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -57.1 -49.74 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.242 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.51 -44.9 95.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -68.33 -44.28 83.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 110.925 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.8 HD23 HG12 ' A' ' 91' ' ' VAL . 23.5 tp -66.63 -37.32 84.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.866 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.679 ' HE2' ' HG1' ' A' ' 13' ' ' THR . 33.4 ttp -63.35 -37.18 86.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.446 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.49 -29.1 69.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.46 -34.95 78.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 0.0 110.26 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.05 29.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.445 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.497 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 55.8 mtm180 -97.86 137.03 37.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 122.763 -0.257 . . . . 0.0 110.452 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -65.38 110.51 2.67 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.429 0.633 . . . . 0.0 111.319 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG23 HD21 ' A' ' 133' ' ' LEU . 5.4 p -130.03 135.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 60' ' ' ALA . 47.0 t -109.52 140.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -122.23 132.93 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.129 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.42 113.97 24.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.343 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.466 HD22 HG23 ' A' ' 123' ' ' THR . 94.2 mt -114.95 125.19 53.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.942 0.401 . . . . 0.0 111.503 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 96' ' ' THR . 97.8 mt -97.76 119.55 62.22 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.213 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 27.6 Cg_endo -89.77 160.18 5.13 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.6 t70 64.59 108.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.676 0.61 . . . . 0.0 110.828 -175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.897 ' HA2' ' HG2' ' A' ' 98' ' ' ARG . . . -140.22 -84.7 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.624 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.79 -40.85 24.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.331 0.586 . . . . 0.0 110.308 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.0 t -83.19 108.32 16.35 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.523 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.79 157.86 19.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -100.1 122.89 43.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.199 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -92.25 152.75 19.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.003 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -63.39 -36.86 85.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.274 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -79.12 -4.51 50.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.813 0.34 . . . . 0.0 110.911 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -83.25 12.77 4.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.52 0.676 . . . . 0.0 109.974 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -108.26 -32.76 7.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.994 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.976 -175.409 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -65.56 -33.54 76.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.488 0.661 . . . . 0.0 109.809 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -95.41 144.74 25.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.985 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -94.89 28.94 2.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.22 0.533 . . . . 0.0 110.845 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 t -159.68 152.7 21.86 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.703 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.61 157.22 86.29 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.72 117.04 3.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.688 2.259 . . . . 0.0 112.385 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.88 115.49 9.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.792 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -71.67 147.07 47.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.96 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.36 131.31 49.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.741 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.67 104.19 0.5 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.27 108.22 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.261 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -111.79 146.7 37.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.186 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.93 125.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -84.15 -46.15 12.22 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 153.09 30.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.516 . . . . 0.0 112.257 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.43 123.54 35.81 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.77 -8.68 60.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.601 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.92 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.636 0.731 . . . . 0.0 110.11 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.9 -19.3 28.1 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -153.21 157.23 39.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.84 133.08 58.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -101.53 122.05 43.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.894 0.378 . . . . 0.0 110.352 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -121.83 96.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.65 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.39 56.12 2.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.087 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 71.26 -8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.079 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.89 117.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -98.14 103.07 14.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.823 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -89.32 114.01 25.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.461 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -89.91 25.44 2.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.22 0.533 . . . . 0.0 110.517 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -147.22 166.48 26.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.057 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB3' HD21 ' A' ' 145' ' ' LEU . . . -66.82 140.3 57.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.314 0.384 . . . . 0.0 110.696 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 pt -135.93 144.85 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.997 0.427 . . . . 0.0 111.516 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.63 112.05 17.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.29 176.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.466 ' HB3' HG13 ' A' ' 41' ' ' VAL . 41.5 p90 -138.28 156.64 47.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.228 0.537 . . . . 0.0 111.797 -173.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.519 ' HA ' ' HH ' ' A' ' 130' ' ' TYR . . . -139.47 157.18 70.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.816 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HD3' ' OH ' ' A' ' 130' ' ' TYR . 24.0 Cg_exo -64.12 -42.33 18.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.383 2.056 . . . . 0.0 110.881 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -106.52 82.45 1.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.546 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.41 -171.17 38.21 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.247 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -92.4 178.62 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.151 2.568 . . . . 0.0 112.934 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 35' ' ' PHE . 47.0 t -114.21 105.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 145.4 24.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.962 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -101.6 129.34 47.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.18 114.15 64.81 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.456 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 39.87 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.387 2.725 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.15 132.0 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.119 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -114.19 -25.41 8.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 110.645 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -114.64 128.37 25.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.731 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.1 -9.37 25.55 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.934 2.423 . . . . 0.0 112.954 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -3.89 55.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.603 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -86.75 -14.69 41.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.544 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.489 HD13 HD13 ' A' ' 145' ' ' LEU . 67.3 mt -58.82 110.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.968 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -133.54 179.18 6.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.29 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -41.98 71.97 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.208 0.317 . . . . 0.0 111.611 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -56.3 -46.0 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.08 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 52' ' ' ILE . 90.8 mt -73.15 -37.15 66.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.91 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -40.46 96.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -66.97 -37.52 84.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.585 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.534 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt-30 -62.88 -42.34 99.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.91 -26.98 66.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.242 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.41 -6.38 55.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.244 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.26 59.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.525 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.5 mt -83.91 11.63 7.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . . . -82.87 -26.48 31.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.014 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -114.64 124.18 51.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.955 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.69 134.79 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.55 94.23 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.302 0.572 . . . . 0.0 110.832 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.908 ' HA ' ' HB3' ' A' ' 77' ' ' PRO . 59.7 mtp85 -94.78 86.08 4.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.405 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.51 96.12 34.91 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.925 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -96.12 30.67 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.422 2.748 . . . . 0.0 112.669 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.68 -42.42 77.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.379 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.38 136.26 48.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.751 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -75.41 88.88 2.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.127 0.489 . . . . 0.0 110.429 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.2 tp -167.77 -42.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.982 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -71.73 -50.06 33.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.112 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 65.88 106.73 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 O-C-N 123.915 0.759 . . . . 0.0 111.479 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.908 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 38.1 Cg_exo -60.4 -35.82 89.42 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.023 2.482 . . . . 0.0 112.785 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.516 ' OE2' ' HB2' ' A' ' 77' ' ' PRO . 4.1 mp0 -84.5 2.0 43.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.275 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.62 14.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.173 0.511 . . . . 0.0 109.971 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.83 -89.56 1.5 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.392 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.82 166.86 32.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.568 0.223 . . . . 0.0 110.62 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.37 -125.56 2.71 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.668 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.43 12.41 14.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.521 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 18.9 ptp180 -77.49 129.15 78.13 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 11.6 Cg_exo -71.53 66.07 2.94 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.494 2.796 . . . . 0.0 113.97 -172.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 71.34 -54.07 0.67 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 170.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 69.44 24.07 5.87 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.512 0.672 . . . . 0.0 110.005 -173.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.618 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -75.21 167.69 34.42 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.59 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 88' ' ' ALA . 15.1 Cg_endo -57.67 142.25 95.76 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.563 2.175 . . . . 0.0 112.476 176.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.673 ' HG3' ' HB3' ' A' ' 139' ' ' ARG . 34.4 mt-10 -71.05 -40.45 71.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.409 0.624 . . . . 0.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 140' ' ' VAL . 4.8 p -138.63 136.63 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.688 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.493 ' HB3' HG21 ' A' ' 118' ' ' VAL . 54.8 tp -116.05 116.66 28.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.577 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.44 124.07 47.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.687 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.84 126.19 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.742 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' A' ' 144' ' ' LEU . . . -108.88 112.95 3.61 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.528 ' HA ' HD12 ' A' ' 145' ' ' LEU . 21.2 p -81.62 -61.38 1.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 122' ' ' ASP . . . 84.92 -22.01 10.32 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.498 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.402 HH21 ' HB2' ' A' ' 146' ' ' PRO . 52.1 mtt180 -113.09 -64.86 1.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 110.084 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -139.73 126.41 20.57 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.485 ' HA ' HG21 ' A' ' 96' ' ' THR . 27.9 mt-30 -70.37 94.98 0.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.165 0.507 . . . . 0.0 110.898 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -73.18 120.12 18.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.553 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.66 119.52 15.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.693 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.9 mt -73.49 139.74 45.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.99 159.01 15.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.205 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.671 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 58.3 Cg_exo -51.86 -41.11 64.72 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.185 2.59 . . . . 0.0 112.04 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.425 ' CD ' HH22 ' A' ' 109' ' ' ARG . 31.1 tp10 -52.51 -28.67 21.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.42 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.23 -42.76 8.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.512 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -87.26 -11.34 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.671 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 27.7 mtm-85 -50.9 -53.99 41.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.542 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.01 -37.47 93.82 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.991 1.794 . . . . 0.0 112.781 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 118' ' ' VAL . 98.1 mt -79.73 -34.84 39.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.879 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.72 -34.09 75.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.32 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.88 78.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.43 -41.42 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.367 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.03 15.68 7.72 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.371 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.93 117.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.18 102.9 1.86 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.826 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 92' ' ' LEU . 41.3 t -102.89 121.73 54.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.18 140.29 52.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.449 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -114.39 125.89 54.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 111.437 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.463 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.8 mtm -144.61 177.31 8.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.429 ' HA ' ' H ' ' A' ' 97' ' ' GLY . 19.9 m-20 -72.38 154.46 40.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.746 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.494 HG22 HD22 ' A' ' 144' ' ' LEU . 28.7 m -47.65 -53.31 15.24 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.846 0.717 . . . . 0.0 112.61 -174.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.48 -46.27 89.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 0.0 111.605 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.45 79.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.272 -177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.03 76.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.35 84.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.324 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -59.35 -51.06 71.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 109.958 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 -36.29 83.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.499 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' HH ' ' HA ' ' A' ' 36' ' ' ALA . 87.7 t80 -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.748 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -60.06 -41.24 91.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.319 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.94 -48.28 89.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.73 -31.19 72.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.025 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.7 ttp -64.59 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.265 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.91 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.822 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.417 ' OE1' ' HD2' ' A' ' 138' ' ' ARG . 38.4 tt0 -74.71 -22.07 59.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.911 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.05 27.48 49.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.34 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.417 ' HD2' ' OE1' ' A' ' 136' ' ' GLU . 15.7 ttt180 -87.33 149.14 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.249 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.673 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 48.3 ttt85 -79.9 85.15 5.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.483 0.658 . . . . 0.0 109.285 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.448 HG23 HG13 ' A' ' 91' ' ' VAL . 4.8 p -120.46 132.98 68.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.009 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 36' ' ' ALA . 40.0 t -115.24 134.21 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 9.9 p -117.71 130.82 72.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.35 106.06 14.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.562 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.494 HD22 HG22 ' A' ' 123' ' ' THR . 92.5 mt -106.4 128.5 54.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.639 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 96' ' ' THR . 78.2 mt -87.5 151.29 50.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.861 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.402 ' HB2' HH21 ' A' ' 98' ' ' ARG . 27.5 Cg_exo -62.6 158.28 42.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.557 2.171 . . . . 0.0 112.075 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.16 -40.93 64.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 165.4 -5.51 0.06 OUTLIER Glycine 0 C--N 1.32 -0.338 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.803 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.621 ' HB2' ' CE1' ' A' ' 154' ' ' HIS . 4.8 m-20 64.46 24.93 13.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.008 0.523 . . . . 0.0 110.447 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -16.25 63.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -173.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.13 -13.53 59.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.254 0.55 . . . . 0.0 110.295 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -112.31 171.18 7.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.774 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.575 ' HB3' ' O ' ' A' ' 155' ' ' HIS . 52.3 m80 -112.88 111.29 21.95 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.858 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.621 ' CE1' ' HB2' ' A' ' 149' ' ' ASP . 81.0 m80 -57.14 -42.59 81.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.43 0.633 . . . . 0.0 109.35 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.575 ' O ' ' HB3' ' A' ' 153' ' ' HIS . 37.9 m-70 -118.81 155.9 30.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 170.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -77.27 43.14 0.36 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.871 0.843 . . . . 0.0 110.817 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.482 ' H ' ' C ' ' A' ' 155' ' ' HIS . 82.2 m-70 -144.26 -42.34 0.26 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.492 -1.231 . . . . 0.0 107.815 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.8 t60 . . . . . 0 C--O 1.249 1.05 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.276 178.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -104.41 130.95 52.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.76 171.18 14.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.191 0.52 . . . . 0.0 111.483 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -87.21 104.93 16.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.136 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.0 p -111.54 103.62 11.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.005 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 6.9 p-10 -75.37 118.68 72.56 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.482 . . . . 0.0 110.054 177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 3.4 Cg_exo -78.95 85.62 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.19 2.593 . . . . 0.0 113.014 -173.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.459 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -63.89 -20.65 65.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.313 0.578 . . . . 0.0 110.448 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -75.25 -8.23 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.688 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.12 14.61 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 8' ' ' ALA . 80.0 mt -85.41 91.56 8.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -77.84 86.83 4.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.279 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 m -116.25 140.44 49.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 ' HA ' HG22 ' A' ' 24' ' ' VAL . 48.6 t -60.62 112.91 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -74.9 -53.33 9.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.517 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -140.34 157.12 46.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.153 0.501 . . . . 0.0 111.258 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -110.01 118.41 36.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.74 156.95 15.65 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.322 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.9 92.49 0.51 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.64 11.43 55.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.105 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -161.13 150.23 16.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.135 0.467 . . . . 0.0 111.159 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.6 mt -96.94 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -118.08 114.83 23.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.037 0.446 . . . . 0.0 110.151 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 14' ' ' VAL . 40.4 t -129.77 113.04 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.669 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 60.14 38.53 20.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.362 0.601 . . . . 0.0 110.298 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 68.59 17.43 8.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.014 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.91 112.85 36.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 28' ' ' ARG . 24.0 ttt85 -72.81 110.79 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.131 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -102.51 98.08 8.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.198 0.523 . . . . 0.0 110.638 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -99.83 28.9 4.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.269 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -148.03 156.4 42.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.45 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 44' ' ' TRP . . . -60.63 136.86 58.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.433 0.458 . . . . 0.0 111.386 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.2 pt -138.04 150.16 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.309 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -135.28 125.8 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.843 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -147.89 157.46 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.234 0.54 . . . . 0.0 111.789 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' HB3' HG23 ' A' ' 141' ' ' VAL . . . -132.19 155.35 81.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.244 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.58 -22.73 57.93 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.74 2.293 . . . . 0.0 112.538 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -116.53 22.71 12.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.59 0.71 . . . . 0.0 109.284 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.71 17.45 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.039 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -89.83 -171.41 0.5 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.083 2.522 . . . . 0.0 112.297 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -111.29 114.79 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.01 151.97 22.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.907 0.384 . . . . 0.0 111.191 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -91.41 126.3 36.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.245 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -101.34 119.78 56.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.113 -176.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.6 Cg_exo -78.79 22.63 0.65 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.439 2.759 . . . . 0.0 113.248 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 56' ' ' LEU . 88.5 t -91.77 132.18 36.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -105.53 -51.22 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.255 0.55 . . . . 0.0 110.939 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -116.89 138.92 25.11 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.148 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HB2' ' HB3' ' A' ' 101' ' ' HIS . 43.9 Cg_endo -67.19 -11.14 31.11 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.939 2.426 . . . . 0.0 112.832 -176.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.73 -15.42 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 63.9 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.654 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.96 100.21 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.974 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -89.04 159.42 17.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.51 68.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.93 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 m -60.06 -36.82 78.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.452 HD12 HG21 ' A' ' 46' ' ' VAL . 81.9 mt -67.75 -36.15 80.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.097 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.42 ' HB3' HD11 ' A' ' 111' ' ' LEU . 97.2 mt -68.2 -37.9 81.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.852 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.26 -39.62 91.04 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.023 0.439 . . . . 0.0 110.492 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -64.65 -40.72 95.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.722 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.86 -20.62 63.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.27 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.508 ' HB2' ' HG2' ' A' ' 89' ' ' PRO . . . -82.11 -5.82 58.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.5 15.29 81.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.699 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.9 mt -73.04 -3.29 25.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.947 0.403 . . . . 0.0 111.442 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.53 -11.57 59.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.731 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.62 -41.43 92.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.159 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.16 -11.28 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 111.297 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.4 t -85.94 -20.87 7.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.054 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -65.63 -45.54 82.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.472 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -149.3 114.24 3.58 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.119 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.54 8.29 1.27 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.022 2.481 . . . . 0.0 113.118 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.4 tp -77.4 -24.67 50.49 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.33 91.22 8.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.282 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 77' ' ' PRO . 99.1 m-85 -74.17 140.05 44.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.909 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.95 -34.55 38.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.58 0.705 . . . . 0.0 109.2 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -100.97 123.59 45.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.82 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 61.67 67.72 1.28 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 121.486 0.66 . . . . 0.0 110.359 -172.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 73' ' ' PHE . 86.8 Cg_endo -90.2 156.08 4.68 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.915 2.41 . . . . 0.0 112.866 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.02 -9.52 59.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.353 0.597 . . . . 0.0 109.795 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.95 100.7 9.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.935 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.57 168.04 12.77 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.889 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.73 88.34 4.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.84 0.352 . . . . 0.0 111.389 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.47 -149.51 47.01 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.623 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.03 142.37 27.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -110.73 129.24 24.16 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.973 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.48 -36.78 84.96 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.721 2.281 . . . . 0.0 111.353 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.84 66.1 5.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -55.36 -44.59 76.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.542 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . . . -108.7 171.83 4.18 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.877 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 88' ' ' ALA . 80.8 Cg_exo -47.46 124.9 10.03 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.497 2.132 . . . . 0.0 112.07 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 39.2 mt-10 -66.16 -45.47 80.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 140' ' ' VAL . 4.0 p -134.72 133.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.248 0.547 . . . . 0.0 111.278 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.38 121.97 42.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.618 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.2 mt -105.58 109.87 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.891 0.377 . . . . 0.0 110.495 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.49 121.74 45.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.18 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -93.3 106.76 3.45 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 24.8 p -59.98 -49.82 76.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.735 0.414 . . . . 0.0 111.915 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.28 -78.03 0.57 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.255 -0.497 . . . . 0.0 113.146 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -69.65 -38.19 77.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.589 ' O ' ' HB ' ' A' ' 96' ' ' THR . 44.7 ttm-85 -166.77 140.73 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.63 0.253 . . . . 0.0 110.81 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.52 ' HA ' HG21 ' A' ' 96' ' ' THR . 90.0 mt-30 -70.73 105.32 3.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . 51.3 t-80 -117.98 111.25 18.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.85 130.34 40.8 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.61 151.88 40.71 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.97 165.31 13.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.264 -176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.6 Cg_endo -56.46 -31.19 84.98 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.173 2.582 . . . . 0.0 112.709 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -67.09 -25.76 66.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.155 0.502 . . . . 0.0 110.705 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -96.36 -23.27 16.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.738 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 26.7 m -106.7 -7.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.725 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 39.9 ttp-105 -53.62 -55.2 37.62 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 38.5 Cg_exo -58.07 -32.99 96.82 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.987 1.791 . . . . 0.0 112.333 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.741 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.3 mt -78.09 -33.91 50.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 90.0 mt -61.08 -38.34 85.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 109.932 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.13 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.198 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 64.4 mtt -89.53 -33.07 16.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.659 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.04 18.48 5.5 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.268 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.741 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 t -93.14 114.48 29.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.727 0.299 . . . . 0.0 111.098 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.44 102.37 2.71 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.1 t -95.69 122.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.814 0.34 . . . . 0.0 111.489 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -120.6 146.33 46.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.061 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.24 119.6 32.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.988 0.423 . . . . 0.0 110.682 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.458 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 64.9 mtm -142.74 175.05 10.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.47 163.29 25.65 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.832 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.2 m -50.77 -52.79 37.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.399 -173.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.46 -43.89 96.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.639 0.257 . . . . 0.0 111.284 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.79 99.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.971 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.91 71.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.96 89.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.793 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttp-105 -67.63 -46.52 72.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 0.0 110.653 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.6 m -65.89 -31.49 72.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.292 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.482 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 75.6 t80 -59.0 -45.59 90.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.387 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -64.15 -41.63 97.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.53 -47.11 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.654 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.98 -28.26 66.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.989 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.33 -47.43 70.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.218 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.59 -25.41 66.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.553 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.43 -12.32 60.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.276 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.86 57.24 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.122 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.453 ' HE ' ' CD ' ' A' ' 90' ' ' GLU . 6.8 tpt180 -105.58 153.11 22.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.694 0.283 . . . . 0.0 110.323 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -82.6 91.12 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.789 0.804 . . . . 0.0 111.144 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.452 HG21 HG11 ' A' ' 91' ' ' VAL . 7.2 p -118.1 142.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.705 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 36' ' ' ALA . 39.4 t -122.31 141.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.4 p -120.39 138.45 50.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 110.855 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.76 107.76 10.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.434 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.6 mt -104.13 129.89 51.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.689 0.281 . . . . 0.0 111.694 -172.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -101.74 105.94 44.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -94.07 -153.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.311 2.674 . . . . 0.0 111.328 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.18 -175.94 3.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.79 -29.4 0.38 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.78 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -69.4 -20.88 63.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.589 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.6 p -71.73 -35.47 70.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.742 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.1 mt -90.71 89.86 7.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.104 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -81.73 110.34 16.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.531 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -94.37 157.79 15.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.781 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -71.37 -16.62 62.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.623 0.249 . . . . 0.0 111.505 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -67.79 -14.59 63.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.2 0.524 . . . . 0.0 110.159 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -101.03 174.79 5.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.587 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -138.09 108.74 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.113 -174.76 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.794 0.33 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -143.47 159.01 43.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -101.14 158.7 15.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.974 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -74.37 -34.78 63.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.3 p -107.11 150.81 26.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.34 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.58 102.15 52.63 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.319 172.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.72 -58.68 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.509 2.139 . . . . 0.0 111.588 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -118.77 98.01 6.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.277 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.4 p -64.78 -38.55 91.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.415 0.626 . . . . 0.0 109.684 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.64 170.7 15.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.82 174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.0 tp -128.37 99.81 5.56 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.425 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -69.2 107.01 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.104 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.435 HG23 ' HE3' ' A' ' 134' ' ' MET . 14.5 m -133.22 135.64 45.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 -175.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.468 HG23 HG21 ' A' ' 24' ' ' VAL . 49.2 t -73.02 118.89 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -93.02 -75.14 0.5 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.894 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.64 98.25 11.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 0.0 110.66 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -86.14 114.98 23.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.196 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.87 168.52 19.0 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.29 -21.41 36.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.121 0.486 . . . . 0.0 110.134 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.56 -38.21 5.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.53 155.6 46.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 110.817 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -114.57 114.16 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.613 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.515 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 42.5 tt0 -99.33 116.21 30.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.468 HG21 HG23 ' A' ' 14' ' ' VAL . 61.3 t -116.06 121.95 68.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.688 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 60.03 31.03 20.45 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.355 0.409 . . . . 0.0 110.506 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 71.16 14.47 6.66 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.57 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -104.8 116.75 49.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 99.0 mtt180 -93.31 116.49 29.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.86 0.362 . . . . 0.0 111.333 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.07 143.08 32.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.331 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.2 p -106.13 1.29 26.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.542 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -128.98 170.65 13.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.065 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.5 143.04 54.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 112.355 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.99 144.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.702 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 120.03 26.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.465 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.8 162.19 36.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.19 0.519 . . . . 0.0 111.709 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.493 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -137.81 151.91 71.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.288 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.46 -45.09 36.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.731 2.287 . . . . 0.0 112.57 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE2' ' HG2' ' A' ' 139' ' ' ARG . 39.0 mt-10 -97.59 23.34 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.823 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.91 -170.84 11.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.22 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -90.05 -168.37 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.89 2.393 . . . . 0.0 112.316 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.34 117.72 56.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.658 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.07 123.21 35.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.233 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.1 t -77.52 113.13 15.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.718 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.19 117.94 64.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.85 25.47 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.903 2.402 . . . . 0.0 111.603 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.548 HG11 ' HB2' ' A' ' 51' ' ' ASP . 83.9 t -86.16 122.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.272 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.619 HE22 HD12 ' A' ' 151' ' ' LEU . 89.5 mt-30 -92.74 -39.89 11.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.646 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 96.1 mtt180 -139.64 157.38 70.19 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.961 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 16.5 Cg_endo -58.44 -11.72 11.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.23 2.62 . . . . 0.0 113.393 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.4 -21.47 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.548 ' HB2' HG11 ' A' ' 46' ' ' VAL . 63.1 m-20 -86.25 -5.12 59.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 145' ' ' LEU . 71.0 mt -74.41 125.46 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.035 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -141.25 175.34 9.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.036 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.488 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -57.63 -45.65 85.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 m -56.4 -44.41 80.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.929 0.395 . . . . 0.0 111.425 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.62 -39.06 84.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.762 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.503 ' HB3' HD11 ' A' ' 111' ' ' LEU . 96.0 mt -66.09 -40.17 90.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.161 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -61.45 -46.91 88.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.453 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -63.19 -36.78 84.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.915 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.68 -32.44 73.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.047 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.63 5.7 8.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.18 -7.67 54.73 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.42 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.4 mt -82.42 25.64 0.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.011 0.434 . . . . 0.0 111.148 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.15 -54.99 4.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.891 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -96.89 -8.38 30.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.219 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.66 142.09 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.8 m -58.15 133.26 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.163 0.506 . . . . 0.0 111.17 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -88.31 -20.39 25.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.53 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -114.76 93.09 32.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.196 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.83 -16.87 20.42 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.169 2.58 . . . . 0.0 112.619 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt -92.93 11.35 27.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.023 0.439 . . . . 0.0 110.742 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.89 161.81 14.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.76 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -81.71 -26.43 34.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.823 0.344 . . . . 0.0 110.117 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.8 mt 61.23 17.2 7.96 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.763 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.5 t70 64.08 18.0 10.97 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.374 0.607 . . . . 0.0 110.796 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -103.32 137.0 19.13 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.321 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.93 -30.34 5.99 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.55 2.166 . . . . 0.0 113.054 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -99.5 128.89 45.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.925 0.393 . . . . 0.0 110.858 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.05 150.53 41.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.16 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.25 -125.64 1.1 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.013 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.98 101.94 3.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.971 0.415 . . . . 0.0 110.526 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.36 -147.71 10.42 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.422 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.12 119.8 16.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.057 0.456 . . . . 0.0 111.117 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.521 ' HD2' ' HB3' ' A' ' 86' ' ' ALA . 6.1 ptp180 -130.18 153.67 81.21 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.68 -32.4 75.47 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.841 2.361 . . . . 0.0 112.614 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.521 ' HB3' ' HD2' ' A' ' 84' ' ' ARG . . . -72.63 -11.88 60.82 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.422 ' CG ' ' HG2' ' A' ' 84' ' ' ARG . 87.2 m-20 -81.33 -20.6 40.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.964 0.411 . . . . 0.0 109.975 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.81 146.98 91.35 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.899 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.3 162.45 7.75 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.095 2.53 . . . . 0.0 112.734 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 139' ' ' ARG . 9.5 mm-40 -72.87 -49.71 28.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 -175.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 12.8 p -148.22 145.52 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.227 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 117' ' ' GLY . 2.0 pt? -119.04 132.01 56.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.128 0.49 . . . . 0.0 110.107 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.77 123.44 41.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.108 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.6 109.13 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.513 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -85.34 108.71 3.23 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.603 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.8 p -69.09 -12.14 61.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.23 -85.31 0.71 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.286 -0.483 . . . . 0.0 114.001 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -61.6 -41.0 96.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.899 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -172.5 158.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.603 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 52.9 tt0 -62.52 137.7 58.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.577 . . . . 0.0 111.718 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -136.19 164.14 28.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.487 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.18 110.13 22.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.885 0.374 . . . . 0.0 110.423 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.14 131.89 38.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.45 -176.78 23.32 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.103 -1.046 . . . . 0.0 114.172 -167.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.605 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 60.4 Cg_endo -72.18 3.75 3.81 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.774 2.982 . . . . 0.0 113.473 -173.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -96.94 -26.6 14.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -96.02 -50.94 4.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.505 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.675 ' HB ' HG12 ' A' ' 118' ' ' VAL . 33.5 m -91.56 5.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.638 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 42.0 ttp-105 -59.85 -52.32 74.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 76.7 Cg_exo -54.8 -29.77 64.31 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.166 1.91 . . . . 0.0 113.075 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 57' ' ' LEU . 58.7 mt -70.04 -49.0 55.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 109.86 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.8 mt -64.19 -32.54 74.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.36 -26.89 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.368 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.445 ' HE1' ' HA ' ' A' ' 111' ' ' LEU . 65.7 mtm -87.34 -33.48 19.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.857 0.361 . . . . 0.0 110.665 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.43 4.25 9.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.408 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.0 131.2 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -82.33 141.3 21.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.736 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.675 HG12 ' HB ' ' A' ' 108' ' ' VAL . 11.7 p -127.33 145.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 122.689 -0.301 . . . . 0.0 110.227 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.86 136.65 27.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.791 0.329 . . . . 0.0 110.632 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.48 127.52 46.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.796 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.497 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 32.8 ttm -147.2 161.75 40.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -174.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.97 159.97 31.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 m -50.5 -63.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.44 -44.19 95.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.723 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.35 89.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.89 94.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.573 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.71 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 132' ' ' ILE . 53.4 ttp180 -60.2 -55.84 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 15.8 m -60.51 -38.03 83.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.04 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.22 -49.6 76.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.994 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.15 -40.85 95.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.627 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 79.5 mt -60.56 -56.4 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.76 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.74 -31.69 72.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.435 ' HE3' HG23 ' A' ' 13' ' ' THR . 58.8 ttp -66.22 -40.83 90.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.213 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.69 -35.45 72.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.66 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 9.1 mm-40 -61.69 -29.71 70.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.79 32.69 7.06 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.829 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -107.28 135.8 48.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.458 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 28.6 mtm180 -67.44 97.65 0.59 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.516 0.674 . . . . 0.0 110.869 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 7.4 p -123.78 139.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.333 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.493 HG22 ' HB1' ' A' ' 36' ' ' ALA . 30.8 t -109.46 150.42 12.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.91 130.98 55.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.006 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.31 120.71 39.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.237 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.76 127.37 53.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.897 0.38 . . . . 0.0 111.55 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.403 HD11 HD11 ' A' ' 52' ' ' ILE . 68.5 mt -99.64 116.64 64.69 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.575 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.87 150.76 27.27 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.616 2.211 . . . . 0.0 112.815 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -76.52 125.76 29.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.635 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.69 -24.73 0.31 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.458 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 59.06 75.77 0.38 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.507 0.67 . . . . 0.0 109.204 -172.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.6 p -80.18 86.3 5.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.895 -168.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.619 HD12 HE22 ' A' ' 47' ' ' GLN . 51.9 tp -110.47 90.23 3.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 166.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.15 126.68 31.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.239 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -72.22 130.58 41.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.846 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -64.68 -37.45 87.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.701 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -116.78 113.48 22.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.288 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -90.2 153.91 20.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -97.53 -45.96 6.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.82 176.348 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.486 0.184 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.56 145.61 40.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.376 . . . . 0.0 110.481 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.94 176.94 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.264 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -77.4 -42.41 36.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.4 0.619 . . . . 0.0 109.357 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.9 m -114.83 154.95 27.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.371 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 70.17 89.64 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 123.636 0.585 . . . . 0.0 110.678 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.13 -10.98 19.53 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.546 2.164 . . . . 0.0 112.206 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.66 116.59 16.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.409 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 m -107.01 156.22 18.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.214 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.63 1.26 6.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.031 0.444 . . . . 0.0 111.513 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -100.21 141.07 33.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.938 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -114.02 112.35 23.13 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m -130.6 143.6 50.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.999 0.428 . . . . 0.0 111.618 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.3 139.35 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.606 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 p -99.1 -40.02 8.21 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.731 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -140.23 116.71 10.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 111.715 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -105.47 104.33 14.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.04 -169.68 14.44 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.124 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.19 94.03 3.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.992 0.425 . . . . 0.0 110.809 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.81 60.35 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.261 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -125.56 152.16 45.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.038 0.419 . . . . 0.0 110.992 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.28 124.6 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.891 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 36.9 tt0 -111.59 122.56 48.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 111.339 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.42 115.19 49.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.051 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.39 -78.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.467 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -138.42 -1.1 1.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.458 0.17 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.58 121.89 68.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.792 0.329 . . . . 0.0 111.198 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.2 ptp180 -97.84 123.37 41.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.292 0.568 . . . . 0.0 110.334 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.43 137.35 37.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.198 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -94.73 17.31 13.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.37 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -147.25 167.78 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.929 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.56 146.95 47.13 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.483 0.489 . . . . 0.0 111.466 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 pt -141.78 147.08 22.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.084 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.76 124.97 40.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.821 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -147.95 161.33 41.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.498 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -136.56 160.74 65.47 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.619 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.541 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 11.3 Cg_endo -56.03 -48.67 18.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.728 2.285 . . . . 0.0 111.941 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -111.71 86.97 2.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.97 178.8 41.76 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.058 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -90.22 143.2 3.85 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.025 2.483 . . . . 0.0 113.076 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.86 114.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.58 154.47 30.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.556 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.1 m -87.25 143.14 27.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 t90 -111.88 121.63 39.16 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 9.8 Cg_exo -72.54 46.99 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.526 2.818 . . . . 0.0 113.409 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG23 HD13 ' A' ' 56' ' ' LEU . 92.0 t -122.19 115.96 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.17 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -82.98 -32.1 27.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.0 110.159 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -160.3 158.57 25.94 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.036 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 17.5 Cg_exo -68.44 33.94 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.964 3.109 . . . . 0.0 114.414 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.68 -27.48 15.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.634 0.254 . . . . 0.0 110.934 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -111.96 7.18 19.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.477 HG13 ' HA ' ' A' ' 49' ' ' PRO . 54.6 mt -61.74 109.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.157 0.504 . . . . 0.0 110.822 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 p -127.89 175.99 7.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.788 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -59.4 -43.69 92.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.82 -175.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -58.21 -42.72 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.786 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.436 HD13 HG23 ' A' ' 46' ' ' VAL . 93.8 mt -67.93 -36.56 80.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.735 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.0 -37.38 85.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.319 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 98.2 mt-30 -58.08 -42.69 86.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.999 0.428 . . . . 0.0 110.443 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.72 -39.76 84.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.271 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.6 -18.0 52.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.11 -20.39 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.33 45.3 30.96 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.65 -22.11 34.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.056 0.455 . . . . 0.0 110.555 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.8 109.74 22.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.391 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.28 106.52 15.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.31 0.576 . . . . 0.0 110.056 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.41 112.8 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.772 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.96 -174.08 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.333 171.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 65.4 ttp85 -96.04 -3.74 44.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.473 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 68' ' ' ARG . 21.6 t70 71.59 99.46 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.722 176.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -92.19 143.72 2.66 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.141 2.561 . . . . 0.0 112.167 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.13 -36.59 61.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.153 0.501 . . . . 0.0 110.074 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.87 87.74 7.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.001 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -69.82 114.33 7.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.41 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.3 mt -103.86 156.62 17.68 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.803 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -77.56 -38.58 48.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.584 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 4.4 tp10 66.81 116.71 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.612 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 76' ' ' GLU . 10.5 Cg_endo -55.05 121.64 10.26 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.715 2.277 . . . . 0.0 111.501 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.44 103.62 9.49 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.468 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.5 152.09 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.126 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.48 -6.68 77.01 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.517 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.93 -26.99 64.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 0.0 110.896 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.21 -38.35 2.58 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.757 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 71.78 -69.05 0.2 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.705 0.802 . . . . 0.0 110.988 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -130.17 107.18 16.32 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.517 . . . . 0.0 110.014 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -87.19 123.01 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.579 2.853 . . . . 0.0 112.691 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 62.41 92.77 0.06 Allowed 'General case' 0 N--CA 1.463 0.217 0 O-C-N 123.872 0.732 . . . . 0.0 111.363 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.94 -36.87 85.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.948 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.26 125.21 90.7 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.568 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.19 154.39 74.44 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.792 2.328 . . . . 0.0 112.516 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.48 -42.7 58.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.476 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.33 139.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.327 0.584 . . . . 0.0 111.899 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 141' ' ' VAL . 51.1 tp -118.11 122.49 43.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.5 mt -104.27 121.72 43.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.741 0.305 . . . . 0.0 110.619 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.37 113.36 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.26 89.76 1.01 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.237 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.52 31.96 4.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.872 0.368 . . . . 0.0 111.234 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.435 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -72.37 -15.08 77.08 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.225 -175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -83.14 -21.96 33.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.41 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.5 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 10.8 tpt180 -168.77 90.95 0.25 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -56.99 106.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.281 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -115.05 99.71 7.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.73 111.7 1.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.6 mt -68.38 133.19 48.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.255 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.05 21.53 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.631 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.9 Cg_endo -55.12 -47.16 27.87 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.509 2.806 . . . . 0.0 112.938 -174.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.67 -25.4 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.769 0.319 . . . . 0.0 111.634 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -78.13 -40.98 36.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 29.0 m -101.24 4.19 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.577 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.506 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 32.8 ttp180 -54.26 -48.9 93.13 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 53.6 Cg_exo -53.49 -34.27 71.4 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.098 1.865 . . . . 0.0 112.59 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.6 mt -86.55 -34.32 19.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.878 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 80.2 mt -63.78 -34.25 77.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.908 0.385 . . . . 0.0 110.157 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.29 -13.11 62.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.115 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -100.82 -25.33 14.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.971 0.415 . . . . 0.0 110.509 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.03 18.64 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.05 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.7 t -94.78 118.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.99 111.24 3.63 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.672 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.71 119.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -108.45 118.67 37.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.998 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.58 106.93 17.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.689 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 40.5 ttm -134.49 163.68 29.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.103 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.96 149.64 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.435 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 9.7 m -60.21 -47.0 87.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.76 0.315 . . . . 0.0 111.376 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -69.93 -40.56 75.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 110.576 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.46 95.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.971 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.4 83.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.97 88.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -64.03 -41.14 97.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.542 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.464 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.9 m -63.52 -43.79 96.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.447 ' CE1' ' HD3' ' A' ' 37' ' ' PRO . 73.2 t80 -57.08 -41.86 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -58.48 -47.13 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.05 -45.6 90.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.704 HD22 ' HD2' ' A' ' 138' ' ' ARG . 87.0 mt -64.21 -34.58 78.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.541 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 50.8 ttp -67.52 -34.28 76.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.345 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.76 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.07 -23.1 61.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.033 0.444 . . . . 0.0 110.415 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.55 31.58 15.64 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.149 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.704 ' HD2' HD22 ' A' ' 133' ' ' LEU . 45.8 mtt180 -83.43 152.46 24.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.797 0.332 . . . . 0.0 110.922 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -83.18 93.02 7.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.891 0.853 . . . . 0.0 109.494 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.7 p -125.77 133.87 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.33 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 36' ' ' ALA . 33.5 t -111.96 133.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.2 p -116.65 130.15 71.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.906 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -109.95 109.49 20.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.453 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.65 129.87 46.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.478 HD13 ' HG3' ' A' ' 49' ' ' PRO . 87.8 mt -103.65 117.34 60.12 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.439 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.25 -158.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.02 2.48 . . . . 0.0 111.856 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.36 -163.08 0.83 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.62 -7.86 0.14 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -121.48 -46.33 2.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 110.316 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.76 -36.51 73.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.5 tp -78.85 82.56 5.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.304 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -94.31 137.0 33.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.826 -175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -100.6 100.59 11.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.76 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -67.49 142.31 56.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -75.59 12.12 1.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -89.5 -3.89 58.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 166.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.446 ' HB3' ' H ' ' A' ' 158' ' ' HIS . 25.8 m-70 -119.79 -162.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.534 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.446 ' H ' ' HB3' ' A' ' 157' ' ' HIS . 79.8 t60 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.09 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.952 0.406 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -111.3 99.84 8.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.73 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 5' ' ' THR . 33.9 tp -130.61 136.4 48.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.839 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -86.99 -3.16 59.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.745 0.307 . . . . 0.0 111.014 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.506 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 7.4 m -71.18 -27.05 63.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.411 0.624 . . . . 0.0 109.778 173.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.08 137.53 68.94 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.348 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.89 127.98 20.85 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.408 2.072 . . . . 0.0 111.588 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.1 109.66 0.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.6 m -61.97 130.79 47.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.388 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.47 88.4 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.127 0.489 . . . . 0.0 111.083 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.93 100.94 12.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.013 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -64.35 109.38 1.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.033 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 m -117.6 133.09 56.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -66.17 110.32 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.552 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 m -82.77 -44.74 15.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.41 150.59 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.042 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -128.36 128.58 44.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.03 -169.02 12.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.857 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.49 -61.2 1.91 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.277 0.561 . . . . 0.0 110.94 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.75 25.08 15.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.737 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -155.13 138.88 16.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.602 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -120.79 120.96 63.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -96.03 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.267 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.51 128.31 66.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 61.27 30.16 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.213 -177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 69.22 15.53 8.58 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.732 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.26 121.72 62.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -87.36 111.76 21.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.004 0.43 . . . . 0.0 111.581 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.58 124.0 45.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.042 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -97.98 22.55 9.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.978 0.418 . . . . 0.0 111.332 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -151.39 171.82 16.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.473 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.85 135.91 57.67 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.604 0.565 . . . . 0.0 111.623 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.67 144.81 26.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.107 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.07 122.18 35.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.519 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 37.7 p90 -143.78 153.51 42.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.102 0.477 . . . . 0.0 111.708 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB3' HG22 ' A' ' 141' ' ' VAL . . . -139.48 158.53 68.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.052 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -58.68 135.22 65.82 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.255 1.97 . . . . 0.0 111.62 173.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 70.02 16.86 7.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.162 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.18 169.46 22.98 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.5 177.24 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.129 . . . . 0.0 112.221 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.406 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 43.1 t -102.81 102.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.35 134.42 35.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.09 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -77.7 118.89 20.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.035 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -98.18 120.31 59.99 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.673 -175.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.3 Cg_exo -77.19 26.56 0.45 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.348 2.699 . . . . 0.0 112.99 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.522 HG13 ' HB3' ' A' ' 51' ' ' ASP . 79.5 t -103.19 110.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.673 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -113.72 -13.88 12.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.318 0.58 . . . . 0.0 109.566 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.035 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 37.2 mtp-105 -101.83 135.25 19.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.44 -33.57 93.92 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.596 2.198 . . . . 0.0 112.319 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.11 9.54 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.456 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 1.035 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 3.6 t70 -85.09 -25.88 27.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.206 0.527 . . . . 0.0 110.13 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.9 109.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.565 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.0 m -112.35 155.53 23.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.168 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -56.68 -38.18 71.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 t -57.34 -42.79 82.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.712 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.82 -27.48 64.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.469 ' HB3' HD11 ' A' ' 111' ' ' LEU . 95.8 mt -71.3 -35.07 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.386 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.102 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -66.34 -43.93 84.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.367 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 -19.33 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.913 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.3 -5.93 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.38 82.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.127 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.8 mt -84.01 35.21 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.358 0.599 . . . . 0.0 110.97 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.28 -17.67 14.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.96 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -103.34 161.47 13.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.39 . . . . 0.0 110.908 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.09 141.11 46.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.297 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.4 153.85 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -54.85 132.88 47.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.856 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.62 121.21 83.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.926 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.42 100.56 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.869 2.379 . . . . 0.0 111.943 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.5 -39.41 74.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.178 0.514 . . . . 0.0 109.784 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.88 64.38 3.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.731 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -84.79 156.56 21.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.225 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' HG ' ' H ' ' A' ' 76' ' ' GLU . 52.6 tp -66.63 134.62 52.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.732 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -67.04 -16.02 64.09 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.187 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.526 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 42.4 mt-10 -115.66 85.19 13.57 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.872 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.59 2.81 8.29 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.055 2.503 . . . . 0.0 112.394 -176.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -100.59 101.26 12.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.49 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.65 169.13 15.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.46 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.81 71.48 2.56 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.318 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.34 125.4 6.05 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.79 57.59 4.79 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.439 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.44 169.38 20.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.545 ' HD2' ' H ' ' A' ' 84' ' ' ARG . 0.1 OUTLIER -71.02 126.74 92.1 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.999 176.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.95 28.37 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.231 2.62 . . . . 0.0 113.526 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.64 -2.84 47.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.564 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.2 m120 57.65 37.73 27.47 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.093 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.52 143.65 74.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.708 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 18.5 Cg_endo -57.77 134.43 62.73 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 123.052 2.502 . . . . 0.0 113.013 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -67.29 -36.82 82.32 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.494 HG12 HG22 ' A' ' 140' ' ' VAL . 6.0 p -139.76 135.78 39.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.993 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.6 tp -111.67 120.6 42.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.193 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 119' ' ' GLU . 94.9 mt -102.08 112.2 24.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.864 0.364 . . . . 0.0 110.895 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.85 113.61 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.959 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -97.77 97.07 1.89 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 p -106.67 56.17 0.65 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.155 0.502 . . . . 0.0 110.931 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.706 ' HA3' HG21 ' A' ' 123' ' ' THR . . . -64.07 -28.54 72.99 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.536 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 148' ' ' GLY . 61.3 ttt180 -63.0 -38.72 92.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.249 0.547 . . . . 0.0 110.768 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -170.44 95.06 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -61.23 128.09 34.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.798 -168.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -107.77 120.93 43.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.833 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.8 tp -80.1 103.18 9.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.91 145.92 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.031 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 173.77 20.1 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.747 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.615 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 54.2 Cg_exo -52.29 -49.34 17.71 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.543 2.829 . . . . 0.0 113.155 -175.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.09 -34.51 73.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.863 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -68.52 -30.27 69.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.88 -8.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 85.7 mtt180 -54.22 -52.49 68.4 Favored Pre-proline 0 N--CA 1.466 0.344 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.514 ' HG2' ' HB1' ' A' ' 54' ' ' ALA . 79.1 Cg_exo -50.96 -34.11 44.8 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.387 2.058 . . . . 0.0 113.173 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.559 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 80.0 mt -89.73 -37.99 14.16 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.146 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.3 mt -60.89 -34.44 74.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.776 0.322 . . . . 0.0 110.694 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.16 -24.06 65.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.092 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.4 mtt -90.67 -9.85 45.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.382 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.19 10.68 54.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.252 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.6 t -94.59 113.55 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.674 0.273 . . . . 0.0 110.537 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.12 118.78 4.78 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.618 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.56 117.18 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HB2' HD22 ' A' ' 93' ' ' LEU . 27.6 mm-40 -114.33 110.1 19.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.195 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.18 110.73 22.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 67.4 mtm -138.56 -171.85 3.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.813 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.06 154.33 39.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.941 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.706 HG21 ' HA3' ' A' ' 97' ' ' GLY . 5.0 t -62.94 -45.79 90.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.777 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -74.7 -38.05 62.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.71 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.696 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.96 78.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.727 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.23 88.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -63.74 -48.27 77.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.374 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -66.13 -39.32 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.11 -44.23 91.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.801 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.61 -50.1 71.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.138 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.35 -48.85 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 91' ' ' VAL . 96.9 mt -65.52 -35.37 80.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.344 -177.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.67 -33.78 74.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.809 0.338 . . . . 0.0 110.097 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.76 -26.17 65.99 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.67 -24.97 58.89 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.133 0.492 . . . . 0.0 110.413 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.13 18.69 53.07 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 40.4 ttm-85 -81.42 154.17 26.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.395 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 89' ' ' PRO . 37.4 mmt180 -79.23 99.07 6.88 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.674 0.75 . . . . 0.0 110.742 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.494 HG22 HG12 ' A' ' 91' ' ' VAL . 4.1 p -134.49 134.7 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.532 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 36' ' ' ALA . 26.4 t -116.66 137.33 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.23 136.23 58.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.071 0.463 . . . . 0.0 111.178 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.12 112.33 18.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.756 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -105.2 138.68 41.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 -175.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.448 HD11 HG11 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -119.45 91.12 43.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.99 151.67 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.186 2.59 . . . . 0.0 113.213 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 t70 60.9 -169.54 0.16 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.966 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 98' ' ' ARG . . . 159.14 -48.91 0.41 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.203 177.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.55 152.21 46.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.068 0.461 . . . . 0.0 111.211 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.1 m -131.97 176.4 8.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.815 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.04 -44.42 97.42 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.196 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.75 64.54 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.019 0.438 . . . . 0.0 111.71 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -79.58 99.27 7.24 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 170.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -68.98 133.45 48.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -77.77 102.1 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 165.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -76.89 69.18 3.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -161.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -101.34 -6.48 24.04 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 154.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.7 p80 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 112.714 -2.039 . . . . 0.0 108.234 172.047 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.044 0.45 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -102.58 129.65 49.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.9 133.37 45.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -62.97 -48.31 79.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.8 m -155.89 114.6 3.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.041 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.91 126.85 83.34 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.022 0.439 . . . . 0.0 110.783 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -90.35 -178.91 1.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.041 2.494 . . . . 0.0 112.134 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.76 133.1 35.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.459 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.59 HG23 ' H ' ' A' ' 11' ' ' LEU . 21.1 m -76.56 128.03 33.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.412 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -10.79 59.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.534 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.59 ' H ' HG23 ' A' ' 9' ' ' THR . 89.8 mt -110.16 71.56 0.76 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.184 0.516 . . . . 0.0 110.136 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -64.62 107.11 1.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.4 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 m -131.24 150.16 52.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.745 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -71.56 129.84 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 p -85.67 -33.73 21.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.711 0.291 . . . . 0.0 111.54 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 23' ' ' GLU . . . -145.26 112.34 6.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.58 0.229 . . . . 0.0 110.476 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -70.38 -38.22 74.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.869 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.9 -163.6 44.33 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.781 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.01 -74.84 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.202 0.525 . . . . 0.0 110.277 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.93 31.99 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.469 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.45 119.25 2.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.4 110.07 26.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 36.7 tt0 -97.95 112.62 24.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 110.543 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.07 109.65 29.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.81 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 62.97 43.57 6.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.654 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 70.48 12.04 7.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.819 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -106.04 113.04 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttm105 -90.72 112.84 24.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.346 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.45 117.56 33.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.686 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 55.5 m -93.9 10.53 32.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -148.2 -179.34 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.362 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.74 146.33 46.3 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.22 148.46 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.573 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.3 131.14 48.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.599 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.04 158.2 38.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.312 0.577 . . . . 0.0 111.789 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' A' ' 141' ' ' VAL . . . -131.51 161.87 59.54 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.547 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.83 -46.36 33.9 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.374 2.049 . . . . 0.0 110.981 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -118.27 96.05 5.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.022 172.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.83 178.64 41.03 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.67 138.97 7.43 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.568 2.178 . . . . 0.0 112.718 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.26 103.02 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.2 121.85 42.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.481 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -66.94 120.74 14.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -97.88 127.21 37.93 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -170.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.4 Cg_exo -70.09 3.99 2.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.408 2.739 . . . . 0.0 113.033 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 51' ' ' ASP . 84.7 t -86.14 134.96 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.682 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 50.0 tp60 -107.16 -41.48 5.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.146 0.498 . . . . 0.0 110.155 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.682 ' HG3' ' HG3' ' A' ' 47' ' ' GLN . 63.5 mtt180 -129.5 156.09 79.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.607 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.64 0.11 2.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.16 2.574 . . . . 0.0 113.172 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.6 -17.23 27.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.148 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.529 ' HB2' HG11 ' A' ' 46' ' ' VAL . 43.5 m-20 -88.15 -16.29 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.048 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.67 114.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.667 -174.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 p -124.27 173.62 8.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.402 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.24 91.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.616 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -60.96 -42.25 97.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.417 0.627 . . . . 0.0 110.797 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD13 HG22 ' A' ' 46' ' ' VAL . 87.5 mt -71.56 -28.85 64.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.856 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.95 -39.14 87.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.488 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -63.67 -37.93 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.3 -44.84 74.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.27 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.529 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . -76.68 -9.21 58.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.28 23.61 71.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.724 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.455 HD22 ' HE3' ' A' ' 114' ' ' MET . 27.9 tp -63.34 -49.46 73.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.974 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.98 81.37 6.87 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.993 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.93 -63.04 1.48 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.82 95.58 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.577 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 50.2 t -87.28 105.15 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.496 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -106.0 131.14 53.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.156 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.63 158.46 83.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.02 74.79 2.35 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.624 2.216 . . . . 0.0 113.088 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.06 -42.37 38.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.3 74.63 0.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.461 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -86.53 162.11 18.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.766 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.7 mt -91.72 -167.6 1.82 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.462 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.22 -22.69 16.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.739 0.78 . . . . 0.0 109.012 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -76.21 142.94 72.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.821 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.11 -17.27 24.88 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.468 2.112 . . . . 0.0 111.105 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -100.47 95.01 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.2 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.17 2.33 55.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.147 0.498 . . . . 0.0 110.345 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.29 98.83 2.32 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.094 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.12 18.06 15.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.166 0.508 . . . . 0.0 110.441 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.82 32.13 41.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.749 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.08 101.04 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.019 0.438 . . . . 0.0 111.05 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 7.1 ptm180 -130.23 143.44 49.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.298 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 23.9 Cg_exo -63.96 145.83 90.52 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.466 2.111 . . . . 0.0 111.347 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.45 -24.14 66.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.951 0.405 . . . . 0.0 111.087 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -103.39 27.23 7.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.95 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.38 153.25 95.87 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.481 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 86.4 Cg_exo -47.6 132.44 20.57 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.247 2.631 . . . . 0.0 113.368 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.5 mt-10 -77.3 -43.03 34.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 7.1 p -140.66 137.45 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.158 -177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 61' ' ' ALA . 45.1 tp -110.0 118.22 35.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.301 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.3 mt -98.06 120.85 39.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.866 0.365 . . . . 0.0 110.747 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.15 122.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.093 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -100.39 113.09 4.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.189 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 22.2 p -83.76 -66.98 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.743 0.306 . . . . 0.0 111.678 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 -65.26 3.87 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.572 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.519 ' HD2' ' HA ' ' A' ' 147' ' ' ASP . 52.3 mtp85 -69.52 -37.6 77.2 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.769 -0.254 . . . . 0.0 111.217 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 96' ' ' THR . 13.7 ptt180 -161.19 138.47 8.95 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 170.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -81.08 91.5 6.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.391 0.615 . . . . 0.0 111.237 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -94.68 106.98 18.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.534 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.26 149.35 38.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.711 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.5 150.39 21.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -105.95 165.48 13.87 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.468 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.51 -26.34 82.6 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 123.397 2.731 . . . . 0.0 113.36 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.69 -11.68 44.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.003 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.54 -45.68 8.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.281 0.563 . . . . 0.0 109.995 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 104' ' ' GLY . 27.0 m -90.79 16.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.499 0.666 . . . . 0.0 109.979 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.629 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 33.2 ttt180 -54.25 -52.95 64.37 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.801 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.9 Cg_exo -59.28 -40.51 67.84 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.961 1.774 . . . . 0.0 112.465 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 91.8 mt -73.94 -42.11 61.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 -176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.6 mt -61.45 -38.17 86.23 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.573 0.225 . . . . 0.0 110.955 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -35.02 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.455 ' HE3' HD22 ' A' ' 63' ' ' LEU . 65.7 mtt -76.38 -29.83 57.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.646 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.95 10.82 13.42 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.99 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.7 t -92.12 113.27 27.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -80.33 130.01 9.48 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.567 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.2 124.04 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.988 0.394 . . . . 0.0 110.393 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -114.43 108.62 17.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.311 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.14 111.06 22.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 68.2 mtm -137.85 -171.65 3.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.56 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.25 152.14 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.873 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.526 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 7.7 t -63.77 -38.24 90.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.68 -37.25 42.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.234 0.54 . . . . 0.0 109.94 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.97 90.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.886 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.43 -40.75 70.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.008 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.0 84.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.424 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -72.76 -43.74 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.1 p -67.04 -32.22 73.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.48 ' HH ' ' HA ' ' A' ' 36' ' ' ALA . 79.7 t80 -57.56 -44.96 85.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.42 174.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.7 -36.39 84.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.54 -49.81 82.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.59 -30.46 71.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttm -65.72 -42.48 91.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.192 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.7 76.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.85 -16.75 60.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.775 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.39 51.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.206 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -93.25 167.63 11.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.803 0.335 . . . . 0.0 110.924 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.692 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 2.1 mmt180 -83.38 90.66 7.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.119 0.485 . . . . 0.0 109.872 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.4 135.84 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 36' ' ' ALA . 16.7 t -125.61 142.92 40.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.459 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 8.3 p -123.63 140.82 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.1 113.34 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.355 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 98.8 mt -104.11 133.94 48.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.338 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.69 103.99 51.32 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.058 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.31 153.57 40.45 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.969 2.446 . . . . 0.0 112.343 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.519 ' HA ' ' HD2' ' A' ' 98' ' ' ARG . 11.6 t70 -83.99 102.49 12.5 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.61 -4.94 1.14 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.136 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -55.58 -40.48 72.05 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.5 p -128.65 141.57 51.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.691 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.17 -45.74 12.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.42 104.58 7.01 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.029 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -90.18 123.24 33.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.311 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -137.26 117.91 13.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.522 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -78.85 126.61 30.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -78.81 0.59 26.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.641 0.734 . . . . 0.0 109.938 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -143.25 137.41 28.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.288 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 43.8 m80 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.98 -0.533 . . . . 0.0 109.869 178.055 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.639 0.257 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HB2' ' OG1' ' A' ' 5' ' ' THR . 61.5 mttm -106.76 128.28 54.1 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.8 tp -87.3 21.13 2.52 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -166.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -144.41 11.69 1.5 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 2' ' ' LYS . 38.1 p -106.87 136.55 46.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.01 109.26 55.59 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.06 25.24 0.52 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.857 2.371 . . . . 0.0 113.432 -173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -150.51 168.48 24.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.477 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.1 m -74.14 117.11 15.55 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.21 104.42 16.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.974 0.416 . . . . 0.0 111.059 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.88 85.13 2.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -101.59 112.06 24.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.128 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 m -100.31 143.57 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.413 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.89 115.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.139 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -45.76 73.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.738 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -141.77 110.52 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.21 0.529 . . . . 0.0 111.439 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -99.21 129.31 45.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.769 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.5 ' HA3' ' CE1' ' A' ' 21' ' ' TYR . . . -132.3 -178.17 15.35 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.137 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -86.51 -20.47 27.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.031 0.443 . . . . 0.0 110.46 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.9 17.43 5.72 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.995 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.5 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 27.3 p90 -164.95 150.36 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.74 0.305 . . . . 0.0 110.76 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.44 106.35 15.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -105.6 118.26 36.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.954 0.407 . . . . 0.0 109.954 -177.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.29 139.18 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.83 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.26 -83.8 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.667 0.604 . . . . 0.0 110.176 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -152.71 13.27 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.466 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.56 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.003 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 48.0 ttp180 -83.45 107.4 15.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.82 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.74 129.83 35.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.099 0.476 . . . . 0.0 110.941 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 m -108.45 19.09 20.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.887 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -145.44 168.92 19.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . . . -65.8 142.77 57.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.108 0.48 . . . . 0.0 111.598 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.8 pt -137.98 138.82 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.7 118.68 25.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -146.52 163.61 35.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.79 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB3' HG21 ' A' ' 141' ' ' VAL . . . -139.23 152.73 70.18 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.1 -32.75 96.28 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.87 2.38 . . . . 0.0 112.959 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.587 ' OE2' ' HD2' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -100.75 19.27 17.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.835 0.35 . . . . 0.0 110.867 -178.016 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.11 -176.15 20.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.853 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.5 -170.28 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.069 2.513 . . . . 0.0 112.437 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.14 116.16 50.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.122 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.68 129.64 35.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.916 0.388 . . . . 0.0 110.74 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p -75.28 121.19 21.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -115.17 117.16 41.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.897 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.26 22.9 0.87 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.228 2.618 . . . . 0.0 113.048 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.34 123.87 41.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.796 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -106.17 -35.93 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.734 0.778 . . . . 0.0 109.389 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 48' ' ' ARG . 47.0 mtm180 -120.18 131.54 24.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.063 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.6 Cg_exo -67.14 8.24 0.39 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.292 2.662 . . . . 0.0 113.092 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 48' ' ' ARG . . . -95.22 -3.01 48.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -109.99 14.09 23.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.2 119.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 111.193 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 p -104.14 168.46 9.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.05 -30.04 70.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 p -66.26 -42.14 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.774 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.53 -34.77 79.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.624 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HB3' HD13 ' A' ' 111' ' ' LEU . 96.7 mt -63.53 -42.42 98.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.15 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.15 -36.63 83.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 110.96 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -71.24 -36.67 71.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.464 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.02 -27.37 67.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.938 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -73.79 -9.12 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.936 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.62 15.32 78.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.523 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.486 HD22 ' HD3' ' A' ' 89' ' ' PRO . 90.1 mt -88.79 15.4 8.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.101 0.477 . . . . 0.0 111.055 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.06 -16.95 20.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -123.13 117.51 25.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.992 0.425 . . . . 0.0 110.658 -177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.23 122.37 39.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.301 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.6 t -93.84 130.86 42.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.194 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -123.51 143.04 50.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.675 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.11 162.83 57.97 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.24 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.4 153.87 16.45 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.519 2.146 . . . . 0.0 112.286 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.76 1.23 5.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.061 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.41 -10.06 53.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.04 0.447 . . . . 0.0 110.384 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -111.96 116.2 30.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.976 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.5 tp -100.06 127.37 46.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.905 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -74.82 165.83 24.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.035 0.445 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.606 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 3.9 mp0 -74.97 -51.12 3.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.632 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 76' ' ' GLU . 16.5 Cg_exo -69.09 -174.22 0.74 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.224 1.949 . . . . 0.0 112.251 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -82.78 -23.49 33.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.469 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . . . -95.63 156.69 16.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.093 176.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.92 -176.17 41.06 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.726 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 73.01 -50.31 0.7 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.498 0.719 . . . . 0.0 111.776 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.57 -55.61 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.931 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . . . 62.92 23.94 14.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.395 0.617 . . . . 0.0 110.245 -175.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -107.58 150.32 39.99 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.553 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -52.86 -34.3 65.19 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.993 2.462 . . . . 0.0 112.973 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.84 -3.61 19.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -75.54 -30.7 59.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.865 0.364 . . . . 0.0 110.399 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.27 151.69 69.78 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.08 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.486 ' HD3' HD22 ' A' ' 63' ' ' LEU . 17.3 Cg_exo -66.51 121.48 8.74 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 111.735 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 109.878 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.672 HG13 HD11 ' A' ' 133' ' ' LEU . 6.4 p -134.12 135.29 54.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.731 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.49 104.72 12.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.414 HD12 HD12 ' A' ' 133' ' ' LEU . 93.9 mt -90.13 110.75 21.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.691 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.78 112.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.436 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.63 92.68 1.79 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.511 ' HA ' HD11 ' A' ' 145' ' ' LEU . 1.3 m -60.75 -24.84 66.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.712 0.405 . . . . 0.0 112.072 -171.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 79.61 -68.62 3.16 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.546 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.796 HH22 ' HB3' ' A' ' 149' ' ' ASP . 29.2 ttm180 -92.82 82.08 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.881 0.372 . . . . 0.0 110.578 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 63.25 -173.99 0.16 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.149 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -90.22 143.3 26.89 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.936 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -136.7 126.72 26.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.851 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -80.96 111.78 17.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.463 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.8 mt -76.85 170.18 16.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 159.53 15.1 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.774 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.27 -34.92 98.06 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.941 2.427 . . . . 0.0 111.91 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.42 -20.59 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -96.34 -63.19 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.814 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.3 -18.93 8.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.44 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 37.0 ttt180 -57.84 -46.51 99.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 73.2 Cg_exo -53.11 -34.3 67.74 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.165 1.91 . . . . 0.0 112.875 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 57' ' ' LEU . 92.3 mt -76.45 -42.09 45.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.641 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.28 -26.52 68.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 0.0 110.467 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.74 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 60.1 mtt -90.82 -7.46 52.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.883 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.48 51.17 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.091 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -91.83 117.16 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.799 0.333 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.65 93.94 1.7 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.961 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.81 120.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -125.29 127.15 46.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.415 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.67 116.67 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.3 mtm -142.34 -171.79 3.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.588 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.32 153.63 42.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.408 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 9.0 m -57.95 -42.96 86.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.261 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.47 -48.45 81.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.46 -50.16 68.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.791 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.69 91.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -60.12 -50.24 74.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.424 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.1 m -65.47 -36.01 82.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.47 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -59.01 -46.88 87.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -56.93 -42.9 80.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.712 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.65 -52.76 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.794 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.672 HD11 HG13 ' A' ' 91' ' ' VAL . 94.7 mt -64.4 -35.23 80.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.507 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 45.0 ttp -65.31 -41.3 94.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.77 73.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.671 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -73.11 -20.57 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.8 39.26 29.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.752 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -97.27 162.69 13.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.578 0.228 . . . . 0.0 110.89 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.587 ' HD2' ' OE2' ' A' ' 38' ' ' GLU . 16.7 mmm180 -75.25 80.84 2.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.0 120.51 64.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.18 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 36' ' ' ALA . 43.9 t -109.87 132.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -117.92 133.8 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.12 0.486 . . . . 0.0 111.122 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.86 110.0 17.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.347 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -100.57 120.97 40.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.944 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.511 HD11 ' HA ' ' A' ' 96' ' ' THR . 73.6 mt -104.21 107.04 56.23 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.629 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.84 141.29 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.236 1.957 . . . . 0.0 110.405 169.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -64.29 150.04 46.86 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.06 -4.36 1.33 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.993 -172.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.796 ' HB3' HH22 ' A' ' 98' ' ' ARG . 8.5 t70 -112.96 153.06 28.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.7 m -85.49 -23.05 27.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.603 -174.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 82.3 mt -126.08 159.37 32.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.742 0.306 . . . . 0.0 111.313 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.29 -36.54 75.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.958 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -120.61 131.63 54.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.694 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -72.49 -21.46 61.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.268 0.556 . . . . 0.0 109.803 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -99.16 133.54 43.3 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -58.16 -39.33 78.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.961 0.41 . . . . 0.0 110.858 -174.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -135.87 95.21 3.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.09 173.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.867 179.102 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.486 0.184 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -113.53 164.3 13.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.816 0.341 . . . . 0.0 111.027 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.54 -36.15 22.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -129.15 103.82 7.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.702 169.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 m -88.74 55.68 3.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.111 0.482 . . . . 0.0 110.895 -174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -175.35 128.06 0.39 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.544 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.07 -27.67 29.48 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.702 2.268 . . . . 0.0 113.146 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -152.74 126.91 9.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.409 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 p -73.97 86.67 1.81 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 68.43 -67.39 0.2 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.965 0.906 . . . . 0.0 113.088 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.3 mt 63.26 66.84 0.69 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.49 0.662 . . . . 0.0 110.149 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -65.48 108.43 1.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.218 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 m -118.17 137.04 53.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.073 0.463 . . . . 0.0 111.816 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 24' ' ' VAL . 63.9 t -67.74 132.96 32.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 174.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 p -94.69 -45.67 7.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.736 0.303 . . . . 0.0 111.688 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.15 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 0.0 111.163 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -105.98 -76.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.838 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.77 -111.75 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.027 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -162.25 130.91 4.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -49.09 3.71 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.915 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -111.71 170.24 8.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 110.987 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.96 117.19 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.447 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 29.5 tt0 -96.87 117.81 31.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.053 0.454 . . . . 0.0 110.797 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 14' ' ' VAL . 25.6 t -113.54 124.37 70.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.639 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 66.67 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.728 0.642 . . . . 0.0 111.376 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -141.34 -3.97 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.11 122.3 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.117 -172.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 12.8 ptt180 -85.76 111.42 20.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.978 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.41 120.08 31.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.3 m -101.97 23.54 11.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.54 0.686 . . . . 0.0 109.572 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -141.7 163.59 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.398 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.72 57.76 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.396 0.435 . . . . 0.0 110.991 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -137.04 137.52 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.32 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.76 109.68 14.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.546 -0.752 . . . . 0.0 108.973 173.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.406 ' HB3' HG12 ' A' ' 41' ' ' VAL . 37.5 p90 -126.43 147.13 49.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 112.359 -173.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -101.95 157.64 33.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.932 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 26.5 Cg_endo -62.84 -17.53 60.0 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.625 2.217 . . . . 0.0 113.116 -176.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 43.1 mt-10 -89.31 9.23 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.3 -69.57 0.41 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.646 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HD2' ' C ' ' A' ' 38' ' ' GLU . 4.5 Cg_exo -37.99 119.85 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.592 3.528 . . . . 0.0 114.923 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 35' ' ' PHE . 41.9 t -113.25 113.56 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.925 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 135.77 33.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.664 0.268 . . . . 0.0 110.794 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 m -88.78 137.89 31.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 m0 -121.15 131.8 24.38 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.3 Cg_exo -81.52 20.5 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.487 2.791 . . . . 0.0 111.619 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.507 HG12 ' HB2' ' A' ' 51' ' ' ASP . 92.4 t -94.75 123.32 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.418 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 6.32 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.293 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.404 ' C ' ' H ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -152.16 152.83 30.26 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.39 14.48 0.38 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.934 2.423 . . . . 0.0 113.162 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 48' ' ' ARG . . . -93.67 -29.53 15.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.258 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' HB2' HG12 ' A' ' 46' ' ' VAL . 28.9 m-20 -77.79 -20.78 52.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.226 -175.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.431 HD11 HG12 ' A' ' 94' ' ' VAL . 23.0 mt -60.04 110.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.22 0.533 . . . . 0.0 111.194 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -131.44 165.6 23.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.482 -178.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.61 65.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.721 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 3.4 p -62.55 -50.74 70.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.856 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.51 -36.91 84.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.824 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.465 ' HB3' HD12 ' A' ' 111' ' ' LEU . 97.5 mt -61.46 -41.86 97.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.98 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.85 -33.17 74.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.86 0.362 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 55' ' ' SER . 87.9 mt-30 -71.38 -35.83 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.75 -26.53 40.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.04 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . . . -77.77 -10.68 59.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.135 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.57 35.17 67.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.623 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.1 mt -77.91 2.1 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 0.0 111.283 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.26 -169.37 2.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.2 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -81.65 131.07 35.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.716 0.293 . . . . 0.0 110.589 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.18 104.63 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.745 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.65 106.7 16.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.27 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -78.23 146.38 34.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.443 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 4.6 p-10 -84.49 137.26 39.15 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 121.123 0.487 . . . . 0.0 110.885 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 93.1 Cg_endo -91.34 120.03 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.097 2.531 . . . . 0.0 112.882 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.0 mt -103.12 -5.45 23.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.013 0.435 . . . . 0.0 110.946 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.59 -6.85 11.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.222 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -139.03 116.19 11.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.535 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.89 -2.1 58.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.702 0.763 . . . . 0.0 109.489 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.58 -11.07 59.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.849 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 62.87 96.03 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.394 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.2 85.26 1.05 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.649 2.233 . . . . 0.0 111.337 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.3 -49.61 22.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.722 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 98.85 4.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.604 173.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.03 27.91 6.39 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.164 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.37 -29.06 68.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.681 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 84' ' ' ARG . . . -73.08 -22.69 78.84 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.12 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.57 -39.3 0.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.845 0.858 . . . . 0.0 112.784 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 82' ' ' GLY . 90.4 mtt180 -107.2 118.01 54.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.72 49.78 2.82 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.416 2.744 . . . . 0.0 113.376 -173.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.58 -65.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.871 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 65.6 t30 56.9 61.51 2.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.743 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.66 124.06 9.34 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.816 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 116' ' ' VAL . 26.0 Cg_endo -63.92 153.47 75.57 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.588 2.192 . . . . 0.0 112.531 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.35 -51.7 6.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.024 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.37 136.65 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 tp -115.33 119.01 34.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.79 119.91 39.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.431 HG12 HD11 ' A' ' 52' ' ' ILE . 58.9 t -111.84 117.87 56.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.363 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.83 102.29 2.9 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 101' ' ' HIS . 6.1 p -78.15 19.12 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.8 -85.03 1.09 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.234 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -79.19 -33.58 43.77 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -169.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -142.3 -173.72 3.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.487 ' HG2' ' H ' ' A' ' 122' ' ' ASP . 93.0 mt-30 -95.31 82.46 3.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.648 165.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.463 ' HB3' HG23 ' A' ' 96' ' ' THR . 58.5 t-80 -94.8 101.77 13.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.726 -174.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 48.0 tp -64.76 143.22 58.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.67 -165.71 1.03 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.324 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.95 150.51 16.92 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.765 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.69 -37.19 83.74 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.265 2.643 . . . . 0.0 112.758 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -72.96 -33.38 65.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.944 0.402 . . . . 0.0 110.761 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.05 -42.32 73.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.1 m -89.99 -6.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.35 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -50.5 87.83 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -54.02 -40.45 81.19 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.14 1.893 . . . . 0.0 112.615 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.668 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 64.7 mt -77.63 -38.08 48.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.129 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 73.8 mt -61.89 -34.34 75.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.11 63.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.6 mtt -91.11 -11.87 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.6 8.79 55.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.668 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.0 t -86.69 111.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.742 0.306 . . . . 0.0 110.44 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.69 104.28 2.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.146 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -91.04 120.19 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.738 0.304 . . . . 0.0 111.027 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -118.48 115.78 25.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.422 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.416 ' HB2' ' HA ' ' A' ' 102' ' ' LEU . . . -99.05 118.52 36.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.655 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.4 mtm -140.02 -171.82 3.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.221 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.487 ' H ' ' HG2' ' A' ' 100' ' ' GLN . 12.8 t70 -70.31 151.55 45.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.477 HG21 HD22 ' A' ' 144' ' ' LEU . 63.8 m -56.96 -37.99 72.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 111.002 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.72 -42.84 70.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.463 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.51 -41.6 84.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.944 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.43 -38.71 90.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.849 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -52.21 66.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.157 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -61.84 -40.18 94.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.999 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.527 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 41.0 m -64.8 -40.32 95.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.398 . . . . 0.0 110.474 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -60.93 -46.76 89.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.711 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -58.32 -37.68 75.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 79.4 mt -68.52 -53.86 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.608 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.658 HD22 ' HD2' ' A' ' 138' ' ' ARG . 61.9 mt -61.91 -41.63 98.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -64.93 -39.47 93.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.579 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.71 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 44.8 mt-10 -73.84 -26.31 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 22.82 12.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.256 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.658 ' HD2' HD22 ' A' ' 133' ' ' LEU . 56.1 mtt-85 -80.35 157.68 26.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.843 0.354 . . . . 0.0 110.204 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -90.0 83.38 6.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.248 0.547 . . . . 0.0 109.932 -178.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.32 134.72 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.529 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.35 136.83 53.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.6 p -120.69 134.46 64.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.048 0.451 . . . . 0.0 111.411 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.14 113.07 20.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.563 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 123' ' ' THR . 91.3 mt -108.4 133.97 51.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.671 -175.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.401 HD11 HD13 ' A' ' 52' ' ' ILE . 83.5 mt -111.0 105.65 57.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.918 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -87.01 128.89 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.212 2.608 . . . . 0.0 110.589 166.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.15 -164.36 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.707 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.13 -4.66 1.27 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.633 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.18 -29.16 34.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.02 0.438 . . . . 0.0 109.903 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.6 m -72.04 118.37 14.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.876 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 81.1 mt -77.43 -178.91 5.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.643 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -38.48 65.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -148.8 165.3 31.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -75.42 -32.29 60.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.477 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -82.36 74.62 9.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.375 0.607 . . . . 0.0 110.344 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -91.16 129.49 37.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -97.14 15.59 22.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -168.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.062 175.161 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.599 0.238 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -98.04 118.49 34.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.82 148.25 50.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.474 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -88.37 88.61 7.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -51.61 125.2 14.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.699 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.88 132.49 86.7 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.0 124.69 9.1 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.9 2.4 . . . . 0.0 112.392 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.56 -57.1 14.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 109.814 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -94.2 146.55 23.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.301 171.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.3 93.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 37' ' ' PRO . 54.7 mt -67.84 106.47 2.29 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.915 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.67 95.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.452 . . . . 0.0 109.971 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -91.31 129.19 37.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.502 -173.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.37 107.32 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 m -79.84 -36.88 36.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.003 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.53 130.74 15.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.203 0.525 . . . . 0.0 111.375 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -100.4 106.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 -170.73 34.66 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.116 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.54 -58.68 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.226 0.536 . . . . 0.0 110.59 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.11 38.11 1.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.766 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -151.76 143.87 23.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.906 0.384 . . . . 0.0 110.294 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.28 118.62 59.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.82 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.77 112.0 23.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.733 0.301 . . . . 0.0 110.274 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.51 115.16 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.999 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.415 ' C ' HD21 ' A' ' 25' ' ' ASN . 0.2 OUTLIER 72.12 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.625 0.77 . . . . 0.0 110.428 -178.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -174.88 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.283 0.633 . . . . 0.0 109.364 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.09 126.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.367 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -95.06 121.1 36.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.604 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.7 113.2 26.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.604 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -92.78 19.91 7.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.568 0.699 . . . . 0.0 110.106 175.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -130.59 151.84 50.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.665 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 44' ' ' TRP . . . -58.56 136.8 57.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.7 pt -141.85 154.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.097 0.475 . . . . 0.0 111.723 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.31 124.04 28.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.327 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -146.24 163.13 36.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.032 0.444 . . . . 0.0 111.529 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.516 ' HB3' ' HD2' ' A' ' 37' ' ' PRO . . . -126.65 163.56 40.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -176.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 36' ' ' ALA . 63.7 Cg_endo -73.4 23.52 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.706 2.27 . . . . 0.0 112.914 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 36' ' ' ALA . 38.9 tt0 -173.49 90.3 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.04 -165.04 29.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.878 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.88 167.22 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.2 2.6 . . . . 0.0 113.034 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.84 122.9 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.148 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.12 140.72 29.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.1 p -84.41 119.73 25.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.069 0.461 . . . . 0.0 110.594 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 2.3 t90 -98.24 116.4 65.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.737 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.15 35.55 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.267 2.645 . . . . 0.0 114.043 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 51' ' ' ASP . 94.6 t -101.14 133.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.684 0.278 . . . . 0.0 110.577 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -113.84 -43.93 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.477 . . . . 0.0 110.554 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -116.92 151.99 48.09 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.24 -6.66 10.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.746 2.297 . . . . 0.0 112.539 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.39 -3.52 46.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.526 ' HB2' HG12 ' A' ' 46' ' ' VAL . 64.2 m-20 -84.19 -28.16 27.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.555 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.4 mt -55.45 113.73 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.759 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.1 p -128.95 175.14 8.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.392 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -58.29 -44.92 88.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.043 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 m -60.93 -42.43 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.47 HD13 HG21 ' A' ' 46' ' ' VAL . 80.7 mt -70.51 -28.26 64.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.435 ' HB3' HD12 ' A' ' 111' ' ' LEU . 83.7 mt -73.45 -30.06 62.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.79 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 95.2 mt-30 -63.75 -43.63 95.86 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 174.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.47 -42.29 92.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.706 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.77 76.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.637 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.48 0.66 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.35 82.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.427 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.53 -4.28 29.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.303 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 -5.76 58.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -120.56 158.32 27.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.169 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.02 109.78 29.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.333 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.06 -32.76 55.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.123 0.487 . . . . 0.0 110.553 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -85.84 57.14 4.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.287 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.679 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 20.3 t70 -73.44 -53.35 4.62 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.78 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 69' ' ' ASP . 24.0 Cg_exo -64.88 141.11 69.79 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.136 1.891 . . . . 0.0 112.428 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.07 -9.66 56.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.208 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.5 83.13 8.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.755 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -76.28 -10.06 59.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.613 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.87 -24.53 66.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.341 173.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -83.24 -31.91 26.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.029 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 66.08 86.88 0.13 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.675 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.427 ' HG3' ' HD2' ' A' ' 70' ' ' PRO . 55.7 Cg_endo -73.91 -20.25 19.81 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.522 2.148 . . . . 0.0 111.201 172.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -107.18 132.76 52.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.433 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.96 70.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.614 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.26 18.43 8.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.028 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.92 -2.68 52.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.016 0.436 . . . . 0.0 110.704 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.55 101.27 2.36 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.628 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.67 -7.86 57.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.151 0.5 . . . . 0.0 110.912 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 17.6 mmm180 -102.92 138.81 19.67 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.859 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 32.0 Cg_exo -60.79 -19.89 63.51 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.062 2.508 . . . . 0.0 112.885 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.75 -1.5 38.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.316 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.1 m120 64.08 37.48 9.08 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.516 0.51 . . . . 0.0 110.916 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -64.98 133.7 95.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.04 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 2.8 Cg_exo -75.54 151.21 36.9 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.041 2.494 . . . . 0.0 112.125 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -67.27 -44.83 78.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.934 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 p -132.4 136.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.484 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 141' ' ' VAL . 62.3 tp -118.07 121.94 41.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.184 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.19 120.85 42.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.5 t -103.31 119.84 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.941 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.492 ' HA3' HD23 ' A' ' 144' ' ' LEU . . . -98.26 98.81 2.1 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.587 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -126.49 93.0 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.45 -10.21 39.16 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.453 -0.88 . . . . 0.0 114.46 -170.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -89.51 -26.41 20.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.716 0.758 . . . . 0.0 110.168 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -159.53 94.24 1.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.902 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -65.23 109.5 2.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.29 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -106.13 122.41 46.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.891 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.7 134.07 39.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.134 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.4 mt -94.12 137.12 33.67 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.28 171.08 17.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.075 -171.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.42 -44.06 30.87 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.745 2.963 . . . . 0.0 113.351 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.24 -46.8 69.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.133 0.492 . . . . 0.0 111.404 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 92.8 mt-30 -75.98 -12.55 60.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.581 -173.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.03 14.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.2 mtm105 -55.84 -54.89 46.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 24.3 Cg_exo -64.15 -26.71 64.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.842 1.695 . . . . 0.0 111.907 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.435 HD12 ' HB3' ' A' ' 57' ' ' LEU . 75.3 mt -78.72 -46.6 18.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.08 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.73 -34.65 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.832 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.89 65.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.188 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.532 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 50.4 mtt -94.3 -7.83 40.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.006 0.432 . . . . 0.0 110.215 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.95 -8.51 55.98 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.13 122.0 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 0.0 111.004 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.67 109.63 3.78 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.74 110.33 24.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.84 0.352 . . . . 0.0 110.917 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -108.55 116.93 32.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.388 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.95 29.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.495 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.1 mtm -137.49 -172.78 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.304 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.9 159.02 29.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.691 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 p -59.02 -53.04 62.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.967 0.413 . . . . 0.0 110.973 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -65.33 -36.81 85.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.17 75.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 0.0 110.893 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.46 90.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.668 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.391 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -65.18 -42.69 93.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.979 0.418 . . . . 0.0 110.485 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.0 m -65.3 -34.39 78.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.979 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.404 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 60.6 t80 -61.69 -42.76 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.95 177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -57.2 -45.23 83.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.014 0.435 . . . . 0.0 110.586 175.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.72 -53.34 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.402 ' HB2' HG13 ' A' ' 140' ' ' VAL . 93.1 mt -62.43 -31.23 71.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 37.5 ttm -59.96 -50.23 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.493 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.69 72.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.076 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.78 -23.49 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.11 18.63 58.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.552 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -82.69 144.51 30.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -70.71 94.09 0.99 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.077 0.465 . . . . 0.0 110.894 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 133' ' ' LEU . 7.4 p -126.37 138.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.41 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 36' ' ' ALA . 44.9 t -118.89 134.92 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.1 p -115.9 128.69 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 0.0 111.002 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.8 109.82 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.521 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.492 HD23 ' HA3' ' A' ' 95' ' ' GLY . 96.1 mt -113.36 136.47 52.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.706 -173.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 91.7 mt -93.72 133.78 27.41 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.245 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 14.9 Cg_exo -68.07 87.6 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.762 2.308 . . . . 0.0 112.804 -178.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -168.15 -161.77 0.38 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.58 -5.32 0.11 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.511 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -131.19 124.44 30.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.937 0.398 . . . . 0.0 110.596 -176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.1 p -67.13 151.56 47.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.648 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.2 tp -59.53 -46.56 88.51 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.02 106.41 3.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -120.9 99.37 6.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.09 0.471 . . . . 0.0 110.937 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -79.7 148.6 31.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -71.69 -14.0 61.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.805 0.336 . . . . 0.0 110.998 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -66.89 -25.73 66.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.407 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -88.23 122.14 31.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.895 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 59.1 m80 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.801 -178.33 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.75 0.31 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -91.04 -43.3 10.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 109.98 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.0 tp -87.85 146.11 25.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.354 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -126.69 92.88 3.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.56 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -75.67 147.6 39.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.464 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 5.1 p-10 -75.47 133.71 73.9 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.224 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 21.1 Cg_exo -65.86 145.39 80.29 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 123.041 2.494 . . . . 0.0 112.298 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.19 179.08 5.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.972 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -115.83 169.95 8.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . -81.12 129.13 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 0.0 110.965 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 134' ' ' MET . 71.9 mt -90.62 93.26 9.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.927 -178.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -78.87 98.97 6.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.1 m -108.32 137.05 46.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.091 0.472 . . . . 0.0 111.931 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.417 HG21 HG21 ' A' ' 24' ' ' VAL . 80.1 t -73.12 126.16 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.479 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.9 p -87.63 -34.65 18.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.61 0.243 . . . . 0.0 111.314 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.77 172.96 12.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.754 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.24 -33.33 6.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.95 -118.46 14.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.962 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -157.42 107.19 2.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.857 0.361 . . . . 0.0 110.475 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.09 18.96 48.49 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.213 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.932 ' HE1' ' HB2' ' A' ' 23' ' ' GLU . 44.3 p90 -160.34 176.25 11.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.873 0.337 . . . . 0.0 110.593 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.2 mt -123.85 122.13 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.932 ' HB2' ' HE1' ' A' ' 21' ' ' TYR . 28.5 tt0 -105.44 108.85 20.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -172.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.417 HG21 HG21 ' A' ' 14' ' ' VAL . 57.7 t -109.91 107.6 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.946 177.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 58.3 53.63 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.274 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 72.96 -17.97 0.38 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.619 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.72 123.14 29.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.145 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -93.27 102.76 15.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.29 118.05 30.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.563 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -95.14 20.3 9.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.217 0.532 . . . . 0.0 110.133 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -151.08 163.87 37.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.898 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.09 146.62 53.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.197 0.522 . . . . 0.0 112.408 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.73 151.0 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.871 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.47 127.3 40.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -148.31 153.46 38.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.041 0.448 . . . . 0.0 111.397 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.455 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -139.65 159.28 65.91 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 50.0 Cg_exo -55.0 -41.36 79.66 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.608 2.205 . . . . 0.0 112.063 174.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -102.99 94.71 5.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.74 -175.0 23.92 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.815 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -97.89 -178.06 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.365 2.71 . . . . 0.0 112.746 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.21 111.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.14 36.94 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 t -79.2 119.01 21.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.505 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.1 126.0 41.75 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -175.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.5 Cg_exo -69.58 -7.46 21.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.27 2.647 . . . . 0.0 113.048 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.598 HG12 HG12 ' A' ' 52' ' ' ILE . 48.5 t -86.26 102.6 11.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.413 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -98.23 -7.98 28.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.199 0.523 . . . . 0.0 110.448 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.611 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 12.1 mtm180 -138.57 146.26 50.03 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.917 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.57 ' HG3' ' HB3' ' A' ' 98' ' ' ARG . 33.8 Cg_endo -64.74 -9.79 22.33 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.799 2.333 . . . . 0.0 113.259 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.4 -2.98 47.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.468 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.611 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 3.6 m-20 -103.39 9.88 37.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.207 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.598 HG12 HG12 ' A' ' 46' ' ' VAL . 58.2 mt -84.7 126.52 40.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.731 0.301 . . . . 0.0 111.578 -175.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.9 p -128.76 166.61 18.67 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.47 -39.38 83.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.473 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 m -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.247 0.546 . . . . 0.0 110.854 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 46' ' ' VAL . 71.1 mt -72.3 -28.86 63.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.75 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.33 -37.79 80.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.252 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.52 -39.62 94.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.231 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -66.21 -41.53 89.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.574 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -20.26 65.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.546 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.74 -7.42 55.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.21 76.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.485 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt -97.48 17.49 17.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.042 0.448 . . . . 0.0 110.837 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.14 95.81 4.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.511 ' OE1' ' HD3' ' A' ' 68' ' ' ARG . 48.5 mt-10 -96.62 95.27 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.088 0.471 . . . . 0.0 110.167 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.9 t -59.91 -24.76 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.155 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -73.02 -14.44 16.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.316 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 14.9 mtm-85 -89.64 -42.95 11.08 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.836 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.48 90.57 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.431 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.97 126.44 17.29 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.562 2.175 . . . . 0.0 111.302 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.5 mt -58.73 -41.53 86.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.271 0.558 . . . . 0.0 110.553 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.53 166.76 28.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.556 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -87.51 12.81 11.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.234 0.54 . . . . 0.0 110.026 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.7 mt -129.15 135.59 49.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.064 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.58 73.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.892 0.745 . . . . 0.0 112.647 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 41.8 tt0 -135.99 129.77 18.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 171.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 17.0 Cg_exo -69.44 59.78 1.48 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.287 2.658 . . . . 0.0 113.258 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 67.97 -72.39 0.1 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.714 0.806 . . . . 0.0 112.651 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.82 30.82 6.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.065 0.46 . . . . 0.0 110.78 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.2 -69.1 2.55 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.35 87.29 3.38 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 171.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.8 64.73 4.05 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.695 -170.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.96 -28.54 62.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.606 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 18.8 ptt-85 -124.82 169.05 11.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.521 174.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 84' ' ' ARG . 21.9 Cg_endo -61.86 171.98 4.27 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.197 1.931 . . . . 0.0 112.485 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.82 -26.92 66.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.989 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.513 ' HB3' ' NH2' ' A' ' 139' ' ' ARG . 5.5 m-20 65.48 46.5 2.5 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.078 0.466 . . . . 0.0 110.835 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.25 143.44 79.36 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.112 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.84 164.56 34.17 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.556 2.171 . . . . 0.0 112.414 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 42.0 mt-10 -92.29 -44.13 8.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 140' ' ' VAL . 7.5 p -139.37 136.87 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.073 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.9 tp -113.28 112.03 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.547 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.99 108.6 21.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.404 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.12 106.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.49 98.4 1.39 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 49' ' ' PRO . 5.3 m -65.96 -14.76 62.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -170.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.34 -72.9 2.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.974 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.57 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 39.6 ttm180 -85.81 70.35 10.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 0.0 110.074 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 66.28 154.46 0.08 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.726 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 53.7 tt0 -62.53 128.92 38.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.878 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -112.93 138.05 50.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.41 97.12 10.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.43 170.74 15.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.321 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.9 144.09 15.78 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.393 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 48.9 Cg_exo -55.78 -36.47 95.29 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.439 2.759 . . . . 0.0 113.296 -173.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 10.9 mm-40 -63.66 -28.87 70.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -88.26 -9.88 51.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.371 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.17 5.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 110.9 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.573 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.7 mmt180 -53.41 -52.79 63.29 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.292 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 61.7 Cg_exo -53.32 -39.68 80.45 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.153 1.902 . . . . 0.0 112.739 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.2 mt -78.72 -42.12 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.024 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.7 -37.06 80.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 110.617 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.75 70.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 65.1 mtt -83.61 -15.34 49.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.97 8.37 42.15 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.177 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 38.2 t -86.54 108.61 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.744 0.307 . . . . 0.0 110.576 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.75 107.23 2.32 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.828 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.5 t -87.09 111.74 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.783 0.325 . . . . 0.0 110.623 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -112.71 117.5 32.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.388 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 100' ' ' GLN . . . -101.98 115.95 31.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.319 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.478 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 65.4 mtm -139.51 -172.81 3.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.052 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.58 157.34 37.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 34.5 m -60.14 -45.83 91.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.241 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -64.39 -41.02 96.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 110.793 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.46 96.43 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.32 86.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.561 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.43 96.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.447 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -62.72 -48.62 78.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.277 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.0 m -62.73 -38.36 90.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.38 -44.04 95.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.75 -46.54 74.34 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 110.711 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.89 -52.25 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.84 -31.44 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.54 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.463 ' HG2' HD22 ' A' ' 11' ' ' LEU . 48.9 ttp -66.84 -43.23 84.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.825 0.345 . . . . 0.0 110.283 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.98 86.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.16 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.45 36.14 5.22 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.347 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -100.91 161.42 13.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.606 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 55.4 mtp85 -78.57 77.98 5.04 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.368 0.604 . . . . 0.0 111.024 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.483 HG21 HG11 ' A' ' 91' ' ' VAL . 5.7 p -112.04 132.96 59.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.372 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.455 HG21 ' HB1' ' A' ' 36' ' ' ALA . 38.5 t -115.65 134.04 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.5 p -119.04 135.45 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.248 0.546 . . . . 0.0 111.226 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 117.78 30.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.188 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.2 mt -107.37 120.44 42.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.173 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.43 HD23 ' CZ3' ' A' ' 44' ' ' TRP . 71.9 mt -100.96 130.09 25.87 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.278 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 1.9 Cg_endo -82.22 105.73 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.995 2.463 . . . . 0.0 110.995 174.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.38 101.61 0.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.19 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.55 -62.93 0.3 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.085 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.4 t70 55.17 53.22 10.42 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.509 1.147 . . . . 0.0 108.473 -169.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.3 m -73.63 -25.02 60.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.032 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.02 109.8 12.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.437 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.492 ' HG2' ' CE1' ' A' ' 158' ' ' HIS . 31.7 mt-10 -76.33 106.46 7.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.215 0.531 . . . . 0.0 109.683 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.407 ' HD2' ' O ' ' A' ' 158' ' ' HIS . 44.0 m-70 -67.41 117.21 9.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.393 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.459 ' C ' ' H ' ' A' ' 156' ' ' HIS . 16.2 t-80 -73.58 -19.05 60.99 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 111.007 -174.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -82.96 36.46 0.5 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.256 1.027 . . . . 0.0 108.469 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.459 ' H ' ' C ' ' A' ' 154' ' ' HIS . 4.8 t-80 179.2 -177.47 0.3 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -170.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -90.97 -56.15 3.28 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.492 ' CE1' ' HG2' ' A' ' 152' ' ' GLU . 9.9 t60 . . . . . 0 C--O 1.246 0.902 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 170.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.99 119.4 9.38 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.88 0.372 . . . . 0.0 110.282 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt -71.21 164.26 26.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.497 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -102.68 -28.9 11.85 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.8 p -76.72 -30.63 56.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.56 104.46 52.89 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.622 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.95 129.66 22.53 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 123.136 2.558 . . . . 0.0 112.716 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.51 107.83 15.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.2 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -61.65 129.96 43.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.819 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.51 69.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.029 0.442 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.9 tp -109.71 117.01 32.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.539 HD22 ' HB2' ' A' ' 35' ' ' PHE . 56.8 t30 -75.05 109.75 8.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -147.06 146.14 29.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.934 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.87 118.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.16 17.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.33 -175.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 23' ' ' GLU . . . -147.44 119.31 8.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.083 0.468 . . . . 0.0 111.332 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -113.18 116.54 29.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.416 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.58 -164.1 9.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.831 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.67 109.05 18.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.748 0.309 . . . . 0.0 110.874 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 147' ' ' ASP . . . 91.2 1.0 72.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.437 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -153.43 142.12 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.556 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.0 mt -126.36 111.95 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.254 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -93.69 117.99 30.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.024 0.44 . . . . 0.0 110.436 -176.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.49 113.05 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.741 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 62.32 39.41 12.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 72.19 9.53 5.95 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.773 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.68 107.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 31.0 ptt-85 -81.53 114.85 20.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.323 0.583 . . . . 0.0 110.394 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.39 128.03 43.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.907 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 p -104.55 14.37 30.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.462 0.649 . . . . 0.0 109.717 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -137.68 171.25 14.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.378 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 145' ' ' LEU . . . -62.27 141.71 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.555 0.534 . . . . 0.0 111.687 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 pt -142.11 136.41 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.26 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.3 120.87 37.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.308 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.539 ' HB2' HD22 ' A' ' 12' ' ' ASN . 40.2 p90 -149.88 162.78 39.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.165 0.507 . . . . 0.0 111.834 -173.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 141' ' ' VAL . . . -130.68 158.62 74.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.747 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.662 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 19.3 Cg_endo -60.1 -32.42 94.68 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.604 2.203 . . . . 0.0 111.702 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -130.44 103.44 6.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.171 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.58 -156.14 26.52 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.923 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.64 162.22 6.43 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.836 2.357 . . . . 0.0 113.091 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -114.27 101.6 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.68 118.99 38.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.954 0.407 . . . . 0.0 111.641 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 65.6 m -66.88 132.66 48.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 170.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.536 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -97.93 129.74 30.42 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -171.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.536 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.83 -0.93 6.0 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.884 2.389 . . . . 0.0 112.917 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.402 ' CG2' HD13 ' A' ' 56' ' ' LEU . 46.8 t -86.22 96.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -89.54 -20.96 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 109.734 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 50' ' ' ALA . 44.4 mtt-85 -129.04 130.85 23.44 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.46 12.06 0.26 Allowed 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.058 2.505 . . . . 0.0 113.669 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' ARG . . . -88.47 -2.59 58.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.998 0.428 . . . . 0.0 110.428 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.87 69.31 1.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.883 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.6 mt -115.26 107.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.159 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -113.85 174.9 5.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.952 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 107' ' ' GLN . . . -62.73 -44.0 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.7 m -59.6 -39.32 83.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.025 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.402 HD13 ' CG2' ' A' ' 46' ' ' VAL . 94.9 mt -70.48 -34.05 71.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.61 -35.59 77.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.1 mt-30 -62.1 -41.91 98.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.46 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -68.62 -38.59 80.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.396 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.8 65.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.57 0.14 35.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 0.0 111.112 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.7 0.1 87.9 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.471 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.526 ' HA ' HG21 ' A' ' 66' ' ' VAL . 66.5 mt -85.89 23.81 1.39 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.814 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.68 -30.4 24.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.19 -175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -112.94 -14.44 13.02 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' A' ' 63' ' ' LEU . 28.3 m -93.75 140.7 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.956 0.408 . . . . 0.0 110.972 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.48 -176.27 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.516 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -104.79 27.9 7.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.216 0.531 . . . . 0.0 110.025 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -112.1 159.89 32.05 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.278 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.88 152.27 44.06 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.747 2.298 . . . . 0.0 112.312 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.3 mt -87.84 21.86 2.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.167 -176.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.1 179.68 7.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.625 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -78.4 -7.59 57.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.568 0.699 . . . . 0.0 109.786 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.9 mt -107.18 168.05 9.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.122 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -100.96 176.15 5.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.934 0.397 . . . . 0.0 110.907 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -131.16 98.44 18.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.278 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -88.72 -18.9 1.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.912 2.408 . . . . 0.0 113.751 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -96.14 -53.02 3.79 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.266 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.39 97.85 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.929 0.395 . . . . 0.0 110.525 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.19 38.08 3.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.589 -176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.6 91.3 2.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.037 0.446 . . . . 0.0 110.347 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.86 110.12 2.37 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.473 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 67.95 101.39 0.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 124.276 0.633 . . . . 0.0 111.036 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 74.3 mtp85 -69.79 133.33 88.45 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.005 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 17.2 Cg_exo -67.91 3.97 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.381 2.72 . . . . 0.0 112.859 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.48 8.02 17.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.086 0.469 . . . . 0.0 110.374 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -95.98 0.37 51.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.237 0.542 . . . . 0.0 109.989 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.13 154.03 38.94 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.832 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.522 ' HB3' HG22 ' A' ' 141' ' ' VAL . 15.8 Cg_endo -58.34 132.22 47.49 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.795 2.33 . . . . 0.0 113.266 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -76.34 -33.98 58.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 p -134.78 134.08 53.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.016 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.3 tp -114.12 112.7 23.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.268 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.59 116.01 28.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.36 100.63 11.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -86.04 76.25 2.17 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.353 -174.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 90.48 4.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.041 0.448 . . . . 0.0 109.972 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.33 -30.78 21.28 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.168 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -64.09 -50.39 68.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.304 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -145.32 132.36 20.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -72.41 91.72 1.38 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.97 108.93 7.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.864 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.8 120.19 9.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.9 mt -80.13 149.02 30.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.54 147.36 16.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.277 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 51.6 Cg_exo -55.9 -32.43 85.29 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.182 2.588 . . . . 0.0 112.51 -177.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.15 -29.35 38.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 98.9 mt-30 -73.82 -41.64 62.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.77 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.07 2.69 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 66.9 ttt180 -59.27 -55.46 45.96 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.292 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 19.0 Cg_endo -57.99 -26.94 77.25 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.026 1.817 . . . . 0.0 112.333 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -83.25 -43.87 15.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.393 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.62 -35.16 77.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.76 68.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.227 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 66.0 mtt -83.97 -23.97 30.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.11 0.481 . . . . 0.0 110.175 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.22 3.37 22.88 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.694 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.77 102.94 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.338 . . . . 0.0 110.341 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.23 99.46 1.57 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.103 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.56 127.51 39.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.625 0.25 . . . . 0.0 110.546 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.92 136.63 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.996 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.12 123.46 35.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.054 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.457 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 38.6 ttm -142.52 160.09 40.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -174.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.62 145.4 54.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.457 HG22 HD23 ' A' ' 144' ' ' LEU . 8.8 m -52.33 -45.66 65.74 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.226 0.329 . . . . 0.0 111.711 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -60.13 -50.14 74.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.65 71.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.294 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.3 88.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.629 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.06 97.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.584 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 132' ' ' ILE . 21.0 ttt180 -58.93 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 28.1 m -62.2 -41.71 98.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.63 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 53.0 t80 -54.85 -51.6 65.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.103 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.46 -41.75 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.084 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 128' ' ' ARG . 80.1 mt -62.46 -54.6 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.62 -32.48 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.174 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.662 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 53.2 ttp -64.42 -43.32 94.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.36 175.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.45 -23.68 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.224 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 32.7 mt-10 -88.33 -3.41 58.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.006 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.7 44.17 82.21 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.228 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -117.65 157.31 26.65 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.576 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -73.16 100.39 3.06 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.114 0.483 . . . . 0.0 111.054 -173.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.69 135.24 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.738 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 89' ' ' PRO . 66.6 t -128.6 142.15 44.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.0 p -129.6 136.94 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.661 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 113.94 22.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.253 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.457 HD23 HG22 ' A' ' 123' ' ' THR . 97.1 mt -100.52 127.89 46.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -172.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 32' ' ' ALA . 18.0 mt -117.26 94.5 45.27 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.853 172.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.75 -158.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.272 2.648 . . . . 0.0 112.909 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.438 ' O ' ' HA2' ' A' ' 20' ' ' GLY . 22.4 t70 -117.64 151.89 36.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.377 176.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 177.62 -43.42 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.723 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -93.66 109.2 20.85 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.0 p -73.34 164.75 26.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.611 -175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 98.3 mt -77.25 -25.46 51.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.106 0.479 . . . . 0.0 110.143 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.565 ' HG3' ' HE1' ' A' ' 157' ' ' HIS . 36.9 tt0 -119.86 108.7 14.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.24 176.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -78.2 130.56 36.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -84.34 -73.18 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.08 -171.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 29.1 m170 -78.88 119.88 22.7 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 60.1 m80 75.0 73.26 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.146 0.904 . . . . 0.0 108.704 -167.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.565 ' HE1' ' HG3' ' A' ' 152' ' ' GLU . 83.5 t60 -86.27 -15.32 41.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.544 -176.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.645 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtm . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.594 0.235 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -75.88 -36.5 59.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.2 87.26 0.79 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.03 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -175.92 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.3 m -81.0 -42.04 21.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.32 148.43 90.96 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.652 172.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.534 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 30.8 Cg_endo -63.74 147.02 92.69 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.718 2.279 . . . . 0.0 112.916 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.65 0.4 43.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.303 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.9 p -113.08 138.21 50.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.286 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.33 65.03 5.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.101 0.477 . . . . 0.0 110.731 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.7 mt -149.92 -35.96 0.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.044 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.534 ' HA ' ' HG3' ' A' ' 7' ' ' PRO . 3.3 m-20 63.74 23.79 13.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.216 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -61.75 139.7 58.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.204 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.402 HG11 HG23 ' A' ' 22' ' ' ILE . 58.3 t -65.78 103.13 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -70.32 -34.45 72.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.907 -176.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -154.46 149.05 26.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.199 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -120.07 132.22 55.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.02 178.91 17.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.677 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.87 99.26 1.02 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.384 0.274 . . . . 0.0 111.281 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.95 15.65 72.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.314 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -157.55 152.14 25.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.186 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.636 HG12 HD13 ' A' ' 144' ' ' LEU . 3.1 mp -113.41 120.64 63.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 40.1 tt0 -97.33 110.83 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 0.0 110.687 -176.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.455 ' HA ' ' OG1' ' A' ' 15' ' ' THR . 57.5 t -119.99 119.76 61.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.529 176.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 63.42 42.5 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.591 0.557 . . . . 0.0 110.22 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 66.79 10.85 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.319 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.5 115.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -82.02 101.99 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.83 89.33 6.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.083 0.468 . . . . 0.0 110.598 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -86.58 52.16 2.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -168.28 156.85 8.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 44' ' ' TRP . . . -56.73 130.5 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.493 0.495 . . . . 0.0 111.262 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.94 136.1 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.298 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -121.03 114.66 21.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.883 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 34.7 p90 -138.9 152.78 48.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.115 0.483 . . . . 0.0 111.785 -174.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.487 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.54 154.62 71.6 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.135 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 -13.7 27.98 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.731 2.287 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -122.45 22.47 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.72 168.91 29.91 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.335 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.62 172.1 15.69 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.581 2.187 . . . . 0.0 112.07 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.46 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 46.2 t -87.62 95.97 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.62 109.25 7.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.344 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -85.69 131.27 34.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 27.6 m0 -98.31 145.77 30.41 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.642 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.4 Cg_exo -81.71 37.01 0.65 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 110.225 168.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' A' ' 51' ' ' ASP . 54.3 t -108.85 123.04 64.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -171.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -119.02 -9.84 9.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 137.77 28.02 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 96' ' ' THR . 28.7 Cg_endo -65.3 -5.45 11.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.477 2.118 . . . . 0.0 112.143 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.31 4.5 53.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.469 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.535 ' HB2' HG13 ' A' ' 46' ' ' VAL . 60.5 m-20 -90.29 -11.24 41.39 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -62.98 105.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.046 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 67.4 p -111.17 166.13 11.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.34 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -62.88 -32.0 73.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.184 175.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -60.29 -47.97 83.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.604 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.58 -34.39 78.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.843 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.486 ' HB3' HD11 ' A' ' 111' ' ' LEU . 98.7 mt -65.06 -38.79 91.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.817 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 94.9 mt-30 -65.56 -39.08 91.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 110.43 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -71.83 -39.32 69.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.97 -17.71 63.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.878 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.402 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -77.53 -7.33 56.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.813 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.56 3.15 78.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.163 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt -71.69 -4.0 24.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.025 0.441 . . . . 0.0 110.922 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.3 -25.81 51.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.912 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.65 163.15 17.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.57 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.09 93.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.6 m -89.68 173.74 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.182 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 64.91 38.63 6.36 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -111.74 104.08 55.74 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.021 -174.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.83 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 91.8 Cg_endo -94.6 15.73 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.242 2.628 . . . . 0.0 112.033 175.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.5 tp -101.77 -41.88 6.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.386 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.02 -24.81 61.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.201 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -126.68 161.15 28.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.444 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.05 -2.99 53.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.027 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -141.82 133.2 26.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.81 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.83 ' HB3' ' HB3' ' A' ' 70' ' ' PRO . 11.2 pt-20 -84.39 119.98 73.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.162 0.506 . . . . 0.0 110.943 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 5.5 Cg_exo -79.96 168.85 18.57 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.38 2.72 . . . . 0.0 112.828 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -92.9 -175.09 3.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.369 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.44 -59.6 2.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.115 0.483 . . . . 0.0 109.761 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.44 -117.96 0.8 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.033 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.33 -10.85 26.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.769 0.319 . . . . 0.0 110.776 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.1 139.79 14.67 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.18 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.67 -27.87 63.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.169 0.509 . . . . 0.0 110.757 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -98.69 155.84 36.28 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.462 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -41.32 126.38 2.81 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.556 2.837 . . . . 0.0 113.431 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.88 76.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.022 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -78.72 62.7 3.31 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.571 0.7 . . . . 0.0 110.388 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . . . -174.4 90.68 0.33 Allowed Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.48 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HB3' ' CG2' ' A' ' 141' ' ' VAL . 6.7 Cg_endo -49.41 136.52 32.33 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 123.996 3.131 . . . . 0.0 113.736 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -77.75 -46.6 21.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.487 HG11 HD22 ' A' ' 133' ' ' LEU . 7.3 p -132.03 133.85 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.637 173.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.45 119.5 35.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.174 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.56 105.22 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.223 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.15 118.34 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -94.43 118.26 5.75 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.558 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -72.13 -5.21 33.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.238 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.23 -80.67 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.537 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 149' ' ' ASP . 38.5 ttm-85 -55.54 -55.72 28.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 110.78 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -172.22 152.44 2.81 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.648 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.558 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 44.4 tt0 -58.4 128.41 37.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.775 0.672 . . . . 0.0 112.375 -168.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.49 ' HB2' HG21 ' A' ' 96' ' ' THR . 32.6 m170 -127.62 148.13 50.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.627 175.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 tp -88.42 126.35 35.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.81 171.54 14.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.423 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.19 156.46 16.33 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.753 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.52 -32.48 88.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.222 2.615 . . . . 0.0 112.973 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 tt0 -81.96 -25.14 35.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 110.709 -177.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.54 -44.73 73.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.492 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 35.5 m -97.83 10.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.881 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.628 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 13.5 ttt180 -54.69 -53.88 55.4 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.503 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.5 Cg_exo -59.62 -35.24 95.73 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.031 1.821 . . . . 0.0 112.552 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.661 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.7 mt -75.15 -36.62 61.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.08 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 89.9 mt -57.96 -42.91 85.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.839 0.352 . . . . 0.0 110.476 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.52 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.425 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -81.19 -22.53 38.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 110.715 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.25 17.47 10.74 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 46.7 t -93.3 108.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.426 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.11 86.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.177 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.28 126.02 39.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.736 0.303 . . . . 0.0 111.299 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -127.93 145.75 50.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.028 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.5 128.36 55.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.231 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.523 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.4 mtm -147.03 -175.13 4.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.918 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.99 163.03 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.663 0.268 . . . . 0.0 110.633 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.469 HG22 HD23 ' A' ' 144' ' ' LEU . 5.6 m -56.77 -39.12 73.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.667 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.1 -53.32 59.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.095 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.33 76.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.153 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.18 95.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.325 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.78 81.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.233 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.408 ' O ' HG13 ' A' ' 132' ' ' ILE . 78.4 mtp180 -63.39 -45.31 91.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.8 m -65.8 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.85 -49.73 76.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.449 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -58.98 -41.0 86.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.982 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 128' ' ' ARG . 73.2 mt -63.09 -53.3 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.487 HD22 HG11 ' A' ' 91' ' ' VAL . 10.8 mp -69.16 -23.78 63.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.237 -177.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.4 ttp -66.82 -43.2 84.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 109.889 174.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.28 64.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.739 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.03 -16.52 63.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.782 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.52 37.84 62.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -115.62 151.96 33.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -80.05 84.39 5.79 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.984 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.73 130.43 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.415 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.542 ' CG2' ' HB3' ' A' ' 89' ' ' PRO . 22.9 t -115.29 129.43 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -115.95 138.4 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.925 0.393 . . . . 0.0 110.843 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.24 105.75 12.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.636 HD13 HG12 ' A' ' 22' ' ' ILE . 77.6 mt -100.43 132.82 45.6 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.485 ' HG ' ' HB1' ' A' ' 32' ' ' ALA . 2.0 tt -119.17 86.95 33.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.228 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -92.35 -159.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.944 2.429 . . . . 0.0 111.439 172.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.2 t0 65.06 27.77 12.47 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.929 0.871 . . . . 0.0 109.877 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.47 -14.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.06 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 9.7 p-10 -61.71 -45.38 94.2 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.327 0.651 . . . . 0.0 111.094 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.7 m -77.73 16.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.888 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.0 tp -83.05 -9.5 59.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.385 0.612 . . . . 0.0 109.412 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -99.72 168.52 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.641 174.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -136.33 99.62 4.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.502 0.668 . . . . 0.0 110.407 173.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -112.81 137.51 51.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.496 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -78.9 160.52 27.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.026 0.441 . . . . 0.0 110.988 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -93.26 112.78 24.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.592 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -96.1 159.9 14.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.258 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 . . . . . 0 C--O 1.245 0.858 0 CA-C-O 119.349 -0.357 . . . . 0.0 110.245 -178.751 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -57.7 143.66 40.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.548 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.61 -41.28 69.78 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -104.57 93.2 4.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m -64.32 104.32 0.75 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.135 0.493 . . . . 0.0 109.817 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -71.16 123.3 89.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.676 -168.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 92.2 Cg_endo -89.61 58.16 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.394 2.729 . . . . 0.0 109.942 169.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 79.17 -160.31 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.228 -168.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.2 p -59.32 -50.06 75.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 65.65 -68.16 0.12 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.355 0.662 . . . . 0.0 111.286 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.98 104.61 13.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 35.9 t-20 -68.13 105.21 2.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.6 m -119.73 126.12 50.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.474 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.2 120.01 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 p -96.04 -23.36 16.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.738 0.304 . . . . 0.0 111.799 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.28 103.23 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.868 0.366 . . . . 0.0 111.309 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HD1' HG12 ' A' ' 22' ' ' ILE . 88.4 t80 -123.96 131.3 53.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.753 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.23 -4.72 33.5 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.29 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -91.34 17.34 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 0.0 110.916 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.01 -42.93 2.09 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 54.0 p90 -111.77 176.28 5.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.45 HG12 ' HD1' ' A' ' 17' ' ' TYR . 48.9 mt -119.49 113.29 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.96 0.409 . . . . 0.0 110.207 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 34.0 tt0 -89.35 118.8 29.28 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.8 t -105.03 104.18 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.161 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 65.69 -80.45 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.935 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -132.22 2.54 3.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.204 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.3 t -125.35 127.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 0.0 111.035 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 66.6 mtt85 -86.99 113.11 22.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 88.8 m-85 -99.24 148.84 23.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.873 0.368 . . . . 0.0 110.836 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -88.72 -67.66 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.067 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.545 ' HB2' ' CG ' ' A' ' 147' ' ' ASP . 16.8 p-80 -115.7 -169.14 1.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.927 -172.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.627 ' HA ' ' O ' ' A' ' 144' ' ' LEU . . . -36.24 128.29 0.74 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.417 HG23 ' HA ' ' A' ' 43' ' ' SER . 18.5 pt -143.71 162.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.32 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -137.15 133.64 35.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.812 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.636 ' HB3' HG11 ' A' ' 41' ' ' VAL . 37.1 p90 -157.2 163.01 39.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.291 0.567 . . . . 0.0 112.244 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.407 ' HA ' ' HH ' ' A' ' 130' ' ' TYR . . . -130.95 161.89 58.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 73.5 Cg_exo -49.45 -55.04 4.52 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.132 2.555 . . . . 0.0 112.347 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -131.93 95.12 3.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.09 -153.54 17.15 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.937 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.1 134.69 13.21 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.758 2.305 . . . . 0.0 113.321 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG11 ' HB3' ' A' ' 35' ' ' PHE . 53.9 t -114.14 121.39 66.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.78 168.16 20.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.127 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 33' ' ' ILE . 11.6 p -99.94 150.23 22.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.937 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.58 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -98.33 131.64 25.83 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.58 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 37.7 Cg_endo -67.01 -11.13 31.06 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.842 2.361 . . . . 0.0 112.592 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.432 ' CG2' HD12 ' A' ' 56' ' ' LEU . 10.9 t -86.1 146.1 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.94 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -129.11 -1.44 5.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.489 ' HD2' ' OD2' ' A' ' 51' ' ' ASP . 50.9 mtt85 -134.67 137.17 26.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.46 -7.02 19.08 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.954 2.436 . . . . 0.0 112.377 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.44 -13.94 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.376 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.489 ' OD2' ' HD2' ' A' ' 48' ' ' ARG . 27.4 m-20 -96.23 3.88 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.164 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.51 122.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.875 0.369 . . . . 0.0 111.257 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.1 p -121.57 176.3 5.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.373 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -64.29 -37.61 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 0.0 110.199 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -48.41 78.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.506 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.432 HD12 ' CG2' ' A' ' 46' ' ' VAL . 44.0 mt -70.63 -30.44 67.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.952 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 111' ' ' LEU . 81.0 mt -67.23 -39.1 86.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.454 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 24.6 mt-30 -58.18 -39.9 80.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.076 0.465 . . . . 0.0 110.214 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -68.41 -42.58 78.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.645 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.68 -13.15 62.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.88 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.1 -13.2 62.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.105 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.99 88.32 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.634 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -86.89 2.64 48.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.47 . . . . 0.0 110.809 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.67 74.81 10.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.335 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -90.9 107.06 18.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.957 174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.4 t -73.26 -38.62 54.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.193 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -82.88 105.84 13.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.316 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -117.02 79.51 1.34 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.572 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.681 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 17.8 m-20 -135.57 -56.8 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.877 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.681 ' HD2' ' H ' ' A' ' 69' ' ' ASP . 34.4 Cg_endo -65.47 -10.91 28.02 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.097 1.865 . . . . 0.0 112.97 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.8 tp -80.01 -16.95 54.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.982 0.42 . . . . 0.0 110.38 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.9 144.22 25.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.549 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -123.46 -176.65 3.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.298 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 27.7 tp -95.52 -1.21 51.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.701 0.762 . . . . 0.0 109.223 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.26 -173.66 4.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.415 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -142.93 143.12 23.95 Favored Pre-proline 0 C--N 1.324 -0.541 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.732 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.25 -3.28 6.04 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.902 2.401 . . . . 0.0 112.274 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 63.9 -74.64 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.667 0.787 . . . . 0.0 112.179 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.15 -27.15 56.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.993 0.425 . . . . 0.0 111.065 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.0 40.85 3.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.342 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.3 -1.92 37.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.779 0.324 . . . . 0.0 111.172 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.03 52.9 2.47 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.953 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.37 -4.57 21.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.234 0.54 . . . . 0.0 110.584 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.417 ' C ' ' H ' ' A' ' 86' ' ' ALA . 98.8 mtt180 -111.41 158.98 34.69 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.061 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.09 39.08 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.568 2.845 . . . . 0.0 113.047 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 84' ' ' ARG . . . -100.36 1.78 41.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.26 0.553 . . . . 0.0 110.001 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -118.39 -31.75 4.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.224 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -85.16 132.3 45.82 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 18.1 Cg_exo -66.42 155.73 68.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.947 2.431 . . . . 0.0 112.15 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.34 -44.9 13.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.0 0.429 . . . . 0.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.485 HG11 HG21 ' A' ' 140' ' ' VAL . 4.9 p -133.02 133.91 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.399 0.618 . . . . 0.0 111.245 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -111.79 110.7 21.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.337 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 119' ' ' GLU . 97.2 mt -90.35 113.12 24.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.58 118.45 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -92.9 101.49 2.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 p -76.33 56.68 1.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 145' ' ' LEU . . . 76.35 -103.38 1.71 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.614 171.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.59 -35.49 11.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.238 . . . . 0.0 111.262 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -142.55 159.71 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.653 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.747 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.7 tt0 -62.79 111.19 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.792 175.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -113.73 116.18 29.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.039 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 143.01 57.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.068 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.27 -164.92 1.16 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.03 147.44 16.24 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.763 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.57 -42.42 65.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.063 2.509 . . . . 0.0 112.658 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.914 0.388 . . . . 0.0 111.697 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 98.7 mt-30 -96.24 -39.98 9.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 109.858 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.82 -24.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.801 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.517 ' HA ' HD13 ' A' ' 112' ' ' LEU . 7.8 ttp180 -63.4 -38.29 38.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.84 -43.41 23.93 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.803 1.668 . . . . 0.0 112.264 170.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.72 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.4 mt -75.5 -36.21 60.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 109' ' ' ARG . 96.3 mt -61.08 -31.24 70.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.73 -22.49 63.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -87.9 -30.62 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 122.47 9.07 6.67 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.155 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.72 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 17.1 t -98.89 110.13 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 111.023 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.28 122.91 6.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.606 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.28 125.23 46.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.937 0.399 . . . . 0.0 111.491 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' HB2' HD21 ' A' ' 93' ' ' LEU . 51.8 mm-40 -110.01 103.24 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.682 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.43 109.8 21.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.614 0.245 . . . . 0.0 110.355 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.747 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 63.2 mtm -141.97 -177.24 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 -176.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.63 147.61 36.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.973 172.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.485 HG22 ' HB3' ' A' ' 144' ' ' LEU . 61.8 m -55.86 -44.46 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.691 0.281 . . . . 0.0 111.323 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -64.0 -44.01 93.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.568 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.07 99.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.003 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.02 79.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.98 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.6 94.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.97 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -61.11 -50.08 74.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.041 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.607 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.54 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 73.2 t80 -61.55 -46.74 88.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.691 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -56.0 -44.55 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.462 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 62.3 mt -69.29 -54.27 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.237 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -57.11 -40.31 76.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -175.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 46.7 ttp -58.95 -36.67 75.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.68 -13.11 54.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 27.1 mm-40 -88.5 -35.44 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 170.42 98.92 0.12 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.06 85.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.409 0.684 . . . . 0.0 112.84 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -144.45 33.79 1.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 133' ' ' LEU . 7.2 p -127.45 140.42 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.567 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.0 t -124.74 143.84 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.54 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 9.9 p -120.63 140.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.305 -176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -129.72 109.23 10.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.315 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 84.2 mt -116.58 138.9 51.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.78 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 5.0 mp -108.76 94.34 14.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 O-C-N 123.239 0.337 . . . . 0.0 110.171 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_endo -91.11 17.45 1.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.281 2.654 . . . . 0.0 111.566 177.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.621 ' HB3' ' NE2' ' A' ' 156' ' ' HIS . 1.1 m-20 -48.82 112.52 0.62 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.44 -175.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.61 -6.66 0.13 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.728 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -53.27 -34.65 58.12 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.0 0.92 . . . . 0.0 111.961 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.3 m -79.47 22.79 0.43 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.02 -173.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.2 mt 72.14 -51.77 0.7 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.673 0.789 . . . . 0.0 111.639 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.433 ' OE1' ' HB2' ' A' ' 154' ' ' HIS . 0.9 OUTLIER -74.71 136.61 41.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -97.39 19.86 12.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.769 0.319 . . . . 0.0 111.758 -171.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.433 ' HB2' ' OE1' ' A' ' 152' ' ' GLU . 60.2 m80 -131.66 -51.57 0.99 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -85.62 152.21 23.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.135 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.621 ' NE2' ' HB3' ' A' ' 147' ' ' ASP . 42.5 m80 -138.3 153.7 49.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -119.92 93.36 4.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.187 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.247 0.952 0 O-C-N 124.037 0.835 . . . . 0.0 111.653 174.817 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 79.5 tttt 67.44 83.43 0.17 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.413 0.625 . . . . 0.0 109.722 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.8 mt -130.93 179.09 6.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.016 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -75.28 -42.99 53.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.6 m -124.2 101.33 7.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.816 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.36 164.39 54.44 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.68 95.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.75 2.3 . . . . 0.0 112.792 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.01 96.66 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.196 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -105.39 164.0 12.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.849 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.12 130.05 39.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.966 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.4 117.52 19.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.475 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -76.69 94.69 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 m -109.44 137.76 46.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.658 -171.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.11 127.35 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 p -105.77 -56.33 2.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.657 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -114.89 135.57 54.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.1 0.476 . . . . 0.0 110.877 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.11 167.38 10.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.649 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.07 -172.43 35.05 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.75 -63.51 1.19 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.134 0.492 . . . . 0.0 110.763 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.785 ' HA3' ' HA ' ' A' ' 149' ' ' ASP . . . -92.12 -5.43 65.83 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.907 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 13.0 p90 -139.9 148.72 42.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.858 0.361 . . . . 0.0 110.045 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.66 120.41 58.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 32.5 tt0 -96.37 114.1 25.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.317 0.58 . . . . 0.0 110.566 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.34 125.23 59.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.679 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.04 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -141.54 16.04 2.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.606 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.58 129.73 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.369 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.3 mtp-105 -88.23 114.84 25.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.074 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.17 100.47 9.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.78 0.324 . . . . 0.0 111.123 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 36.2 m -83.81 36.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.439 0.637 . . . . 0.0 109.818 173.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.489 ' HB2' HG22 ' A' ' 33' ' ' ILE . 8.1 m170 -120.22 169.81 9.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.2 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.33 105.26 15.86 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 164.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 31' ' ' HIS . 19.4 pt -112.24 132.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.419 0.628 . . . . 0.0 112.625 -169.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -113.6 121.63 44.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.429 174.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -147.88 155.79 41.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.273 0.559 . . . . 0.0 111.773 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.487 ' HB1' HG23 ' A' ' 141' ' ' VAL . . . -129.23 159.88 66.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.628 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 23.0 Cg_endo -62.71 -25.68 75.08 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.447 2.098 . . . . 0.0 111.628 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -125.63 108.23 11.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.561 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.05 -170.3 23.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.323 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.93 -177.29 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.38 121.86 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.976 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.7 119.46 38.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.962 0.41 . . . . 0.0 110.789 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -94.06 131.8 39.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.345 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -98.28 137.1 20.74 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.037 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.53 0.05 9.91 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.017 2.478 . . . . 0.0 111.374 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.415 HG23 HD11 ' A' ' 56' ' ' LEU . 29.7 t -85.88 113.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.486 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -111.79 7.77 20.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 0.0 110.794 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.521 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 54.0 ttp180 -127.02 115.44 21.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 26.8 Cg_exo -63.44 -10.81 22.99 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.4 2.733 . . . . 0.0 113.883 -173.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.37 -2.0 58.35 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.269 -0.269 . . . . 0.0 111.38 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.521 ' OD2' ' HB3' ' A' ' 48' ' ' ARG . 42.5 m-20 -98.16 -2.83 39.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.89 118.55 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.206 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.7 m -129.4 169.16 15.27 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 107' ' ' GLN . . . -49.71 -54.33 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -173.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.7 -33.52 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.415 HD11 HG23 ' A' ' 46' ' ' VAL . 98.3 mt -65.23 -44.54 87.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.498 . . . . 0.0 110.224 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.99 -37.25 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.664 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.511 ' HA ' HD21 ' A' ' 111' ' ' LEU . 48.2 tt0 -62.09 -37.52 85.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.701 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -71.61 -41.3 69.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.58 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.11 -4.94 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.875 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.09 -4.42 38.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.531 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.42 35.52 52.01 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.096 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -90.88 13.09 17.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 110.661 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.16 75.88 6.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.417 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -78.37 111.32 14.24 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p -127.37 138.93 53.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.069 0.461 . . . . 0.0 111.622 -171.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.24 148.56 8.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.06 18.37 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -173.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 t70 64.75 96.84 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.368 0 C-N-CA 123.273 0.629 . . . . 0.0 110.434 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.718 ' HB3' ' H ' ' A' ' 75' ' ' ASP . 11.8 Cg_exo -69.92 83.92 0.7 Allowed 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.198 2.599 . . . . 0.0 113.368 -173.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.75 -16.63 16.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.334 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.28 -67.76 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.483 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 77.4 m-85 -123.0 -84.68 0.66 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 70' ' ' PRO . 6.6 mt 176.92 107.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.849 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.718 ' H ' ' HB3' ' A' ' 70' ' ' PRO . 13.2 m-20 -77.27 100.74 5.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.813 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.04 104.92 5.4 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.187 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 75' ' ' ASP . 86.9 Cg_endo -86.31 -6.25 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.943 2.428 . . . . 0.0 113.509 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.92 -51.93 62.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.095 0.474 . . . . 0.0 110.114 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.44 74.75 9.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.031 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.17 41.76 2.06 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.787 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.45 106.31 3.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.066 0.46 . . . . 0.0 110.65 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.08 -3.01 11.59 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.848 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.41 139.05 42.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.605 0.24 . . . . 0.0 110.479 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -105.55 107.73 59.92 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.979 0.419 . . . . 0.0 110.578 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.84 -39.37 3.39 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.689 2.26 . . . . 0.0 111.654 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.64 43.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.771 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -74.48 -71.69 0.33 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.899 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 64.57 158.82 0.12 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 124.024 0.827 . . . . 0.0 112.625 176.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.45 165.86 26.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.695 2.264 . . . . 0.0 111.271 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.724 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.2 mt-10 -94.8 -38.01 10.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.769 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.496 HG12 HG22 ' A' ' 140' ' ' VAL . 6.0 p -144.08 137.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 111.179 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.6 tp -113.26 115.39 28.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.702 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.05 116.16 28.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.578 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.51 121.64 52.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.261 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.38 89.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.044 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.59 36.91 1.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.227 0.537 . . . . 0.0 109.832 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.552 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -79.78 63.3 4.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.009 -170.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.473 ' NH2' ' HA ' ' A' ' 147' ' ' ASP . 8.9 ttm180 -161.11 -52.62 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.54 90.3 2.4 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -71.24 93.12 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.7 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -76.09 107.46 8.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.207 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.64 126.04 26.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.16 165.7 15.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.68 157.91 15.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.93 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.94 -33.72 97.46 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.04 2.493 . . . . 0.0 112.594 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.79 -20.5 62.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.952 0.406 . . . . 0.0 111.005 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 87.9 mt-30 -88.02 -35.11 17.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.448 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 30.2 m -92.48 -21.03 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.741 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.547 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 7.5 tmm_? -59.07 -48.55 96.38 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 8.5 Cg_endo -51.14 -43.42 48.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.323 2.015 . . . . 0.0 112.626 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 58' ' ' GLN . 91.8 mt -75.04 -37.03 61.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.9 mt -66.02 -34.71 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.0 -31.22 72.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.213 0.53 . . . . 0.0 110.363 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -75.39 -38.28 60.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.79 -12.25 5.91 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.934 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.08 109.66 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.753 0.311 . . . . 0.0 110.871 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.34 115.98 4.79 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.003 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.55 123.53 43.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.621 0.248 . . . . 0.0 110.812 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -129.39 120.2 25.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.12 122.8 44.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.494 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 70.0 mtm -139.9 -171.82 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.36 150.04 49.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.715 0.293 . . . . 0.0 110.218 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.552 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 8.2 m -56.36 -42.53 77.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.337 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 52.3 tt0 -72.82 -35.98 67.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.18 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.34 -36.46 82.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.126 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.23 95.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.142 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.551 ' O ' HG12 ' A' ' 132' ' ' ILE . 69.5 mtm180 -64.59 -55.85 17.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.412 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -59.71 -32.95 70.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.261 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.431 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 81.7 t80 -59.03 -54.27 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -61.3 -34.22 74.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.472 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 128' ' ' ARG . 45.0 mm -59.76 -55.31 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.551 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 72.0 mt -71.89 -31.05 66.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.3 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 ttp -62.12 -49.97 73.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 110.48 178.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.18 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.736 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.42 -16.63 61.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.516 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.46 31.53 24.59 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -106.05 147.4 28.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.012 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.724 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 68.9 mtm180 -81.41 88.81 6.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.274 0.559 . . . . 0.0 110.6 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 91' ' ' VAL . 7.4 p -120.19 138.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.958 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.487 HG23 ' HB1' ' A' ' 36' ' ' ALA . 40.1 t -121.06 140.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -124.21 138.9 52.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.008 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.84 103.98 9.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.408 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.8 mt -100.63 122.59 43.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.879 0.371 . . . . 0.0 111.165 -173.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.08 109.02 54.89 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.461 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.89 -157.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.311 2.674 . . . . 0.0 110.904 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.473 ' HA ' ' NH2' ' A' ' 98' ' ' ARG . 3.1 p30 -86.84 -55.13 3.99 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.102 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.51 -4.84 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.113 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.785 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 8.2 t0 82.86 65.62 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.3 m -93.59 115.2 27.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.966 -175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.9 mt -81.18 139.81 35.34 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.016 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.95 136.09 50.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.997 0.427 . . . . 0.0 110.515 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -120.56 157.29 29.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -92.2 26.91 2.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.255 0.55 . . . . 0.0 110.823 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -128.99 104.12 7.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.135 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.59 92.52 6.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.072 -174.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -144.84 133.42 22.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.216 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.474 179.471 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.476 HD13 ' HG2' ' A' ' 134' ' ' MET . 3.9 mm? . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.798 0.332 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -70.06 104.08 2.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.357 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.4 m -126.14 151.71 46.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.231 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.01 122.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.183 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.2 p -89.54 -20.3 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.315 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -161.44 140.59 10.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.657 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.43 -79.82 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.5 162.68 38.53 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.839 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -107.99 111.25 23.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.857 0.36 . . . . 0.0 110.674 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.2 4.32 57.53 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.238 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -162.14 172.41 15.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.73 124.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 28.9 tt0 -94.53 109.5 21.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.002 0.43 . . . . 0.0 111.169 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -117.05 124.01 72.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.3 t30 62.85 29.55 16.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.604 0.716 . . . . 0.0 109.506 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HA ' ' CG ' ' A' ' 23' ' ' GLU . 34.8 mt-30 65.64 13.98 9.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.723 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.2 110.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 92.1 mtt180 -86.41 96.8 10.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.993 -174.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.78 115.43 22.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.7 p -90.47 28.71 1.41 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.261 0.553 . . . . 0.0 111.064 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -154.1 171.39 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.785 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.23 138.05 58.24 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.286 0.366 . . . . 0.0 111.2 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.19 147.69 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -123.1 116.52 23.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 175.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -135.83 157.82 45.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.957 0.408 . . . . 0.0 111.057 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.5 160.16 62.73 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 11.2 Cg_endo -56.65 -57.04 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.456 2.104 . . . . 0.0 110.492 172.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.79 103.11 12.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.35 178.73 32.65 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.902 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -88.61 176.02 3.6 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 112.919 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.14 104.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.344 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . . . -85.99 126.62 34.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.559 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -91.26 118.62 30.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.794 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.406 ' CZ2' ' HB2' ' A' ' 60' ' ' ALA . 1.3 m0 -98.32 130.23 28.78 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.42 23.48 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.937 2.425 . . . . 0.0 111.178 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 51' ' ' ASP . 73.2 t -85.71 136.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.771 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -117.85 -24.26 7.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.068 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HG2' ' OD2' ' A' ' 51' ' ' ASP . 8.0 ptt180 -139.03 155.66 72.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.02 -176.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 1.88 2.41 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.538 2.159 . . . . 0.0 112.897 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.73 -14.74 24.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.33 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.594 ' HB2' HG13 ' A' ' 46' ' ' VAL . 65.1 m-20 -77.32 -19.34 56.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.12 117.53 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.006 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.441 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 30.7 p -121.57 175.45 6.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.852 175.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.9 71.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -62.31 -45.39 93.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.133 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.53 -30.71 68.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.003 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 53' ' ' THR . 90.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.356 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -65.27 -38.3 89.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -68.46 -42.58 78.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.376 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.406 ' HB2' ' CZ2' ' A' ' 44' ' ' TRP . . . -65.38 -26.39 67.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.562 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.401 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -73.74 -12.88 60.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.022 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.57 28.41 73.17 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.603 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 61' ' ' ALA . 91.4 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 120.495 0.188 . . . . 0.0 111.268 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HB3' HG23 ' A' ' 141' ' ' VAL . 9.1 Cg_endo -51.29 111.7 0.63 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.841 2.361 . . . . 0.0 111.985 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 3.9 tt0 -69.5 -32.47 71.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.696 HG11 HD13 ' A' ' 133' ' ' LEU . 3.3 p -136.01 131.31 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.456 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -112.96 121.19 43.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.866 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.5 mt -101.2 104.55 15.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.284 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.865 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -105.69 114.31 4.5 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.491 HG21 ' H ' ' A' ' 101' ' ' HIS . 1.2 p -76.11 -20.97 57.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 -58.4 4.79 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.402 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -81.17 -55.31 4.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.744 0.307 . . . . 0.0 110.565 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -159.89 143.45 14.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -52.66 114.61 1.45 Allowed 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.118 0.886 . . . . 0.0 112.113 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.491 ' H ' HG21 ' A' ' 96' ' ' THR . 11.7 t-160 -96.85 111.85 23.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.21 98.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.814 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.07 134.26 40.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -106.04 175.27 21.26 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.735 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 74.3 Cg_exo -49.63 -34.61 35.25 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.351 2.7 . . . . 0.0 112.542 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -49.47 -43.66 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.283 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -96.01 -37.9 10.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.185 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 104' ' ' GLY . 35.0 m -91.42 -14.36 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -171.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 1.1 tmt_? -57.33 -44.7 99.78 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -47.45 -32.08 14.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.3 2.0 . . . . 0.0 113.188 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 93.7 mt -92.33 -36.24 13.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.679 0.276 . . . . 0.0 110.785 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 87.2 mt -58.49 -36.7 74.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.02 68.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.16 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.87 -12.18 45.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.65 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.14 14.69 38.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.029 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.1 t -86.99 107.82 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 0.0 110.659 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.77 111.33 3.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.605 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.12 124.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 111.487 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -102.86 129.11 49.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.193 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.01 102.5 13.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 0.0 110.495 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.538 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.8 mtm -140.43 -171.77 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -105.42 172.13 6.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.594 HG23 HD22 ' A' ' 144' ' ' LEU . 88.5 m -52.29 -48.52 65.3 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.586 0.554 . . . . 0.0 112.345 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -62.37 -50.01 73.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.99 85.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.711 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.91 75.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.41 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 132' ' ' ILE . 47.0 mtt180 -59.82 -48.07 83.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.835 0.35 . . . . 0.0 111.117 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -66.25 -36.73 83.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -60.45 -45.39 93.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.528 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -58.56 -40.32 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.4 mt -62.11 -54.63 31.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.723 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.696 HD13 HG11 ' A' ' 91' ' ' VAL . 74.3 mt -66.95 -32.28 73.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.365 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.476 ' HG2' HD13 ' A' ' 11' ' ' LEU . 54.2 ttp -72.74 -36.88 67.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.36 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.48 80.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.073 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.51 -36.97 74.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.32 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.04 41.79 5.79 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.482 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -111.77 153.62 26.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 90' ' ' GLU . 19.9 mmt180 -63.52 97.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 111.307 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.66 136.25 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.305 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 89' ' ' PRO . 37.5 t -123.83 133.51 69.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.4 p -116.43 130.53 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.254 0.55 . . . . 0.0 111.068 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.16 112.41 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.594 HD22 HG23 ' A' ' 123' ' ' THR . 77.2 mt -103.31 139.55 38.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.547 HD23 ' HD2' ' A' ' 146' ' ' PRO . 2.2 tt -122.86 132.41 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.547 ' HD2' HD23 ' A' ' 145' ' ' LEU . 56.0 Cg_exo . . . . . 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.479 . . . . 0.0 112.216 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.566 0.222 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 61.62 87.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.417 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.3 m -107.32 118.79 37.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.088 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -69.16 100.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.701 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.44 -25.32 42.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.507 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -155.88 149.67 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.741 176.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -87.0 -15.14 39.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.54 -161.87 48.13 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.294 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.05 87.03 2.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.29 60.89 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.673 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.53 148.36 17.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.8 mt -97.08 138.75 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.2 tm-20 -110.22 109.7 20.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 109.932 -175.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.67 111.22 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 m120 53.39 52.64 13.06 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.722 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 73.3 -0.02 3.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.172 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.14 122.64 64.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 53.7 mtm180 -97.0 111.26 23.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.498 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -93.53 117.75 30.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 m -88.35 -7.64 56.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.177 0.513 . . . . 0.0 110.008 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -116.07 161.62 18.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.181 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 145.5 55.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 110.733 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.03 147.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.919 0.39 . . . . 0.0 111.671 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -129.08 112.5 14.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.682 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.524 ' HB3' HG13 ' A' ' 41' ' ' VAL . 32.5 p90 -139.4 162.27 35.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.994 0.426 . . . . 0.0 111.813 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.36 156.56 71.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.136 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.587 ' HD3' ' HE1' ' A' ' 130' ' ' TYR . 6.2 Cg_exo -78.66 9.56 3.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.121 2.547 . . . . 0.0 112.068 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -152.32 21.31 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.781 0.8 . . . . 0.0 108.997 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.14 -169.69 12.6 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.915 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -86.75 176.56 4.58 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.787 2.325 . . . . 0.0 112.612 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.524 HG13 ' HB3' ' A' ' 35' ' ' PHE . 34.2 t -112.58 104.5 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.649 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.85 152.36 21.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.701 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 m -108.87 132.69 53.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.533 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -113.05 126.65 27.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.534 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 2.0 Cg_endo -83.37 9.74 3.97 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.218 2.612 . . . . 0.0 111.302 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 51' ' ' ASP . 41.5 t -86.8 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.508 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -120.98 -33.75 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.815 0.34 . . . . 0.0 111.383 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' A' ' 51' ' ' ASP . 69.6 mtp85 -108.03 147.66 35.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.973 0.416 . . . . 0.0 110.818 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HG3' ' O ' ' A' ' 96' ' ' THR . 12.7 Cg_exo -70.21 -6.01 17.82 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.047 2.498 . . . . 0.0 112.212 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.75 -19.68 24.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.321 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.591 ' HB2' HG13 ' A' ' 46' ' ' VAL . 30.1 m-20 -82.91 -20.21 35.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.13 116.94 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.825 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 31.1 p -113.48 169.51 8.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.371 175.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -60.27 -34.62 73.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m -59.1 -46.87 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.504 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 46' ' ' VAL . 97.9 mt -66.93 -33.78 76.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.627 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 53' ' ' THR . 96.9 mt -64.22 -40.9 97.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.8 mt-30 -62.95 -33.77 76.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.06 -43.74 56.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.32 66.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.746 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -21.98 66.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.86 94.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.331 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 111.309 -177.034 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.488 ' O ' HG22 ' A' ' 116' ' ' VAL . 53.9 Cg_exo -53.44 139.04 65.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.473 2.115 . . . . 0.0 112.06 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' OE1' ' HG3' ' A' ' 138' ' ' ARG . 37.3 tt0 -88.22 -36.89 16.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.036 0.446 . . . . 0.0 110.134 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.73 138.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.237 0.541 . . . . 0.0 111.258 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -114.92 118.77 34.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.661 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.07 119.46 39.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.202 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.58 121.74 59.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.838 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -96.81 106.31 3.33 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.544 ' HA ' HD12 ' A' ' 145' ' ' LEU . 12.6 p -83.5 13.35 4.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -171.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.09 -102.4 1.15 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.213 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 72.3 mtt-85 -62.99 -45.73 91.03 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -142.49 140.23 31.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.844 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.9 tt0 -66.17 96.73 0.35 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.144 0.497 . . . . 0.0 110.241 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -99.42 99.65 10.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.743 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.5 mt -60.57 137.83 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.05 -178.69 5.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.474 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 147.79 16.32 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.872 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.665 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 11.4 Cg_endo -55.17 -40.77 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.852 2.368 . . . . 0.0 112.113 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.17 -27.79 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.182 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -74.82 -37.51 62.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.986 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 34.5 m -92.13 -7.68 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 42.7 mtm180 -53.95 -49.18 91.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 66.6 Cg_exo -53.7 -39.36 83.75 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.103 1.869 . . . . 0.0 112.704 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 94.0 mt -78.13 -39.1 42.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.62 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 85.5 mt -62.39 -32.63 73.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.642 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.15 78.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.747 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 60.3 mtt -77.83 -38.86 45.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.041 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.09 3.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 31.0 t -90.43 115.8 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.53 0.205 . . . . 0.0 110.539 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.03 132.26 10.96 Favored Glycine 0 C--O 1.224 -0.531 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.02 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.63 123.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 117.318 0.559 . . . . 0.0 111.115 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.69 131.75 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.501 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.15 128.68 51.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.844 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 71.7 mtm -144.96 -171.82 3.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.3 156.25 34.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.451 HG23 HD22 ' A' ' 144' ' ' LEU . 40.4 m -57.91 -43.75 86.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.916 0.389 . . . . 0.0 110.927 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.51 -40.65 80.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.71 89.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 110.966 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.4 -47.36 76.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.51 96.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' HG13 ' A' ' 132' ' ' ILE . 42.4 ttm180 -63.4 -50.15 70.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.69 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -63.32 -35.85 81.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.432 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.587 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 50.9 t80 -57.73 -44.99 86.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.761 175.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -64.14 -39.26 93.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.2 mt -64.18 -50.23 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.747 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.401 ' HB2' HG11 ' A' ' 140' ' ' VAL . 91.8 mt -67.85 -26.04 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.799 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 36.8 ttm -61.88 -50.42 72.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.068 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.491 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.88 -44.37 97.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.59 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 105.42 33.33 3.67 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.061 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.428 ' HG3' ' OE1' ' A' ' 90' ' ' GLU . 17.0 ttm180 -100.05 144.98 28.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -70.46 79.62 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.987 0.422 . . . . 0.0 110.879 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 133' ' ' LEU . 5.9 p -106.31 128.54 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.924 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 36' ' ' ALA . 25.9 t -113.11 131.57 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.8 p -115.67 131.64 67.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.57 111.34 22.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.395 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 123' ' ' THR . 98.9 mt -107.05 120.83 43.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.738 0.304 . . . . 0.0 111.672 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 96' ' ' THR . 94.8 mt -93.93 126.0 50.84 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.699 172.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.234 0.303 0 C-N-CA 122.611 2.208 . . . . 0.0 112.426 179.084 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--O 1.235 0.308 0 CA-C-O 120.972 0.415 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 34.8 t30 -74.6 125.6 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.018 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -154.48 142.77 20.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.831 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.98 112.5 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.231 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 p -74.23 -32.8 63.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.296 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -131.19 92.13 3.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.761 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' HE2' ' HG2' ' A' ' 124' ' ' GLN . 71.0 t80 -104.61 -3.22 24.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.377 0.608 . . . . 0.0 109.904 175.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.32 -23.71 70.24 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.927 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.98 -175.58 4.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 111.152 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.48 14.69 60.57 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.523 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.452 ' CE1' ' HD2' ' A' ' 28' ' ' ARG . 27.4 p90 -148.97 173.35 13.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.75 108.19 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 0.0 111.091 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 45.7 tt0 -93.5 112.5 24.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.133 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.4 95.92 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.887 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 64.63 -77.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.757 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -119.09 -28.11 5.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.074 -176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.39 127.7 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -173.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 23.3 mtm180 -98.52 109.68 22.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.277 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -91.2 131.71 36.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -101.9 14.51 31.75 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.561 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -148.98 179.06 8.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.821 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.81 139.9 58.36 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.551 0.532 . . . . 0.0 111.25 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 pt -145.1 156.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.305 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.56 130.6 50.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.251 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.577 ' HB3' HG13 ' A' ' 41' ' ' VAL . 36.5 p90 -150.43 154.86 38.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.367 0.603 . . . . 0.0 112.06 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -119.17 164.56 20.68 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.531 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 26.4 Cg_exo -63.32 -42.37 22.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.413 2.075 . . . . 0.0 111.607 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.75 101.55 7.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.23 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.78 -157.55 27.67 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.297 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -93.39 163.81 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.285 2.656 . . . . 0.0 113.197 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -114.15 116.67 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.46 145.92 41.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.341 . . . . 0.0 111.419 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -79.07 128.73 33.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.606 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 60' ' ' ALA . 1.7 t90 -98.32 116.97 65.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 12.8 Cg_exo -71.56 33.93 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.503 2.802 . . . . 0.0 112.888 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 51' ' ' ASP . 94.2 t -114.68 125.44 72.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.534 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.12 -49.42 4.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.176 0.512 . . . . 0.0 110.894 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -107.88 150.91 40.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 14.7 Cg_endo -59.63 -19.78 54.68 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.336 2.024 . . . . 0.0 111.796 174.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.26 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.296 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.62 ' HB2' HG13 ' A' ' 46' ' ' VAL . 11.8 m-20 -68.73 -28.4 66.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.805 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -54.44 115.06 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.608 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -121.95 159.77 26.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.874 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -52.84 -44.32 66.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -63.16 -35.8 81.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.226 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.458 HD13 HG22 ' A' ' 46' ' ' VAL . 49.9 mt -69.57 -31.83 70.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.36 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.79 -35.46 80.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.182 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.342 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -70.66 -39.37 73.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.452 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' A' ' 44' ' ' TRP . . . -69.68 -23.85 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.853 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -81.43 -7.36 59.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.957 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.55 37.83 85.67 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.388 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 111.527 -177.602 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.416 ' HG2' ' HB1' ' A' ' 61' ' ' ALA . 50.2 Cg_exo -56.4 127.8 27.46 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.884 2.39 . . . . 0.0 112.686 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -64.24 -46.87 81.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.448 0.642 . . . . 0.0 109.528 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.79 132.07 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.876 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.519 ' HB3' HG22 ' A' ' 118' ' ' VAL . 57.3 tp -114.26 117.38 30.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.96 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.1 mt -101.51 117.03 34.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.336 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.2 t -104.05 110.32 29.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.444 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.08 96.84 2.17 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 33.4 p -80.87 -13.63 58.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.776 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.69 -101.52 1.42 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.751 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -62.85 -58.49 7.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.345 . . . . 0.0 111.336 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.4 mmt-85 -109.2 122.33 47.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.992 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.599 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 53.3 tt0 -74.51 97.19 3.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.471 ' HB3' HG21 ' A' ' 96' ' ' THR . 40.1 t-80 -73.6 104.82 4.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.862 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.63 142.26 53.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.442 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -93.16 160.22 14.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.852 0.358 . . . . 0.0 110.617 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.79 162.36 14.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.625 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.27 -49.52 16.06 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.74 2.293 . . . . 0.0 112.253 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -62.48 -25.79 68.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.568 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 93.7 mt-30 -76.78 -34.35 57.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.775 0.322 . . . . 0.0 111.316 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.8 -11.57 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 68.0 mtm180 -52.34 -55.26 33.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 23.0 Cg_endo -61.19 -35.4 85.85 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.038 1.826 . . . . 0.0 113.006 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.4 mt -80.77 -37.85 29.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.0 111.179 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.6 mt -69.26 -23.89 63.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.318 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.72 68.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.445 175.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 62.4 mtt -88.46 -35.85 16.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.29 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.55 14.51 5.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.289 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.1 t -85.32 108.44 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.694 0.283 . . . . 0.0 110.568 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.46 94.72 1.73 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.969 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 92' ' ' LEU . 39.9 t -88.6 129.88 38.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 0.0 111.213 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -126.73 139.89 52.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.124 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.4 128.23 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.411 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 66.7 mtt -140.31 -173.38 3.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.224 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -91.84 168.31 11.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.4 m -59.49 -35.76 74.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 111.761 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.589 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 7.1 tm0? -75.84 -52.46 10.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.62 98.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.535 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 121' ' ' MET . . . -63.03 -46.43 87.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.83 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.11 78.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -73.66 -45.49 52.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.639 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -63.04 -35.75 81.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.128 0.49 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -54.01 -46.25 71.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.948 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -63.34 -41.57 98.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.836 0.35 . . . . 0.0 110.814 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.0 mt -64.02 -47.4 90.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.793 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.94 -27.62 66.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.004 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 56.3 ttp -65.58 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.041 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.01 -26.66 61.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.34 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -67.31 -35.8 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.452 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.2 9.72 55.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.91 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -87.85 155.5 19.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -82.78 87.13 6.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.473 0.654 . . . . 0.0 111.09 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -103.66 132.88 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.757 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 36' ' ' ALA . 57.6 t -120.3 136.13 58.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.1 p -121.57 135.81 60.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.313 0.577 . . . . 0.0 111.232 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.08 119.85 36.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.115 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.7 mt -110.17 125.31 52.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.971 0.415 . . . . 0.0 111.616 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 96' ' ' THR . 95.5 mt -104.09 153.63 38.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.073 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 122.922 2.415 . . . . 0.0 112.011 176.623 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -64.75 102.12 0.55 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 0.0 110.365 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -110.03 146.09 35.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.764 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 17' ' ' TYR . 47.9 t -68.32 109.73 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -44.49 61.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.573 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -139.35 116.87 11.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.244 0.545 . . . . 0.0 111.377 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' HB2' HG11 ' A' ' 14' ' ' VAL . 89.5 t80 -136.5 142.29 43.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.072 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.81 -90.02 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -144.41 137.14 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.02 -91.17 0.79 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.341 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -111.81 177.71 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.701 0.286 . . . . 0.0 110.951 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.5 mt -128.92 136.31 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -114.82 120.56 40.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.144 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.72 117.62 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 64.36 49.72 2.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.507 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 68.25 18.55 9.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.173 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -128.61 121.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 28' ' ' ARG . 29.4 mtm-85 -88.42 110.87 21.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.639 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -90.91 114.7 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.017 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.2 m -92.99 29.01 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.304 0.573 . . . . 0.0 110.179 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -152.51 167.97 27.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.533 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.43 147.53 52.49 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.384 0.428 . . . . 0.0 111.233 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -140.74 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.074 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.72 123.08 25.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.46 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 45.2 p90 -152.36 162.19 41.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.35 0.595 . . . . 0.0 111.956 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.94 155.05 58.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.571 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.91 -57.65 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.678 2.252 . . . . 0.0 111.987 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.35 27.68 3.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.5 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.65 -172.57 13.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.273 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -87.05 173.39 5.85 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.823 2.349 . . . . 0.0 112.593 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -109.1 113.79 45.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.983 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.5 133.57 50.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.036 0.446 . . . . 0.0 111.158 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m -76.44 124.16 27.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.165 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.46 126.27 40.03 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 0.9 OUTLIER -83.43 8.63 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.46 2.773 . . . . 0.0 113.111 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.09 135.82 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -120.69 -48.83 2.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.106 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.569 HH11 ' HG2' ' A' ' 48' ' ' ARG . 24.3 mtt-85 -93.37 139.89 23.06 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.449 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.2 Cg_exo -66.85 -10.29 27.8 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.185 2.59 . . . . 0.0 112.494 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.21 5.0 52.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 1.2 m-20 -109.7 0.24 18.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.36 127.01 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -135.14 156.9 48.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.25 62.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -57.56 -37.73 73.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.272 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.464 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.31 -34.79 63.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.541 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.17 -41.82 98.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.95 -41.48 86.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.82 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.66 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.347 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -79.88 -4.57 52.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.141 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.52 17.7 77.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.55 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 88' ' ' ALA . 96.4 mt . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.967 0.413 . . . . 0.0 110.697 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HA ' HD21 ' A' ' 63' ' ' LEU . . . . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HG2' ' HB1' ' A' ' 61' ' ' ALA . 70.0 Cg_exo -52.28 137.37 55.68 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.559 2.173 . . . . 0.0 112.159 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -68.91 -41.47 78.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.78 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.462 HG11 HD13 ' A' ' 133' ' ' LEU . 3.6 p -140.71 137.75 35.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.445 ' HB3' HG22 ' A' ' 118' ' ' VAL . 58.9 tp -122.16 118.62 29.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.58 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 133' ' ' LEU . 89.3 mt -98.49 119.04 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.388 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.1 t -109.85 114.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.385 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.51 106.69 3.08 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 101' ' ' HIS . 6.0 p -76.16 -30.88 58.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.53 -61.84 2.36 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.164 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -73.18 -75.14 0.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.326 0.584 . . . . 0.0 110.89 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -134.36 137.05 43.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.084 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -73.73 109.32 7.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.881 0.372 . . . . 0.0 111.218 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.419 ' H ' HG21 ' A' ' 96' ' ' THR . 5.0 t60 -72.7 108.01 5.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.5 108.79 3.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.04 141.41 58.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.404 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.36 150.78 16.91 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.7 -19.34 60.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.013 2.475 . . . . 0.0 112.699 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 mt-10 -94.91 -14.43 24.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.231 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -86.27 -40.76 15.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 111' ' ' LEU . 3.7 t -96.21 13.61 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.638 0.732 . . . . 0.0 109.654 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 106' ' ' GLU . 56.1 ttt85 -49.83 -54.81 28.34 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.16 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.17 -33.51 49.31 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.692 1.595 . . . . 0.0 112.325 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.46 ' HB2' HG12 ' A' ' 108' ' ' VAL . 88.9 mt -73.34 -46.44 49.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.66 -33.98 76.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.17 -32.67 74.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 73.8 mtm -81.75 -25.07 35.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.659 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.23 22.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.449 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.53 107.73 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 110.697 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.67 96.15 1.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.781 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 92' ' ' LEU . 46.5 t -89.33 118.83 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.811 0.339 . . . . 0.0 110.717 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -107.07 108.4 19.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.66 106.01 17.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 110.267 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.2 mtm -136.34 -171.68 2.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.032 0.444 . . . . 0.0 110.791 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 125' ' ' ALA . 1.9 m-20 -66.76 158.92 29.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.399 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -63.07 -42.44 99.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.221 0.534 . . . . 0.0 109.917 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.544 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 53.1 tt0 -66.23 -42.7 88.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.441 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.478 ' H ' ' HB2' ' A' ' 122' ' ' ASP . . . -63.68 -44.15 94.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.99 96.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.938 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.37 93.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 124' ' ' GLN . 63.0 mtm180 -62.77 -48.38 79.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.9 m -62.99 -34.01 76.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.787 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -62.69 -44.74 95.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.369 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 134' ' ' MET . 90.6 m-20 -65.84 -28.15 68.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.714 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 128' ' ' ARG . 81.3 mt -72.16 -50.74 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.516 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.462 HD13 HG11 ' A' ' 91' ' ' VAL . 98.0 mt -67.51 -34.97 78.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.804 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.402 ' HG2' ' HA ' ' A' ' 131' ' ' ASN . 19.0 ptp -67.84 -29.94 69.21 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.418 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.71 -26.69 40.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.59 -39.79 57.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.532 . . . . 0.0 109.903 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 30.84 5.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.821 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -100.92 148.26 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -71.11 99.83 1.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.031 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.56 140.56 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.107 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.401 ' O ' HD12 ' A' ' 92' ' ' LEU . 44.4 t -121.67 142.64 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 7.2 p -120.83 139.52 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.187 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -126.55 115.04 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -116.24 135.39 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.2 mt -109.21 99.67 37.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--O 1.233 0.257 0 C-N-CA 122.337 2.025 . . . . 0.0 111.496 176.805 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.866 0.365 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -87.95 113.97 24.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.13 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -116.3 143.13 45.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.646 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.91 115.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -87.26 -46.31 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.147 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.71 138.54 19.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.721 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -156.69 104.61 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.88 -29.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.841 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.426 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 23.1 m-20 -73.45 -29.26 62.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.018 0.437 . . . . 0.0 111.057 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.59 -12.53 4.28 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.5 p90 -111.92 154.9 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.35 111.37 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -94.17 112.94 24.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.038 0.447 . . . . 0.0 110.387 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.72 110.61 28.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.462 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 62.54 45.33 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.546 . . . . 0.0 109.965 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 73.73 -6.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.047 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.05 117.86 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -91.25 102.36 15.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.368 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.89 127.19 35.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.771 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -104.97 17.36 24.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -116.62 172.39 7.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB1' HD23 ' A' ' 145' ' ' LEU . . . -74.31 137.35 42.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 164.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 pt -134.99 144.87 33.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.413 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.74 125.67 38.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.575 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 44.7 p90 -149.08 162.58 39.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.075 0.464 . . . . 0.0 111.326 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.75 163.28 45.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.699 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.72 -36.93 34.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.72 2.28 . . . . 0.0 112.946 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -124.85 32.7 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.053 0.454 . . . . 0.0 110.521 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.31 16.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.873 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.83 147.32 80.63 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.687 2.258 . . . . 0.0 111.502 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.575 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 26.1 t -80.24 88.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.1 124.57 29.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.377 -174.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.7 m -82.05 121.89 27.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 56' ' ' LEU . 1.2 t90 -103.79 121.76 46.97 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.57 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.66 13.98 1.54 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.821 2.347 . . . . 0.0 112.951 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.465 HG21 HD13 ' A' ' 56' ' ' LEU . 48.5 t -95.79 112.82 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.47 -29.34 18.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -113.54 126.33 28.29 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.463 -173.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.16 -1.53 4.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.995 2.463 . . . . 0.0 113.209 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.14 -15.09 23.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -84.32 -7.81 59.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.015 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.532 ' HA ' HD12 ' A' ' 56' ' ' LEU . 60.1 mt -69.62 130.44 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.501 -175.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' A' ' 56' ' ' LEU . 41.2 p -111.25 179.77 3.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.702 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -68.33 -35.08 77.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 m -65.11 -41.72 94.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.49 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.621 ' HB3' ' HZ2' ' A' ' 44' ' ' TRP . 61.7 mt -65.17 -36.57 84.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.071 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.53 ' HB3' HD11 ' A' ' 111' ' ' LEU . 72.1 mt -63.09 -37.32 86.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.709 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 96.6 mt-30 -65.97 -40.69 91.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.83 -40.66 88.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.813 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.34 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.45 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HB2' HD22 ' A' ' 92' ' ' LEU . . . -82.33 -2.02 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.87 72.74 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.349 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.437 HD13 ' SD ' ' A' ' 114' ' ' MET . 96.4 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 121.82 0.819 . . . . 0.0 110.758 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.224 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.59 123.77 14.66 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.746 2.297 . . . . 0.0 112.296 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 50.6 mt-10 -65.11 -50.62 65.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.63 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 140' ' ' VAL . 4.2 p -135.02 130.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.382 0.611 . . . . 0.0 111.47 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 61' ' ' ALA . 65.2 tp -107.52 113.28 26.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.521 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 119' ' ' GLU . 95.9 mt -93.19 98.11 11.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.539 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -91.6 105.72 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -84.27 108.82 3.15 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 175.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.446 HG21 ' H ' ' A' ' 101' ' ' HIS . 8.0 p -62.62 -17.44 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.618 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 65.5 -92.2 0.15 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.853 171.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.22 -51.25 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.711 0.405 . . . . 0.0 111.638 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -144.66 134.26 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -70.04 112.03 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.813 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.446 ' H ' HG21 ' A' ' 96' ' ' THR . 66.5 m80 -113.06 147.43 37.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.255 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.68 106.86 18.84 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.7 169.79 12.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.14 147.96 16.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.728 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.623 ' HA ' HG22 ' A' ' 108' ' ' VAL . 51.1 Cg_exo -57.15 -24.59 59.5 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.354 2.703 . . . . 0.0 112.601 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -56.16 -31.97 63.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.223 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -89.28 -23.43 22.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.825 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.623 HG22 ' HA ' ' A' ' 105' ' ' PRO . 20.2 m -93.68 -21.57 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.544 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 57.5 mtm-85 -53.94 -49.36 90.0 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 11.7 Cg_endo -55.72 -34.52 91.03 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.982 1.788 . . . . 0.0 112.754 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 62.5 mt -81.57 -37.5 27.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.736 0.303 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.1 mt -64.69 -32.67 74.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.924 0.392 . . . . 0.0 110.584 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.72 -10.26 59.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 63' ' ' LEU . 67.1 mtt -97.05 -43.82 7.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.257 0.551 . . . . 0.0 109.737 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.02 10.71 2.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.208 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 39.7 t -98.5 125.99 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 110.475 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.23 124.51 8.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.41 ' CG2' HD12 ' A' ' 111' ' ' LEU . 23.3 t -93.71 115.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.646 0.26 . . . . 0.0 110.994 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.47 ' HB2' HD23 ' A' ' 93' ' ' LEU . 27.1 mm-40 -112.35 127.97 56.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.856 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.29 104.91 14.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 36.9 ttm -129.78 168.73 16.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.323 -169.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.13 155.67 27.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.915 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.618 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -54.37 -52.4 61.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.861 -177.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -77.65 -37.96 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.426 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.26 91.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.091 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 121' ' ' MET . . . -65.92 -44.29 85.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.729 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.05 93.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.702 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -64.5 -51.86 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.6 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.9 m -59.0 -36.97 75.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.92 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -57.99 -46.35 85.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.958 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -64.12 -37.24 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 110.592 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.65 -46.74 85.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.02 -24.11 64.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.4 ttm -64.97 -47.22 78.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.87 62.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.57 -11.76 59.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.061 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 70.14 32.64 69.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.815 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -100.78 150.38 22.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.745 0.307 . . . . 0.0 110.641 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 49.8 mtm180 -78.69 90.7 4.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.474 0.654 . . . . 0.0 110.94 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.497 HG23 HG13 ' A' ' 91' ' ' VAL . 6.0 p -123.4 137.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.587 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 36' ' ' ALA . 39.5 t -116.41 133.2 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.3 p -110.72 134.92 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.28 113.53 16.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.643 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -110.41 129.36 55.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.782 0.325 . . . . 0.0 111.197 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.563 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 69.6 mt -103.67 98.84 13.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.393 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.459 -0.516 0 C-N-CA 122.555 2.17 . . . . 0.0 112.225 179.466 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 37' ' ' PRO . 88.0 mt . . . . . 0 C--O 1.234 0.283 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -152.94 127.25 9.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.747 0.308 . . . . 0.0 110.355 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 m -110.9 141.01 44.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -68.19 115.59 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -49.09 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.94 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -134.66 129.48 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.234 0.54 . . . . 0.0 111.817 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.487 ' HE1' HG22 ' A' ' 123' ' ' THR . 85.0 t80 -104.14 102.57 12.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.49 175.2 47.38 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.784 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -81.19 -21.46 39.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.042 0.449 . . . . 0.0 110.64 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.63 -39.68 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.35 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -124.23 170.5 10.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.98 133.42 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -113.99 120.88 42.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.924 0.393 . . . . 0.0 110.035 -177.288 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -124.58 110.73 25.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.436 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 61.6 51.27 4.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.63 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 68.85 14.25 8.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.283 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.0 108.89 26.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -83.05 119.37 24.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.188 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -98.6 107.61 20.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.401 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -89.61 14.08 12.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.865 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -140.9 161.5 37.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.589 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -58.72 142.79 48.89 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.586 0.554 . . . . 0.0 111.097 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 pt -136.41 139.78 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.362 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -133.19 109.72 9.64 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 41' ' ' VAL . 42.8 p90 -146.83 161.01 41.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.486 0.66 . . . . 0.0 112.24 -170.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -109.48 154.81 42.1 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.565 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.537 ' HB2' ' HA ' ' A' ' 11' ' ' LEU . 54.0 Cg_endo -70.14 -5.71 17.09 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.145 1.896 . . . . 0.0 111.891 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -92.15 17.14 9.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.004 -170.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.95 -99.74 0.34 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.298 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.82 134.59 65.46 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.681 2.921 . . . . 0.0 114.658 -170.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 35' ' ' PHE . 96.3 t -113.69 119.95 62.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 157.61 16.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 m -124.52 148.14 47.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -115.92 139.54 25.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.983 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.11 23.98 0.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.195 2.597 . . . . 0.0 110.499 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.604 HG13 ' HB2' ' A' ' 51' ' ' ASP . 93.3 t -85.9 130.25 36.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.572 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -113.14 -40.98 3.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -106.01 145.62 31.29 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 28.1 Cg_endo -64.32 -8.82 17.83 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.791 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.12 -12.71 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.604 ' HB2' HG13 ' A' ' 46' ' ' VAL . 73.4 m-20 -81.13 -16.42 53.07 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.46 114.57 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.758 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.404 ' H ' HD12 ' A' ' 56' ' ' LEU . 6.4 m -111.47 155.44 23.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.846 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -52.17 -38.96 59.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.758 0.313 . . . . 0.0 111.318 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m -57.46 -43.82 84.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.997 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD12 ' H ' ' A' ' 53' ' ' THR . 78.4 mt -68.67 -32.8 72.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 -178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.21 -35.77 81.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -69.65 -33.16 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 110.394 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.23 -44.78 78.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.886 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.557 ' O ' HG11 ' A' ' 141' ' ' VAL . . . -64.01 -35.22 80.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.276 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.98 62.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.316 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.53 40.4 59.58 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.364 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.714 0.769 . . . . 0.0 110.668 -179.113 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.959 0.409 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.83 173.56 14.22 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.61 2.206 . . . . 0.0 111.715 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' OE2' ' HD2' ' A' ' 138' ' ' ARG . 34.1 tt0 -90.58 -38.71 12.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.347 0.594 . . . . 0.0 109.762 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.814 HG11 HD21 ' A' ' 133' ' ' LEU . 3.3 p -139.59 142.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.284 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 141' ' ' VAL . 68.3 tp -118.84 118.12 30.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.487 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.56 115.07 29.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.383 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.8 t -107.0 115.05 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.808 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.66 105.25 3.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 101' ' ' HIS . 19.8 p -77.08 4.42 10.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -171.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.468 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 74.07 -91.12 0.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.338 -0.458 . . . . 0.0 114.228 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.535 ' C ' ' HD2' ' A' ' 99' ' ' ARG . 52.9 mtt-85 -67.83 -60.93 2.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.967 0.413 . . . . 0.0 111.077 -171.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.535 ' HD2' ' C ' ' A' ' 98' ' ' ARG . 3.4 mpt_? -129.41 148.34 51.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.9 99.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 109.841 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.554 ' HB3' HG21 ' A' ' 96' ' ' THR . 51.2 t-80 -92.34 118.43 30.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.606 -174.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.71 110.59 4.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.231 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.1 mt -77.48 151.98 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 161.84 14.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.23 -170.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 46.9 Cg_endo -68.41 -1.24 6.99 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.238 2.625 . . . . 0.0 112.721 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -89.09 -23.0 22.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.39 0.614 . . . . 0.0 109.871 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.568 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 77.5 mt-30 -94.63 -47.89 6.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.507 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 m -86.13 -1.02 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.739 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 18.3 ttm180 -56.19 -56.02 35.65 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 41.9 Cg_exo -57.82 -39.72 84.71 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.923 1.749 . . . . 0.0 112.365 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.8 mt -74.09 -40.98 62.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.7 tp -60.86 -36.47 79.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.531 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.24 -27.67 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.998 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.04 -9.38 59.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.15 0.5 . . . . 0.0 110.102 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.83 -0.44 55.21 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.273 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 40.8 t -79.63 103.3 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.817 0.342 . . . . 0.0 110.361 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.45 101.74 1.3 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.921 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -88.74 110.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.701 0.286 . . . . 0.0 110.588 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -110.76 135.82 50.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.18 124.9 50.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.071 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.02 -171.83 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.72 164.88 19.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.501 HG23 HD22 ' A' ' 144' ' ' LEU . 21.1 m -64.19 -34.09 77.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.066 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.41 -47.38 27.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.589 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.28 86.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.695 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.801 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.89 -45.58 93.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.919 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.06 -51.29 70.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.716 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.5 m -62.19 -39.28 92.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.725 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -57.1 -49.74 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.242 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.51 -44.9 95.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -68.33 -44.28 83.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 110.925 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.814 HD21 HG11 ' A' ' 91' ' ' VAL . 23.5 tp -66.63 -37.32 84.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.866 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 33.4 ttp -63.35 -37.18 86.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.446 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.49 -29.1 69.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.46 -34.95 78.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 0.0 110.26 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.05 29.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.445 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.511 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 55.8 mtm180 -97.86 137.03 37.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 122.763 -0.257 . . . . 0.0 110.452 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -65.38 110.51 2.67 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.429 0.633 . . . . 0.0 111.319 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.489 HG21 HD23 ' A' ' 133' ' ' LEU . 5.4 p -130.03 135.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 60' ' ' ALA . 47.0 t -109.52 140.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -122.23 132.93 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.129 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . . . -115.42 113.97 24.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.343 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.501 HD22 HG23 ' A' ' 123' ' ' THR . 94.2 mt -114.95 125.19 53.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.942 0.401 . . . . 0.0 111.503 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 96' ' ' THR . 97.8 mt -97.76 119.55 62.22 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.213 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 27.6 Cg_endo . . . . . 0 N--CA 1.453 -0.869 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.961 0.41 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.27 108.22 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.261 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -111.79 146.7 37.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.186 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.93 125.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -84.15 -46.15 12.22 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 153.09 30.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.516 . . . . 0.0 112.257 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.43 123.54 35.81 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.77 -8.68 60.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.601 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.92 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.636 0.731 . . . . 0.0 110.11 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.9 -19.3 28.1 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -153.21 157.23 39.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.84 133.08 58.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -101.53 122.05 43.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.894 0.378 . . . . 0.0 110.352 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -121.83 96.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.65 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.39 56.12 2.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.087 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 71.26 -8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.079 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.89 117.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -98.14 103.07 14.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.823 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -89.32 114.01 25.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.461 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -89.91 25.44 2.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.22 0.533 . . . . 0.0 110.517 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -147.22 166.48 26.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.057 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -66.82 140.3 57.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.314 0.384 . . . . 0.0 110.696 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 pt -135.93 144.85 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.997 0.427 . . . . 0.0 111.516 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.63 112.05 17.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.29 176.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HB3' HG13 ' A' ' 41' ' ' VAL . 41.5 p90 -138.28 156.64 47.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.228 0.537 . . . . 0.0 111.797 -173.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.47 157.18 70.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.816 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD3' ' OH ' ' A' ' 130' ' ' TYR . 24.0 Cg_exo -64.12 -42.33 18.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.383 2.056 . . . . 0.0 110.881 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -106.52 82.45 1.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.546 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.41 -171.17 38.21 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.247 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -92.4 178.62 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.151 2.568 . . . . 0.0 112.934 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 35' ' ' PHE . 47.0 t -114.21 105.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 145.4 24.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.962 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -101.6 129.34 47.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.18 114.15 64.81 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.456 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 39.87 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.387 2.725 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.15 132.0 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.119 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -114.19 -25.41 8.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 110.645 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -114.64 128.37 25.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.731 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.1 -9.37 25.55 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.934 2.423 . . . . 0.0 112.954 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -3.89 55.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.603 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -86.75 -14.69 41.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.544 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 145' ' ' LEU . 67.3 mt -58.82 110.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.968 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -133.54 179.18 6.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.29 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -41.98 71.97 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.208 0.317 . . . . 0.0 111.611 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -56.3 -46.0 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.08 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 52' ' ' ILE . 90.8 mt -73.15 -37.15 66.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.91 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -40.46 96.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -66.97 -37.52 84.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.585 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.88 -42.34 99.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.91 -26.98 66.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.242 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.41 -6.38 55.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.244 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.26 59.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.525 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 -177.157 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.623 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.623 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 15.1 Cg_endo -57.67 142.25 95.76 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.563 2.175 . . . . 0.0 112.476 176.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.681 ' HG3' ' HB3' ' A' ' 139' ' ' ARG . 34.4 mt-10 -71.05 -40.45 71.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.409 0.624 . . . . 0.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.465 HG13 HG23 ' A' ' 140' ' ' VAL . 4.8 p -138.63 136.63 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.688 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB3' HG22 ' A' ' 118' ' ' VAL . 54.8 tp -116.05 116.66 28.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.577 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.44 124.07 47.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.687 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.84 126.19 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.742 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.48 ' HA3' HD23 ' A' ' 144' ' ' LEU . . . -108.88 112.95 3.61 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.548 ' HA ' HD12 ' A' ' 145' ' ' LEU . 21.2 p -81.62 -61.38 1.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.489 ' H ' ' HA ' ' A' ' 122' ' ' ASP . . . 84.92 -22.01 10.32 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.498 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.4 HH21 ' HB2' ' A' ' 146' ' ' PRO . 52.1 mtt180 -113.09 -64.86 1.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 110.084 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -139.73 126.41 20.57 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HA ' HG21 ' A' ' 96' ' ' THR . 27.9 mt-30 -70.37 94.98 0.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.165 0.507 . . . . 0.0 110.898 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -73.18 120.12 18.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.553 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.66 119.52 15.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.693 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.9 mt -73.49 139.74 45.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.99 159.01 15.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.205 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.669 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 58.3 Cg_exo -51.86 -41.11 64.72 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.185 2.59 . . . . 0.0 112.04 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.43 ' CD ' HH22 ' A' ' 109' ' ' ARG . 31.1 tp10 -52.51 -28.67 21.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.42 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.23 -42.76 8.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.512 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.5 m -87.26 -11.34 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.669 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 27.7 mtm-85 -50.9 -53.99 41.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.01 -37.47 93.82 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.991 1.794 . . . . 0.0 112.781 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.48 HD13 HG21 ' A' ' 118' ' ' VAL . 98.1 mt -79.73 -34.84 39.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.879 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 75.5 mt -68.72 -34.09 75.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.32 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.88 78.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.43 -41.42 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.367 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.03 15.68 7.72 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.371 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.93 117.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.18 102.9 1.86 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.826 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 92' ' ' LEU . 41.3 t -102.89 121.73 54.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.18 140.29 52.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.449 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -114.39 125.89 54.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 111.437 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.463 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.8 mtm -144.61 177.31 8.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.489 ' HA ' ' H ' ' A' ' 97' ' ' GLY . 19.9 m-20 -72.38 154.46 40.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.746 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.517 HG23 HD22 ' A' ' 144' ' ' LEU . 28.7 m -47.65 -53.31 15.24 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.846 0.717 . . . . 0.0 112.61 -174.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.48 -46.27 89.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 0.0 111.605 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.45 79.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.272 -177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.03 76.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.35 84.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.324 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -59.35 -51.06 71.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 109.958 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 -36.29 83.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.499 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.434 ' OH ' ' HA ' ' A' ' 36' ' ' ALA . 87.7 t80 -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.748 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -60.06 -41.24 91.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.319 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.94 -48.28 89.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.73 -31.19 72.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.025 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.7 ttp -64.59 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.265 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.91 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.822 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 138' ' ' ARG . 38.4 tt0 -74.71 -22.07 59.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.911 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.05 27.48 49.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.34 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.426 ' HD2' ' OE1' ' A' ' 136' ' ' GLU . 15.7 ttt180 -87.33 149.14 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.249 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.681 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 48.3 ttt85 -79.9 85.15 5.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.483 0.658 . . . . 0.0 109.285 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.465 HG23 HG13 ' A' ' 91' ' ' VAL . 4.8 p -120.46 132.98 68.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.009 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 89' ' ' PRO . 40.0 t -115.24 134.21 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 9.9 p -117.71 130.82 72.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.35 106.06 14.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.562 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.517 HD22 HG23 ' A' ' 123' ' ' THR . 92.5 mt -106.4 128.5 54.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.639 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 96' ' ' THR . 78.2 mt -87.5 151.29 50.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.861 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HB2' HH21 ' A' ' 98' ' ' ARG . 27.5 Cg_exo . . . . . 0 C--N 1.345 0.348 0 C-N-CA 122.557 2.171 . . . . 0.0 112.075 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -77.84 86.83 4.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.279 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 m -116.25 140.44 49.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.571 ' HA ' HG22 ' A' ' 24' ' ' VAL . 48.6 t -60.62 112.91 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -74.9 -53.33 9.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.517 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -140.34 157.12 46.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.153 0.501 . . . . 0.0 111.258 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -110.01 118.41 36.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.74 156.95 15.65 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.322 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.9 92.49 0.51 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.64 11.43 55.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.105 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -161.13 150.23 16.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.135 0.467 . . . . 0.0 111.159 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 29' ' ' PHE . 61.6 mt -96.94 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -118.08 114.83 23.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.037 0.446 . . . . 0.0 110.151 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.571 HG22 ' HA ' ' A' ' 14' ' ' VAL . 40.4 t -129.77 113.04 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.669 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 60.14 38.53 20.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.362 0.601 . . . . 0.0 110.298 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 68.59 17.43 8.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.014 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.91 112.85 36.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 28' ' ' ARG . 24.0 ttt85 -72.81 110.79 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.131 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 66.0 m-85 -102.51 98.08 8.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.198 0.523 . . . . 0.0 110.638 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -99.83 28.9 4.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.269 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -148.03 156.4 42.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.45 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 44' ' ' TRP . . . -60.63 136.86 58.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.433 0.458 . . . . 0.0 111.386 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.2 pt -138.04 150.16 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.309 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -135.28 125.8 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.843 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 41.8 p90 -147.89 157.46 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.234 0.54 . . . . 0.0 111.789 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -132.19 155.35 81.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.244 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.58 -22.73 57.93 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.74 2.293 . . . . 0.0 112.538 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -116.53 22.71 12.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.59 0.71 . . . . 0.0 109.284 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.71 17.45 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.039 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -89.83 -171.41 0.5 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.083 2.522 . . . . 0.0 112.297 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.4 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 40.8 t -111.29 114.79 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.01 151.97 22.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.907 0.384 . . . . 0.0 111.191 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -91.41 126.3 36.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.245 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -101.34 119.78 56.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.113 -176.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.6 Cg_exo -78.79 22.63 0.65 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.439 2.759 . . . . 0.0 113.248 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HD13 ' A' ' 56' ' ' LEU . 88.5 t -91.77 132.18 36.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -105.53 -51.22 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.255 0.55 . . . . 0.0 110.939 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -116.89 138.92 25.11 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.148 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HB2' ' HB3' ' A' ' 101' ' ' HIS . 43.9 Cg_endo -67.19 -11.14 31.11 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.939 2.426 . . . . 0.0 112.832 -176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.73 -15.42 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 63.9 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.654 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.96 100.21 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.974 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.43 ' H ' HD12 ' A' ' 56' ' ' LEU . 2.2 m -89.04 159.42 17.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.51 68.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.93 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 m -60.06 -36.82 78.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 46' ' ' VAL . 81.9 mt -67.75 -36.15 80.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.097 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 111' ' ' LEU . 97.2 mt -68.2 -37.9 81.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.852 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.26 -39.62 91.04 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.023 0.439 . . . . 0.0 110.492 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -64.65 -40.72 95.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.722 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.86 -20.62 63.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.27 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -82.11 -5.82 58.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.5 15.29 81.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.699 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.947 0.403 . . . . 0.0 111.442 -177.121 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 80.8 Cg_exo -47.46 124.9 10.03 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.497 2.132 . . . . 0.0 112.07 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.487 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 39.2 mt-10 -66.16 -45.47 80.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.475 HG13 HG23 ' A' ' 140' ' ' VAL . 4.0 p -134.72 133.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.248 0.547 . . . . 0.0 111.278 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.38 121.97 42.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.618 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.2 mt -105.58 109.87 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.891 0.377 . . . . 0.0 110.495 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.49 121.74 45.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.18 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -93.3 106.76 3.45 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 24.8 p -59.98 -49.82 76.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.735 0.414 . . . . 0.0 111.915 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.28 -78.03 0.57 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.255 -0.497 . . . . 0.0 113.146 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -69.65 -38.19 77.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.595 ' O ' ' HB ' ' A' ' 96' ' ' THR . 44.7 ttm-85 -166.77 140.73 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.63 0.253 . . . . 0.0 110.81 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.536 ' HA ' HG21 ' A' ' 96' ' ' THR . 90.0 mt-30 -70.73 105.32 3.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . 51.3 t-80 -117.98 111.25 18.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.85 130.34 40.8 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.61 151.88 40.71 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.97 165.31 13.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.264 -176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.6 Cg_endo -56.46 -31.19 84.98 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.173 2.582 . . . . 0.0 112.709 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -67.09 -25.76 66.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.155 0.502 . . . . 0.0 110.705 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -96.36 -23.27 16.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.738 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 26.7 m -106.7 -7.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.732 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 39.9 ttp-105 -53.62 -55.2 37.62 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 38.5 Cg_exo -58.07 -32.99 96.82 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.987 1.791 . . . . 0.0 112.333 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.761 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.3 mt -78.09 -33.91 50.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 90.0 mt -61.08 -38.34 85.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 109.932 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.13 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.198 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 64.4 mtt -89.53 -33.07 16.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.659 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.04 18.48 5.5 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.268 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 t -93.14 114.48 29.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.727 0.299 . . . . 0.0 111.098 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.44 102.37 2.71 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.1 t -95.69 122.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.814 0.34 . . . . 0.0 111.489 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -120.6 146.33 46.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.061 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.24 119.6 32.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.988 0.423 . . . . 0.0 110.682 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.459 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 64.9 mtm -142.74 175.05 10.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.47 163.29 25.65 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.832 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.2 m -50.77 -52.79 37.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.399 -173.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.46 -43.89 96.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.639 0.257 . . . . 0.0 111.284 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.79 99.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.971 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.91 71.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.96 89.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.793 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttp-105 -67.63 -46.52 72.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 0.0 110.653 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.6 m -65.89 -31.49 72.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.292 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.49 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 75.6 t80 -59.0 -45.59 90.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.387 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -64.15 -41.63 97.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.53 -47.11 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.654 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.418 HD13 HG11 ' A' ' 91' ' ' VAL . 97.5 mt -68.98 -28.26 66.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.33 -47.43 70.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.218 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.59 -25.41 66.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.553 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.43 -12.32 60.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.276 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.86 57.24 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.122 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.487 ' HE ' ' CD ' ' A' ' 90' ' ' GLU . 6.8 tpt180 -105.58 153.11 22.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.694 0.283 . . . . 0.0 110.323 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -82.6 91.12 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.789 0.804 . . . . 0.0 111.144 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG23 HG13 ' A' ' 91' ' ' VAL . 7.2 p -118.1 142.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.705 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 36' ' ' ALA . 39.4 t -122.31 141.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.4 p -120.39 138.45 50.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 110.855 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.76 107.76 10.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.434 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.6 mt -104.13 129.89 51.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.689 0.281 . . . . 0.0 111.694 -172.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -101.74 105.94 44.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 30.0 Cg_endo . . . . . 0 N--CA 1.45 -1.035 0 C-N-CA 123.311 2.674 . . . . 0.0 111.328 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.0 tp . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.868 0.366 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -69.2 107.01 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.104 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 m -133.22 135.64 45.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 24' ' ' VAL . 49.2 t -73.02 118.89 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -93.02 -75.14 0.5 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.894 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.64 98.25 11.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 0.0 110.66 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -86.14 114.98 23.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.196 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.87 168.52 19.0 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.29 -21.41 36.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.121 0.486 . . . . 0.0 110.134 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.56 -38.21 5.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.53 155.6 46.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 110.817 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -114.57 114.16 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.613 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 42.5 tt0 -99.33 116.21 30.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 14' ' ' VAL . 61.3 t -116.06 121.95 68.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.688 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 60.03 31.03 20.45 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.355 0.409 . . . . 0.0 110.506 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HA ' ' CD ' ' A' ' 23' ' ' GLU . 96.7 mt-30 71.16 14.47 6.66 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.57 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -104.8 116.75 49.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 99.0 mtt180 -93.31 116.49 29.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.86 0.362 . . . . 0.0 111.333 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.07 143.08 32.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.331 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.2 p -106.13 1.29 26.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.542 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -128.98 170.65 13.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.065 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -60.5 143.04 54.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 112.355 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.99 144.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.702 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 120.03 26.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.465 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.8 162.19 36.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.19 0.519 . . . . 0.0 111.709 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -137.81 151.91 71.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.288 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.46 -45.09 36.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.731 2.287 . . . . 0.0 112.57 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' OE2' ' HG2' ' A' ' 139' ' ' ARG . 39.0 mt-10 -97.59 23.34 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.823 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.91 -170.84 11.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.22 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -90.05 -168.37 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.89 2.393 . . . . 0.0 112.316 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.34 117.72 56.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.658 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.07 123.21 35.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.233 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.1 t -77.52 113.13 15.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.718 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.19 117.94 64.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.85 25.47 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.903 2.402 . . . . 0.0 111.603 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 51' ' ' ASP . 83.9 t -86.16 122.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.272 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.74 -39.89 11.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.646 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -139.64 157.38 70.19 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.961 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.44 -11.72 11.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.23 2.62 . . . . 0.0 113.393 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.4 -21.47 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.583 ' HB2' HG13 ' A' ' 46' ' ' VAL . 63.1 m-20 -86.25 -5.12 59.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 145' ' ' LEU . 71.0 mt -74.41 125.46 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.035 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -141.25 175.34 9.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.036 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -57.63 -45.65 85.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 m -56.4 -44.41 80.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.929 0.395 . . . . 0.0 111.425 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.62 -39.06 84.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.762 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.565 ' HB3' HD11 ' A' ' 111' ' ' LEU . 96.0 mt -66.09 -40.17 90.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.161 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -61.45 -46.91 88.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.453 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -63.19 -36.78 84.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.915 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.68 -32.44 73.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.047 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.63 5.7 8.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.18 -7.67 54.73 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.42 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.011 0.434 . . . . 0.0 111.148 -176.713 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.454 0.169 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.3 162.45 7.75 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.095 2.53 . . . . 0.0 112.734 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 139' ' ' ARG . 9.5 mm-40 -72.87 -49.71 28.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 -175.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 12.8 p -148.22 145.52 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.227 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 117' ' ' GLY . 2.0 pt? -119.04 132.01 56.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.128 0.49 . . . . 0.0 110.107 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.77 123.44 41.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.108 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.6 109.13 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.513 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -85.34 108.71 3.23 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.616 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.8 p -69.09 -12.14 61.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.23 -85.31 0.71 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.286 -0.483 . . . . 0.0 114.001 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -61.6 -41.0 96.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.899 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -172.5 158.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.616 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 52.9 tt0 -62.52 137.7 58.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.577 . . . . 0.0 111.718 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -136.19 164.14 28.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.487 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.18 110.13 22.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.885 0.374 . . . . 0.0 110.423 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.14 131.89 38.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -106.45 -176.78 23.32 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.103 -1.046 . . . . 0.0 114.172 -167.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.616 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 60.4 Cg_endo -72.18 3.75 3.81 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.774 2.982 . . . . 0.0 113.473 -173.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HA ' ' NH1' ' A' ' 109' ' ' ARG . 11.7 tp10 -96.94 -26.6 14.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -96.02 -50.94 4.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.505 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.691 ' HB ' HG11 ' A' ' 118' ' ' VAL . 33.5 m -91.56 5.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.649 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 42.0 ttp-105 -59.85 -52.32 74.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 76.7 Cg_exo -54.8 -29.77 64.31 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.166 1.91 . . . . 0.0 113.075 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 57' ' ' LEU . 58.7 mt -70.04 -49.0 55.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 109.86 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.8 mt -64.19 -32.54 74.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.36 -26.89 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.368 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.453 ' HE2' ' HA ' ' A' ' 111' ' ' LEU . 65.7 mtm -87.34 -33.48 19.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.857 0.361 . . . . 0.0 110.665 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.43 4.25 9.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.408 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.0 131.2 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -82.33 141.3 21.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.736 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' A' ' 108' ' ' VAL . 11.7 p -127.33 145.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 122.689 -0.301 . . . . 0.0 110.227 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.86 136.65 27.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.791 0.329 . . . . 0.0 110.632 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.48 127.52 46.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.796 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.501 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 32.8 ttm -147.2 161.75 40.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -174.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.97 159.97 31.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 m -50.5 -63.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.44 -44.19 95.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.723 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.35 89.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.89 94.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.573 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.71 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 132' ' ' ILE . 53.4 ttp180 -60.2 -55.84 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 15.8 m -60.51 -38.03 83.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.04 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.22 -49.6 76.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.994 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.15 -40.85 95.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.627 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 79.5 mt -60.56 -56.4 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.76 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.74 -31.69 72.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.8 ttp -66.22 -40.83 90.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.213 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.69 -35.45 72.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.66 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 9.1 mm-40 -61.69 -29.71 70.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.79 32.69 7.06 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.829 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -107.28 135.8 48.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.468 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 28.6 mtm180 -67.44 97.65 0.59 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.516 0.674 . . . . 0.0 110.869 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 7.4 p -123.78 139.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.333 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 36' ' ' ALA . 30.8 t -109.46 150.42 12.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.91 130.98 55.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.006 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.31 120.71 39.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.237 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.76 127.37 53.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.897 0.38 . . . . 0.0 111.55 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 52' ' ' ILE . 68.5 mt -99.64 116.64 64.69 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.575 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 72.2 Cg_endo . . . . . 0 C--O 1.233 0.253 0 C-N-CA 122.616 2.211 . . . . 0.0 112.815 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -114.02 112.35 23.13 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m -130.6 143.6 50.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.999 0.428 . . . . 0.0 111.618 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.3 139.35 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.606 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 p -99.1 -40.02 8.21 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.731 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -140.23 116.71 10.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 111.715 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -105.47 104.33 14.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.04 -169.68 14.44 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.124 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.19 94.03 3.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.992 0.425 . . . . 0.0 110.809 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.81 60.35 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.261 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -125.56 152.16 45.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.038 0.419 . . . . 0.0 110.992 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.28 124.6 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.891 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 36.9 tt0 -111.59 122.56 48.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 111.339 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.42 115.19 49.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.051 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 67.39 -78.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.467 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -138.42 -1.1 1.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.458 0.17 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.58 121.89 68.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.792 0.329 . . . . 0.0 111.198 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.2 ptp180 -97.84 123.37 41.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.292 0.568 . . . . 0.0 110.334 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.43 137.35 37.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.198 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -94.73 17.31 13.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.37 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -147.25 167.78 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.929 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -61.56 146.95 47.13 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.483 0.489 . . . . 0.0 111.466 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 pt -141.78 147.08 22.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.084 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.76 124.97 40.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.821 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -147.95 161.33 41.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.52 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -136.56 160.74 65.47 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.619 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.56 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 11.3 Cg_endo -56.03 -48.67 18.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.728 2.285 . . . . 0.0 111.941 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -111.71 86.97 2.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.97 178.8 41.76 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.058 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -90.22 143.2 3.85 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.025 2.483 . . . . 0.0 113.076 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.86 114.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.58 154.47 30.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.556 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.1 m -87.25 143.14 27.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 t90 -111.88 121.63 39.16 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 9.8 Cg_exo -72.54 46.99 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.526 2.818 . . . . 0.0 113.409 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 HD13 ' A' ' 56' ' ' LEU . 92.0 t -122.19 115.96 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.17 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -82.98 -32.1 27.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.0 110.159 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -160.3 158.57 25.94 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.036 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HA ' HG13 ' A' ' 52' ' ' ILE . 17.5 Cg_exo -68.44 33.94 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.964 3.109 . . . . 0.0 114.414 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.68 -27.48 15.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.634 0.254 . . . . 0.0 110.934 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -111.96 7.18 19.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.503 HG13 ' HA ' ' A' ' 49' ' ' PRO . 54.6 mt -61.74 109.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.157 0.504 . . . . 0.0 110.822 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 p -127.89 175.99 7.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.788 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -59.4 -43.69 92.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.82 -175.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -58.21 -42.72 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.786 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.449 HD13 HG22 ' A' ' 46' ' ' VAL . 93.8 mt -67.93 -36.56 80.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.735 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.0 -37.38 85.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.319 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 98.2 mt-30 -58.08 -42.69 86.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.999 0.428 . . . . 0.0 110.443 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.72 -39.76 84.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.271 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.6 -18.0 52.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.11 -20.39 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.33 45.3 30.96 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.056 0.455 . . . . 0.0 110.555 -177.352 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.708 0.29 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.19 154.39 74.44 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.792 2.328 . . . . 0.0 112.516 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.48 -42.7 58.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.476 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 140' ' ' VAL . 3.6 p -135.33 139.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.327 0.584 . . . . 0.0 111.899 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 141' ' ' VAL . 51.1 tp -118.11 122.49 43.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.5 mt -104.27 121.72 43.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.741 0.305 . . . . 0.0 110.619 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.37 113.36 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.26 89.76 1.01 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.237 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.52 31.96 4.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.872 0.368 . . . . 0.0 111.234 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -72.37 -15.08 77.08 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.225 -175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -83.14 -21.96 33.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.41 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 10.8 tpt180 -168.77 90.95 0.25 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -56.99 106.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.281 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -115.05 99.71 7.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.73 111.7 1.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 97.6 mt -68.38 133.19 48.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.255 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.05 21.53 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.631 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.9 Cg_endo -55.12 -47.16 27.87 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.509 2.806 . . . . 0.0 112.938 -174.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.67 -25.4 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.769 0.319 . . . . 0.0 111.634 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 103' ' ' LEU . 97.2 mt-30 -78.13 -40.98 36.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 29.0 m -101.24 4.19 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.577 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.518 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 32.8 ttp180 -54.26 -48.9 93.13 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 53.6 Cg_exo -53.49 -34.27 71.4 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.098 1.865 . . . . 0.0 112.59 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.6 mt -86.55 -34.32 19.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.878 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 80.2 mt -63.78 -34.25 77.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.908 0.385 . . . . 0.0 110.157 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.29 -13.11 62.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.115 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -100.82 -25.33 14.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.971 0.415 . . . . 0.0 110.509 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.03 18.64 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.05 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.7 t -94.78 118.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.99 111.24 3.63 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.672 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.71 119.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -108.45 118.67 37.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.998 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.58 106.93 17.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.689 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 40.5 ttm -134.49 163.68 29.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.103 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.96 149.64 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.455 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 9.7 m -60.21 -47.0 87.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.76 0.315 . . . . 0.0 111.376 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -69.93 -40.56 75.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 110.576 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.46 95.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.971 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.4 83.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.97 88.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -64.03 -41.14 97.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.542 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.9 m -63.52 -43.79 96.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.464 ' CE1' ' HD3' ' A' ' 37' ' ' PRO . 73.2 t80 -57.08 -41.86 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -58.48 -47.13 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.05 -45.6 90.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.718 HD22 ' HD2' ' A' ' 138' ' ' ARG . 87.0 mt -64.21 -34.58 78.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.56 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 50.8 ttp -67.52 -34.28 76.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.345 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.76 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.07 -23.1 61.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.033 0.444 . . . . 0.0 110.415 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.55 31.58 15.64 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.149 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.718 ' HD2' HD22 ' A' ' 133' ' ' LEU . 45.8 mtt180 -83.43 152.46 24.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.797 0.332 . . . . 0.0 110.922 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -83.18 93.02 7.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.891 0.853 . . . . 0.0 109.494 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 91' ' ' VAL . 3.7 p -125.77 133.87 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.33 -177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 36' ' ' ALA . 33.5 t -111.96 133.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.2 p -116.65 130.15 71.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.906 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -109.95 109.49 20.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.453 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.65 129.87 46.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.479 HD13 ' HG3' ' A' ' 49' ' ' PRO . 87.8 mt -103.65 117.34 60.12 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.439 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 84.2 Cg_endo . . . . . 0 N--CA 1.458 -0.571 0 C-N-CA 123.02 2.48 . . . . 0.0 111.856 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.408 ' HA ' ' OD1' ' A' ' 25' ' ' ASN . 88.3 m-20 -64.35 109.38 1.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.033 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 m -117.6 133.09 56.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -66.17 110.32 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.552 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 m -82.77 -44.74 15.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.41 150.59 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.042 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -128.36 128.58 44.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.03 -169.02 12.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.857 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.49 -61.2 1.91 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.277 0.561 . . . . 0.0 110.94 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.75 25.08 15.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.737 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -155.13 138.88 16.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.602 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -120.79 120.96 63.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 39.1 tt0 -96.03 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.267 -176.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.51 128.31 66.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 12' ' ' ASN . 7.8 m-20 61.27 30.16 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.213 -177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 69.22 15.53 8.58 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.732 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.26 121.72 62.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 93.2 mtt180 -87.36 111.76 21.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.004 0.43 . . . . 0.0 111.581 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.58 124.0 45.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.042 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -97.98 22.55 9.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.978 0.418 . . . . 0.0 111.332 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -151.39 171.82 16.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.473 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.85 135.91 57.67 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.604 0.565 . . . . 0.0 111.623 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.67 144.81 26.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.107 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.07 122.18 35.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.519 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 37.7 p90 -143.78 153.51 42.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.102 0.477 . . . . 0.0 111.708 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.48 158.53 68.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.052 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -58.68 135.22 65.82 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.255 1.97 . . . . 0.0 111.62 173.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 70.02 16.86 7.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.162 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.18 169.46 22.98 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.5 177.24 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.129 . . . . 0.0 112.221 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 43.1 t -102.81 102.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.35 134.42 35.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.09 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -77.7 118.89 20.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.035 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -98.18 120.31 59.99 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.673 -175.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.3 Cg_exo -77.19 26.56 0.45 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.348 2.699 . . . . 0.0 112.99 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 51' ' ' ASP . 79.5 t -103.19 110.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.673 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.406 ' HA ' HD21 ' A' ' 145' ' ' LEU . 91.0 mt-30 -113.72 -13.88 12.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.318 0.58 . . . . 0.0 109.566 174.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.071 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 37.2 mtp-105 -101.83 135.25 19.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.44 -33.57 93.92 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.596 2.198 . . . . 0.0 112.319 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.11 9.54 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.456 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 1.071 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 3.6 t70 -85.09 -25.88 27.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.206 0.527 . . . . 0.0 110.13 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.9 109.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.565 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.0 m -112.35 155.53 23.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.168 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.542 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -56.68 -38.18 71.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 t -57.34 -42.79 82.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.712 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.82 -27.48 64.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' HD11 ' A' ' 111' ' ' LEU . 95.8 mt -71.3 -35.07 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.386 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.102 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -66.34 -43.93 84.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.367 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 -19.33 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.913 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.3 -5.93 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.38 82.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.127 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.358 0.599 . . . . 0.0 110.97 -176.674 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.521 0.201 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 18.5 Cg_endo -57.77 134.43 62.73 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 123.052 2.502 . . . . 0.0 113.013 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -67.29 -36.82 82.32 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.514 HG13 HG23 ' A' ' 140' ' ' VAL . 6.0 p -139.76 135.78 39.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.993 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.6 tp -111.67 120.6 42.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.193 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 119' ' ' GLU . 94.9 mt -102.08 112.2 24.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.864 0.364 . . . . 0.0 110.895 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.85 113.61 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.959 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -97.77 97.07 1.89 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 p -106.67 56.17 0.65 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.155 0.502 . . . . 0.0 110.931 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.729 ' HA3' HG22 ' A' ' 123' ' ' THR . . . -64.07 -28.54 72.99 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.536 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -63.0 -38.72 92.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.249 0.547 . . . . 0.0 110.768 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -170.44 95.06 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -61.23 128.09 34.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.798 -168.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -107.77 120.93 43.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.833 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.8 tp -80.1 103.18 9.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.91 145.92 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.031 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 173.77 20.1 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.747 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.622 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 54.2 Cg_exo -52.29 -49.34 17.71 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.543 2.829 . . . . 0.0 113.155 -175.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.09 -34.51 73.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.863 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -68.52 -30.27 69.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.88 -8.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 85.7 mtt180 -54.22 -52.49 68.4 Favored Pre-proline 0 N--CA 1.466 0.344 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.542 ' HG2' ' HB1' ' A' ' 54' ' ' ALA . 79.1 Cg_exo -50.96 -34.11 44.8 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.387 2.058 . . . . 0.0 113.173 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 80.0 mt -89.73 -37.99 14.16 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.146 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.3 mt -60.89 -34.44 74.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.776 0.322 . . . . 0.0 110.694 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.16 -24.06 65.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.092 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.4 mtt -90.67 -9.85 45.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.382 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.19 10.68 54.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.252 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.6 t -94.59 113.55 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.674 0.273 . . . . 0.0 110.537 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.12 118.78 4.78 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.618 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.56 117.18 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.449 ' HB2' HD23 ' A' ' 93' ' ' LEU . 27.6 mm-40 -114.33 110.1 19.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.195 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.18 110.73 22.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 67.4 mtm -138.56 -171.85 3.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.813 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.06 154.33 39.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.941 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.729 HG22 ' HA3' ' A' ' 97' ' ' GLY . 5.0 t -62.94 -45.79 90.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.777 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -74.7 -38.05 62.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.71 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.696 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.96 78.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.727 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.23 88.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -63.74 -48.27 77.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.374 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -66.13 -39.32 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.11 -44.23 91.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.801 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.61 -50.1 71.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.138 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.35 -48.85 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD13 HG11 ' A' ' 91' ' ' VAL . 96.9 mt -65.52 -35.37 80.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.344 -177.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.67 -33.78 74.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.809 0.338 . . . . 0.0 110.097 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.76 -26.17 65.99 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.67 -24.97 58.89 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.133 0.492 . . . . 0.0 110.413 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.13 18.69 53.07 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 40.4 ttm-85 -81.42 154.17 26.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.395 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB3' ' HA ' ' A' ' 89' ' ' PRO . 37.4 mmt180 -79.23 99.07 6.88 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.674 0.75 . . . . 0.0 110.742 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.514 HG23 HG13 ' A' ' 91' ' ' VAL . 4.1 p -134.49 134.7 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.532 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 36' ' ' ALA . 26.4 t -116.66 137.33 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.23 136.23 58.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.071 0.463 . . . . 0.0 111.178 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.12 112.33 18.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.756 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -105.2 138.68 41.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 -175.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.465 HD11 HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -119.45 91.12 43.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 123.186 2.59 . . . . 0.0 113.213 178.81 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 121.184 0.516 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.62 107.11 1.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.4 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 m -131.24 150.16 52.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.745 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -71.56 129.84 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 p -85.67 -33.73 21.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.711 0.291 . . . . 0.0 111.54 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -145.26 112.34 6.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.58 0.229 . . . . 0.0 110.476 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -70.38 -38.22 74.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.869 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.9 -163.6 44.33 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.781 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.01 -74.84 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.202 0.525 . . . . 0.0 110.277 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.93 31.99 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.469 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.45 119.25 2.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.4 110.07 26.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 36.7 tt0 -97.95 112.62 24.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 110.543 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.07 109.65 29.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.81 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 62.97 43.57 6.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.654 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 70.48 12.04 7.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.819 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -106.04 113.04 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttm105 -90.72 112.84 24.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.346 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.45 117.56 33.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.686 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 55.5 m -93.9 10.53 32.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -148.2 -179.34 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.362 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.74 146.33 46.3 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.22 148.46 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.573 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.3 131.14 48.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.599 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.04 158.2 38.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.312 0.577 . . . . 0.0 111.789 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -131.51 161.87 59.54 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.547 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.83 -46.36 33.9 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.374 2.049 . . . . 0.0 110.981 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -118.27 96.05 5.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.022 172.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.83 178.64 41.03 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.67 138.97 7.43 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.568 2.178 . . . . 0.0 112.718 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.26 103.02 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.2 121.85 42.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.481 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -66.94 120.74 14.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -97.88 127.21 37.93 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -170.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.4 Cg_exo -70.09 3.99 2.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.408 2.739 . . . . 0.0 113.033 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 51' ' ' ASP . 84.7 t -86.14 134.96 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.71 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 50.0 tp60 -107.16 -41.48 5.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.146 0.498 . . . . 0.0 110.155 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.71 ' HG3' ' HG3' ' A' ' 47' ' ' GLN . 63.5 mtt180 -129.5 156.09 79.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.607 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.64 0.11 2.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.16 2.574 . . . . 0.0 113.172 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HB2' ' NH2' ' A' ' 99' ' ' ARG . . . -90.6 -17.23 27.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.148 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.552 ' HB2' HG13 ' A' ' 46' ' ' VAL . 43.5 m-20 -88.15 -16.29 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.048 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.67 114.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.667 -174.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 p -124.27 173.62 8.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.402 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.24 91.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.616 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -60.96 -42.25 97.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.417 0.627 . . . . 0.0 110.797 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.466 HD13 HG22 ' A' ' 46' ' ' VAL . 87.5 mt -71.56 -28.85 64.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.856 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.95 -39.14 87.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.488 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -63.67 -37.93 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.3 -44.84 74.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.27 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.529 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . -76.68 -9.21 58.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.28 23.61 71.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.724 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.974 -176.22 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 86.4 Cg_exo -47.6 132.44 20.57 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.247 2.631 . . . . 0.0 113.368 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.5 mt-10 -77.3 -43.03 34.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 7.1 p -140.66 137.45 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.158 -177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 61' ' ' ALA . 45.1 tp -110.0 118.22 35.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.301 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.3 mt -98.06 120.85 39.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.866 0.365 . . . . 0.0 110.747 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.15 122.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.093 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -100.39 113.09 4.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.189 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 22.2 p -83.76 -66.98 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.743 0.306 . . . . 0.0 111.678 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 -65.26 3.87 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.572 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -69.52 -37.6 77.2 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.769 -0.254 . . . . 0.0 111.217 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 96' ' ' THR . 13.7 ptt180 -161.19 138.47 8.95 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 170.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -81.08 91.5 6.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.391 0.615 . . . . 0.0 111.237 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -94.68 106.98 18.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.534 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.26 149.35 38.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.711 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.5 150.39 21.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.423 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -105.95 165.48 13.87 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.468 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.51 -26.34 82.6 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 123.397 2.731 . . . . 0.0 113.36 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.69 -11.68 44.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.003 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.54 -45.68 8.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.281 0.563 . . . . 0.0 109.995 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 104' ' ' GLY . 27.0 m -90.79 16.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.499 0.666 . . . . 0.0 109.979 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.632 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 33.2 ttt180 -54.25 -52.95 64.37 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.801 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.9 Cg_exo -59.28 -40.51 67.84 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.961 1.774 . . . . 0.0 112.465 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 91.8 mt -73.94 -42.11 61.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 -176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.6 mt -61.45 -38.17 86.23 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.573 0.225 . . . . 0.0 110.955 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -35.02 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 65.7 mtt -76.38 -29.83 57.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.646 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.95 10.82 13.42 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.99 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.7 t -92.12 113.27 27.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -80.33 130.01 9.48 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.567 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.2 124.04 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.988 0.394 . . . . 0.0 110.393 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -114.43 108.62 17.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.311 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.14 111.06 22.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 68.2 mtm -137.85 -171.65 3.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.56 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.25 152.14 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.873 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.548 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 7.7 t -63.77 -38.24 90.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.68 -37.25 42.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.234 0.54 . . . . 0.0 109.94 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.97 90.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.886 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.43 -40.75 70.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.008 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.0 84.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.424 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -72.76 -43.74 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.1 p -67.04 -32.22 73.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.469 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 79.7 t80 -57.56 -44.96 85.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.42 174.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.7 -36.39 84.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.54 -49.81 82.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.59 -30.46 71.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttm -65.72 -42.48 91.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.192 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.7 76.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.85 -16.75 60.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.775 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.39 51.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.206 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -93.25 167.63 11.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.803 0.335 . . . . 0.0 110.924 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.694 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 2.1 mmt180 -83.38 90.66 7.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.119 0.485 . . . . 0.0 109.872 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.4 135.84 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 36' ' ' ALA . 16.7 t -125.61 142.92 40.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.469 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 8.3 p -123.63 140.82 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.1 113.34 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.355 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 98.8 mt -104.11 133.94 48.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.338 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.69 103.99 51.32 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.058 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.462 -0.351 0 C-N-CA 122.969 2.446 . . . . 0.0 112.343 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -101.59 112.06 24.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.128 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 m -100.31 143.57 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.413 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.89 115.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.139 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -45.76 73.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.738 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -141.77 110.52 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.21 0.529 . . . . 0.0 111.439 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -99.21 129.31 45.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.769 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 21' ' ' TYR . . . -132.3 -178.17 15.35 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.137 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -86.51 -20.47 27.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.031 0.443 . . . . 0.0 110.46 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.9 17.43 5.72 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.995 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.512 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 27.3 p90 -164.95 150.36 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.74 0.305 . . . . 0.0 110.76 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.44 106.35 15.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -105.6 118.26 36.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.954 0.407 . . . . 0.0 109.954 -177.118 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.29 139.18 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.83 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.26 -83.8 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.667 0.604 . . . . 0.0 110.176 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -152.71 13.27 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.466 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.56 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.003 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 48.0 ttp180 -83.45 107.4 15.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.82 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.74 129.83 35.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.099 0.476 . . . . 0.0 110.941 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 m -108.45 19.09 20.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.887 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -145.44 168.92 19.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . . . -65.8 142.77 57.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.108 0.48 . . . . 0.0 111.598 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.8 pt -137.98 138.82 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.7 118.68 25.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -146.52 163.61 35.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.79 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.23 152.73 70.18 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.1 -32.75 96.28 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.87 2.38 . . . . 0.0 112.959 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.604 ' OE2' ' HD2' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -100.75 19.27 17.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.835 0.35 . . . . 0.0 110.867 -178.016 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.11 -176.15 20.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.853 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.5 -170.28 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.069 2.513 . . . . 0.0 112.437 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.14 116.16 50.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.122 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.68 129.64 35.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.916 0.388 . . . . 0.0 110.74 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p -75.28 121.19 21.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -115.17 117.16 41.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.897 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.26 22.9 0.87 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.228 2.618 . . . . 0.0 113.048 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.34 123.87 41.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.796 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -106.17 -35.93 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.734 0.778 . . . . 0.0 109.389 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 48' ' ' ARG . 47.0 mtm180 -120.18 131.54 24.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.063 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.6 Cg_exo -67.14 8.24 0.39 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.292 2.662 . . . . 0.0 113.092 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.22 -3.01 48.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -109.99 14.09 23.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.2 119.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 111.193 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 p -104.14 168.46 9.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -65.05 -30.04 70.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 p -66.26 -42.14 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.774 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.53 -34.77 79.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.624 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.504 ' HB3' HD11 ' A' ' 111' ' ' LEU . 96.7 mt -63.53 -42.42 98.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.15 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.426 ' HG2' HD21 ' A' ' 111' ' ' LEU . 91.1 mt-30 -66.15 -36.63 83.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 110.96 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -71.24 -36.67 71.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.464 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.02 -27.37 67.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.938 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -73.79 -9.12 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.936 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.62 15.32 78.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.523 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' HD3' ' A' ' 89' ' ' PRO . 90.1 mt . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.101 0.477 . . . . 0.0 111.055 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD3' HD21 ' A' ' 63' ' ' LEU . 17.3 Cg_exo -66.51 121.48 8.74 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 111.735 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 109.878 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.686 HG11 HD13 ' A' ' 133' ' ' LEU . 6.4 p -134.12 135.29 54.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.731 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.49 104.72 12.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.427 HD11 HD12 ' A' ' 133' ' ' LEU . 93.9 mt -90.13 110.75 21.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.691 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.78 112.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.436 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.63 92.68 1.79 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.544 ' HA ' HD12 ' A' ' 145' ' ' LEU . 1.3 m -60.75 -24.84 66.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.712 0.405 . . . . 0.0 112.072 -171.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 79.61 -68.62 3.16 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.546 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -92.82 82.08 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.881 0.372 . . . . 0.0 110.578 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 63.25 -173.99 0.16 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.149 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -90.22 143.3 26.89 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.936 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -136.7 126.72 26.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.851 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -80.96 111.78 17.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.463 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.8 mt -76.85 170.18 16.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 159.53 15.1 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.774 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.27 -34.92 98.06 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.941 2.427 . . . . 0.0 111.91 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.42 -20.59 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 88.9 mt-30 -96.34 -63.19 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.814 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.3 -18.93 8.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 37.0 ttt180 -57.84 -46.51 99.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 73.2 Cg_exo -53.11 -34.3 67.74 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.165 1.91 . . . . 0.0 112.875 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 57' ' ' LEU . 92.3 mt -76.45 -42.09 45.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.641 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.28 -26.52 68.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 0.0 110.467 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.74 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 60.1 mtt -90.82 -7.46 52.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.883 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.48 51.17 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.091 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -91.83 117.16 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.799 0.333 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.65 93.94 1.7 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.961 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.81 120.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -125.29 127.15 46.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.415 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.67 116.67 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.3 mtm -142.34 -171.79 3.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.588 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.32 153.63 42.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.415 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 9.0 m -57.95 -42.96 86.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.261 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.47 -48.45 81.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.46 -50.16 68.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.791 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.69 91.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -60.12 -50.24 74.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.424 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.1 m -65.47 -36.01 82.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.47 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -59.01 -46.88 87.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -56.93 -42.9 80.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.712 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.65 -52.76 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.794 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.686 HD13 HG11 ' A' ' 91' ' ' VAL . 94.7 mt -64.4 -35.23 80.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.507 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 45.0 ttp -65.31 -41.3 94.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.77 73.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.671 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -73.11 -20.57 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.8 39.26 29.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.752 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -97.27 162.69 13.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.578 0.228 . . . . 0.0 110.89 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.604 ' HD2' ' OE2' ' A' ' 38' ' ' GLU . 16.7 mmm180 -75.25 80.84 2.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.0 120.51 64.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.18 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 36' ' ' ALA . 43.9 t -109.87 132.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -117.92 133.8 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.12 0.486 . . . . 0.0 111.122 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.86 110.0 17.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.347 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -100.57 120.97 40.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.944 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 96' ' ' THR . 73.6 mt -104.21 107.04 56.23 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.629 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.452 -0.933 0 C-N-CA 122.236 1.957 . . . . 0.0 110.405 169.212 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.49 0.662 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -65.48 108.43 1.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.218 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 m -118.17 137.04 53.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.073 0.463 . . . . 0.0 111.816 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 24' ' ' VAL . 63.9 t -67.74 132.96 32.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 174.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 p -94.69 -45.67 7.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.736 0.303 . . . . 0.0 111.688 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.15 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 0.0 111.163 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -105.98 -76.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.838 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.77 -111.75 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.027 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -162.25 130.91 4.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -49.09 3.71 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.915 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -111.71 170.24 8.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 110.987 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.96 117.19 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.447 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 29.5 tt0 -96.87 117.81 31.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.053 0.454 . . . . 0.0 110.797 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 14' ' ' VAL . 25.6 t -113.54 124.37 70.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.639 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 66.67 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.728 0.642 . . . . 0.0 111.376 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -141.34 -3.97 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.11 122.3 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.117 -172.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 12.8 ptt180 -85.76 111.42 20.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.978 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.41 120.08 31.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.3 m -101.97 23.54 11.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.54 0.686 . . . . 0.0 109.572 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -141.7 163.59 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.398 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.72 57.76 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.396 0.435 . . . . 0.0 110.991 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -137.04 137.52 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.32 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.76 109.68 14.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.546 -0.752 . . . . 0.0 108.973 173.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.419 ' HB3' HG13 ' A' ' 41' ' ' VAL . 37.5 p90 -126.43 147.13 49.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 112.359 -173.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -101.95 157.64 33.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.932 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 26.5 Cg_endo -62.84 -17.53 60.0 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.625 2.217 . . . . 0.0 113.116 -176.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 43.1 mt-10 -89.31 9.23 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.3 -69.57 0.41 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.646 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' A' ' 38' ' ' GLU . 4.5 Cg_exo -37.99 119.85 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.592 3.528 . . . . 0.0 114.923 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 35' ' ' PHE . 41.9 t -113.25 113.56 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.925 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 135.77 33.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.664 0.268 . . . . 0.0 110.794 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 m -88.78 137.89 31.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 m0 -121.15 131.8 24.38 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.3 Cg_exo -81.52 20.5 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.487 2.791 . . . . 0.0 111.619 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 51' ' ' ASP . 92.4 t -94.75 123.32 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.418 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 6.32 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.293 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 152.83 30.26 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.39 14.48 0.38 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.934 2.423 . . . . 0.0 113.162 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.67 -29.53 15.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.258 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.577 ' HB2' HG13 ' A' ' 46' ' ' VAL . 28.9 m-20 -77.79 -20.78 52.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.226 -175.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.45 HD13 HG11 ' A' ' 94' ' ' VAL . 23.0 mt -60.04 110.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.22 0.533 . . . . 0.0 111.194 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.45 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -131.44 165.6 23.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.482 -178.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.61 65.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.721 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 3.4 p -62.55 -50.74 70.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.856 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.51 -36.91 84.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.824 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' HD11 ' A' ' 111' ' ' LEU . 97.5 mt -61.46 -41.86 97.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.98 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.85 -33.17 74.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.86 0.362 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 55' ' ' SER . 87.9 mt-30 -71.38 -35.83 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.75 -26.53 40.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.04 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 89' ' ' PRO . . . -77.77 -10.68 59.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.135 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.57 35.17 67.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.623 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 0.0 111.283 -177.424 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.448 ' O ' HG22 ' A' ' 116' ' ' VAL . 26.0 Cg_endo -63.92 153.47 75.57 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.588 2.192 . . . . 0.0 112.531 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.35 -51.7 6.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.024 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.37 136.65 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 tp -115.33 119.01 34.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.79 119.91 39.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.45 HG11 HD13 ' A' ' 52' ' ' ILE . 58.9 t -111.84 117.87 56.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.363 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.83 102.29 2.9 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 101' ' ' HIS . 6.1 p -78.15 19.12 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.8 -85.03 1.09 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.234 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -79.19 -33.58 43.77 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -169.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -142.3 -173.72 3.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HG2' ' H ' ' A' ' 122' ' ' ASP . 93.0 mt-30 -95.31 82.46 3.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.648 165.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.467 ' HB3' HG21 ' A' ' 96' ' ' THR . 58.5 t-80 -94.8 101.77 13.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.726 -174.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 120' ' ' ALA . 48.0 tp -64.76 143.22 58.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.67 -165.71 1.03 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.324 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.95 150.51 16.92 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.765 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.69 -37.19 83.74 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.265 2.643 . . . . 0.0 112.758 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -72.96 -33.38 65.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.944 0.402 . . . . 0.0 110.761 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.05 -42.32 73.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.1 m -89.99 -6.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.35 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -50.5 87.83 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -54.02 -40.45 81.19 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.14 1.893 . . . . 0.0 112.615 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 64.7 mt -77.63 -38.08 48.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.129 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 73.8 mt -61.89 -34.34 75.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.11 63.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.6 mtt -91.11 -11.87 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.6 8.79 55.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.0 t -86.69 111.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.742 0.306 . . . . 0.0 110.44 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.69 104.28 2.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.146 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -91.04 120.19 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.738 0.304 . . . . 0.0 111.027 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -118.48 115.78 25.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.422 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 102' ' ' LEU . . . -99.05 118.52 36.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.655 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.4 mtm -140.02 -171.82 3.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.221 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.505 ' H ' ' HG2' ' A' ' 100' ' ' GLN . 12.8 t70 -70.31 151.55 45.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.534 HG23 HD22 ' A' ' 144' ' ' LEU . 63.8 m -56.96 -37.99 72.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 111.002 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.72 -42.84 70.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.463 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.51 -41.6 84.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.944 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.43 -38.71 90.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.849 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -52.21 66.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.157 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -61.84 -40.18 94.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.999 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 41.0 m -64.8 -40.32 95.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.398 . . . . 0.0 110.474 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -60.93 -46.76 89.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.711 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -58.32 -37.68 75.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 79.4 mt -68.52 -53.86 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.608 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.681 HD22 ' HD2' ' A' ' 138' ' ' ARG . 61.9 mt -61.91 -41.63 98.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -64.93 -39.47 93.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.579 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.71 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 44.8 mt-10 -73.84 -26.31 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 22.82 12.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.256 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.681 ' HD2' HD22 ' A' ' 133' ' ' LEU . 56.1 mtt-85 -80.35 157.68 26.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.843 0.354 . . . . 0.0 110.204 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.0 83.38 6.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.248 0.547 . . . . 0.0 109.932 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.32 134.72 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.529 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.35 136.83 53.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.6 p -120.69 134.46 64.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.048 0.451 . . . . 0.0 111.411 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.14 113.07 20.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.563 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.534 HD22 HG23 ' A' ' 123' ' ' THR . 91.3 mt -108.4 133.97 51.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.671 -175.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 52' ' ' ILE . 83.5 mt -111.0 105.65 57.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.918 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.457 -0.658 0 C-N-CA 123.212 2.608 . . . . 0.0 110.589 166.902 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 37' ' ' PRO . 54.7 mt . . . . . 0 C--O 1.236 0.392 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.67 95.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.452 . . . . 0.0 109.971 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -91.31 129.19 37.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.502 -173.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.37 107.32 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 m -79.84 -36.88 36.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.003 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.53 130.74 15.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.203 0.525 . . . . 0.0 111.375 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -100.4 106.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 -170.73 34.66 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.116 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.54 -58.68 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.226 0.536 . . . . 0.0 110.59 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.11 38.11 1.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.766 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -151.76 143.87 23.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.906 0.384 . . . . 0.0 110.294 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.28 118.62 59.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.82 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.77 112.0 23.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.733 0.301 . . . . 0.0 110.274 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.51 115.16 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.999 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 72.12 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.625 0.77 . . . . 0.0 110.428 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -174.88 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.283 0.633 . . . . 0.0 109.364 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.09 126.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.367 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -95.06 121.1 36.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.604 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.7 113.2 26.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.604 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -92.78 19.91 7.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.568 0.699 . . . . 0.0 110.106 175.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -130.59 151.84 50.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.665 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 44' ' ' TRP . . . -58.56 136.8 57.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.7 pt -141.85 154.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.097 0.475 . . . . 0.0 111.723 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.31 124.04 28.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.327 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -146.24 163.13 36.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.032 0.444 . . . . 0.0 111.529 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -126.65 163.56 40.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -176.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 63.7 Cg_endo -73.4 23.52 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.706 2.27 . . . . 0.0 112.914 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ALA . 38.9 tt0 -173.49 90.3 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.04 -165.04 29.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.878 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.88 167.22 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.2 2.6 . . . . 0.0 113.034 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.84 122.9 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.148 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.12 140.72 29.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.1 p -84.41 119.73 25.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.069 0.461 . . . . 0.0 110.594 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.409 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.3 t90 -98.24 116.4 65.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.737 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.15 35.55 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.267 2.645 . . . . 0.0 114.043 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 51' ' ' ASP . 94.6 t -101.14 133.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.684 0.278 . . . . 0.0 110.577 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -113.84 -43.93 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.477 . . . . 0.0 110.554 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -116.92 151.99 48.09 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.24 -6.66 10.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.746 2.297 . . . . 0.0 112.539 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.39 -3.52 46.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.552 ' HB2' HG13 ' A' ' 46' ' ' VAL . 64.2 m-20 -84.19 -28.16 27.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.555 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.4 mt -55.45 113.73 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.759 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 39.1 p -128.95 175.14 8.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -58.29 -44.92 88.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.043 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 m -60.93 -42.43 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.5 HD13 HG22 ' A' ' 46' ' ' VAL . 80.7 mt -70.51 -28.26 64.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' A' ' 111' ' ' LEU . 83.7 mt -73.45 -30.06 62.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.79 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 95.2 mt-30 -63.75 -43.63 95.86 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 174.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.47 -42.29 92.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.706 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.77 76.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.637 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.48 0.66 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.35 82.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.427 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.1 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.303 -177.141 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.501 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.641 0.258 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 2.8 Cg_exo -75.54 151.21 36.9 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.041 2.494 . . . . 0.0 112.125 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -67.27 -44.83 78.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.934 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 140' ' ' VAL . 5.4 p -132.4 136.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.484 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 141' ' ' VAL . 62.3 tp -118.07 121.94 41.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.184 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.19 120.85 42.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.5 t -103.31 119.84 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.941 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' A' ' 144' ' ' LEU . . . -98.26 98.81 2.1 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.587 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -126.49 93.0 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.45 -10.21 39.16 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.453 -0.88 . . . . 0.0 114.46 -170.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -89.51 -26.41 20.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.716 0.758 . . . . 0.0 110.168 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -159.53 94.24 1.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.902 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -65.23 109.5 2.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.29 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -106.13 122.41 46.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.891 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.7 134.07 39.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.134 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.4 mt -94.12 137.12 33.67 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.28 171.08 17.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.075 -171.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.42 -44.06 30.87 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.745 2.963 . . . . 0.0 113.351 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.24 -46.8 69.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.133 0.492 . . . . 0.0 111.404 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 92.8 mt-30 -75.98 -12.55 60.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.581 -173.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.03 14.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.656 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.2 mtm105 -55.84 -54.89 46.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.656 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 24.3 Cg_exo -64.15 -26.71 64.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.842 1.695 . . . . 0.0 111.907 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 57' ' ' LEU . 75.3 mt -78.72 -46.6 18.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.08 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.73 -34.65 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.832 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.89 65.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.188 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 50.4 mtt -94.3 -7.83 40.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.006 0.432 . . . . 0.0 110.215 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.95 -8.51 55.98 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.13 122.0 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 0.0 111.004 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.67 109.63 3.78 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.74 110.33 24.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.84 0.352 . . . . 0.0 110.917 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -108.55 116.93 32.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.388 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.95 29.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.495 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.1 mtm -137.49 -172.78 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.304 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.9 159.02 29.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.691 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 p -59.02 -53.04 62.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.967 0.413 . . . . 0.0 110.973 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -65.33 -36.81 85.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.17 75.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 0.0 110.893 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.46 90.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.668 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.391 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -65.18 -42.69 93.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.979 0.418 . . . . 0.0 110.485 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.0 m -65.3 -34.39 78.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.979 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.413 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 60.6 t80 -61.69 -42.76 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.95 177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -57.2 -45.23 83.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.014 0.435 . . . . 0.0 110.586 175.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.72 -53.34 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.429 ' HB2' HG11 ' A' ' 140' ' ' VAL . 93.1 mt -62.43 -31.23 71.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 37.5 ttm -59.96 -50.23 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.493 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.69 72.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.076 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.78 -23.49 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.11 18.63 58.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.552 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -82.69 144.51 30.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -70.71 94.09 0.99 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.077 0.465 . . . . 0.0 110.894 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 133' ' ' LEU . 7.4 p -126.37 138.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.41 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' A' ' 36' ' ' ALA . 44.9 t -118.89 134.92 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.1 p -115.9 128.69 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 0.0 111.002 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.8 109.82 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.521 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.503 HD23 ' HA3' ' A' ' 95' ' ' GLY . 96.1 mt -113.36 136.47 52.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.706 -173.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 91.7 mt -93.72 133.78 27.41 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.245 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 14.9 Cg_exo . . . . . 0 C--O 1.233 0.242 0 C-N-CA 122.762 2.308 . . . . 0.0 112.804 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.491 HD22 ' HG2' ' A' ' 134' ' ' MET . 71.9 mt . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.634 0.254 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -78.87 98.97 6.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.1 m -108.32 137.05 46.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.091 0.472 . . . . 0.0 111.931 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 24' ' ' VAL . 80.1 t -73.12 126.16 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.479 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.9 p -87.63 -34.65 18.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.61 0.243 . . . . 0.0 111.314 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.77 172.96 12.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.754 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.24 -33.33 6.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.95 -118.46 14.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.962 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -157.42 107.19 2.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.857 0.361 . . . . 0.0 110.475 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.09 18.96 48.49 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.213 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.938 ' HE1' ' HB2' ' A' ' 23' ' ' GLU . 44.3 p90 -160.34 176.25 11.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.873 0.337 . . . . 0.0 110.593 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.2 mt -123.85 122.13 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.938 ' HB2' ' HE1' ' A' ' 21' ' ' TYR . 28.5 tt0 -105.44 108.85 20.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -172.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 14' ' ' VAL . 57.7 t -109.91 107.6 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.946 177.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 58.3 53.63 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.274 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 72.96 -17.97 0.38 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.619 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 40.3 t -74.72 123.14 29.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.145 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -93.27 102.76 15.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.29 118.05 30.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.563 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -95.14 20.3 9.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.217 0.532 . . . . 0.0 110.133 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -151.08 163.87 37.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.898 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.09 146.62 53.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.197 0.522 . . . . 0.0 112.408 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.73 151.0 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.871 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.47 127.3 40.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -148.31 153.46 38.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.041 0.448 . . . . 0.0 111.397 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.65 159.28 65.91 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.0 -41.36 79.66 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.608 2.205 . . . . 0.0 112.063 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -102.99 94.71 5.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.74 -175.0 23.92 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.815 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -97.89 -178.06 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.365 2.71 . . . . 0.0 112.746 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.21 111.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.14 36.94 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 t -79.2 119.01 21.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.515 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.1 126.0 41.75 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -175.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.5 Cg_exo -69.58 -7.46 21.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.27 2.647 . . . . 0.0 113.048 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.636 HG11 HG12 ' A' ' 52' ' ' ILE . 48.5 t -86.26 102.6 11.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.413 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -98.23 -7.98 28.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.199 0.523 . . . . 0.0 110.448 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.621 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 12.1 mtm180 -138.57 146.26 50.03 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.917 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.606 ' HG3' ' HB3' ' A' ' 98' ' ' ARG . 33.8 Cg_endo -64.74 -9.79 22.33 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.799 2.333 . . . . 0.0 113.259 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.4 -2.98 47.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.468 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.621 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 3.6 m-20 -103.39 9.88 37.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.207 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.636 HG12 HG11 ' A' ' 46' ' ' VAL . 58.2 mt -84.7 126.52 40.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.731 0.301 . . . . 0.0 111.578 -175.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.9 p -128.76 166.61 18.67 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.47 -39.38 83.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.473 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 m -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.247 0.546 . . . . 0.0 110.854 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD13 ' CG2' ' A' ' 46' ' ' VAL . 71.1 mt -72.3 -28.86 63.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.75 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.33 -37.79 80.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.252 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.52 -39.62 94.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.231 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -66.21 -41.53 89.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.574 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -20.26 65.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.546 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.74 -7.42 55.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.21 76.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.485 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.042 0.448 . . . . 0.0 110.837 -177.715 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 CA-C-O 120.836 0.351 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.84 164.56 34.17 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.556 2.171 . . . . 0.0 112.414 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 42.0 mt-10 -92.29 -44.13 8.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 140' ' ' VAL . 7.5 p -139.37 136.87 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.073 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.9 tp -113.28 112.03 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.547 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.99 108.6 21.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.404 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.12 106.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.49 98.4 1.39 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 49' ' ' PRO . 5.3 m -65.96 -14.76 62.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -170.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.34 -72.9 2.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.974 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.606 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 39.6 ttm180 -85.81 70.35 10.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 0.0 110.074 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 66.28 154.46 0.08 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.726 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 53.7 tt0 -62.53 128.92 38.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.878 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -112.93 138.05 50.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.41 97.12 10.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.43 170.74 15.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.321 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.9 144.09 15.78 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.393 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.525 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 48.9 Cg_exo -55.78 -36.47 95.29 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.439 2.759 . . . . 0.0 113.296 -173.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.566 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 10.9 mm-40 -63.66 -28.87 70.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -88.26 -9.88 51.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.371 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.17 5.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 110.9 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.589 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.7 mmt180 -53.41 -52.79 63.29 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.292 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 61.7 Cg_exo -53.32 -39.68 80.45 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.153 1.902 . . . . 0.0 112.739 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.2 mt -78.72 -42.12 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.024 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.7 -37.06 80.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 110.617 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.75 70.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 65.1 mtt -83.61 -15.34 49.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.97 8.37 42.15 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.177 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 38.2 t -86.54 108.61 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.744 0.307 . . . . 0.0 110.576 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.75 107.23 2.32 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.828 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.5 t -87.09 111.74 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.783 0.325 . . . . 0.0 110.623 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -112.71 117.5 32.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.388 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 100' ' ' GLN . . . -101.98 115.95 31.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.319 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.478 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 65.4 mtm -139.51 -172.81 3.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.052 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.58 157.34 37.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 34.5 m -60.14 -45.83 91.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.241 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -64.39 -41.02 96.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 110.793 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.46 96.43 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.32 86.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.561 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.43 96.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.447 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -62.72 -48.62 78.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.277 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.0 m -62.73 -38.36 90.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.38 -44.04 95.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.75 -46.54 74.34 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 110.711 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.89 -52.25 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.84 -31.44 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.54 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.491 ' HG2' HD22 ' A' ' 11' ' ' LEU . 48.9 ttp -66.84 -43.23 84.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.825 0.345 . . . . 0.0 110.283 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.98 86.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.16 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.45 36.14 5.22 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.347 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -100.91 161.42 13.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.605 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 55.4 mtp85 -78.57 77.98 5.04 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.368 0.604 . . . . 0.0 111.024 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 91' ' ' VAL . 5.7 p -112.04 132.96 59.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.372 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 36' ' ' ALA . 38.5 t -115.65 134.04 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.5 p -119.04 135.45 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.248 0.546 . . . . 0.0 111.226 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 117.78 30.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.188 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.2 mt -107.37 120.44 42.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.173 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.44 HD21 ' CZ3' ' A' ' 44' ' ' TRP . 71.9 mt -100.96 130.09 25.87 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.278 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 1.9 Cg_endo . . . . . 0 N--CA 1.453 -0.899 0 C-N-CA 122.995 2.463 . . . . 0.0 110.995 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.593 HD21 ' HB2' ' A' ' 35' ' ' PHE . 56.8 t30 -75.05 109.75 8.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -147.06 146.14 29.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.934 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.87 118.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.16 17.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.33 -175.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -147.44 119.31 8.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.083 0.468 . . . . 0.0 111.332 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -113.18 116.54 29.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.416 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.58 -164.1 9.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.831 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.67 109.05 18.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.748 0.309 . . . . 0.0 110.874 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.2 1.0 72.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.437 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -153.43 142.12 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.556 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.0 mt -126.36 111.95 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.254 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -93.69 117.99 30.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.024 0.44 . . . . 0.0 110.436 -176.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.49 113.05 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.741 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 62.32 39.41 12.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 72.19 9.53 5.95 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.773 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.68 107.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 31.0 ptt-85 -81.53 114.85 20.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.323 0.583 . . . . 0.0 110.394 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.39 128.03 43.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.907 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 p -104.55 14.37 30.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.462 0.649 . . . . 0.0 109.717 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -137.68 171.25 14.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.378 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -62.27 141.71 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.555 0.534 . . . . 0.0 111.687 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 pt -142.11 136.41 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.26 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.3 120.87 37.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.308 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.593 ' HB2' HD21 ' A' ' 12' ' ' ASN . 40.2 p90 -149.88 162.78 39.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.165 0.507 . . . . 0.0 111.834 -173.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -130.68 158.62 74.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.747 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.689 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 19.3 Cg_endo -60.1 -32.42 94.68 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.604 2.203 . . . . 0.0 111.702 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -130.44 103.44 6.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.171 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.58 -156.14 26.52 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.923 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.64 162.22 6.43 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.836 2.357 . . . . 0.0 113.091 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -114.27 101.6 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.68 118.99 38.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.954 0.407 . . . . 0.0 111.641 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 65.6 m -66.88 132.66 48.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 170.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.55 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -97.93 129.74 30.42 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -171.244 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.55 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.83 -0.93 6.0 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.884 2.389 . . . . 0.0 112.917 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' CG2' HD13 ' A' ' 56' ' ' LEU . 46.8 t -86.22 96.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -89.54 -20.96 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 109.734 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -129.04 130.85 23.44 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.46 12.06 0.26 Allowed 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.058 2.505 . . . . 0.0 113.669 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.47 -2.59 58.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.998 0.428 . . . . 0.0 110.428 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.87 69.31 1.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.883 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 66.6 mt -115.26 107.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.159 173.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 61.1 p -113.85 174.9 5.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.952 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -62.73 -44.0 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.7 m -59.6 -39.32 83.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.025 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.413 HD13 ' CG2' ' A' ' 46' ' ' VAL . 94.9 mt -70.48 -34.05 71.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 53' ' ' THR . 95.7 mt -68.61 -35.59 77.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.1 mt-30 -62.1 -41.91 98.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.46 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -68.62 -38.59 80.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.396 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.8 65.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.57 0.14 35.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 0.0 111.112 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.7 0.1 87.9 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.471 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.814 -176.71 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.6 ' HB3' HG23 ' A' ' 141' ' ' VAL . 15.8 Cg_endo -58.34 132.22 47.49 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.795 2.33 . . . . 0.0 113.266 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -76.34 -33.98 58.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 140' ' ' VAL . 6.4 p -134.78 134.08 53.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.016 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.407 ' HB3' HG22 ' A' ' 118' ' ' VAL . 64.3 tp -114.12 112.7 23.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.268 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.59 116.01 28.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.36 100.63 11.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -86.04 76.25 2.17 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.353 -174.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 90.48 4.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.041 0.448 . . . . 0.0 109.972 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.33 -30.78 21.28 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.168 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -64.09 -50.39 68.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.304 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -145.32 132.36 20.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -72.41 91.72 1.38 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.403 ' CE1' ' HB ' ' A' ' 52' ' ' ILE . 54.2 t-80 -73.97 108.93 7.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.864 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.8 120.19 9.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.9 mt -80.13 149.02 30.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.54 147.36 16.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.277 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 51.6 Cg_exo -55.9 -32.43 85.29 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.182 2.588 . . . . 0.0 112.51 -177.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.15 -29.35 38.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 98.9 mt-30 -73.82 -41.64 62.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.77 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.6 m -92.07 2.69 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 66.9 ttt180 -59.27 -55.46 45.96 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.292 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 19.0 Cg_endo -57.99 -26.94 77.25 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.026 1.817 . . . . 0.0 112.333 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -83.25 -43.87 15.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.393 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 86.8 mt -61.62 -35.16 77.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.76 68.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.227 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 66.0 mtt -83.97 -23.97 30.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.11 0.481 . . . . 0.0 110.175 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.22 3.37 22.88 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.694 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.77 102.94 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.338 . . . . 0.0 110.341 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.23 99.46 1.57 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.103 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 92' ' ' LEU . 21.5 t -84.56 127.51 39.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.625 0.25 . . . . 0.0 110.546 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.92 136.63 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.996 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.12 123.46 35.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.054 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.455 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 38.6 ttm -142.52 160.09 40.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -174.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.62 145.4 54.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.481 HG23 HD22 ' A' ' 144' ' ' LEU . 8.8 m -52.33 -45.66 65.74 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.226 0.329 . . . . 0.0 111.711 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -60.13 -50.14 74.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.65 71.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.294 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.3 88.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.629 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.06 97.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.584 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 132' ' ' ILE . 21.0 ttt180 -58.93 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 28.1 m -62.2 -41.71 98.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.65 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 53.0 t80 -54.85 -51.6 65.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.103 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.46 -41.75 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.084 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 128' ' ' ARG . 80.1 mt -62.46 -54.6 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.62 -32.48 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.174 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.689 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 53.2 ttp -64.42 -43.32 94.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.36 175.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.45 -23.68 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.224 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 32.7 mt-10 -88.33 -3.41 58.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.006 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.7 44.17 82.21 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.228 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -117.65 157.31 26.65 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.633 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -73.16 100.39 3.06 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.114 0.483 . . . . 0.0 111.054 -173.58 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.418 HG23 HG13 ' A' ' 91' ' ' VAL . 7.4 p -131.69 135.24 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.738 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' A' ' 89' ' ' PRO . 66.6 t -128.6 142.15 44.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.0 p -129.6 136.94 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.661 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 113.94 22.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.253 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.481 HD22 HG23 ' A' ' 123' ' ' THR . 97.1 mt -100.52 127.89 46.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -172.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' A' ' 32' ' ' ALA . 18.0 mt -117.26 94.5 45.27 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.853 172.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 N--CA 1.455 -0.757 0 C-N-CA 123.272 2.648 . . . . 0.0 112.909 -177.725 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 CA--C 1.523 -0.09 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.459 HD22 ' HB2' ' A' ' 35' ' ' PHE . 3.3 m-20 63.74 23.79 13.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.216 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -61.75 139.7 58.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.204 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 22' ' ' ILE . 58.3 t -65.78 103.13 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -70.32 -34.45 72.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.907 -176.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -154.46 149.05 26.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.199 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -120.07 132.22 55.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.02 178.91 17.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.677 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.87 99.26 1.02 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.384 0.274 . . . . 0.0 111.281 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.95 15.65 72.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.314 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -157.55 152.14 25.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.186 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.642 HG12 HD13 ' A' ' 144' ' ' LEU . 3.1 mp -113.41 120.64 63.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 40.1 tt0 -97.33 110.83 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 0.0 110.687 -176.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.453 ' HA ' ' OG1' ' A' ' 15' ' ' THR . 57.5 t -119.99 119.76 61.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.529 176.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 63.42 42.5 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.591 0.557 . . . . 0.0 110.22 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 66.79 10.85 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.319 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.5 115.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -82.02 101.99 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.83 89.33 6.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.083 0.468 . . . . 0.0 110.598 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -86.58 52.16 2.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -168.28 156.85 8.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 44' ' ' TRP . . . -56.73 130.5 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.493 0.495 . . . . 0.0 111.262 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.94 136.1 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.298 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -121.03 114.66 21.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.883 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.49 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 34.7 p90 -138.9 152.78 48.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.115 0.483 . . . . 0.0 111.785 -174.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.54 154.62 71.6 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.135 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 -13.7 27.98 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.731 2.287 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -122.45 22.47 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.72 168.91 29.91 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.335 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.62 172.1 15.69 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.581 2.187 . . . . 0.0 112.07 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 46.2 t -87.62 95.97 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.62 109.25 7.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.344 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -85.69 131.27 34.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 27.6 m0 -98.31 145.77 30.41 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.642 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.4 Cg_exo -81.71 37.01 0.65 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 110.225 168.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.638 HG13 ' HB2' ' A' ' 51' ' ' ASP . 54.3 t -108.85 123.04 64.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -171.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -119.02 -9.84 9.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 137.77 28.02 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HB3' ' O ' ' A' ' 96' ' ' THR . 28.7 Cg_endo -65.3 -5.45 11.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.477 2.118 . . . . 0.0 112.143 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.31 4.5 53.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.469 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.638 ' HB2' HG13 ' A' ' 46' ' ' VAL . 60.5 m-20 -90.29 -11.24 41.39 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -62.98 105.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.046 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.443 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 67.4 p -111.17 166.13 11.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.34 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -62.88 -32.0 73.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.184 175.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -60.29 -47.97 83.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.604 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.58 -34.39 78.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.843 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HB3' HD11 ' A' ' 111' ' ' LEU . 98.7 mt -65.06 -38.79 91.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.817 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 94.9 mt-30 -65.56 -39.08 91.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 110.43 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -71.83 -39.32 69.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.97 -17.71 63.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.878 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.53 -7.33 56.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.813 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.56 3.15 78.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.163 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.025 0.441 . . . . 0.0 110.922 -178.893 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.54 ' HB3' ' CG2' ' A' ' 141' ' ' VAL . 6.7 Cg_endo -49.41 136.52 32.33 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 123.996 3.131 . . . . 0.0 113.736 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -77.75 -46.6 21.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.497 HG11 HD23 ' A' ' 133' ' ' LEU . 7.3 p -132.03 133.85 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.637 173.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.45 119.5 35.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.174 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.56 105.22 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.223 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.15 118.34 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -94.43 118.26 5.75 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -72.13 -5.21 33.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.238 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.23 -80.67 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.537 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.5 ttm-85 -55.54 -55.72 28.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 110.78 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 99' ' ' ARG . 10.0 ptt180 -172.22 152.44 2.81 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.648 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.579 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 44.4 tt0 -58.4 128.41 37.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.775 0.672 . . . . 0.0 112.375 -168.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.509 ' HB2' HG21 ' A' ' 96' ' ' THR . 32.6 m170 -127.62 148.13 50.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.627 175.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 tp -88.42 126.35 35.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.81 171.54 14.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.423 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.19 156.46 16.33 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.753 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.52 -32.48 88.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.222 2.615 . . . . 0.0 112.973 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 tt0 -81.96 -25.14 35.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 110.709 -177.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.54 -44.73 73.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 35.5 m -97.83 10.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.881 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 13.5 ttt180 -54.69 -53.88 55.4 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.503 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.5 Cg_exo -59.62 -35.24 95.73 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.031 1.821 . . . . 0.0 112.552 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.682 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.7 mt -75.15 -36.62 61.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.08 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 89.9 mt -57.96 -42.91 85.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.839 0.352 . . . . 0.0 110.476 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.52 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.425 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -81.19 -22.53 38.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 110.715 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.25 17.47 10.74 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 46.7 t -93.3 108.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.426 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.11 86.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.177 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.28 126.02 39.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.736 0.303 . . . . 0.0 111.299 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -127.93 145.75 50.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.028 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.5 128.36 55.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.231 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.525 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.4 mtm -147.03 -175.13 4.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.918 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.99 163.03 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.663 0.268 . . . . 0.0 110.633 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.523 HG23 HD22 ' A' ' 144' ' ' LEU . 5.6 m -56.77 -39.12 73.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.667 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.1 -53.32 59.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.095 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.33 76.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.153 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.18 95.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.325 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.78 81.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.233 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.409 ' O ' HG13 ' A' ' 132' ' ' ILE . 78.4 mtp180 -63.39 -45.31 91.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.8 m -65.8 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.85 -49.73 76.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.449 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -58.98 -41.0 86.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.982 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 128' ' ' ARG . 73.2 mt -63.09 -53.3 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.497 HD23 HG11 ' A' ' 91' ' ' VAL . 10.8 mp -69.16 -23.78 63.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.237 -177.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.4 ttp -66.82 -43.2 84.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 109.889 174.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.28 64.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.739 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.03 -16.52 63.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.782 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.52 37.84 62.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -115.62 151.96 33.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -80.05 84.39 5.79 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.984 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.73 130.43 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.415 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' A' ' 36' ' ' ALA . 22.9 t -115.29 129.43 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -115.95 138.4 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.925 0.393 . . . . 0.0 110.843 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.24 105.75 12.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.642 HD13 HG12 ' A' ' 22' ' ' ILE . 77.6 mt -100.43 132.82 45.6 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 32' ' ' ALA . 2.0 tt -119.17 86.95 33.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.228 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 N--CA 1.454 -0.853 0 C-N-CA 122.944 2.429 . . . . 0.0 111.439 172.292 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 35.9 t-20 -68.13 105.21 2.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.6 m -119.73 126.12 50.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.474 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.2 120.01 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 p -96.04 -23.36 16.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.738 0.304 . . . . 0.0 111.799 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -143.28 103.23 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.868 0.366 . . . . 0.0 111.309 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HD1' HG12 ' A' ' 22' ' ' ILE . 88.4 t80 -123.96 131.3 53.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.753 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.23 -4.72 33.5 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.29 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -91.34 17.34 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 0.0 110.916 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.01 -42.93 2.09 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 54.0 p90 -111.77 176.28 5.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.45 HG12 ' HD1' ' A' ' 17' ' ' TYR . 48.9 mt -119.49 113.29 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.96 0.409 . . . . 0.0 110.207 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 34.0 tt0 -89.35 118.8 29.28 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.8 t -105.03 104.18 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.161 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 65.69 -80.45 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.935 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -132.22 2.54 3.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.204 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.3 t -125.35 127.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 0.0 111.035 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 66.6 mtt85 -86.99 113.11 22.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 88.8 m-85 -99.24 148.84 23.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.873 0.368 . . . . 0.0 110.836 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -88.72 -67.66 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.067 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -115.7 -169.14 1.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.927 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 144' ' ' LEU . . . -36.24 128.29 0.74 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 43' ' ' SER . 18.5 pt -143.71 162.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.32 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -137.15 133.64 35.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.812 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.657 ' HB3' HG13 ' A' ' 41' ' ' VAL . 37.1 p90 -157.2 163.01 39.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.291 0.567 . . . . 0.0 112.244 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.95 161.89 58.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 73.5 Cg_exo -49.45 -55.04 4.52 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.132 2.555 . . . . 0.0 112.347 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -131.93 95.12 3.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.09 -153.54 17.15 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.937 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.1 134.69 13.21 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.758 2.305 . . . . 0.0 113.321 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.657 HG13 ' HB3' ' A' ' 35' ' ' PHE . 53.9 t -114.14 121.39 66.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.78 168.16 20.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.127 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.439 ' HA ' HG22 ' A' ' 33' ' ' ILE . 11.6 p -99.94 150.23 22.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.937 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.594 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -98.33 131.64 25.83 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.499 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.594 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 37.7 Cg_endo -67.01 -11.13 31.06 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.842 2.361 . . . . 0.0 112.592 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.454 ' CG2' HD13 ' A' ' 56' ' ' LEU . 10.9 t -86.1 146.1 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.94 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -129.11 -1.44 5.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HD2' ' OD2' ' A' ' 51' ' ' ASP . 50.9 mtt85 -134.67 137.17 26.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.46 -7.02 19.08 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.954 2.436 . . . . 0.0 112.377 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.44 -13.94 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.376 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' OD2' ' HD2' ' A' ' 48' ' ' ARG . 27.4 m-20 -96.23 3.88 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.164 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.51 122.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.875 0.369 . . . . 0.0 111.257 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.1 p -121.57 176.3 5.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.373 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -64.29 -37.61 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 0.0 110.199 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -48.41 78.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.506 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD13 ' CG2' ' A' ' 46' ' ' VAL . 44.0 mt -70.63 -30.44 67.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.952 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.505 ' HB3' HD11 ' A' ' 111' ' ' LEU . 81.0 mt -67.23 -39.1 86.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.454 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.7 mt-30 -58.18 -39.9 80.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.076 0.465 . . . . 0.0 110.214 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -68.41 -42.58 78.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.645 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.68 -13.15 62.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.88 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.1 -13.2 62.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.105 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.99 88.32 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.634 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.47 . . . . 0.0 110.809 -178.797 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 18.1 Cg_exo -66.42 155.73 68.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.947 2.431 . . . . 0.0 112.15 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.34 -44.9 13.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.0 0.429 . . . . 0.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 140' ' ' VAL . 4.9 p -133.02 133.91 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.399 0.618 . . . . 0.0 111.245 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -111.79 110.7 21.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.337 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 119' ' ' GLU . 97.2 mt -90.35 113.12 24.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.58 118.45 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -92.9 101.49 2.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 p -76.33 56.68 1.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 145' ' ' LEU . . . 76.35 -103.38 1.71 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.614 171.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.59 -35.49 11.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.238 . . . . 0.0 111.262 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -142.55 159.71 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.653 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.737 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.7 tt0 -62.79 111.19 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.792 175.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -113.73 116.18 29.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.039 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 143.01 57.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.068 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.27 -164.92 1.16 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.03 147.44 16.24 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.763 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.57 -42.42 65.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.063 2.509 . . . . 0.0 112.658 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.914 0.388 . . . . 0.0 111.697 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.59 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 98.7 mt-30 -96.24 -39.98 9.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 109.858 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.82 -24.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.801 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.53 ' HA ' HD12 ' A' ' 112' ' ' LEU . 7.8 ttp180 -63.4 -38.29 38.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.84 -43.41 23.93 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.803 1.668 . . . . 0.0 112.264 170.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.733 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.4 mt -75.5 -36.21 60.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 109' ' ' ARG . 96.3 mt -61.08 -31.24 70.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.73 -22.49 63.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -87.9 -30.62 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 122.47 9.07 6.67 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.155 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.733 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 17.1 t -98.89 110.13 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 111.023 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.28 122.91 6.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.606 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.28 125.23 46.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.937 0.399 . . . . 0.0 111.491 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' HB2' HD23 ' A' ' 93' ' ' LEU . 51.8 mm-40 -110.01 103.24 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.682 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.43 109.8 21.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.614 0.245 . . . . 0.0 110.355 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.737 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 63.2 mtm -141.97 -177.24 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 -176.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.63 147.61 36.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.973 172.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.501 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 61.8 m -55.86 -44.46 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.691 0.281 . . . . 0.0 111.323 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -64.0 -44.01 93.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.568 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.07 99.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.003 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.02 79.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.98 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.6 94.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.97 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -61.11 -50.08 74.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.041 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.607 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.548 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 73.2 t80 -61.55 -46.74 88.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.691 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -56.0 -44.55 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.462 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.418 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 62.3 mt -69.29 -54.27 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.237 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.5 HD12 ' HB ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -57.11 -40.31 76.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -175.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 46.7 ttp -58.95 -36.67 75.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.68 -13.11 54.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 27.1 mm-40 -88.5 -35.44 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 170.42 98.92 0.12 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.06 85.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.409 0.684 . . . . 0.0 112.84 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -144.45 33.79 1.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.5 ' HB ' HD12 ' A' ' 133' ' ' LEU . 7.2 p -127.45 140.42 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.567 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.0 t -124.74 143.84 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 9.9 p -120.63 140.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.305 -176.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -129.72 109.23 10.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.315 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 84.2 mt -116.58 138.9 51.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.78 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.549 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 5.0 mp -108.76 94.34 14.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 O-C-N 123.239 0.337 . . . . 0.0 110.171 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_endo . . . . . 0 N--CA 1.458 -0.575 0 C-N-CA 123.281 2.654 . . . . 0.0 111.566 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.235 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -76.69 94.69 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 m -109.44 137.76 46.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.658 -171.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.11 127.35 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 p -105.77 -56.33 2.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.657 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -114.89 135.57 54.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.1 0.476 . . . . 0.0 110.877 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.11 167.38 10.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.649 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.07 -172.43 35.05 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.75 -63.51 1.19 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.134 0.492 . . . . 0.0 110.763 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.12 -5.43 65.83 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.907 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 13.0 p90 -139.9 148.72 42.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.858 0.361 . . . . 0.0 110.045 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.66 120.41 58.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 32.5 tt0 -96.37 114.1 25.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.317 0.58 . . . . 0.0 110.566 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.34 125.23 59.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.679 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.04 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -141.54 16.04 2.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.606 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.58 129.73 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.369 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.3 mtp-105 -88.23 114.84 25.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.074 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.17 100.47 9.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.78 0.324 . . . . 0.0 111.123 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 36.2 m -83.81 36.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.439 0.637 . . . . 0.0 109.818 173.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.513 ' HB2' HG23 ' A' ' 33' ' ' ILE . 8.1 m170 -120.22 169.81 9.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.2 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 44' ' ' TRP . . . -85.33 105.26 15.86 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 164.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 31' ' ' HIS . 19.4 pt -112.24 132.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.419 0.628 . . . . 0.0 112.625 -169.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -113.6 121.63 44.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.429 174.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -147.88 155.79 41.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.273 0.559 . . . . 0.0 111.773 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -129.23 159.88 66.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.628 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 23.0 Cg_endo -62.71 -25.68 75.08 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.447 2.098 . . . . 0.0 111.628 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -125.63 108.23 11.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.561 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.05 -170.3 23.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.323 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.93 -177.29 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.38 121.86 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.976 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.7 119.46 38.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.962 0.41 . . . . 0.0 110.789 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -94.06 131.8 39.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.345 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 3.9 m0 -98.28 137.1 20.74 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.037 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.53 0.05 9.91 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.017 2.478 . . . . 0.0 111.374 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 56' ' ' LEU . 29.7 t -85.88 113.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.486 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -111.79 7.77 20.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 0.0 110.794 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 54.0 ttp180 -127.02 115.44 21.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 26.8 Cg_exo -63.44 -10.81 22.99 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.4 2.733 . . . . 0.0 113.883 -173.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.37 -2.0 58.35 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.269 -0.269 . . . . 0.0 111.38 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' A' ' 48' ' ' ARG . 42.5 m-20 -98.16 -2.83 39.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.89 118.55 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.206 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 54' ' ' ALA . 1.7 m -129.4 169.16 15.27 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -49.71 -54.33 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -173.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.7 -33.52 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.436 HD13 HG21 ' A' ' 46' ' ' VAL . 98.3 mt -65.23 -44.54 87.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.498 . . . . 0.0 110.224 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.99 -37.25 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.664 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.522 ' HA ' HD21 ' A' ' 111' ' ' LEU . 48.2 tt0 -62.09 -37.52 85.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.701 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -71.61 -41.3 69.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.58 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.11 -4.94 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.875 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 89' ' ' PRO . . . -75.09 -4.42 38.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.531 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.42 35.52 52.01 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.096 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 110.661 -179.351 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 121.404 0.621 . . . . 0.0 112.625 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 3.5 Cg_exo -77.45 165.86 26.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.695 2.264 . . . . 0.0 111.271 170.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.734 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.2 mt-10 -94.8 -38.01 10.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.769 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.503 HG13 HG23 ' A' ' 140' ' ' VAL . 6.0 p -144.08 137.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 111.179 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.6 tp -113.26 115.39 28.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.702 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.05 116.16 28.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.578 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.51 121.64 52.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.261 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.38 89.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.044 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -101.59 36.91 1.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.227 0.537 . . . . 0.0 109.832 -179.065 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.577 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -79.78 63.3 4.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.009 -170.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -161.11 -52.62 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.54 90.3 2.4 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -71.24 93.12 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.7 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -76.09 107.46 8.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.207 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.64 126.04 26.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.16 165.7 15.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.68 157.91 15.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.93 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.94 -33.72 97.46 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.04 2.493 . . . . 0.0 112.594 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.79 -20.5 62.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.952 0.406 . . . . 0.0 111.005 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.556 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 87.9 mt-30 -88.02 -35.11 17.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.448 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 30.2 m -92.48 -21.03 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.741 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.548 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 7.5 tmm_? -59.07 -48.55 96.38 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 8.5 Cg_endo -51.14 -43.42 48.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.323 2.015 . . . . 0.0 112.626 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 58' ' ' GLN . 91.8 mt -75.04 -37.03 61.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.9 mt -66.02 -34.71 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.0 -31.22 72.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.213 0.53 . . . . 0.0 110.363 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -75.39 -38.28 60.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.79 -12.25 5.91 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.934 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.08 109.66 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.753 0.311 . . . . 0.0 110.871 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.34 115.98 4.79 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.003 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.55 123.53 43.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.621 0.248 . . . . 0.0 110.812 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -129.39 120.2 25.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.12 122.8 44.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.494 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 70.0 mtm -139.9 -171.82 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.36 150.04 49.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.715 0.293 . . . . 0.0 110.218 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.577 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 8.2 m -56.36 -42.53 77.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.337 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 52.3 tt0 -72.82 -35.98 67.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.18 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.34 -36.46 82.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.126 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.23 95.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.142 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.568 ' O ' HG12 ' A' ' 132' ' ' ILE . 69.5 mtm180 -64.59 -55.85 17.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.412 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -59.71 -32.95 70.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.261 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.44 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 81.7 t80 -59.03 -54.27 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -61.3 -34.22 74.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.472 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 128' ' ' ARG . 45.0 mm -59.76 -55.31 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.551 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 72.0 mt -71.89 -31.05 66.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.3 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 ttp -62.12 -49.97 73.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 110.48 178.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.18 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.736 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.42 -16.63 61.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.516 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.46 31.53 24.59 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 138' ' ' ARG . 27.7 ttt180 -106.05 147.4 28.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.012 -175.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.734 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 68.9 mtm180 -81.41 88.81 6.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.274 0.559 . . . . 0.0 110.6 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.503 HG23 HG13 ' A' ' 91' ' ' VAL . 7.4 p -120.19 138.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.958 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 36' ' ' ALA . 40.1 t -121.06 140.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -124.21 138.9 52.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.008 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.84 103.98 9.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.408 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.8 mt -100.63 122.59 43.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.879 0.371 . . . . 0.0 111.165 -173.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.08 109.02 54.89 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.461 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 C--N 1.342 0.221 0 C-N-CA 123.311 2.674 . . . . 0.0 110.904 174.152 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mmm . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.679 0.276 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -91.84 116.33 28.81 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.0 mt -73.01 117.74 15.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.988 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -76.43 124.95 28.35 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.4 m -91.34 104.39 16.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 20.1 m-20 -88.17 107.54 16.87 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.841 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 1.5 Cg_endo -82.48 120.7 3.25 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.091 2.527 . . . . 0.0 112.66 -174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.643 ' HB3' HD23 ' A' ' 11' ' ' LEU . . . -95.26 122.94 38.48 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -2.46 17.32 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.83 -14.78 57.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.194 0.521 . . . . 0.0 110.422 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.643 HD23 ' HB3' ' A' ' 8' ' ' ALA . 3.9 mm? -88.84 84.82 6.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -70.06 104.08 2.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.357 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.4 m -126.14 151.71 46.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.231 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.01 122.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.183 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.2 p -89.54 -20.3 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.315 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -161.44 140.59 10.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.657 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.43 -79.82 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.5 162.68 38.53 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.839 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -107.99 111.25 23.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.857 0.36 . . . . 0.0 110.674 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.693 ' HA2' ' HB2' ' A' ' 149' ' ' ASP . . . 98.2 4.32 57.53 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.238 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -162.14 172.41 15.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.73 124.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 28.9 tt0 -94.53 109.5 21.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.002 0.43 . . . . 0.0 111.169 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -117.05 124.01 72.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.3 t30 62.85 29.55 16.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.604 0.716 . . . . 0.0 109.506 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HA ' ' CG ' ' A' ' 23' ' ' GLU . 34.8 mt-30 65.64 13.98 9.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.723 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.2 110.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 92.1 mtt180 -86.41 96.8 10.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.993 -174.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.78 115.43 22.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.489 ' OG ' ' HG ' ' A' ' 151' ' ' LEU . 2.7 p -90.47 28.71 1.41 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.261 0.553 . . . . 0.0 111.064 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -154.1 171.39 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.785 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.23 138.05 58.24 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.286 0.366 . . . . 0.0 111.2 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.19 147.69 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -123.1 116.52 23.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 175.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -135.83 157.82 45.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.957 0.408 . . . . 0.0 111.057 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.5 160.16 62.73 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 11.2 Cg_endo -56.65 -57.04 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.456 2.104 . . . . 0.0 110.492 172.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.79 103.11 12.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.35 178.73 32.65 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.902 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -88.61 176.02 3.6 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 112.919 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.14 104.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.344 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . . . -85.99 126.62 34.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.559 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -91.26 118.62 30.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.794 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.406 ' CZ2' ' HB2' ' A' ' 60' ' ' ALA . 1.3 m0 -98.32 130.23 28.78 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.42 23.48 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.937 2.425 . . . . 0.0 111.178 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 51' ' ' ASP . 73.2 t -85.71 136.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.771 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -117.85 -24.26 7.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.068 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HG2' ' OD2' ' A' ' 51' ' ' ASP . 8.0 ptt180 -139.03 155.66 72.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.02 -176.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 1.88 2.41 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.538 2.159 . . . . 0.0 112.897 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.73 -14.74 24.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.33 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.594 ' HB2' HG13 ' A' ' 46' ' ' VAL . 65.1 m-20 -77.32 -19.34 56.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.12 117.53 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.006 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.441 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 30.7 p -121.57 175.45 6.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.852 175.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.9 71.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -62.31 -45.39 93.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.133 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.53 -30.71 68.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.003 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 53' ' ' THR . 90.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.356 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -65.27 -38.3 89.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -68.46 -42.58 78.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.376 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.406 ' HB2' ' CZ2' ' A' ' 44' ' ' TRP . . . -65.38 -26.39 67.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.562 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.401 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -73.74 -12.88 60.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.022 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.57 28.41 73.17 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.603 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 61' ' ' ALA . 91.4 mt -70.99 -75.83 0.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.495 0.188 . . . . 0.0 111.268 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 53.35 69.2 0.73 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.935 -176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.03 -43.19 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.866 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 p -90.38 115.09 29.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.648 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.13 125.23 42.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.718 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -65.2 -40.08 93.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.038 0.447 . . . . 0.0 110.068 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 70' ' ' PRO . 37.8 m-20 -122.57 94.25 47.8 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.932 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 69' ' ' ASP . 21.1 Cg_endo -61.32 121.53 9.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.734 2.289 . . . . 0.0 112.435 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.6 mt -81.49 -42.3 20.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.458 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.35 96.58 5.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.413 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -77.74 118.12 19.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.201 0.524 . . . . 0.0 110.997 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.97 128.44 36.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.584 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -82.17 -0.4 44.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.286 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.77 82.12 0.22 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.43 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -88.45 3.6 5.86 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.823 2.348 . . . . 0.0 111.591 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.74 ' HG2' ' H ' ' A' ' 80' ' ' GLY . 24.0 tt0 -141.77 156.89 45.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.55 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.402 ' N ' ' HG2' ' A' ' 78' ' ' GLU . . . -136.15 19.76 3.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.097 0.475 . . . . 0.0 110.241 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.74 ' H ' ' HG2' ' A' ' 78' ' ' GLU . . . -81.69 -75.77 1.1 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.631 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.84 164.72 37.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.013 0.435 . . . . 0.0 111.154 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.52 153.76 16.7 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.27 121.19 41.43 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -81.01 155.6 72.56 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.773 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.57 -48.91 14.39 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.588 2.859 . . . . 0.0 114.3 -172.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.87 1.18 2.17 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.396 0.617 . . . . 0.0 110.849 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -100.56 13.49 34.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.562 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.24 158.53 87.31 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.144 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HB3' HG23 ' A' ' 141' ' ' VAL . 9.1 Cg_endo -51.29 111.7 0.63 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.841 2.361 . . . . 0.0 111.985 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 3.9 tt0 -69.5 -32.47 71.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.696 HG11 HD13 ' A' ' 133' ' ' LEU . 3.3 p -136.01 131.31 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.456 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -112.96 121.19 43.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.866 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.5 mt -101.2 104.55 15.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.284 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.865 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -105.69 114.31 4.5 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.491 HG21 ' H ' ' A' ' 101' ' ' HIS . 1.2 p -76.11 -20.97 57.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 -58.4 4.79 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.402 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -81.17 -55.31 4.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.744 0.307 . . . . 0.0 110.565 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -159.89 143.45 14.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -52.66 114.61 1.45 Allowed 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.118 0.886 . . . . 0.0 112.113 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.491 ' H ' HG21 ' A' ' 96' ' ' THR . 11.7 t-160 -96.85 111.85 23.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.21 98.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.814 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.07 134.26 40.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -106.04 175.27 21.26 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.735 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 74.3 Cg_exo -49.63 -34.61 35.25 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.351 2.7 . . . . 0.0 112.542 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -49.47 -43.66 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.283 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -96.01 -37.9 10.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.185 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 104' ' ' GLY . 35.0 m -91.42 -14.36 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -171.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 1.1 tmt_? -57.33 -44.7 99.78 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -47.45 -32.08 14.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.3 2.0 . . . . 0.0 113.188 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 93.7 mt -92.33 -36.24 13.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.679 0.276 . . . . 0.0 110.785 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 87.2 mt -58.49 -36.7 74.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.02 68.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.16 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.87 -12.18 45.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.65 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.14 14.69 38.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.029 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.1 t -86.99 107.82 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 0.0 110.659 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.77 111.33 3.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.605 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.12 124.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 111.487 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -102.86 129.11 49.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.193 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.01 102.5 13.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 0.0 110.495 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.538 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.8 mtm -140.43 -171.77 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -105.42 172.13 6.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.594 HG23 HD22 ' A' ' 144' ' ' LEU . 88.5 m -52.29 -48.52 65.3 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.586 0.554 . . . . 0.0 112.345 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -62.37 -50.01 73.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.99 85.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.711 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.91 75.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.41 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 132' ' ' ILE . 47.0 mtt180 -59.82 -48.07 83.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.835 0.35 . . . . 0.0 111.117 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -66.25 -36.73 83.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -60.45 -45.39 93.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.528 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -58.56 -40.32 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.4 mt -62.11 -54.63 31.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.723 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.696 HD13 HG11 ' A' ' 91' ' ' VAL . 74.3 mt -66.95 -32.28 73.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.365 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.476 ' HG2' HD13 ' A' ' 11' ' ' LEU . 54.2 ttp -72.74 -36.88 67.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.36 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.48 80.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.073 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.51 -36.97 74.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.32 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.04 41.79 5.79 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.482 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -111.77 153.62 26.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 90' ' ' GLU . 19.9 mmt180 -63.52 97.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 111.307 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.66 136.25 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.305 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 89' ' ' PRO . 37.5 t -123.83 133.51 69.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.4 p -116.43 130.53 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.254 0.55 . . . . 0.0 111.068 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.16 112.41 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.594 HD22 HG23 ' A' ' 123' ' ' THR . 77.2 mt -103.31 139.55 38.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.547 HD23 ' HD2' ' A' ' 146' ' ' PRO . 2.2 tt -122.86 132.41 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.547 ' HD2' HD23 ' A' ' 145' ' ' LEU . 56.0 Cg_exo -53.25 134.61 57.39 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.479 . . . . 0.0 112.216 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -93.91 14.26 20.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.08 -38.61 0.21 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.153 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.693 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 24.9 m-20 -110.68 176.36 5.07 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.628 -175.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 76.1 p -174.09 -171.19 0.6 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.847 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 151' ' ' LEU . 4.4 mp -60.55 -33.16 72.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.895 0.379 . . . . 0.0 110.77 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -59.79 -36.86 77.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.004 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -74.73 -10.49 59.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -75.91 -22.66 55.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.848 0.356 . . . . 0.0 110.336 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -101.51 173.81 6.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -122.72 0.93 9.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.309 0.576 . . . . 0.0 109.725 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -136.48 -172.63 3.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.397 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 53.2 m80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.569 178.082 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mmm . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -100.47 -57.66 2.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.844 0.354 . . . . 0.0 111.598 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.1 mt -81.08 67.9 7.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.476 0.655 . . . . 0.0 111.497 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -144.75 11.35 1.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.569 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -146.52 -178.99 6.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.968 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.82 144.44 52.9 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -54.53 -22.21 27.07 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.76 2.307 . . . . 0.0 112.653 174.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 73.87 -61.53 0.49 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.681 0.792 . . . . 0.0 111.788 176.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -74.04 104.35 4.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.713 0.292 . . . . 0.0 110.95 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . -77.39 130.42 37.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.51 -42.71 61.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.701 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 61.62 87.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.417 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.3 m -107.32 118.79 37.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.088 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -69.16 100.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.701 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.44 -25.32 42.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.507 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -155.88 149.67 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.741 176.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -87.0 -15.14 39.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.54 -161.87 48.13 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.294 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.05 87.03 2.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.29 60.89 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.673 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.53 148.36 17.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.8 mt -97.08 138.75 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.2 tm-20 -110.22 109.7 20.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 109.932 -175.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.67 111.22 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 m120 53.39 52.64 13.06 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.722 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 73.3 -0.02 3.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.172 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.14 122.64 64.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 53.7 mtm180 -97.0 111.26 23.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.498 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -93.53 117.75 30.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 m -88.35 -7.64 56.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.177 0.513 . . . . 0.0 110.008 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -116.07 161.62 18.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.181 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 145.5 55.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 110.733 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.03 147.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.919 0.39 . . . . 0.0 111.671 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -129.08 112.5 14.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.682 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.524 ' HB3' HG13 ' A' ' 41' ' ' VAL . 32.5 p90 -139.4 162.27 35.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.994 0.426 . . . . 0.0 111.813 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.36 156.56 71.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.136 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.587 ' HD3' ' HE1' ' A' ' 130' ' ' TYR . 6.2 Cg_exo -78.66 9.56 3.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.121 2.547 . . . . 0.0 112.068 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -152.32 21.31 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.781 0.8 . . . . 0.0 108.997 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.14 -169.69 12.6 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.915 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -86.75 176.56 4.58 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.787 2.325 . . . . 0.0 112.612 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG13 ' HB3' ' A' ' 35' ' ' PHE . 34.2 t -112.58 104.5 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.649 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.85 152.36 21.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.701 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 m -108.87 132.69 53.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.533 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -113.05 126.65 27.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.534 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 2.0 Cg_endo -83.37 9.74 3.97 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.218 2.612 . . . . 0.0 111.302 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 51' ' ' ASP . 41.5 t -86.8 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.508 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -120.98 -33.75 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.815 0.34 . . . . 0.0 111.383 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' A' ' 51' ' ' ASP . 69.6 mtp85 -108.03 147.66 35.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.973 0.416 . . . . 0.0 110.818 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HG3' ' O ' ' A' ' 96' ' ' THR . 12.7 Cg_exo -70.21 -6.01 17.82 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.047 2.498 . . . . 0.0 112.212 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.75 -19.68 24.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.321 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.591 ' HB2' HG13 ' A' ' 46' ' ' VAL . 30.1 m-20 -82.91 -20.21 35.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.13 116.94 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.825 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 31.1 p -113.48 169.51 8.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.371 175.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -60.27 -34.62 73.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m -59.1 -46.87 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.504 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 46' ' ' VAL . 97.9 mt -66.93 -33.78 76.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.627 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 53' ' ' THR . 96.9 mt -64.22 -40.9 97.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.8 mt-30 -62.95 -33.77 76.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.06 -43.74 56.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.32 66.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.746 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -21.98 66.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.86 94.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.331 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.8 25.06 0.69 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 111.309 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.16 123.24 13.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.78 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.07 106.61 17.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.323 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.66 100.54 6.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.564 HG22 ' H ' ' A' ' 69' ' ' ASP . 11.5 p -120.43 159.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.256 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.6 mtm-85 -89.54 -6.43 56.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.931 0.396 . . . . 0.0 110.743 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.564 ' H ' HG22 ' A' ' 67' ' ' VAL . 35.4 t70 -121.48 101.09 43.89 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.914 0.388 . . . . 0.0 110.711 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -89.25 5.83 4.73 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.773 2.315 . . . . 0.0 112.208 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.1 mt -89.6 -42.66 11.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 46.55 72.92 0.2 Allowed 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.859 0.724 . . . . 0.0 111.93 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.22 -27.07 62.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.144 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.47 -12.96 60.02 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.883 0.373 . . . . 0.0 110.947 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.45 125.8 46.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.12 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -75.26 136.26 72.41 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.8 86.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.634 2.889 . . . . 0.0 114.193 -172.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.72 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 4.9 mm-40 -140.52 91.4 2.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.033 175.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.63 96.44 8.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.78 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.31 -55.88 5.04 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.484 173.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.49 -17.98 62.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.654 0.264 . . . . 0.0 111.68 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.72 ' HA3' ' HB3' ' A' ' 78' ' ' GLU . . . -89.8 39.17 3.13 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.45 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.76 171.53 20.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -120.56 157.55 53.82 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.285 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.41 12.06 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.707 2.271 . . . . 0.0 112.79 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.81 -17.87 59.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.075 0.464 . . . . 0.0 110.204 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -87.17 2.29 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.473 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.73 159.75 31.79 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.415 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.488 ' O ' HG22 ' A' ' 116' ' ' VAL . 53.9 Cg_exo -53.44 139.04 65.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.473 2.115 . . . . 0.0 112.06 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' OE1' ' HG3' ' A' ' 138' ' ' ARG . 37.3 tt0 -88.22 -36.89 16.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.036 0.446 . . . . 0.0 110.134 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.73 138.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.237 0.541 . . . . 0.0 111.258 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -114.92 118.77 34.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.661 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.07 119.46 39.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.202 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.58 121.74 59.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.838 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -96.81 106.31 3.33 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.544 ' HA ' HD12 ' A' ' 145' ' ' LEU . 12.6 p -83.5 13.35 4.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -171.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.09 -102.4 1.15 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.213 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 72.3 mtt-85 -62.99 -45.73 91.03 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -142.49 140.23 31.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.844 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.9 tt0 -66.17 96.73 0.35 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.144 0.497 . . . . 0.0 110.241 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -99.42 99.65 10.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.743 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.5 mt -60.57 137.83 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.05 -178.69 5.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.474 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 147.79 16.32 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.872 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.665 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 11.4 Cg_endo -55.17 -40.77 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.852 2.368 . . . . 0.0 112.113 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.17 -27.79 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.182 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -74.82 -37.51 62.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.986 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 34.5 m -92.13 -7.68 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 42.7 mtm180 -53.95 -49.18 91.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 66.6 Cg_exo -53.7 -39.36 83.75 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.103 1.869 . . . . 0.0 112.704 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 94.0 mt -78.13 -39.1 42.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.62 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 85.5 mt -62.39 -32.63 73.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.642 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.15 78.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.747 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 60.3 mtt -77.83 -38.86 45.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.041 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.09 3.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 31.0 t -90.43 115.8 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.53 0.205 . . . . 0.0 110.539 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.03 132.26 10.96 Favored Glycine 0 C--O 1.224 -0.531 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.02 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.63 123.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 117.318 0.559 . . . . 0.0 111.115 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.69 131.75 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.501 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.15 128.68 51.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.844 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 71.7 mtm -144.96 -171.82 3.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.3 156.25 34.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.451 HG23 HD22 ' A' ' 144' ' ' LEU . 40.4 m -57.91 -43.75 86.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.916 0.389 . . . . 0.0 110.927 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.51 -40.65 80.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.71 89.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 110.966 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.4 -47.36 76.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.51 96.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' HG13 ' A' ' 132' ' ' ILE . 42.4 ttm180 -63.4 -50.15 70.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.69 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -63.32 -35.85 81.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.432 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.587 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 50.9 t80 -57.73 -44.99 86.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.761 175.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -64.14 -39.26 93.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.2 mt -64.18 -50.23 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.747 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.401 ' HB2' HG11 ' A' ' 140' ' ' VAL . 91.8 mt -67.85 -26.04 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.799 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 36.8 ttm -61.88 -50.42 72.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.068 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.491 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.88 -44.37 97.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.59 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 105.42 33.33 3.67 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.061 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.428 ' HG3' ' OE1' ' A' ' 90' ' ' GLU . 17.0 ttm180 -100.05 144.98 28.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -70.46 79.62 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.987 0.422 . . . . 0.0 110.879 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 133' ' ' LEU . 5.9 p -106.31 128.54 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.924 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 36' ' ' ALA . 25.9 t -113.11 131.57 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.8 p -115.67 131.64 67.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.57 111.34 22.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.395 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 123' ' ' THR . 98.9 mt -107.05 120.83 43.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.738 0.304 . . . . 0.0 111.672 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 96' ' ' THR . 94.8 mt -93.93 126.0 50.84 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.699 172.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 118.73 5.63 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.611 2.208 . . . . 0.0 112.426 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.8 115.31 6.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.751 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.11 -44.77 0.22 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.627 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 68.47 -176.37 0.2 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.054 0.542 . . . . 0.0 110.248 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.3 m -159.46 -24.64 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 122.876 0.47 . . . . 0.0 109.78 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.5 tp -86.71 -40.38 15.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.242 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -107.48 114.09 27.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.638 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -112.23 165.67 11.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -70.28 -49.26 51.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -82.45 134.83 35.23 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -95.69 -16.9 21.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.017 0.437 . . . . 0.0 110.797 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -120.7 -90.31 0.58 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.7 m80 . . . . . 0 C--O 1.246 0.879 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.612 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -66.48 -46.17 77.23 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.4 tp -79.09 125.35 29.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -57.0 -53.31 59.5 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.185 0.303 . . . . 0.0 111.594 -171.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.582 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 24.2 m -87.54 116.83 25.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.785 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.44 101.36 1.29 Allowed Pre-proline 0 C--O 1.234 0.268 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 5' ' ' THR . 83.7 Cg_endo -95.9 157.19 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.234 2.623 . . . . 0.0 113.006 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.83 103.9 15.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.608 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -11.39 60.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.754 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.38 -12.15 60.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 0.0 110.858 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.9 mt -104.9 93.54 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.94 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 34.8 t30 -74.6 125.6 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.018 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -154.48 142.77 20.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.831 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.98 112.5 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.231 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 p -74.23 -32.8 63.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.296 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -131.19 92.13 3.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.761 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' HE2' ' HG2' ' A' ' 124' ' ' GLN . 71.0 t80 -104.61 -3.22 24.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.377 0.608 . . . . 0.0 109.904 175.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.32 -23.71 70.24 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.927 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.98 -175.58 4.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 111.152 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.48 14.69 60.57 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.523 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.483 ' HB3' HD23 ' A' ' 151' ' ' LEU . 27.4 p90 -148.97 173.35 13.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.75 108.19 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 0.0 111.091 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 45.7 tt0 -93.5 112.5 24.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.133 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.4 95.92 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.887 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 64.63 -77.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.757 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -119.09 -28.11 5.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.074 -176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.39 127.7 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -173.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 23.3 mtm180 -98.52 109.68 22.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.277 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -91.2 131.71 36.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -101.9 14.51 31.75 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.561 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -148.98 179.06 8.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.821 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.81 139.9 58.36 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.551 0.532 . . . . 0.0 111.25 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 pt -145.1 156.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.305 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.56 130.6 50.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.251 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.577 ' HB3' HG13 ' A' ' 41' ' ' VAL . 36.5 p90 -150.43 154.86 38.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.367 0.603 . . . . 0.0 112.06 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -119.17 164.56 20.68 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.531 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 26.4 Cg_exo -63.32 -42.37 22.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.413 2.075 . . . . 0.0 111.607 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.75 101.55 7.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.23 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.78 -157.55 27.67 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.297 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -93.39 163.81 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.285 2.656 . . . . 0.0 113.197 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -114.15 116.67 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.46 145.92 41.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.341 . . . . 0.0 111.419 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -79.07 128.73 33.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.606 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 60' ' ' ALA . 1.7 t90 -98.32 116.97 65.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 12.8 Cg_exo -71.56 33.93 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.503 2.802 . . . . 0.0 112.888 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 51' ' ' ASP . 94.2 t -114.68 125.44 72.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.534 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.12 -49.42 4.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.176 0.512 . . . . 0.0 110.894 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -107.88 150.91 40.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 14.7 Cg_endo -59.63 -19.78 54.68 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.336 2.024 . . . . 0.0 111.796 174.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.26 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.296 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.62 ' HB2' HG13 ' A' ' 46' ' ' VAL . 11.8 m-20 -68.73 -28.4 66.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.805 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -54.44 115.06 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.608 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -121.95 159.77 26.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.874 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -52.84 -44.32 66.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -63.16 -35.8 81.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.226 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.458 HD13 HG22 ' A' ' 46' ' ' VAL . 49.9 mt -69.57 -31.83 70.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.36 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.79 -35.46 80.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.182 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.342 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -70.66 -39.37 73.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.452 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' A' ' 44' ' ' TRP . . . -69.68 -23.85 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.853 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -81.43 -7.36 59.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.957 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.55 37.83 85.67 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.388 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.02 13.43 4.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 111.527 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.8 82.27 5.21 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -81.53 143.55 31.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.199 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 21.8 t -138.43 166.37 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' N ' HG12 ' A' ' 66' ' ' VAL . 48.8 t -58.67 -24.45 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 110.051 172.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 66' ' ' VAL . 96.3 mtt180 72.75 -68.86 0.21 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.415 176.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.707 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 12.6 t70 -168.52 -57.65 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.668 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' A' ' 69' ' ' ASP . 93.1 Cg_endo -90.37 142.0 3.5 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.894 1.729 . . . . 0.0 112.262 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.63 -19.88 61.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.232 0.539 . . . . 0.0 109.888 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.29 109.5 20.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.956 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -75.91 135.26 40.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.239 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.4 -42.72 5.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.24 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.59 -62.34 1.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.238 0.336 . . . . 0.0 110.153 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -81.98 108.92 12.76 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.53 -46.3 4.04 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.696 2.264 . . . . 0.0 112.82 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.74 166.96 23.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.385 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.18 -1.88 28.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.274 0.559 . . . . 0.0 109.753 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.77 -139.62 27.69 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.458 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.96 21.94 10.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.997 0.427 . . . . 0.0 110.755 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.97 -153.39 5.91 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.911 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.5 11.1 12.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.016 0.436 . . . . 0.0 110.557 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.5 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 8.8 ptp180 -124.26 123.61 25.93 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.791 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 2.7 Cg_endo -86.47 -157.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.469 2.779 . . . . 0.0 111.642 176.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.01 20.18 17.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.36 0.6 . . . . 0.0 110.104 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -69.08 -15.22 63.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.994 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -74.55 133.95 76.57 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.173 175.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.416 ' HG2' ' HB1' ' A' ' 61' ' ' ALA . 50.2 Cg_exo -56.4 127.8 27.46 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.884 2.39 . . . . 0.0 112.686 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -64.24 -46.87 81.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.448 0.642 . . . . 0.0 109.528 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.79 132.07 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.876 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.519 ' HB3' HG22 ' A' ' 118' ' ' VAL . 57.3 tp -114.26 117.38 30.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.96 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.1 mt -101.51 117.03 34.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.336 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.2 t -104.05 110.32 29.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.444 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.08 96.84 2.17 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 33.4 p -80.87 -13.63 58.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.776 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.69 -101.52 1.42 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.751 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -62.85 -58.49 7.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.345 . . . . 0.0 111.336 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.4 mmt-85 -109.2 122.33 47.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.992 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.599 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 53.3 tt0 -74.51 97.19 3.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.471 ' HB3' HG21 ' A' ' 96' ' ' THR . 40.1 t-80 -73.6 104.82 4.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.862 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.63 142.26 53.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.442 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -93.16 160.22 14.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.852 0.358 . . . . 0.0 110.617 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.79 162.36 14.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.625 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.27 -49.52 16.06 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.74 2.293 . . . . 0.0 112.253 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -62.48 -25.79 68.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.568 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 93.7 mt-30 -76.78 -34.35 57.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.775 0.322 . . . . 0.0 111.316 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.8 -11.57 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 68.0 mtm180 -52.34 -55.26 33.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 23.0 Cg_endo -61.19 -35.4 85.85 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.038 1.826 . . . . 0.0 113.006 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.4 mt -80.77 -37.85 29.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.0 111.179 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.6 mt -69.26 -23.89 63.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.318 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.72 68.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.445 175.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 62.4 mtt -88.46 -35.85 16.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.29 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.55 14.51 5.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.289 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.1 t -85.32 108.44 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.694 0.283 . . . . 0.0 110.568 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.46 94.72 1.73 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.969 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 92' ' ' LEU . 39.9 t -88.6 129.88 38.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 0.0 111.213 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -126.73 139.89 52.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.124 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.4 128.23 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.411 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 66.7 mtt -140.31 -173.38 3.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.224 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -91.84 168.31 11.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.4 m -59.49 -35.76 74.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 111.761 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.589 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 7.1 tm0? -75.84 -52.46 10.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.62 98.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.535 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 121' ' ' MET . . . -63.03 -46.43 87.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.83 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.11 78.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -73.66 -45.49 52.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.639 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -63.04 -35.75 81.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.128 0.49 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -54.01 -46.25 71.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.948 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -63.34 -41.57 98.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.836 0.35 . . . . 0.0 110.814 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.0 mt -64.02 -47.4 90.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.793 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.94 -27.62 66.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.004 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 56.3 ttp -65.58 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.041 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.01 -26.66 61.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.34 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -67.31 -35.8 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.452 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.2 9.72 55.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.91 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -87.85 155.5 19.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -82.78 87.13 6.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.473 0.654 . . . . 0.0 111.09 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -103.66 132.88 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.757 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 36' ' ' ALA . 57.6 t -120.3 136.13 58.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.1 p -121.57 135.81 60.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.313 0.577 . . . . 0.0 111.232 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.08 119.85 36.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.115 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.7 mt -110.17 125.31 52.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.971 0.415 . . . . 0.0 111.616 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 96' ' ' THR . 95.5 mt -104.09 153.63 38.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.073 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.02 172.81 12.59 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.922 2.415 . . . . 0.0 112.011 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.47 -34.26 60.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.616 0.722 . . . . 0.0 110.009 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.31 -41.62 0.48 Allowed Glycine 0 CA--C 1.502 -0.78 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -78.8 143.41 36.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.886 -0.657 . . . . 0.0 109.988 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.7 m -143.03 156.19 44.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.29 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 21' ' ' TYR . 4.5 mm? -70.01 -25.42 63.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.928 0.394 . . . . 0.0 110.446 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.82 105.89 7.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -62.38 -34.17 76.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.876 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -109.54 106.71 16.54 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -55.93 128.58 35.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.0 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -97.33 135.56 39.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.56 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -117.01 -35.91 3.96 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 167.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.2 t60 . . . . . 0 C--O 1.246 0.887 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.434 173.695 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.661 0.267 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -143.58 150.67 39.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.267 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -71.73 -21.67 61.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.237 0.541 . . . . 0.0 109.934 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -127.42 102.34 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.557 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 p -88.13 130.95 34.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.534 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 56.93 64.93 4.16 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.669 -173.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.48 5.3 5.65 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.787 2.324 . . . . 0.0 112.09 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.14 90.97 5.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.675 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -73.15 156.26 38.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.223 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.18 48.46 0.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 0.0 111.78 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.8 mt -147.72 80.58 1.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.984 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -64.75 102.12 0.55 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 0.0 110.365 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -110.03 146.09 35.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.764 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 17' ' ' TYR . 47.9 t -68.32 109.73 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -44.49 61.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.573 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -139.35 116.87 11.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.244 0.545 . . . . 0.0 111.377 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' HB2' HG11 ' A' ' 14' ' ' VAL . 89.5 t80 -136.5 142.29 43.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.072 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.81 -90.02 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -144.41 137.14 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.02 -91.17 0.79 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.341 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -111.81 177.71 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.701 0.286 . . . . 0.0 110.951 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.5 mt -128.92 136.31 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -114.82 120.56 40.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.144 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.72 117.62 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 64.36 49.72 2.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.507 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 68.25 18.55 9.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.173 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -128.61 121.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 28' ' ' ARG . 29.4 mtm-85 -88.42 110.87 21.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.639 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -90.91 114.7 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.017 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.2 m -92.99 29.01 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.304 0.573 . . . . 0.0 110.179 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -152.51 167.97 27.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.533 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.43 147.53 52.49 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.384 0.428 . . . . 0.0 111.233 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -140.74 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.074 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.72 123.08 25.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.46 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 45.2 p90 -152.36 162.19 41.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.35 0.595 . . . . 0.0 111.956 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.94 155.05 58.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.571 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.91 -57.65 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.678 2.252 . . . . 0.0 111.987 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.35 27.68 3.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.5 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.65 -172.57 13.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.273 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -87.05 173.39 5.85 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.823 2.349 . . . . 0.0 112.593 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -109.1 113.79 45.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.983 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.5 133.57 50.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.036 0.446 . . . . 0.0 111.158 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m -76.44 124.16 27.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.165 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.46 126.27 40.03 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 0.9 OUTLIER -83.43 8.63 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.46 2.773 . . . . 0.0 113.111 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.09 135.82 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -120.69 -48.83 2.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.106 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.569 HH11 ' HG2' ' A' ' 48' ' ' ARG . 24.3 mtt-85 -93.37 139.89 23.06 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.449 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.2 Cg_exo -66.85 -10.29 27.8 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.185 2.59 . . . . 0.0 112.494 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.21 5.0 52.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 1.2 m-20 -109.7 0.24 18.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.36 127.01 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -135.14 156.9 48.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.25 62.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -57.56 -37.73 73.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.272 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.464 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.31 -34.79 63.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.541 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.17 -41.82 98.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.95 -41.48 86.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.82 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.66 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.347 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -79.88 -4.57 52.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.141 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.52 17.7 77.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.55 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 88' ' ' ALA . 96.4 mt -86.69 -9.83 55.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.967 0.413 . . . . 0.0 110.697 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.69 -173.68 3.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.468 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.19 108.3 4.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.937 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.0 128.87 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.982 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 m -75.1 74.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.567 0.698 . . . . 0.0 112.497 -174.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -129.58 -88.63 0.51 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -175.88 99.52 0.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 170.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.37 98.94 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.887 2.391 . . . . 0.0 112.594 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.9 mt -90.33 -27.01 19.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.975 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.07 100.8 12.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.161 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -83.02 137.01 34.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.036 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.7 mt -80.14 3.13 21.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.721 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.39 -11.71 60.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.588 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -109.62 151.62 42.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.579 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.47 128.38 29.93 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.347 2.698 . . . . 0.0 112.953 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -88.73 146.08 25.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.08 -168.05 2.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.977 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.03 61.48 3.75 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.295 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.6 -66.14 0.97 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.813 0.339 . . . . 0.0 110.418 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.66 -37.41 4.49 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 71.21 -17.58 0.31 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.789 0.836 . . . . 0.0 112.779 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -130.26 134.01 25.6 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.97 -16.45 29.09 Favored 'Trans proline' 0 N--CA 1.466 -0.093 0 C-N-CA 122.677 2.251 . . . . 0.0 112.143 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -120.08 76.32 1.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.871 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -110.73 71.4 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.444 0.64 . . . . 0.0 109.439 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HA ' HD21 ' A' ' 63' ' ' LEU . . . -90.91 157.55 43.22 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.631 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HG2' ' HB1' ' A' ' 61' ' ' ALA . 70.0 Cg_exo -52.28 137.37 55.68 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.559 2.173 . . . . 0.0 112.159 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -68.91 -41.47 78.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.78 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.462 HG11 HD13 ' A' ' 133' ' ' LEU . 3.6 p -140.71 137.75 35.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.445 ' HB3' HG22 ' A' ' 118' ' ' VAL . 58.9 tp -122.16 118.62 29.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.58 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 133' ' ' LEU . 89.3 mt -98.49 119.04 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.388 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.1 t -109.85 114.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.385 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.51 106.69 3.08 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 101' ' ' HIS . 6.0 p -76.16 -30.88 58.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.53 -61.84 2.36 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.164 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.515 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 64.1 mtt85 -73.18 -75.14 0.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.326 0.584 . . . . 0.0 110.89 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -134.36 137.05 43.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.084 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -73.73 109.32 7.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.881 0.372 . . . . 0.0 111.218 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.419 ' H ' HG21 ' A' ' 96' ' ' THR . 5.0 t60 -72.7 108.01 5.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.5 108.79 3.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.04 141.41 58.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.404 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.36 150.78 16.91 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.7 -19.34 60.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.013 2.475 . . . . 0.0 112.699 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 mt-10 -94.91 -14.43 24.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.231 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -86.27 -40.76 15.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 111' ' ' LEU . 3.7 t -96.21 13.61 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.638 0.732 . . . . 0.0 109.654 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 106' ' ' GLU . 56.1 ttt85 -49.83 -54.81 28.34 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.16 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.17 -33.51 49.31 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.692 1.595 . . . . 0.0 112.325 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.46 ' HB2' HG12 ' A' ' 108' ' ' VAL . 88.9 mt -73.34 -46.44 49.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.66 -33.98 76.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.17 -32.67 74.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 73.8 mtm -81.75 -25.07 35.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.659 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.23 22.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.449 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.53 107.73 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 110.697 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.67 96.15 1.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.781 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 92' ' ' LEU . 46.5 t -89.33 118.83 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.811 0.339 . . . . 0.0 110.717 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -107.07 108.4 19.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.66 106.01 17.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 110.267 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.2 mtm -136.34 -171.68 2.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.032 0.444 . . . . 0.0 110.791 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 125' ' ' ALA . 1.9 m-20 -66.76 158.92 29.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.399 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -63.07 -42.44 99.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.221 0.534 . . . . 0.0 109.917 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.544 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 53.1 tt0 -66.23 -42.7 88.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.441 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.478 ' H ' ' HB2' ' A' ' 122' ' ' ASP . . . -63.68 -44.15 94.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.99 96.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.938 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.37 93.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 124' ' ' GLN . 63.0 mtm180 -62.77 -48.38 79.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.9 m -62.99 -34.01 76.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.787 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -62.69 -44.74 95.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.369 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 134' ' ' MET . 90.6 m-20 -65.84 -28.15 68.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.714 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 128' ' ' ARG . 81.3 mt -72.16 -50.74 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.516 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.462 HD13 HG11 ' A' ' 91' ' ' VAL . 98.0 mt -67.51 -34.97 78.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.804 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.402 ' HG2' ' HA ' ' A' ' 131' ' ' ASN . 19.0 ptp -67.84 -29.94 69.21 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.418 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.71 -26.69 40.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.59 -39.79 57.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.532 . . . . 0.0 109.903 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 30.84 5.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.821 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -100.92 148.26 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -71.11 99.83 1.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.031 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.56 140.56 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.107 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.401 ' O ' HD12 ' A' ' 92' ' ' LEU . 44.4 t -121.67 142.64 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 7.2 p -120.83 139.52 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.187 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -126.55 115.04 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -116.24 135.39 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.2 mt -109.21 99.67 37.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.49 135.7 26.98 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.337 2.025 . . . . 0.0 111.496 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.515 ' OD1' ' HG2' ' A' ' 98' ' ' ARG . 30.4 t70 -88.27 158.31 18.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.44 -5.41 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.129 -0.558 . . . . 0.0 111.962 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.87 114.79 4.76 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.4 p -80.91 94.48 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.5 tp -75.39 112.96 12.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.629 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.73 156.37 39.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.304 177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -102.31 88.2 3.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -85.6 145.8 27.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.92 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -104.38 140.21 38.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -87.65 12.76 11.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.571 0.701 . . . . 0.0 110.448 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -75.38 -21.55 58.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.894 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.844 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.66 0.266 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -120.1 150.56 40.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.22 110.41 21.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.648 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -65.49 109.87 2.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.146 0.498 . . . . 0.0 110.065 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 135' ' ' ALA . 26.6 m -82.7 102.4 11.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.958 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.18 90.67 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.994 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.67 23.35 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.385 2.723 . . . . 0.0 113.004 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.67 -43.84 53.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.147 0.499 . . . . 0.0 110.229 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.481 HG21 ' HG2' ' A' ' 38' ' ' GLU . 16.1 p -132.52 151.2 51.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.607 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 108.77 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.922 0.392 . . . . 0.0 110.227 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.16 117.91 14.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.222 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -87.95 113.97 24.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.13 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -116.3 143.13 45.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.646 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.91 115.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -87.26 -46.31 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.147 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.71 138.54 19.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.721 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -156.69 104.61 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.88 -29.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.841 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.426 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 23.1 m-20 -73.45 -29.26 62.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.018 0.437 . . . . 0.0 111.057 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.59 -12.53 4.28 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.5 p90 -111.92 154.9 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.35 111.37 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -94.17 112.94 24.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.038 0.447 . . . . 0.0 110.387 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.72 110.61 28.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.462 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 62.54 45.33 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.546 . . . . 0.0 109.965 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 73.73 -6.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.047 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.05 117.86 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -91.25 102.36 15.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.368 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.89 127.19 35.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.771 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -104.97 17.36 24.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -116.62 172.39 7.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB1' HD23 ' A' ' 145' ' ' LEU . . . -74.31 137.35 42.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 164.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 pt -134.99 144.87 33.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.413 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.74 125.67 38.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.575 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 44.7 p90 -149.08 162.58 39.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.075 0.464 . . . . 0.0 111.326 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.75 163.28 45.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.699 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.72 -36.93 34.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.72 2.28 . . . . 0.0 112.946 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.481 ' HG2' HG21 ' A' ' 9' ' ' THR . 24.0 mt-10 -124.85 32.7 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.053 0.454 . . . . 0.0 110.521 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.31 16.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.873 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.83 147.32 80.63 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.687 2.258 . . . . 0.0 111.502 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.575 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 26.1 t -80.24 88.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.1 124.57 29.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.377 -174.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.7 m -82.05 121.89 27.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 56' ' ' LEU . 1.2 t90 -103.79 121.76 46.97 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.57 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.66 13.98 1.54 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.821 2.347 . . . . 0.0 112.951 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.465 HG21 HD13 ' A' ' 56' ' ' LEU . 48.5 t -95.79 112.82 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.47 -29.34 18.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -113.54 126.33 28.29 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.463 -173.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.16 -1.53 4.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.995 2.463 . . . . 0.0 113.209 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.14 -15.09 23.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -84.32 -7.81 59.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.015 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.532 ' HA ' HD12 ' A' ' 56' ' ' LEU . 60.1 mt -69.62 130.44 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.501 -175.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' A' ' 56' ' ' LEU . 41.2 p -111.25 179.77 3.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.702 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -68.33 -35.08 77.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 m -65.11 -41.72 94.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.49 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.621 ' HB3' ' HZ2' ' A' ' 44' ' ' TRP . 61.7 mt -65.17 -36.57 84.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.071 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.53 ' HB3' HD11 ' A' ' 111' ' ' LEU . 72.1 mt -63.09 -37.32 86.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.709 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 96.6 mt-30 -65.97 -40.69 91.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.83 -40.66 88.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.813 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.34 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.45 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HB2' HD22 ' A' ' 92' ' ' LEU . . . -82.33 -2.02 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.87 72.74 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.349 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.437 HD13 ' SD ' ' A' ' 114' ' ' MET . 96.4 mt -85.87 64.31 8.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.82 0.819 . . . . 0.0 110.758 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -135.57 126.49 27.65 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.273 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.74 105.05 2.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.979 0.419 . . . . 0.0 110.706 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.724 HG12 HG23 ' A' ' 67' ' ' VAL . 48.0 t -111.15 137.26 44.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.291 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.724 HG23 HG12 ' A' ' 66' ' ' VAL . 93.1 t 74.17 117.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 123.918 0.761 . . . . 0.0 111.575 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 68' ' ' ARG . 56.4 mtt180 -79.38 96.58 6.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.711 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -84.35 117.62 69.15 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.134 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -85.37 -0.78 9.02 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.817 2.345 . . . . 0.0 113.388 -176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.8 mt -87.73 -4.02 58.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.36 . . . . 0.0 111.021 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.95 0.87 14.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.285 0.564 . . . . 0.0 110.581 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -69.3 -27.98 65.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.481 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 98.0 mt -133.42 166.15 23.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.118 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.822 ' HB3' ' HA2' ' A' ' 82' ' ' GLY . 4.1 p30 -142.94 151.22 40.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.002 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -70.99 120.18 77.88 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -14.06 75.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 126.355 4.703 . . . . 0.0 115.847 -163.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -120.74 -47.94 2.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.312 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.82 26.38 16.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.147 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.45 -75.82 0.75 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.48 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.7 -40.46 9.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.832 0.348 . . . . 0.0 111.268 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.822 ' HA2' ' HB3' ' A' ' 75' ' ' ASP . . . 83.5 28.5 35.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.341 -176.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -168.66 -167.53 0.78 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -89.68 110.81 42.08 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.31 153.98 51.02 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 123.046 2.497 . . . . 0.0 112.121 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 55.37 65.38 1.49 Allowed 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.8 0.687 . . . . 0.0 110.978 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.55 3.86 11.18 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.696 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.89 148.29 92.01 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.378 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.59 123.77 14.66 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.746 2.297 . . . . 0.0 112.296 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 50.6 mt-10 -65.11 -50.62 65.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.63 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 140' ' ' VAL . 4.2 p -135.02 130.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.382 0.611 . . . . 0.0 111.47 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 61' ' ' ALA . 65.2 tp -107.52 113.28 26.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.521 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 119' ' ' GLU . 95.9 mt -93.19 98.11 11.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.539 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -91.6 105.72 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -84.27 108.82 3.15 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 175.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.446 HG21 ' H ' ' A' ' 101' ' ' HIS . 8.0 p -62.62 -17.44 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.618 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 65.5 -92.2 0.15 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.853 171.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.22 -51.25 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.711 0.405 . . . . 0.0 111.638 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -144.66 134.26 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -70.04 112.03 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.813 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.446 ' H ' HG21 ' A' ' 96' ' ' THR . 66.5 m80 -113.06 147.43 37.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.255 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.68 106.86 18.84 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.7 169.79 12.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.14 147.96 16.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.728 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.623 ' HA ' HG22 ' A' ' 108' ' ' VAL . 51.1 Cg_exo -57.15 -24.59 59.5 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.354 2.703 . . . . 0.0 112.601 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -56.16 -31.97 63.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.223 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -89.28 -23.43 22.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.825 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.623 HG22 ' HA ' ' A' ' 105' ' ' PRO . 20.2 m -93.68 -21.57 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.544 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 57.5 mtm-85 -53.94 -49.36 90.0 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 11.7 Cg_endo -55.72 -34.52 91.03 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.982 1.788 . . . . 0.0 112.754 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 62.5 mt -81.57 -37.5 27.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.736 0.303 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.1 mt -64.69 -32.67 74.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.924 0.392 . . . . 0.0 110.584 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.72 -10.26 59.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 63' ' ' LEU . 67.1 mtt -97.05 -43.82 7.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.257 0.551 . . . . 0.0 109.737 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.02 10.71 2.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.208 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 39.7 t -98.5 125.99 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 110.475 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.23 124.51 8.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.41 ' CG2' HD12 ' A' ' 111' ' ' LEU . 23.3 t -93.71 115.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.646 0.26 . . . . 0.0 110.994 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.47 ' HB2' HD23 ' A' ' 93' ' ' LEU . 27.1 mm-40 -112.35 127.97 56.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.856 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.29 104.91 14.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 36.9 ttm -129.78 168.73 16.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.323 -169.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.13 155.67 27.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.915 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.618 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -54.37 -52.4 61.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.861 -177.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -77.65 -37.96 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.426 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.26 91.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.091 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 121' ' ' MET . . . -65.92 -44.29 85.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.729 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.05 93.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.702 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -64.5 -51.86 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.6 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.9 m -59.0 -36.97 75.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.92 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -57.99 -46.35 85.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.958 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -64.12 -37.24 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 110.592 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.65 -46.74 85.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.02 -24.11 64.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.4 ttm -64.97 -47.22 78.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' HG21 ' A' ' 5' ' ' THR . . . -70.52 -21.87 62.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.57 -11.76 59.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.061 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 70.14 32.64 69.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.815 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -100.78 150.38 22.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.745 0.307 . . . . 0.0 110.641 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 49.8 mtm180 -78.69 90.7 4.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.474 0.654 . . . . 0.0 110.94 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.497 HG23 HG13 ' A' ' 91' ' ' VAL . 6.0 p -123.4 137.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.587 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 36' ' ' ALA . 39.5 t -116.41 133.2 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.3 p -110.72 134.92 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.28 113.53 16.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.643 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -110.41 129.36 55.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.782 0.325 . . . . 0.0 111.197 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.563 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 69.6 mt -103.67 98.84 13.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.393 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.03 175.88 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.555 2.17 . . . . 0.0 112.225 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -98.36 -170.71 2.0 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.48 -15.08 0.22 Allowed Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -102.1 -29.57 11.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.208 -0.496 . . . . 0.0 111.101 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.9 m -73.03 -32.03 64.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 0.0 110.245 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.45 100.92 11.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.82 142.58 58.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.747 -172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -104.9 104.41 14.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.896 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -70.37 -44.41 68.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.99 110.59 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 164.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -82.27 -38.13 24.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -162.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -94.21 -10.64 32.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.515 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.065 177.407 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.807 0.337 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -134.44 -174.8 3.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.735 172.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 7' ' ' PRO . 87.8 mt -110.07 179.51 4.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.854 0.359 . . . . 0.0 110.975 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -95.76 -40.83 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.322 0.582 . . . . 0.0 109.572 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -99.06 -164.86 1.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.607 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.807 ' HB3' ' HA2' ' A' ' 82' ' ' GLY . 3.9 p-10 -65.47 147.78 98.45 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.729 0.3 . . . . 0.0 110.59 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.651 ' HA ' HD12 ' A' ' 3' ' ' LEU . 5.0 Cg_exo -76.42 33.71 0.42 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.401 2.734 . . . . 0.0 112.913 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 68.94 113.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.455 0.702 . . . . 0.0 112.282 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 10' ' ' ALA . 8.0 p -90.56 -153.59 0.31 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.744 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' H ' ' HB ' ' A' ' 9' ' ' THR . . . -120.45 166.67 13.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.554 0.216 . . . . 0.0 111.099 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 37' ' ' PRO . 88.0 mt -126.1 152.35 46.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -152.94 127.25 9.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.747 0.308 . . . . 0.0 110.355 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 m -110.9 141.01 44.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -68.19 115.59 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -49.09 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.94 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -134.66 129.48 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.234 0.54 . . . . 0.0 111.817 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.487 ' HE1' HG22 ' A' ' 123' ' ' THR . 85.0 t80 -104.14 102.57 12.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.49 175.2 47.38 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.784 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -81.19 -21.46 39.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.042 0.449 . . . . 0.0 110.64 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.63 -39.68 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.35 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -124.23 170.5 10.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.98 133.42 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -113.99 120.88 42.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.924 0.393 . . . . 0.0 110.035 -177.288 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -124.58 110.73 25.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.436 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 61.6 51.27 4.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.63 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 68.85 14.25 8.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.283 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.0 108.89 26.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -83.05 119.37 24.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.188 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -98.6 107.61 20.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.401 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -89.61 14.08 12.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.865 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -140.9 161.5 37.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.589 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -58.72 142.79 48.89 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.586 0.554 . . . . 0.0 111.097 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 pt -136.41 139.78 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.362 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -133.19 109.72 9.64 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 41' ' ' VAL . 42.8 p90 -146.83 161.01 41.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.486 0.66 . . . . 0.0 112.24 -170.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -109.48 154.81 42.1 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.565 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.537 ' HB2' ' HA ' ' A' ' 11' ' ' LEU . 54.0 Cg_endo -70.14 -5.71 17.09 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.145 1.896 . . . . 0.0 111.891 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -92.15 17.14 9.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.004 -170.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.95 -99.74 0.34 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.298 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 16.7 Cg_endo -56.82 134.59 65.46 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.681 2.921 . . . . 0.0 114.658 -170.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 35' ' ' PHE . 96.3 t -113.69 119.95 62.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 157.61 16.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 m -124.52 148.14 47.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -115.92 139.54 25.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.983 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.11 23.98 0.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.195 2.597 . . . . 0.0 110.499 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.604 HG13 ' HB2' ' A' ' 51' ' ' ASP . 93.3 t -85.9 130.25 36.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.572 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -113.14 -40.98 3.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -106.01 145.62 31.29 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 28.1 Cg_endo -64.32 -8.82 17.83 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.791 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.12 -12.71 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.604 ' HB2' HG13 ' A' ' 46' ' ' VAL . 73.4 m-20 -81.13 -16.42 53.07 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.46 114.57 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.758 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.404 ' H ' HD12 ' A' ' 56' ' ' LEU . 6.4 m -111.47 155.44 23.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.846 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -52.17 -38.96 59.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.758 0.313 . . . . 0.0 111.318 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m -57.46 -43.82 84.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.997 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD12 ' H ' ' A' ' 53' ' ' THR . 78.4 mt -68.67 -32.8 72.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 -178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.21 -35.77 81.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -69.65 -33.16 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 110.394 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.23 -44.78 78.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.886 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.557 ' O ' HG11 ' A' ' 141' ' ' VAL . . . -64.01 -35.22 80.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.276 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.98 62.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.316 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.53 40.4 59.58 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.364 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt -82.35 62.23 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.714 0.769 . . . . 0.0 110.668 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.51 146.49 42.03 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.465 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -60.84 -52.76 63.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.321 0.581 . . . . 0.0 109.767 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 77' ' ' PRO . 46.6 t -122.16 104.32 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.438 173.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.0 t -70.02 108.86 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.923 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -72.51 93.87 1.62 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.77 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 40' ' ' PRO . 25.5 t70 -69.62 123.43 88.49 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.726 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.01 2.88 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.044 2.496 . . . . 0.0 113.245 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -91.29 -42.22 10.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.02 0.438 . . . . 0.0 110.031 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.48 -171.13 3.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.364 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -130.35 28.7 4.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.082 0.468 . . . . 0.0 110.226 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.6 mt -127.73 -165.87 1.54 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 12.3 m-20 -125.74 84.91 2.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.412 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -102.36 106.77 50.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.79 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.728 ' HB3' HG22 ' A' ' 66' ' ' VAL . 91.6 Cg_endo -96.51 -164.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.367 2.711 . . . . 0.0 112.28 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE2' ' HA ' ' A' ' 87' ' ' ASN . 42.1 tt0 -78.95 127.7 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.97 111.27 13.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.805 0.336 . . . . 0.0 110.887 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.72 -100.06 1.42 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.983 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -162.0 127.48 3.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.807 ' HA2' ' HB3' ' A' ' 6' ' ' ASP . . . -79.08 -169.82 37.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.864 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.06 83.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.056 0.455 . . . . 0.0 110.894 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.714 HH12 ' HA3' ' A' ' 115' ' ' GLY . 53.7 mtt180 -113.15 125.73 29.29 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 63.4 Cg_exo -51.73 -40.13 65.77 Favored 'Trans proline' 0 N--CA 1.477 0.54 0 C-N-CA 124.051 3.167 . . . . 0.0 115.318 -166.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.86 30.28 0.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.448 ' HA ' ' OE2' ' A' ' 78' ' ' GLU . 64.9 t30 58.8 28.39 17.34 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.965 0.888 . . . . 0.0 109.721 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . -88.87 130.65 44.05 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.766 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.83 173.56 14.22 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.61 2.206 . . . . 0.0 111.715 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' OE2' ' HD2' ' A' ' 138' ' ' ARG . 34.1 tt0 -90.58 -38.71 12.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.347 0.594 . . . . 0.0 109.762 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.814 HG11 HD21 ' A' ' 133' ' ' LEU . 3.3 p -139.59 142.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.284 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 141' ' ' VAL . 68.3 tp -118.84 118.12 30.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.487 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.56 115.07 29.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.383 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.8 t -107.0 115.05 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.808 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.66 105.25 3.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 101' ' ' HIS . 19.8 p -77.08 4.42 10.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -171.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.468 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 74.07 -91.12 0.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.338 -0.458 . . . . 0.0 114.228 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.91 ' HG2' ' HA2' ' A' ' 148' ' ' GLY . 52.9 mtt-85 -67.83 -60.93 2.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.967 0.413 . . . . 0.0 111.077 -171.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.535 ' HD2' ' C ' ' A' ' 98' ' ' ARG . 3.4 mpt_? -129.41 148.34 51.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.9 99.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 109.841 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.554 ' HB3' HG21 ' A' ' 96' ' ' THR . 51.2 t-80 -92.34 118.43 30.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.606 -174.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.71 110.59 4.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.231 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.1 mt -77.48 151.98 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 161.84 14.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.23 -170.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 46.9 Cg_endo -68.41 -1.24 6.99 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.238 2.625 . . . . 0.0 112.721 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -89.09 -23.0 22.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.39 0.614 . . . . 0.0 109.871 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.568 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 77.5 mt-30 -94.63 -47.89 6.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.507 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 m -86.13 -1.02 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.739 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 18.3 ttm180 -56.19 -56.02 35.65 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 41.9 Cg_exo -57.82 -39.72 84.71 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.923 1.749 . . . . 0.0 112.365 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.8 mt -74.09 -40.98 62.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.7 tp -60.86 -36.47 79.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.531 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.24 -27.67 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.998 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.04 -9.38 59.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.15 0.5 . . . . 0.0 110.102 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.714 ' HA3' HH12 ' A' ' 84' ' ' ARG . . . 100.83 -0.44 55.21 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.273 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 40.8 t -79.63 103.3 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.817 0.342 . . . . 0.0 110.361 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.45 101.74 1.3 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.921 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -88.74 110.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.701 0.286 . . . . 0.0 110.588 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -110.76 135.82 50.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.18 124.9 50.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.071 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.02 -171.83 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.72 164.88 19.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.501 HG23 HD22 ' A' ' 144' ' ' LEU . 21.1 m -64.19 -34.09 77.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.066 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.41 -47.38 27.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.589 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.28 86.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.695 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.801 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.89 -45.58 93.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.919 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.06 -51.29 70.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.716 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.5 m -62.19 -39.28 92.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.725 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -57.1 -49.74 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.242 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.51 -44.9 95.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -68.33 -44.28 83.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 110.925 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.814 HD21 HG11 ' A' ' 91' ' ' VAL . 23.5 tp -66.63 -37.32 84.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.866 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 33.4 ttp -63.35 -37.18 86.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.446 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.49 -29.1 69.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.46 -34.95 78.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 0.0 110.26 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.05 29.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.445 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.511 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 55.8 mtm180 -97.86 137.03 37.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 122.763 -0.257 . . . . 0.0 110.452 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -65.38 110.51 2.67 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.429 0.633 . . . . 0.0 111.319 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.489 HG21 HD23 ' A' ' 133' ' ' LEU . 5.4 p -130.03 135.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 60' ' ' ALA . 47.0 t -109.52 140.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -122.23 132.93 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.129 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . . . -115.42 113.97 24.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.343 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.501 HD22 HG23 ' A' ' 123' ' ' THR . 94.2 mt -114.95 125.19 53.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.942 0.401 . . . . 0.0 111.503 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 96' ' ' THR . 97.8 mt -97.76 119.55 62.22 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.213 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 27.6 Cg_endo -89.77 160.18 5.13 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.6 t70 64.59 108.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.676 0.61 . . . . 0.0 110.828 -175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.91 ' HA2' ' HG2' ' A' ' 98' ' ' ARG . . . -140.22 -84.7 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.624 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.79 -40.85 24.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.331 0.586 . . . . 0.0 110.308 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.0 t -83.19 108.32 16.35 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.523 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.79 157.86 19.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -100.1 122.89 43.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.199 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -92.25 152.75 19.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.003 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -63.39 -36.86 85.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.274 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -79.12 -4.51 50.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.813 0.34 . . . . 0.0 110.911 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -83.25 12.77 4.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.52 0.676 . . . . 0.0 109.974 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -108.26 -32.76 7.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.994 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.976 -175.409 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -65.56 -33.54 76.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.488 0.661 . . . . 0.0 109.809 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -95.41 144.74 25.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.985 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -94.89 28.94 2.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.22 0.533 . . . . 0.0 110.845 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 t -159.68 152.7 21.86 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.703 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.61 157.22 86.29 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.72 117.04 3.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.688 2.259 . . . . 0.0 112.385 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.88 115.49 9.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.792 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -71.67 147.07 47.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.96 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.36 131.31 49.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.741 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.67 104.19 0.5 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.27 108.22 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.261 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -111.79 146.7 37.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.186 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.93 125.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -84.15 -46.15 12.22 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 153.09 30.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.516 . . . . 0.0 112.257 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.43 123.54 35.81 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.77 -8.68 60.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.601 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.92 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.636 0.731 . . . . 0.0 110.11 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.9 -19.3 28.1 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -153.21 157.23 39.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.84 133.08 58.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -101.53 122.05 43.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.894 0.378 . . . . 0.0 110.352 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -121.83 96.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.65 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.39 56.12 2.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.087 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 71.26 -8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.079 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.89 117.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -98.14 103.07 14.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.823 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -89.32 114.01 25.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.461 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -89.91 25.44 2.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.22 0.533 . . . . 0.0 110.517 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -147.22 166.48 26.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.057 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -66.82 140.3 57.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.314 0.384 . . . . 0.0 110.696 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 pt -135.93 144.85 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.997 0.427 . . . . 0.0 111.516 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.63 112.05 17.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.29 176.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HB3' HG13 ' A' ' 41' ' ' VAL . 41.5 p90 -138.28 156.64 47.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.228 0.537 . . . . 0.0 111.797 -173.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.47 157.18 70.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.816 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD3' ' OH ' ' A' ' 130' ' ' TYR . 24.0 Cg_exo -64.12 -42.33 18.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.383 2.056 . . . . 0.0 110.881 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -106.52 82.45 1.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.546 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.41 -171.17 38.21 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.247 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -92.4 178.62 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.151 2.568 . . . . 0.0 112.934 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 35' ' ' PHE . 47.0 t -114.21 105.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 145.4 24.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.962 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -101.6 129.34 47.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.18 114.15 64.81 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.456 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 39.87 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.387 2.725 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.15 132.0 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.119 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -114.19 -25.41 8.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 110.645 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -114.64 128.37 25.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.731 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.1 -9.37 25.55 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.934 2.423 . . . . 0.0 112.954 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -3.89 55.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.603 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -86.75 -14.69 41.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.544 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 145' ' ' LEU . 67.3 mt -58.82 110.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.968 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -133.54 179.18 6.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.29 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -41.98 71.97 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.208 0.317 . . . . 0.0 111.611 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -56.3 -46.0 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.08 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 52' ' ' ILE . 90.8 mt -73.15 -37.15 66.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.91 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -40.46 96.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -66.97 -37.52 84.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.585 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt-30 -62.88 -42.34 99.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.91 -26.98 66.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.242 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.41 -6.38 55.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.244 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.26 59.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.525 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.5 mt -83.91 11.63 7.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . . . -82.87 -26.48 31.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.014 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -114.64 124.18 51.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.955 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.69 134.79 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.55 94.23 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.302 0.572 . . . . 0.0 110.832 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.917 ' HA ' ' HB3' ' A' ' 77' ' ' PRO . 59.7 mtp85 -94.78 86.08 4.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.405 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.51 96.12 34.91 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.925 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -96.12 30.67 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.422 2.748 . . . . 0.0 112.669 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.68 -42.42 77.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.379 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.38 136.26 48.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.751 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -75.41 88.88 2.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.127 0.489 . . . . 0.0 110.429 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.2 tp -167.77 -42.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.982 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -71.73 -50.06 33.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.112 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 65.88 106.73 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 O-C-N 123.915 0.759 . . . . 0.0 111.479 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.917 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 38.1 Cg_exo -60.4 -35.82 89.42 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.023 2.482 . . . . 0.0 112.785 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.526 ' OE2' ' HB2' ' A' ' 77' ' ' PRO . 4.1 mp0 -84.5 2.0 43.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.275 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.62 14.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.173 0.511 . . . . 0.0 109.971 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.83 -89.56 1.5 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.392 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.82 166.86 32.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.568 0.223 . . . . 0.0 110.62 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.37 -125.56 2.71 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.668 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.43 12.41 14.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.527 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 18.9 ptp180 -77.49 129.15 78.13 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 11.6 Cg_exo -71.53 66.07 2.94 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.494 2.796 . . . . 0.0 113.97 -172.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 71.34 -54.07 0.67 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 170.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 69.44 24.07 5.87 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.512 0.672 . . . . 0.0 110.005 -173.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.623 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -75.21 167.69 34.42 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.59 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.623 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 15.1 Cg_endo -57.67 142.25 95.76 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.563 2.175 . . . . 0.0 112.476 176.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.681 ' HG3' ' HB3' ' A' ' 139' ' ' ARG . 34.4 mt-10 -71.05 -40.45 71.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.409 0.624 . . . . 0.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.465 HG13 HG23 ' A' ' 140' ' ' VAL . 4.8 p -138.63 136.63 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.688 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB3' HG22 ' A' ' 118' ' ' VAL . 54.8 tp -116.05 116.66 28.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.577 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.44 124.07 47.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.687 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.84 126.19 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.742 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.48 ' HA3' HD23 ' A' ' 144' ' ' LEU . . . -108.88 112.95 3.61 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.548 ' HA ' HD12 ' A' ' 145' ' ' LEU . 21.2 p -81.62 -61.38 1.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.489 ' H ' ' HA ' ' A' ' 122' ' ' ASP . . . 84.92 -22.01 10.32 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.498 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.4 HH21 ' HB2' ' A' ' 146' ' ' PRO . 52.1 mtt180 -113.09 -64.86 1.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 110.084 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -139.73 126.41 20.57 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HA ' HG21 ' A' ' 96' ' ' THR . 27.9 mt-30 -70.37 94.98 0.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.165 0.507 . . . . 0.0 110.898 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -73.18 120.12 18.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.553 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.66 119.52 15.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.693 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.9 mt -73.49 139.74 45.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.99 159.01 15.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.205 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.669 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 58.3 Cg_exo -51.86 -41.11 64.72 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.185 2.59 . . . . 0.0 112.04 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.43 ' CD ' HH22 ' A' ' 109' ' ' ARG . 31.1 tp10 -52.51 -28.67 21.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.42 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.23 -42.76 8.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.512 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.5 m -87.26 -11.34 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.669 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 27.7 mtm-85 -50.9 -53.99 41.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.01 -37.47 93.82 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.991 1.794 . . . . 0.0 112.781 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.48 HD13 HG21 ' A' ' 118' ' ' VAL . 98.1 mt -79.73 -34.84 39.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.879 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 75.5 mt -68.72 -34.09 75.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.32 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.88 78.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.43 -41.42 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.367 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.03 15.68 7.72 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.371 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.93 117.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.18 102.9 1.86 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.826 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 92' ' ' LEU . 41.3 t -102.89 121.73 54.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.18 140.29 52.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.449 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -114.39 125.89 54.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 111.437 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.463 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.8 mtm -144.61 177.31 8.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.489 ' HA ' ' H ' ' A' ' 97' ' ' GLY . 19.9 m-20 -72.38 154.46 40.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.746 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.517 HG23 HD22 ' A' ' 144' ' ' LEU . 28.7 m -47.65 -53.31 15.24 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.846 0.717 . . . . 0.0 112.61 -174.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.48 -46.27 89.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 0.0 111.605 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.45 79.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.272 -177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.03 76.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.35 84.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.324 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -59.35 -51.06 71.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 109.958 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 -36.29 83.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.499 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.434 ' OH ' ' HA ' ' A' ' 36' ' ' ALA . 87.7 t80 -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.748 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -60.06 -41.24 91.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.319 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.94 -48.28 89.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.73 -31.19 72.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.025 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.7 ttp -64.59 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.265 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.91 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.822 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 138' ' ' ARG . 38.4 tt0 -74.71 -22.07 59.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.911 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.05 27.48 49.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.34 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.426 ' HD2' ' OE1' ' A' ' 136' ' ' GLU . 15.7 ttt180 -87.33 149.14 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.249 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.681 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 48.3 ttt85 -79.9 85.15 5.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.483 0.658 . . . . 0.0 109.285 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.465 HG23 HG13 ' A' ' 91' ' ' VAL . 4.8 p -120.46 132.98 68.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.009 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 89' ' ' PRO . 40.0 t -115.24 134.21 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 9.9 p -117.71 130.82 72.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.35 106.06 14.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.562 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.517 HD22 HG23 ' A' ' 123' ' ' THR . 92.5 mt -106.4 128.5 54.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.639 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 96' ' ' THR . 78.2 mt -87.5 151.29 50.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.861 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HB2' HH21 ' A' ' 98' ' ' ARG . 27.5 Cg_exo -62.6 158.28 42.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.557 2.171 . . . . 0.0 112.075 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.16 -40.93 64.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 165.4 -5.51 0.06 OUTLIER Glycine 0 C--N 1.32 -0.338 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.803 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.631 ' HB2' ' CE1' ' A' ' 154' ' ' HIS . 4.8 m-20 64.46 24.93 13.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.008 0.523 . . . . 0.0 110.447 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -16.25 63.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.13 -13.53 59.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.254 0.55 . . . . 0.0 110.295 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -112.31 171.18 7.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.774 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.59 ' HB3' ' O ' ' A' ' 155' ' ' HIS . 91.0 m-70 -112.88 111.29 21.95 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.858 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.631 ' CE1' ' HB2' ' A' ' 149' ' ' ASP . 81.0 m80 -57.14 -42.59 81.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.43 0.633 . . . . 0.0 109.35 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.59 ' O ' ' HB3' ' A' ' 153' ' ' HIS . 37.9 m-70 -118.81 155.9 30.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 170.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -77.27 43.14 0.36 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.871 0.843 . . . . 0.0 110.817 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.449 ' H ' ' C ' ' A' ' 155' ' ' HIS . 82.2 m-70 -144.26 -42.34 0.26 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.492 -1.231 . . . . 0.0 107.815 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.8 t60 . . . . . 0 C--O 1.249 1.05 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.276 178.767 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -104.41 130.95 52.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.76 171.18 14.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.191 0.52 . . . . 0.0 111.483 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -87.21 104.93 16.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.136 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.0 p -111.54 103.62 11.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.005 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.47 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 6.9 p-10 -75.37 118.68 72.56 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.482 . . . . 0.0 110.054 177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 3.4 Cg_exo -78.95 85.62 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.19 2.593 . . . . 0.0 113.014 -173.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.464 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -63.89 -20.65 65.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.313 0.578 . . . . 0.0 110.448 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -75.25 -8.23 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.688 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.12 14.61 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 8' ' ' ALA . 80.0 mt -85.41 91.56 8.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -77.84 86.83 4.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.279 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 m -116.25 140.44 49.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.571 ' HA ' HG22 ' A' ' 24' ' ' VAL . 48.6 t -60.62 112.91 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -74.9 -53.33 9.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.517 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -140.34 157.12 46.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.153 0.501 . . . . 0.0 111.258 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -110.01 118.41 36.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.74 156.95 15.65 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.322 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.9 92.49 0.51 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.64 11.43 55.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.105 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -161.13 150.23 16.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.135 0.467 . . . . 0.0 111.159 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 29' ' ' PHE . 61.6 mt -96.94 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -118.08 114.83 23.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.037 0.446 . . . . 0.0 110.151 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.571 HG22 ' HA ' ' A' ' 14' ' ' VAL . 40.4 t -129.77 113.04 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.669 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 60.14 38.53 20.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.362 0.601 . . . . 0.0 110.298 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 68.59 17.43 8.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.014 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.91 112.85 36.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 28' ' ' ARG . 24.0 ttt85 -72.81 110.79 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.131 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 66.0 m-85 -102.51 98.08 8.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.198 0.523 . . . . 0.0 110.638 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -99.83 28.9 4.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.269 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -148.03 156.4 42.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.45 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 44' ' ' TRP . . . -60.63 136.86 58.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.433 0.458 . . . . 0.0 111.386 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.2 pt -138.04 150.16 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.309 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -135.28 125.8 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.843 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 41.8 p90 -147.89 157.46 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.234 0.54 . . . . 0.0 111.789 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -132.19 155.35 81.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.244 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.58 -22.73 57.93 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.74 2.293 . . . . 0.0 112.538 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -116.53 22.71 12.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.59 0.71 . . . . 0.0 109.284 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.71 17.45 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.039 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -89.83 -171.41 0.5 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.083 2.522 . . . . 0.0 112.297 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.4 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 40.8 t -111.29 114.79 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.01 151.97 22.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.907 0.384 . . . . 0.0 111.191 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -91.41 126.3 36.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.245 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -101.34 119.78 56.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.113 -176.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.6 Cg_exo -78.79 22.63 0.65 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.439 2.759 . . . . 0.0 113.248 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HD13 ' A' ' 56' ' ' LEU . 88.5 t -91.77 132.18 36.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -105.53 -51.22 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.255 0.55 . . . . 0.0 110.939 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -116.89 138.92 25.11 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.148 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HB2' ' HB3' ' A' ' 101' ' ' HIS . 43.9 Cg_endo -67.19 -11.14 31.11 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.939 2.426 . . . . 0.0 112.832 -176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.73 -15.42 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 63.9 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.654 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.96 100.21 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.974 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.43 ' H ' HD12 ' A' ' 56' ' ' LEU . 2.2 m -89.04 159.42 17.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.51 68.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.93 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 m -60.06 -36.82 78.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 46' ' ' VAL . 81.9 mt -67.75 -36.15 80.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.097 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 111' ' ' LEU . 97.2 mt -68.2 -37.9 81.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.852 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.26 -39.62 91.04 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.023 0.439 . . . . 0.0 110.492 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -64.65 -40.72 95.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.722 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.86 -20.62 63.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.27 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -82.11 -5.82 58.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.5 15.29 81.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.699 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.9 mt -73.04 -3.29 25.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.947 0.403 . . . . 0.0 111.442 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.53 -11.57 59.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.731 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.62 -41.43 92.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.159 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.16 -11.28 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 111.297 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.4 t -85.94 -20.87 7.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.054 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -65.63 -45.54 82.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.472 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -149.3 114.24 3.58 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.119 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.54 8.29 1.27 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.022 2.481 . . . . 0.0 113.118 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.4 tp -77.4 -24.67 50.49 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.33 91.22 8.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.282 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' O ' ' HB3' ' A' ' 77' ' ' PRO . 99.1 m-85 -74.17 140.05 44.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.909 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.95 -34.55 38.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.58 0.705 . . . . 0.0 109.2 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -100.97 123.59 45.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.82 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 61.67 67.72 1.28 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 121.486 0.66 . . . . 0.0 110.359 -172.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 73' ' ' PHE . 86.8 Cg_endo -90.2 156.08 4.68 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.915 2.41 . . . . 0.0 112.866 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.02 -9.52 59.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.353 0.597 . . . . 0.0 109.795 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.95 100.7 9.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.935 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.57 168.04 12.77 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.889 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.73 88.34 4.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.84 0.352 . . . . 0.0 111.389 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.47 -149.51 47.01 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.623 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.03 142.37 27.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -110.73 129.24 24.16 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.973 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.48 -36.78 84.96 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.721 2.281 . . . . 0.0 111.353 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.84 66.1 5.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -55.36 -44.59 76.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.542 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -108.7 171.83 4.18 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.877 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 80.8 Cg_exo -47.46 124.9 10.03 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.497 2.132 . . . . 0.0 112.07 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 39.2 mt-10 -66.16 -45.47 80.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.475 HG13 HG23 ' A' ' 140' ' ' VAL . 4.0 p -134.72 133.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.248 0.547 . . . . 0.0 111.278 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.38 121.97 42.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.618 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.2 mt -105.58 109.87 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.891 0.377 . . . . 0.0 110.495 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.49 121.74 45.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.18 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -93.3 106.76 3.45 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 24.8 p -59.98 -49.82 76.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.735 0.414 . . . . 0.0 111.915 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.28 -78.03 0.57 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.255 -0.497 . . . . 0.0 113.146 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -69.65 -38.19 77.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.595 ' O ' ' HB ' ' A' ' 96' ' ' THR . 44.7 ttm-85 -166.77 140.73 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.63 0.253 . . . . 0.0 110.81 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.536 ' HA ' HG21 ' A' ' 96' ' ' THR . 90.0 mt-30 -70.73 105.32 3.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . 51.3 t-80 -117.98 111.25 18.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.85 130.34 40.8 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.61 151.88 40.71 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.97 165.31 13.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.264 -176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.6 Cg_endo -56.46 -31.19 84.98 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.173 2.582 . . . . 0.0 112.709 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -67.09 -25.76 66.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.155 0.502 . . . . 0.0 110.705 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -96.36 -23.27 16.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.738 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 26.7 m -106.7 -7.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.732 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 39.9 ttp-105 -53.62 -55.2 37.62 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 38.5 Cg_exo -58.07 -32.99 96.82 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.987 1.791 . . . . 0.0 112.333 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.761 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.3 mt -78.09 -33.91 50.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 90.0 mt -61.08 -38.34 85.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 109.932 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.13 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.198 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 64.4 mtt -89.53 -33.07 16.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.659 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.04 18.48 5.5 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.268 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 t -93.14 114.48 29.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.727 0.299 . . . . 0.0 111.098 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.44 102.37 2.71 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.1 t -95.69 122.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.814 0.34 . . . . 0.0 111.489 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -120.6 146.33 46.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.061 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.24 119.6 32.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.988 0.423 . . . . 0.0 110.682 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.459 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 64.9 mtm -142.74 175.05 10.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.47 163.29 25.65 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.832 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.2 m -50.77 -52.79 37.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.399 -173.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.46 -43.89 96.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.639 0.257 . . . . 0.0 111.284 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.79 99.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.971 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.91 71.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.96 89.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.793 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttp-105 -67.63 -46.52 72.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 0.0 110.653 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.6 m -65.89 -31.49 72.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.292 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.49 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 75.6 t80 -59.0 -45.59 90.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.387 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -64.15 -41.63 97.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.53 -47.11 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.654 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.418 HD13 HG11 ' A' ' 91' ' ' VAL . 97.5 mt -68.98 -28.26 66.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.33 -47.43 70.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.218 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.59 -25.41 66.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.553 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.43 -12.32 60.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.276 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.86 57.24 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.122 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.487 ' HE ' ' CD ' ' A' ' 90' ' ' GLU . 6.8 tpt180 -105.58 153.11 22.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.694 0.283 . . . . 0.0 110.323 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -82.6 91.12 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.789 0.804 . . . . 0.0 111.144 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG23 HG13 ' A' ' 91' ' ' VAL . 7.2 p -118.1 142.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.705 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 36' ' ' ALA . 39.4 t -122.31 141.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.4 p -120.39 138.45 50.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 110.855 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.76 107.76 10.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.434 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.6 mt -104.13 129.89 51.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.689 0.281 . . . . 0.0 111.694 -172.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -101.74 105.94 44.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 30.0 Cg_endo -94.07 -153.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.311 2.674 . . . . 0.0 111.328 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.18 -175.94 3.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.79 -29.4 0.38 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.78 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -69.4 -20.88 63.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.589 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.6 p -71.73 -35.47 70.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.742 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.1 mt -90.71 89.86 7.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.104 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -81.73 110.34 16.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.531 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -94.37 157.79 15.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.781 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -71.37 -16.62 62.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.623 0.249 . . . . 0.0 111.505 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -67.79 -14.59 63.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.2 0.524 . . . . 0.0 110.159 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -101.03 174.79 5.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.587 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -138.09 108.74 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.113 -174.76 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.794 0.33 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -143.47 159.01 43.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -101.14 158.7 15.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.974 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -74.37 -34.78 63.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.3 p -107.11 150.81 26.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.34 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.58 102.15 52.63 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.319 172.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.72 -58.68 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.509 2.139 . . . . 0.0 111.588 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -118.77 98.01 6.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.277 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.4 p -64.78 -38.55 91.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.415 0.626 . . . . 0.0 109.684 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.64 170.7 15.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.82 174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.0 tp -128.37 99.81 5.56 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.425 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -69.2 107.01 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.104 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 m -133.22 135.64 45.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 24' ' ' VAL . 49.2 t -73.02 118.89 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -93.02 -75.14 0.5 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.894 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.64 98.25 11.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 0.0 110.66 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -86.14 114.98 23.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.196 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.87 168.52 19.0 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.29 -21.41 36.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.121 0.486 . . . . 0.0 110.134 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.56 -38.21 5.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.53 155.6 46.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 110.817 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -114.57 114.16 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.613 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 42.5 tt0 -99.33 116.21 30.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 14' ' ' VAL . 61.3 t -116.06 121.95 68.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.688 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 60.03 31.03 20.45 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.355 0.409 . . . . 0.0 110.506 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HA ' ' CD ' ' A' ' 23' ' ' GLU . 96.7 mt-30 71.16 14.47 6.66 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.57 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -104.8 116.75 49.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 99.0 mtt180 -93.31 116.49 29.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.86 0.362 . . . . 0.0 111.333 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.07 143.08 32.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.331 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.2 p -106.13 1.29 26.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.542 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -128.98 170.65 13.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.065 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -60.5 143.04 54.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 112.355 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.99 144.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.702 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 120.03 26.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.465 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.8 162.19 36.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.19 0.519 . . . . 0.0 111.709 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -137.81 151.91 71.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.288 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.46 -45.09 36.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.731 2.287 . . . . 0.0 112.57 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' OE2' ' HG2' ' A' ' 139' ' ' ARG . 39.0 mt-10 -97.59 23.34 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.823 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.91 -170.84 11.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.22 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -90.05 -168.37 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.89 2.393 . . . . 0.0 112.316 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.34 117.72 56.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.658 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.07 123.21 35.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.233 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.1 t -77.52 113.13 15.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.718 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.19 117.94 64.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.85 25.47 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.903 2.402 . . . . 0.0 111.603 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 51' ' ' ASP . 83.9 t -86.16 122.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.272 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -92.74 -39.89 11.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.646 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -139.64 157.38 70.19 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.961 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.44 -11.72 11.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.23 2.62 . . . . 0.0 113.393 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.4 -21.47 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.583 ' HB2' HG13 ' A' ' 46' ' ' VAL . 63.1 m-20 -86.25 -5.12 59.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 145' ' ' LEU . 71.0 mt -74.41 125.46 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.035 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -141.25 175.34 9.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.036 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -57.63 -45.65 85.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 m -56.4 -44.41 80.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.929 0.395 . . . . 0.0 111.425 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.62 -39.06 84.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.762 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.565 ' HB3' HD11 ' A' ' 111' ' ' LEU . 96.0 mt -66.09 -40.17 90.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.161 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -61.45 -46.91 88.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.453 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 98.9 mt-30 -63.19 -36.78 84.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.915 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.68 -32.44 73.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.047 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.63 5.7 8.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.18 -7.67 54.73 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.42 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.4 mt -82.42 25.64 0.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.011 0.434 . . . . 0.0 111.148 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 59' ' ' GLN . . . -87.15 -54.99 4.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.891 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -96.89 -8.38 30.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.219 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.66 142.09 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.403 HG11 HD13 ' A' ' 74' ' ' LEU . 28.8 m -58.15 133.26 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.163 0.506 . . . . 0.0 111.17 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 68' ' ' ARG . 25.2 ttt85 -88.31 -20.39 25.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.53 -176.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -114.76 93.09 32.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.196 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.83 -16.87 20.42 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.169 2.58 . . . . 0.0 112.619 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt -92.93 11.35 27.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.023 0.439 . . . . 0.0 110.742 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.89 161.81 14.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.76 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -81.71 -26.43 34.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.823 0.344 . . . . 0.0 110.117 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.403 HD13 HG11 ' A' ' 67' ' ' VAL . 66.8 mt 61.23 17.2 7.96 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.763 174.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.5 t70 64.08 18.0 10.97 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.374 0.607 . . . . 0.0 110.796 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -103.32 137.0 19.13 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.321 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.93 -30.34 5.99 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.55 2.166 . . . . 0.0 113.054 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -99.5 128.89 45.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.925 0.393 . . . . 0.0 110.858 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.05 150.53 41.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.16 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.25 -125.64 1.1 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.013 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.98 101.94 3.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.971 0.415 . . . . 0.0 110.526 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.36 -147.71 10.42 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.422 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.12 119.8 16.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.057 0.456 . . . . 0.0 111.117 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.543 ' HD2' ' HB3' ' A' ' 86' ' ' ALA . 6.1 ptp180 -130.18 153.67 81.21 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.68 -32.4 75.47 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.841 2.361 . . . . 0.0 112.614 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB3' ' HD2' ' A' ' 84' ' ' ARG . . . -72.63 -11.88 60.82 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.437 ' CG ' ' HG2' ' A' ' 84' ' ' ARG . 87.2 m-20 -81.33 -20.6 40.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.964 0.411 . . . . 0.0 109.975 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.81 146.98 91.35 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.899 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.3 162.45 7.75 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.095 2.53 . . . . 0.0 112.734 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 139' ' ' ARG . 9.5 mm-40 -72.87 -49.71 28.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 -175.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 12.8 p -148.22 145.52 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.227 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 117' ' ' GLY . 2.0 pt? -119.04 132.01 56.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.128 0.49 . . . . 0.0 110.107 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.77 123.44 41.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.108 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.6 109.13 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.513 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -85.34 108.71 3.23 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.616 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.8 p -69.09 -12.14 61.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.23 -85.31 0.71 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.286 -0.483 . . . . 0.0 114.001 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -61.6 -41.0 96.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.899 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -172.5 158.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.616 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 52.9 tt0 -62.52 137.7 58.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.577 . . . . 0.0 111.718 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -136.19 164.14 28.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.487 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.18 110.13 22.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.885 0.374 . . . . 0.0 110.423 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.14 131.89 38.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -106.45 -176.78 23.32 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.103 -1.046 . . . . 0.0 114.172 -167.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.616 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 60.4 Cg_endo -72.18 3.75 3.81 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.774 2.982 . . . . 0.0 113.473 -173.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HA ' ' NH1' ' A' ' 109' ' ' ARG . 11.7 tp10 -96.94 -26.6 14.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -96.02 -50.94 4.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.505 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.691 ' HB ' HG11 ' A' ' 118' ' ' VAL . 33.5 m -91.56 5.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.649 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 42.0 ttp-105 -59.85 -52.32 74.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 76.7 Cg_exo -54.8 -29.77 64.31 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.166 1.91 . . . . 0.0 113.075 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 57' ' ' LEU . 58.7 mt -70.04 -49.0 55.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 109.86 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.8 mt -64.19 -32.54 74.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.36 -26.89 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.368 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.453 ' HE2' ' HA ' ' A' ' 111' ' ' LEU . 65.7 mtm -87.34 -33.48 19.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.857 0.361 . . . . 0.0 110.665 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.43 4.25 9.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.408 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.0 131.2 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -82.33 141.3 21.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.736 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' A' ' 108' ' ' VAL . 11.7 p -127.33 145.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 122.689 -0.301 . . . . 0.0 110.227 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.86 136.65 27.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.791 0.329 . . . . 0.0 110.632 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.48 127.52 46.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.796 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.501 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 32.8 ttm -147.2 161.75 40.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -174.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.97 159.97 31.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 m -50.5 -63.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.44 -44.19 95.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.723 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.35 89.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.89 94.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.573 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.71 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 132' ' ' ILE . 53.4 ttp180 -60.2 -55.84 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 15.8 m -60.51 -38.03 83.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.04 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.22 -49.6 76.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.994 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.15 -40.85 95.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.627 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 79.5 mt -60.56 -56.4 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.76 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.74 -31.69 72.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.8 ttp -66.22 -40.83 90.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.213 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.69 -35.45 72.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.66 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 9.1 mm-40 -61.69 -29.71 70.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.79 32.69 7.06 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.829 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -107.28 135.8 48.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.468 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 28.6 mtm180 -67.44 97.65 0.59 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.516 0.674 . . . . 0.0 110.869 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 7.4 p -123.78 139.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.333 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 36' ' ' ALA . 30.8 t -109.46 150.42 12.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.91 130.98 55.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.006 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.31 120.71 39.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.237 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.76 127.37 53.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.897 0.38 . . . . 0.0 111.55 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 52' ' ' ILE . 68.5 mt -99.64 116.64 64.69 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.575 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 72.2 Cg_endo -77.87 150.76 27.27 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.616 2.211 . . . . 0.0 112.815 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -76.52 125.76 29.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.635 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.69 -24.73 0.31 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.458 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 59.06 75.77 0.38 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.507 0.67 . . . . 0.0 109.204 -172.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.6 p -80.18 86.3 5.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.895 -168.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.9 tp -110.47 90.23 3.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 166.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.15 126.68 31.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.239 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -72.22 130.58 41.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.846 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -64.68 -37.45 87.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.701 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -116.78 113.48 22.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.288 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -90.2 153.91 20.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -97.53 -45.96 6.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.82 176.348 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.486 0.184 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.56 145.61 40.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.376 . . . . 0.0 110.481 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.94 176.94 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.264 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -77.4 -42.41 36.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.4 0.619 . . . . 0.0 109.357 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.9 m -114.83 154.95 27.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.371 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 70.17 89.64 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 123.636 0.585 . . . . 0.0 110.678 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.13 -10.98 19.53 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.546 2.164 . . . . 0.0 112.206 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.66 116.59 16.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.409 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 m -107.01 156.22 18.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.214 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.63 1.26 6.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.031 0.444 . . . . 0.0 111.513 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -100.21 141.07 33.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.938 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -114.02 112.35 23.13 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m -130.6 143.6 50.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.999 0.428 . . . . 0.0 111.618 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.3 139.35 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.606 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 p -99.1 -40.02 8.21 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.731 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -140.23 116.71 10.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 111.715 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -105.47 104.33 14.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.04 -169.68 14.44 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.124 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.19 94.03 3.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.992 0.425 . . . . 0.0 110.809 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.81 60.35 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.261 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -125.56 152.16 45.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.038 0.419 . . . . 0.0 110.992 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.28 124.6 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.891 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 36.9 tt0 -111.59 122.56 48.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 111.339 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.42 115.19 49.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.051 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 67.39 -78.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.467 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -138.42 -1.1 1.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.458 0.17 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.58 121.89 68.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.792 0.329 . . . . 0.0 111.198 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.2 ptp180 -97.84 123.37 41.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.292 0.568 . . . . 0.0 110.334 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.43 137.35 37.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.198 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -94.73 17.31 13.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.37 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -147.25 167.78 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.929 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -61.56 146.95 47.13 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.483 0.489 . . . . 0.0 111.466 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 pt -141.78 147.08 22.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.084 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.76 124.97 40.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.821 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -147.95 161.33 41.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.52 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -136.56 160.74 65.47 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.619 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.56 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 11.3 Cg_endo -56.03 -48.67 18.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.728 2.285 . . . . 0.0 111.941 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -111.71 86.97 2.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.97 178.8 41.76 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.058 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -90.22 143.2 3.85 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.025 2.483 . . . . 0.0 113.076 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.86 114.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.58 154.47 30.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.556 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.1 m -87.25 143.14 27.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 t90 -111.88 121.63 39.16 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 9.8 Cg_exo -72.54 46.99 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.526 2.818 . . . . 0.0 113.409 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 HD13 ' A' ' 56' ' ' LEU . 92.0 t -122.19 115.96 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.17 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -82.98 -32.1 27.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.0 110.159 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -160.3 158.57 25.94 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.036 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HA ' HG13 ' A' ' 52' ' ' ILE . 17.5 Cg_exo -68.44 33.94 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.964 3.109 . . . . 0.0 114.414 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.68 -27.48 15.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.634 0.254 . . . . 0.0 110.934 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -111.96 7.18 19.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.503 HG13 ' HA ' ' A' ' 49' ' ' PRO . 54.6 mt -61.74 109.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.157 0.504 . . . . 0.0 110.822 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 p -127.89 175.99 7.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.788 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -59.4 -43.69 92.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.82 -175.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -58.21 -42.72 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.786 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.449 HD13 HG22 ' A' ' 46' ' ' VAL . 93.8 mt -67.93 -36.56 80.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.735 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.0 -37.38 85.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.319 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 98.2 mt-30 -58.08 -42.69 86.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.999 0.428 . . . . 0.0 110.443 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.72 -39.76 84.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.271 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.6 -18.0 52.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.11 -20.39 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.33 45.3 30.96 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.65 -22.11 34.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.056 0.455 . . . . 0.0 110.555 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.8 109.74 22.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.391 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.28 106.52 15.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.31 0.576 . . . . 0.0 110.056 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.41 112.8 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.772 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.96 -174.08 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.333 171.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 65.4 ttp85 -96.04 -3.74 44.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.473 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 68' ' ' ARG . 21.6 t70 71.59 99.46 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.722 176.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -92.19 143.72 2.66 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.141 2.561 . . . . 0.0 112.167 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.13 -36.59 61.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.153 0.501 . . . . 0.0 110.074 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.87 87.74 7.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.001 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -69.82 114.33 7.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.41 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.3 mt -103.86 156.62 17.68 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.803 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -77.56 -38.58 48.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.584 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.488 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 4.4 tp10 66.81 116.71 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.612 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 76' ' ' GLU . 10.5 Cg_endo -55.05 121.64 10.26 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.715 2.277 . . . . 0.0 111.501 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.44 103.62 9.49 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.468 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.5 152.09 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.126 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.48 -6.68 77.01 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.517 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.93 -26.99 64.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 0.0 110.896 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.21 -38.35 2.58 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.757 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 71.78 -69.05 0.2 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.705 0.802 . . . . 0.0 110.988 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 5.2 ptp180 -130.17 107.18 16.32 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.517 . . . . 0.0 110.014 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 4.5 Cg_endo -87.19 123.01 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.579 2.853 . . . . 0.0 112.691 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 62.41 92.77 0.06 Allowed 'General case' 0 N--CA 1.463 0.217 0 O-C-N 123.872 0.732 . . . . 0.0 111.363 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.94 -36.87 85.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.948 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.26 125.21 90.7 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.568 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.19 154.39 74.44 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.792 2.328 . . . . 0.0 112.516 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.48 -42.7 58.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.476 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 140' ' ' VAL . 3.6 p -135.33 139.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.327 0.584 . . . . 0.0 111.899 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 141' ' ' VAL . 51.1 tp -118.11 122.49 43.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.5 mt -104.27 121.72 43.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.741 0.305 . . . . 0.0 110.619 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.37 113.36 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.26 89.76 1.01 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.237 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.52 31.96 4.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.872 0.368 . . . . 0.0 111.234 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -72.37 -15.08 77.08 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.225 -175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -83.14 -21.96 33.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.41 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 10.8 tpt180 -168.77 90.95 0.25 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -56.99 106.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.281 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -115.05 99.71 7.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.73 111.7 1.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 97.6 mt -68.38 133.19 48.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.255 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.05 21.53 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.631 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.9 Cg_endo -55.12 -47.16 27.87 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.509 2.806 . . . . 0.0 112.938 -174.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.67 -25.4 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.769 0.319 . . . . 0.0 111.634 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 103' ' ' LEU . 97.2 mt-30 -78.13 -40.98 36.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 29.0 m -101.24 4.19 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.577 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.518 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 32.8 ttp180 -54.26 -48.9 93.13 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 53.6 Cg_exo -53.49 -34.27 71.4 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.098 1.865 . . . . 0.0 112.59 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.6 mt -86.55 -34.32 19.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.878 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 80.2 mt -63.78 -34.25 77.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.908 0.385 . . . . 0.0 110.157 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.29 -13.11 62.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.115 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -100.82 -25.33 14.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.971 0.415 . . . . 0.0 110.509 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.03 18.64 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.05 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.7 t -94.78 118.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.99 111.24 3.63 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.672 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.71 119.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -108.45 118.67 37.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.998 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.58 106.93 17.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.689 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 40.5 ttm -134.49 163.68 29.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.103 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.96 149.64 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.455 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 9.7 m -60.21 -47.0 87.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.76 0.315 . . . . 0.0 111.376 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -69.93 -40.56 75.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 110.576 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.46 95.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.971 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.4 83.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.97 88.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -64.03 -41.14 97.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.542 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.9 m -63.52 -43.79 96.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.464 ' CE1' ' HD3' ' A' ' 37' ' ' PRO . 73.2 t80 -57.08 -41.86 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -58.48 -47.13 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.05 -45.6 90.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.718 HD22 ' HD2' ' A' ' 138' ' ' ARG . 87.0 mt -64.21 -34.58 78.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.56 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 50.8 ttp -67.52 -34.28 76.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.345 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.76 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.07 -23.1 61.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.033 0.444 . . . . 0.0 110.415 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.55 31.58 15.64 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.149 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.718 ' HD2' HD22 ' A' ' 133' ' ' LEU . 45.8 mtt180 -83.43 152.46 24.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.797 0.332 . . . . 0.0 110.922 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -83.18 93.02 7.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.891 0.853 . . . . 0.0 109.494 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 91' ' ' VAL . 3.7 p -125.77 133.87 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.33 -177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 36' ' ' ALA . 33.5 t -111.96 133.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.2 p -116.65 130.15 71.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.906 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -109.95 109.49 20.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.453 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.65 129.87 46.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.479 HD13 ' HG3' ' A' ' 49' ' ' PRO . 87.8 mt -103.65 117.34 60.12 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.439 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 84.2 Cg_endo -86.25 -158.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.02 2.48 . . . . 0.0 111.856 177.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.36 -163.08 0.83 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.62 -7.86 0.14 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -121.48 -46.33 2.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 110.316 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.76 -36.51 73.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.5 tp -78.85 82.56 5.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.304 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -94.31 137.0 33.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.826 -175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -100.6 100.59 11.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.76 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -67.49 142.31 56.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -75.59 12.12 1.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -89.5 -3.89 58.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 166.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -119.79 -162.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.534 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.8 t60 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.09 177.024 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.952 0.406 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -111.3 99.84 8.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.73 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.588 ' HG ' ' H ' ' A' ' 5' ' ' THR . 33.9 tp -130.61 136.4 48.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.839 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -86.99 -3.16 59.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.745 0.307 . . . . 0.0 111.014 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.588 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 7.4 m -71.18 -27.05 63.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.411 0.624 . . . . 0.0 109.778 173.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.08 137.53 68.94 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.348 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.89 127.98 20.85 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.408 2.072 . . . . 0.0 111.588 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.1 109.66 0.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.6 m -61.97 130.79 47.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.388 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.47 88.4 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.127 0.489 . . . . 0.0 111.083 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.93 100.94 12.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.013 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.408 ' HA ' ' OD1' ' A' ' 25' ' ' ASN . 88.3 m-20 -64.35 109.38 1.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.033 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 m -117.6 133.09 56.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -66.17 110.32 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.552 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 m -82.77 -44.74 15.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.41 150.59 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.042 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -128.36 128.58 44.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.03 -169.02 12.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.857 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.49 -61.2 1.91 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.277 0.561 . . . . 0.0 110.94 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.75 25.08 15.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.737 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -155.13 138.88 16.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.602 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -120.79 120.96 63.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 39.1 tt0 -96.03 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.267 -176.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.51 128.31 66.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 12' ' ' ASN . 7.8 m-20 61.27 30.16 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.213 -177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 69.22 15.53 8.58 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.732 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.26 121.72 62.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 93.2 mtt180 -87.36 111.76 21.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.004 0.43 . . . . 0.0 111.581 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.58 124.0 45.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.042 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -97.98 22.55 9.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.978 0.418 . . . . 0.0 111.332 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -151.39 171.82 16.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.473 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.85 135.91 57.67 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.604 0.565 . . . . 0.0 111.623 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.67 144.81 26.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.107 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.07 122.18 35.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.519 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 37.7 p90 -143.78 153.51 42.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.102 0.477 . . . . 0.0 111.708 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.48 158.53 68.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.052 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -58.68 135.22 65.82 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.255 1.97 . . . . 0.0 111.62 173.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 70.02 16.86 7.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.162 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.18 169.46 22.98 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.5 177.24 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.129 . . . . 0.0 112.221 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 43.1 t -102.81 102.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.35 134.42 35.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.09 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -77.7 118.89 20.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.035 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -98.18 120.31 59.99 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.673 -175.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.3 Cg_exo -77.19 26.56 0.45 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.348 2.699 . . . . 0.0 112.99 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 51' ' ' ASP . 79.5 t -103.19 110.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.673 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.406 ' HA ' HD21 ' A' ' 145' ' ' LEU . 91.0 mt-30 -113.72 -13.88 12.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.318 0.58 . . . . 0.0 109.566 174.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.071 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 37.2 mtp-105 -101.83 135.25 19.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.44 -33.57 93.92 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.596 2.198 . . . . 0.0 112.319 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.11 9.54 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.456 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 1.071 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 3.6 t70 -85.09 -25.88 27.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.206 0.527 . . . . 0.0 110.13 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.9 109.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.565 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.0 m -112.35 155.53 23.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.168 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.542 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -56.68 -38.18 71.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 t -57.34 -42.79 82.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.712 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.82 -27.48 64.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' HD11 ' A' ' 111' ' ' LEU . 95.8 mt -71.3 -35.07 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.386 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.102 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -66.34 -43.93 84.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.367 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 -19.33 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.913 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.3 -5.93 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.38 82.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.127 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.8 mt -84.01 35.21 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.358 0.599 . . . . 0.0 110.97 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.28 -17.67 14.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.96 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -103.34 161.47 13.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.39 . . . . 0.0 110.908 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.09 141.11 46.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.297 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.4 153.85 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -54.85 132.88 47.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.856 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.62 121.21 83.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.926 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.42 100.56 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.869 2.379 . . . . 0.0 111.943 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.5 -39.41 74.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.178 0.514 . . . . 0.0 109.784 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.88 64.38 3.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.731 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -84.79 156.56 21.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.225 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.591 ' HG ' ' H ' ' A' ' 76' ' ' GLU . 52.6 tp -66.63 134.62 52.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.732 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -67.04 -16.02 64.09 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.187 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.591 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 42.4 mt-10 -115.66 85.19 13.57 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.872 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.59 2.81 8.29 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.055 2.503 . . . . 0.0 112.394 -176.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -100.59 101.26 12.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.49 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.65 169.13 15.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.46 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.81 71.48 2.56 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.318 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.34 125.4 6.05 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.79 57.59 4.79 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.439 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.44 169.38 20.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.606 ' HD2' ' H ' ' A' ' 84' ' ' ARG . 0.1 OUTLIER -71.02 126.74 92.1 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.999 176.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.95 28.37 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.231 2.62 . . . . 0.0 113.526 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.64 -2.84 47.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.564 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 57.65 37.73 27.47 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.093 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.52 143.65 74.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.708 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 18.5 Cg_endo -57.77 134.43 62.73 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 123.052 2.502 . . . . 0.0 113.013 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -67.29 -36.82 82.32 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.514 HG13 HG23 ' A' ' 140' ' ' VAL . 6.0 p -139.76 135.78 39.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.993 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.6 tp -111.67 120.6 42.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.193 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 119' ' ' GLU . 94.9 mt -102.08 112.2 24.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.864 0.364 . . . . 0.0 110.895 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.85 113.61 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.959 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -97.77 97.07 1.89 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 p -106.67 56.17 0.65 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.155 0.502 . . . . 0.0 110.931 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.729 ' HA3' HG22 ' A' ' 123' ' ' THR . . . -64.07 -28.54 72.99 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.536 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' CZ ' ' HA3' ' A' ' 148' ' ' GLY . 61.3 ttt180 -63.0 -38.72 92.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.249 0.547 . . . . 0.0 110.768 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -170.44 95.06 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -61.23 128.09 34.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.798 -168.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -107.77 120.93 43.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.833 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.8 tp -80.1 103.18 9.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.91 145.92 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.031 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 173.77 20.1 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.747 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.622 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 54.2 Cg_exo -52.29 -49.34 17.71 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.543 2.829 . . . . 0.0 113.155 -175.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.09 -34.51 73.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.863 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -68.52 -30.27 69.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.88 -8.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 85.7 mtt180 -54.22 -52.49 68.4 Favored Pre-proline 0 N--CA 1.466 0.344 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.542 ' HG2' ' HB1' ' A' ' 54' ' ' ALA . 79.1 Cg_exo -50.96 -34.11 44.8 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.387 2.058 . . . . 0.0 113.173 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 80.0 mt -89.73 -37.99 14.16 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.146 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.3 mt -60.89 -34.44 74.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.776 0.322 . . . . 0.0 110.694 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.16 -24.06 65.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.092 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.4 mtt -90.67 -9.85 45.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.382 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.19 10.68 54.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.252 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.6 t -94.59 113.55 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.674 0.273 . . . . 0.0 110.537 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.12 118.78 4.78 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.618 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.56 117.18 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.449 ' HB2' HD23 ' A' ' 93' ' ' LEU . 27.6 mm-40 -114.33 110.1 19.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.195 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.18 110.73 22.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 67.4 mtm -138.56 -171.85 3.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.813 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.06 154.33 39.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.941 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.729 HG22 ' HA3' ' A' ' 97' ' ' GLY . 5.0 t -62.94 -45.79 90.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.777 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -74.7 -38.05 62.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.71 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.696 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.96 78.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.727 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.23 88.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -63.74 -48.27 77.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.374 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -66.13 -39.32 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.11 -44.23 91.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.801 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.61 -50.1 71.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.138 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.35 -48.85 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD13 HG11 ' A' ' 91' ' ' VAL . 96.9 mt -65.52 -35.37 80.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.344 -177.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.67 -33.78 74.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.809 0.338 . . . . 0.0 110.097 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.76 -26.17 65.99 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.67 -24.97 58.89 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.133 0.492 . . . . 0.0 110.413 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.13 18.69 53.07 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 40.4 ttm-85 -81.42 154.17 26.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.395 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB3' ' HA ' ' A' ' 89' ' ' PRO . 37.4 mmt180 -79.23 99.07 6.88 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.674 0.75 . . . . 0.0 110.742 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.514 HG23 HG13 ' A' ' 91' ' ' VAL . 4.1 p -134.49 134.7 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.532 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 36' ' ' ALA . 26.4 t -116.66 137.33 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.23 136.23 58.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.071 0.463 . . . . 0.0 111.178 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.12 112.33 18.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.756 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -105.2 138.68 41.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 -175.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.465 HD11 HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -119.45 91.12 43.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.99 151.67 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.186 2.59 . . . . 0.0 113.213 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 t70 60.9 -169.54 0.16 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.966 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.448 ' HA3' ' CZ ' ' A' ' 98' ' ' ARG . . . 159.14 -48.91 0.41 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.203 177.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.55 152.21 46.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.068 0.461 . . . . 0.0 111.211 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.1 m -131.97 176.4 8.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.815 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.04 -44.42 97.42 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.196 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.75 64.54 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.019 0.438 . . . . 0.0 111.71 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -79.58 99.27 7.24 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 170.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -68.98 133.45 48.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -77.77 102.1 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 165.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -76.89 69.18 3.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -161.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -101.34 -6.48 24.04 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 154.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.7 p80 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 112.714 -2.039 . . . . 0.0 108.234 172.047 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.044 0.45 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -102.58 129.65 49.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.9 133.37 45.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -62.97 -48.31 79.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.8 m -155.89 114.6 3.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.041 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.91 126.85 83.34 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.022 0.439 . . . . 0.0 110.783 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -90.35 -178.91 1.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.041 2.494 . . . . 0.0 112.134 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.76 133.1 35.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.459 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 11' ' ' LEU . 21.1 m -76.56 128.03 33.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.412 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -10.79 59.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.534 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.66 ' H ' HG22 ' A' ' 9' ' ' THR . 89.8 mt -110.16 71.56 0.76 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.184 0.516 . . . . 0.0 110.136 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.62 107.11 1.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.4 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 m -131.24 150.16 52.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.745 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -71.56 129.84 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 p -85.67 -33.73 21.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.711 0.291 . . . . 0.0 111.54 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -145.26 112.34 6.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.58 0.229 . . . . 0.0 110.476 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -70.38 -38.22 74.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.869 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.9 -163.6 44.33 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.781 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.01 -74.84 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.202 0.525 . . . . 0.0 110.277 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.93 31.99 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.469 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.45 119.25 2.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.4 110.07 26.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 36.7 tt0 -97.95 112.62 24.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 110.543 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.07 109.65 29.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.81 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 62.97 43.57 6.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.654 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 70.48 12.04 7.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.819 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -106.04 113.04 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttm105 -90.72 112.84 24.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.346 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.45 117.56 33.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.686 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 55.5 m -93.9 10.53 32.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -148.2 -179.34 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.362 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.74 146.33 46.3 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.22 148.46 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.573 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.3 131.14 48.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.599 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.04 158.2 38.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.312 0.577 . . . . 0.0 111.789 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -131.51 161.87 59.54 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.547 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.83 -46.36 33.9 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.374 2.049 . . . . 0.0 110.981 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -118.27 96.05 5.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.022 172.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.83 178.64 41.03 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.67 138.97 7.43 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.568 2.178 . . . . 0.0 112.718 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.26 103.02 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.2 121.85 42.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.481 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -66.94 120.74 14.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -97.88 127.21 37.93 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -170.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.4 Cg_exo -70.09 3.99 2.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.408 2.739 . . . . 0.0 113.033 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 51' ' ' ASP . 84.7 t -86.14 134.96 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.71 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 50.0 tp60 -107.16 -41.48 5.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.146 0.498 . . . . 0.0 110.155 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.71 ' HG3' ' HG3' ' A' ' 47' ' ' GLN . 63.5 mtt180 -129.5 156.09 79.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.607 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.64 0.11 2.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.16 2.574 . . . . 0.0 113.172 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HB2' ' NH2' ' A' ' 99' ' ' ARG . . . -90.6 -17.23 27.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.148 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.552 ' HB2' HG13 ' A' ' 46' ' ' VAL . 43.5 m-20 -88.15 -16.29 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.048 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.67 114.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.667 -174.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 p -124.27 173.62 8.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.402 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.24 91.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.616 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -60.96 -42.25 97.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.417 0.627 . . . . 0.0 110.797 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.466 HD13 HG22 ' A' ' 46' ' ' VAL . 87.5 mt -71.56 -28.85 64.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.856 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.95 -39.14 87.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.488 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -63.67 -37.93 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.3 -44.84 74.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.27 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.529 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . -76.68 -9.21 58.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.28 23.61 71.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.724 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -63.34 -49.46 73.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.974 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.98 81.37 6.87 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.993 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.93 -63.04 1.48 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.82 95.58 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.577 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 50.2 t -87.28 105.15 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.496 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -106.0 131.14 53.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.156 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.63 158.46 83.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.02 74.79 2.35 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.624 2.216 . . . . 0.0 113.088 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 71' ' ' LEU . 3.8 mm? -77.06 -42.37 38.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.3 74.63 0.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.461 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -86.53 162.11 18.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.766 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.7 mt -91.72 -167.6 1.82 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.462 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.22 -22.69 16.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.739 0.78 . . . . 0.0 109.012 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -76.21 142.94 72.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.821 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.11 -17.27 24.88 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.468 2.112 . . . . 0.0 111.105 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -100.47 95.01 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.2 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.17 2.33 55.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.147 0.498 . . . . 0.0 110.345 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.29 98.83 2.32 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.094 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.12 18.06 15.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.166 0.508 . . . . 0.0 110.441 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.82 32.13 41.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.749 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.08 101.04 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.019 0.438 . . . . 0.0 111.05 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 7.1 ptm180 -130.23 143.44 49.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.298 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 23.9 Cg_exo -63.96 145.83 90.52 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.466 2.111 . . . . 0.0 111.347 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.45 -24.14 66.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.951 0.405 . . . . 0.0 111.087 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -103.39 27.23 7.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.95 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.38 153.25 95.87 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.481 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 86.4 Cg_exo -47.6 132.44 20.57 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.247 2.631 . . . . 0.0 113.368 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.5 mt-10 -77.3 -43.03 34.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 7.1 p -140.66 137.45 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.158 -177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 61' ' ' ALA . 45.1 tp -110.0 118.22 35.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.301 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.3 mt -98.06 120.85 39.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.866 0.365 . . . . 0.0 110.747 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.15 122.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.093 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -100.39 113.09 4.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.189 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 22.2 p -83.76 -66.98 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.743 0.306 . . . . 0.0 111.678 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 -65.26 3.87 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.572 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.559 ' HD2' ' HA ' ' A' ' 147' ' ' ASP . 52.3 mtp85 -69.52 -37.6 77.2 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.769 -0.254 . . . . 0.0 111.217 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 96' ' ' THR . 13.7 ptt180 -161.19 138.47 8.95 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 170.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -81.08 91.5 6.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.391 0.615 . . . . 0.0 111.237 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -94.68 106.98 18.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.534 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.26 149.35 38.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.711 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.5 150.39 21.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.423 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -105.95 165.48 13.87 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.468 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.51 -26.34 82.6 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 123.397 2.731 . . . . 0.0 113.36 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.69 -11.68 44.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.003 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.54 -45.68 8.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.281 0.563 . . . . 0.0 109.995 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 104' ' ' GLY . 27.0 m -90.79 16.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.499 0.666 . . . . 0.0 109.979 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.632 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 33.2 ttt180 -54.25 -52.95 64.37 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.801 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.9 Cg_exo -59.28 -40.51 67.84 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.961 1.774 . . . . 0.0 112.465 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 91.8 mt -73.94 -42.11 61.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 -176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.6 mt -61.45 -38.17 86.23 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.573 0.225 . . . . 0.0 110.955 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -35.02 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 65.7 mtt -76.38 -29.83 57.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.646 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.95 10.82 13.42 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.99 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.7 t -92.12 113.27 27.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -80.33 130.01 9.48 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.567 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.2 124.04 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.988 0.394 . . . . 0.0 110.393 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -114.43 108.62 17.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.311 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.14 111.06 22.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 68.2 mtm -137.85 -171.65 3.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.56 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.25 152.14 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.873 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.548 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 7.7 t -63.77 -38.24 90.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.68 -37.25 42.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.234 0.54 . . . . 0.0 109.94 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.97 90.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.886 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.43 -40.75 70.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.008 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.0 84.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.424 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -72.76 -43.74 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.1 p -67.04 -32.22 73.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.469 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 79.7 t80 -57.56 -44.96 85.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.42 174.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.7 -36.39 84.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.54 -49.81 82.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.59 -30.46 71.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttm -65.72 -42.48 91.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.192 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.7 76.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.85 -16.75 60.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.775 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.39 51.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.206 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -93.25 167.63 11.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.803 0.335 . . . . 0.0 110.924 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.694 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 2.1 mmt180 -83.38 90.66 7.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.119 0.485 . . . . 0.0 109.872 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.4 135.84 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 36' ' ' ALA . 16.7 t -125.61 142.92 40.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.469 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 8.3 p -123.63 140.82 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.1 113.34 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.355 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 98.8 mt -104.11 133.94 48.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.338 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.69 103.99 51.32 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.058 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.31 153.57 40.45 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.969 2.446 . . . . 0.0 112.343 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.559 ' HA ' ' HD2' ' A' ' 98' ' ' ARG . 11.6 t70 -83.99 102.49 12.5 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.61 -4.94 1.14 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.136 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -55.58 -40.48 72.05 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.5 p -128.65 141.57 51.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.691 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.17 -45.74 12.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.42 104.58 7.01 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.029 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -90.18 123.24 33.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.311 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -137.26 117.91 13.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.522 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -78.85 126.61 30.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -78.81 0.59 26.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.641 0.734 . . . . 0.0 109.938 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -143.25 137.41 28.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.288 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 43.8 m80 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.98 -0.533 . . . . 0.0 109.869 178.055 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.639 0.257 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HB2' ' OG1' ' A' ' 5' ' ' THR . 61.5 mttm -106.76 128.28 54.1 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.8 tp -87.3 21.13 2.52 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -166.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -144.41 11.69 1.5 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 2' ' ' LYS . 38.1 p -106.87 136.55 46.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.01 109.26 55.59 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.06 25.24 0.52 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.857 2.371 . . . . 0.0 113.432 -173.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -150.51 168.48 24.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.477 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.1 m -74.14 117.11 15.55 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.21 104.42 16.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.974 0.416 . . . . 0.0 111.059 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.88 85.13 2.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -101.59 112.06 24.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.128 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 m -100.31 143.57 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.413 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.89 115.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.139 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -45.76 73.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.738 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -141.77 110.52 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.21 0.529 . . . . 0.0 111.439 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -99.21 129.31 45.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.769 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 21' ' ' TYR . . . -132.3 -178.17 15.35 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.137 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -86.51 -20.47 27.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.031 0.443 . . . . 0.0 110.46 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.9 17.43 5.72 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.995 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.512 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 27.3 p90 -164.95 150.36 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.74 0.305 . . . . 0.0 110.76 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.44 106.35 15.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -105.6 118.26 36.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.954 0.407 . . . . 0.0 109.954 -177.118 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.29 139.18 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.83 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.26 -83.8 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.667 0.604 . . . . 0.0 110.176 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -152.71 13.27 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.466 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.56 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.003 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 48.0 ttp180 -83.45 107.4 15.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.82 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.74 129.83 35.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.099 0.476 . . . . 0.0 110.941 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 m -108.45 19.09 20.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.887 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -145.44 168.92 19.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . . . -65.8 142.77 57.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.108 0.48 . . . . 0.0 111.598 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.8 pt -137.98 138.82 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.7 118.68 25.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -146.52 163.61 35.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.79 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.23 152.73 70.18 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.1 -32.75 96.28 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.87 2.38 . . . . 0.0 112.959 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.604 ' OE2' ' HD2' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -100.75 19.27 17.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.835 0.35 . . . . 0.0 110.867 -178.016 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.11 -176.15 20.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.853 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.5 -170.28 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.069 2.513 . . . . 0.0 112.437 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.14 116.16 50.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.122 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.68 129.64 35.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.916 0.388 . . . . 0.0 110.74 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p -75.28 121.19 21.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -115.17 117.16 41.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.897 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.26 22.9 0.87 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.228 2.618 . . . . 0.0 113.048 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.34 123.87 41.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.796 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -106.17 -35.93 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.734 0.778 . . . . 0.0 109.389 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 48' ' ' ARG . 47.0 mtm180 -120.18 131.54 24.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.063 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.6 Cg_exo -67.14 8.24 0.39 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.292 2.662 . . . . 0.0 113.092 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.22 -3.01 48.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -109.99 14.09 23.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.2 119.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 111.193 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 p -104.14 168.46 9.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -65.05 -30.04 70.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 p -66.26 -42.14 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.774 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.53 -34.77 79.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.624 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.504 ' HB3' HD11 ' A' ' 111' ' ' LEU . 96.7 mt -63.53 -42.42 98.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.15 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.426 ' HG2' HD21 ' A' ' 111' ' ' LEU . 91.1 mt-30 -66.15 -36.63 83.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 110.96 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -71.24 -36.67 71.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.464 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.02 -27.37 67.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.938 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -73.79 -9.12 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.936 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.62 15.32 78.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.523 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' HD3' ' A' ' 89' ' ' PRO . 90.1 mt -88.79 15.4 8.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.101 0.477 . . . . 0.0 111.055 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.06 -16.95 20.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -123.13 117.51 25.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.992 0.425 . . . . 0.0 110.658 -177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.23 122.37 39.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.301 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.6 t -93.84 130.86 42.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.194 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -123.51 143.04 50.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.675 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.11 162.83 57.97 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.24 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.4 153.87 16.45 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.519 2.146 . . . . 0.0 112.286 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.76 1.23 5.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.061 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.41 -10.06 53.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.04 0.447 . . . . 0.0 110.384 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -111.96 116.2 30.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.976 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.5 tp -100.06 127.37 46.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.905 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.423 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 7.3 m-20 -74.82 165.83 24.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.035 0.445 . . . . 0.0 111.185 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.613 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 3.9 mp0 -74.97 -51.12 3.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.632 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 76' ' ' GLU . 16.5 Cg_exo -69.09 -174.22 0.74 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.224 1.949 . . . . 0.0 112.251 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -82.78 -23.49 33.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.469 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . . . -95.63 156.69 16.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.093 176.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.92 -176.17 41.06 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.726 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 73.01 -50.31 0.7 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.498 0.719 . . . . 0.0 111.776 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.57 -55.61 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.931 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . . . 62.92 23.94 14.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.395 0.617 . . . . 0.0 110.245 -175.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -107.58 150.32 39.99 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.553 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -52.86 -34.3 65.19 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.993 2.462 . . . . 0.0 112.973 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.84 -3.61 19.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -75.54 -30.7 59.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.865 0.364 . . . . 0.0 110.399 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -81.27 151.69 69.78 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.08 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD3' HD21 ' A' ' 63' ' ' LEU . 17.3 Cg_exo -66.51 121.48 8.74 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 111.735 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 109.878 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.686 HG11 HD13 ' A' ' 133' ' ' LEU . 6.4 p -134.12 135.29 54.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.731 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.49 104.72 12.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.427 HD11 HD12 ' A' ' 133' ' ' LEU . 93.9 mt -90.13 110.75 21.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.691 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.78 112.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.436 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.63 92.68 1.79 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.544 ' HA ' HD12 ' A' ' 145' ' ' LEU . 1.3 m -60.75 -24.84 66.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.712 0.405 . . . . 0.0 112.072 -171.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 79.61 -68.62 3.16 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.546 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.83 HH22 ' HB3' ' A' ' 149' ' ' ASP . 29.2 ttm180 -92.82 82.08 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.881 0.372 . . . . 0.0 110.578 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 63.25 -173.99 0.16 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.149 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -90.22 143.3 26.89 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.936 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -136.7 126.72 26.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.851 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -80.96 111.78 17.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.463 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.8 mt -76.85 170.18 16.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 159.53 15.1 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.774 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.27 -34.92 98.06 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.941 2.427 . . . . 0.0 111.91 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.42 -20.59 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 88.9 mt-30 -96.34 -63.19 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.814 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.3 -18.93 8.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 37.0 ttt180 -57.84 -46.51 99.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 73.2 Cg_exo -53.11 -34.3 67.74 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.165 1.91 . . . . 0.0 112.875 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 57' ' ' LEU . 92.3 mt -76.45 -42.09 45.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.641 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.28 -26.52 68.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 0.0 110.467 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.74 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 60.1 mtt -90.82 -7.46 52.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.883 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.48 51.17 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.091 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -91.83 117.16 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.799 0.333 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.65 93.94 1.7 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.961 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.81 120.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -125.29 127.15 46.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.415 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.67 116.67 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.3 mtm -142.34 -171.79 3.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.588 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.32 153.63 42.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.415 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 9.0 m -57.95 -42.96 86.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.261 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.47 -48.45 81.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.46 -50.16 68.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.791 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.69 91.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -60.12 -50.24 74.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.424 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.1 m -65.47 -36.01 82.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.47 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -59.01 -46.88 87.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -56.93 -42.9 80.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.712 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.65 -52.76 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.794 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.686 HD13 HG11 ' A' ' 91' ' ' VAL . 94.7 mt -64.4 -35.23 80.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.507 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 45.0 ttp -65.31 -41.3 94.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.77 73.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.671 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -73.11 -20.57 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.8 39.26 29.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.752 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -97.27 162.69 13.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.578 0.228 . . . . 0.0 110.89 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.604 ' HD2' ' OE2' ' A' ' 38' ' ' GLU . 16.7 mmm180 -75.25 80.84 2.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.0 120.51 64.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.18 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 36' ' ' ALA . 43.9 t -109.87 132.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -117.92 133.8 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.12 0.486 . . . . 0.0 111.122 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.86 110.0 17.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.347 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -100.57 120.97 40.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.944 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 96' ' ' THR . 73.6 mt -104.21 107.04 56.23 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.629 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.84 141.29 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.236 1.957 . . . . 0.0 110.405 169.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -64.29 150.04 46.86 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.06 -4.36 1.33 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.993 -172.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.83 ' HB3' HH22 ' A' ' 98' ' ' ARG . 8.5 t70 -112.96 153.06 28.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.7 m -85.49 -23.05 27.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.603 -174.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 82.3 mt -126.08 159.37 32.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.742 0.306 . . . . 0.0 111.313 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.29 -36.54 75.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.958 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -120.61 131.63 54.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.694 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -72.49 -21.46 61.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.268 0.556 . . . . 0.0 109.803 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -99.16 133.54 43.3 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -58.16 -39.33 78.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.961 0.41 . . . . 0.0 110.858 -174.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -135.87 95.21 3.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.09 173.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.867 179.102 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.486 0.184 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -113.53 164.3 13.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.816 0.341 . . . . 0.0 111.027 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.54 -36.15 22.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -129.15 103.82 7.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.702 169.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 m -88.74 55.68 3.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.111 0.482 . . . . 0.0 110.895 -174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -175.35 128.06 0.39 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.544 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.07 -27.67 29.48 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.702 2.268 . . . . 0.0 113.146 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -152.74 126.91 9.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.409 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 p -73.97 86.67 1.81 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 68.43 -67.39 0.2 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.965 0.906 . . . . 0.0 113.088 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.3 mt 63.26 66.84 0.69 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.49 0.662 . . . . 0.0 110.149 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -65.48 108.43 1.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.218 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 m -118.17 137.04 53.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.073 0.463 . . . . 0.0 111.816 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 24' ' ' VAL . 63.9 t -67.74 132.96 32.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 174.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 p -94.69 -45.67 7.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.736 0.303 . . . . 0.0 111.688 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.15 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 0.0 111.163 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -105.98 -76.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.838 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.77 -111.75 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.027 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -162.25 130.91 4.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -49.09 3.71 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.915 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -111.71 170.24 8.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 110.987 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.96 117.19 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.447 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 29.5 tt0 -96.87 117.81 31.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.053 0.454 . . . . 0.0 110.797 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 14' ' ' VAL . 25.6 t -113.54 124.37 70.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.639 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 66.67 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.728 0.642 . . . . 0.0 111.376 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -141.34 -3.97 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.11 122.3 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.117 -172.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 12.8 ptt180 -85.76 111.42 20.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.978 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.41 120.08 31.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.3 m -101.97 23.54 11.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.54 0.686 . . . . 0.0 109.572 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -141.7 163.59 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.398 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.72 57.76 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.396 0.435 . . . . 0.0 110.991 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -137.04 137.52 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.32 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.76 109.68 14.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.546 -0.752 . . . . 0.0 108.973 173.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.419 ' HB3' HG13 ' A' ' 41' ' ' VAL . 37.5 p90 -126.43 147.13 49.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 112.359 -173.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -101.95 157.64 33.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.932 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 26.5 Cg_endo -62.84 -17.53 60.0 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.625 2.217 . . . . 0.0 113.116 -176.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 43.1 mt-10 -89.31 9.23 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.3 -69.57 0.41 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.646 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' A' ' 38' ' ' GLU . 4.5 Cg_exo -37.99 119.85 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.592 3.528 . . . . 0.0 114.923 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 35' ' ' PHE . 41.9 t -113.25 113.56 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.925 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 135.77 33.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.664 0.268 . . . . 0.0 110.794 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 m -88.78 137.89 31.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 m0 -121.15 131.8 24.38 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.3 Cg_exo -81.52 20.5 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.487 2.791 . . . . 0.0 111.619 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 51' ' ' ASP . 92.4 t -94.75 123.32 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.418 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 6.32 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.293 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 152.83 30.26 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.39 14.48 0.38 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.934 2.423 . . . . 0.0 113.162 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.67 -29.53 15.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.258 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.577 ' HB2' HG13 ' A' ' 46' ' ' VAL . 28.9 m-20 -77.79 -20.78 52.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.226 -175.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.45 HD13 HG11 ' A' ' 94' ' ' VAL . 23.0 mt -60.04 110.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.22 0.533 . . . . 0.0 111.194 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.45 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -131.44 165.6 23.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.482 -178.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.61 65.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.721 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 3.4 p -62.55 -50.74 70.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.856 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.51 -36.91 84.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.824 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' HD11 ' A' ' 111' ' ' LEU . 97.5 mt -61.46 -41.86 97.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.98 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.85 -33.17 74.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.86 0.362 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 55' ' ' SER . 87.9 mt-30 -71.38 -35.83 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.75 -26.53 40.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.04 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 89' ' ' PRO . . . -77.77 -10.68 59.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.135 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.57 35.17 67.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.623 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.1 mt -77.91 2.1 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 0.0 111.283 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.26 -169.37 2.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.2 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -81.65 131.07 35.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.716 0.293 . . . . 0.0 110.589 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.18 104.63 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.745 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.65 106.7 16.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.27 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -78.23 146.38 34.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.443 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 4.6 p-10 -84.49 137.26 39.15 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 121.123 0.487 . . . . 0.0 110.885 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 93.1 Cg_endo -91.34 120.03 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.097 2.531 . . . . 0.0 112.882 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.0 mt -103.12 -5.45 23.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.013 0.435 . . . . 0.0 110.946 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.59 -6.85 11.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.222 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -139.03 116.19 11.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.535 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.89 -2.1 58.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.702 0.763 . . . . 0.0 109.489 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.58 -11.07 59.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.849 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 62.87 96.03 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.394 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.2 85.26 1.05 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.649 2.233 . . . . 0.0 111.337 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.3 -49.61 22.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.722 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 98.85 4.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.604 173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.03 27.91 6.39 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.164 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.37 -29.06 68.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.681 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.08 -22.69 78.84 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.12 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.57 -39.3 0.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.845 0.858 . . . . 0.0 112.784 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -107.2 118.01 54.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.72 49.78 2.82 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.416 2.744 . . . . 0.0 113.376 -173.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.58 -65.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.871 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 65.6 t30 56.9 61.51 2.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.743 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.66 124.06 9.34 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.816 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.448 ' O ' HG22 ' A' ' 116' ' ' VAL . 26.0 Cg_endo -63.92 153.47 75.57 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.588 2.192 . . . . 0.0 112.531 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.35 -51.7 6.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.024 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.37 136.65 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 tp -115.33 119.01 34.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.79 119.91 39.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.45 HG11 HD13 ' A' ' 52' ' ' ILE . 58.9 t -111.84 117.87 56.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.363 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.83 102.29 2.9 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 101' ' ' HIS . 6.1 p -78.15 19.12 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.8 -85.03 1.09 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.234 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -79.19 -33.58 43.77 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -169.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -142.3 -173.72 3.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HG2' ' H ' ' A' ' 122' ' ' ASP . 93.0 mt-30 -95.31 82.46 3.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.648 165.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.467 ' HB3' HG21 ' A' ' 96' ' ' THR . 58.5 t-80 -94.8 101.77 13.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.726 -174.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 120' ' ' ALA . 48.0 tp -64.76 143.22 58.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.67 -165.71 1.03 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.324 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.95 150.51 16.92 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.765 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.69 -37.19 83.74 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.265 2.643 . . . . 0.0 112.758 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -72.96 -33.38 65.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.944 0.402 . . . . 0.0 110.761 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.05 -42.32 73.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.1 m -89.99 -6.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.35 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -50.5 87.83 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -54.02 -40.45 81.19 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.14 1.893 . . . . 0.0 112.615 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 64.7 mt -77.63 -38.08 48.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.129 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 73.8 mt -61.89 -34.34 75.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.11 63.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.6 mtt -91.11 -11.87 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.6 8.79 55.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.0 t -86.69 111.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.742 0.306 . . . . 0.0 110.44 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.69 104.28 2.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.146 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -91.04 120.19 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.738 0.304 . . . . 0.0 111.027 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -118.48 115.78 25.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.422 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 102' ' ' LEU . . . -99.05 118.52 36.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.655 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.4 mtm -140.02 -171.82 3.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.221 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.505 ' H ' ' HG2' ' A' ' 100' ' ' GLN . 12.8 t70 -70.31 151.55 45.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.534 HG23 HD22 ' A' ' 144' ' ' LEU . 63.8 m -56.96 -37.99 72.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 111.002 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.72 -42.84 70.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.463 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.51 -41.6 84.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.944 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.43 -38.71 90.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.849 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -52.21 66.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.157 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -61.84 -40.18 94.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.999 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 41.0 m -64.8 -40.32 95.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.398 . . . . 0.0 110.474 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -60.93 -46.76 89.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.711 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -58.32 -37.68 75.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 79.4 mt -68.52 -53.86 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.608 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.681 HD22 ' HD2' ' A' ' 138' ' ' ARG . 61.9 mt -61.91 -41.63 98.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -64.93 -39.47 93.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.579 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.71 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 44.8 mt-10 -73.84 -26.31 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 22.82 12.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.256 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.681 ' HD2' HD22 ' A' ' 133' ' ' LEU . 56.1 mtt-85 -80.35 157.68 26.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.843 0.354 . . . . 0.0 110.204 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.0 83.38 6.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.248 0.547 . . . . 0.0 109.932 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.32 134.72 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.529 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.35 136.83 53.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.6 p -120.69 134.46 64.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.048 0.451 . . . . 0.0 111.411 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.14 113.07 20.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.563 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.534 HD22 HG23 ' A' ' 123' ' ' THR . 91.3 mt -108.4 133.97 51.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.671 -175.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 52' ' ' ILE . 83.5 mt -111.0 105.65 57.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.918 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -87.01 128.89 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.212 2.608 . . . . 0.0 110.589 166.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.15 -164.36 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.707 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.13 -4.66 1.27 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.633 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.18 -29.16 34.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.02 0.438 . . . . 0.0 109.903 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.6 m -72.04 118.37 14.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.876 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 81.1 mt -77.43 -178.91 5.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.643 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -38.48 65.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -148.8 165.3 31.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -75.42 -32.29 60.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.477 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -82.36 74.62 9.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.375 0.607 . . . . 0.0 110.344 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -91.16 129.49 37.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -97.14 15.59 22.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -168.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.062 175.161 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.599 0.238 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -98.04 118.49 34.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.82 148.25 50.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.474 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -88.37 88.61 7.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -51.61 125.2 14.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.699 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.88 132.49 86.7 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.0 124.69 9.1 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.9 2.4 . . . . 0.0 112.392 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.56 -57.1 14.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 109.814 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -94.2 146.55 23.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.301 171.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.3 93.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 37' ' ' PRO . 54.7 mt -67.84 106.47 2.29 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.915 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.67 95.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.452 . . . . 0.0 109.971 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -91.31 129.19 37.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.502 -173.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.37 107.32 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 m -79.84 -36.88 36.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.003 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.53 130.74 15.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.203 0.525 . . . . 0.0 111.375 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -100.4 106.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 -170.73 34.66 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.116 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.54 -58.68 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.226 0.536 . . . . 0.0 110.59 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.11 38.11 1.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.766 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -151.76 143.87 23.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.906 0.384 . . . . 0.0 110.294 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.28 118.62 59.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.82 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.77 112.0 23.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.733 0.301 . . . . 0.0 110.274 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.51 115.16 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.999 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 72.12 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.625 0.77 . . . . 0.0 110.428 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -174.88 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.283 0.633 . . . . 0.0 109.364 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.09 126.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.367 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -95.06 121.1 36.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.604 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.7 113.2 26.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.604 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -92.78 19.91 7.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.568 0.699 . . . . 0.0 110.106 175.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -130.59 151.84 50.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.665 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 44' ' ' TRP . . . -58.56 136.8 57.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.7 pt -141.85 154.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.097 0.475 . . . . 0.0 111.723 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.31 124.04 28.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.327 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -146.24 163.13 36.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.032 0.444 . . . . 0.0 111.529 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -126.65 163.56 40.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -176.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 63.7 Cg_endo -73.4 23.52 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.706 2.27 . . . . 0.0 112.914 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ALA . 38.9 tt0 -173.49 90.3 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.04 -165.04 29.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.878 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.88 167.22 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.2 2.6 . . . . 0.0 113.034 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.84 122.9 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.148 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.12 140.72 29.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.1 p -84.41 119.73 25.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.069 0.461 . . . . 0.0 110.594 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.409 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.3 t90 -98.24 116.4 65.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.737 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.15 35.55 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.267 2.645 . . . . 0.0 114.043 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 51' ' ' ASP . 94.6 t -101.14 133.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.684 0.278 . . . . 0.0 110.577 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -113.84 -43.93 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.477 . . . . 0.0 110.554 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -116.92 151.99 48.09 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.24 -6.66 10.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.746 2.297 . . . . 0.0 112.539 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.39 -3.52 46.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.552 ' HB2' HG13 ' A' ' 46' ' ' VAL . 64.2 m-20 -84.19 -28.16 27.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.555 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.4 mt -55.45 113.73 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.759 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 39.1 p -128.95 175.14 8.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -58.29 -44.92 88.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.043 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 m -60.93 -42.43 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.5 HD13 HG22 ' A' ' 46' ' ' VAL . 80.7 mt -70.51 -28.26 64.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' A' ' 111' ' ' LEU . 83.7 mt -73.45 -30.06 62.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.79 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 95.2 mt-30 -63.75 -43.63 95.86 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 174.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.47 -42.29 92.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.706 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.77 76.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.637 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.48 0.66 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.35 82.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.427 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.53 -4.28 29.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.303 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 -5.76 58.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -120.56 158.32 27.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.169 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.02 109.78 29.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.333 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.06 -32.76 55.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.123 0.487 . . . . 0.0 110.553 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -85.84 57.14 4.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.287 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.68 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 20.3 t70 -73.44 -53.35 4.62 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.78 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 69' ' ' ASP . 24.0 Cg_exo -64.88 141.11 69.79 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.136 1.891 . . . . 0.0 112.428 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.07 -9.66 56.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.208 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.5 83.13 8.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.755 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -76.28 -10.06 59.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.613 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.87 -24.53 66.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.341 173.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -83.24 -31.91 26.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.029 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 66.08 86.88 0.13 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.675 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HG3' ' HD2' ' A' ' 70' ' ' PRO . 55.7 Cg_endo -73.91 -20.25 19.81 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.522 2.148 . . . . 0.0 111.201 172.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -107.18 132.76 52.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.433 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.96 70.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.614 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.26 18.43 8.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.028 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HB3' ' HG2' ' A' ' 139' ' ' ARG . . . -93.92 -2.68 52.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.016 0.436 . . . . 0.0 110.704 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.55 101.27 2.36 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.628 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.67 -7.86 57.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.151 0.5 . . . . 0.0 110.912 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.465 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 17.6 mmm180 -102.92 138.81 19.67 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.859 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 32.0 Cg_exo -60.79 -19.89 63.51 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.062 2.508 . . . . 0.0 112.885 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.75 -1.5 38.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.316 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.1 m120 64.08 37.48 9.08 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.516 0.51 . . . . 0.0 110.916 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.501 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -64.98 133.7 95.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.04 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 2.8 Cg_exo -75.54 151.21 36.9 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.041 2.494 . . . . 0.0 112.125 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -67.27 -44.83 78.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.934 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 140' ' ' VAL . 5.4 p -132.4 136.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.484 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 141' ' ' VAL . 62.3 tp -118.07 121.94 41.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.184 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.19 120.85 42.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.5 t -103.31 119.84 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.941 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' A' ' 144' ' ' LEU . . . -98.26 98.81 2.1 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.587 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -126.49 93.0 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.45 -10.21 39.16 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.453 -0.88 . . . . 0.0 114.46 -170.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HD3' ' CG ' ' A' ' 147' ' ' ASP . 41.9 ttp180 -89.51 -26.41 20.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.716 0.758 . . . . 0.0 110.168 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -159.53 94.24 1.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.902 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -65.23 109.5 2.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.29 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -106.13 122.41 46.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.891 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.7 134.07 39.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.134 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.4 mt -94.12 137.12 33.67 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.28 171.08 17.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.075 -171.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.42 -44.06 30.87 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.745 2.963 . . . . 0.0 113.351 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.24 -46.8 69.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.133 0.492 . . . . 0.0 111.404 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 92.8 mt-30 -75.98 -12.55 60.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.581 -173.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.03 14.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.656 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.2 mtm105 -55.84 -54.89 46.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.656 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 24.3 Cg_exo -64.15 -26.71 64.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.842 1.695 . . . . 0.0 111.907 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 57' ' ' LEU . 75.3 mt -78.72 -46.6 18.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.08 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.73 -34.65 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.832 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.89 65.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.188 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 50.4 mtt -94.3 -7.83 40.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.006 0.432 . . . . 0.0 110.215 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.95 -8.51 55.98 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.13 122.0 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 0.0 111.004 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.67 109.63 3.78 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.74 110.33 24.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.84 0.352 . . . . 0.0 110.917 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -108.55 116.93 32.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.388 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.95 29.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.495 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.1 mtm -137.49 -172.78 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.304 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.9 159.02 29.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.691 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 p -59.02 -53.04 62.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.967 0.413 . . . . 0.0 110.973 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -65.33 -36.81 85.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.17 75.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 0.0 110.893 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.46 90.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.668 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.391 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -65.18 -42.69 93.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.979 0.418 . . . . 0.0 110.485 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.0 m -65.3 -34.39 78.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.979 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.413 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 60.6 t80 -61.69 -42.76 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.95 177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -57.2 -45.23 83.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.014 0.435 . . . . 0.0 110.586 175.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.72 -53.34 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.429 ' HB2' HG11 ' A' ' 140' ' ' VAL . 93.1 mt -62.43 -31.23 71.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 37.5 ttm -59.96 -50.23 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.493 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.69 72.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.076 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.78 -23.49 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.11 18.63 58.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.552 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -82.69 144.51 30.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HG2' ' HB3' ' A' ' 81' ' ' ALA . 11.7 mmt180 -70.71 94.09 0.99 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.077 0.465 . . . . 0.0 110.894 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 133' ' ' LEU . 7.4 p -126.37 138.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.41 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' A' ' 36' ' ' ALA . 44.9 t -118.89 134.92 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.1 p -115.9 128.69 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 0.0 111.002 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.8 109.82 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.521 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.503 HD23 ' HA3' ' A' ' 95' ' ' GLY . 96.1 mt -113.36 136.47 52.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.706 -173.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 91.7 mt -93.72 133.78 27.41 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.245 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 14.9 Cg_exo -68.07 87.6 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.762 2.308 . . . . 0.0 112.804 -178.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.401 ' CG ' ' HD3' ' A' ' 98' ' ' ARG . 7.0 t70 -168.15 -161.77 0.38 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.58 -5.32 0.11 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.511 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -131.19 124.44 30.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.937 0.398 . . . . 0.0 110.596 -176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.1 p -67.13 151.56 47.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.648 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.2 tp -59.53 -46.56 88.51 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.02 106.41 3.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -120.9 99.37 6.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.09 0.471 . . . . 0.0 110.937 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -79.7 148.6 31.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -71.69 -14.0 61.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.805 0.336 . . . . 0.0 110.998 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -66.89 -25.73 66.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.407 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -88.23 122.14 31.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.895 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 59.1 m80 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.801 -178.33 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.75 0.31 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -91.04 -43.3 10.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 109.98 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.0 tp -87.85 146.11 25.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.354 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -126.69 92.88 3.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.56 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -75.67 147.6 39.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.464 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 5.1 p-10 -75.47 133.71 73.9 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.224 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 21.1 Cg_exo -65.86 145.39 80.29 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 123.041 2.494 . . . . 0.0 112.298 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.19 179.08 5.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.972 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -115.83 169.95 8.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . -81.12 129.13 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 0.0 110.965 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.491 HD22 ' HG2' ' A' ' 134' ' ' MET . 71.9 mt -90.62 93.26 9.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.927 -178.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -78.87 98.97 6.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.1 m -108.32 137.05 46.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.091 0.472 . . . . 0.0 111.931 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 24' ' ' VAL . 80.1 t -73.12 126.16 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.479 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.9 p -87.63 -34.65 18.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.61 0.243 . . . . 0.0 111.314 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.77 172.96 12.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.754 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.24 -33.33 6.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.95 -118.46 14.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.962 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -157.42 107.19 2.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.857 0.361 . . . . 0.0 110.475 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.09 18.96 48.49 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.213 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.938 ' HE1' ' HB2' ' A' ' 23' ' ' GLU . 44.3 p90 -160.34 176.25 11.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.873 0.337 . . . . 0.0 110.593 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.2 mt -123.85 122.13 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.938 ' HB2' ' HE1' ' A' ' 21' ' ' TYR . 28.5 tt0 -105.44 108.85 20.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -172.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 14' ' ' VAL . 57.7 t -109.91 107.6 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.946 177.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 58.3 53.63 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.274 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 72.96 -17.97 0.38 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.619 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 40.3 t -74.72 123.14 29.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.145 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -93.27 102.76 15.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.29 118.05 30.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.563 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -95.14 20.3 9.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.217 0.532 . . . . 0.0 110.133 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -151.08 163.87 37.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.898 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.09 146.62 53.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.197 0.522 . . . . 0.0 112.408 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.73 151.0 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.871 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.47 127.3 40.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -148.31 153.46 38.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.041 0.448 . . . . 0.0 111.397 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.65 159.28 65.91 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 50.0 Cg_exo -55.0 -41.36 79.66 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.608 2.205 . . . . 0.0 112.063 174.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -102.99 94.71 5.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.74 -175.0 23.92 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.815 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -97.89 -178.06 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.365 2.71 . . . . 0.0 112.746 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.21 111.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.14 36.94 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 t -79.2 119.01 21.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.515 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.1 126.0 41.75 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -175.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.5 Cg_exo -69.58 -7.46 21.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.27 2.647 . . . . 0.0 113.048 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.636 HG11 HG12 ' A' ' 52' ' ' ILE . 48.5 t -86.26 102.6 11.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.413 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -98.23 -7.98 28.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.199 0.523 . . . . 0.0 110.448 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.621 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 12.1 mtm180 -138.57 146.26 50.03 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.917 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.606 ' HG3' ' HB3' ' A' ' 98' ' ' ARG . 33.8 Cg_endo -64.74 -9.79 22.33 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.799 2.333 . . . . 0.0 113.259 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.4 -2.98 47.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.468 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.621 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 3.6 m-20 -103.39 9.88 37.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.207 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.636 HG12 HG11 ' A' ' 46' ' ' VAL . 58.2 mt -84.7 126.52 40.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.731 0.301 . . . . 0.0 111.578 -175.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.9 p -128.76 166.61 18.67 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.47 -39.38 83.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.473 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 m -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.247 0.546 . . . . 0.0 110.854 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD13 ' CG2' ' A' ' 46' ' ' VAL . 71.1 mt -72.3 -28.86 63.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.75 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.33 -37.79 80.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.252 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.52 -39.62 94.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.231 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -66.21 -41.53 89.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.574 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -20.26 65.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.546 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.74 -7.42 55.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.21 76.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.485 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt -97.48 17.49 17.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.042 0.448 . . . . 0.0 110.837 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.14 95.81 4.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' OE1' ' HD3' ' A' ' 68' ' ' ARG . 48.5 mt-10 -96.62 95.27 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.088 0.471 . . . . 0.0 110.167 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.9 t -59.91 -24.76 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.155 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -73.02 -14.44 16.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.316 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 14.9 mtm-85 -89.64 -42.95 11.08 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.836 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.48 90.57 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.431 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.97 126.44 17.29 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.562 2.175 . . . . 0.0 111.302 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.5 mt -58.73 -41.53 86.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.271 0.558 . . . . 0.0 110.553 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.53 166.76 28.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.556 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -87.51 12.81 11.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.234 0.54 . . . . 0.0 110.026 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.7 mt -129.15 135.59 49.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.064 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.58 73.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.892 0.745 . . . . 0.0 112.647 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 41.8 tt0 -135.99 129.77 18.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 171.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 17.0 Cg_exo -69.44 59.78 1.48 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.287 2.658 . . . . 0.0 113.258 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 43.4 mt-10 67.97 -72.39 0.1 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.714 0.806 . . . . 0.0 112.651 173.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.82 30.82 6.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.065 0.46 . . . . 0.0 110.78 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.2 -69.1 2.55 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -176.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.35 87.29 3.38 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 171.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.8 64.73 4.05 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.695 -170.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.96 -28.54 62.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.604 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 18.8 ptt-85 -124.82 169.05 11.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.521 174.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 84' ' ' ARG . 21.9 Cg_endo -61.86 171.98 4.27 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.197 1.931 . . . . 0.0 112.485 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 78' ' ' GLU . . . -59.82 -26.92 66.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.989 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.516 ' HB3' ' NH2' ' A' ' 139' ' ' ARG . 5.5 m-20 65.48 46.5 2.5 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.078 0.466 . . . . 0.0 110.835 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.25 143.44 79.36 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.112 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.84 164.56 34.17 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.556 2.171 . . . . 0.0 112.414 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 42.0 mt-10 -92.29 -44.13 8.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 140' ' ' VAL . 7.5 p -139.37 136.87 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.073 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.9 tp -113.28 112.03 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.547 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.99 108.6 21.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.404 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.12 106.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.49 98.4 1.39 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 49' ' ' PRO . 5.3 m -65.96 -14.76 62.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -170.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.34 -72.9 2.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.974 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.606 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 39.6 ttm180 -85.81 70.35 10.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 0.0 110.074 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 66.28 154.46 0.08 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.726 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 53.7 tt0 -62.53 128.92 38.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.878 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -112.93 138.05 50.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.41 97.12 10.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.43 170.74 15.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.321 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.9 144.09 15.78 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.393 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.525 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 48.9 Cg_exo -55.78 -36.47 95.29 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.439 2.759 . . . . 0.0 113.296 -173.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.566 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 10.9 mm-40 -63.66 -28.87 70.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -88.26 -9.88 51.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.371 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.17 5.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 110.9 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.589 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.7 mmt180 -53.41 -52.79 63.29 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.292 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 61.7 Cg_exo -53.32 -39.68 80.45 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.153 1.902 . . . . 0.0 112.739 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.2 mt -78.72 -42.12 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.024 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.7 -37.06 80.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 110.617 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.75 70.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 65.1 mtt -83.61 -15.34 49.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.97 8.37 42.15 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.177 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 38.2 t -86.54 108.61 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.744 0.307 . . . . 0.0 110.576 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.75 107.23 2.32 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.828 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.5 t -87.09 111.74 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.783 0.325 . . . . 0.0 110.623 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -112.71 117.5 32.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.388 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 100' ' ' GLN . . . -101.98 115.95 31.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.319 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.478 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 65.4 mtm -139.51 -172.81 3.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.052 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.58 157.34 37.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 34.5 m -60.14 -45.83 91.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.241 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -64.39 -41.02 96.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 110.793 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.46 96.43 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.32 86.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.561 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.43 96.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.447 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -62.72 -48.62 78.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.277 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.0 m -62.73 -38.36 90.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.38 -44.04 95.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.75 -46.54 74.34 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 110.711 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.89 -52.25 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.84 -31.44 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.54 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.491 ' HG2' HD22 ' A' ' 11' ' ' LEU . 48.9 ttp -66.84 -43.23 84.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.825 0.345 . . . . 0.0 110.283 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.98 86.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.16 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.45 36.14 5.22 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.347 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -100.91 161.42 13.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.605 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 55.4 mtp85 -78.57 77.98 5.04 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.368 0.604 . . . . 0.0 111.024 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 91' ' ' VAL . 5.7 p -112.04 132.96 59.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.372 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 36' ' ' ALA . 38.5 t -115.65 134.04 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.5 p -119.04 135.45 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.248 0.546 . . . . 0.0 111.226 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 117.78 30.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.188 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.2 mt -107.37 120.44 42.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.173 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.44 HD21 ' CZ3' ' A' ' 44' ' ' TRP . 71.9 mt -100.96 130.09 25.87 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.278 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 1.9 Cg_endo -82.22 105.73 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.995 2.463 . . . . 0.0 110.995 174.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.38 101.61 0.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.19 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.55 -62.93 0.3 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.085 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.4 t70 55.17 53.22 10.42 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.509 1.147 . . . . 0.0 108.473 -169.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.3 m -73.63 -25.02 60.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.032 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.02 109.8 12.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.437 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.503 ' HG2' ' CE1' ' A' ' 158' ' ' HIS . 31.7 mt-10 -76.33 106.46 7.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.215 0.531 . . . . 0.0 109.683 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.406 ' HD2' ' O ' ' A' ' 158' ' ' HIS . 44.0 m-70 -67.41 117.21 9.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.393 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 156' ' ' HIS . 16.2 t-80 -73.58 -19.05 60.99 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 111.007 -174.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -82.96 36.46 0.5 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.256 1.027 . . . . 0.0 108.469 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.434 ' H ' ' C ' ' A' ' 154' ' ' HIS . 4.8 t-80 179.2 -177.47 0.3 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -170.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -90.97 -56.15 3.28 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.503 ' CE1' ' HG2' ' A' ' 152' ' ' GLU . 9.9 t60 . . . . . 0 C--O 1.246 0.902 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 170.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.99 119.4 9.38 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.88 0.372 . . . . 0.0 110.282 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt -71.21 164.26 26.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.497 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -102.68 -28.9 11.85 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.8 p -76.72 -30.63 56.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.56 104.46 52.89 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.622 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.95 129.66 22.53 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 123.136 2.558 . . . . 0.0 112.716 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.51 107.83 15.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.2 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -61.65 129.96 43.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.819 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.51 69.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.029 0.442 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.9 tp -109.71 117.01 32.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.593 HD21 ' HB2' ' A' ' 35' ' ' PHE . 56.8 t30 -75.05 109.75 8.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -147.06 146.14 29.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.934 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.87 118.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.16 17.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.33 -175.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -147.44 119.31 8.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.083 0.468 . . . . 0.0 111.332 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -113.18 116.54 29.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.416 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.58 -164.1 9.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.831 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.67 109.05 18.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.748 0.309 . . . . 0.0 110.874 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 147' ' ' ASP . . . 91.2 1.0 72.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.437 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -153.43 142.12 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.556 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.0 mt -126.36 111.95 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.254 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -93.69 117.99 30.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.024 0.44 . . . . 0.0 110.436 -176.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.49 113.05 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.741 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 62.32 39.41 12.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 72.19 9.53 5.95 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.773 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.68 107.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 31.0 ptt-85 -81.53 114.85 20.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.323 0.583 . . . . 0.0 110.394 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.39 128.03 43.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.907 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 p -104.55 14.37 30.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.462 0.649 . . . . 0.0 109.717 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -137.68 171.25 14.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.378 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -62.27 141.71 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.555 0.534 . . . . 0.0 111.687 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 pt -142.11 136.41 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.26 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.3 120.87 37.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.308 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.593 ' HB2' HD21 ' A' ' 12' ' ' ASN . 40.2 p90 -149.88 162.78 39.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.165 0.507 . . . . 0.0 111.834 -173.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -130.68 158.62 74.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.747 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.689 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 19.3 Cg_endo -60.1 -32.42 94.68 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.604 2.203 . . . . 0.0 111.702 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -130.44 103.44 6.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.171 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.58 -156.14 26.52 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.923 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.64 162.22 6.43 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.836 2.357 . . . . 0.0 113.091 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -114.27 101.6 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.68 118.99 38.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.954 0.407 . . . . 0.0 111.641 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 65.6 m -66.88 132.66 48.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 170.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.55 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -97.93 129.74 30.42 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -171.244 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.55 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.83 -0.93 6.0 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.884 2.389 . . . . 0.0 112.917 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' CG2' HD13 ' A' ' 56' ' ' LEU . 46.8 t -86.22 96.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -89.54 -20.96 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 109.734 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -129.04 130.85 23.44 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.46 12.06 0.26 Allowed 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.058 2.505 . . . . 0.0 113.669 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.47 -2.59 58.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.998 0.428 . . . . 0.0 110.428 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.87 69.31 1.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.883 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 66.6 mt -115.26 107.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.159 173.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 61.1 p -113.85 174.9 5.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.952 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -62.73 -44.0 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.7 m -59.6 -39.32 83.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.025 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.413 HD13 ' CG2' ' A' ' 46' ' ' VAL . 94.9 mt -70.48 -34.05 71.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 53' ' ' THR . 95.7 mt -68.61 -35.59 77.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.1 mt-30 -62.1 -41.91 98.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.46 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -68.62 -38.59 80.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.396 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.8 65.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.57 0.14 35.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 0.0 111.112 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.7 0.1 87.9 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.471 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' HA ' HG22 ' A' ' 66' ' ' VAL . 66.5 mt -85.89 23.81 1.39 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.814 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.68 -30.4 24.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.19 -175.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -112.94 -14.44 13.02 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 63' ' ' LEU . 28.3 m -93.75 140.7 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.956 0.408 . . . . 0.0 110.972 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.464 HG23 ' H ' ' A' ' 69' ' ' ASP . 18.7 m -133.48 -176.27 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.516 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -104.79 27.9 7.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.216 0.531 . . . . 0.0 110.025 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 67' ' ' VAL . 15.7 m-20 -112.1 159.89 32.05 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.278 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.88 152.27 44.06 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.747 2.298 . . . . 0.0 112.312 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.3 mt -87.84 21.86 2.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.167 -176.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.1 179.68 7.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.625 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -78.4 -7.59 57.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.568 0.699 . . . . 0.0 109.786 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.9 mt -107.18 168.05 9.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.122 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -100.96 176.15 5.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.934 0.397 . . . . 0.0 110.907 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -131.16 98.44 18.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.278 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -88.72 -18.9 1.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.912 2.408 . . . . 0.0 113.751 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -96.14 -53.02 3.79 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.266 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.39 97.85 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.929 0.395 . . . . 0.0 110.525 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.19 38.08 3.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.589 -176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.6 91.3 2.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.037 0.446 . . . . 0.0 110.347 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.86 110.12 2.37 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.473 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 67.95 101.39 0.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 124.276 0.633 . . . . 0.0 111.036 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 74.3 mtp85 -69.79 133.33 88.45 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.005 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 17.2 Cg_exo -67.91 3.97 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.381 2.72 . . . . 0.0 112.859 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.48 8.02 17.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.086 0.469 . . . . 0.0 110.374 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -95.98 0.37 51.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.237 0.542 . . . . 0.0 109.989 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.13 154.03 38.94 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.832 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.6 ' HB3' HG23 ' A' ' 141' ' ' VAL . 15.8 Cg_endo -58.34 132.22 47.49 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.795 2.33 . . . . 0.0 113.266 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -76.34 -33.98 58.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 140' ' ' VAL . 6.4 p -134.78 134.08 53.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.016 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.407 ' HB3' HG22 ' A' ' 118' ' ' VAL . 64.3 tp -114.12 112.7 23.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.268 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.59 116.01 28.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.36 100.63 11.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -86.04 76.25 2.17 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.353 -174.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 90.48 4.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.041 0.448 . . . . 0.0 109.972 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.33 -30.78 21.28 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.168 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -64.09 -50.39 68.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.304 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -145.32 132.36 20.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -72.41 91.72 1.38 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.403 ' CE1' ' HB ' ' A' ' 52' ' ' ILE . 54.2 t-80 -73.97 108.93 7.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.864 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.8 120.19 9.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.9 mt -80.13 149.02 30.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.54 147.36 16.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.277 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 51.6 Cg_exo -55.9 -32.43 85.29 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.182 2.588 . . . . 0.0 112.51 -177.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.15 -29.35 38.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 98.9 mt-30 -73.82 -41.64 62.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.77 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.6 m -92.07 2.69 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 66.9 ttt180 -59.27 -55.46 45.96 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.292 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 19.0 Cg_endo -57.99 -26.94 77.25 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.026 1.817 . . . . 0.0 112.333 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -83.25 -43.87 15.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.393 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 86.8 mt -61.62 -35.16 77.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.76 68.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.227 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 66.0 mtt -83.97 -23.97 30.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.11 0.481 . . . . 0.0 110.175 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.22 3.37 22.88 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.694 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.77 102.94 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.338 . . . . 0.0 110.341 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.23 99.46 1.57 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.103 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 92' ' ' LEU . 21.5 t -84.56 127.51 39.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.625 0.25 . . . . 0.0 110.546 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.92 136.63 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.996 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.12 123.46 35.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.054 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.455 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 38.6 ttm -142.52 160.09 40.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -174.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.62 145.4 54.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.481 HG23 HD22 ' A' ' 144' ' ' LEU . 8.8 m -52.33 -45.66 65.74 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.226 0.329 . . . . 0.0 111.711 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -60.13 -50.14 74.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.65 71.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.294 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.3 88.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.629 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.06 97.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.584 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 132' ' ' ILE . 21.0 ttt180 -58.93 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 28.1 m -62.2 -41.71 98.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.65 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 53.0 t80 -54.85 -51.6 65.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.103 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.46 -41.75 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.084 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 128' ' ' ARG . 80.1 mt -62.46 -54.6 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.62 -32.48 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.174 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.689 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 53.2 ttp -64.42 -43.32 94.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.36 175.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.45 -23.68 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.224 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 32.7 mt-10 -88.33 -3.41 58.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.006 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.7 44.17 82.21 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.228 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -117.65 157.31 26.65 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.633 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -73.16 100.39 3.06 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.114 0.483 . . . . 0.0 111.054 -173.58 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.418 HG23 HG13 ' A' ' 91' ' ' VAL . 7.4 p -131.69 135.24 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.738 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' A' ' 89' ' ' PRO . 66.6 t -128.6 142.15 44.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.0 p -129.6 136.94 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.661 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 113.94 22.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.253 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.481 HD22 HG23 ' A' ' 123' ' ' THR . 97.1 mt -100.52 127.89 46.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -172.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' A' ' 32' ' ' ALA . 18.0 mt -117.26 94.5 45.27 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.853 172.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.75 -158.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.272 2.648 . . . . 0.0 112.909 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.44 ' O ' ' HA2' ' A' ' 20' ' ' GLY . 22.4 t70 -117.64 151.89 36.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.377 176.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 177.62 -43.42 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.723 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -93.66 109.2 20.85 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.0 p -73.34 164.75 26.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.611 -175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 98.3 mt -77.25 -25.46 51.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.106 0.479 . . . . 0.0 110.143 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.573 ' HG3' ' HE1' ' A' ' 157' ' ' HIS . 36.9 tt0 -119.86 108.7 14.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.24 176.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -78.2 130.56 36.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -84.34 -73.18 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.08 -171.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 29.1 m170 -78.88 119.88 22.7 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 60.1 m80 75.0 73.26 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.146 0.904 . . . . 0.0 108.704 -167.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.573 ' HE1' ' HG3' ' A' ' 152' ' ' GLU . 83.5 t60 -86.27 -15.32 41.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.544 -176.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.645 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtm . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.594 0.235 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -75.88 -36.5 59.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.2 87.26 0.79 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.03 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -175.92 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.3 m -81.0 -42.04 21.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.32 148.43 90.96 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.652 172.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 30.8 Cg_endo -63.74 147.02 92.69 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.718 2.279 . . . . 0.0 112.916 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.65 0.4 43.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.303 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.9 p -113.08 138.21 50.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.286 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.33 65.03 5.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.101 0.477 . . . . 0.0 110.731 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.7 mt -149.92 -35.96 0.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.044 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.569 ' HA ' ' HG3' ' A' ' 7' ' ' PRO . 3.3 m-20 63.74 23.79 13.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.216 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -61.75 139.7 58.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.204 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 22' ' ' ILE . 58.3 t -65.78 103.13 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -70.32 -34.45 72.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.907 -176.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -154.46 149.05 26.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.199 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -120.07 132.22 55.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.02 178.91 17.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.677 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.87 99.26 1.02 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.384 0.274 . . . . 0.0 111.281 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.95 15.65 72.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.314 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -157.55 152.14 25.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.186 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.642 HG12 HD13 ' A' ' 144' ' ' LEU . 3.1 mp -113.41 120.64 63.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 40.1 tt0 -97.33 110.83 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 0.0 110.687 -176.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.453 ' HA ' ' OG1' ' A' ' 15' ' ' THR . 57.5 t -119.99 119.76 61.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.529 176.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 63.42 42.5 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.591 0.557 . . . . 0.0 110.22 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 66.79 10.85 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.319 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.5 115.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -82.02 101.99 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.83 89.33 6.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.083 0.468 . . . . 0.0 110.598 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -86.58 52.16 2.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -168.28 156.85 8.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 44' ' ' TRP . . . -56.73 130.5 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.493 0.495 . . . . 0.0 111.262 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.94 136.1 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.298 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -121.03 114.66 21.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.883 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.49 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 34.7 p90 -138.9 152.78 48.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.115 0.483 . . . . 0.0 111.785 -174.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.54 154.62 71.6 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.135 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 -13.7 27.98 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.731 2.287 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -122.45 22.47 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.72 168.91 29.91 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.335 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.62 172.1 15.69 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.581 2.187 . . . . 0.0 112.07 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 46.2 t -87.62 95.97 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.62 109.25 7.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.344 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -85.69 131.27 34.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 27.6 m0 -98.31 145.77 30.41 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.642 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.4 Cg_exo -81.71 37.01 0.65 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 110.225 168.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.638 HG13 ' HB2' ' A' ' 51' ' ' ASP . 54.3 t -108.85 123.04 64.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -171.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -119.02 -9.84 9.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 137.77 28.02 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HB3' ' O ' ' A' ' 96' ' ' THR . 28.7 Cg_endo -65.3 -5.45 11.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.477 2.118 . . . . 0.0 112.143 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.31 4.5 53.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.469 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.638 ' HB2' HG13 ' A' ' 46' ' ' VAL . 60.5 m-20 -90.29 -11.24 41.39 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -62.98 105.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.046 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.443 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 67.4 p -111.17 166.13 11.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.34 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -62.88 -32.0 73.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.184 175.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -60.29 -47.97 83.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.604 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.58 -34.39 78.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.843 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HB3' HD11 ' A' ' 111' ' ' LEU . 98.7 mt -65.06 -38.79 91.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.817 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 94.9 mt-30 -65.56 -39.08 91.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 110.43 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -71.83 -39.32 69.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.97 -17.71 63.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.878 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.53 -7.33 56.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.813 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.56 3.15 78.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.163 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt -71.69 -4.0 24.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.025 0.441 . . . . 0.0 110.922 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.3 -25.81 51.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.912 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.65 163.15 17.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.57 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.09 93.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.6 m -89.68 173.74 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.182 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 64.91 38.63 6.36 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -111.74 104.08 55.74 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.021 -174.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.862 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 91.8 Cg_endo -94.6 15.73 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.242 2.628 . . . . 0.0 112.033 175.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.5 tp -101.77 -41.88 6.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.386 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.02 -24.81 61.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.201 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -126.68 161.15 28.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.444 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.05 -2.99 53.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.027 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -141.82 133.2 26.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.81 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.862 ' HB3' ' HB3' ' A' ' 70' ' ' PRO . 11.2 pt-20 -84.39 119.98 73.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.162 0.506 . . . . 0.0 110.943 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 5.5 Cg_exo -79.96 168.85 18.57 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.38 2.72 . . . . 0.0 112.828 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -92.9 -175.09 3.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.369 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.44 -59.6 2.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.115 0.483 . . . . 0.0 109.761 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.44 -117.96 0.8 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.033 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.33 -10.85 26.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.769 0.319 . . . . 0.0 110.776 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.1 139.79 14.67 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.18 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.67 -27.87 63.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.169 0.509 . . . . 0.0 110.757 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -98.69 155.84 36.28 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.462 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -41.32 126.38 2.81 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.556 2.837 . . . . 0.0 113.431 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.88 76.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.022 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -78.72 62.7 3.31 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.571 0.7 . . . . 0.0 110.388 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -174.4 90.68 0.33 Allowed Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.48 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.54 ' HB3' ' CG2' ' A' ' 141' ' ' VAL . 6.7 Cg_endo -49.41 136.52 32.33 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 123.996 3.131 . . . . 0.0 113.736 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -77.75 -46.6 21.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.497 HG11 HD23 ' A' ' 133' ' ' LEU . 7.3 p -132.03 133.85 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.637 173.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.45 119.5 35.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.174 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.56 105.22 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.223 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.15 118.34 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -94.43 118.26 5.75 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -72.13 -5.21 33.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.238 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.23 -80.67 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.537 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 149' ' ' ASP . 38.5 ttm-85 -55.54 -55.72 28.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 110.78 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 99' ' ' ARG . 10.0 ptt180 -172.22 152.44 2.81 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.648 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.579 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 44.4 tt0 -58.4 128.41 37.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.775 0.672 . . . . 0.0 112.375 -168.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.509 ' HB2' HG21 ' A' ' 96' ' ' THR . 32.6 m170 -127.62 148.13 50.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.627 175.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 tp -88.42 126.35 35.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.81 171.54 14.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.423 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.19 156.46 16.33 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.753 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.52 -32.48 88.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.222 2.615 . . . . 0.0 112.973 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 tt0 -81.96 -25.14 35.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 110.709 -177.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.54 -44.73 73.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 35.5 m -97.83 10.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.881 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 13.5 ttt180 -54.69 -53.88 55.4 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.503 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.5 Cg_exo -59.62 -35.24 95.73 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.031 1.821 . . . . 0.0 112.552 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.682 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.7 mt -75.15 -36.62 61.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.08 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 89.9 mt -57.96 -42.91 85.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.839 0.352 . . . . 0.0 110.476 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.52 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.425 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -81.19 -22.53 38.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 110.715 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.25 17.47 10.74 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 46.7 t -93.3 108.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.426 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.11 86.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.177 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.28 126.02 39.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.736 0.303 . . . . 0.0 111.299 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -127.93 145.75 50.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.028 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.5 128.36 55.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.231 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.525 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.4 mtm -147.03 -175.13 4.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.918 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.99 163.03 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.663 0.268 . . . . 0.0 110.633 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.523 HG23 HD22 ' A' ' 144' ' ' LEU . 5.6 m -56.77 -39.12 73.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.667 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.1 -53.32 59.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.095 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.33 76.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.153 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.18 95.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.325 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.78 81.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.233 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.409 ' O ' HG13 ' A' ' 132' ' ' ILE . 78.4 mtp180 -63.39 -45.31 91.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.8 m -65.8 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.85 -49.73 76.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.449 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -58.98 -41.0 86.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.982 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 128' ' ' ARG . 73.2 mt -63.09 -53.3 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.497 HD23 HG11 ' A' ' 91' ' ' VAL . 10.8 mp -69.16 -23.78 63.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.237 -177.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.4 ttp -66.82 -43.2 84.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 109.889 174.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.28 64.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.739 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.03 -16.52 63.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.782 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.52 37.84 62.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -115.62 151.96 33.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -80.05 84.39 5.79 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.984 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.73 130.43 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.415 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' A' ' 36' ' ' ALA . 22.9 t -115.29 129.43 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -115.95 138.4 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.925 0.393 . . . . 0.0 110.843 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.24 105.75 12.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.642 HD13 HG12 ' A' ' 22' ' ' ILE . 77.6 mt -100.43 132.82 45.6 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 32' ' ' ALA . 2.0 tt -119.17 86.95 33.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.228 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -92.35 -159.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.944 2.429 . . . . 0.0 111.439 172.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.2 t0 65.06 27.77 12.47 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.929 0.871 . . . . 0.0 109.877 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.47 -14.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.06 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 9.7 p-10 -61.71 -45.38 94.2 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.327 0.651 . . . . 0.0 111.094 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.7 m -77.73 16.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.888 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.0 tp -83.05 -9.5 59.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.385 0.612 . . . . 0.0 109.412 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.403 ' HG2' ' HG3' ' A' ' 98' ' ' ARG . 15.5 mm-40 -99.72 168.52 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.641 174.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -136.33 99.62 4.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.502 0.668 . . . . 0.0 110.407 173.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -112.81 137.51 51.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.496 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -78.9 160.52 27.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.026 0.441 . . . . 0.0 110.988 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -93.26 112.78 24.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.592 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -96.1 159.9 14.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.258 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 . . . . . 0 C--O 1.245 0.858 0 CA-C-O 119.349 -0.357 . . . . 0.0 110.245 -178.751 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -57.7 143.66 40.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.548 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.61 -41.28 69.78 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -104.57 93.2 4.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m -64.32 104.32 0.75 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.135 0.493 . . . . 0.0 109.817 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -71.16 123.3 89.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.676 -168.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 92.2 Cg_endo -89.61 58.16 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.394 2.729 . . . . 0.0 109.942 169.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 79.17 -160.31 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.228 -168.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.2 p -59.32 -50.06 75.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 65.65 -68.16 0.12 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.355 0.662 . . . . 0.0 111.286 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.98 104.61 13.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 35.9 t-20 -68.13 105.21 2.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.6 m -119.73 126.12 50.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.474 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.2 120.01 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 p -96.04 -23.36 16.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.738 0.304 . . . . 0.0 111.799 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -143.28 103.23 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.868 0.366 . . . . 0.0 111.309 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HD1' HG12 ' A' ' 22' ' ' ILE . 88.4 t80 -123.96 131.3 53.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.753 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.23 -4.72 33.5 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.29 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -91.34 17.34 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 0.0 110.916 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.01 -42.93 2.09 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 54.0 p90 -111.77 176.28 5.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.45 HG12 ' HD1' ' A' ' 17' ' ' TYR . 48.9 mt -119.49 113.29 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.96 0.409 . . . . 0.0 110.207 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 34.0 tt0 -89.35 118.8 29.28 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.8 t -105.03 104.18 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.161 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 65.69 -80.45 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.935 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -132.22 2.54 3.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.204 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.3 t -125.35 127.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 0.0 111.035 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 66.6 mtt85 -86.99 113.11 22.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 88.8 m-85 -99.24 148.84 23.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.873 0.368 . . . . 0.0 110.836 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -88.72 -67.66 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.067 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 147' ' ' ASP . 16.8 p-80 -115.7 -169.14 1.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.927 -172.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 144' ' ' LEU . . . -36.24 128.29 0.74 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 43' ' ' SER . 18.5 pt -143.71 162.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.32 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -137.15 133.64 35.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.812 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.657 ' HB3' HG13 ' A' ' 41' ' ' VAL . 37.1 p90 -157.2 163.01 39.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.291 0.567 . . . . 0.0 112.244 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.95 161.89 58.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 73.5 Cg_exo -49.45 -55.04 4.52 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.132 2.555 . . . . 0.0 112.347 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -131.93 95.12 3.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.09 -153.54 17.15 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.937 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.1 134.69 13.21 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.758 2.305 . . . . 0.0 113.321 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.657 HG13 ' HB3' ' A' ' 35' ' ' PHE . 53.9 t -114.14 121.39 66.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.78 168.16 20.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.127 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.439 ' HA ' HG22 ' A' ' 33' ' ' ILE . 11.6 p -99.94 150.23 22.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.937 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.594 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -98.33 131.64 25.83 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.499 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.594 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 37.7 Cg_endo -67.01 -11.13 31.06 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.842 2.361 . . . . 0.0 112.592 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' CG2' HD13 ' A' ' 56' ' ' LEU . 10.9 t -86.1 146.1 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.94 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -129.11 -1.44 5.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HD2' ' OD2' ' A' ' 51' ' ' ASP . 50.9 mtt85 -134.67 137.17 26.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.46 -7.02 19.08 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.954 2.436 . . . . 0.0 112.377 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.44 -13.94 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.376 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' OD2' ' HD2' ' A' ' 48' ' ' ARG . 27.4 m-20 -96.23 3.88 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.164 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.51 122.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.875 0.369 . . . . 0.0 111.257 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.1 p -121.57 176.3 5.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.373 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -64.29 -37.61 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 0.0 110.199 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -48.41 78.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.506 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD13 ' CG2' ' A' ' 46' ' ' VAL . 44.0 mt -70.63 -30.44 67.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.952 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.505 ' HB3' HD11 ' A' ' 111' ' ' LEU . 81.0 mt -67.23 -39.1 86.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.454 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.7 mt-30 -58.18 -39.9 80.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.076 0.465 . . . . 0.0 110.214 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -68.41 -42.58 78.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.645 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.68 -13.15 62.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.88 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.1 -13.2 62.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.105 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.99 88.32 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.634 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -86.89 2.64 48.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.47 . . . . 0.0 110.809 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.67 74.81 10.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.335 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -90.9 107.06 18.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.957 174.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.4 t -73.26 -38.62 54.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.193 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -82.88 105.84 13.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.316 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -117.02 79.51 1.34 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.572 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.764 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 17.8 m-20 -135.57 -56.8 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.877 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.764 ' HD2' ' H ' ' A' ' 69' ' ' ASP . 34.4 Cg_endo -65.47 -10.91 28.02 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.097 1.865 . . . . 0.0 112.97 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.8 tp -80.01 -16.95 54.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.982 0.42 . . . . 0.0 110.38 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.9 144.22 25.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.549 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -123.46 -176.65 3.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.298 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 27.7 tp -95.52 -1.21 51.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.701 0.762 . . . . 0.0 109.223 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.26 -173.66 4.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.415 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -142.93 143.12 23.95 Favored Pre-proline 0 C--N 1.324 -0.541 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.732 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.25 -3.28 6.04 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.902 2.401 . . . . 0.0 112.274 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 63.9 -74.64 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.667 0.787 . . . . 0.0 112.179 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.15 -27.15 56.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.993 0.425 . . . . 0.0 111.065 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.0 40.85 3.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.342 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.3 -1.92 37.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.779 0.324 . . . . 0.0 111.172 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.03 52.9 2.47 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.953 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.37 -4.57 21.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.234 0.54 . . . . 0.0 110.584 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -111.41 158.98 34.69 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.061 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.09 39.08 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.568 2.845 . . . . 0.0 113.047 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.36 1.78 41.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.26 0.553 . . . . 0.0 110.001 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -118.39 -31.75 4.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.224 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -85.16 132.3 45.82 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 18.1 Cg_exo -66.42 155.73 68.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.947 2.431 . . . . 0.0 112.15 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.34 -44.9 13.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.0 0.429 . . . . 0.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 140' ' ' VAL . 4.9 p -133.02 133.91 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.399 0.618 . . . . 0.0 111.245 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -111.79 110.7 21.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.337 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 119' ' ' GLU . 97.2 mt -90.35 113.12 24.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.58 118.45 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -92.9 101.49 2.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 p -76.33 56.68 1.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 145' ' ' LEU . . . 76.35 -103.38 1.71 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.614 171.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.59 -35.49 11.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.238 . . . . 0.0 111.262 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -142.55 159.71 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.653 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.737 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.7 tt0 -62.79 111.19 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.792 175.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -113.73 116.18 29.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.039 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 143.01 57.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.068 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.27 -164.92 1.16 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.03 147.44 16.24 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.763 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.57 -42.42 65.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.063 2.509 . . . . 0.0 112.658 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.914 0.388 . . . . 0.0 111.697 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.59 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 98.7 mt-30 -96.24 -39.98 9.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 109.858 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.82 -24.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.801 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.53 ' HA ' HD12 ' A' ' 112' ' ' LEU . 7.8 ttp180 -63.4 -38.29 38.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.84 -43.41 23.93 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.803 1.668 . . . . 0.0 112.264 170.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.733 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.4 mt -75.5 -36.21 60.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 109' ' ' ARG . 96.3 mt -61.08 -31.24 70.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.73 -22.49 63.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -87.9 -30.62 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 122.47 9.07 6.67 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.155 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.733 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 17.1 t -98.89 110.13 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 111.023 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.28 122.91 6.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.606 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.28 125.23 46.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.937 0.399 . . . . 0.0 111.491 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' HB2' HD23 ' A' ' 93' ' ' LEU . 51.8 mm-40 -110.01 103.24 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.682 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.43 109.8 21.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.614 0.245 . . . . 0.0 110.355 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.737 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 63.2 mtm -141.97 -177.24 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 -176.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.63 147.61 36.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.973 172.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.501 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 61.8 m -55.86 -44.46 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.691 0.281 . . . . 0.0 111.323 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -64.0 -44.01 93.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.568 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.07 99.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.003 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.02 79.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.98 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.6 94.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.97 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -61.11 -50.08 74.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.041 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.607 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.548 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 73.2 t80 -61.55 -46.74 88.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.691 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -56.0 -44.55 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.462 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.418 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 62.3 mt -69.29 -54.27 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.237 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.5 HD12 ' HB ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -57.11 -40.31 76.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -175.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 46.7 ttp -58.95 -36.67 75.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.68 -13.11 54.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 27.1 mm-40 -88.5 -35.44 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 170.42 98.92 0.12 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.06 85.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.409 0.684 . . . . 0.0 112.84 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -144.45 33.79 1.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.5 ' HB ' HD12 ' A' ' 133' ' ' LEU . 7.2 p -127.45 140.42 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.567 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.0 t -124.74 143.84 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 9.9 p -120.63 140.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.305 -176.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -129.72 109.23 10.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.315 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 84.2 mt -116.58 138.9 51.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.78 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.549 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 5.0 mp -108.76 94.34 14.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 O-C-N 123.239 0.337 . . . . 0.0 110.171 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_endo -91.11 17.45 1.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.281 2.654 . . . . 0.0 111.566 177.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.627 ' HB3' ' NE2' ' A' ' 156' ' ' HIS . 1.1 m-20 -48.82 112.52 0.62 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.44 -175.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.61 -6.66 0.13 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.728 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -53.27 -34.65 58.12 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.0 0.92 . . . . 0.0 111.961 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.3 m -79.47 22.79 0.43 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.02 -173.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.2 mt 72.14 -51.77 0.7 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.673 0.789 . . . . 0.0 111.639 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 154' ' ' HIS . 0.9 OUTLIER -74.71 136.61 41.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -97.39 19.86 12.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.769 0.319 . . . . 0.0 111.758 -171.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.434 ' HB2' ' OE1' ' A' ' 152' ' ' GLU . 60.2 m80 -131.66 -51.57 0.99 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -85.62 152.21 23.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.135 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.627 ' NE2' ' HB3' ' A' ' 147' ' ' ASP . 42.5 m80 -138.3 153.7 49.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -119.92 93.36 4.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.187 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.247 0.952 0 O-C-N 124.037 0.835 . . . . 0.0 111.653 174.817 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 79.5 tttt 67.44 83.43 0.17 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.413 0.625 . . . . 0.0 109.722 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.8 mt -130.93 179.09 6.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.016 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -75.28 -42.99 53.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.6 m -124.2 101.33 7.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.816 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.36 164.39 54.44 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.68 95.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.75 2.3 . . . . 0.0 112.792 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.01 96.66 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.196 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -105.39 164.0 12.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.849 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.12 130.05 39.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.966 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.4 117.52 19.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.475 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -76.69 94.69 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 m -109.44 137.76 46.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.658 -171.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.11 127.35 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 p -105.77 -56.33 2.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.657 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -114.89 135.57 54.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.1 0.476 . . . . 0.0 110.877 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.11 167.38 10.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.649 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.07 -172.43 35.05 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.75 -63.51 1.19 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.134 0.492 . . . . 0.0 110.763 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.78 ' HA3' ' HA ' ' A' ' 149' ' ' ASP . . . -92.12 -5.43 65.83 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.907 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 13.0 p90 -139.9 148.72 42.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.858 0.361 . . . . 0.0 110.045 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.66 120.41 58.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 32.5 tt0 -96.37 114.1 25.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.317 0.58 . . . . 0.0 110.566 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.34 125.23 59.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.679 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.04 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -141.54 16.04 2.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.606 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.58 129.73 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.369 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.3 mtp-105 -88.23 114.84 25.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.074 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.17 100.47 9.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.78 0.324 . . . . 0.0 111.123 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 36.2 m -83.81 36.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.439 0.637 . . . . 0.0 109.818 173.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.513 ' HB2' HG23 ' A' ' 33' ' ' ILE . 8.1 m170 -120.22 169.81 9.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.2 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 44' ' ' TRP . . . -85.33 105.26 15.86 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 164.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 31' ' ' HIS . 19.4 pt -112.24 132.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.419 0.628 . . . . 0.0 112.625 -169.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -113.6 121.63 44.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.429 174.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -147.88 155.79 41.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.273 0.559 . . . . 0.0 111.773 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -129.23 159.88 66.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.628 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 23.0 Cg_endo -62.71 -25.68 75.08 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.447 2.098 . . . . 0.0 111.628 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -125.63 108.23 11.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.561 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.05 -170.3 23.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.323 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.93 -177.29 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.38 121.86 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.976 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.7 119.46 38.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.962 0.41 . . . . 0.0 110.789 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -94.06 131.8 39.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.345 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 3.9 m0 -98.28 137.1 20.74 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.037 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.53 0.05 9.91 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.017 2.478 . . . . 0.0 111.374 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 56' ' ' LEU . 29.7 t -85.88 113.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.486 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -111.79 7.77 20.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 0.0 110.794 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 54.0 ttp180 -127.02 115.44 21.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 26.8 Cg_exo -63.44 -10.81 22.99 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.4 2.733 . . . . 0.0 113.883 -173.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.37 -2.0 58.35 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.269 -0.269 . . . . 0.0 111.38 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' A' ' 48' ' ' ARG . 42.5 m-20 -98.16 -2.83 39.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.89 118.55 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.206 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 54' ' ' ALA . 1.7 m -129.4 169.16 15.27 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -49.71 -54.33 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -173.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.7 -33.52 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.436 HD13 HG21 ' A' ' 46' ' ' VAL . 98.3 mt -65.23 -44.54 87.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.498 . . . . 0.0 110.224 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.99 -37.25 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.664 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.522 ' HA ' HD21 ' A' ' 111' ' ' LEU . 48.2 tt0 -62.09 -37.52 85.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.701 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -71.61 -41.3 69.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.58 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.11 -4.94 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.875 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 89' ' ' PRO . . . -75.09 -4.42 38.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.531 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.42 35.52 52.01 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.096 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -90.88 13.09 17.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 110.661 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.16 75.88 6.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.417 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -78.37 111.32 14.24 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p -127.37 138.93 53.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.069 0.461 . . . . 0.0 111.622 -171.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.24 148.56 8.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.06 18.37 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -173.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 t70 64.75 96.84 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.368 0 C-N-CA 123.273 0.629 . . . . 0.0 110.434 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.759 ' HB3' ' H ' ' A' ' 75' ' ' ASP . 11.8 Cg_exo -69.92 83.92 0.7 Allowed 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.198 2.599 . . . . 0.0 113.368 -173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.75 -16.63 16.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.334 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.28 -67.76 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.483 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.474 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 77.4 m-85 -123.0 -84.68 0.66 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.666 HD23 ' HB2' ' A' ' 70' ' ' PRO . 6.6 mt 176.92 107.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.849 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.759 ' H ' ' HB3' ' A' ' 70' ' ' PRO . 13.2 m-20 -77.27 100.74 5.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.813 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.04 104.92 5.4 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.187 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 75' ' ' ASP . 86.9 Cg_endo -86.31 -6.25 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.943 2.428 . . . . 0.0 113.509 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.92 -51.93 62.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.095 0.474 . . . . 0.0 110.114 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.44 74.75 9.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.031 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.17 41.76 2.06 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.787 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.45 106.31 3.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.066 0.46 . . . . 0.0 110.65 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.08 -3.01 11.59 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.848 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.41 139.05 42.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.605 0.24 . . . . 0.0 110.479 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -105.55 107.73 59.92 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.979 0.419 . . . . 0.0 110.578 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.84 -39.37 3.39 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.689 2.26 . . . . 0.0 111.654 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.64 43.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.771 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -74.48 -71.69 0.33 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.899 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . 64.57 158.82 0.12 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 124.024 0.827 . . . . 0.0 112.625 176.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 3.5 Cg_exo -77.45 165.86 26.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.695 2.264 . . . . 0.0 111.271 170.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.734 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.2 mt-10 -94.8 -38.01 10.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.769 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.503 HG13 HG23 ' A' ' 140' ' ' VAL . 6.0 p -144.08 137.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 111.179 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.6 tp -113.26 115.39 28.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.702 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.05 116.16 28.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.578 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.51 121.64 52.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.261 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.38 89.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.044 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -101.59 36.91 1.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.227 0.537 . . . . 0.0 109.832 -179.065 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.577 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -79.78 63.3 4.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.009 -170.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.473 ' NH2' ' HA ' ' A' ' 147' ' ' ASP . 8.9 ttm180 -161.11 -52.62 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.54 90.3 2.4 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -71.24 93.12 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.7 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -76.09 107.46 8.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.207 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.64 126.04 26.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.16 165.7 15.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.68 157.91 15.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.93 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.94 -33.72 97.46 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.04 2.493 . . . . 0.0 112.594 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.79 -20.5 62.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.952 0.406 . . . . 0.0 111.005 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.556 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 87.9 mt-30 -88.02 -35.11 17.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.448 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 30.2 m -92.48 -21.03 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.741 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.548 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 7.5 tmm_? -59.07 -48.55 96.38 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 8.5 Cg_endo -51.14 -43.42 48.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.323 2.015 . . . . 0.0 112.626 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 58' ' ' GLN . 91.8 mt -75.04 -37.03 61.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.9 mt -66.02 -34.71 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.0 -31.22 72.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.213 0.53 . . . . 0.0 110.363 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -75.39 -38.28 60.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.79 -12.25 5.91 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.934 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.08 109.66 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.753 0.311 . . . . 0.0 110.871 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.34 115.98 4.79 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.003 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.55 123.53 43.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.621 0.248 . . . . 0.0 110.812 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -129.39 120.2 25.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.12 122.8 44.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.494 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 70.0 mtm -139.9 -171.82 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.36 150.04 49.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.715 0.293 . . . . 0.0 110.218 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.577 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 8.2 m -56.36 -42.53 77.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.337 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 52.3 tt0 -72.82 -35.98 67.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.18 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.34 -36.46 82.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.126 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.23 95.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.142 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.568 ' O ' HG12 ' A' ' 132' ' ' ILE . 69.5 mtm180 -64.59 -55.85 17.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.412 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -59.71 -32.95 70.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.261 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.44 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 81.7 t80 -59.03 -54.27 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -61.3 -34.22 74.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.472 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 128' ' ' ARG . 45.0 mm -59.76 -55.31 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.551 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 72.0 mt -71.89 -31.05 66.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.3 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 ttp -62.12 -49.97 73.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 110.48 178.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.18 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.736 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.42 -16.63 61.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.516 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.46 31.53 24.59 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 138' ' ' ARG . 27.7 ttt180 -106.05 147.4 28.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.012 -175.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.734 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 68.9 mtm180 -81.41 88.81 6.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.274 0.559 . . . . 0.0 110.6 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.503 HG23 HG13 ' A' ' 91' ' ' VAL . 7.4 p -120.19 138.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.958 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 36' ' ' ALA . 40.1 t -121.06 140.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -124.21 138.9 52.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.008 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.84 103.98 9.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.408 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.8 mt -100.63 122.59 43.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.879 0.371 . . . . 0.0 111.165 -173.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.08 109.02 54.89 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.461 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.89 -157.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.311 2.674 . . . . 0.0 110.904 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.473 ' HA ' ' NH2' ' A' ' 98' ' ' ARG . 3.1 p30 -86.84 -55.13 3.99 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.102 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.51 -4.84 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.113 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.78 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 8.2 t0 82.86 65.62 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.3 m -93.59 115.2 27.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.966 -175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.9 mt -81.18 139.81 35.34 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.016 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.95 136.09 50.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.997 0.427 . . . . 0.0 110.515 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -120.56 157.29 29.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -92.2 26.91 2.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.255 0.55 . . . . 0.0 110.823 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -128.99 104.12 7.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.135 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.59 92.52 6.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.072 -174.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -144.84 133.42 22.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.216 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.6 p80 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.474 179.471 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.476 HD13 ' HG2' ' A' ' 134' ' ' MET . 3.9 mm? . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.798 0.332 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -70.06 104.08 2.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.357 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.4 m -126.14 151.71 46.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.231 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.01 122.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.183 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.2 p -89.54 -20.3 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.315 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -161.44 140.59 10.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.657 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.43 -79.82 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.5 162.68 38.53 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.839 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -107.99 111.25 23.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.857 0.36 . . . . 0.0 110.674 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.2 4.32 57.53 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.238 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -162.14 172.41 15.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.73 124.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 28.9 tt0 -94.53 109.5 21.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.002 0.43 . . . . 0.0 111.169 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -117.05 124.01 72.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 62.85 29.55 16.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.604 0.716 . . . . 0.0 109.506 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HA ' ' CG ' ' A' ' 23' ' ' GLU . 34.8 mt-30 65.64 13.98 9.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.723 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.2 110.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 92.1 mtt180 -86.41 96.8 10.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.993 -174.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.78 115.43 22.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.7 p -90.47 28.71 1.41 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.261 0.553 . . . . 0.0 111.064 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -154.1 171.39 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.785 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.23 138.05 58.24 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.286 0.366 . . . . 0.0 111.2 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.19 147.69 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -123.1 116.52 23.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 175.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -135.83 157.82 45.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.957 0.408 . . . . 0.0 111.057 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.5 160.16 62.73 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 11.2 Cg_endo -56.65 -57.04 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.456 2.104 . . . . 0.0 110.492 172.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.79 103.11 12.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.35 178.73 32.65 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.902 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -88.61 176.02 3.6 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 112.919 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.14 104.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.344 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . . . -85.99 126.62 34.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.559 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -91.26 118.62 30.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.794 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.406 ' CZ2' ' HB2' ' A' ' 60' ' ' ALA . 1.3 m0 -98.32 130.23 28.78 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.42 23.48 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.937 2.425 . . . . 0.0 111.178 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 51' ' ' ASP . 73.2 t -85.71 136.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.771 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -117.85 -24.26 7.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.068 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HG2' ' OD2' ' A' ' 51' ' ' ASP . 8.0 ptt180 -139.03 155.66 72.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.02 -176.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 1.88 2.41 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.538 2.159 . . . . 0.0 112.897 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.73 -14.74 24.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.33 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.594 ' HB2' HG13 ' A' ' 46' ' ' VAL . 65.1 m-20 -77.32 -19.34 56.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.12 117.53 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.006 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.441 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 30.7 p -121.57 175.45 6.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.852 175.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.9 71.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -62.31 -45.39 93.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.133 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.53 -30.71 68.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.003 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 53' ' ' THR . 90.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.356 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -65.27 -38.3 89.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -68.46 -42.58 78.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.376 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.406 ' HB2' ' CZ2' ' A' ' 44' ' ' TRP . . . -65.38 -26.39 67.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.562 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.401 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -73.74 -12.88 60.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.022 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.57 28.41 73.17 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.603 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 61' ' ' ALA . 91.4 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 120.495 0.188 . . . . 0.0 111.268 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HB3' HG23 ' A' ' 141' ' ' VAL . 9.1 Cg_endo -51.29 111.7 0.63 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.841 2.361 . . . . 0.0 111.985 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 3.9 tt0 -69.5 -32.47 71.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.696 HG11 HD13 ' A' ' 133' ' ' LEU . 3.3 p -136.01 131.31 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.456 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -112.96 121.19 43.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.866 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.5 mt -101.2 104.55 15.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.284 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.865 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -105.69 114.31 4.5 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.491 HG21 ' H ' ' A' ' 101' ' ' HIS . 1.2 p -76.11 -20.97 57.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 -58.4 4.79 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.402 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -81.17 -55.31 4.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.744 0.307 . . . . 0.0 110.565 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -159.89 143.45 14.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -52.66 114.61 1.45 Allowed 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.118 0.886 . . . . 0.0 112.113 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.491 ' H ' HG21 ' A' ' 96' ' ' THR . 11.7 t-160 -96.85 111.85 23.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.21 98.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.814 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.07 134.26 40.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -106.04 175.27 21.26 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.735 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 74.3 Cg_exo -49.63 -34.61 35.25 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.351 2.7 . . . . 0.0 112.542 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -49.47 -43.66 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.283 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -96.01 -37.9 10.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.185 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 104' ' ' GLY . 35.0 m -91.42 -14.36 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -171.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 1.1 tmt_? -57.33 -44.7 99.78 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -47.45 -32.08 14.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.3 2.0 . . . . 0.0 113.188 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 93.7 mt -92.33 -36.24 13.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.679 0.276 . . . . 0.0 110.785 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 87.2 mt -58.49 -36.7 74.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.02 68.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.16 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.87 -12.18 45.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.65 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.14 14.69 38.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.029 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.1 t -86.99 107.82 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 0.0 110.659 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.77 111.33 3.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.605 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.12 124.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 111.487 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -102.86 129.11 49.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.193 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.01 102.5 13.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 0.0 110.495 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.538 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.8 mtm -140.43 -171.77 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -105.42 172.13 6.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.594 HG23 HD22 ' A' ' 144' ' ' LEU . 88.5 m -52.29 -48.52 65.3 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.586 0.554 . . . . 0.0 112.345 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -62.37 -50.01 73.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.99 85.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.711 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.91 75.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.41 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 132' ' ' ILE . 47.0 mtt180 -59.82 -48.07 83.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.835 0.35 . . . . 0.0 111.117 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -66.25 -36.73 83.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -60.45 -45.39 93.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.528 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -58.56 -40.32 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.4 mt -62.11 -54.63 31.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.723 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.696 HD13 HG11 ' A' ' 91' ' ' VAL . 74.3 mt -66.95 -32.28 73.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.365 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.476 ' HG2' HD13 ' A' ' 11' ' ' LEU . 54.2 ttp -72.74 -36.88 67.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.36 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.48 80.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.073 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.51 -36.97 74.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.32 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.04 41.79 5.79 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.482 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -111.77 153.62 26.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 90' ' ' GLU . 19.9 mmt180 -63.52 97.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 111.307 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.66 136.25 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.305 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 89' ' ' PRO . 37.5 t -123.83 133.51 69.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.4 p -116.43 130.53 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.254 0.55 . . . . 0.0 111.068 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.16 112.41 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.594 HD22 HG23 ' A' ' 123' ' ' THR . 77.2 mt -103.31 139.55 38.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.547 HD23 ' HD2' ' A' ' 146' ' ' PRO . 2.2 tt -122.86 132.41 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.547 ' HD2' HD23 ' A' ' 145' ' ' LEU . 56.0 Cg_exo . . . . . 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.479 . . . . 0.0 112.216 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.566 0.222 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 61.62 87.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.417 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.3 m -107.32 118.79 37.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.088 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -69.16 100.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.701 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.44 -25.32 42.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.507 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -155.88 149.67 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.741 176.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -87.0 -15.14 39.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.54 -161.87 48.13 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.294 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.05 87.03 2.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.29 60.89 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.673 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.53 148.36 17.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.8 mt -97.08 138.75 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.2 tm-20 -110.22 109.7 20.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 109.932 -175.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.67 111.22 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 m120 53.39 52.64 13.06 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.722 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 73.3 -0.02 3.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.172 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.14 122.64 64.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 53.7 mtm180 -97.0 111.26 23.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.498 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -93.53 117.75 30.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 m -88.35 -7.64 56.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.177 0.513 . . . . 0.0 110.008 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -116.07 161.62 18.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.181 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 145.5 55.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 110.733 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.03 147.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.919 0.39 . . . . 0.0 111.671 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -129.08 112.5 14.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.682 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.524 ' HB3' HG13 ' A' ' 41' ' ' VAL . 32.5 p90 -139.4 162.27 35.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.994 0.426 . . . . 0.0 111.813 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.36 156.56 71.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.136 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.587 ' HD3' ' HE1' ' A' ' 130' ' ' TYR . 6.2 Cg_exo -78.66 9.56 3.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.121 2.547 . . . . 0.0 112.068 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -152.32 21.31 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.781 0.8 . . . . 0.0 108.997 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.14 -169.69 12.6 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.915 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -86.75 176.56 4.58 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.787 2.325 . . . . 0.0 112.612 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.524 HG13 ' HB3' ' A' ' 35' ' ' PHE . 34.2 t -112.58 104.5 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.649 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.85 152.36 21.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.701 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 m -108.87 132.69 53.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.533 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -113.05 126.65 27.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.534 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 2.0 Cg_endo -83.37 9.74 3.97 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.218 2.612 . . . . 0.0 111.302 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 51' ' ' ASP . 41.5 t -86.8 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.508 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -120.98 -33.75 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.815 0.34 . . . . 0.0 111.383 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' A' ' 51' ' ' ASP . 69.6 mtp85 -108.03 147.66 35.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.973 0.416 . . . . 0.0 110.818 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HG3' ' O ' ' A' ' 96' ' ' THR . 12.7 Cg_exo -70.21 -6.01 17.82 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.047 2.498 . . . . 0.0 112.212 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.75 -19.68 24.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.321 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.591 ' HB2' HG13 ' A' ' 46' ' ' VAL . 30.1 m-20 -82.91 -20.21 35.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.13 116.94 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.825 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 31.1 p -113.48 169.51 8.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.371 175.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -60.27 -34.62 73.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m -59.1 -46.87 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.504 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 46' ' ' VAL . 97.9 mt -66.93 -33.78 76.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.627 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 53' ' ' THR . 96.9 mt -64.22 -40.9 97.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.8 mt-30 -62.95 -33.77 76.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.06 -43.74 56.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.32 66.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.746 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -21.98 66.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.86 94.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.331 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 111.309 -177.034 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.488 ' O ' HG22 ' A' ' 116' ' ' VAL . 53.9 Cg_exo -53.44 139.04 65.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.473 2.115 . . . . 0.0 112.06 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' OE1' ' HG3' ' A' ' 138' ' ' ARG . 37.3 tt0 -88.22 -36.89 16.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.036 0.446 . . . . 0.0 110.134 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.73 138.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.237 0.541 . . . . 0.0 111.258 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -114.92 118.77 34.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.661 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.07 119.46 39.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.202 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.58 121.74 59.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.838 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -96.81 106.31 3.33 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.544 ' HA ' HD12 ' A' ' 145' ' ' LEU . 12.6 p -83.5 13.35 4.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -171.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.09 -102.4 1.15 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.213 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 72.3 mtt-85 -62.99 -45.73 91.03 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -142.49 140.23 31.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.844 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.9 tt0 -66.17 96.73 0.35 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.144 0.497 . . . . 0.0 110.241 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -99.42 99.65 10.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.743 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.5 mt -60.57 137.83 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.05 -178.69 5.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.474 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 147.79 16.32 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.872 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.665 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 11.4 Cg_endo -55.17 -40.77 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.852 2.368 . . . . 0.0 112.113 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.17 -27.79 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.182 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -74.82 -37.51 62.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.986 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 34.5 m -92.13 -7.68 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 42.7 mtm180 -53.95 -49.18 91.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 66.6 Cg_exo -53.7 -39.36 83.75 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.103 1.869 . . . . 0.0 112.704 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 94.0 mt -78.13 -39.1 42.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.62 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 85.5 mt -62.39 -32.63 73.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.642 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.15 78.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.747 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 60.3 mtt -77.83 -38.86 45.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.041 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.09 3.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 31.0 t -90.43 115.8 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.53 0.205 . . . . 0.0 110.539 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.03 132.26 10.96 Favored Glycine 0 C--O 1.224 -0.531 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.02 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.63 123.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 117.318 0.559 . . . . 0.0 111.115 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.69 131.75 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.501 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.15 128.68 51.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.844 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 71.7 mtm -144.96 -171.82 3.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.3 156.25 34.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.451 HG23 HD22 ' A' ' 144' ' ' LEU . 40.4 m -57.91 -43.75 86.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.916 0.389 . . . . 0.0 110.927 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.51 -40.65 80.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.71 89.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 110.966 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.4 -47.36 76.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.51 96.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' HG13 ' A' ' 132' ' ' ILE . 42.4 ttm180 -63.4 -50.15 70.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.69 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -63.32 -35.85 81.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.432 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.587 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 50.9 t80 -57.73 -44.99 86.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.761 175.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -64.14 -39.26 93.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.2 mt -64.18 -50.23 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.747 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.401 ' HB2' HG11 ' A' ' 140' ' ' VAL . 91.8 mt -67.85 -26.04 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.799 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 36.8 ttm -61.88 -50.42 72.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.068 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.491 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.88 -44.37 97.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.59 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 105.42 33.33 3.67 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.061 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.428 ' HG3' ' OE1' ' A' ' 90' ' ' GLU . 17.0 ttm180 -100.05 144.98 28.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -70.46 79.62 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.987 0.422 . . . . 0.0 110.879 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 133' ' ' LEU . 5.9 p -106.31 128.54 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.924 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 36' ' ' ALA . 25.9 t -113.11 131.57 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.8 p -115.67 131.64 67.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.57 111.34 22.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.395 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 123' ' ' THR . 98.9 mt -107.05 120.83 43.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.738 0.304 . . . . 0.0 111.672 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 96' ' ' THR . 94.8 mt -93.93 126.0 50.84 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.699 172.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.234 0.303 0 C-N-CA 122.611 2.208 . . . . 0.0 112.426 179.084 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--O 1.235 0.308 0 CA-C-O 120.972 0.415 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 34.8 t30 -74.6 125.6 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.018 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -154.48 142.77 20.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.831 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.98 112.5 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.231 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 p -74.23 -32.8 63.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.296 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -131.19 92.13 3.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.761 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' HE2' ' HG2' ' A' ' 124' ' ' GLN . 71.0 t80 -104.61 -3.22 24.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.377 0.608 . . . . 0.0 109.904 175.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.32 -23.71 70.24 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.927 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.98 -175.58 4.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 111.152 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.48 14.69 60.57 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.523 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.452 ' CE1' ' HD2' ' A' ' 28' ' ' ARG . 27.4 p90 -148.97 173.35 13.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.75 108.19 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 0.0 111.091 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 45.7 tt0 -93.5 112.5 24.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.133 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.4 95.92 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.887 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 m120 64.63 -77.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.757 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -119.09 -28.11 5.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.074 -176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.39 127.7 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -173.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 23.3 mtm180 -98.52 109.68 22.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.277 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -91.2 131.71 36.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -101.9 14.51 31.75 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.561 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -148.98 179.06 8.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.821 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.81 139.9 58.36 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.551 0.532 . . . . 0.0 111.25 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 pt -145.1 156.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.305 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.56 130.6 50.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.251 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.577 ' HB3' HG13 ' A' ' 41' ' ' VAL . 36.5 p90 -150.43 154.86 38.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.367 0.603 . . . . 0.0 112.06 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -119.17 164.56 20.68 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.531 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 26.4 Cg_exo -63.32 -42.37 22.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.413 2.075 . . . . 0.0 111.607 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.75 101.55 7.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.23 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.78 -157.55 27.67 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.297 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -93.39 163.81 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.285 2.656 . . . . 0.0 113.197 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -114.15 116.67 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.46 145.92 41.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.341 . . . . 0.0 111.419 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -79.07 128.73 33.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.606 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 60' ' ' ALA . 1.7 t90 -98.32 116.97 65.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 12.8 Cg_exo -71.56 33.93 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.503 2.802 . . . . 0.0 112.888 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 51' ' ' ASP . 94.2 t -114.68 125.44 72.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.534 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.12 -49.42 4.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.176 0.512 . . . . 0.0 110.894 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -107.88 150.91 40.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 14.7 Cg_endo -59.63 -19.78 54.68 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.336 2.024 . . . . 0.0 111.796 174.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.26 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.296 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.62 ' HB2' HG13 ' A' ' 46' ' ' VAL . 11.8 m-20 -68.73 -28.4 66.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.805 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -54.44 115.06 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.608 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -121.95 159.77 26.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.874 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -52.84 -44.32 66.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -63.16 -35.8 81.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.226 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.458 HD13 HG22 ' A' ' 46' ' ' VAL . 49.9 mt -69.57 -31.83 70.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.36 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.79 -35.46 80.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.182 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.342 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -70.66 -39.37 73.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.452 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' A' ' 44' ' ' TRP . . . -69.68 -23.85 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.853 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -81.43 -7.36 59.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.957 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.55 37.83 85.67 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.388 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 111.527 -177.602 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.416 ' HG2' ' HB1' ' A' ' 61' ' ' ALA . 50.2 Cg_exo -56.4 127.8 27.46 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.884 2.39 . . . . 0.0 112.686 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -64.24 -46.87 81.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.448 0.642 . . . . 0.0 109.528 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.79 132.07 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.876 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.519 ' HB3' HG22 ' A' ' 118' ' ' VAL . 57.3 tp -114.26 117.38 30.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.96 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.1 mt -101.51 117.03 34.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.336 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.2 t -104.05 110.32 29.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.444 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.08 96.84 2.17 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 33.4 p -80.87 -13.63 58.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.776 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.69 -101.52 1.42 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.751 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -62.85 -58.49 7.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.345 . . . . 0.0 111.336 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.4 mmt-85 -109.2 122.33 47.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.992 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.599 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 53.3 tt0 -74.51 97.19 3.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.471 ' HB3' HG21 ' A' ' 96' ' ' THR . 40.1 t-80 -73.6 104.82 4.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.862 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.63 142.26 53.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.442 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -93.16 160.22 14.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.852 0.358 . . . . 0.0 110.617 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.79 162.36 14.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.625 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.27 -49.52 16.06 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.74 2.293 . . . . 0.0 112.253 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -62.48 -25.79 68.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.568 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 93.7 mt-30 -76.78 -34.35 57.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.775 0.322 . . . . 0.0 111.316 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.8 -11.57 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 68.0 mtm180 -52.34 -55.26 33.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 23.0 Cg_endo -61.19 -35.4 85.85 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.038 1.826 . . . . 0.0 113.006 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.4 mt -80.77 -37.85 29.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.0 111.179 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.6 mt -69.26 -23.89 63.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.318 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.72 68.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.445 175.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 62.4 mtt -88.46 -35.85 16.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.29 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.55 14.51 5.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.289 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.1 t -85.32 108.44 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.694 0.283 . . . . 0.0 110.568 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.46 94.72 1.73 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.969 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 92' ' ' LEU . 39.9 t -88.6 129.88 38.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 0.0 111.213 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -126.73 139.89 52.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.124 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.4 128.23 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.411 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 66.7 mtt -140.31 -173.38 3.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.224 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -91.84 168.31 11.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.4 m -59.49 -35.76 74.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 111.761 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.589 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 7.1 tm0? -75.84 -52.46 10.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.62 98.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.535 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 121' ' ' MET . . . -63.03 -46.43 87.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.83 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.11 78.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -73.66 -45.49 52.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.639 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -63.04 -35.75 81.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.128 0.49 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -54.01 -46.25 71.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.948 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -63.34 -41.57 98.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.836 0.35 . . . . 0.0 110.814 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.0 mt -64.02 -47.4 90.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.793 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.94 -27.62 66.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.004 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 56.3 ttp -65.58 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.041 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.01 -26.66 61.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.34 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -67.31 -35.8 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.452 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.2 9.72 55.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.91 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -87.85 155.5 19.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -82.78 87.13 6.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.473 0.654 . . . . 0.0 111.09 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -103.66 132.88 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.757 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 36' ' ' ALA . 57.6 t -120.3 136.13 58.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.1 p -121.57 135.81 60.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.313 0.577 . . . . 0.0 111.232 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.08 119.85 36.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.115 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.7 mt -110.17 125.31 52.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.971 0.415 . . . . 0.0 111.616 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 96' ' ' THR . 95.5 mt -104.09 153.63 38.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.073 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 122.922 2.415 . . . . 0.0 112.011 176.623 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -64.75 102.12 0.55 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 0.0 110.365 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -110.03 146.09 35.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.764 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 17' ' ' TYR . 47.9 t -68.32 109.73 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -44.49 61.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.573 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -139.35 116.87 11.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.244 0.545 . . . . 0.0 111.377 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' HB2' HG11 ' A' ' 14' ' ' VAL . 89.5 t80 -136.5 142.29 43.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.072 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.81 -90.02 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -144.41 137.14 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.02 -91.17 0.79 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.341 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -111.81 177.71 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.701 0.286 . . . . 0.0 110.951 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.5 mt -128.92 136.31 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -114.82 120.56 40.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.72 117.62 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 64.36 49.72 2.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.507 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 68.25 18.55 9.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.173 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -128.61 121.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 28' ' ' ARG . 29.4 mtm-85 -88.42 110.87 21.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.639 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -90.91 114.7 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.017 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.2 m -92.99 29.01 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.304 0.573 . . . . 0.0 110.179 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -152.51 167.97 27.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.533 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.43 147.53 52.49 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.384 0.428 . . . . 0.0 111.233 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -140.74 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.074 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.72 123.08 25.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.46 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 45.2 p90 -152.36 162.19 41.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.35 0.595 . . . . 0.0 111.956 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.94 155.05 58.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.571 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.91 -57.65 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.678 2.252 . . . . 0.0 111.987 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.35 27.68 3.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.5 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.65 -172.57 13.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.273 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -87.05 173.39 5.85 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.823 2.349 . . . . 0.0 112.593 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -109.1 113.79 45.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.983 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.5 133.57 50.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.036 0.446 . . . . 0.0 111.158 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m -76.44 124.16 27.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.165 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.46 126.27 40.03 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 0.9 OUTLIER -83.43 8.63 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.46 2.773 . . . . 0.0 113.111 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.09 135.82 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -120.69 -48.83 2.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.106 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.569 HH11 ' HG2' ' A' ' 48' ' ' ARG . 24.3 mtt-85 -93.37 139.89 23.06 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.449 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.2 Cg_exo -66.85 -10.29 27.8 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.185 2.59 . . . . 0.0 112.494 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.21 5.0 52.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 1.2 m-20 -109.7 0.24 18.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.36 127.01 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -135.14 156.9 48.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.25 62.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -57.56 -37.73 73.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.272 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.464 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.31 -34.79 63.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.541 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.17 -41.82 98.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.95 -41.48 86.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.82 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.66 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.347 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -79.88 -4.57 52.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.141 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.52 17.7 77.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.55 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 88' ' ' ALA . 96.4 mt . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.967 0.413 . . . . 0.0 110.697 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HA ' HD21 ' A' ' 63' ' ' LEU . . . . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HG2' ' HB1' ' A' ' 61' ' ' ALA . 70.0 Cg_exo -52.28 137.37 55.68 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.559 2.173 . . . . 0.0 112.159 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -68.91 -41.47 78.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.78 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.462 HG11 HD13 ' A' ' 133' ' ' LEU . 3.6 p -140.71 137.75 35.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.445 ' HB3' HG22 ' A' ' 118' ' ' VAL . 58.9 tp -122.16 118.62 29.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.58 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 133' ' ' LEU . 89.3 mt -98.49 119.04 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.388 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.1 t -109.85 114.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.385 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.51 106.69 3.08 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 101' ' ' HIS . 6.0 p -76.16 -30.88 58.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.53 -61.84 2.36 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.164 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -73.18 -75.14 0.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.326 0.584 . . . . 0.0 110.89 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -134.36 137.05 43.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.084 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -73.73 109.32 7.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.881 0.372 . . . . 0.0 111.218 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.419 ' H ' HG21 ' A' ' 96' ' ' THR . 5.0 t60 -72.7 108.01 5.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.5 108.79 3.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.04 141.41 58.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.404 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.36 150.78 16.91 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.7 -19.34 60.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.013 2.475 . . . . 0.0 112.699 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 mt-10 -94.91 -14.43 24.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.231 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -86.27 -40.76 15.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 111' ' ' LEU . 3.7 t -96.21 13.61 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.638 0.732 . . . . 0.0 109.654 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 106' ' ' GLU . 56.1 ttt85 -49.83 -54.81 28.34 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.16 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.17 -33.51 49.31 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.692 1.595 . . . . 0.0 112.325 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.46 ' HB2' HG12 ' A' ' 108' ' ' VAL . 88.9 mt -73.34 -46.44 49.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.66 -33.98 76.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.17 -32.67 74.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 73.8 mtm -81.75 -25.07 35.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.659 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.23 22.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.449 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.53 107.73 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 110.697 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.67 96.15 1.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.781 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 92' ' ' LEU . 46.5 t -89.33 118.83 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.811 0.339 . . . . 0.0 110.717 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -107.07 108.4 19.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.66 106.01 17.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 110.267 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.2 mtm -136.34 -171.68 2.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.032 0.444 . . . . 0.0 110.791 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 125' ' ' ALA . 1.9 m-20 -66.76 158.92 29.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.399 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -63.07 -42.44 99.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.221 0.534 . . . . 0.0 109.917 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.544 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 53.1 tt0 -66.23 -42.7 88.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.441 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.478 ' H ' ' HB2' ' A' ' 122' ' ' ASP . . . -63.68 -44.15 94.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.99 96.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.938 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.37 93.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 124' ' ' GLN . 63.0 mtm180 -62.77 -48.38 79.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.9 m -62.99 -34.01 76.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.787 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -62.69 -44.74 95.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.369 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 134' ' ' MET . 90.6 m-20 -65.84 -28.15 68.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.714 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 128' ' ' ARG . 81.3 mt -72.16 -50.74 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.516 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.462 HD13 HG11 ' A' ' 91' ' ' VAL . 98.0 mt -67.51 -34.97 78.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.804 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.402 ' HG2' ' HA ' ' A' ' 131' ' ' ASN . 19.0 ptp -67.84 -29.94 69.21 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.418 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.71 -26.69 40.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.59 -39.79 57.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.532 . . . . 0.0 109.903 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 30.84 5.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.821 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -100.92 148.26 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -71.11 99.83 1.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.031 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.56 140.56 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.107 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.401 ' O ' HD12 ' A' ' 92' ' ' LEU . 44.4 t -121.67 142.64 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 7.2 p -120.83 139.52 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.187 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -126.55 115.04 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -116.24 135.39 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.2 mt -109.21 99.67 37.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--O 1.233 0.257 0 C-N-CA 122.337 2.025 . . . . 0.0 111.496 176.805 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.866 0.365 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.95 113.97 24.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.13 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -116.3 143.13 45.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.646 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.91 115.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -87.26 -46.31 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.147 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.71 138.54 19.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.721 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -156.69 104.61 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.88 -29.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.841 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.426 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 23.1 m-20 -73.45 -29.26 62.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.018 0.437 . . . . 0.0 111.057 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.59 -12.53 4.28 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.5 p90 -111.92 154.9 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.35 111.37 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -94.17 112.94 24.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.038 0.447 . . . . 0.0 110.387 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.72 110.61 28.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.462 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 62.54 45.33 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.546 . . . . 0.0 109.965 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 73.73 -6.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.047 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.05 117.86 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -91.25 102.36 15.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.368 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.89 127.19 35.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.771 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -104.97 17.36 24.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -116.62 172.39 7.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB1' HD23 ' A' ' 145' ' ' LEU . . . -74.31 137.35 42.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 164.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 pt -134.99 144.87 33.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.413 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.74 125.67 38.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.575 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 44.7 p90 -149.08 162.58 39.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.075 0.464 . . . . 0.0 111.326 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.75 163.28 45.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.699 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.72 -36.93 34.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.72 2.28 . . . . 0.0 112.946 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -124.85 32.7 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.053 0.454 . . . . 0.0 110.521 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.31 16.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.873 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.83 147.32 80.63 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.687 2.258 . . . . 0.0 111.502 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.575 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 26.1 t -80.24 88.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.1 124.57 29.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.377 -174.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.7 m -82.05 121.89 27.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 56' ' ' LEU . 1.2 t90 -103.79 121.76 46.97 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.57 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.66 13.98 1.54 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.821 2.347 . . . . 0.0 112.951 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.465 HG21 HD13 ' A' ' 56' ' ' LEU . 48.5 t -95.79 112.82 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.47 -29.34 18.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -113.54 126.33 28.29 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.463 -173.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.16 -1.53 4.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.995 2.463 . . . . 0.0 113.209 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.14 -15.09 23.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -84.32 -7.81 59.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.015 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.532 ' HA ' HD12 ' A' ' 56' ' ' LEU . 60.1 mt -69.62 130.44 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.501 -175.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' A' ' 56' ' ' LEU . 41.2 p -111.25 179.77 3.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.702 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -68.33 -35.08 77.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 m -65.11 -41.72 94.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.49 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.621 ' HB3' ' HZ2' ' A' ' 44' ' ' TRP . 61.7 mt -65.17 -36.57 84.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.071 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.53 ' HB3' HD11 ' A' ' 111' ' ' LEU . 72.1 mt -63.09 -37.32 86.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.709 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 96.6 mt-30 -65.97 -40.69 91.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.83 -40.66 88.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.813 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.34 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.45 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HB2' HD22 ' A' ' 92' ' ' LEU . . . -82.33 -2.02 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.87 72.74 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.349 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.437 HD13 ' SD ' ' A' ' 114' ' ' MET . 96.4 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 121.82 0.819 . . . . 0.0 110.758 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.224 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.59 123.77 14.66 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.746 2.297 . . . . 0.0 112.296 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 50.6 mt-10 -65.11 -50.62 65.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.63 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 140' ' ' VAL . 4.2 p -135.02 130.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.382 0.611 . . . . 0.0 111.47 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 61' ' ' ALA . 65.2 tp -107.52 113.28 26.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.521 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 119' ' ' GLU . 95.9 mt -93.19 98.11 11.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.539 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -91.6 105.72 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -84.27 108.82 3.15 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 175.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.446 HG21 ' H ' ' A' ' 101' ' ' HIS . 8.0 p -62.62 -17.44 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.618 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 65.5 -92.2 0.15 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.853 171.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.22 -51.25 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.711 0.405 . . . . 0.0 111.638 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -144.66 134.26 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -70.04 112.03 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.813 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.446 ' H ' HG21 ' A' ' 96' ' ' THR . 66.5 m80 -113.06 147.43 37.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.255 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.68 106.86 18.84 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.7 169.79 12.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.14 147.96 16.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.728 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.623 ' HA ' HG22 ' A' ' 108' ' ' VAL . 51.1 Cg_exo -57.15 -24.59 59.5 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.354 2.703 . . . . 0.0 112.601 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -56.16 -31.97 63.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.223 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -89.28 -23.43 22.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.825 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.623 HG22 ' HA ' ' A' ' 105' ' ' PRO . 20.2 m -93.68 -21.57 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.544 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 57.5 mtm-85 -53.94 -49.36 90.0 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 11.7 Cg_endo -55.72 -34.52 91.03 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.982 1.788 . . . . 0.0 112.754 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 62.5 mt -81.57 -37.5 27.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.736 0.303 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.1 mt -64.69 -32.67 74.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.924 0.392 . . . . 0.0 110.584 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.72 -10.26 59.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 63' ' ' LEU . 67.1 mtt -97.05 -43.82 7.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.257 0.551 . . . . 0.0 109.737 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.02 10.71 2.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.208 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 39.7 t -98.5 125.99 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 110.475 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.23 124.51 8.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.41 ' CG2' HD12 ' A' ' 111' ' ' LEU . 23.3 t -93.71 115.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.646 0.26 . . . . 0.0 110.994 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.47 ' HB2' HD23 ' A' ' 93' ' ' LEU . 27.1 mm-40 -112.35 127.97 56.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.856 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.29 104.91 14.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 36.9 ttm -129.78 168.73 16.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.323 -169.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.13 155.67 27.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.915 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.618 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -54.37 -52.4 61.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.861 -177.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -77.65 -37.96 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.426 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.26 91.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.091 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 121' ' ' MET . . . -65.92 -44.29 85.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.729 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.05 93.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.702 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -64.5 -51.86 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.6 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.9 m -59.0 -36.97 75.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.92 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -57.99 -46.35 85.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.958 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -64.12 -37.24 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 110.592 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.65 -46.74 85.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.02 -24.11 64.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.4 ttm -64.97 -47.22 78.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.87 62.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.57 -11.76 59.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.061 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 70.14 32.64 69.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.815 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -100.78 150.38 22.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.745 0.307 . . . . 0.0 110.641 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 49.8 mtm180 -78.69 90.7 4.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.474 0.654 . . . . 0.0 110.94 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.497 HG23 HG13 ' A' ' 91' ' ' VAL . 6.0 p -123.4 137.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.587 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 36' ' ' ALA . 39.5 t -116.41 133.2 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.3 p -110.72 134.92 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.28 113.53 16.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.643 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -110.41 129.36 55.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.782 0.325 . . . . 0.0 111.197 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.563 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 69.6 mt -103.67 98.84 13.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.393 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.459 -0.516 0 C-N-CA 122.555 2.17 . . . . 0.0 112.225 179.466 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 37' ' ' PRO . 88.0 mt . . . . . 0 C--O 1.234 0.283 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -152.94 127.25 9.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.747 0.308 . . . . 0.0 110.355 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 m -110.9 141.01 44.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -68.19 115.59 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -49.09 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.94 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -134.66 129.48 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.234 0.54 . . . . 0.0 111.817 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.487 ' HE1' HG22 ' A' ' 123' ' ' THR . 85.0 t80 -104.14 102.57 12.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.49 175.2 47.38 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.784 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -81.19 -21.46 39.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.042 0.449 . . . . 0.0 110.64 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.63 -39.68 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.35 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -124.23 170.5 10.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.98 133.42 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -113.99 120.88 42.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.924 0.393 . . . . 0.0 110.035 -177.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -124.58 110.73 25.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.436 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 61.6 51.27 4.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.63 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 68.85 14.25 8.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.283 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.0 108.89 26.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -83.05 119.37 24.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.188 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -98.6 107.61 20.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.401 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -89.61 14.08 12.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.865 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -140.9 161.5 37.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.589 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -58.72 142.79 48.89 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.586 0.554 . . . . 0.0 111.097 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 pt -136.41 139.78 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.362 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -133.19 109.72 9.64 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 41' ' ' VAL . 42.8 p90 -146.83 161.01 41.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.486 0.66 . . . . 0.0 112.24 -170.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -109.48 154.81 42.1 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.565 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.537 ' HB2' ' HA ' ' A' ' 11' ' ' LEU . 54.0 Cg_endo -70.14 -5.71 17.09 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.145 1.896 . . . . 0.0 111.891 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -92.15 17.14 9.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.004 -170.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.95 -99.74 0.34 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.298 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.82 134.59 65.46 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.681 2.921 . . . . 0.0 114.658 -170.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 35' ' ' PHE . 96.3 t -113.69 119.95 62.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 157.61 16.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 m -124.52 148.14 47.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -115.92 139.54 25.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.983 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.11 23.98 0.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.195 2.597 . . . . 0.0 110.499 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.604 HG13 ' HB2' ' A' ' 51' ' ' ASP . 93.3 t -85.9 130.25 36.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.572 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -113.14 -40.98 3.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -106.01 145.62 31.29 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 28.1 Cg_endo -64.32 -8.82 17.83 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.791 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.12 -12.71 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.604 ' HB2' HG13 ' A' ' 46' ' ' VAL . 73.4 m-20 -81.13 -16.42 53.07 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.46 114.57 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.758 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.404 ' H ' HD12 ' A' ' 56' ' ' LEU . 6.4 m -111.47 155.44 23.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.846 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -52.17 -38.96 59.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.758 0.313 . . . . 0.0 111.318 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m -57.46 -43.82 84.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.997 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD12 ' H ' ' A' ' 53' ' ' THR . 78.4 mt -68.67 -32.8 72.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 -178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.21 -35.77 81.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -69.65 -33.16 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 110.394 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.23 -44.78 78.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.886 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.557 ' O ' HG11 ' A' ' 141' ' ' VAL . . . -64.01 -35.22 80.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.276 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.98 62.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.316 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.53 40.4 59.58 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.364 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.714 0.769 . . . . 0.0 110.668 -179.113 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.959 0.409 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.83 173.56 14.22 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.61 2.206 . . . . 0.0 111.715 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' OE2' ' HD2' ' A' ' 138' ' ' ARG . 34.1 tt0 -90.58 -38.71 12.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.347 0.594 . . . . 0.0 109.762 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.814 HG11 HD21 ' A' ' 133' ' ' LEU . 3.3 p -139.59 142.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.284 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 141' ' ' VAL . 68.3 tp -118.84 118.12 30.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.487 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.56 115.07 29.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.383 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.8 t -107.0 115.05 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.808 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.66 105.25 3.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 101' ' ' HIS . 19.8 p -77.08 4.42 10.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -171.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.468 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 74.07 -91.12 0.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.338 -0.458 . . . . 0.0 114.228 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.535 ' C ' ' HD2' ' A' ' 99' ' ' ARG . 52.9 mtt-85 -67.83 -60.93 2.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.967 0.413 . . . . 0.0 111.077 -171.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.535 ' HD2' ' C ' ' A' ' 98' ' ' ARG . 3.4 mpt_? -129.41 148.34 51.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.9 99.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 109.841 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.712 ' HD2' HD23 ' A' ' 103' ' ' LEU . 47.8 t60 -92.34 118.43 30.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.606 -174.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.71 110.59 4.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.231 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.712 HD23 ' HD2' ' A' ' 101' ' ' HIS . 67.1 mt -77.48 151.98 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 161.84 14.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.23 -170.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 46.9 Cg_endo -68.41 -1.24 6.99 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.238 2.625 . . . . 0.0 112.721 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -89.09 -23.0 22.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.39 0.614 . . . . 0.0 109.871 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.568 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 77.5 mt-30 -94.63 -47.89 6.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.507 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 m -86.13 -1.02 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.739 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 18.3 ttm180 -56.19 -56.02 35.65 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 41.9 Cg_exo -57.82 -39.72 84.71 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.923 1.749 . . . . 0.0 112.365 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.8 mt -74.09 -40.98 62.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.7 tp -60.86 -36.47 79.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.531 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.24 -27.67 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.998 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.04 -9.38 59.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.15 0.5 . . . . 0.0 110.102 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.83 -0.44 55.21 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.273 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 40.8 t -79.63 103.3 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.817 0.342 . . . . 0.0 110.361 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.45 101.74 1.3 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.921 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -88.74 110.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.701 0.286 . . . . 0.0 110.588 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -110.76 135.82 50.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.18 124.9 50.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.071 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.02 -171.83 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.72 164.88 19.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.501 HG23 HD22 ' A' ' 144' ' ' LEU . 21.1 m -64.19 -34.09 77.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.066 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.41 -47.38 27.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.589 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.28 86.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.695 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.801 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.89 -45.58 93.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.919 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.06 -51.29 70.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.716 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.5 m -62.19 -39.28 92.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.725 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -57.1 -49.74 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.242 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.51 -44.9 95.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -68.33 -44.28 83.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 110.925 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.814 HD21 HG11 ' A' ' 91' ' ' VAL . 23.5 tp -66.63 -37.32 84.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.866 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 33.4 ttp -63.35 -37.18 86.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.446 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.49 -29.1 69.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.46 -34.95 78.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 0.0 110.26 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.05 29.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.445 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.511 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 55.8 mtm180 -97.86 137.03 37.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 122.763 -0.257 . . . . 0.0 110.452 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -65.38 110.51 2.67 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.429 0.633 . . . . 0.0 111.319 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.489 HG21 HD23 ' A' ' 133' ' ' LEU . 5.4 p -130.03 135.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 60' ' ' ALA . 47.0 t -109.52 140.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -122.23 132.93 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.129 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . . . -115.42 113.97 24.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.343 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.501 HD22 HG23 ' A' ' 123' ' ' THR . 94.2 mt -114.95 125.19 53.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.942 0.401 . . . . 0.0 111.503 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 96' ' ' THR . 97.8 mt -97.76 119.55 62.22 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.213 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 27.6 Cg_endo . . . . . 0 N--CA 1.453 -0.869 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.961 0.41 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.27 108.22 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.261 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -111.79 146.7 37.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.186 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.93 125.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -84.15 -46.15 12.22 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 153.09 30.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.516 . . . . 0.0 112.257 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.43 123.54 35.81 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.77 -8.68 60.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.601 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.92 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.636 0.731 . . . . 0.0 110.11 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.9 -19.3 28.1 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -153.21 157.23 39.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.84 133.08 58.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -101.53 122.05 43.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.894 0.378 . . . . 0.0 110.352 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -121.83 96.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.65 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.39 56.12 2.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.087 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 71.26 -8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.079 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.89 117.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -98.14 103.07 14.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.823 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -89.32 114.01 25.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.461 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -89.91 25.44 2.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.22 0.533 . . . . 0.0 110.517 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -147.22 166.48 26.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.057 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -66.82 140.3 57.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.314 0.384 . . . . 0.0 110.696 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 pt -135.93 144.85 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.997 0.427 . . . . 0.0 111.516 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.63 112.05 17.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.29 176.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HB3' HG13 ' A' ' 41' ' ' VAL . 41.5 p90 -138.28 156.64 47.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.228 0.537 . . . . 0.0 111.797 -173.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.47 157.18 70.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.816 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD3' ' OH ' ' A' ' 130' ' ' TYR . 24.0 Cg_exo -64.12 -42.33 18.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.383 2.056 . . . . 0.0 110.881 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -106.52 82.45 1.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.546 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.41 -171.17 38.21 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.247 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -92.4 178.62 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.151 2.568 . . . . 0.0 112.934 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 35' ' ' PHE . 47.0 t -114.21 105.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 145.4 24.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.962 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -101.6 129.34 47.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.18 114.15 64.81 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.456 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 39.87 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.387 2.725 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.15 132.0 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.119 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -114.19 -25.41 8.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 110.645 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -114.64 128.37 25.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.731 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.1 -9.37 25.55 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.934 2.423 . . . . 0.0 112.954 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -3.89 55.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.603 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -86.75 -14.69 41.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.544 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 145' ' ' LEU . 67.3 mt -58.82 110.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.968 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -133.54 179.18 6.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.29 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -41.98 71.97 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.208 0.317 . . . . 0.0 111.611 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -56.3 -46.0 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.08 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 52' ' ' ILE . 90.8 mt -73.15 -37.15 66.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.91 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -40.46 96.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -66.97 -37.52 84.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.585 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.88 -42.34 99.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.91 -26.98 66.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.242 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.41 -6.38 55.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.244 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.26 59.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.525 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 -177.157 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.623 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.623 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 15.1 Cg_endo -57.67 142.25 95.76 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.563 2.175 . . . . 0.0 112.476 176.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.681 ' HG3' ' HB3' ' A' ' 139' ' ' ARG . 34.4 mt-10 -71.05 -40.45 71.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.409 0.624 . . . . 0.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.465 HG13 HG23 ' A' ' 140' ' ' VAL . 4.8 p -138.63 136.63 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.688 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB3' HG22 ' A' ' 118' ' ' VAL . 54.8 tp -116.05 116.66 28.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.577 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.44 124.07 47.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.687 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.84 126.19 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.742 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.48 ' HA3' HD23 ' A' ' 144' ' ' LEU . . . -108.88 112.95 3.61 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.548 ' HA ' HD12 ' A' ' 145' ' ' LEU . 21.2 p -81.62 -61.38 1.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.489 ' H ' ' HA ' ' A' ' 122' ' ' ASP . . . 84.92 -22.01 10.32 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.498 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.4 HH21 ' HB2' ' A' ' 146' ' ' PRO . 52.1 mtt180 -113.09 -64.86 1.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 110.084 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -139.73 126.41 20.57 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HA ' HG21 ' A' ' 96' ' ' THR . 27.9 mt-30 -70.37 94.98 0.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.165 0.507 . . . . 0.0 110.898 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -73.18 120.12 18.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.553 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.66 119.52 15.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.693 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.9 mt -73.49 139.74 45.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.99 159.01 15.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.205 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.669 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 58.3 Cg_exo -51.86 -41.11 64.72 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.185 2.59 . . . . 0.0 112.04 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.43 ' CD ' HH22 ' A' ' 109' ' ' ARG . 31.1 tp10 -52.51 -28.67 21.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.42 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.23 -42.76 8.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.512 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.5 m -87.26 -11.34 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.669 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 27.7 mtm-85 -50.9 -53.99 41.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.01 -37.47 93.82 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.991 1.794 . . . . 0.0 112.781 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.48 HD13 HG21 ' A' ' 118' ' ' VAL . 98.1 mt -79.73 -34.84 39.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.879 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 75.5 mt -68.72 -34.09 75.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.32 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.88 78.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.43 -41.42 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.367 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.03 15.68 7.72 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.371 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.93 117.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.18 102.9 1.86 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.826 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 92' ' ' LEU . 41.3 t -102.89 121.73 54.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.18 140.29 52.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.449 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -114.39 125.89 54.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 111.437 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.463 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.8 mtm -144.61 177.31 8.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.489 ' HA ' ' H ' ' A' ' 97' ' ' GLY . 19.9 m-20 -72.38 154.46 40.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.746 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.517 HG23 HD22 ' A' ' 144' ' ' LEU . 28.7 m -47.65 -53.31 15.24 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.846 0.717 . . . . 0.0 112.61 -174.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.48 -46.27 89.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 0.0 111.605 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.45 79.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.272 -177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.03 76.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.35 84.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.324 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -59.35 -51.06 71.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 109.958 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 -36.29 83.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.499 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.434 ' OH ' ' HA ' ' A' ' 36' ' ' ALA . 87.7 t80 -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.748 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -60.06 -41.24 91.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.319 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.94 -48.28 89.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.73 -31.19 72.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.025 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.7 ttp -64.59 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.265 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.91 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.822 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 138' ' ' ARG . 38.4 tt0 -74.71 -22.07 59.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.911 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.05 27.48 49.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.34 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.426 ' HD2' ' OE1' ' A' ' 136' ' ' GLU . 15.7 ttt180 -87.33 149.14 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.249 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.681 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 48.3 ttt85 -79.9 85.15 5.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.483 0.658 . . . . 0.0 109.285 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.465 HG23 HG13 ' A' ' 91' ' ' VAL . 4.8 p -120.46 132.98 68.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.009 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 89' ' ' PRO . 40.0 t -115.24 134.21 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 9.9 p -117.71 130.82 72.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.35 106.06 14.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.562 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.517 HD22 HG23 ' A' ' 123' ' ' THR . 92.5 mt -106.4 128.5 54.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.639 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 96' ' ' THR . 78.2 mt -87.5 151.29 50.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.861 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HB2' HH21 ' A' ' 98' ' ' ARG . 27.5 Cg_exo . . . . . 0 C--N 1.345 0.348 0 C-N-CA 122.557 2.171 . . . . 0.0 112.075 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -77.84 86.83 4.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.279 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 m -116.25 140.44 49.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.571 ' HA ' HG22 ' A' ' 24' ' ' VAL . 48.6 t -60.62 112.91 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -74.9 -53.33 9.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.517 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -140.34 157.12 46.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.153 0.501 . . . . 0.0 111.258 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -110.01 118.41 36.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.74 156.95 15.65 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.322 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.9 92.49 0.51 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.64 11.43 55.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.105 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -161.13 150.23 16.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.135 0.467 . . . . 0.0 111.159 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 29' ' ' PHE . 61.6 mt -96.94 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -118.08 114.83 23.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.037 0.446 . . . . 0.0 110.151 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.571 HG22 ' HA ' ' A' ' 14' ' ' VAL . 40.4 t -129.77 113.04 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.669 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 60.14 38.53 20.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.362 0.601 . . . . 0.0 110.298 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 68.59 17.43 8.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.014 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.91 112.85 36.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 28' ' ' ARG . 24.0 ttt85 -72.81 110.79 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.131 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 66.0 m-85 -102.51 98.08 8.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.198 0.523 . . . . 0.0 110.638 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -99.83 28.9 4.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.269 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -148.03 156.4 42.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.45 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 44' ' ' TRP . . . -60.63 136.86 58.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.433 0.458 . . . . 0.0 111.386 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.2 pt -138.04 150.16 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.309 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -135.28 125.8 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.843 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 41.8 p90 -147.89 157.46 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.234 0.54 . . . . 0.0 111.789 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -132.19 155.35 81.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.244 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.58 -22.73 57.93 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.74 2.293 . . . . 0.0 112.538 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -116.53 22.71 12.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.59 0.71 . . . . 0.0 109.284 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.71 17.45 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.039 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -89.83 -171.41 0.5 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.083 2.522 . . . . 0.0 112.297 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.4 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 40.8 t -111.29 114.79 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.01 151.97 22.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.907 0.384 . . . . 0.0 111.191 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -91.41 126.3 36.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.245 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -101.34 119.78 56.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.113 -176.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.6 Cg_exo -78.79 22.63 0.65 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.439 2.759 . . . . 0.0 113.248 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HD13 ' A' ' 56' ' ' LEU . 88.5 t -91.77 132.18 36.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -105.53 -51.22 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.255 0.55 . . . . 0.0 110.939 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -116.89 138.92 25.11 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.148 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HB2' ' HB3' ' A' ' 101' ' ' HIS . 43.9 Cg_endo -67.19 -11.14 31.11 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.939 2.426 . . . . 0.0 112.832 -176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.73 -15.42 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 63.9 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.654 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.96 100.21 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.974 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.43 ' H ' HD12 ' A' ' 56' ' ' LEU . 2.2 m -89.04 159.42 17.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.51 68.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.93 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 m -60.06 -36.82 78.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 46' ' ' VAL . 81.9 mt -67.75 -36.15 80.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.097 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 111' ' ' LEU . 97.2 mt -68.2 -37.9 81.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.852 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.26 -39.62 91.04 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.023 0.439 . . . . 0.0 110.492 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -64.65 -40.72 95.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.722 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.86 -20.62 63.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.27 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -82.11 -5.82 58.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.5 15.29 81.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.699 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.947 0.403 . . . . 0.0 111.442 -177.121 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 80.8 Cg_exo -47.46 124.9 10.03 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.497 2.132 . . . . 0.0 112.07 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.487 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 39.2 mt-10 -66.16 -45.47 80.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.475 HG13 HG23 ' A' ' 140' ' ' VAL . 4.0 p -134.72 133.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.248 0.547 . . . . 0.0 111.278 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.38 121.97 42.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.618 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.2 mt -105.58 109.87 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.891 0.377 . . . . 0.0 110.495 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.49 121.74 45.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.18 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -93.3 106.76 3.45 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 24.8 p -59.98 -49.82 76.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.735 0.414 . . . . 0.0 111.915 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.28 -78.03 0.57 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.255 -0.497 . . . . 0.0 113.146 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -69.65 -38.19 77.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.595 ' O ' ' HB ' ' A' ' 96' ' ' THR . 44.7 ttm-85 -166.77 140.73 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.63 0.253 . . . . 0.0 110.81 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.536 ' HA ' HG21 ' A' ' 96' ' ' THR . 90.0 mt-30 -70.73 105.32 3.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . 51.3 t-80 -117.98 111.25 18.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.85 130.34 40.8 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.61 151.88 40.71 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.97 165.31 13.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.264 -176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.6 Cg_endo -56.46 -31.19 84.98 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.173 2.582 . . . . 0.0 112.709 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -67.09 -25.76 66.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.155 0.502 . . . . 0.0 110.705 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -96.36 -23.27 16.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.738 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 26.7 m -106.7 -7.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.732 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 39.9 ttp-105 -53.62 -55.2 37.62 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 38.5 Cg_exo -58.07 -32.99 96.82 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.987 1.791 . . . . 0.0 112.333 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.761 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.3 mt -78.09 -33.91 50.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 90.0 mt -61.08 -38.34 85.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 109.932 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.13 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.198 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 64.4 mtt -89.53 -33.07 16.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.659 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.04 18.48 5.5 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.268 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 t -93.14 114.48 29.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.727 0.299 . . . . 0.0 111.098 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.44 102.37 2.71 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.1 t -95.69 122.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.814 0.34 . . . . 0.0 111.489 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -120.6 146.33 46.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.061 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.24 119.6 32.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.988 0.423 . . . . 0.0 110.682 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.459 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 64.9 mtm -142.74 175.05 10.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.47 163.29 25.65 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.832 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.2 m -50.77 -52.79 37.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.399 -173.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.46 -43.89 96.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.639 0.257 . . . . 0.0 111.284 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.79 99.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.971 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.91 71.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.96 89.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.793 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttp-105 -67.63 -46.52 72.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 0.0 110.653 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.6 m -65.89 -31.49 72.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.292 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.49 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 75.6 t80 -59.0 -45.59 90.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.387 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -64.15 -41.63 97.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.53 -47.11 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.654 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.418 HD13 HG11 ' A' ' 91' ' ' VAL . 97.5 mt -68.98 -28.26 66.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.33 -47.43 70.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.218 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.59 -25.41 66.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.553 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.43 -12.32 60.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.276 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.86 57.24 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.122 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.487 ' HE ' ' CD ' ' A' ' 90' ' ' GLU . 6.8 tpt180 -105.58 153.11 22.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.694 0.283 . . . . 0.0 110.323 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -82.6 91.12 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.789 0.804 . . . . 0.0 111.144 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG23 HG13 ' A' ' 91' ' ' VAL . 7.2 p -118.1 142.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.705 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 36' ' ' ALA . 39.4 t -122.31 141.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.4 p -120.39 138.45 50.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 110.855 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.76 107.76 10.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.434 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.6 mt -104.13 129.89 51.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.689 0.281 . . . . 0.0 111.694 -172.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -101.74 105.94 44.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 30.0 Cg_endo . . . . . 0 N--CA 1.45 -1.035 0 C-N-CA 123.311 2.674 . . . . 0.0 111.328 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.0 tp . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.868 0.366 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -69.2 107.01 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.104 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 m -133.22 135.64 45.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 24' ' ' VAL . 49.2 t -73.02 118.89 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -93.02 -75.14 0.5 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.894 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.64 98.25 11.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 0.0 110.66 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -86.14 114.98 23.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.196 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.87 168.52 19.0 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.29 -21.41 36.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.121 0.486 . . . . 0.0 110.134 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.56 -38.21 5.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.53 155.6 46.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 110.817 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -114.57 114.16 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.613 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 42.5 tt0 -99.33 116.21 30.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 14' ' ' VAL . 61.3 t -116.06 121.95 68.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.688 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 60.03 31.03 20.45 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.355 0.409 . . . . 0.0 110.506 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HA ' ' CD ' ' A' ' 23' ' ' GLU . 96.7 mt-30 71.16 14.47 6.66 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.57 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -104.8 116.75 49.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 99.0 mtt180 -93.31 116.49 29.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.86 0.362 . . . . 0.0 111.333 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.07 143.08 32.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.331 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.2 p -106.13 1.29 26.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.542 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -128.98 170.65 13.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.065 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -60.5 143.04 54.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 112.355 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.99 144.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.702 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 120.03 26.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.465 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.8 162.19 36.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.19 0.519 . . . . 0.0 111.709 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -137.81 151.91 71.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.288 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.46 -45.09 36.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.731 2.287 . . . . 0.0 112.57 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' OE2' ' HG2' ' A' ' 139' ' ' ARG . 39.0 mt-10 -97.59 23.34 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.823 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.91 -170.84 11.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.22 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -90.05 -168.37 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.89 2.393 . . . . 0.0 112.316 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.34 117.72 56.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.658 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.07 123.21 35.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.233 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.1 t -77.52 113.13 15.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.718 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.19 117.94 64.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.85 25.47 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.903 2.402 . . . . 0.0 111.603 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 51' ' ' ASP . 83.9 t -86.16 122.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.272 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.74 -39.89 11.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.646 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -139.64 157.38 70.19 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.961 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.44 -11.72 11.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.23 2.62 . . . . 0.0 113.393 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.4 -21.47 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.583 ' HB2' HG13 ' A' ' 46' ' ' VAL . 63.1 m-20 -86.25 -5.12 59.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 145' ' ' LEU . 71.0 mt -74.41 125.46 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.035 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -141.25 175.34 9.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.036 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -57.63 -45.65 85.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 m -56.4 -44.41 80.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.929 0.395 . . . . 0.0 111.425 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.62 -39.06 84.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.762 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.565 ' HB3' HD11 ' A' ' 111' ' ' LEU . 96.0 mt -66.09 -40.17 90.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.161 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -61.45 -46.91 88.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.453 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -63.19 -36.78 84.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.915 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.68 -32.44 73.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.047 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.63 5.7 8.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.18 -7.67 54.73 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.42 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.011 0.434 . . . . 0.0 111.148 -176.713 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.454 0.169 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.3 162.45 7.75 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.095 2.53 . . . . 0.0 112.734 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 139' ' ' ARG . 9.5 mm-40 -72.87 -49.71 28.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 -175.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 12.8 p -148.22 145.52 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.227 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 117' ' ' GLY . 2.0 pt? -119.04 132.01 56.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.128 0.49 . . . . 0.0 110.107 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.77 123.44 41.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.108 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.6 109.13 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.513 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -85.34 108.71 3.23 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.616 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.8 p -69.09 -12.14 61.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.23 -85.31 0.71 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.286 -0.483 . . . . 0.0 114.001 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -61.6 -41.0 96.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.899 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -172.5 158.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.616 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 52.9 tt0 -62.52 137.7 58.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.577 . . . . 0.0 111.718 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -136.19 164.14 28.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.487 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.18 110.13 22.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.885 0.374 . . . . 0.0 110.423 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.14 131.89 38.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -106.45 -176.78 23.32 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.103 -1.046 . . . . 0.0 114.172 -167.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.616 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 60.4 Cg_endo -72.18 3.75 3.81 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.774 2.982 . . . . 0.0 113.473 -173.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HA ' ' NH1' ' A' ' 109' ' ' ARG . 11.7 tp10 -96.94 -26.6 14.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -96.02 -50.94 4.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.505 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.691 ' HB ' HG11 ' A' ' 118' ' ' VAL . 33.5 m -91.56 5.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.649 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 42.0 ttp-105 -59.85 -52.32 74.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 76.7 Cg_exo -54.8 -29.77 64.31 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.166 1.91 . . . . 0.0 113.075 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 57' ' ' LEU . 58.7 mt -70.04 -49.0 55.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 109.86 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.8 mt -64.19 -32.54 74.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.36 -26.89 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.368 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.453 ' HE2' ' HA ' ' A' ' 111' ' ' LEU . 65.7 mtm -87.34 -33.48 19.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.857 0.361 . . . . 0.0 110.665 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.43 4.25 9.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.408 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.0 131.2 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -82.33 141.3 21.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.736 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' A' ' 108' ' ' VAL . 11.7 p -127.33 145.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 122.689 -0.301 . . . . 0.0 110.227 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.86 136.65 27.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.791 0.329 . . . . 0.0 110.632 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.48 127.52 46.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.796 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.501 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 32.8 ttm -147.2 161.75 40.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -174.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.97 159.97 31.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 m -50.5 -63.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.44 -44.19 95.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.723 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.35 89.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.89 94.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.573 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.71 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 132' ' ' ILE . 53.4 ttp180 -60.2 -55.84 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 15.8 m -60.51 -38.03 83.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.04 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.22 -49.6 76.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.994 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.15 -40.85 95.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.627 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 79.5 mt -60.56 -56.4 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.76 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.74 -31.69 72.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.8 ttp -66.22 -40.83 90.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.213 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.69 -35.45 72.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.66 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 9.1 mm-40 -61.69 -29.71 70.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.79 32.69 7.06 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.829 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -107.28 135.8 48.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.468 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 28.6 mtm180 -67.44 97.65 0.59 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.516 0.674 . . . . 0.0 110.869 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 7.4 p -123.78 139.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.333 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 36' ' ' ALA . 30.8 t -109.46 150.42 12.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.91 130.98 55.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.006 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.31 120.71 39.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.237 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.76 127.37 53.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.897 0.38 . . . . 0.0 111.55 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 52' ' ' ILE . 68.5 mt -99.64 116.64 64.69 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.575 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 72.2 Cg_endo . . . . . 0 C--O 1.233 0.253 0 C-N-CA 122.616 2.211 . . . . 0.0 112.815 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -114.02 112.35 23.13 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m -130.6 143.6 50.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.999 0.428 . . . . 0.0 111.618 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.3 139.35 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.606 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 p -99.1 -40.02 8.21 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.731 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -140.23 116.71 10.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 111.715 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -105.47 104.33 14.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.04 -169.68 14.44 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.124 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.19 94.03 3.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.992 0.425 . . . . 0.0 110.809 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.81 60.35 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.261 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -125.56 152.16 45.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.038 0.419 . . . . 0.0 110.992 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.28 124.6 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.891 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 36.9 tt0 -111.59 122.56 48.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 111.339 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.42 115.19 49.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.051 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.39 -78.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.467 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -138.42 -1.1 1.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.458 0.17 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.58 121.89 68.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.792 0.329 . . . . 0.0 111.198 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.2 ptp180 -97.84 123.37 41.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.292 0.568 . . . . 0.0 110.334 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.43 137.35 37.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.198 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -94.73 17.31 13.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.37 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -147.25 167.78 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.929 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -61.56 146.95 47.13 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.483 0.489 . . . . 0.0 111.466 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 pt -141.78 147.08 22.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.084 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.76 124.97 40.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.821 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -147.95 161.33 41.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.52 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -136.56 160.74 65.47 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.619 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.56 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 11.3 Cg_endo -56.03 -48.67 18.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.728 2.285 . . . . 0.0 111.941 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -111.71 86.97 2.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.97 178.8 41.76 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.058 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -90.22 143.2 3.85 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.025 2.483 . . . . 0.0 113.076 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.86 114.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.58 154.47 30.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.556 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.1 m -87.25 143.14 27.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 t90 -111.88 121.63 39.16 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 9.8 Cg_exo -72.54 46.99 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.526 2.818 . . . . 0.0 113.409 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 HD13 ' A' ' 56' ' ' LEU . 92.0 t -122.19 115.96 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.17 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -82.98 -32.1 27.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.0 110.159 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -160.3 158.57 25.94 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.036 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HA ' HG13 ' A' ' 52' ' ' ILE . 17.5 Cg_exo -68.44 33.94 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.964 3.109 . . . . 0.0 114.414 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.68 -27.48 15.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.634 0.254 . . . . 0.0 110.934 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -111.96 7.18 19.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.503 HG13 ' HA ' ' A' ' 49' ' ' PRO . 54.6 mt -61.74 109.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.157 0.504 . . . . 0.0 110.822 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 p -127.89 175.99 7.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.788 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -59.4 -43.69 92.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.82 -175.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -58.21 -42.72 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.786 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.449 HD13 HG22 ' A' ' 46' ' ' VAL . 93.8 mt -67.93 -36.56 80.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.735 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.0 -37.38 85.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.319 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 98.2 mt-30 -58.08 -42.69 86.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.999 0.428 . . . . 0.0 110.443 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.72 -39.76 84.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.271 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.6 -18.0 52.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.11 -20.39 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.33 45.3 30.96 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.056 0.455 . . . . 0.0 110.555 -177.352 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.708 0.29 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.19 154.39 74.44 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.792 2.328 . . . . 0.0 112.516 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.48 -42.7 58.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.476 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 140' ' ' VAL . 3.6 p -135.33 139.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.327 0.584 . . . . 0.0 111.899 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 141' ' ' VAL . 51.1 tp -118.11 122.49 43.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.5 mt -104.27 121.72 43.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.741 0.305 . . . . 0.0 110.619 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.37 113.36 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.26 89.76 1.01 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.237 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.52 31.96 4.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.872 0.368 . . . . 0.0 111.234 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -72.37 -15.08 77.08 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.225 -175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -83.14 -21.96 33.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.41 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 10.8 tpt180 -168.77 90.95 0.25 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -56.99 106.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.281 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -115.05 99.71 7.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.73 111.7 1.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 97.6 mt -68.38 133.19 48.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.255 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.05 21.53 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.631 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.9 Cg_endo -55.12 -47.16 27.87 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.509 2.806 . . . . 0.0 112.938 -174.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.67 -25.4 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.769 0.319 . . . . 0.0 111.634 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 103' ' ' LEU . 97.2 mt-30 -78.13 -40.98 36.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 29.0 m -101.24 4.19 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.577 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.518 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 32.8 ttp180 -54.26 -48.9 93.13 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 53.6 Cg_exo -53.49 -34.27 71.4 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.098 1.865 . . . . 0.0 112.59 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.6 mt -86.55 -34.32 19.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.878 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 80.2 mt -63.78 -34.25 77.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.908 0.385 . . . . 0.0 110.157 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.29 -13.11 62.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.115 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -100.82 -25.33 14.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.971 0.415 . . . . 0.0 110.509 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.03 18.64 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.05 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.7 t -94.78 118.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.99 111.24 3.63 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.672 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.71 119.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -108.45 118.67 37.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.998 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.58 106.93 17.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.689 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 40.5 ttm -134.49 163.68 29.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.103 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.96 149.64 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.455 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 9.7 m -60.21 -47.0 87.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.76 0.315 . . . . 0.0 111.376 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -69.93 -40.56 75.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 110.576 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.46 95.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.971 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.4 83.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.97 88.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -64.03 -41.14 97.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.542 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.9 m -63.52 -43.79 96.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.464 ' CE1' ' HD3' ' A' ' 37' ' ' PRO . 73.2 t80 -57.08 -41.86 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -58.48 -47.13 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.05 -45.6 90.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.718 HD22 ' HD2' ' A' ' 138' ' ' ARG . 87.0 mt -64.21 -34.58 78.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.56 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 50.8 ttp -67.52 -34.28 76.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.345 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.76 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.07 -23.1 61.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.033 0.444 . . . . 0.0 110.415 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.55 31.58 15.64 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.149 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.718 ' HD2' HD22 ' A' ' 133' ' ' LEU . 45.8 mtt180 -83.43 152.46 24.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.797 0.332 . . . . 0.0 110.922 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -83.18 93.02 7.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.891 0.853 . . . . 0.0 109.494 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 91' ' ' VAL . 3.7 p -125.77 133.87 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.33 -177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 36' ' ' ALA . 33.5 t -111.96 133.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.2 p -116.65 130.15 71.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.906 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -109.95 109.49 20.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.453 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.65 129.87 46.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.479 HD13 ' HG3' ' A' ' 49' ' ' PRO . 87.8 mt -103.65 117.34 60.12 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.439 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 84.2 Cg_endo . . . . . 0 N--CA 1.458 -0.571 0 C-N-CA 123.02 2.48 . . . . 0.0 111.856 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.408 ' HA ' ' OD1' ' A' ' 25' ' ' ASN . 88.3 m-20 -64.35 109.38 1.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.033 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 m -117.6 133.09 56.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -66.17 110.32 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.552 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 m -82.77 -44.74 15.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.41 150.59 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.042 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -128.36 128.58 44.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.03 -169.02 12.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.857 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.49 -61.2 1.91 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.277 0.561 . . . . 0.0 110.94 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.75 25.08 15.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.737 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -155.13 138.88 16.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.602 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -120.79 120.96 63.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 39.1 tt0 -96.03 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.267 -176.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.51 128.31 66.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 12' ' ' ASN . 7.8 m-20 61.27 30.16 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.213 -177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 69.22 15.53 8.58 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.732 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.26 121.72 62.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 93.2 mtt180 -87.36 111.76 21.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.004 0.43 . . . . 0.0 111.581 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.58 124.0 45.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.042 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -97.98 22.55 9.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.978 0.418 . . . . 0.0 111.332 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -151.39 171.82 16.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.473 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.85 135.91 57.67 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.604 0.565 . . . . 0.0 111.623 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.67 144.81 26.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.107 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.07 122.18 35.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.519 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 37.7 p90 -143.78 153.51 42.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.102 0.477 . . . . 0.0 111.708 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.48 158.53 68.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.052 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -58.68 135.22 65.82 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.255 1.97 . . . . 0.0 111.62 173.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 70.02 16.86 7.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.162 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.18 169.46 22.98 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.5 177.24 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.129 . . . . 0.0 112.221 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 43.1 t -102.81 102.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.35 134.42 35.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.09 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -77.7 118.89 20.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.035 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -98.18 120.31 59.99 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.673 -175.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.3 Cg_exo -77.19 26.56 0.45 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.348 2.699 . . . . 0.0 112.99 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 51' ' ' ASP . 79.5 t -103.19 110.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.673 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.406 ' HA ' HD21 ' A' ' 145' ' ' LEU . 23.9 mt-30 -113.72 -13.88 12.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.318 0.58 . . . . 0.0 109.566 174.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.071 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 37.2 mtp-105 -101.83 135.25 19.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.44 -33.57 93.92 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.596 2.198 . . . . 0.0 112.319 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.11 9.54 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.456 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 1.071 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 3.6 t70 -85.09 -25.88 27.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.206 0.527 . . . . 0.0 110.13 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.9 109.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.565 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.0 m -112.35 155.53 23.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.168 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.542 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -56.68 -38.18 71.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 t -57.34 -42.79 82.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.712 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.82 -27.48 64.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' HD11 ' A' ' 111' ' ' LEU . 95.8 mt -71.3 -35.07 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.386 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.102 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -66.34 -43.93 84.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.367 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 -19.33 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.913 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.3 -5.93 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.38 82.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.127 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.358 0.599 . . . . 0.0 110.97 -176.674 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.521 0.201 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 18.5 Cg_endo -57.77 134.43 62.73 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 123.052 2.502 . . . . 0.0 113.013 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -67.29 -36.82 82.32 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.514 HG13 HG23 ' A' ' 140' ' ' VAL . 6.0 p -139.76 135.78 39.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.993 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.6 tp -111.67 120.6 42.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.193 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 119' ' ' GLU . 94.9 mt -102.08 112.2 24.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.864 0.364 . . . . 0.0 110.895 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.85 113.61 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.959 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -97.77 97.07 1.89 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 p -106.67 56.17 0.65 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.155 0.502 . . . . 0.0 110.931 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.729 ' HA3' HG22 ' A' ' 123' ' ' THR . . . -64.07 -28.54 72.99 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.536 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -63.0 -38.72 92.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.249 0.547 . . . . 0.0 110.768 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -170.44 95.06 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -61.23 128.09 34.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.798 -168.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -107.77 120.93 43.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.833 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.8 tp -80.1 103.18 9.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.91 145.92 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.031 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 173.77 20.1 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.747 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.622 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 54.2 Cg_exo -52.29 -49.34 17.71 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.543 2.829 . . . . 0.0 113.155 -175.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.09 -34.51 73.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.863 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -68.52 -30.27 69.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.88 -8.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 85.7 mtt180 -54.22 -52.49 68.4 Favored Pre-proline 0 N--CA 1.466 0.344 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.542 ' HG2' ' HB1' ' A' ' 54' ' ' ALA . 79.1 Cg_exo -50.96 -34.11 44.8 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.387 2.058 . . . . 0.0 113.173 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 80.0 mt -89.73 -37.99 14.16 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.146 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.3 mt -60.89 -34.44 74.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.776 0.322 . . . . 0.0 110.694 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.16 -24.06 65.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.092 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.4 mtt -90.67 -9.85 45.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.382 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.19 10.68 54.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.252 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.6 t -94.59 113.55 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.674 0.273 . . . . 0.0 110.537 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.12 118.78 4.78 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.618 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.56 117.18 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.449 ' HB2' HD23 ' A' ' 93' ' ' LEU . 27.6 mm-40 -114.33 110.1 19.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.195 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.18 110.73 22.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 67.4 mtm -138.56 -171.85 3.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.813 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.06 154.33 39.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.941 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.729 HG22 ' HA3' ' A' ' 97' ' ' GLY . 5.0 t -62.94 -45.79 90.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.777 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -74.7 -38.05 62.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.71 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.696 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.96 78.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.727 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.23 88.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -63.74 -48.27 77.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.374 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -66.13 -39.32 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.11 -44.23 91.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.801 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.61 -50.1 71.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.138 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.35 -48.85 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD13 HG11 ' A' ' 91' ' ' VAL . 96.9 mt -65.52 -35.37 80.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.344 -177.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.67 -33.78 74.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.809 0.338 . . . . 0.0 110.097 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.76 -26.17 65.99 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.67 -24.97 58.89 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.133 0.492 . . . . 0.0 110.413 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.13 18.69 53.07 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 40.4 ttm-85 -81.42 154.17 26.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.395 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB3' ' HA ' ' A' ' 89' ' ' PRO . 37.4 mmt180 -79.23 99.07 6.88 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.674 0.75 . . . . 0.0 110.742 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.514 HG23 HG13 ' A' ' 91' ' ' VAL . 4.1 p -134.49 134.7 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.532 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 36' ' ' ALA . 26.4 t -116.66 137.33 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.23 136.23 58.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.071 0.463 . . . . 0.0 111.178 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.12 112.33 18.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.756 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -105.2 138.68 41.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 -175.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.465 HD11 HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -119.45 91.12 43.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 123.186 2.59 . . . . 0.0 113.213 178.81 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 121.184 0.516 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -64.62 107.11 1.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.4 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 m -131.24 150.16 52.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.745 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -71.56 129.84 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 p -85.67 -33.73 21.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.711 0.291 . . . . 0.0 111.54 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -145.26 112.34 6.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.58 0.229 . . . . 0.0 110.476 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -70.38 -38.22 74.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.869 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.9 -163.6 44.33 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.781 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.01 -74.84 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.202 0.525 . . . . 0.0 110.277 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.93 31.99 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.469 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.45 119.25 2.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.4 110.07 26.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 36.7 tt0 -97.95 112.62 24.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 110.543 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.07 109.65 29.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.81 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 62.97 43.57 6.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.654 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 70.48 12.04 7.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.819 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -106.04 113.04 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttm105 -90.72 112.84 24.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.346 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.45 117.56 33.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.686 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 55.5 m -93.9 10.53 32.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -148.2 -179.34 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.362 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.74 146.33 46.3 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.22 148.46 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.573 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.3 131.14 48.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.599 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.04 158.2 38.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.312 0.577 . . . . 0.0 111.789 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -131.51 161.87 59.54 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.547 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.83 -46.36 33.9 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.374 2.049 . . . . 0.0 110.981 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -118.27 96.05 5.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.022 172.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.83 178.64 41.03 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.67 138.97 7.43 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.568 2.178 . . . . 0.0 112.718 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.26 103.02 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.2 121.85 42.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.481 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -66.94 120.74 14.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -97.88 127.21 37.93 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -170.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.4 Cg_exo -70.09 3.99 2.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.408 2.739 . . . . 0.0 113.033 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 51' ' ' ASP . 84.7 t -86.14 134.96 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.71 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 50.0 tp60 -107.16 -41.48 5.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.146 0.498 . . . . 0.0 110.155 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.71 ' HG3' ' HG3' ' A' ' 47' ' ' GLN . 63.5 mtt180 -129.5 156.09 79.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.607 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.64 0.11 2.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.16 2.574 . . . . 0.0 113.172 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HB2' ' NH2' ' A' ' 99' ' ' ARG . . . -90.6 -17.23 27.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.148 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.552 ' HB2' HG13 ' A' ' 46' ' ' VAL . 43.5 m-20 -88.15 -16.29 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.048 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.67 114.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.667 -174.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 p -124.27 173.62 8.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.402 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.24 91.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.616 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -60.96 -42.25 97.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.417 0.627 . . . . 0.0 110.797 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.466 HD13 HG22 ' A' ' 46' ' ' VAL . 87.5 mt -71.56 -28.85 64.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.856 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.95 -39.14 87.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.488 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -63.67 -37.93 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.3 -44.84 74.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.27 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.529 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . -76.68 -9.21 58.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.28 23.61 71.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.724 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.974 -176.22 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 86.4 Cg_exo -47.6 132.44 20.57 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.247 2.631 . . . . 0.0 113.368 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.5 mt-10 -77.3 -43.03 34.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 7.1 p -140.66 137.45 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.158 -177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 61' ' ' ALA . 45.1 tp -110.0 118.22 35.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.301 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.3 mt -98.06 120.85 39.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.866 0.365 . . . . 0.0 110.747 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.15 122.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.093 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -100.39 113.09 4.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.189 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 22.2 p -83.76 -66.98 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.743 0.306 . . . . 0.0 111.678 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 -65.26 3.87 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.572 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -69.52 -37.6 77.2 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.769 -0.254 . . . . 0.0 111.217 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 96' ' ' THR . 13.7 ptt180 -161.19 138.47 8.95 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 170.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -81.08 91.5 6.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.391 0.615 . . . . 0.0 111.237 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -94.68 106.98 18.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.534 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.26 149.35 38.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.711 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.5 150.39 21.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.423 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -105.95 165.48 13.87 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.468 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.51 -26.34 82.6 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 123.397 2.731 . . . . 0.0 113.36 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.69 -11.68 44.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.003 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.54 -45.68 8.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.281 0.563 . . . . 0.0 109.995 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 104' ' ' GLY . 27.0 m -90.79 16.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.499 0.666 . . . . 0.0 109.979 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.632 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 33.2 ttt180 -54.25 -52.95 64.37 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.801 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.9 Cg_exo -59.28 -40.51 67.84 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.961 1.774 . . . . 0.0 112.465 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 91.8 mt -73.94 -42.11 61.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 -176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.6 mt -61.45 -38.17 86.23 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.573 0.225 . . . . 0.0 110.955 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -35.02 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 65.7 mtt -76.38 -29.83 57.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.646 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.95 10.82 13.42 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.99 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.7 t -92.12 113.27 27.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -80.33 130.01 9.48 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.567 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.2 124.04 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.988 0.394 . . . . 0.0 110.393 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -114.43 108.62 17.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.311 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.14 111.06 22.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 68.2 mtm -137.85 -171.65 3.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.56 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.25 152.14 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.873 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.548 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 7.7 t -63.77 -38.24 90.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.68 -37.25 42.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.234 0.54 . . . . 0.0 109.94 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.97 90.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.886 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.43 -40.75 70.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.008 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.0 84.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.424 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -72.76 -43.74 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.1 p -67.04 -32.22 73.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.469 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 79.7 t80 -57.56 -44.96 85.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.42 174.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.7 -36.39 84.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.54 -49.81 82.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.59 -30.46 71.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttm -65.72 -42.48 91.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.192 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.7 76.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.85 -16.75 60.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.775 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.39 51.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.206 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -93.25 167.63 11.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.803 0.335 . . . . 0.0 110.924 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.694 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 2.1 mmt180 -83.38 90.66 7.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.119 0.485 . . . . 0.0 109.872 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.4 135.84 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 36' ' ' ALA . 16.7 t -125.61 142.92 40.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.469 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 8.3 p -123.63 140.82 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.1 113.34 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.355 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 98.8 mt -104.11 133.94 48.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.338 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.69 103.99 51.32 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.058 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.462 -0.351 0 C-N-CA 122.969 2.446 . . . . 0.0 112.343 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -101.59 112.06 24.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.128 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 m -100.31 143.57 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.413 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.89 115.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.139 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -45.76 73.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.738 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -141.77 110.52 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.21 0.529 . . . . 0.0 111.439 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -99.21 129.31 45.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.769 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 21' ' ' TYR . . . -132.3 -178.17 15.35 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.137 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -86.51 -20.47 27.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.031 0.443 . . . . 0.0 110.46 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.9 17.43 5.72 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.995 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.512 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 27.3 p90 -164.95 150.36 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.74 0.305 . . . . 0.0 110.76 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.44 106.35 15.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -105.6 118.26 36.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.954 0.407 . . . . 0.0 109.954 -177.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.29 139.18 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.83 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.26 -83.8 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.667 0.604 . . . . 0.0 110.176 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -152.71 13.27 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.466 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.56 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.003 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 48.0 ttp180 -83.45 107.4 15.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.82 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.74 129.83 35.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.099 0.476 . . . . 0.0 110.941 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 m -108.45 19.09 20.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.887 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -145.44 168.92 19.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . . . -65.8 142.77 57.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.108 0.48 . . . . 0.0 111.598 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.8 pt -137.98 138.82 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.7 118.68 25.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -146.52 163.61 35.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.79 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.23 152.73 70.18 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.1 -32.75 96.28 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.87 2.38 . . . . 0.0 112.959 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.604 ' OE2' ' HD2' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -100.75 19.27 17.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.835 0.35 . . . . 0.0 110.867 -178.016 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.11 -176.15 20.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.853 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.5 -170.28 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.069 2.513 . . . . 0.0 112.437 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.14 116.16 50.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.122 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.68 129.64 35.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.916 0.388 . . . . 0.0 110.74 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p -75.28 121.19 21.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -115.17 117.16 41.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.897 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.26 22.9 0.87 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.228 2.618 . . . . 0.0 113.048 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.34 123.87 41.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.796 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -106.17 -35.93 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.734 0.778 . . . . 0.0 109.389 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 48' ' ' ARG . 47.0 mtm180 -120.18 131.54 24.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.063 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.6 Cg_exo -67.14 8.24 0.39 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.292 2.662 . . . . 0.0 113.092 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.22 -3.01 48.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -109.99 14.09 23.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.2 119.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 111.193 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 p -104.14 168.46 9.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -65.05 -30.04 70.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 p -66.26 -42.14 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.774 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.53 -34.77 79.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.624 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.504 ' HB3' HD11 ' A' ' 111' ' ' LEU . 96.7 mt -63.53 -42.42 98.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.15 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.426 ' HG2' HD21 ' A' ' 111' ' ' LEU . 91.1 mt-30 -66.15 -36.63 83.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 110.96 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -71.24 -36.67 71.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.464 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.02 -27.37 67.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.938 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -73.79 -9.12 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.936 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.62 15.32 78.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.523 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' HD3' ' A' ' 89' ' ' PRO . 90.1 mt . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.101 0.477 . . . . 0.0 111.055 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD3' HD21 ' A' ' 63' ' ' LEU . 17.3 Cg_exo -66.51 121.48 8.74 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 111.735 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 109.878 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.686 HG11 HD13 ' A' ' 133' ' ' LEU . 6.4 p -134.12 135.29 54.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.731 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.49 104.72 12.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.427 HD11 HD12 ' A' ' 133' ' ' LEU . 93.9 mt -90.13 110.75 21.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.691 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.78 112.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.436 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.63 92.68 1.79 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.544 ' HA ' HD12 ' A' ' 145' ' ' LEU . 1.3 m -60.75 -24.84 66.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.712 0.405 . . . . 0.0 112.072 -171.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 79.61 -68.62 3.16 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.546 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -92.82 82.08 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.881 0.372 . . . . 0.0 110.578 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 63.25 -173.99 0.16 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.149 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -90.22 143.3 26.89 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.936 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -136.7 126.72 26.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.851 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -80.96 111.78 17.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.463 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.8 mt -76.85 170.18 16.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 159.53 15.1 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.774 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.27 -34.92 98.06 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.941 2.427 . . . . 0.0 111.91 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.42 -20.59 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 88.9 mt-30 -96.34 -63.19 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.814 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.3 -18.93 8.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 37.0 ttt180 -57.84 -46.51 99.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 73.2 Cg_exo -53.11 -34.3 67.74 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.165 1.91 . . . . 0.0 112.875 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 57' ' ' LEU . 92.3 mt -76.45 -42.09 45.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.641 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.28 -26.52 68.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 0.0 110.467 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.74 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 60.1 mtt -90.82 -7.46 52.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.883 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.48 51.17 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.091 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -91.83 117.16 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.799 0.333 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.65 93.94 1.7 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.961 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.81 120.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -125.29 127.15 46.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.415 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.67 116.67 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.3 mtm -142.34 -171.79 3.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.588 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.32 153.63 42.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.415 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 9.0 m -57.95 -42.96 86.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.261 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.47 -48.45 81.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.46 -50.16 68.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.791 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.69 91.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -60.12 -50.24 74.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.424 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.1 m -65.47 -36.01 82.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.47 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -59.01 -46.88 87.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -56.93 -42.9 80.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.712 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.65 -52.76 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.794 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.686 HD13 HG11 ' A' ' 91' ' ' VAL . 94.7 mt -64.4 -35.23 80.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.507 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 45.0 ttp -65.31 -41.3 94.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.77 73.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.671 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -73.11 -20.57 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.8 39.26 29.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.752 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -97.27 162.69 13.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.578 0.228 . . . . 0.0 110.89 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.604 ' HD2' ' OE2' ' A' ' 38' ' ' GLU . 16.7 mmm180 -75.25 80.84 2.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.0 120.51 64.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.18 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 36' ' ' ALA . 43.9 t -109.87 132.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -117.92 133.8 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.12 0.486 . . . . 0.0 111.122 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.86 110.0 17.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.347 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -100.57 120.97 40.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.944 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 96' ' ' THR . 73.6 mt -104.21 107.04 56.23 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.629 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.452 -0.933 0 C-N-CA 122.236 1.957 . . . . 0.0 110.405 169.212 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.49 0.662 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -65.48 108.43 1.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.218 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 m -118.17 137.04 53.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.073 0.463 . . . . 0.0 111.816 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 24' ' ' VAL . 63.9 t -67.74 132.96 32.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 174.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 p -94.69 -45.67 7.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.736 0.303 . . . . 0.0 111.688 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.15 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 0.0 111.163 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -105.98 -76.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.838 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.77 -111.75 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.027 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -162.25 130.91 4.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -49.09 3.71 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.915 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -111.71 170.24 8.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 110.987 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.96 117.19 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.447 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 29.5 tt0 -96.87 117.81 31.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.053 0.454 . . . . 0.0 110.797 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 14' ' ' VAL . 25.6 t -113.54 124.37 70.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.639 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 66.67 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.728 0.642 . . . . 0.0 111.376 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -141.34 -3.97 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.11 122.3 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.117 -172.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 12.8 ptt180 -85.76 111.42 20.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.978 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.41 120.08 31.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.3 m -101.97 23.54 11.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.54 0.686 . . . . 0.0 109.572 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -141.7 163.59 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.398 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.72 57.76 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.396 0.435 . . . . 0.0 110.991 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -137.04 137.52 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.32 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.76 109.68 14.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.546 -0.752 . . . . 0.0 108.973 173.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.419 ' HB3' HG13 ' A' ' 41' ' ' VAL . 37.5 p90 -126.43 147.13 49.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 112.359 -173.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -101.95 157.64 33.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.932 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 26.5 Cg_endo -62.84 -17.53 60.0 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.625 2.217 . . . . 0.0 113.116 -176.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 43.1 mt-10 -89.31 9.23 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.3 -69.57 0.41 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.646 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' A' ' 38' ' ' GLU . 4.5 Cg_exo -37.99 119.85 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.592 3.528 . . . . 0.0 114.923 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 35' ' ' PHE . 41.9 t -113.25 113.56 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.925 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 135.77 33.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.664 0.268 . . . . 0.0 110.794 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 m -88.78 137.89 31.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 m0 -121.15 131.8 24.38 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.3 Cg_exo -81.52 20.5 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.487 2.791 . . . . 0.0 111.619 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 51' ' ' ASP . 92.4 t -94.75 123.32 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.418 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 6.32 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.293 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 152.83 30.26 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.39 14.48 0.38 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.934 2.423 . . . . 0.0 113.162 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.67 -29.53 15.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.258 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.577 ' HB2' HG13 ' A' ' 46' ' ' VAL . 28.9 m-20 -77.79 -20.78 52.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.226 -175.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.45 HD13 HG11 ' A' ' 94' ' ' VAL . 23.0 mt -60.04 110.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.22 0.533 . . . . 0.0 111.194 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.45 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -131.44 165.6 23.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.482 -178.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.61 65.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.721 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 3.4 p -62.55 -50.74 70.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.856 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.51 -36.91 84.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.824 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' HD11 ' A' ' 111' ' ' LEU . 97.5 mt -61.46 -41.86 97.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.98 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.85 -33.17 74.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.86 0.362 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 55' ' ' SER . 87.9 mt-30 -71.38 -35.83 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.75 -26.53 40.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.04 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 89' ' ' PRO . . . -77.77 -10.68 59.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.135 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.57 35.17 67.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.623 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 0.0 111.283 -177.424 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.448 ' O ' HG22 ' A' ' 116' ' ' VAL . 26.0 Cg_endo -63.92 153.47 75.57 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.588 2.192 . . . . 0.0 112.531 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.35 -51.7 6.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.024 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.37 136.65 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 tp -115.33 119.01 34.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.79 119.91 39.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.45 HG11 HD13 ' A' ' 52' ' ' ILE . 58.9 t -111.84 117.87 56.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.363 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.83 102.29 2.9 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 101' ' ' HIS . 6.1 p -78.15 19.12 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.8 -85.03 1.09 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.234 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -79.19 -33.58 43.77 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -169.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -142.3 -173.72 3.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HG2' ' H ' ' A' ' 122' ' ' ASP . 93.0 mt-30 -95.31 82.46 3.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.648 165.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.467 ' HB3' HG21 ' A' ' 96' ' ' THR . 58.5 t-80 -94.8 101.77 13.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.726 -174.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 120' ' ' ALA . 48.0 tp -64.76 143.22 58.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.67 -165.71 1.03 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.324 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.95 150.51 16.92 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.765 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.69 -37.19 83.74 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.265 2.643 . . . . 0.0 112.758 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -72.96 -33.38 65.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.944 0.402 . . . . 0.0 110.761 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.05 -42.32 73.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.1 m -89.99 -6.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.35 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -50.5 87.83 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -54.02 -40.45 81.19 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.14 1.893 . . . . 0.0 112.615 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 64.7 mt -77.63 -38.08 48.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.129 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 73.8 mt -61.89 -34.34 75.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.11 63.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.6 mtt -91.11 -11.87 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.6 8.79 55.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.0 t -86.69 111.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.742 0.306 . . . . 0.0 110.44 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.69 104.28 2.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.146 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -91.04 120.19 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.738 0.304 . . . . 0.0 111.027 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -118.48 115.78 25.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.422 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 102' ' ' LEU . . . -99.05 118.52 36.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.655 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.4 mtm -140.02 -171.82 3.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.221 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.505 ' H ' ' HG2' ' A' ' 100' ' ' GLN . 12.8 t70 -70.31 151.55 45.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.534 HG23 HD22 ' A' ' 144' ' ' LEU . 63.8 m -56.96 -37.99 72.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 111.002 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.72 -42.84 70.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.463 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.51 -41.6 84.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.944 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.43 -38.71 90.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.849 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -52.21 66.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.157 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -61.84 -40.18 94.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.999 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 41.0 m -64.8 -40.32 95.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.398 . . . . 0.0 110.474 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -60.93 -46.76 89.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.711 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -58.32 -37.68 75.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 79.4 mt -68.52 -53.86 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.608 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.681 HD22 ' HD2' ' A' ' 138' ' ' ARG . 61.9 mt -61.91 -41.63 98.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -64.93 -39.47 93.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.579 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.71 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 44.8 mt-10 -73.84 -26.31 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 22.82 12.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.256 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.681 ' HD2' HD22 ' A' ' 133' ' ' LEU . 56.1 mtt-85 -80.35 157.68 26.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.843 0.354 . . . . 0.0 110.204 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.0 83.38 6.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.248 0.547 . . . . 0.0 109.932 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.32 134.72 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.529 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.35 136.83 53.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.6 p -120.69 134.46 64.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.048 0.451 . . . . 0.0 111.411 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.14 113.07 20.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.563 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.534 HD22 HG23 ' A' ' 123' ' ' THR . 91.3 mt -108.4 133.97 51.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.671 -175.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 52' ' ' ILE . 83.5 mt -111.0 105.65 57.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.918 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.457 -0.658 0 C-N-CA 123.212 2.608 . . . . 0.0 110.589 166.902 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 37' ' ' PRO . 54.7 mt . . . . . 0 C--O 1.236 0.392 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.67 95.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.452 . . . . 0.0 109.971 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -91.31 129.19 37.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.502 -173.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.37 107.32 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 m -79.84 -36.88 36.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.003 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.53 130.74 15.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.203 0.525 . . . . 0.0 111.375 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -100.4 106.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 -170.73 34.66 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.116 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.54 -58.68 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.226 0.536 . . . . 0.0 110.59 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.11 38.11 1.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.766 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -151.76 143.87 23.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.906 0.384 . . . . 0.0 110.294 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.28 118.62 59.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.82 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.77 112.0 23.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.733 0.301 . . . . 0.0 110.274 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.51 115.16 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.999 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.42 ' C ' HD22 ' A' ' 25' ' ' ASN . 0.2 OUTLIER 72.12 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.625 0.77 . . . . 0.0 110.428 -178.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -174.88 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.283 0.633 . . . . 0.0 109.364 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.09 126.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.367 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -95.06 121.1 36.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.604 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.7 113.2 26.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.604 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -92.78 19.91 7.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.568 0.699 . . . . 0.0 110.106 175.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -130.59 151.84 50.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.665 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 44' ' ' TRP . . . -58.56 136.8 57.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.7 pt -141.85 154.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.097 0.475 . . . . 0.0 111.723 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.31 124.04 28.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.327 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -146.24 163.13 36.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.032 0.444 . . . . 0.0 111.529 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -126.65 163.56 40.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -176.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 63.7 Cg_endo -73.4 23.52 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.706 2.27 . . . . 0.0 112.914 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ALA . 38.9 tt0 -173.49 90.3 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.04 -165.04 29.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.878 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.88 167.22 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.2 2.6 . . . . 0.0 113.034 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.84 122.9 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.148 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.12 140.72 29.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.1 p -84.41 119.73 25.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.069 0.461 . . . . 0.0 110.594 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.409 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.3 t90 -98.24 116.4 65.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.737 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.15 35.55 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.267 2.645 . . . . 0.0 114.043 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 51' ' ' ASP . 94.6 t -101.14 133.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.684 0.278 . . . . 0.0 110.577 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -113.84 -43.93 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.477 . . . . 0.0 110.554 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -116.92 151.99 48.09 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.24 -6.66 10.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.746 2.297 . . . . 0.0 112.539 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.39 -3.52 46.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.552 ' HB2' HG13 ' A' ' 46' ' ' VAL . 64.2 m-20 -84.19 -28.16 27.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.555 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.4 mt -55.45 113.73 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.759 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 39.1 p -128.95 175.14 8.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -58.29 -44.92 88.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.043 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 m -60.93 -42.43 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.5 HD13 HG22 ' A' ' 46' ' ' VAL . 80.7 mt -70.51 -28.26 64.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' A' ' 111' ' ' LEU . 83.7 mt -73.45 -30.06 62.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.79 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 95.2 mt-30 -63.75 -43.63 95.86 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 174.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.47 -42.29 92.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.706 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.77 76.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.637 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.48 0.66 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.35 82.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.427 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.1 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.303 -177.141 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.501 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.641 0.258 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 2.8 Cg_exo -75.54 151.21 36.9 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.041 2.494 . . . . 0.0 112.125 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -67.27 -44.83 78.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.934 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 140' ' ' VAL . 5.4 p -132.4 136.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.484 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 141' ' ' VAL . 62.3 tp -118.07 121.94 41.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.184 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.19 120.85 42.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.5 t -103.31 119.84 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.941 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' A' ' 144' ' ' LEU . . . -98.26 98.81 2.1 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.587 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -126.49 93.0 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.45 -10.21 39.16 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.453 -0.88 . . . . 0.0 114.46 -170.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -89.51 -26.41 20.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.716 0.758 . . . . 0.0 110.168 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -159.53 94.24 1.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.902 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -65.23 109.5 2.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.29 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -106.13 122.41 46.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.891 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.7 134.07 39.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.134 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.4 mt -94.12 137.12 33.67 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.28 171.08 17.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.075 -171.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.42 -44.06 30.87 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.745 2.963 . . . . 0.0 113.351 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.24 -46.8 69.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.133 0.492 . . . . 0.0 111.404 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 92.8 mt-30 -75.98 -12.55 60.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.581 -173.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.03 14.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.656 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.2 mtm105 -55.84 -54.89 46.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.656 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 24.3 Cg_exo -64.15 -26.71 64.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.842 1.695 . . . . 0.0 111.907 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 57' ' ' LEU . 75.3 mt -78.72 -46.6 18.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.08 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.73 -34.65 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.832 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.89 65.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.188 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 50.4 mtt -94.3 -7.83 40.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.006 0.432 . . . . 0.0 110.215 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.95 -8.51 55.98 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.13 122.0 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 0.0 111.004 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.67 109.63 3.78 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.74 110.33 24.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.84 0.352 . . . . 0.0 110.917 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -108.55 116.93 32.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.388 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.95 29.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.495 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.1 mtm -137.49 -172.78 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.304 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.9 159.02 29.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.691 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 p -59.02 -53.04 62.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.967 0.413 . . . . 0.0 110.973 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -65.33 -36.81 85.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.17 75.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 0.0 110.893 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.46 90.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.668 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.391 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -65.18 -42.69 93.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.979 0.418 . . . . 0.0 110.485 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.0 m -65.3 -34.39 78.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.979 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.413 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 60.6 t80 -61.69 -42.76 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.95 177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -57.2 -45.23 83.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.014 0.435 . . . . 0.0 110.586 175.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.72 -53.34 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.429 ' HB2' HG11 ' A' ' 140' ' ' VAL . 93.1 mt -62.43 -31.23 71.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 37.5 ttm -59.96 -50.23 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.493 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.69 72.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.076 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.78 -23.49 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.11 18.63 58.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.552 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -82.69 144.51 30.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -70.71 94.09 0.99 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.077 0.465 . . . . 0.0 110.894 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 133' ' ' LEU . 7.4 p -126.37 138.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.41 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' A' ' 36' ' ' ALA . 44.9 t -118.89 134.92 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.1 p -115.9 128.69 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 0.0 111.002 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.8 109.82 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.521 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.503 HD23 ' HA3' ' A' ' 95' ' ' GLY . 96.1 mt -113.36 136.47 52.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.706 -173.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 91.7 mt -93.72 133.78 27.41 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.245 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 14.9 Cg_exo . . . . . 0 C--O 1.233 0.242 0 C-N-CA 122.762 2.308 . . . . 0.0 112.804 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.491 HD22 ' HG2' ' A' ' 134' ' ' MET . 71.9 mt . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.634 0.254 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -78.87 98.97 6.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.1 m -108.32 137.05 46.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.091 0.472 . . . . 0.0 111.931 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 24' ' ' VAL . 80.1 t -73.12 126.16 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.479 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.9 p -87.63 -34.65 18.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.61 0.243 . . . . 0.0 111.314 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.77 172.96 12.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.754 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.24 -33.33 6.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.95 -118.46 14.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.962 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -157.42 107.19 2.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.857 0.361 . . . . 0.0 110.475 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.09 18.96 48.49 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.213 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.938 ' HE1' ' HB2' ' A' ' 23' ' ' GLU . 44.3 p90 -160.34 176.25 11.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.873 0.337 . . . . 0.0 110.593 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.2 mt -123.85 122.13 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.938 ' HB2' ' HE1' ' A' ' 21' ' ' TYR . 28.5 tt0 -105.44 108.85 20.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -172.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 14' ' ' VAL . 57.7 t -109.91 107.6 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.946 177.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 58.3 53.63 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.274 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 72.96 -17.97 0.38 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.619 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 40.3 t -74.72 123.14 29.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.145 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -93.27 102.76 15.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.29 118.05 30.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.563 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -95.14 20.3 9.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.217 0.532 . . . . 0.0 110.133 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -151.08 163.87 37.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.898 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.09 146.62 53.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.197 0.522 . . . . 0.0 112.408 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.73 151.0 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.871 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.47 127.3 40.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -148.31 153.46 38.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.041 0.448 . . . . 0.0 111.397 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.65 159.28 65.91 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.0 -41.36 79.66 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.608 2.205 . . . . 0.0 112.063 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -102.99 94.71 5.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.74 -175.0 23.92 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.815 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -97.89 -178.06 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.365 2.71 . . . . 0.0 112.746 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.21 111.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.14 36.94 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 t -79.2 119.01 21.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.515 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.1 126.0 41.75 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -175.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.5 Cg_exo -69.58 -7.46 21.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.27 2.647 . . . . 0.0 113.048 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.636 HG11 HG12 ' A' ' 52' ' ' ILE . 48.5 t -86.26 102.6 11.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.413 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -98.23 -7.98 28.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.199 0.523 . . . . 0.0 110.448 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.621 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 12.1 mtm180 -138.57 146.26 50.03 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.917 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.606 ' HG3' ' HB3' ' A' ' 98' ' ' ARG . 33.8 Cg_endo -64.74 -9.79 22.33 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.799 2.333 . . . . 0.0 113.259 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.4 -2.98 47.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.468 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.621 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 3.6 m-20 -103.39 9.88 37.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.207 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.636 HG12 HG11 ' A' ' 46' ' ' VAL . 58.2 mt -84.7 126.52 40.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.731 0.301 . . . . 0.0 111.578 -175.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.9 p -128.76 166.61 18.67 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.47 -39.38 83.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.473 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 m -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.247 0.546 . . . . 0.0 110.854 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD13 ' CG2' ' A' ' 46' ' ' VAL . 71.1 mt -72.3 -28.86 63.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.75 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.33 -37.79 80.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.252 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.52 -39.62 94.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.231 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -66.21 -41.53 89.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.574 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -20.26 65.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.546 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.74 -7.42 55.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.21 76.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.485 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.042 0.448 . . . . 0.0 110.837 -177.715 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 CA-C-O 120.836 0.351 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.84 164.56 34.17 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.556 2.171 . . . . 0.0 112.414 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 42.0 mt-10 -92.29 -44.13 8.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 140' ' ' VAL . 7.5 p -139.37 136.87 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.073 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.9 tp -113.28 112.03 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.547 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.99 108.6 21.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.404 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.12 106.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.49 98.4 1.39 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 49' ' ' PRO . 5.3 m -65.96 -14.76 62.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -170.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.34 -72.9 2.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.974 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.606 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 39.6 ttm180 -85.81 70.35 10.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 0.0 110.074 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 66.28 154.46 0.08 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.726 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 53.7 tt0 -62.53 128.92 38.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.878 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -112.93 138.05 50.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.41 97.12 10.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.43 170.74 15.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.321 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.9 144.09 15.78 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.393 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.525 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 48.9 Cg_exo -55.78 -36.47 95.29 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.439 2.759 . . . . 0.0 113.296 -173.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.566 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 10.9 mm-40 -63.66 -28.87 70.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -88.26 -9.88 51.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.371 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.17 5.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 110.9 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.589 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.7 mmt180 -53.41 -52.79 63.29 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.292 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 61.7 Cg_exo -53.32 -39.68 80.45 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.153 1.902 . . . . 0.0 112.739 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.2 mt -78.72 -42.12 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.024 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.7 -37.06 80.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 110.617 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.75 70.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 65.1 mtt -83.61 -15.34 49.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.97 8.37 42.15 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.177 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 38.2 t -86.54 108.61 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.744 0.307 . . . . 0.0 110.576 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.75 107.23 2.32 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.828 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.5 t -87.09 111.74 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.783 0.325 . . . . 0.0 110.623 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -112.71 117.5 32.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.388 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 100' ' ' GLN . . . -101.98 115.95 31.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.319 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.478 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 65.4 mtm -139.51 -172.81 3.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.052 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.58 157.34 37.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 34.5 m -60.14 -45.83 91.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.241 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -64.39 -41.02 96.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 110.793 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.46 96.43 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.32 86.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.561 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.43 96.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.447 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -62.72 -48.62 78.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.277 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.0 m -62.73 -38.36 90.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.38 -44.04 95.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.75 -46.54 74.34 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 110.711 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.89 -52.25 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.84 -31.44 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.54 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.491 ' HG2' HD22 ' A' ' 11' ' ' LEU . 48.9 ttp -66.84 -43.23 84.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.825 0.345 . . . . 0.0 110.283 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.98 86.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.16 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.45 36.14 5.22 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.347 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -100.91 161.42 13.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.605 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 55.4 mtp85 -78.57 77.98 5.04 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.368 0.604 . . . . 0.0 111.024 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 91' ' ' VAL . 5.7 p -112.04 132.96 59.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.372 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 36' ' ' ALA . 38.5 t -115.65 134.04 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.5 p -119.04 135.45 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.248 0.546 . . . . 0.0 111.226 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 117.78 30.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.188 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.2 mt -107.37 120.44 42.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.173 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.44 HD21 ' CZ3' ' A' ' 44' ' ' TRP . 71.9 mt -100.96 130.09 25.87 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.278 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 1.9 Cg_endo . . . . . 0 N--CA 1.453 -0.899 0 C-N-CA 122.995 2.463 . . . . 0.0 110.995 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.593 HD21 ' HB2' ' A' ' 35' ' ' PHE . 56.8 t30 -75.05 109.75 8.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -147.06 146.14 29.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.934 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.87 118.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.16 17.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.33 -175.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -147.44 119.31 8.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.083 0.468 . . . . 0.0 111.332 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -113.18 116.54 29.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.416 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.58 -164.1 9.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.831 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.67 109.05 18.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.748 0.309 . . . . 0.0 110.874 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.2 1.0 72.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.437 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -153.43 142.12 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.556 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.0 mt -126.36 111.95 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.254 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -93.69 117.99 30.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.024 0.44 . . . . 0.0 110.436 -176.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.49 113.05 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.741 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 62.32 39.41 12.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 72.19 9.53 5.95 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.773 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.68 107.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 31.0 ptt-85 -81.53 114.85 20.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.323 0.583 . . . . 0.0 110.394 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.39 128.03 43.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.907 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 p -104.55 14.37 30.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.462 0.649 . . . . 0.0 109.717 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -137.68 171.25 14.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.378 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -62.27 141.71 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.555 0.534 . . . . 0.0 111.687 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 pt -142.11 136.41 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.26 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.3 120.87 37.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.308 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.593 ' HB2' HD21 ' A' ' 12' ' ' ASN . 40.2 p90 -149.88 162.78 39.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.165 0.507 . . . . 0.0 111.834 -173.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -130.68 158.62 74.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.747 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.689 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 19.3 Cg_endo -60.1 -32.42 94.68 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.604 2.203 . . . . 0.0 111.702 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -130.44 103.44 6.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.171 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.58 -156.14 26.52 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.923 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.64 162.22 6.43 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.836 2.357 . . . . 0.0 113.091 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -114.27 101.6 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.68 118.99 38.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.954 0.407 . . . . 0.0 111.641 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 65.6 m -66.88 132.66 48.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 170.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.55 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -97.93 129.74 30.42 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -171.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.55 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.83 -0.93 6.0 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.884 2.389 . . . . 0.0 112.917 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' CG2' HD13 ' A' ' 56' ' ' LEU . 46.8 t -86.22 96.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -89.54 -20.96 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 109.734 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -129.04 130.85 23.44 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.46 12.06 0.26 Allowed 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.058 2.505 . . . . 0.0 113.669 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.47 -2.59 58.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.998 0.428 . . . . 0.0 110.428 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.87 69.31 1.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.883 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 66.6 mt -115.26 107.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.159 173.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 61.1 p -113.85 174.9 5.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.952 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -62.73 -44.0 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.7 m -59.6 -39.32 83.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.025 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.413 HD13 ' CG2' ' A' ' 46' ' ' VAL . 94.9 mt -70.48 -34.05 71.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 53' ' ' THR . 95.7 mt -68.61 -35.59 77.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.1 mt-30 -62.1 -41.91 98.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.46 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -68.62 -38.59 80.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.396 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.8 65.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.57 0.14 35.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 0.0 111.112 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.7 0.1 87.9 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.471 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.814 -176.71 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.6 ' HB3' HG23 ' A' ' 141' ' ' VAL . 15.8 Cg_endo -58.34 132.22 47.49 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.795 2.33 . . . . 0.0 113.266 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -76.34 -33.98 58.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 140' ' ' VAL . 6.4 p -134.78 134.08 53.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.016 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.407 ' HB3' HG22 ' A' ' 118' ' ' VAL . 64.3 tp -114.12 112.7 23.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.268 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.59 116.01 28.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.36 100.63 11.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -86.04 76.25 2.17 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.353 -174.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 90.48 4.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.041 0.448 . . . . 0.0 109.972 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.33 -30.78 21.28 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.168 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -64.09 -50.39 68.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.304 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -145.32 132.36 20.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -72.41 91.72 1.38 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.403 ' CE1' ' HB ' ' A' ' 52' ' ' ILE . 54.2 t-80 -73.97 108.93 7.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.864 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.8 120.19 9.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.9 mt -80.13 149.02 30.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.54 147.36 16.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.277 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 51.6 Cg_exo -55.9 -32.43 85.29 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.182 2.588 . . . . 0.0 112.51 -177.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.15 -29.35 38.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 98.9 mt-30 -73.82 -41.64 62.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.77 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.6 m -92.07 2.69 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 66.9 ttt180 -59.27 -55.46 45.96 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.292 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 19.0 Cg_endo -57.99 -26.94 77.25 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.026 1.817 . . . . 0.0 112.333 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -83.25 -43.87 15.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.393 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 86.8 mt -61.62 -35.16 77.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.76 68.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.227 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 66.0 mtt -83.97 -23.97 30.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.11 0.481 . . . . 0.0 110.175 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.22 3.37 22.88 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.694 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.77 102.94 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.338 . . . . 0.0 110.341 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.23 99.46 1.57 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.103 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 92' ' ' LEU . 21.5 t -84.56 127.51 39.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.625 0.25 . . . . 0.0 110.546 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.92 136.63 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.996 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.12 123.46 35.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.054 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.455 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 38.6 ttm -142.52 160.09 40.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -174.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.62 145.4 54.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.481 HG23 HD22 ' A' ' 144' ' ' LEU . 8.8 m -52.33 -45.66 65.74 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.226 0.329 . . . . 0.0 111.711 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -60.13 -50.14 74.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.65 71.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.294 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.3 88.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.629 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.06 97.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.584 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 132' ' ' ILE . 21.0 ttt180 -58.93 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 28.1 m -62.2 -41.71 98.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.65 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 53.0 t80 -54.85 -51.6 65.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.103 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.46 -41.75 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.084 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 128' ' ' ARG . 80.1 mt -62.46 -54.6 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.62 -32.48 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.174 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.689 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 53.2 ttp -64.42 -43.32 94.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.36 175.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.45 -23.68 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.224 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 32.7 mt-10 -88.33 -3.41 58.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.006 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.7 44.17 82.21 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.228 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -117.65 157.31 26.65 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.633 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -73.16 100.39 3.06 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.114 0.483 . . . . 0.0 111.054 -173.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.418 HG23 HG13 ' A' ' 91' ' ' VAL . 7.4 p -131.69 135.24 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.738 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' A' ' 89' ' ' PRO . 66.6 t -128.6 142.15 44.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.0 p -129.6 136.94 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.661 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 113.94 22.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.253 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.481 HD22 HG23 ' A' ' 123' ' ' THR . 97.1 mt -100.52 127.89 46.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -172.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' A' ' 32' ' ' ALA . 18.0 mt -117.26 94.5 45.27 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.853 172.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 N--CA 1.455 -0.757 0 C-N-CA 123.272 2.648 . . . . 0.0 112.909 -177.725 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 CA--C 1.523 -0.09 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.459 HD22 ' HB2' ' A' ' 35' ' ' PHE . 3.3 m-20 63.74 23.79 13.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.216 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -61.75 139.7 58.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.204 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 22' ' ' ILE . 58.3 t -65.78 103.13 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -70.32 -34.45 72.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.907 -176.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -154.46 149.05 26.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.199 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -120.07 132.22 55.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.02 178.91 17.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.677 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.87 99.26 1.02 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.384 0.274 . . . . 0.0 111.281 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.95 15.65 72.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.314 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -157.55 152.14 25.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.186 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.642 HG12 HD13 ' A' ' 144' ' ' LEU . 3.1 mp -113.41 120.64 63.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 40.1 tt0 -97.33 110.83 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 0.0 110.687 -176.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.453 ' HA ' ' OG1' ' A' ' 15' ' ' THR . 57.5 t -119.99 119.76 61.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.529 176.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 63.42 42.5 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.591 0.557 . . . . 0.0 110.22 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 66.79 10.85 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.319 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.5 115.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -82.02 101.99 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.83 89.33 6.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.083 0.468 . . . . 0.0 110.598 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -86.58 52.16 2.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -168.28 156.85 8.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 44' ' ' TRP . . . -56.73 130.5 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.493 0.495 . . . . 0.0 111.262 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.94 136.1 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.298 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -121.03 114.66 21.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.883 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.49 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 34.7 p90 -138.9 152.78 48.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.115 0.483 . . . . 0.0 111.785 -174.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.54 154.62 71.6 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.135 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 -13.7 27.98 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.731 2.287 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -122.45 22.47 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.72 168.91 29.91 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.335 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.62 172.1 15.69 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.581 2.187 . . . . 0.0 112.07 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 46.2 t -87.62 95.97 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.62 109.25 7.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.344 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -85.69 131.27 34.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 27.6 m0 -98.31 145.77 30.41 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.642 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.4 Cg_exo -81.71 37.01 0.65 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 110.225 168.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.638 HG13 ' HB2' ' A' ' 51' ' ' ASP . 54.3 t -108.85 123.04 64.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -171.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -119.02 -9.84 9.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 137.77 28.02 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HB3' ' O ' ' A' ' 96' ' ' THR . 28.7 Cg_endo -65.3 -5.45 11.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.477 2.118 . . . . 0.0 112.143 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.31 4.5 53.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.469 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.638 ' HB2' HG13 ' A' ' 46' ' ' VAL . 60.5 m-20 -90.29 -11.24 41.39 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -62.98 105.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.046 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.443 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 67.4 p -111.17 166.13 11.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.34 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -62.88 -32.0 73.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.184 175.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -60.29 -47.97 83.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.604 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.58 -34.39 78.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.843 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HB3' HD11 ' A' ' 111' ' ' LEU . 98.7 mt -65.06 -38.79 91.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.817 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 94.9 mt-30 -65.56 -39.08 91.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 110.43 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -71.83 -39.32 69.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.97 -17.71 63.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.878 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.53 -7.33 56.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.813 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.56 3.15 78.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.163 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.025 0.441 . . . . 0.0 110.922 -178.893 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.54 ' HB3' ' CG2' ' A' ' 141' ' ' VAL . 6.7 Cg_endo -49.41 136.52 32.33 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 123.996 3.131 . . . . 0.0 113.736 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -77.75 -46.6 21.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.497 HG11 HD23 ' A' ' 133' ' ' LEU . 7.3 p -132.03 133.85 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.637 173.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.45 119.5 35.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.174 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.56 105.22 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.223 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.15 118.34 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -94.43 118.26 5.75 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -72.13 -5.21 33.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.238 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.23 -80.67 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.537 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.5 ttm-85 -55.54 -55.72 28.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 110.78 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 99' ' ' ARG . 10.0 ptt180 -172.22 152.44 2.81 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.648 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.579 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 44.4 tt0 -58.4 128.41 37.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.775 0.672 . . . . 0.0 112.375 -168.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.509 ' HB2' HG21 ' A' ' 96' ' ' THR . 32.6 m170 -127.62 148.13 50.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.627 175.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 tp -88.42 126.35 35.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.81 171.54 14.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.423 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.19 156.46 16.33 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.753 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.52 -32.48 88.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.222 2.615 . . . . 0.0 112.973 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 tt0 -81.96 -25.14 35.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 110.709 -177.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.54 -44.73 73.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 35.5 m -97.83 10.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.881 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 13.5 ttt180 -54.69 -53.88 55.4 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.503 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.5 Cg_exo -59.62 -35.24 95.73 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.031 1.821 . . . . 0.0 112.552 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.682 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.7 mt -75.15 -36.62 61.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.08 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 89.9 mt -57.96 -42.91 85.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.839 0.352 . . . . 0.0 110.476 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.52 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.425 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -81.19 -22.53 38.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 110.715 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.25 17.47 10.74 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 46.7 t -93.3 108.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.426 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.11 86.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.177 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.28 126.02 39.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.736 0.303 . . . . 0.0 111.299 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -127.93 145.75 50.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.028 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.5 128.36 55.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.231 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.525 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.4 mtm -147.03 -175.13 4.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.918 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.99 163.03 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.663 0.268 . . . . 0.0 110.633 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.523 HG23 HD22 ' A' ' 144' ' ' LEU . 5.6 m -56.77 -39.12 73.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.667 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.1 -53.32 59.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.095 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.33 76.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.153 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.18 95.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.325 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.78 81.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.233 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.409 ' O ' HG13 ' A' ' 132' ' ' ILE . 78.4 mtp180 -63.39 -45.31 91.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.8 m -65.8 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.85 -49.73 76.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.449 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -58.98 -41.0 86.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.982 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 128' ' ' ARG . 73.2 mt -63.09 -53.3 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.497 HD23 HG11 ' A' ' 91' ' ' VAL . 10.8 mp -69.16 -23.78 63.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.237 -177.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.4 ttp -66.82 -43.2 84.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 109.889 174.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.28 64.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.739 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.03 -16.52 63.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.782 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.52 37.84 62.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -115.62 151.96 33.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -80.05 84.39 5.79 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.984 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.73 130.43 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.415 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' A' ' 36' ' ' ALA . 22.9 t -115.29 129.43 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -115.95 138.4 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.925 0.393 . . . . 0.0 110.843 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.24 105.75 12.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.642 HD13 HG12 ' A' ' 22' ' ' ILE . 77.6 mt -100.43 132.82 45.6 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 32' ' ' ALA . 2.0 tt -119.17 86.95 33.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.228 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 N--CA 1.454 -0.853 0 C-N-CA 122.944 2.429 . . . . 0.0 111.439 172.292 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 35.9 t-20 -68.13 105.21 2.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.6 m -119.73 126.12 50.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.474 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.2 120.01 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 p -96.04 -23.36 16.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.738 0.304 . . . . 0.0 111.799 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -143.28 103.23 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.868 0.366 . . . . 0.0 111.309 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HD1' HG12 ' A' ' 22' ' ' ILE . 88.4 t80 -123.96 131.3 53.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.753 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.23 -4.72 33.5 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.29 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -91.34 17.34 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 0.0 110.916 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.01 -42.93 2.09 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 54.0 p90 -111.77 176.28 5.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.45 HG12 ' HD1' ' A' ' 17' ' ' TYR . 48.9 mt -119.49 113.29 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.96 0.409 . . . . 0.0 110.207 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 34.0 tt0 -89.35 118.8 29.28 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.8 t -105.03 104.18 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.161 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 65.69 -80.45 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.935 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -132.22 2.54 3.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.204 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.3 t -125.35 127.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 0.0 111.035 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 66.6 mtt85 -86.99 113.11 22.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 88.8 m-85 -99.24 148.84 23.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.873 0.368 . . . . 0.0 110.836 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -88.72 -67.66 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.067 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -115.7 -169.14 1.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.927 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 144' ' ' LEU . . . -36.24 128.29 0.74 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 43' ' ' SER . 18.5 pt -143.71 162.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.32 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -137.15 133.64 35.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.812 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.657 ' HB3' HG13 ' A' ' 41' ' ' VAL . 37.1 p90 -157.2 163.01 39.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.291 0.567 . . . . 0.0 112.244 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.95 161.89 58.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 73.5 Cg_exo -49.45 -55.04 4.52 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.132 2.555 . . . . 0.0 112.347 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -131.93 95.12 3.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.09 -153.54 17.15 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.937 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.1 134.69 13.21 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.758 2.305 . . . . 0.0 113.321 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.657 HG13 ' HB3' ' A' ' 35' ' ' PHE . 53.9 t -114.14 121.39 66.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.78 168.16 20.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.127 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.439 ' HA ' HG22 ' A' ' 33' ' ' ILE . 11.6 p -99.94 150.23 22.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.937 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.594 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -98.33 131.64 25.83 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.594 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 37.7 Cg_endo -67.01 -11.13 31.06 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.842 2.361 . . . . 0.0 112.592 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.454 ' CG2' HD13 ' A' ' 56' ' ' LEU . 10.9 t -86.1 146.1 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.94 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -129.11 -1.44 5.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HD2' ' OD2' ' A' ' 51' ' ' ASP . 50.9 mtt85 -134.67 137.17 26.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.46 -7.02 19.08 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.954 2.436 . . . . 0.0 112.377 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.44 -13.94 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.376 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' OD2' ' HD2' ' A' ' 48' ' ' ARG . 27.4 m-20 -96.23 3.88 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.164 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.51 122.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.875 0.369 . . . . 0.0 111.257 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.1 p -121.57 176.3 5.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.373 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -64.29 -37.61 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 0.0 110.199 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -48.41 78.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.506 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD13 ' CG2' ' A' ' 46' ' ' VAL . 44.0 mt -70.63 -30.44 67.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.952 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.505 ' HB3' HD11 ' A' ' 111' ' ' LEU . 81.0 mt -67.23 -39.1 86.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.454 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 24.6 mt-30 -58.18 -39.9 80.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.076 0.465 . . . . 0.0 110.214 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -68.41 -42.58 78.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.645 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.68 -13.15 62.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.88 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.1 -13.2 62.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.105 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.99 88.32 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.634 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.47 . . . . 0.0 110.809 -178.797 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 18.1 Cg_exo -66.42 155.73 68.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.947 2.431 . . . . 0.0 112.15 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.34 -44.9 13.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.0 0.429 . . . . 0.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 140' ' ' VAL . 4.9 p -133.02 133.91 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.399 0.618 . . . . 0.0 111.245 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -111.79 110.7 21.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.337 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 119' ' ' GLU . 97.2 mt -90.35 113.12 24.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.58 118.45 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -92.9 101.49 2.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 p -76.33 56.68 1.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 145' ' ' LEU . . . 76.35 -103.38 1.71 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.614 171.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.59 -35.49 11.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.238 . . . . 0.0 111.262 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -142.55 159.71 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.653 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.737 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.7 tt0 -62.79 111.19 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.792 175.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -113.73 116.18 29.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.039 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 143.01 57.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.068 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.27 -164.92 1.16 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.03 147.44 16.24 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.763 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.57 -42.42 65.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.063 2.509 . . . . 0.0 112.658 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.914 0.388 . . . . 0.0 111.697 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.59 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 98.7 mt-30 -96.24 -39.98 9.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 109.858 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.82 -24.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.801 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.53 ' HA ' HD12 ' A' ' 112' ' ' LEU . 7.8 ttp180 -63.4 -38.29 38.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.84 -43.41 23.93 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.803 1.668 . . . . 0.0 112.264 170.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.733 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.4 mt -75.5 -36.21 60.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 109' ' ' ARG . 96.3 mt -61.08 -31.24 70.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.73 -22.49 63.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -87.9 -30.62 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 122.47 9.07 6.67 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.155 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.733 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 17.1 t -98.89 110.13 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 111.023 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.28 122.91 6.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.606 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.28 125.23 46.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.937 0.399 . . . . 0.0 111.491 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' HB2' HD23 ' A' ' 93' ' ' LEU . 51.8 mm-40 -110.01 103.24 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.682 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.43 109.8 21.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.614 0.245 . . . . 0.0 110.355 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.737 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 63.2 mtm -141.97 -177.24 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 -176.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.63 147.61 36.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.973 172.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.501 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 61.8 m -55.86 -44.46 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.691 0.281 . . . . 0.0 111.323 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -64.0 -44.01 93.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.568 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.07 99.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.003 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.02 79.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.98 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.6 94.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.97 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -61.11 -50.08 74.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.041 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.607 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.548 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 73.2 t80 -61.55 -46.74 88.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.691 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -56.0 -44.55 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.462 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.418 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 62.3 mt -69.29 -54.27 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.237 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.5 HD12 ' HB ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -57.11 -40.31 76.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -175.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 46.7 ttp -58.95 -36.67 75.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.68 -13.11 54.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 27.1 mm-40 -88.5 -35.44 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 170.42 98.92 0.12 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.06 85.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.409 0.684 . . . . 0.0 112.84 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -144.45 33.79 1.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.5 ' HB ' HD12 ' A' ' 133' ' ' LEU . 7.2 p -127.45 140.42 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.567 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.0 t -124.74 143.84 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 9.9 p -120.63 140.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.305 -176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -129.72 109.23 10.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.315 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 84.2 mt -116.58 138.9 51.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.78 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.549 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 5.0 mp -108.76 94.34 14.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 O-C-N 123.239 0.337 . . . . 0.0 110.171 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_endo . . . . . 0 N--CA 1.458 -0.575 0 C-N-CA 123.281 2.654 . . . . 0.0 111.566 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.235 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -76.69 94.69 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 m -109.44 137.76 46.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.658 -171.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.11 127.35 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 p -105.77 -56.33 2.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.657 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -114.89 135.57 54.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.1 0.476 . . . . 0.0 110.877 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.11 167.38 10.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.649 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.07 -172.43 35.05 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.75 -63.51 1.19 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.134 0.492 . . . . 0.0 110.763 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.12 -5.43 65.83 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.907 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 13.0 p90 -139.9 148.72 42.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.858 0.361 . . . . 0.0 110.045 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.66 120.41 58.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 32.5 tt0 -96.37 114.1 25.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.317 0.58 . . . . 0.0 110.566 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.34 125.23 59.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.679 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.04 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -141.54 16.04 2.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.606 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.58 129.73 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.369 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.3 mtp-105 -88.23 114.84 25.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.074 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.17 100.47 9.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.78 0.324 . . . . 0.0 111.123 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 36.2 m -83.81 36.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.439 0.637 . . . . 0.0 109.818 173.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.513 ' HB2' HG23 ' A' ' 33' ' ' ILE . 8.1 m170 -120.22 169.81 9.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.2 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 44' ' ' TRP . . . -85.33 105.26 15.86 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 164.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 31' ' ' HIS . 19.4 pt -112.24 132.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.419 0.628 . . . . 0.0 112.625 -169.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -113.6 121.63 44.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.429 174.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -147.88 155.79 41.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.273 0.559 . . . . 0.0 111.773 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -129.23 159.88 66.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.628 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 23.0 Cg_endo -62.71 -25.68 75.08 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.447 2.098 . . . . 0.0 111.628 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -125.63 108.23 11.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.561 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.05 -170.3 23.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.323 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.93 -177.29 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.38 121.86 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.976 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.7 119.46 38.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.962 0.41 . . . . 0.0 110.789 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -94.06 131.8 39.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.345 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 3.9 m0 -98.28 137.1 20.74 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.037 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.53 0.05 9.91 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.017 2.478 . . . . 0.0 111.374 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 56' ' ' LEU . 29.7 t -85.88 113.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.486 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -111.79 7.77 20.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 0.0 110.794 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 54.0 ttp180 -127.02 115.44 21.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 26.8 Cg_exo -63.44 -10.81 22.99 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.4 2.733 . . . . 0.0 113.883 -173.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.37 -2.0 58.35 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.269 -0.269 . . . . 0.0 111.38 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' A' ' 48' ' ' ARG . 42.5 m-20 -98.16 -2.83 39.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.89 118.55 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.206 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 54' ' ' ALA . 1.7 m -129.4 169.16 15.27 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -49.71 -54.33 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -173.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.7 -33.52 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.436 HD13 HG21 ' A' ' 46' ' ' VAL . 98.3 mt -65.23 -44.54 87.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.498 . . . . 0.0 110.224 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.99 -37.25 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.664 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.522 ' HA ' HD21 ' A' ' 111' ' ' LEU . 48.2 tt0 -62.09 -37.52 85.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.701 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -71.61 -41.3 69.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.58 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.11 -4.94 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.875 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 89' ' ' PRO . . . -75.09 -4.42 38.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.531 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.42 35.52 52.01 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.096 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 110.661 -179.351 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 121.404 0.621 . . . . 0.0 112.625 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 3.5 Cg_exo -77.45 165.86 26.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.695 2.264 . . . . 0.0 111.271 170.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.734 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.2 mt-10 -94.8 -38.01 10.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.769 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.503 HG13 HG23 ' A' ' 140' ' ' VAL . 6.0 p -144.08 137.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 111.179 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.6 tp -113.26 115.39 28.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.702 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.05 116.16 28.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.578 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.51 121.64 52.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.261 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.38 89.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.044 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -101.59 36.91 1.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.227 0.537 . . . . 0.0 109.832 -179.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.577 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -79.78 63.3 4.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.009 -170.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -161.11 -52.62 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.54 90.3 2.4 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -71.24 93.12 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.7 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -76.09 107.46 8.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.207 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.64 126.04 26.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.16 165.7 15.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.68 157.91 15.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.93 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.94 -33.72 97.46 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.04 2.493 . . . . 0.0 112.594 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.79 -20.5 62.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.952 0.406 . . . . 0.0 111.005 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.556 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 87.9 mt-30 -88.02 -35.11 17.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.448 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 30.2 m -92.48 -21.03 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.741 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.548 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 7.5 tmm_? -59.07 -48.55 96.38 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 8.5 Cg_endo -51.14 -43.42 48.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.323 2.015 . . . . 0.0 112.626 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 58' ' ' GLN . 91.8 mt -75.04 -37.03 61.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.9 mt -66.02 -34.71 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.0 -31.22 72.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.213 0.53 . . . . 0.0 110.363 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -75.39 -38.28 60.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.79 -12.25 5.91 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.934 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.08 109.66 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.753 0.311 . . . . 0.0 110.871 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.34 115.98 4.79 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.003 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.55 123.53 43.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.621 0.248 . . . . 0.0 110.812 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -129.39 120.2 25.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.12 122.8 44.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.494 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 70.0 mtm -139.9 -171.82 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.36 150.04 49.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.715 0.293 . . . . 0.0 110.218 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.577 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 8.2 m -56.36 -42.53 77.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.337 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 52.3 tt0 -72.82 -35.98 67.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.18 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.34 -36.46 82.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.126 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.23 95.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.142 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.568 ' O ' HG12 ' A' ' 132' ' ' ILE . 69.5 mtm180 -64.59 -55.85 17.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.412 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -59.71 -32.95 70.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.261 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.44 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 81.7 t80 -59.03 -54.27 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -61.3 -34.22 74.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.472 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 128' ' ' ARG . 45.0 mm -59.76 -55.31 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.551 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 72.0 mt -71.89 -31.05 66.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.3 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 ttp -62.12 -49.97 73.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 110.48 178.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.18 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.736 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.42 -16.63 61.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.516 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.46 31.53 24.59 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 138' ' ' ARG . 27.7 ttt180 -106.05 147.4 28.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.012 -175.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.734 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 68.9 mtm180 -81.41 88.81 6.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.274 0.559 . . . . 0.0 110.6 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.503 HG23 HG13 ' A' ' 91' ' ' VAL . 7.4 p -120.19 138.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.958 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 36' ' ' ALA . 40.1 t -121.06 140.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -124.21 138.9 52.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.008 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.84 103.98 9.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.408 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.8 mt -100.63 122.59 43.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.879 0.371 . . . . 0.0 111.165 -173.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.08 109.02 54.89 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.461 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 C--N 1.342 0.221 0 C-N-CA 123.311 2.674 . . . . 0.0 110.904 174.152 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mmm . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.679 0.276 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -91.84 116.33 28.81 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.0 mt -73.01 117.74 15.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.988 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -76.43 124.95 28.35 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.4 m -91.34 104.39 16.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 20.1 m-20 -88.17 107.54 16.87 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.841 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 1.5 Cg_endo -82.48 120.7 3.25 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.091 2.527 . . . . 0.0 112.66 -174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.643 ' HB3' HD23 ' A' ' 11' ' ' LEU . . . -95.26 122.94 38.48 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -2.46 17.32 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.83 -14.78 57.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.194 0.521 . . . . 0.0 110.422 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.643 HD23 ' HB3' ' A' ' 8' ' ' ALA . 3.9 mm? -88.84 84.82 6.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -70.06 104.08 2.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.357 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.4 m -126.14 151.71 46.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.231 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.01 122.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.183 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.2 p -89.54 -20.3 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.315 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -161.44 140.59 10.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.657 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.43 -79.82 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.5 162.68 38.53 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.839 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -107.99 111.25 23.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.857 0.36 . . . . 0.0 110.674 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.693 ' HA2' ' HB2' ' A' ' 149' ' ' ASP . . . 98.2 4.32 57.53 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.238 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -162.14 172.41 15.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.73 124.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 28.9 tt0 -94.53 109.5 21.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.002 0.43 . . . . 0.0 111.169 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -117.05 124.01 72.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 62.85 29.55 16.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.604 0.716 . . . . 0.0 109.506 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HA ' ' CG ' ' A' ' 23' ' ' GLU . 34.8 mt-30 65.64 13.98 9.24 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.723 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.2 110.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 92.1 mtt180 -86.41 96.8 10.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.993 -174.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.78 115.43 22.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.489 ' OG ' ' HG ' ' A' ' 151' ' ' LEU . 2.7 p -90.47 28.71 1.41 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.261 0.553 . . . . 0.0 111.064 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -154.1 171.39 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.785 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.23 138.05 58.24 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.286 0.366 . . . . 0.0 111.2 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.19 147.69 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -123.1 116.52 23.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 175.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -135.83 157.82 45.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.957 0.408 . . . . 0.0 111.057 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.5 160.16 62.73 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.433 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 11.2 Cg_endo -56.65 -57.04 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.456 2.104 . . . . 0.0 110.492 172.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.79 103.11 12.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.35 178.73 32.65 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.902 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -88.61 176.02 3.6 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 112.919 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.14 104.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.344 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . . . -85.99 126.62 34.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.559 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -91.26 118.62 30.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.794 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.406 ' CZ2' ' HB2' ' A' ' 60' ' ' ALA . 1.3 m0 -98.32 130.23 28.78 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.42 23.48 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.937 2.425 . . . . 0.0 111.178 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 51' ' ' ASP . 73.2 t -85.71 136.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.771 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -117.85 -24.26 7.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.068 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HG2' ' OD2' ' A' ' 51' ' ' ASP . 8.0 ptt180 -139.03 155.66 72.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.02 -176.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 1.88 2.41 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.538 2.159 . . . . 0.0 112.897 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.73 -14.74 24.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.33 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.594 ' HB2' HG13 ' A' ' 46' ' ' VAL . 65.1 m-20 -77.32 -19.34 56.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.12 117.53 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.006 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.441 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 30.7 p -121.57 175.45 6.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.852 175.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.9 71.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -62.31 -45.39 93.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.133 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.53 -30.71 68.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.003 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 53' ' ' THR . 90.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.356 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -65.27 -38.3 89.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -68.46 -42.58 78.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.376 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.406 ' HB2' ' CZ2' ' A' ' 44' ' ' TRP . . . -65.38 -26.39 67.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.562 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.401 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -73.74 -12.88 60.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.022 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.57 28.41 73.17 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.603 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 61' ' ' ALA . 91.4 mt -70.99 -75.83 0.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.495 0.188 . . . . 0.0 111.268 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 53.35 69.2 0.73 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.935 -176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.03 -43.19 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.866 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 p -90.38 115.09 29.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.648 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.13 125.23 42.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.718 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -65.2 -40.08 93.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.038 0.447 . . . . 0.0 110.068 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 70' ' ' PRO . 37.8 m-20 -122.57 94.25 47.8 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.932 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 69' ' ' ASP . 21.1 Cg_endo -61.32 121.53 9.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.734 2.289 . . . . 0.0 112.435 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.6 mt -81.49 -42.3 20.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.458 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.35 96.58 5.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.413 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -77.74 118.12 19.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.201 0.524 . . . . 0.0 110.997 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.97 128.44 36.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.584 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -82.17 -0.4 44.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.286 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.77 82.12 0.22 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.43 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -88.45 3.6 5.86 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.823 2.348 . . . . 0.0 111.591 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.74 ' HG2' ' H ' ' A' ' 80' ' ' GLY . 24.0 tt0 -141.77 156.89 45.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.55 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.402 ' N ' ' HG2' ' A' ' 78' ' ' GLU . . . -136.15 19.76 3.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.097 0.475 . . . . 0.0 110.241 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.74 ' H ' ' HG2' ' A' ' 78' ' ' GLU . . . -81.69 -75.77 1.1 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.631 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.84 164.72 37.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.013 0.435 . . . . 0.0 111.154 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.52 153.76 16.7 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.27 121.19 41.43 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -81.01 155.6 72.56 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.773 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.57 -48.91 14.39 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.588 2.859 . . . . 0.0 114.3 -172.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.87 1.18 2.17 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.396 0.617 . . . . 0.0 110.849 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -100.56 13.49 34.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.562 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.24 158.53 87.31 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.144 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HB3' HG23 ' A' ' 141' ' ' VAL . 9.1 Cg_endo -51.29 111.7 0.63 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.841 2.361 . . . . 0.0 111.985 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 3.9 tt0 -69.5 -32.47 71.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.696 HG11 HD13 ' A' ' 133' ' ' LEU . 3.3 p -136.01 131.31 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.456 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -112.96 121.19 43.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.866 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.5 mt -101.2 104.55 15.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.284 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.28 116.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.865 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -105.69 114.31 4.5 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.491 HG21 ' H ' ' A' ' 101' ' ' HIS . 1.2 p -76.11 -20.97 57.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 -58.4 4.79 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.402 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -81.17 -55.31 4.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.744 0.307 . . . . 0.0 110.565 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -159.89 143.45 14.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -52.66 114.61 1.45 Allowed 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.118 0.886 . . . . 0.0 112.113 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.491 ' H ' HG21 ' A' ' 96' ' ' THR . 11.7 t-160 -96.85 111.85 23.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.21 98.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.814 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.07 134.26 40.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -106.04 175.27 21.26 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.735 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 74.3 Cg_exo -49.63 -34.61 35.25 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.351 2.7 . . . . 0.0 112.542 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -49.47 -43.66 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.283 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -96.01 -37.9 10.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.185 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 104' ' ' GLY . 35.0 m -91.42 -14.36 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -171.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 1.1 tmt_? -57.33 -44.7 99.78 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -47.45 -32.08 14.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.3 2.0 . . . . 0.0 113.188 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 93.7 mt -92.33 -36.24 13.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.679 0.276 . . . . 0.0 110.785 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 87.2 mt -58.49 -36.7 74.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.02 68.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.16 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.2 mtt -87.87 -12.18 45.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.65 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.14 14.69 38.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.029 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.1 t -86.99 107.82 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 0.0 110.659 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.77 111.33 3.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.605 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.12 124.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 111.487 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -102.86 129.11 49.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.193 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.01 102.5 13.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 0.0 110.495 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.538 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.8 mtm -140.43 -171.77 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -105.42 172.13 6.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.594 HG23 HD22 ' A' ' 144' ' ' LEU . 88.5 m -52.29 -48.52 65.3 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.586 0.554 . . . . 0.0 112.345 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -62.37 -50.01 73.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.73 83.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.99 85.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.711 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.91 75.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.41 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 132' ' ' ILE . 47.0 mtt180 -59.82 -48.07 83.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.835 0.35 . . . . 0.0 111.117 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -66.25 -36.73 83.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -60.45 -45.39 93.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.528 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -58.56 -40.32 82.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.4 mt -62.11 -54.63 31.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.723 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.696 HD13 HG11 ' A' ' 91' ' ' VAL . 74.3 mt -66.95 -32.28 73.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.365 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.476 ' HG2' HD13 ' A' ' 11' ' ' LEU . 54.2 ttp -72.74 -36.88 67.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.36 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.48 80.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.911 0.386 . . . . 0.0 110.073 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.51 -36.97 74.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.32 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.04 41.79 5.79 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.482 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -111.77 153.62 26.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 90' ' ' GLU . 19.9 mmt180 -63.52 97.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 111.307 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.66 136.25 57.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.305 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 89' ' ' PRO . 37.5 t -123.83 133.51 69.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.4 p -116.43 130.53 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.254 0.55 . . . . 0.0 111.068 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.16 112.41 24.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.837 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.594 HD22 HG23 ' A' ' 123' ' ' THR . 77.2 mt -103.31 139.55 38.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.547 HD23 ' HD2' ' A' ' 146' ' ' PRO . 2.2 tt -122.86 132.41 24.28 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.152 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.547 ' HD2' HD23 ' A' ' 145' ' ' LEU . 56.0 Cg_exo -53.25 134.61 57.39 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.019 2.479 . . . . 0.0 112.216 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -93.91 14.26 20.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.08 -38.61 0.21 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.153 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.693 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 24.9 m-20 -110.68 176.36 5.07 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.628 -175.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 76.1 p -174.09 -171.19 0.6 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.847 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 151' ' ' LEU . 4.4 mp -60.55 -33.16 72.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.895 0.379 . . . . 0.0 110.77 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -59.79 -36.86 77.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.004 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -74.73 -10.49 59.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -75.91 -22.66 55.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.848 0.356 . . . . 0.0 110.336 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -101.51 173.81 6.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.506 ' HD2' ' HD2' ' A' ' 157' ' ' HIS . 26.5 p-80 -122.72 0.93 9.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.309 0.576 . . . . 0.0 109.725 173.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.506 ' HD2' ' HD2' ' A' ' 156' ' ' HIS . 2.9 m-70 -136.48 -172.63 3.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.397 174.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 53.2 m80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.569 178.082 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mmm . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -100.47 -57.66 2.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.844 0.354 . . . . 0.0 111.598 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.1 mt -81.08 67.9 7.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.476 0.655 . . . . 0.0 111.497 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -144.75 11.35 1.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.569 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -146.52 -178.99 6.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.968 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.82 144.44 52.9 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -54.53 -22.21 27.07 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.76 2.307 . . . . 0.0 112.653 174.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 73.87 -61.53 0.49 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.681 0.792 . . . . 0.0 111.788 176.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -74.04 104.35 4.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.713 0.292 . . . . 0.0 110.95 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . -77.39 130.42 37.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.51 -42.71 61.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.701 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 61.62 87.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.417 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.3 m -107.32 118.79 37.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.088 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -69.16 100.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.701 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.44 -25.32 42.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.507 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -155.88 149.67 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.741 176.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -87.0 -15.14 39.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.54 -161.87 48.13 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.294 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.05 87.03 2.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.29 60.89 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.673 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.53 148.36 17.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.8 mt -97.08 138.75 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.2 tm-20 -110.22 109.7 20.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 109.932 -175.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.67 111.22 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 m120 53.39 52.64 13.06 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.722 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 73.3 -0.02 3.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.172 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.14 122.64 64.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 53.7 mtm180 -97.0 111.26 23.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.498 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -93.53 117.75 30.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 m -88.35 -7.64 56.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.177 0.513 . . . . 0.0 110.008 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -116.07 161.62 18.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.181 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 145.5 55.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 0.0 110.733 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.03 147.74 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.919 0.39 . . . . 0.0 111.671 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -129.08 112.5 14.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.682 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.524 ' HB3' HG13 ' A' ' 41' ' ' VAL . 32.5 p90 -139.4 162.27 35.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.994 0.426 . . . . 0.0 111.813 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.36 156.56 71.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.136 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.587 ' HD3' ' HE1' ' A' ' 130' ' ' TYR . 6.2 Cg_exo -78.66 9.56 3.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.121 2.547 . . . . 0.0 112.068 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -152.32 21.31 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.781 0.8 . . . . 0.0 108.997 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.14 -169.69 12.6 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.915 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -86.75 176.56 4.58 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.787 2.325 . . . . 0.0 112.612 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG13 ' HB3' ' A' ' 35' ' ' PHE . 34.2 t -112.58 104.5 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.649 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.85 152.36 21.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.701 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 m -108.87 132.69 53.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.533 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -113.05 126.65 27.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.534 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 2.0 Cg_endo -83.37 9.74 3.97 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.218 2.612 . . . . 0.0 111.302 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 51' ' ' ASP . 41.5 t -86.8 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.508 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -120.98 -33.75 3.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.815 0.34 . . . . 0.0 111.383 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' A' ' 51' ' ' ASP . 69.6 mtp85 -108.03 147.66 35.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.973 0.416 . . . . 0.0 110.818 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HG3' ' O ' ' A' ' 96' ' ' THR . 12.7 Cg_exo -70.21 -6.01 17.82 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.047 2.498 . . . . 0.0 112.212 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.75 -19.68 24.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.321 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.591 ' HB2' HG13 ' A' ' 46' ' ' VAL . 30.1 m-20 -82.91 -20.21 35.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.881 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.13 116.94 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.825 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 31.1 p -113.48 169.51 8.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.371 175.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -60.27 -34.62 73.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 110.027 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m -59.1 -46.87 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.504 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 46' ' ' VAL . 97.9 mt -66.93 -33.78 76.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.627 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 53' ' ' THR . 96.9 mt -64.22 -40.9 97.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.8 mt-30 -62.95 -33.77 76.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.06 -43.74 56.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.32 66.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.746 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -21.98 66.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.86 94.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.331 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.8 25.06 0.69 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 111.309 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.16 123.24 13.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.78 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.07 106.61 17.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.323 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.66 100.54 6.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.564 HG22 ' H ' ' A' ' 69' ' ' ASP . 11.5 p -120.43 159.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.256 -174.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.6 mtm-85 -89.54 -6.43 56.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.931 0.396 . . . . 0.0 110.743 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.564 ' H ' HG22 ' A' ' 67' ' ' VAL . 35.4 t70 -121.48 101.09 43.89 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.914 0.388 . . . . 0.0 110.711 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -89.25 5.83 4.73 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.773 2.315 . . . . 0.0 112.208 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.1 mt -89.6 -42.66 11.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 46.55 72.92 0.2 Allowed 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.859 0.724 . . . . 0.0 111.93 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.22 -27.07 62.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.144 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.47 -12.96 60.02 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.883 0.373 . . . . 0.0 110.947 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.45 125.8 46.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.12 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -75.26 136.26 72.41 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.8 86.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.634 2.889 . . . . 0.0 114.193 -172.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.72 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 4.9 mm-40 -140.52 91.4 2.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.033 175.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.63 96.44 8.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.78 -173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.31 -55.88 5.04 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.484 173.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.49 -17.98 62.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.654 0.264 . . . . 0.0 111.68 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.72 ' HA3' ' HB3' ' A' ' 78' ' ' GLU . . . -89.8 39.17 3.13 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.45 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.76 171.53 20.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -120.56 157.55 53.82 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.285 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.41 12.06 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.707 2.271 . . . . 0.0 112.79 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.81 -17.87 59.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.075 0.464 . . . . 0.0 110.204 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -87.17 2.29 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.473 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.73 159.75 31.79 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.415 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.488 ' O ' HG22 ' A' ' 116' ' ' VAL . 53.9 Cg_exo -53.44 139.04 65.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.473 2.115 . . . . 0.0 112.06 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' OE1' ' HG3' ' A' ' 138' ' ' ARG . 37.3 tt0 -88.22 -36.89 16.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.036 0.446 . . . . 0.0 110.134 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.73 138.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.237 0.541 . . . . 0.0 111.258 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -114.92 118.77 34.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.661 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.07 119.46 39.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.202 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.58 121.74 59.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.838 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -96.81 106.31 3.33 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.544 ' HA ' HD12 ' A' ' 145' ' ' LEU . 12.6 p -83.5 13.35 4.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -171.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.09 -102.4 1.15 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.213 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 72.3 mtt-85 -62.99 -45.73 91.03 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -142.49 140.23 31.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.844 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.9 tt0 -66.17 96.73 0.35 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.144 0.497 . . . . 0.0 110.241 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -99.42 99.65 10.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.743 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.5 mt -60.57 137.83 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.05 -178.69 5.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.474 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 147.79 16.32 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.872 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.665 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 11.4 Cg_endo -55.17 -40.77 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.852 2.368 . . . . 0.0 112.113 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.17 -27.79 68.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.182 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -74.82 -37.51 62.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.986 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 34.5 m -92.13 -7.68 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 42.7 mtm180 -53.95 -49.18 91.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 66.6 Cg_exo -53.7 -39.36 83.75 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.103 1.869 . . . . 0.0 112.704 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 94.0 mt -78.13 -39.1 42.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.62 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 85.5 mt -62.39 -32.63 73.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.642 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -35.15 78.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.747 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 60.3 mtt -77.83 -38.86 45.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.041 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.09 3.17 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 31.0 t -90.43 115.8 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.53 0.205 . . . . 0.0 110.539 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.03 132.26 10.96 Favored Glycine 0 C--O 1.224 -0.531 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.02 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.63 123.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 117.318 0.559 . . . . 0.0 111.115 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.69 131.75 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.501 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.15 128.68 51.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.844 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 71.7 mtm -144.96 -171.82 3.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.3 156.25 34.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.451 HG23 HD22 ' A' ' 144' ' ' LEU . 40.4 m -57.91 -43.75 86.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.916 0.389 . . . . 0.0 110.927 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.51 -40.65 80.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.2 -41.71 89.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 110.966 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.4 -47.36 76.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.51 96.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.389 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' HG13 ' A' ' 132' ' ' ILE . 42.4 ttm180 -63.4 -50.15 70.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.69 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -63.32 -35.85 81.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.432 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.587 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 50.9 t80 -57.73 -44.99 86.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.761 175.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -64.14 -39.26 93.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 128' ' ' ARG . 70.2 mt -64.18 -50.23 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.747 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.401 ' HB2' HG11 ' A' ' 140' ' ' VAL . 91.8 mt -67.85 -26.04 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.799 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 36.8 ttm -61.88 -50.42 72.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.068 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.491 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.88 -44.37 97.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.59 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 105.42 33.33 3.67 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.061 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.428 ' HG3' ' OE1' ' A' ' 90' ' ' GLU . 17.0 ttm180 -100.05 144.98 28.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -70.46 79.62 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.987 0.422 . . . . 0.0 110.879 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 133' ' ' LEU . 5.9 p -106.31 128.54 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.924 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 36' ' ' ALA . 25.9 t -113.11 131.57 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.8 p -115.67 131.64 67.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.57 111.34 22.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.395 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 123' ' ' THR . 98.9 mt -107.05 120.83 43.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.738 0.304 . . . . 0.0 111.672 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 96' ' ' THR . 94.8 mt -93.93 126.0 50.84 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.699 172.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 118.73 5.63 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.611 2.208 . . . . 0.0 112.426 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.8 115.31 6.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.751 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.11 -44.77 0.22 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.627 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 68.47 -176.37 0.2 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.054 0.542 . . . . 0.0 110.248 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 66.3 m -159.46 -24.64 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 122.876 0.47 . . . . 0.0 109.78 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.5 tp -86.71 -40.38 15.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.242 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -107.48 114.09 27.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.638 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -112.23 165.67 11.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -70.28 -49.26 51.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -82.45 134.83 35.23 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -95.69 -16.9 21.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.017 0.437 . . . . 0.0 110.797 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -120.7 -90.31 0.58 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.7 m80 . . . . . 0 C--O 1.246 0.879 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.612 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -66.48 -46.17 77.23 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.4 tp -79.09 125.35 29.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -57.0 -53.31 59.5 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.185 0.303 . . . . 0.0 111.594 -171.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.582 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 24.2 m -87.54 116.83 25.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.785 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.44 101.36 1.29 Allowed Pre-proline 0 C--O 1.234 0.268 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 5' ' ' THR . 83.7 Cg_endo -95.9 157.19 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.234 2.623 . . . . 0.0 113.006 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.83 103.9 15.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.608 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -11.39 60.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.754 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.38 -12.15 60.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 0.0 110.858 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.9 mt -104.9 93.54 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.94 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 34.8 t30 -74.6 125.6 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.018 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -154.48 142.77 20.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.831 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.98 112.5 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.231 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 p -74.23 -32.8 63.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.296 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -131.19 92.13 3.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.761 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' HE2' ' HG2' ' A' ' 124' ' ' GLN . 71.0 t80 -104.61 -3.22 24.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.377 0.608 . . . . 0.0 109.904 175.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.32 -23.71 70.24 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.927 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -78.98 -175.58 4.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 111.152 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.48 14.69 60.57 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.523 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.483 ' HB3' HD23 ' A' ' 151' ' ' LEU . 27.4 p90 -148.97 173.35 13.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.75 108.19 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 0.0 111.091 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 45.7 tt0 -93.5 112.5 24.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.133 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.4 95.92 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.887 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 m120 64.63 -77.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.757 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -119.09 -28.11 5.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.074 -176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.39 127.7 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -173.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 23.3 mtm180 -98.52 109.68 22.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.277 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -91.2 131.71 36.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -101.9 14.51 31.75 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.561 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -148.98 179.06 8.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.821 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.81 139.9 58.36 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.551 0.532 . . . . 0.0 111.25 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 pt -145.1 156.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.305 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.56 130.6 50.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.251 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.577 ' HB3' HG13 ' A' ' 41' ' ' VAL . 36.5 p90 -150.43 154.86 38.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.367 0.603 . . . . 0.0 112.06 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -119.17 164.56 20.68 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.531 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 26.4 Cg_exo -63.32 -42.37 22.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.413 2.075 . . . . 0.0 111.607 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.75 101.55 7.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.23 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.78 -157.55 27.67 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.297 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -93.39 163.81 2.42 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.285 2.656 . . . . 0.0 113.197 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -114.15 116.67 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.46 145.92 41.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.341 . . . . 0.0 111.419 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -79.07 128.73 33.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.606 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 60' ' ' ALA . 1.7 t90 -98.32 116.97 65.39 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 12.8 Cg_exo -71.56 33.93 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.503 2.802 . . . . 0.0 112.888 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 51' ' ' ASP . 94.2 t -114.68 125.44 72.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.534 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.12 -49.42 4.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.176 0.512 . . . . 0.0 110.894 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -107.88 150.91 40.91 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.091 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 14.7 Cg_endo -59.63 -19.78 54.68 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.336 2.024 . . . . 0.0 111.796 174.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.26 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.296 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.62 ' HB2' HG13 ' A' ' 46' ' ' VAL . 11.8 m-20 -68.73 -28.4 66.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.805 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -54.44 115.06 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.608 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -121.95 159.77 26.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.874 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -52.84 -44.32 66.65 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -63.16 -35.8 81.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.226 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.458 HD13 HG22 ' A' ' 46' ' ' VAL . 49.9 mt -69.57 -31.83 70.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.36 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.79 -35.46 80.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.182 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.342 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -70.66 -39.37 73.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.452 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' A' ' 44' ' ' TRP . . . -69.68 -23.85 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.853 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -81.43 -7.36 59.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.957 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.55 37.83 85.67 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.388 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.02 13.43 4.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 111.527 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.8 82.27 5.21 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -81.53 143.55 31.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.199 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 21.8 t -138.43 166.37 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' N ' HG12 ' A' ' 66' ' ' VAL . 48.8 t -58.67 -24.45 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 110.051 172.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 66' ' ' VAL . 96.3 mtt180 72.75 -68.86 0.21 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.415 176.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.707 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 12.6 t70 -168.52 -57.65 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.668 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' A' ' 69' ' ' ASP . 93.1 Cg_endo -90.37 142.0 3.5 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.894 1.729 . . . . 0.0 112.262 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.63 -19.88 61.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.232 0.539 . . . . 0.0 109.888 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.29 109.5 20.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.956 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -75.91 135.26 40.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.239 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.4 -42.72 5.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.24 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.59 -62.34 1.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.238 0.336 . . . . 0.0 110.153 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -81.98 108.92 12.76 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.53 -46.3 4.04 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.696 2.264 . . . . 0.0 112.82 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.74 166.96 23.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.385 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.18 -1.88 28.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.274 0.559 . . . . 0.0 109.753 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.77 -139.62 27.69 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.458 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.96 21.94 10.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.997 0.427 . . . . 0.0 110.755 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.97 -153.39 5.91 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.911 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.5 11.1 12.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.016 0.436 . . . . 0.0 110.557 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.5 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 8.8 ptp180 -124.26 123.61 25.93 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.791 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 2.7 Cg_endo -86.47 -157.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.469 2.779 . . . . 0.0 111.642 176.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.01 20.18 17.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.36 0.6 . . . . 0.0 110.104 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -69.08 -15.22 63.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.994 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -74.55 133.95 76.57 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.173 175.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.416 ' HG2' ' HB1' ' A' ' 61' ' ' ALA . 50.2 Cg_exo -56.4 127.8 27.46 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.884 2.39 . . . . 0.0 112.686 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -64.24 -46.87 81.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.448 0.642 . . . . 0.0 109.528 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.79 132.07 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.876 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.519 ' HB3' HG22 ' A' ' 118' ' ' VAL . 57.3 tp -114.26 117.38 30.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.96 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.1 mt -101.51 117.03 34.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.336 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.2 t -104.05 110.32 29.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.444 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.08 96.84 2.17 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 33.4 p -80.87 -13.63 58.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.776 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.69 -101.52 1.42 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.751 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -62.85 -58.49 7.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.345 . . . . 0.0 111.336 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.4 mmt-85 -109.2 122.33 47.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.992 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.599 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 53.3 tt0 -74.51 97.19 3.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.471 ' HB3' HG21 ' A' ' 96' ' ' THR . 40.1 t-80 -73.6 104.82 4.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.862 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.63 142.26 53.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.442 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -93.16 160.22 14.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.852 0.358 . . . . 0.0 110.617 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.79 162.36 14.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.625 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.27 -49.52 16.06 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.74 2.293 . . . . 0.0 112.253 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -62.48 -25.79 68.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.568 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 93.7 mt-30 -76.78 -34.35 57.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.775 0.322 . . . . 0.0 111.316 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.8 -11.57 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 68.0 mtm180 -52.34 -55.26 33.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 23.0 Cg_endo -61.19 -35.4 85.85 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.038 1.826 . . . . 0.0 113.006 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.4 mt -80.77 -37.85 29.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.0 111.179 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.6 mt -69.26 -23.89 63.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.004 0.43 . . . . 0.0 110.318 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.72 68.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.445 175.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 62.4 mtt -88.46 -35.85 16.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.29 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.55 14.51 5.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.289 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.1 t -85.32 108.44 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.694 0.283 . . . . 0.0 110.568 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.46 94.72 1.73 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.969 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 92' ' ' LEU . 39.9 t -88.6 129.88 38.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 0.0 111.213 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -126.73 139.89 52.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.124 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.4 128.23 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.411 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 66.7 mtt -140.31 -173.38 3.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.224 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -91.84 168.31 11.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.4 m -59.49 -35.76 74.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 111.761 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.589 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 7.1 tm0? -75.84 -52.46 10.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.62 98.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.535 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 121' ' ' MET . . . -63.03 -46.43 87.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.83 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.11 78.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -73.66 -45.49 52.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.639 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -63.04 -35.75 81.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.128 0.49 . . . . 0.0 109.902 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -54.01 -46.25 71.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.948 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -63.34 -41.57 98.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.836 0.35 . . . . 0.0 110.814 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.0 mt -64.02 -47.4 90.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.793 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.94 -27.62 66.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.004 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 56.3 ttp -65.58 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.041 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.01 -26.66 61.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.34 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -67.31 -35.8 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.452 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.2 9.72 55.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.91 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -87.85 155.5 19.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -82.78 87.13 6.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.473 0.654 . . . . 0.0 111.09 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -103.66 132.88 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.757 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 36' ' ' ALA . 57.6 t -120.3 136.13 58.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.1 p -121.57 135.81 60.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.313 0.577 . . . . 0.0 111.232 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.08 119.85 36.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.115 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.7 mt -110.17 125.31 52.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.971 0.415 . . . . 0.0 111.616 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 96' ' ' THR . 95.5 mt -104.09 153.63 38.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.073 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.02 172.81 12.59 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.922 2.415 . . . . 0.0 112.011 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.47 -34.26 60.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.616 0.722 . . . . 0.0 110.009 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.31 -41.62 0.48 Allowed Glycine 0 CA--C 1.502 -0.78 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -78.8 143.41 36.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.886 -0.657 . . . . 0.0 109.988 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.7 m -143.03 156.19 44.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.29 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 21' ' ' TYR . 4.5 mm? -70.01 -25.42 63.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.928 0.394 . . . . 0.0 110.446 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.82 105.89 7.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -62.38 -34.17 76.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.876 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -109.54 106.71 16.54 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -55.93 128.58 35.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.0 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -97.33 135.56 39.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.56 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -117.01 -35.91 3.96 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 167.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.2 t60 . . . . . 0 C--O 1.246 0.887 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.434 173.695 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.661 0.267 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -143.58 150.67 39.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.267 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -71.73 -21.67 61.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.237 0.541 . . . . 0.0 109.934 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -127.42 102.34 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.557 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 p -88.13 130.95 34.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.534 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 56.93 64.93 4.16 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.669 -173.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.48 5.3 5.65 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.787 2.324 . . . . 0.0 112.09 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.14 90.97 5.48 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.675 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -73.15 156.26 38.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.223 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.18 48.46 0.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 0.0 111.78 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.8 mt -147.72 80.58 1.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.984 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -64.75 102.12 0.55 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 0.0 110.365 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -110.03 146.09 35.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.764 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 17' ' ' TYR . 47.9 t -68.32 109.73 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -44.49 61.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.573 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -139.35 116.87 11.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.244 0.545 . . . . 0.0 111.377 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' HB2' HG11 ' A' ' 14' ' ' VAL . 89.5 t80 -136.5 142.29 43.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.072 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.81 -90.02 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 176.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -144.41 137.14 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.02 -91.17 0.79 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.341 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -111.81 177.71 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.701 0.286 . . . . 0.0 110.951 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.5 mt -128.92 136.31 60.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.462 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -114.82 120.56 40.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.72 117.62 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.325 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 64.36 49.72 2.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.507 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 68.25 18.55 9.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.173 173.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -128.61 121.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 28' ' ' ARG . 29.4 mtm-85 -88.42 110.87 21.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.639 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -90.91 114.7 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.017 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.2 m -92.99 29.01 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.304 0.573 . . . . 0.0 110.179 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -152.51 167.97 27.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.533 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.43 147.53 52.49 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.384 0.428 . . . . 0.0 111.233 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -140.74 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.074 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.72 123.08 25.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.46 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 45.2 p90 -152.36 162.19 41.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.35 0.595 . . . . 0.0 111.956 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.94 155.05 58.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.571 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.91 -57.65 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.678 2.252 . . . . 0.0 111.987 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.35 27.68 3.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.5 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.65 -172.57 13.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.273 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -87.05 173.39 5.85 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.823 2.349 . . . . 0.0 112.593 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 48.1 t -109.1 113.79 45.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.983 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.5 133.57 50.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.036 0.446 . . . . 0.0 111.158 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m -76.44 124.16 27.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.165 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.46 126.27 40.03 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 0.9 OUTLIER -83.43 8.63 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.46 2.773 . . . . 0.0 113.111 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.9 t -92.09 135.82 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -120.69 -48.83 2.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.106 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.569 HH11 ' HG2' ' A' ' 48' ' ' ARG . 24.3 mtt-85 -93.37 139.89 23.06 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.449 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.2 Cg_exo -66.85 -10.29 27.8 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.185 2.59 . . . . 0.0 112.494 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.21 5.0 52.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 1.2 m-20 -109.7 0.24 18.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.36 127.01 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -135.14 156.9 48.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.25 62.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m -57.56 -37.73 73.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.272 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.94 -34.12 77.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.464 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.31 -34.79 63.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.541 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.17 -41.82 98.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.95 -41.48 86.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.82 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.66 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.347 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -79.88 -4.57 52.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.141 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.52 17.7 77.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.55 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 88' ' ' ALA . 96.4 mt -86.69 -9.83 55.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.967 0.413 . . . . 0.0 110.697 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.69 -173.68 3.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.468 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.19 108.3 4.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.937 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.0 128.87 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.982 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 m -75.1 74.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.567 0.698 . . . . 0.0 112.497 -174.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -129.58 -88.63 0.51 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -175.88 99.52 0.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 170.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.37 98.94 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.887 2.391 . . . . 0.0 112.594 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.9 mt -90.33 -27.01 19.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.975 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.07 100.8 12.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.161 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -83.02 137.01 34.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.036 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.7 mt -80.14 3.13 21.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.043 0.449 . . . . 0.0 110.721 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.39 -11.71 60.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.588 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -109.62 151.62 42.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.579 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.47 128.38 29.93 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.347 2.698 . . . . 0.0 112.953 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -88.73 146.08 25.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.08 -168.05 2.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.977 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.03 61.48 3.75 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.295 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.6 -66.14 0.97 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.813 0.339 . . . . 0.0 110.418 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.66 -37.41 4.49 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 71.21 -17.58 0.31 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.789 0.836 . . . . 0.0 112.779 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -130.26 134.01 25.6 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.97 -16.45 29.09 Favored 'Trans proline' 0 N--CA 1.466 -0.093 0 C-N-CA 122.677 2.251 . . . . 0.0 112.143 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -120.08 76.32 1.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.871 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -110.73 71.4 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.444 0.64 . . . . 0.0 109.439 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HA ' HD21 ' A' ' 63' ' ' LEU . . . -90.91 157.55 43.22 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.631 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HG2' ' HB1' ' A' ' 61' ' ' ALA . 70.0 Cg_exo -52.28 137.37 55.68 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.559 2.173 . . . . 0.0 112.159 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -68.91 -41.47 78.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.78 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.462 HG11 HD13 ' A' ' 133' ' ' LEU . 3.6 p -140.71 137.75 35.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.445 ' HB3' HG22 ' A' ' 118' ' ' VAL . 58.9 tp -122.16 118.62 29.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.58 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 133' ' ' LEU . 89.3 mt -98.49 119.04 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.388 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.1 t -109.85 114.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.385 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.51 106.69 3.08 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 101' ' ' HIS . 6.0 p -76.16 -30.88 58.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.53 -61.84 2.36 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.164 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.515 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 64.1 mtt85 -73.18 -75.14 0.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.326 0.584 . . . . 0.0 110.89 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -134.36 137.05 43.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.084 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -73.73 109.32 7.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.881 0.372 . . . . 0.0 111.218 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.419 ' H ' HG21 ' A' ' 96' ' ' THR . 5.0 t60 -72.7 108.01 5.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.5 108.79 3.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.04 141.41 58.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.404 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.36 150.78 16.91 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.7 -19.34 60.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.013 2.475 . . . . 0.0 112.699 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 mt-10 -94.91 -14.43 24.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.231 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -86.27 -40.76 15.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 111' ' ' LEU . 3.7 t -96.21 13.61 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.638 0.732 . . . . 0.0 109.654 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 106' ' ' GLU . 56.1 ttt85 -49.83 -54.81 28.34 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.16 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.17 -33.51 49.31 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.692 1.595 . . . . 0.0 112.325 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.46 ' HB2' HG12 ' A' ' 108' ' ' VAL . 88.9 mt -73.34 -46.44 49.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.66 -33.98 76.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.17 -32.67 74.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 73.8 mtm -81.75 -25.07 35.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.659 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.23 22.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.449 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.53 107.73 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 110.697 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.67 96.15 1.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.781 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 92' ' ' LEU . 46.5 t -89.33 118.83 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.811 0.339 . . . . 0.0 110.717 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -107.07 108.4 19.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.66 106.01 17.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 110.267 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.2 mtm -136.34 -171.68 2.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.032 0.444 . . . . 0.0 110.791 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 125' ' ' ALA . 1.9 m-20 -66.76 158.92 29.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.399 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -63.07 -42.44 99.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.221 0.534 . . . . 0.0 109.917 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.544 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 53.1 tt0 -66.23 -42.7 88.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.441 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.478 ' H ' ' HB2' ' A' ' 122' ' ' ASP . . . -63.68 -44.15 94.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.99 96.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.938 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.37 93.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 124' ' ' GLN . 63.0 mtm180 -62.77 -48.38 79.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.9 m -62.99 -34.01 76.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.787 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -62.69 -44.74 95.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.369 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 134' ' ' MET . 90.6 m-20 -65.84 -28.15 68.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.714 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 128' ' ' ARG . 81.3 mt -72.16 -50.74 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.516 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.462 HD13 HG11 ' A' ' 91' ' ' VAL . 98.0 mt -67.51 -34.97 78.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.804 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.402 ' HG2' ' HA ' ' A' ' 131' ' ' ASN . 19.0 ptp -67.84 -29.94 69.21 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.418 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.71 -26.69 40.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.59 -39.79 57.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.532 . . . . 0.0 109.903 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 30.84 5.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.821 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -100.92 148.26 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -71.11 99.83 1.92 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.031 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.56 140.56 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.107 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.401 ' O ' HD12 ' A' ' 92' ' ' LEU . 44.4 t -121.67 142.64 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 7.2 p -120.83 139.52 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.187 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -126.55 115.04 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -116.24 135.39 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.2 mt -109.21 99.67 37.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.49 135.7 26.98 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.337 2.025 . . . . 0.0 111.496 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.515 ' OD1' ' HG2' ' A' ' 98' ' ' ARG . 30.4 t70 -88.27 158.31 18.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.44 -5.41 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.129 -0.558 . . . . 0.0 111.962 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.87 114.79 4.76 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.4 p -80.91 94.48 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.5 tp -75.39 112.96 12.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.629 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.73 156.37 39.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.304 177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -102.31 88.2 3.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -85.6 145.8 27.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.92 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -104.38 140.21 38.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -87.65 12.76 11.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.571 0.701 . . . . 0.0 110.448 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -75.38 -21.55 58.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.894 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.844 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.66 0.266 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -120.1 150.56 40.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.22 110.41 21.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.648 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -65.49 109.87 2.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.146 0.498 . . . . 0.0 110.065 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 135' ' ' ALA . 26.6 m -82.7 102.4 11.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.958 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.18 90.67 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.994 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.67 23.35 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.385 2.723 . . . . 0.0 113.004 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.67 -43.84 53.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.147 0.499 . . . . 0.0 110.229 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.481 HG21 ' HG2' ' A' ' 38' ' ' GLU . 16.1 p -132.52 151.2 51.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.607 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 108.77 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.922 0.392 . . . . 0.0 110.227 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.16 117.91 14.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.222 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.95 113.97 24.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.13 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m -116.3 143.13 45.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.646 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.91 115.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -87.26 -46.31 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.147 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.71 138.54 19.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.721 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -156.69 104.61 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.88 -29.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.841 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.426 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 23.1 m-20 -73.45 -29.26 62.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.018 0.437 . . . . 0.0 111.057 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.59 -12.53 4.28 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.5 p90 -111.92 154.9 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.35 111.37 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -94.17 112.94 24.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.038 0.447 . . . . 0.0 110.387 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.72 110.61 28.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.462 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 62.54 45.33 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.546 . . . . 0.0 109.965 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 73.73 -6.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.047 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.05 117.86 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -91.25 102.36 15.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.368 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.89 127.19 35.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.771 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -104.97 17.36 24.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -116.62 172.39 7.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB1' HD23 ' A' ' 145' ' ' LEU . . . -74.31 137.35 42.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 164.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 pt -134.99 144.87 33.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.413 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.74 125.67 38.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.575 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 44.7 p90 -149.08 162.58 39.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.075 0.464 . . . . 0.0 111.326 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.75 163.28 45.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.699 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.72 -36.93 34.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.72 2.28 . . . . 0.0 112.946 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.481 ' HG2' HG21 ' A' ' 9' ' ' THR . 24.0 mt-10 -124.85 32.7 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.053 0.454 . . . . 0.0 110.521 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.31 16.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.873 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.83 147.32 80.63 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.687 2.258 . . . . 0.0 111.502 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.575 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 26.1 t -80.24 88.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.1 124.57 29.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.377 -174.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.7 m -82.05 121.89 27.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 56' ' ' LEU . 1.2 t90 -103.79 121.76 46.97 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.57 -175.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.66 13.98 1.54 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.821 2.347 . . . . 0.0 112.951 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.465 HG21 HD13 ' A' ' 56' ' ' LEU . 48.5 t -95.79 112.82 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.378 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.47 -29.34 18.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -113.54 126.33 28.29 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.463 -173.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.16 -1.53 4.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.995 2.463 . . . . 0.0 113.209 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.14 -15.09 23.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -84.32 -7.81 59.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.015 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.532 ' HA ' HD12 ' A' ' 56' ' ' LEU . 60.1 mt -69.62 130.44 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.501 -175.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' A' ' 56' ' ' LEU . 41.2 p -111.25 179.77 3.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.702 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -68.33 -35.08 77.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 m -65.11 -41.72 94.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.49 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.621 ' HB3' ' HZ2' ' A' ' 44' ' ' TRP . 61.7 mt -65.17 -36.57 84.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.071 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.53 ' HB3' HD11 ' A' ' 111' ' ' LEU . 72.1 mt -63.09 -37.32 86.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.709 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 96.6 mt-30 -65.97 -40.69 91.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.83 -40.66 88.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.813 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.34 64.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.45 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HB2' HD22 ' A' ' 92' ' ' LEU . . . -82.33 -2.02 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.87 72.74 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.349 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.437 HD13 ' SD ' ' A' ' 114' ' ' MET . 96.4 mt -85.87 64.31 8.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.82 0.819 . . . . 0.0 110.758 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -135.57 126.49 27.65 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.273 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.74 105.05 2.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.979 0.419 . . . . 0.0 110.706 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.724 HG12 HG23 ' A' ' 67' ' ' VAL . 48.0 t -111.15 137.26 44.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.291 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.724 HG23 HG12 ' A' ' 66' ' ' VAL . 93.1 t 74.17 117.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 123.918 0.761 . . . . 0.0 111.575 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 68' ' ' ARG . 56.4 mtt180 -79.38 96.58 6.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.711 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -84.35 117.62 69.15 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.134 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -85.37 -0.78 9.02 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.817 2.345 . . . . 0.0 113.388 -176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.8 mt -87.73 -4.02 58.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.36 . . . . 0.0 111.021 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.95 0.87 14.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.285 0.564 . . . . 0.0 110.581 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -69.3 -27.98 65.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.481 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 98.0 mt -133.42 166.15 23.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.118 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.822 ' HB3' ' HA2' ' A' ' 82' ' ' GLY . 4.1 p30 -142.94 151.22 40.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.002 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -70.99 120.18 77.88 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -14.06 75.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 126.355 4.703 . . . . 0.0 115.847 -163.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -120.74 -47.94 2.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.312 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.82 26.38 16.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.147 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.45 -75.82 0.75 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.48 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.7 -40.46 9.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.832 0.348 . . . . 0.0 111.268 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.822 ' HA2' ' HB3' ' A' ' 75' ' ' ASP . . . 83.5 28.5 35.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.341 -176.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -168.66 -167.53 0.78 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -89.68 110.81 42.08 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.31 153.98 51.02 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 123.046 2.497 . . . . 0.0 112.121 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 55.37 65.38 1.49 Allowed 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.8 0.687 . . . . 0.0 110.978 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.55 3.86 11.18 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.696 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.89 148.29 92.01 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.378 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.59 123.77 14.66 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.746 2.297 . . . . 0.0 112.296 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 50.6 mt-10 -65.11 -50.62 65.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.63 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 140' ' ' VAL . 4.2 p -135.02 130.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.382 0.611 . . . . 0.0 111.47 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 61' ' ' ALA . 65.2 tp -107.52 113.28 26.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.521 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 119' ' ' GLU . 95.9 mt -93.19 98.11 11.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.539 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -91.6 105.72 16.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -84.27 108.82 3.15 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 175.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.446 HG21 ' H ' ' A' ' 101' ' ' HIS . 8.0 p -62.62 -17.44 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.618 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 65.5 -92.2 0.15 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.853 171.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.22 -51.25 70.8 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.711 0.405 . . . . 0.0 111.638 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -144.66 134.26 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -70.04 112.03 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.813 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.446 ' H ' HG21 ' A' ' 96' ' ' THR . 66.5 m80 -113.06 147.43 37.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.255 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.68 106.86 18.84 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.7 169.79 12.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.14 147.96 16.35 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.728 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.623 ' HA ' HG22 ' A' ' 108' ' ' VAL . 51.1 Cg_exo -57.15 -24.59 59.5 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.354 2.703 . . . . 0.0 112.601 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -56.16 -31.97 63.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.223 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -89.28 -23.43 22.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.825 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.623 HG22 ' HA ' ' A' ' 105' ' ' PRO . 20.2 m -93.68 -21.57 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.544 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 57.5 mtm-85 -53.94 -49.36 90.0 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 11.7 Cg_endo -55.72 -34.52 91.03 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.982 1.788 . . . . 0.0 112.754 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 62.5 mt -81.57 -37.5 27.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.736 0.303 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.1 mt -64.69 -32.67 74.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.924 0.392 . . . . 0.0 110.584 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.72 -10.26 59.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.214 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 63' ' ' LEU . 67.1 mtt -97.05 -43.82 7.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.257 0.551 . . . . 0.0 109.737 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.02 10.71 2.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.208 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 39.7 t -98.5 125.99 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.612 0.244 . . . . 0.0 110.475 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.23 124.51 8.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.41 ' CG2' HD12 ' A' ' 111' ' ' LEU . 23.3 t -93.71 115.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.646 0.26 . . . . 0.0 110.994 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.47 ' HB2' HD23 ' A' ' 93' ' ' LEU . 27.1 mm-40 -112.35 127.97 56.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.856 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.29 104.91 14.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 36.9 ttm -129.78 168.73 16.11 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.323 -169.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.13 155.67 27.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.915 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.618 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -54.37 -52.4 61.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.861 -177.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -77.65 -37.96 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.426 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.26 91.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.091 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 121' ' ' MET . . . -65.92 -44.29 85.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.729 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.05 93.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.702 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -64.5 -51.86 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.6 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.9 m -59.0 -36.97 75.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.92 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -57.99 -46.35 85.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.958 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -64.12 -37.24 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 110.592 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.65 -46.74 85.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.02 -24.11 64.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 38.4 ttm -64.97 -47.22 78.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.128 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' HG21 ' A' ' 5' ' ' THR . . . -70.52 -21.87 62.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.57 -11.76 59.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.061 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 70.14 32.64 69.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.815 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -100.78 150.38 22.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.745 0.307 . . . . 0.0 110.641 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 49.8 mtm180 -78.69 90.7 4.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.474 0.654 . . . . 0.0 110.94 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.497 HG23 HG13 ' A' ' 91' ' ' VAL . 6.0 p -123.4 137.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.587 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 36' ' ' ALA . 39.5 t -116.41 133.2 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.3 p -110.72 134.92 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.28 113.53 16.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.643 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -110.41 129.36 55.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.782 0.325 . . . . 0.0 111.197 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.563 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 69.6 mt -103.67 98.84 13.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.393 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.03 175.88 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.555 2.17 . . . . 0.0 112.225 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -98.36 -170.71 2.0 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.48 -15.08 0.22 Allowed Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -102.1 -29.57 11.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.208 -0.496 . . . . 0.0 111.101 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.9 m -73.03 -32.03 64.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 0.0 110.245 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.45 100.92 11.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.82 142.58 58.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.747 -172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -104.9 104.41 14.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.896 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -70.37 -44.41 68.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.99 110.59 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 164.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -82.27 -38.13 24.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -162.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -94.21 -10.64 32.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.515 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.065 177.407 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.807 0.337 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -134.44 -174.8 3.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.735 172.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 7' ' ' PRO . 87.8 mt -110.07 179.51 4.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.854 0.359 . . . . 0.0 110.975 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -95.76 -40.83 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.322 0.582 . . . . 0.0 109.572 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -99.06 -164.86 1.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.607 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.807 ' HB3' ' HA2' ' A' ' 82' ' ' GLY . 3.9 p-10 -65.47 147.78 98.45 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.729 0.3 . . . . 0.0 110.59 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.651 ' HA ' HD12 ' A' ' 3' ' ' LEU . 5.0 Cg_exo -76.42 33.71 0.42 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.401 2.734 . . . . 0.0 112.913 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 68.94 113.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.455 0.702 . . . . 0.0 112.282 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 10' ' ' ALA . 8.0 p -90.56 -153.59 0.31 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.744 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' H ' ' HB ' ' A' ' 9' ' ' THR . . . -120.45 166.67 13.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.554 0.216 . . . . 0.0 111.099 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 37' ' ' PRO . 88.0 mt -126.1 152.35 46.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -152.94 127.25 9.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.747 0.308 . . . . 0.0 110.355 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 m -110.9 141.01 44.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -68.19 115.59 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -49.09 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.94 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -134.66 129.48 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.234 0.54 . . . . 0.0 111.817 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.487 ' HE1' HG22 ' A' ' 123' ' ' THR . 85.0 t80 -104.14 102.57 12.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.49 175.2 47.38 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.784 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -81.19 -21.46 39.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.042 0.449 . . . . 0.0 110.64 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.63 -39.68 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.35 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -124.23 170.5 10.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.98 133.42 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -113.99 120.88 42.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.924 0.393 . . . . 0.0 110.035 -177.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -124.58 110.73 25.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.436 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 61.6 51.27 4.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.63 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 68.85 14.25 8.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.283 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.0 108.89 26.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -83.05 119.37 24.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.188 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -98.6 107.61 20.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.401 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -89.61 14.08 12.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.865 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -140.9 161.5 37.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.589 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -58.72 142.79 48.89 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.586 0.554 . . . . 0.0 111.097 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 pt -136.41 139.78 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.362 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -133.19 109.72 9.64 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 41' ' ' VAL . 42.8 p90 -146.83 161.01 41.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.486 0.66 . . . . 0.0 112.24 -170.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -109.48 154.81 42.1 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.565 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.537 ' HB2' ' HA ' ' A' ' 11' ' ' LEU . 54.0 Cg_endo -70.14 -5.71 17.09 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.145 1.896 . . . . 0.0 111.891 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -92.15 17.14 9.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.004 -170.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.95 -99.74 0.34 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.298 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 16.7 Cg_endo -56.82 134.59 65.46 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.681 2.921 . . . . 0.0 114.658 -170.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 35' ' ' PHE . 96.3 t -113.69 119.95 62.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.28 157.61 16.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 m -124.52 148.14 47.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.882 0.372 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -115.92 139.54 25.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.983 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.11 23.98 0.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.195 2.597 . . . . 0.0 110.499 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.604 HG13 ' HB2' ' A' ' 51' ' ' ASP . 93.3 t -85.9 130.25 36.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.572 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -113.14 -40.98 3.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.13 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -106.01 145.62 31.29 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 28.1 Cg_endo -64.32 -8.82 17.83 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.791 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.12 -12.71 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.604 ' HB2' HG13 ' A' ' 46' ' ' VAL . 73.4 m-20 -81.13 -16.42 53.07 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.46 114.57 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.758 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.404 ' H ' HD12 ' A' ' 56' ' ' LEU . 6.4 m -111.47 155.44 23.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.846 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -52.17 -38.96 59.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.758 0.313 . . . . 0.0 111.318 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m -57.46 -43.82 84.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.997 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD12 ' H ' ' A' ' 53' ' ' THR . 78.4 mt -68.67 -32.8 72.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 -178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.21 -35.77 81.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -69.65 -33.16 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 110.394 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.23 -44.78 78.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.886 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.557 ' O ' HG11 ' A' ' 141' ' ' VAL . . . -64.01 -35.22 80.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.276 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.98 62.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.316 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.53 40.4 59.58 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.364 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt -82.35 62.23 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.714 0.769 . . . . 0.0 110.668 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.51 146.49 42.03 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.465 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -60.84 -52.76 63.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.321 0.581 . . . . 0.0 109.767 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 77' ' ' PRO . 46.6 t -122.16 104.32 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.438 173.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.0 t -70.02 108.86 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.923 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -72.51 93.87 1.62 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.77 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 40' ' ' PRO . 25.5 t70 -69.62 123.43 88.49 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.726 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.01 2.88 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.044 2.496 . . . . 0.0 113.245 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -91.29 -42.22 10.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.02 0.438 . . . . 0.0 110.031 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.48 -171.13 3.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.364 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -130.35 28.7 4.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.082 0.468 . . . . 0.0 110.226 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.6 mt -127.73 -165.87 1.54 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 12.3 m-20 -125.74 84.91 2.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.412 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -102.36 106.77 50.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.79 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.728 ' HB3' HG22 ' A' ' 66' ' ' VAL . 91.6 Cg_endo -96.51 -164.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.367 2.711 . . . . 0.0 112.28 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE2' ' HA ' ' A' ' 87' ' ' ASN . 42.1 tt0 -78.95 127.7 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.97 111.27 13.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.805 0.336 . . . . 0.0 110.887 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.72 -100.06 1.42 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.983 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -162.0 127.48 3.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.807 ' HA2' ' HB3' ' A' ' 6' ' ' ASP . . . -79.08 -169.82 37.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.864 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.06 83.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.056 0.455 . . . . 0.0 110.894 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.714 HH12 ' HA3' ' A' ' 115' ' ' GLY . 53.7 mtt180 -113.15 125.73 29.29 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 63.4 Cg_exo -51.73 -40.13 65.77 Favored 'Trans proline' 0 N--CA 1.477 0.54 0 C-N-CA 124.051 3.167 . . . . 0.0 115.318 -166.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.86 30.28 0.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.448 ' HA ' ' OE2' ' A' ' 78' ' ' GLU . 64.9 t30 58.8 28.39 17.34 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.965 0.888 . . . . 0.0 109.721 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . -88.87 130.65 44.05 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.766 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.83 173.56 14.22 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.61 2.206 . . . . 0.0 111.715 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' OE2' ' HD2' ' A' ' 138' ' ' ARG . 34.1 tt0 -90.58 -38.71 12.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.347 0.594 . . . . 0.0 109.762 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.814 HG11 HD21 ' A' ' 133' ' ' LEU . 3.3 p -139.59 142.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.284 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 141' ' ' VAL . 68.3 tp -118.84 118.12 30.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.487 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.56 115.07 29.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.383 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.8 t -107.0 115.05 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.808 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.66 105.25 3.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 101' ' ' HIS . 19.8 p -77.08 4.42 10.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -171.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.468 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 74.07 -91.12 0.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.338 -0.458 . . . . 0.0 114.228 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.91 ' HG2' ' HA2' ' A' ' 148' ' ' GLY . 52.9 mtt-85 -67.83 -60.93 2.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.967 0.413 . . . . 0.0 111.077 -171.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.535 ' HD2' ' C ' ' A' ' 98' ' ' ARG . 3.4 mpt_? -129.41 148.34 51.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.9 99.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 109.841 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.712 ' HD2' HD23 ' A' ' 103' ' ' LEU . 47.8 t60 -92.34 118.43 30.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.606 -174.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.71 110.59 4.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.231 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.712 HD23 ' HD2' ' A' ' 101' ' ' HIS . 67.1 mt -77.48 151.98 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.1 161.84 14.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.23 -170.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 46.9 Cg_endo -68.41 -1.24 6.99 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.238 2.625 . . . . 0.0 112.721 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -89.09 -23.0 22.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.39 0.614 . . . . 0.0 109.871 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.568 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 77.5 mt-30 -94.63 -47.89 6.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.507 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 m -86.13 -1.02 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.739 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 18.3 ttm180 -56.19 -56.02 35.65 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 41.9 Cg_exo -57.82 -39.72 84.71 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.923 1.749 . . . . 0.0 112.365 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.8 mt -74.09 -40.98 62.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.7 tp -60.86 -36.47 79.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.531 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.24 -27.67 66.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.998 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.04 -9.38 59.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.15 0.5 . . . . 0.0 110.102 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.714 ' HA3' HH12 ' A' ' 84' ' ' ARG . . . 100.83 -0.44 55.21 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.273 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 40.8 t -79.63 103.3 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.817 0.342 . . . . 0.0 110.361 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.45 101.74 1.3 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.921 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -88.74 110.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.701 0.286 . . . . 0.0 110.588 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -110.76 135.82 50.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.18 124.9 50.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.071 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.02 -171.83 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.72 164.88 19.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.501 HG23 HD22 ' A' ' 144' ' ' LEU . 21.1 m -64.19 -34.09 77.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.066 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.41 -47.38 27.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.589 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.28 86.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.695 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.801 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.89 -45.58 93.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.919 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.06 -51.29 70.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.716 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.5 m -62.19 -39.28 92.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.725 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -57.1 -49.74 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.242 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.51 -44.9 95.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -68.33 -44.28 83.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 110.925 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.814 HD21 HG11 ' A' ' 91' ' ' VAL . 23.5 tp -66.63 -37.32 84.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.866 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 33.4 ttp -63.35 -37.18 86.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.446 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.49 -29.1 69.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.46 -34.95 78.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 0.0 110.26 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 17.05 29.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.445 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.511 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 55.8 mtm180 -97.86 137.03 37.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 122.763 -0.257 . . . . 0.0 110.452 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -65.38 110.51 2.67 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.429 0.633 . . . . 0.0 111.319 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.489 HG21 HD23 ' A' ' 133' ' ' LEU . 5.4 p -130.03 135.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 60' ' ' ALA . 47.0 t -109.52 140.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -122.23 132.93 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.195 0.521 . . . . 0.0 111.129 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . . . -115.42 113.97 24.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.343 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.501 HD22 HG23 ' A' ' 123' ' ' THR . 94.2 mt -114.95 125.19 53.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.942 0.401 . . . . 0.0 111.503 -173.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 96' ' ' THR . 97.8 mt -97.76 119.55 62.22 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.213 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 27.6 Cg_endo -89.77 160.18 5.13 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.6 t70 64.59 108.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.676 0.61 . . . . 0.0 110.828 -175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.91 ' HA2' ' HG2' ' A' ' 98' ' ' ARG . . . -140.22 -84.7 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.624 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.79 -40.85 24.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.331 0.586 . . . . 0.0 110.308 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.0 t -83.19 108.32 16.35 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.523 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.79 157.86 19.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -100.1 122.89 43.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.199 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -92.25 152.75 19.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.003 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -63.39 -36.86 85.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.274 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -79.12 -4.51 50.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.813 0.34 . . . . 0.0 110.911 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -83.25 12.77 4.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.52 0.676 . . . . 0.0 109.974 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -108.26 -32.76 7.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.994 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.976 -175.409 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -65.56 -33.54 76.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.488 0.661 . . . . 0.0 109.809 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -95.41 144.74 25.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.985 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -94.89 28.94 2.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.22 0.533 . . . . 0.0 110.845 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 t -159.68 152.7 21.86 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.703 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.61 157.22 86.29 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.72 117.04 3.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.688 2.259 . . . . 0.0 112.385 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.88 115.49 9.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.792 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -71.67 147.07 47.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.96 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.36 131.31 49.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.741 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.67 104.19 0.5 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.27 108.22 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.261 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -111.79 146.7 37.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.186 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.6 t -73.93 125.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -84.15 -46.15 12.22 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 153.09 30.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.516 . . . . 0.0 112.257 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.43 123.54 35.81 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.77 -8.68 60.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.601 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.92 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.636 0.731 . . . . 0.0 110.11 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.9 -19.3 28.1 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -153.21 157.23 39.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.84 133.08 58.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -101.53 122.05 43.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.894 0.378 . . . . 0.0 110.352 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -121.83 96.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.65 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.39 56.12 2.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.087 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 71.26 -8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.079 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.89 117.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -98.14 103.07 14.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.823 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -89.32 114.01 25.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.461 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -89.91 25.44 2.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.22 0.533 . . . . 0.0 110.517 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -147.22 166.48 26.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.057 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -66.82 140.3 57.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.314 0.384 . . . . 0.0 110.696 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 pt -135.93 144.85 32.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.997 0.427 . . . . 0.0 111.516 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.63 112.05 17.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.29 176.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HB3' HG13 ' A' ' 41' ' ' VAL . 41.5 p90 -138.28 156.64 47.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.228 0.537 . . . . 0.0 111.797 -173.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.47 157.18 70.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.816 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD3' ' OH ' ' A' ' 130' ' ' TYR . 24.0 Cg_exo -64.12 -42.33 18.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.383 2.056 . . . . 0.0 110.881 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -106.52 82.45 1.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.546 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.41 -171.17 38.21 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.247 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -92.4 178.62 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.151 2.568 . . . . 0.0 112.934 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 35' ' ' PHE . 47.0 t -114.21 105.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 145.4 24.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.962 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -101.6 129.34 47.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.18 114.15 64.81 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.456 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 39.87 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.387 2.725 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.15 132.0 58.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.119 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -114.19 -25.41 8.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 110.645 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -114.64 128.37 25.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.731 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.1 -9.37 25.55 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.934 2.423 . . . . 0.0 112.954 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -3.89 55.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.603 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -86.75 -14.69 41.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.544 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 145' ' ' LEU . 67.3 mt -58.82 110.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.968 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -133.54 179.18 6.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.29 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.01 -41.98 71.97 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.208 0.317 . . . . 0.0 111.611 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -56.3 -46.0 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.08 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 52' ' ' ILE . 90.8 mt -73.15 -37.15 66.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.91 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -40.46 96.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -66.97 -37.52 84.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.585 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 96.6 mt-30 -62.88 -42.34 99.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.91 -26.98 66.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.242 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.41 -6.38 55.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.244 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.15 2.26 59.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.525 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.5 mt -83.91 11.63 7.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . . . -82.87 -26.48 31.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.014 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -114.64 124.18 51.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.955 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.69 134.79 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.55 94.23 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.302 0.572 . . . . 0.0 110.832 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.917 ' HA ' ' HB3' ' A' ' 77' ' ' PRO . 59.7 mtp85 -94.78 86.08 4.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.405 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.51 96.12 34.91 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.925 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -96.12 30.67 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.422 2.748 . . . . 0.0 112.669 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.68 -42.42 77.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.379 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.38 136.26 48.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.751 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -75.41 88.88 2.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.127 0.489 . . . . 0.0 110.429 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.2 tp -167.77 -42.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.982 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -71.73 -50.06 33.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.112 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 65.88 106.73 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 O-C-N 123.915 0.759 . . . . 0.0 111.479 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.917 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 38.1 Cg_exo -60.4 -35.82 89.42 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.023 2.482 . . . . 0.0 112.785 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.526 ' OE2' ' HB2' ' A' ' 77' ' ' PRO . 4.1 mp0 -84.5 2.0 43.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.275 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.35 -34.62 14.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.173 0.511 . . . . 0.0 109.971 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.83 -89.56 1.5 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.392 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.82 166.86 32.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.568 0.223 . . . . 0.0 110.62 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.37 -125.56 2.71 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.668 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.43 12.41 14.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.527 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 18.9 ptp180 -77.49 129.15 78.13 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 11.6 Cg_exo -71.53 66.07 2.94 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.494 2.796 . . . . 0.0 113.97 -172.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 71.34 -54.07 0.67 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 170.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 69.44 24.07 5.87 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.512 0.672 . . . . 0.0 110.005 -173.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.623 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -75.21 167.69 34.42 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.59 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.623 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 15.1 Cg_endo -57.67 142.25 95.76 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.563 2.175 . . . . 0.0 112.476 176.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.681 ' HG3' ' HB3' ' A' ' 139' ' ' ARG . 34.4 mt-10 -71.05 -40.45 71.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.409 0.624 . . . . 0.0 110.156 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.465 HG13 HG23 ' A' ' 140' ' ' VAL . 4.8 p -138.63 136.63 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.688 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB3' HG22 ' A' ' 118' ' ' VAL . 54.8 tp -116.05 116.66 28.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.577 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.2 mt -102.44 124.07 47.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.687 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.84 126.19 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.742 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.48 ' HA3' HD23 ' A' ' 144' ' ' LEU . . . -108.88 112.95 3.61 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.548 ' HA ' HD12 ' A' ' 145' ' ' LEU . 21.2 p -81.62 -61.38 1.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.489 ' H ' ' HA ' ' A' ' 122' ' ' ASP . . . 84.92 -22.01 10.32 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.498 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.4 HH21 ' HB2' ' A' ' 146' ' ' PRO . 52.1 mtt180 -113.09 -64.86 1.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 110.084 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -139.73 126.41 20.57 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HA ' HG21 ' A' ' 96' ' ' THR . 27.9 mt-30 -70.37 94.98 0.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.165 0.507 . . . . 0.0 110.898 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -73.18 120.12 18.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.553 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.66 119.52 15.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.693 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.9 mt -73.49 139.74 45.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.99 159.01 15.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.205 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.669 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 58.3 Cg_exo -51.86 -41.11 64.72 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.185 2.59 . . . . 0.0 112.04 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.43 ' CD ' HH22 ' A' ' 109' ' ' ARG . 31.1 tp10 -52.51 -28.67 21.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.42 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.23 -42.76 8.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.512 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.5 m -87.26 -11.34 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -168.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.669 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 27.7 mtm-85 -50.9 -53.99 41.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 50.6 Cg_exo -55.01 -37.47 93.82 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.991 1.794 . . . . 0.0 112.781 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.48 HD13 HG21 ' A' ' 118' ' ' VAL . 98.1 mt -79.73 -34.84 39.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.879 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 75.5 mt -68.72 -34.09 75.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.32 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.88 78.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.43 -41.42 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.367 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.03 15.68 7.72 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.371 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.93 117.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.18 102.9 1.86 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.826 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 92' ' ' LEU . 41.3 t -102.89 121.73 54.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.631 0.253 . . . . 0.0 110.564 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.18 140.29 52.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.449 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -114.39 125.89 54.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 111.437 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.463 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.8 mtm -144.61 177.31 8.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.489 ' HA ' ' H ' ' A' ' 97' ' ' GLY . 19.9 m-20 -72.38 154.46 40.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.746 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.517 HG23 HD22 ' A' ' 144' ' ' LEU . 28.7 m -47.65 -53.31 15.24 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.846 0.717 . . . . 0.0 112.61 -174.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.48 -46.27 89.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 0.0 111.605 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.45 79.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.272 -177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.03 76.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.35 84.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.324 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -59.35 -51.06 71.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.202 0.525 . . . . 0.0 109.958 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 -36.29 83.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.499 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.434 ' OH ' ' HA ' ' A' ' 36' ' ' ALA . 87.7 t80 -58.68 -45.06 90.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.748 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -60.06 -41.24 91.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.319 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.94 -48.28 89.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.815 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.73 -31.19 72.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.025 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.7 ttp -64.59 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.265 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.91 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.822 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 138' ' ' ARG . 38.4 tt0 -74.71 -22.07 59.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.911 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.05 27.48 49.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.34 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.426 ' HD2' ' OE1' ' A' ' 136' ' ' GLU . 15.7 ttt180 -87.33 149.14 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.249 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.681 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 48.3 ttt85 -79.9 85.15 5.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.483 0.658 . . . . 0.0 109.285 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.465 HG23 HG13 ' A' ' 91' ' ' VAL . 4.8 p -120.46 132.98 68.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.009 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 89' ' ' PRO . 40.0 t -115.24 134.21 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 9.9 p -117.71 130.82 72.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.933 0.397 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.35 106.06 14.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.562 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.517 HD22 HG23 ' A' ' 123' ' ' THR . 92.5 mt -106.4 128.5 54.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.639 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 96' ' ' THR . 78.2 mt -87.5 151.29 50.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.861 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HB2' HH21 ' A' ' 98' ' ' ARG . 27.5 Cg_exo -62.6 158.28 42.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.557 2.171 . . . . 0.0 112.075 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.16 -40.93 64.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 165.4 -5.51 0.06 OUTLIER Glycine 0 C--N 1.32 -0.338 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.803 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.631 ' HB2' ' CE1' ' A' ' 154' ' ' HIS . 4.8 m-20 64.46 24.93 13.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.008 0.523 . . . . 0.0 110.447 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -16.25 63.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.13 -13.53 59.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.254 0.55 . . . . 0.0 110.295 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -112.31 171.18 7.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.774 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.59 ' HB3' ' O ' ' A' ' 155' ' ' HIS . 52.3 m80 -112.88 111.29 21.95 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.858 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.631 ' CE1' ' HB2' ' A' ' 149' ' ' ASP . 81.0 m80 -57.14 -42.59 81.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.43 0.633 . . . . 0.0 109.35 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.59 ' O ' ' HB3' ' A' ' 153' ' ' HIS . 37.9 m-70 -118.81 155.9 30.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 170.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -77.27 43.14 0.36 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.871 0.843 . . . . 0.0 110.817 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.449 ' H ' ' C ' ' A' ' 155' ' ' HIS . 82.2 m-70 -144.26 -42.34 0.26 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.492 -1.231 . . . . 0.0 107.815 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.8 t60 . . . . . 0 C--O 1.249 1.05 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.276 178.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -104.41 130.95 52.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.76 171.18 14.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.191 0.52 . . . . 0.0 111.483 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -87.21 104.93 16.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.136 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.0 p -111.54 103.62 11.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.005 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.47 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 6.9 p-10 -75.37 118.68 72.56 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.482 . . . . 0.0 110.054 177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 3.4 Cg_exo -78.95 85.62 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.19 2.593 . . . . 0.0 113.014 -173.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.464 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -63.89 -20.65 65.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.313 0.578 . . . . 0.0 110.448 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -75.25 -8.23 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.688 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.12 14.61 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 8' ' ' ALA . 80.0 mt -85.41 91.56 8.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -77.84 86.83 4.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.279 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 m -116.25 140.44 49.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.571 ' HA ' HG22 ' A' ' 24' ' ' VAL . 48.6 t -60.62 112.91 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -74.9 -53.33 9.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.517 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -140.34 157.12 46.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.153 0.501 . . . . 0.0 111.258 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -110.01 118.41 36.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.74 156.95 15.65 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.322 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.9 92.49 0.51 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.64 11.43 55.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.105 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -161.13 150.23 16.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.135 0.467 . . . . 0.0 111.159 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 29' ' ' PHE . 61.6 mt -96.94 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -118.08 114.83 23.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.037 0.446 . . . . 0.0 110.151 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.571 HG22 ' HA ' ' A' ' 14' ' ' VAL . 40.4 t -129.77 113.04 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.669 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.1 t30 60.14 38.53 20.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.362 0.601 . . . . 0.0 110.298 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 68.59 17.43 8.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.014 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.91 112.85 36.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 28' ' ' ARG . 24.0 ttt85 -72.81 110.79 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.131 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 66.0 m-85 -102.51 98.08 8.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.198 0.523 . . . . 0.0 110.638 175.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -99.83 28.9 4.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.269 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -148.03 156.4 42.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.45 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 44' ' ' TRP . . . -60.63 136.86 58.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.433 0.458 . . . . 0.0 111.386 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.2 pt -138.04 150.16 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.309 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -135.28 125.8 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.843 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 41.8 p90 -147.89 157.46 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.234 0.54 . . . . 0.0 111.789 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -132.19 155.35 81.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.244 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.58 -22.73 57.93 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.74 2.293 . . . . 0.0 112.538 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -116.53 22.71 12.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.59 0.71 . . . . 0.0 109.284 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -177.71 17.45 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.039 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -89.83 -171.41 0.5 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.083 2.522 . . . . 0.0 112.297 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.4 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 40.8 t -111.29 114.79 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.01 151.97 22.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.907 0.384 . . . . 0.0 111.191 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -91.41 126.3 36.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.245 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -101.34 119.78 56.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.113 -176.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.6 Cg_exo -78.79 22.63 0.65 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.439 2.759 . . . . 0.0 113.248 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HD13 ' A' ' 56' ' ' LEU . 88.5 t -91.77 132.18 36.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -105.53 -51.22 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.255 0.55 . . . . 0.0 110.939 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -116.89 138.92 25.11 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.148 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HB2' ' HB3' ' A' ' 101' ' ' HIS . 43.9 Cg_endo -67.19 -11.14 31.11 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.939 2.426 . . . . 0.0 112.832 -176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.73 -15.42 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.18 63.9 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.654 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.96 100.21 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.974 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.43 ' H ' HD12 ' A' ' 56' ' ' LEU . 2.2 m -89.04 159.42 17.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.51 68.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.93 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 m -60.06 -36.82 78.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 46' ' ' VAL . 81.9 mt -67.75 -36.15 80.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 110.097 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 111' ' ' LEU . 97.2 mt -68.2 -37.9 81.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.852 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.26 -39.62 91.04 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.023 0.439 . . . . 0.0 110.492 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -64.65 -40.72 95.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.722 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.86 -20.62 63.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.27 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -82.11 -5.82 58.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.5 15.29 81.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.699 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.9 mt -73.04 -3.29 25.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.947 0.403 . . . . 0.0 111.442 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.53 -11.57 59.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.731 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.62 -41.43 92.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.159 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.16 -11.28 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 111.297 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.4 t -85.94 -20.87 7.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.054 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -65.63 -45.54 82.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.472 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -149.3 114.24 3.58 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.119 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.54 8.29 1.27 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.022 2.481 . . . . 0.0 113.118 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.4 tp -77.4 -24.67 50.49 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.33 91.22 8.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.282 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' O ' ' HB3' ' A' ' 77' ' ' PRO . 99.1 m-85 -74.17 140.05 44.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.909 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.95 -34.55 38.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.58 0.705 . . . . 0.0 109.2 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -100.97 123.59 45.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.82 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 61.67 67.72 1.28 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 121.486 0.66 . . . . 0.0 110.359 -172.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 73' ' ' PHE . 86.8 Cg_endo -90.2 156.08 4.68 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.915 2.41 . . . . 0.0 112.866 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.02 -9.52 59.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.353 0.597 . . . . 0.0 109.795 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.95 100.7 9.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.935 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.57 168.04 12.77 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.889 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.73 88.34 4.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.84 0.352 . . . . 0.0 111.389 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.47 -149.51 47.01 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.623 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.03 142.37 27.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -110.73 129.24 24.16 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.973 -174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.48 -36.78 84.96 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.721 2.281 . . . . 0.0 111.353 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.84 66.1 5.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -55.36 -44.59 76.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.542 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -108.7 171.83 4.18 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.877 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 80.8 Cg_exo -47.46 124.9 10.03 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.497 2.132 . . . . 0.0 112.07 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 39.2 mt-10 -66.16 -45.47 80.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.475 HG13 HG23 ' A' ' 140' ' ' VAL . 4.0 p -134.72 133.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.248 0.547 . . . . 0.0 111.278 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.38 121.97 42.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.618 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.2 mt -105.58 109.87 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.891 0.377 . . . . 0.0 110.495 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.49 121.74 45.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.18 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -93.3 106.76 3.45 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 24.8 p -59.98 -49.82 76.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.735 0.414 . . . . 0.0 111.915 -175.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.28 -78.03 0.57 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.255 -0.497 . . . . 0.0 113.146 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -69.65 -38.19 77.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.595 ' O ' ' HB ' ' A' ' 96' ' ' THR . 44.7 ttm-85 -166.77 140.73 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.63 0.253 . . . . 0.0 110.81 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.536 ' HA ' HG21 ' A' ' 96' ' ' THR . 90.0 mt-30 -70.73 105.32 3.15 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . 51.3 t-80 -117.98 111.25 18.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.85 130.34 40.8 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.61 151.88 40.71 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.97 165.31 13.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.264 -176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.6 Cg_endo -56.46 -31.19 84.98 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.173 2.582 . . . . 0.0 112.709 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -67.09 -25.76 66.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.155 0.502 . . . . 0.0 110.705 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -96.36 -23.27 16.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.738 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 26.7 m -106.7 -7.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.732 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 39.9 ttp-105 -53.62 -55.2 37.62 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 38.5 Cg_exo -58.07 -32.99 96.82 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.987 1.791 . . . . 0.0 112.333 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.761 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.3 mt -78.09 -33.91 50.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 90.0 mt -61.08 -38.34 85.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 109.932 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.13 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.198 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 64.4 mtt -89.53 -33.07 16.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.659 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.04 18.48 5.5 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.268 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 25.8 t -93.14 114.48 29.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.727 0.299 . . . . 0.0 111.098 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.44 102.37 2.71 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.1 t -95.69 122.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.814 0.34 . . . . 0.0 111.489 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -120.6 146.33 46.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.061 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.24 119.6 32.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.988 0.423 . . . . 0.0 110.682 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.459 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 64.9 mtm -142.74 175.05 10.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.47 163.29 25.65 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.832 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.2 m -50.77 -52.79 37.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.399 -173.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.46 -43.89 96.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.639 0.257 . . . . 0.0 111.284 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.79 99.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.971 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.91 71.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.96 89.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.793 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttp-105 -67.63 -46.52 72.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 0.0 110.653 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.6 m -65.89 -31.49 72.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.292 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.49 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 75.6 t80 -59.0 -45.59 90.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.387 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -64.15 -41.63 97.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.53 -47.11 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.654 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.418 HD13 HG11 ' A' ' 91' ' ' VAL . 97.5 mt -68.98 -28.26 66.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.33 -47.43 70.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.218 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.59 -25.41 66.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.553 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.43 -12.32 60.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.276 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.32 34.86 57.24 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.122 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.487 ' HE ' ' CD ' ' A' ' 90' ' ' GLU . 6.8 tpt180 -105.58 153.11 22.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.694 0.283 . . . . 0.0 110.323 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -82.6 91.12 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.789 0.804 . . . . 0.0 111.144 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG23 HG13 ' A' ' 91' ' ' VAL . 7.2 p -118.1 142.97 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.705 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 36' ' ' ALA . 39.4 t -122.31 141.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 11.4 p -120.39 138.45 50.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 110.855 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.76 107.76 10.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.434 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.6 mt -104.13 129.89 51.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.689 0.281 . . . . 0.0 111.694 -172.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -101.74 105.94 44.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 30.0 Cg_endo -94.07 -153.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.311 2.674 . . . . 0.0 111.328 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.18 -175.94 3.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.79 -29.4 0.38 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.78 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -69.4 -20.88 63.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.589 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.6 p -71.73 -35.47 70.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.742 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.1 mt -90.71 89.86 7.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.104 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -81.73 110.34 16.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.531 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -94.37 157.79 15.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.781 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -71.37 -16.62 62.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.623 0.249 . . . . 0.0 111.505 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -67.79 -14.59 63.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.2 0.524 . . . . 0.0 110.159 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -101.03 174.79 5.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.587 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -138.09 108.74 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.113 -174.76 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.794 0.33 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -143.47 159.01 43.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -101.14 158.7 15.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.974 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -74.37 -34.78 63.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.3 p -107.11 150.81 26.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.34 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.58 102.15 52.63 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.319 172.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.72 -58.68 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.509 2.139 . . . . 0.0 111.588 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -118.77 98.01 6.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.277 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.4 p -64.78 -38.55 91.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.415 0.626 . . . . 0.0 109.684 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.64 170.7 15.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.82 174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.0 tp -128.37 99.81 5.56 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.425 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -69.2 107.01 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.104 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 m -133.22 135.64 45.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 24' ' ' VAL . 49.2 t -73.02 118.89 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -93.02 -75.14 0.5 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.894 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.64 98.25 11.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 0.0 110.66 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -86.14 114.98 23.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.196 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.87 168.52 19.0 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.29 -21.41 36.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.121 0.486 . . . . 0.0 110.134 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.56 -38.21 5.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.53 155.6 46.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 110.817 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -114.57 114.16 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.613 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 42.5 tt0 -99.33 116.21 30.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 14' ' ' VAL . 61.3 t -116.06 121.95 68.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.688 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 60.03 31.03 20.45 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.355 0.409 . . . . 0.0 110.506 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HA ' ' CD ' ' A' ' 23' ' ' GLU . 96.7 mt-30 71.16 14.47 6.66 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.57 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -104.8 116.75 49.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 99.0 mtt180 -93.31 116.49 29.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.86 0.362 . . . . 0.0 111.333 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.07 143.08 32.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.331 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.2 p -106.13 1.29 26.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.542 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -128.98 170.65 13.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.065 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -60.5 143.04 54.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.244 0.545 . . . . 0.0 112.355 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.99 144.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.702 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 120.03 26.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.465 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.8 162.19 36.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.19 0.519 . . . . 0.0 111.709 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -137.81 151.91 71.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.288 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.46 -45.09 36.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.731 2.287 . . . . 0.0 112.57 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' OE2' ' HG2' ' A' ' 139' ' ' ARG . 39.0 mt-10 -97.59 23.34 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.823 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.91 -170.84 11.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.22 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -90.05 -168.37 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.89 2.393 . . . . 0.0 112.316 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.34 117.72 56.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.658 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.07 123.21 35.26 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.233 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.1 t -77.52 113.13 15.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.718 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.19 117.94 64.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.85 25.47 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.903 2.402 . . . . 0.0 111.603 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 51' ' ' ASP . 83.9 t -86.16 122.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.272 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.686 HE22 HD13 ' A' ' 151' ' ' LEU . 89.5 mt-30 -92.74 -39.89 11.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.646 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -139.64 157.38 70.19 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.961 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.44 -11.72 11.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.23 2.62 . . . . 0.0 113.393 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.4 -21.47 60.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.583 ' HB2' HG13 ' A' ' 46' ' ' VAL . 63.1 m-20 -86.25 -5.12 59.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 145' ' ' LEU . 71.0 mt -74.41 125.46 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.035 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -141.25 175.34 9.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.036 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -57.63 -45.65 85.15 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.1 m -56.4 -44.41 80.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.929 0.395 . . . . 0.0 111.425 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.62 -39.06 84.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.762 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.565 ' HB3' HD11 ' A' ' 111' ' ' LEU . 96.0 mt -66.09 -40.17 90.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.161 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -61.45 -46.91 88.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.453 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 98.9 mt-30 -63.19 -36.78 84.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.915 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.68 -32.44 73.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.047 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.63 5.7 8.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.18 -7.67 54.73 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.42 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.4 mt -82.42 25.64 0.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.011 0.434 . . . . 0.0 111.148 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 59' ' ' GLN . . . -87.15 -54.99 4.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.891 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -96.89 -8.38 30.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.219 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.66 142.09 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.403 HG11 HD13 ' A' ' 74' ' ' LEU . 28.8 m -58.15 133.26 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.163 0.506 . . . . 0.0 111.17 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 68' ' ' ARG . 25.2 ttt85 -88.31 -20.39 25.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.53 -176.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -114.76 93.09 32.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.196 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.83 -16.87 20.42 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.169 2.58 . . . . 0.0 112.619 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt -92.93 11.35 27.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.023 0.439 . . . . 0.0 110.742 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.89 161.81 14.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.76 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -81.71 -26.43 34.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.823 0.344 . . . . 0.0 110.117 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.403 HD13 HG11 ' A' ' 67' ' ' VAL . 66.8 mt 61.23 17.2 7.96 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.763 174.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.5 t70 64.08 18.0 10.97 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.374 0.607 . . . . 0.0 110.796 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -103.32 137.0 19.13 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.321 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.93 -30.34 5.99 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.55 2.166 . . . . 0.0 113.054 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -99.5 128.89 45.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.925 0.393 . . . . 0.0 110.858 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.05 150.53 41.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.16 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.25 -125.64 1.1 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.013 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.98 101.94 3.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.971 0.415 . . . . 0.0 110.526 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.36 -147.71 10.42 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.422 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.12 119.8 16.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.057 0.456 . . . . 0.0 111.117 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.543 ' HD2' ' HB3' ' A' ' 86' ' ' ALA . 6.1 ptp180 -130.18 153.67 81.21 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.68 -32.4 75.47 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.841 2.361 . . . . 0.0 112.614 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB3' ' HD2' ' A' ' 84' ' ' ARG . . . -72.63 -11.88 60.82 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.437 ' CG ' ' HG2' ' A' ' 84' ' ' ARG . 87.2 m-20 -81.33 -20.6 40.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.964 0.411 . . . . 0.0 109.975 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.81 146.98 91.35 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.899 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.3 162.45 7.75 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.095 2.53 . . . . 0.0 112.734 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 139' ' ' ARG . 9.5 mm-40 -72.87 -49.71 28.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 -175.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 12.8 p -148.22 145.52 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.227 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 117' ' ' GLY . 2.0 pt? -119.04 132.01 56.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.128 0.49 . . . . 0.0 110.107 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.77 123.44 41.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.108 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.6 109.13 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.513 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -85.34 108.71 3.23 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.616 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.8 p -69.09 -12.14 61.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.23 -85.31 0.71 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.286 -0.483 . . . . 0.0 114.001 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -61.6 -41.0 96.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.899 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.3 ptt85 -172.5 158.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.616 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 52.9 tt0 -62.52 137.7 58.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.577 . . . . 0.0 111.718 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -136.19 164.14 28.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.487 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.18 110.13 22.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.885 0.374 . . . . 0.0 110.423 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.6 mt -77.14 131.89 38.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -106.45 -176.78 23.32 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.103 -1.046 . . . . 0.0 114.172 -167.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.616 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 60.4 Cg_endo -72.18 3.75 3.81 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.774 2.982 . . . . 0.0 113.473 -173.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HA ' ' NH1' ' A' ' 109' ' ' ARG . 11.7 tp10 -96.94 -26.6 14.99 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -96.02 -50.94 4.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.505 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.691 ' HB ' HG11 ' A' ' 118' ' ' VAL . 33.5 m -91.56 5.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.649 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 42.0 ttp-105 -59.85 -52.32 74.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 76.7 Cg_exo -54.8 -29.77 64.31 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.166 1.91 . . . . 0.0 113.075 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 57' ' ' LEU . 58.7 mt -70.04 -49.0 55.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 109.86 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.8 mt -64.19 -32.54 74.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.36 -26.89 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.368 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.453 ' HE2' ' HA ' ' A' ' 111' ' ' LEU . 65.7 mtm -87.34 -33.48 19.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.857 0.361 . . . . 0.0 110.665 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.43 4.25 9.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.408 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.0 131.2 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -82.33 141.3 21.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.736 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' A' ' 108' ' ' VAL . 11.7 p -127.33 145.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 122.689 -0.301 . . . . 0.0 110.227 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.86 136.65 27.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.791 0.329 . . . . 0.0 110.632 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.48 127.52 46.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.796 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.501 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 32.8 ttm -147.2 161.75 40.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -174.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.97 159.97 31.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 m -50.5 -63.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.44 -44.19 95.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.723 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.35 89.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.89 94.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.573 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.71 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 132' ' ' ILE . 53.4 ttp180 -60.2 -55.84 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 15.8 m -60.51 -38.03 83.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.04 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.22 -49.6 76.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.994 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.15 -40.85 95.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.627 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 79.5 mt -60.56 -56.4 17.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.76 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.74 -31.69 72.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.8 ttp -66.22 -40.83 90.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.213 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.69 -35.45 72.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.66 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 9.1 mm-40 -61.69 -29.71 70.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.79 32.69 7.06 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.829 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -107.28 135.8 48.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.468 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 28.6 mtm180 -67.44 97.65 0.59 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.516 0.674 . . . . 0.0 110.869 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 7.4 p -123.78 139.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.333 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 36' ' ' ALA . 30.8 t -109.46 150.42 12.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.91 130.98 55.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.006 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.31 120.71 39.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.237 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.76 127.37 53.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.897 0.38 . . . . 0.0 111.55 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 52' ' ' ILE . 68.5 mt -99.64 116.64 64.69 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.575 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 72.2 Cg_endo -77.87 150.76 27.27 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.616 2.211 . . . . 0.0 112.815 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -76.52 125.76 29.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.635 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.69 -24.73 0.31 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.458 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 59.06 75.77 0.38 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.507 0.67 . . . . 0.0 109.204 -172.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.6 p -80.18 86.3 5.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.895 -168.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.686 HD13 HE22 ' A' ' 47' ' ' GLN . 51.9 tp -110.47 90.23 3.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 166.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.15 126.68 31.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.239 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -72.22 130.58 41.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.846 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -64.68 -37.45 87.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.701 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -116.78 113.48 22.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.288 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -90.2 153.91 20.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -97.53 -45.96 6.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.82 176.348 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.486 0.184 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.56 145.61 40.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.376 . . . . 0.0 110.481 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.94 176.94 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.264 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -77.4 -42.41 36.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.4 0.619 . . . . 0.0 109.357 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.9 m -114.83 154.95 27.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.371 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 70.17 89.64 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 123.636 0.585 . . . . 0.0 110.678 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.13 -10.98 19.53 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.546 2.164 . . . . 0.0 112.206 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.66 116.59 16.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.409 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 m -107.01 156.22 18.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.214 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.63 1.26 6.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.031 0.444 . . . . 0.0 111.513 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -100.21 141.07 33.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.938 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -114.02 112.35 23.13 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m -130.6 143.6 50.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.999 0.428 . . . . 0.0 111.618 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.3 139.35 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.606 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 p -99.1 -40.02 8.21 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.731 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -140.23 116.71 10.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 111.715 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -105.47 104.33 14.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.04 -169.68 14.44 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.124 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.19 94.03 3.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.992 0.425 . . . . 0.0 110.809 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.81 60.35 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.261 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -125.56 152.16 45.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.038 0.419 . . . . 0.0 110.992 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.28 124.6 60.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.891 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 36.9 tt0 -111.59 122.56 48.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 111.339 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.42 115.19 49.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.051 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.39 -78.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.467 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -138.42 -1.1 1.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.458 0.17 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.58 121.89 68.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.792 0.329 . . . . 0.0 111.198 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.2 ptp180 -97.84 123.37 41.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.292 0.568 . . . . 0.0 110.334 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.43 137.35 37.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.198 -174.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -94.73 17.31 13.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.37 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -147.25 167.78 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.929 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . . . -61.56 146.95 47.13 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.483 0.489 . . . . 0.0 111.466 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 pt -141.78 147.08 22.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.084 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.76 124.97 40.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.821 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -147.95 161.33 41.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.52 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -136.56 160.74 65.47 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.619 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.56 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 11.3 Cg_endo -56.03 -48.67 18.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.728 2.285 . . . . 0.0 111.941 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -111.71 86.97 2.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.97 178.8 41.76 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.058 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -90.22 143.2 3.85 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.025 2.483 . . . . 0.0 113.076 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.86 114.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 172.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.58 154.47 30.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.556 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.1 m -87.25 143.14 27.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.004 0.431 . . . . 0.0 110.275 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 t90 -111.88 121.63 39.16 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 9.8 Cg_exo -72.54 46.99 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.526 2.818 . . . . 0.0 113.409 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 HD13 ' A' ' 56' ' ' LEU . 92.0 t -122.19 115.96 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.17 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -82.98 -32.1 27.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.0 110.159 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -160.3 158.57 25.94 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.036 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HA ' HG13 ' A' ' 52' ' ' ILE . 17.5 Cg_exo -68.44 33.94 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.964 3.109 . . . . 0.0 114.414 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.68 -27.48 15.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.634 0.254 . . . . 0.0 110.934 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -111.96 7.18 19.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.503 HG13 ' HA ' ' A' ' 49' ' ' PRO . 54.6 mt -61.74 109.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.157 0.504 . . . . 0.0 110.822 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 p -127.89 175.99 7.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.788 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -59.4 -43.69 92.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.82 -175.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -58.21 -42.72 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.786 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.449 HD13 HG22 ' A' ' 46' ' ' VAL . 93.8 mt -67.93 -36.56 80.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.735 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.0 -37.38 85.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.319 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 98.2 mt-30 -58.08 -42.69 86.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.999 0.428 . . . . 0.0 110.443 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.72 -39.76 84.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.271 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.6 -18.0 52.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.11 -20.39 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.33 45.3 30.96 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.65 -22.11 34.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.056 0.455 . . . . 0.0 110.555 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.8 109.74 22.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.391 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.28 106.52 15.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.31 0.576 . . . . 0.0 110.056 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.41 112.8 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.772 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.96 -174.08 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.333 171.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 65.4 ttp85 -96.04 -3.74 44.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.473 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 68' ' ' ARG . 21.6 t70 71.59 99.46 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.722 176.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -92.19 143.72 2.66 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.141 2.561 . . . . 0.0 112.167 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.13 -36.59 61.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.153 0.501 . . . . 0.0 110.074 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.87 87.74 7.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.001 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -69.82 114.33 7.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.41 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.3 mt -103.86 156.62 17.68 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.803 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -77.56 -38.58 48.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.584 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.488 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 4.4 tp10 66.81 116.71 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.612 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 76' ' ' GLU . 10.5 Cg_endo -55.05 121.64 10.26 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.715 2.277 . . . . 0.0 111.501 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.44 103.62 9.49 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.468 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.5 152.09 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.126 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.48 -6.68 77.01 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.517 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.93 -26.99 64.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 0.0 110.896 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.21 -38.35 2.58 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.757 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 71.78 -69.05 0.2 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.705 0.802 . . . . 0.0 110.988 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 5.2 ptp180 -130.17 107.18 16.32 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.517 . . . . 0.0 110.014 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 4.5 Cg_endo -87.19 123.01 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.579 2.853 . . . . 0.0 112.691 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 62.41 92.77 0.06 Allowed 'General case' 0 N--CA 1.463 0.217 0 O-C-N 123.872 0.732 . . . . 0.0 111.363 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.94 -36.87 85.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.948 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.26 125.21 90.7 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.568 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.19 154.39 74.44 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.792 2.328 . . . . 0.0 112.516 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.48 -42.7 58.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.476 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 140' ' ' VAL . 3.6 p -135.33 139.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.327 0.584 . . . . 0.0 111.899 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 141' ' ' VAL . 51.1 tp -118.11 122.49 43.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.5 mt -104.27 121.72 43.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.741 0.305 . . . . 0.0 110.619 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.37 113.36 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.26 89.76 1.01 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.237 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.52 31.96 4.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.872 0.368 . . . . 0.0 111.234 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -72.37 -15.08 77.08 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.225 -175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -83.14 -21.96 33.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.41 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 10.8 tpt180 -168.77 90.95 0.25 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -56.99 106.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.281 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -115.05 99.71 7.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.73 111.7 1.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.218 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 97.6 mt -68.38 133.19 48.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.255 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.05 21.53 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.631 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 12.9 Cg_endo -55.12 -47.16 27.87 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.509 2.806 . . . . 0.0 112.938 -174.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.67 -25.4 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.769 0.319 . . . . 0.0 111.634 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 103' ' ' LEU . 97.2 mt-30 -78.13 -40.98 36.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 29.0 m -101.24 4.19 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.577 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.518 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 32.8 ttp180 -54.26 -48.9 93.13 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 53.6 Cg_exo -53.49 -34.27 71.4 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.098 1.865 . . . . 0.0 112.59 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 84.6 mt -86.55 -34.32 19.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.878 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 80.2 mt -63.78 -34.25 77.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.908 0.385 . . . . 0.0 110.157 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.29 -13.11 62.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.115 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -100.82 -25.33 14.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.971 0.415 . . . . 0.0 110.509 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.03 18.64 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.05 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.7 t -94.78 118.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.99 111.24 3.63 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.672 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.71 119.06 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -108.45 118.67 37.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.998 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.58 106.93 17.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.689 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 40.5 ttm -134.49 163.68 29.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.103 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.96 149.64 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.455 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 9.7 m -60.21 -47.0 87.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.76 0.315 . . . . 0.0 111.376 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -69.93 -40.56 75.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 110.576 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.46 95.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.971 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.4 83.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.97 88.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -64.03 -41.14 97.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.542 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.9 m -63.52 -43.79 96.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.464 ' CE1' ' HD3' ' A' ' 37' ' ' PRO . 73.2 t80 -57.08 -41.86 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -58.48 -47.13 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.05 -45.6 90.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.718 HD22 ' HD2' ' A' ' 138' ' ' ARG . 87.0 mt -64.21 -34.58 78.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.56 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 50.8 ttp -67.52 -34.28 76.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.345 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.76 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.07 -23.1 61.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.033 0.444 . . . . 0.0 110.415 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.55 31.58 15.64 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.149 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.718 ' HD2' HD22 ' A' ' 133' ' ' LEU . 45.8 mtt180 -83.43 152.46 24.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.797 0.332 . . . . 0.0 110.922 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -83.18 93.02 7.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.891 0.853 . . . . 0.0 109.494 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 91' ' ' VAL . 3.7 p -125.77 133.87 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.33 -177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 36' ' ' ALA . 33.5 t -111.96 133.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.2 p -116.65 130.15 71.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.202 0.525 . . . . 0.0 110.906 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -109.95 109.49 20.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.453 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.65 129.87 46.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.479 HD13 ' HG3' ' A' ' 49' ' ' PRO . 87.8 mt -103.65 117.34 60.12 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.439 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 84.2 Cg_endo -86.25 -158.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.02 2.48 . . . . 0.0 111.856 177.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.36 -163.08 0.83 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.62 -7.86 0.14 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -121.48 -46.33 2.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 110.316 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.76 -36.51 73.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.5 tp -78.85 82.56 5.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.304 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -94.31 137.0 33.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.826 -175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -100.6 100.59 11.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.76 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -67.49 142.31 56.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -75.59 12.12 1.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -89.5 -3.89 58.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 166.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -119.79 -162.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.534 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.8 t60 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.09 177.024 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.952 0.406 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -111.3 99.84 8.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.73 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.588 ' HG ' ' H ' ' A' ' 5' ' ' THR . 33.9 tp -130.61 136.4 48.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.839 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -86.99 -3.16 59.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.745 0.307 . . . . 0.0 111.014 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.588 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 7.4 m -71.18 -27.05 63.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.411 0.624 . . . . 0.0 109.778 173.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.08 137.53 68.94 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.348 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.89 127.98 20.85 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.408 2.072 . . . . 0.0 111.588 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.1 109.66 0.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.6 m -61.97 130.79 47.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.388 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.47 88.4 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.127 0.489 . . . . 0.0 111.083 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.93 100.94 12.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.013 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.408 ' HA ' ' OD1' ' A' ' 25' ' ' ASN . 88.3 m-20 -64.35 109.38 1.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.033 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 m -117.6 133.09 56.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -66.17 110.32 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.552 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 m -82.77 -44.74 15.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.41 150.59 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.042 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -128.36 128.58 44.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.03 -169.02 12.64 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.857 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.49 -61.2 1.91 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.277 0.561 . . . . 0.0 110.94 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.75 25.08 15.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.737 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -155.13 138.88 16.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.602 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -120.79 120.96 63.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 39.1 tt0 -96.03 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.267 -176.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.51 128.31 66.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 12' ' ' ASN . 7.8 m-20 61.27 30.16 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 110.213 -177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 69.22 15.53 8.58 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.732 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.26 121.72 62.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 93.2 mtt180 -87.36 111.76 21.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.004 0.43 . . . . 0.0 111.581 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.58 124.0 45.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.042 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -97.98 22.55 9.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.978 0.418 . . . . 0.0 111.332 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -151.39 171.82 16.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.473 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.85 135.91 57.67 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.604 0.565 . . . . 0.0 111.623 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.67 144.81 26.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.107 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.07 122.18 35.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.519 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 37.7 p90 -143.78 153.51 42.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.102 0.477 . . . . 0.0 111.708 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.48 158.53 68.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.052 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -58.68 135.22 65.82 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.255 1.97 . . . . 0.0 111.62 173.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 70.02 16.86 7.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.162 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.18 169.46 22.98 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.5 177.24 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.129 . . . . 0.0 112.221 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 43.1 t -102.81 102.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.35 134.42 35.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.09 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -77.7 118.89 20.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.035 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -98.18 120.31 59.99 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.673 -175.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.3 Cg_exo -77.19 26.56 0.45 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.348 2.699 . . . . 0.0 112.99 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 51' ' ' ASP . 79.5 t -103.19 110.92 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.673 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.406 ' HA ' HD21 ' A' ' 145' ' ' LEU . 23.9 mt-30 -113.72 -13.88 12.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.318 0.58 . . . . 0.0 109.566 174.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.071 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 37.2 mtp-105 -101.83 135.25 19.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.44 -33.57 93.92 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.596 2.198 . . . . 0.0 112.319 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.11 9.54 39.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.456 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 1.071 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 3.6 t70 -85.09 -25.88 27.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.206 0.527 . . . . 0.0 110.13 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.9 109.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.565 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.0 m -112.35 155.53 23.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.168 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.542 ' HB1' ' HG2' ' A' ' 110' ' ' PRO . . . -56.68 -38.18 71.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 t -57.34 -42.79 82.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.712 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.82 -27.48 64.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' HD11 ' A' ' 111' ' ' LEU . 95.8 mt -71.3 -35.07 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.386 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.102 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -66.34 -43.93 84.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.367 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 -19.33 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.913 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.3 -5.93 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.38 82.55 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.127 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.8 mt -84.01 35.21 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.358 0.599 . . . . 0.0 110.97 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.28 -17.67 14.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.96 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -103.34 161.47 13.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.39 . . . . 0.0 110.908 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.09 141.11 46.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.297 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.4 153.85 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -54.85 132.88 47.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.856 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.62 121.21 83.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.926 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.42 100.56 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.869 2.379 . . . . 0.0 111.943 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.5 -39.41 74.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.178 0.514 . . . . 0.0 109.784 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.88 64.38 3.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.731 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -84.79 156.56 21.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.225 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.591 ' HG ' ' H ' ' A' ' 76' ' ' GLU . 52.6 tp -66.63 134.62 52.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.732 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -67.04 -16.02 64.09 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.187 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.591 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 42.4 mt-10 -115.66 85.19 13.57 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.872 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.59 2.81 8.29 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.055 2.503 . . . . 0.0 112.394 -176.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -100.59 101.26 12.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.49 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.65 169.13 15.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.46 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.81 71.48 2.56 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.318 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -156.34 125.4 6.05 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.79 57.59 4.79 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.439 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.44 169.38 20.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.606 ' HD2' ' H ' ' A' ' 84' ' ' ARG . 0.1 OUTLIER -71.02 126.74 92.1 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.999 176.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.95 28.37 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.231 2.62 . . . . 0.0 113.526 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.64 -2.84 47.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.564 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 87' ' ' ASN . 7.2 m120 57.65 37.73 27.47 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.093 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.52 143.65 74.27 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.708 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 18.5 Cg_endo -57.77 134.43 62.73 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 123.052 2.502 . . . . 0.0 113.013 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -67.29 -36.82 82.32 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.514 HG13 HG23 ' A' ' 140' ' ' VAL . 6.0 p -139.76 135.78 39.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.993 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.6 tp -111.67 120.6 42.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.193 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 119' ' ' GLU . 94.9 mt -102.08 112.2 24.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.864 0.364 . . . . 0.0 110.895 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.85 113.61 35.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.959 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -97.77 97.07 1.89 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 p -106.67 56.17 0.65 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.155 0.502 . . . . 0.0 110.931 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.729 ' HA3' HG22 ' A' ' 123' ' ' THR . . . -64.07 -28.54 72.99 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.536 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' CZ ' ' HA3' ' A' ' 148' ' ' GLY . 61.3 ttt180 -63.0 -38.72 92.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.249 0.547 . . . . 0.0 110.768 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -170.44 95.06 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -61.23 128.09 34.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.798 -168.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -107.77 120.93 43.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.833 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.8 tp -80.1 103.18 9.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.91 145.92 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.031 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 173.77 20.1 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.747 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.622 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 54.2 Cg_exo -52.29 -49.34 17.71 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.543 2.829 . . . . 0.0 113.155 -175.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -70.09 -34.51 73.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.863 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -68.52 -30.27 69.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.88 -8.73 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 85.7 mtt180 -54.22 -52.49 68.4 Favored Pre-proline 0 N--CA 1.466 0.344 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.542 ' HG2' ' HB1' ' A' ' 54' ' ' ALA . 79.1 Cg_exo -50.96 -34.11 44.8 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.387 2.058 . . . . 0.0 113.173 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 80.0 mt -89.73 -37.99 14.16 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.146 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.3 mt -60.89 -34.44 74.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.776 0.322 . . . . 0.0 110.694 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.16 -24.06 65.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.092 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.4 mtt -90.67 -9.85 45.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.382 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.19 10.68 54.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.252 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.6 t -94.59 113.55 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.674 0.273 . . . . 0.0 110.537 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.12 118.78 4.78 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.618 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.56 117.18 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.449 ' HB2' HD23 ' A' ' 93' ' ' LEU . 27.6 mm-40 -114.33 110.1 19.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.195 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.18 110.73 22.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 67.4 mtm -138.56 -171.85 3.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.813 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.06 154.33 39.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.941 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.729 HG22 ' HA3' ' A' ' 97' ' ' GLY . 5.0 t -62.94 -45.79 90.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.777 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -74.7 -38.05 62.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.71 94.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.696 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.96 78.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.727 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.23 88.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -63.74 -48.27 77.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.374 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 m -66.13 -39.32 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.11 -44.23 91.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.801 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.61 -50.1 71.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.138 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.35 -48.85 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD13 HG11 ' A' ' 91' ' ' VAL . 96.9 mt -65.52 -35.37 80.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.344 -177.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.67 -33.78 74.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.809 0.338 . . . . 0.0 110.097 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.76 -26.17 65.99 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.67 -24.97 58.89 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.133 0.492 . . . . 0.0 110.413 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.13 18.69 53.07 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 40.4 ttm-85 -81.42 154.17 26.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.395 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB3' ' HA ' ' A' ' 89' ' ' PRO . 37.4 mmt180 -79.23 99.07 6.88 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.674 0.75 . . . . 0.0 110.742 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.514 HG23 HG13 ' A' ' 91' ' ' VAL . 4.1 p -134.49 134.7 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.532 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 36' ' ' ALA . 26.4 t -116.66 137.33 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.23 136.23 58.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.071 0.463 . . . . 0.0 111.178 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.12 112.33 18.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.756 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -105.2 138.68 41.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 -175.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.465 HD11 HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -119.45 91.12 43.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.99 151.67 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.186 2.59 . . . . 0.0 113.213 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 t70 60.9 -169.54 0.16 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.966 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.448 ' HA3' ' CZ ' ' A' ' 98' ' ' ARG . . . 159.14 -48.91 0.41 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.203 177.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.55 152.21 46.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.068 0.461 . . . . 0.0 111.211 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.1 m -131.97 176.4 8.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.815 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.04 -44.42 97.42 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.196 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.75 64.54 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.019 0.438 . . . . 0.0 111.71 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -79.58 99.27 7.24 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 170.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -68.98 133.45 48.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -77.77 102.1 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 165.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -76.89 69.18 3.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -161.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -101.34 -6.48 24.04 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 154.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.7 p80 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 112.714 -2.039 . . . . 0.0 108.234 172.047 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.044 0.45 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -102.58 129.65 49.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.9 133.37 45.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -62.97 -48.31 79.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.8 m -155.89 114.6 3.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.041 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.91 126.85 83.34 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.022 0.439 . . . . 0.0 110.783 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -90.35 -178.91 1.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.041 2.494 . . . . 0.0 112.134 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.76 133.1 35.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.459 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 11' ' ' LEU . 21.1 m -76.56 128.03 33.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.412 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -10.79 59.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.534 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.66 ' H ' HG22 ' A' ' 9' ' ' THR . 89.8 mt -110.16 71.56 0.76 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.184 0.516 . . . . 0.0 110.136 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -64.62 107.11 1.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.4 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 m -131.24 150.16 52.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.745 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.7 t -71.56 129.84 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.1 p -85.67 -33.73 21.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.711 0.291 . . . . 0.0 111.54 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -145.26 112.34 6.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.58 0.229 . . . . 0.0 110.476 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -70.38 -38.22 74.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.869 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.9 -163.6 44.33 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.781 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.01 -74.84 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.202 0.525 . . . . 0.0 110.277 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.93 31.99 7.48 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.469 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.45 119.25 2.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.8 mt -100.4 110.07 26.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 36.7 tt0 -97.95 112.62 24.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 110.543 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.07 109.65 29.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.81 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 62.97 43.57 6.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.654 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 70.48 12.04 7.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.819 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -106.04 113.04 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttm105 -90.72 112.84 24.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.346 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -98.45 117.56 33.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.686 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 55.5 m -93.9 10.53 32.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -148.2 -179.34 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.362 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.74 146.33 46.3 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.22 148.46 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.573 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -128.3 131.14 48.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.599 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.04 158.2 38.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.312 0.577 . . . . 0.0 111.789 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -131.51 161.87 59.54 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.547 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.83 -46.36 33.9 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.374 2.049 . . . . 0.0 110.981 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -118.27 96.05 5.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.022 172.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.83 178.64 41.03 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.67 138.97 7.43 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.568 2.178 . . . . 0.0 112.718 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.26 103.02 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.2 121.85 42.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.481 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -66.94 120.74 14.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -97.88 127.21 37.93 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -170.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.4 Cg_exo -70.09 3.99 2.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.408 2.739 . . . . 0.0 113.033 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 51' ' ' ASP . 84.7 t -86.14 134.96 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.71 ' HG3' ' HG3' ' A' ' 48' ' ' ARG . 50.0 tp60 -107.16 -41.48 5.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.146 0.498 . . . . 0.0 110.155 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.71 ' HG3' ' HG3' ' A' ' 47' ' ' GLN . 63.5 mtt180 -129.5 156.09 79.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.607 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.64 0.11 2.14 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.16 2.574 . . . . 0.0 113.172 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HB2' ' NH2' ' A' ' 99' ' ' ARG . . . -90.6 -17.23 27.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.148 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.552 ' HB2' HG13 ' A' ' 46' ' ' VAL . 43.5 m-20 -88.15 -16.29 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.048 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.67 114.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.667 -174.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 p -124.27 173.62 8.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.402 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.24 91.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.616 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -60.96 -42.25 97.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.417 0.627 . . . . 0.0 110.797 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.466 HD13 HG22 ' A' ' 46' ' ' VAL . 87.5 mt -71.56 -28.85 64.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.856 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.95 -39.14 87.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.488 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -63.67 -37.93 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.3 -44.84 74.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.27 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.529 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . -76.68 -9.21 58.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.28 23.61 71.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.724 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -63.34 -49.46 73.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.974 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.98 81.37 6.87 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.993 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.93 -63.04 1.48 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.82 95.58 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.577 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 50.2 t -87.28 105.15 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.496 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -106.0 131.14 53.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.156 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.63 158.46 83.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.02 74.79 2.35 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.624 2.216 . . . . 0.0 113.088 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 71' ' ' LEU . 3.8 mm? -77.06 -42.37 38.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.3 74.63 0.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.461 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -86.53 162.11 18.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.766 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.7 mt -91.72 -167.6 1.82 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.462 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.22 -22.69 16.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.739 0.78 . . . . 0.0 109.012 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -76.21 142.94 72.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.821 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.11 -17.27 24.88 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.468 2.112 . . . . 0.0 111.105 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -100.47 95.01 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.2 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.17 2.33 55.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.147 0.498 . . . . 0.0 110.345 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.29 98.83 2.32 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.094 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.12 18.06 15.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.166 0.508 . . . . 0.0 110.441 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.82 32.13 41.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.749 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.08 101.04 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.019 0.438 . . . . 0.0 111.05 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 7.1 ptm180 -130.23 143.44 49.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.298 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 23.9 Cg_exo -63.96 145.83 90.52 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.466 2.111 . . . . 0.0 111.347 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.45 -24.14 66.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.951 0.405 . . . . 0.0 111.087 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -103.39 27.23 7.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.95 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.38 153.25 95.87 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.481 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 86.4 Cg_exo -47.6 132.44 20.57 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.247 2.631 . . . . 0.0 113.368 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.5 mt-10 -77.3 -43.03 34.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 117' ' ' GLY . 7.1 p -140.66 137.45 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.158 -177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 61' ' ' ALA . 45.1 tp -110.0 118.22 35.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.301 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.3 mt -98.06 120.85 39.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.866 0.365 . . . . 0.0 110.747 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.15 122.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.093 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -100.39 113.09 4.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.189 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 99' ' ' ARG . 22.2 p -83.76 -66.98 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.743 0.306 . . . . 0.0 111.678 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 -65.26 3.87 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.572 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.559 ' HD2' ' HA ' ' A' ' 147' ' ' ASP . 52.3 mtp85 -69.52 -37.6 77.2 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.769 -0.254 . . . . 0.0 111.217 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 96' ' ' THR . 13.7 ptt180 -161.19 138.47 8.95 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 170.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -81.08 91.5 6.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.391 0.615 . . . . 0.0 111.237 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -94.68 106.98 18.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.534 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.26 149.35 38.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.711 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.5 150.39 21.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.423 ' O ' HG22 ' A' ' 108' ' ' VAL . . . -105.95 165.48 13.87 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.468 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.51 -26.34 82.6 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 123.397 2.731 . . . . 0.0 113.36 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.69 -11.68 44.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.003 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.54 -45.68 8.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.281 0.563 . . . . 0.0 109.995 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 104' ' ' GLY . 27.0 m -90.79 16.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.499 0.666 . . . . 0.0 109.979 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.632 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 33.2 ttt180 -54.25 -52.95 64.37 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.801 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.9 Cg_exo -59.28 -40.51 67.84 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.961 1.774 . . . . 0.0 112.465 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 91.8 mt -73.94 -42.11 61.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.902 -176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.6 mt -61.45 -38.17 86.23 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.573 0.225 . . . . 0.0 110.955 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.32 -35.02 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 65.7 mtt -76.38 -29.83 57.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.646 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.95 10.82 13.42 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.99 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 55.7 t -92.12 113.27 27.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -80.33 130.01 9.48 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.567 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.2 124.04 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.988 0.394 . . . . 0.0 110.393 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -114.43 108.62 17.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.311 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.14 111.06 22.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 68.2 mtm -137.85 -171.65 3.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.56 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.25 152.14 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.873 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.548 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 7.7 t -63.77 -38.24 90.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.68 -37.25 42.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.234 0.54 . . . . 0.0 109.94 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.97 90.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.886 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.43 -40.75 70.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.008 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.0 84.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.424 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -72.76 -43.74 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.1 p -67.04 -32.22 73.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.469 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 79.7 t80 -57.56 -44.96 85.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.42 174.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.7 -36.39 84.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.54 -49.81 82.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.59 -30.46 71.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttm -65.72 -42.48 91.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.192 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.7 76.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.85 -16.75 60.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.775 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.39 51.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.206 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -93.25 167.63 11.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.803 0.335 . . . . 0.0 110.924 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.694 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 2.1 mmt180 -83.38 90.66 7.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.119 0.485 . . . . 0.0 109.872 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.4 135.84 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 36' ' ' ALA . 16.7 t -125.61 142.92 40.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.469 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 8.3 p -123.63 140.82 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.1 113.34 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.355 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 98.8 mt -104.11 133.94 48.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.338 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.69 103.99 51.32 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.058 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.31 153.57 40.45 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.969 2.446 . . . . 0.0 112.343 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.559 ' HA ' ' HD2' ' A' ' 98' ' ' ARG . 11.6 t70 -83.99 102.49 12.5 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.61 -4.94 1.14 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.136 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -55.58 -40.48 72.05 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.5 p -128.65 141.57 51.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.691 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.17 -45.74 12.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.42 104.58 7.01 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.029 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -90.18 123.24 33.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.311 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -137.26 117.91 13.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.522 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -78.85 126.61 30.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -78.81 0.59 26.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.641 0.734 . . . . 0.0 109.938 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -143.25 137.41 28.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.288 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 43.8 m80 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.98 -0.533 . . . . 0.0 109.869 178.055 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.639 0.257 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HB2' ' OG1' ' A' ' 5' ' ' THR . 61.5 mttm -106.76 128.28 54.1 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.8 tp -87.3 21.13 2.52 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -166.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -144.41 11.69 1.5 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 2' ' ' LYS . 38.1 p -106.87 136.55 46.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.01 109.26 55.59 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.06 25.24 0.52 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.857 2.371 . . . . 0.0 113.432 -173.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -150.51 168.48 24.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.477 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.1 m -74.14 117.11 15.55 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.21 104.42 16.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.974 0.416 . . . . 0.0 111.059 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.88 85.13 2.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -101.59 112.06 24.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.128 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 m -100.31 143.57 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.413 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.89 115.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.139 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -45.76 73.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.738 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -141.77 110.52 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.21 0.529 . . . . 0.0 111.439 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -99.21 129.31 45.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.769 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 21' ' ' TYR . . . -132.3 -178.17 15.35 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.137 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -86.51 -20.47 27.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.031 0.443 . . . . 0.0 110.46 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.9 17.43 5.72 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.995 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.512 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 27.3 p90 -164.95 150.36 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.74 0.305 . . . . 0.0 110.76 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.44 106.35 15.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -105.6 118.26 36.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.954 0.407 . . . . 0.0 109.954 -177.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.29 139.18 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.83 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.26 -83.8 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.667 0.604 . . . . 0.0 110.176 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -152.71 13.27 0.53 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.466 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.56 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.003 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 48.0 ttp180 -83.45 107.4 15.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.82 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.74 129.83 35.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.099 0.476 . . . . 0.0 110.941 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 m -108.45 19.09 20.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.887 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -145.44 168.92 19.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . . . -65.8 142.77 57.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.108 0.48 . . . . 0.0 111.598 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.8 pt -137.98 138.82 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -126.7 118.68 25.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.81 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -146.52 163.61 35.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.255 0.55 . . . . 0.0 111.79 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.23 152.73 70.18 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.1 -32.75 96.28 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.87 2.38 . . . . 0.0 112.959 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.604 ' OE2' ' HD2' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -100.75 19.27 17.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.835 0.35 . . . . 0.0 110.867 -178.016 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.11 -176.15 20.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.853 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -89.5 -170.28 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.069 2.513 . . . . 0.0 112.437 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.14 116.16 50.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.122 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.68 129.64 35.07 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.916 0.388 . . . . 0.0 110.74 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p -75.28 121.19 21.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -115.17 117.16 41.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.897 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.26 22.9 0.87 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.228 2.618 . . . . 0.0 113.048 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.5 t -89.34 123.87 41.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.796 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -106.17 -35.93 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.734 0.778 . . . . 0.0 109.389 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 48' ' ' ARG . 47.0 mtm180 -120.18 131.54 24.39 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.063 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.6 Cg_exo -67.14 8.24 0.39 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.292 2.662 . . . . 0.0 113.092 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.22 -3.01 48.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -109.99 14.09 23.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.2 119.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 111.193 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 p -104.14 168.46 9.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -65.05 -30.04 70.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 p -66.26 -42.14 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.774 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.53 -34.77 79.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.624 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.504 ' HB3' HD11 ' A' ' 111' ' ' LEU . 96.7 mt -63.53 -42.42 98.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.15 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.426 ' HG2' HD21 ' A' ' 111' ' ' LEU . 91.1 mt-30 -66.15 -36.63 83.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.369 . . . . 0.0 110.96 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -71.24 -36.67 71.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.464 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.02 -27.37 67.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.938 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HB1' ' HG2' ' A' ' 89' ' ' PRO . . . -73.79 -9.12 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.936 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.62 15.32 78.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.523 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' HD3' ' A' ' 89' ' ' PRO . 90.1 mt -88.79 15.4 8.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.101 0.477 . . . . 0.0 111.055 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.06 -16.95 20.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -123.13 117.51 25.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.992 0.425 . . . . 0.0 110.658 -177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.23 122.37 39.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.301 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.6 t -93.84 130.86 42.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.194 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -123.51 143.04 50.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.675 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.11 162.83 57.97 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.24 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.4 153.87 16.45 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.519 2.146 . . . . 0.0 112.286 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.76 1.23 5.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.061 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.41 -10.06 53.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.04 0.447 . . . . 0.0 110.384 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -111.96 116.2 30.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.976 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.5 tp -100.06 127.37 46.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.905 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.423 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 7.3 m-20 -74.82 165.83 24.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.035 0.445 . . . . 0.0 111.185 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.613 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . 3.9 mp0 -74.97 -51.12 3.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.632 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 76' ' ' GLU . 16.5 Cg_exo -69.09 -174.22 0.74 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.224 1.949 . . . . 0.0 112.251 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -82.78 -23.49 33.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.469 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . . . -95.63 156.69 16.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.093 176.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.92 -176.17 41.06 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.726 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 73.01 -50.31 0.7 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.498 0.719 . . . . 0.0 111.776 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.57 -55.61 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.931 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . . . 62.92 23.94 14.27 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.395 0.617 . . . . 0.0 110.245 -175.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -107.58 150.32 39.99 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.553 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -52.86 -34.3 65.19 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.993 2.462 . . . . 0.0 112.973 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.84 -3.61 19.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -75.54 -30.7 59.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.865 0.364 . . . . 0.0 110.399 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -81.27 151.69 69.78 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.08 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD3' HD21 ' A' ' 63' ' ' LEU . 17.3 Cg_exo -66.51 121.48 8.74 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 111.735 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 109.878 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.686 HG11 HD13 ' A' ' 133' ' ' LEU . 6.4 p -134.12 135.29 54.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.731 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -112.49 104.72 12.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.427 HD11 HD12 ' A' ' 133' ' ' LEU . 93.9 mt -90.13 110.75 21.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.691 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.78 112.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.436 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.63 92.68 1.79 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.544 ' HA ' HD12 ' A' ' 145' ' ' LEU . 1.3 m -60.75 -24.84 66.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.712 0.405 . . . . 0.0 112.072 -171.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA2' ' OG1' ' A' ' 123' ' ' THR . . . 79.61 -68.62 3.16 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.546 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.83 HH22 ' HB3' ' A' ' 149' ' ' ASP . 29.2 ttm180 -92.82 82.08 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.881 0.372 . . . . 0.0 110.578 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 63.25 -173.99 0.16 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.149 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -90.22 143.3 26.89 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.936 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -136.7 126.72 26.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.851 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -80.96 111.78 17.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.463 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.8 mt -76.85 170.18 16.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.08 159.53 15.1 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.774 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.27 -34.92 98.06 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.941 2.427 . . . . 0.0 111.91 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.42 -20.59 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 88.9 mt-30 -96.34 -63.19 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.814 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.3 -18.93 8.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 37.0 ttt180 -57.84 -46.51 99.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 73.2 Cg_exo -53.11 -34.3 67.74 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.165 1.91 . . . . 0.0 112.875 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 57' ' ' LEU . 92.3 mt -76.45 -42.09 45.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.641 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.28 -26.52 68.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 0.0 110.467 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.74 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 60.1 mtt -90.82 -7.46 52.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.883 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.48 51.17 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.091 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -91.83 117.16 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.799 0.333 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.65 93.94 1.7 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.961 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.81 120.36 34.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -125.29 127.15 46.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.415 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.67 116.67 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.3 mtm -142.34 -171.79 3.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.588 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.32 153.63 42.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.415 ' OG1' ' HA2' ' A' ' 97' ' ' GLY . 9.0 m -57.95 -42.96 86.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.261 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.47 -48.45 81.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.46 -50.16 68.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.791 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.69 91.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -60.12 -50.24 74.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.424 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.1 m -65.47 -36.01 82.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.47 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -59.01 -46.88 87.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -56.93 -42.9 80.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.712 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.65 -52.76 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.794 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.686 HD13 HG11 ' A' ' 91' ' ' VAL . 94.7 mt -64.4 -35.23 80.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.507 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 45.0 ttp -65.31 -41.3 94.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.77 73.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.671 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -73.11 -20.57 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.8 39.26 29.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.752 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -97.27 162.69 13.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.578 0.228 . . . . 0.0 110.89 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.604 ' HD2' ' OE2' ' A' ' 38' ' ' GLU . 16.7 mmm180 -75.25 80.84 2.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.0 120.51 64.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.18 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 36' ' ' ALA . 43.9 t -109.87 132.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 12.4 p -117.92 133.8 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.12 0.486 . . . . 0.0 111.122 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.86 110.0 17.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.347 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -100.57 120.97 40.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.944 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 96' ' ' THR . 73.6 mt -104.21 107.04 56.23 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.629 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.84 141.29 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.236 1.957 . . . . 0.0 110.405 169.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -64.29 150.04 46.86 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.06 -4.36 1.33 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.993 -172.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.83 ' HB3' HH22 ' A' ' 98' ' ' ARG . 8.5 t70 -112.96 153.06 28.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.7 m -85.49 -23.05 27.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.603 -174.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 82.3 mt -126.08 159.37 32.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.742 0.306 . . . . 0.0 111.313 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.29 -36.54 75.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.958 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -120.61 131.63 54.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.694 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -72.49 -21.46 61.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.268 0.556 . . . . 0.0 109.803 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -99.16 133.54 43.3 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -58.16 -39.33 78.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.961 0.41 . . . . 0.0 110.858 -174.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -135.87 95.21 3.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.09 173.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.867 179.102 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.486 0.184 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -113.53 164.3 13.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.816 0.341 . . . . 0.0 111.027 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.54 -36.15 22.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -129.15 103.82 7.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.702 169.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 m -88.74 55.68 3.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.111 0.482 . . . . 0.0 110.895 -174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -175.35 128.06 0.39 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.544 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.07 -27.67 29.48 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.702 2.268 . . . . 0.0 113.146 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -152.74 126.91 9.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.409 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 p -73.97 86.67 1.81 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 68.43 -67.39 0.2 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.965 0.906 . . . . 0.0 113.088 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.3 mt 63.26 66.84 0.69 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.49 0.662 . . . . 0.0 110.149 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -65.48 108.43 1.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.218 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 m -118.17 137.04 53.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.073 0.463 . . . . 0.0 111.816 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 24' ' ' VAL . 63.9 t -67.74 132.96 32.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 174.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 p -94.69 -45.67 7.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.736 0.303 . . . . 0.0 111.688 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.15 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 0.0 111.163 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -105.98 -76.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.838 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.77 -111.75 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.027 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -162.25 130.91 4.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -49.09 3.71 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.915 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -111.71 170.24 8.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 110.987 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.96 117.19 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.447 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 29.5 tt0 -96.87 117.81 31.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.053 0.454 . . . . 0.0 110.797 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 14' ' ' VAL . 25.6 t -113.54 124.37 70.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.639 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 66.67 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.728 0.642 . . . . 0.0 111.376 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -141.34 -3.97 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.11 122.3 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.117 -172.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 12.8 ptt180 -85.76 111.42 20.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.978 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.41 120.08 31.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.3 m -101.97 23.54 11.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.54 0.686 . . . . 0.0 109.572 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -141.7 163.59 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.398 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.72 57.76 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.396 0.435 . . . . 0.0 110.991 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -137.04 137.52 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.32 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -122.76 109.68 14.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.546 -0.752 . . . . 0.0 108.973 173.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.419 ' HB3' HG13 ' A' ' 41' ' ' VAL . 37.5 p90 -126.43 147.13 49.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 112.359 -173.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -101.95 157.64 33.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.932 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 26.5 Cg_endo -62.84 -17.53 60.0 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.625 2.217 . . . . 0.0 113.116 -176.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 43.1 mt-10 -89.31 9.23 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.3 -69.57 0.41 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.646 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' A' ' 38' ' ' GLU . 4.5 Cg_exo -37.99 119.85 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.592 3.528 . . . . 0.0 114.923 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 35' ' ' PHE . 41.9 t -113.25 113.56 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.925 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 135.77 33.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.664 0.268 . . . . 0.0 110.794 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 m -88.78 137.89 31.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 2.4 m0 -121.15 131.8 24.38 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 5.3 Cg_exo -81.52 20.5 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.487 2.791 . . . . 0.0 111.619 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 51' ' ' ASP . 92.4 t -94.75 123.32 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.418 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 6.32 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 111.293 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 152.83 30.26 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.39 14.48 0.38 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.934 2.423 . . . . 0.0 113.162 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.67 -29.53 15.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.258 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.577 ' HB2' HG13 ' A' ' 46' ' ' VAL . 28.9 m-20 -77.79 -20.78 52.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.226 -175.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.45 HD13 HG11 ' A' ' 94' ' ' VAL . 23.0 mt -60.04 110.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.22 0.533 . . . . 0.0 111.194 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.45 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -131.44 165.6 23.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.482 -178.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.61 65.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.721 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 3.4 p -62.55 -50.74 70.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.856 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.51 -36.91 84.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.824 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' HD11 ' A' ' 111' ' ' LEU . 97.5 mt -61.46 -41.86 97.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.98 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.85 -33.17 74.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.86 0.362 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 55' ' ' SER . 87.9 mt-30 -71.38 -35.83 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.75 -26.53 40.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.04 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 89' ' ' PRO . . . -77.77 -10.68 59.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.135 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.57 35.17 67.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.623 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.1 mt -77.91 2.1 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 0.0 111.283 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.26 -169.37 2.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.2 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -81.65 131.07 35.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.716 0.293 . . . . 0.0 110.589 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.18 104.63 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.745 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.65 106.7 16.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.27 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -78.23 146.38 34.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.443 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 4.6 p-10 -84.49 137.26 39.15 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 121.123 0.487 . . . . 0.0 110.885 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 93.1 Cg_endo -91.34 120.03 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.097 2.531 . . . . 0.0 112.882 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.0 mt -103.12 -5.45 23.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.013 0.435 . . . . 0.0 110.946 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.59 -6.85 11.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.222 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -139.03 116.19 11.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.535 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.89 -2.1 58.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.702 0.763 . . . . 0.0 109.489 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.58 -11.07 59.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.849 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 62.87 96.03 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.394 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.2 85.26 1.05 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.649 2.233 . . . . 0.0 111.337 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.3 -49.61 22.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.722 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 98.85 4.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.604 173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.03 27.91 6.39 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.164 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.37 -29.06 68.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.681 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.08 -22.69 78.84 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.12 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.57 -39.3 0.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.845 0.858 . . . . 0.0 112.784 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -107.2 118.01 54.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.72 49.78 2.82 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.416 2.744 . . . . 0.0 113.376 -173.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.58 -65.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.871 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 65.6 t30 56.9 61.51 2.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.743 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.66 124.06 9.34 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.816 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.448 ' O ' HG22 ' A' ' 116' ' ' VAL . 26.0 Cg_endo -63.92 153.47 75.57 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.588 2.192 . . . . 0.0 112.531 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.35 -51.7 6.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.024 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.37 136.65 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 tp -115.33 119.01 34.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.79 119.91 39.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.45 HG11 HD13 ' A' ' 52' ' ' ILE . 58.9 t -111.84 117.87 56.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.363 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.83 102.29 2.9 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 101' ' ' HIS . 6.1 p -78.15 19.12 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.8 -85.03 1.09 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.234 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -79.19 -33.58 43.77 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -169.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -142.3 -173.72 3.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HG2' ' H ' ' A' ' 122' ' ' ASP . 93.0 mt-30 -95.31 82.46 3.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.648 165.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.467 ' HB3' HG21 ' A' ' 96' ' ' THR . 58.5 t-80 -94.8 101.77 13.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.726 -174.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 120' ' ' ALA . 48.0 tp -64.76 143.22 58.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.67 -165.71 1.03 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.324 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.95 150.51 16.92 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.765 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.69 -37.19 83.74 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.265 2.643 . . . . 0.0 112.758 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -72.96 -33.38 65.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.944 0.402 . . . . 0.0 110.761 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.05 -42.32 73.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.1 m -89.99 -6.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.35 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -50.5 87.83 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -54.02 -40.45 81.19 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.14 1.893 . . . . 0.0 112.615 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 64.7 mt -77.63 -38.08 48.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.129 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 73.8 mt -61.89 -34.34 75.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.11 63.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.6 mtt -91.11 -11.87 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.6 8.79 55.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 42.0 t -86.69 111.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.742 0.306 . . . . 0.0 110.44 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.69 104.28 2.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.146 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -91.04 120.19 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.738 0.304 . . . . 0.0 111.027 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -118.48 115.78 25.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.422 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 102' ' ' LEU . . . -99.05 118.52 36.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.655 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 73.4 mtm -140.02 -171.82 3.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.221 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.505 ' H ' ' HG2' ' A' ' 100' ' ' GLN . 12.8 t70 -70.31 151.55 45.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.534 HG23 HD22 ' A' ' 144' ' ' LEU . 63.8 m -56.96 -37.99 72.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 111.002 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.72 -42.84 70.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.016 0.436 . . . . 0.0 110.463 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.51 -41.6 84.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.944 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.43 -38.71 90.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.849 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -52.21 66.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.157 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -61.84 -40.18 94.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.999 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 41.0 m -64.8 -40.32 95.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.398 . . . . 0.0 110.474 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -60.93 -46.76 89.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.711 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -58.32 -37.68 75.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 79.4 mt -68.52 -53.86 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.608 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.681 HD22 ' HD2' ' A' ' 138' ' ' ARG . 61.9 mt -61.91 -41.63 98.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -64.93 -39.47 93.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.579 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.63 -32.71 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 44.8 mt-10 -73.84 -26.31 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.87 22.82 12.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.256 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.681 ' HD2' HD22 ' A' ' 133' ' ' LEU . 56.1 mtt-85 -80.35 157.68 26.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.843 0.354 . . . . 0.0 110.204 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.0 83.38 6.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.248 0.547 . . . . 0.0 109.932 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.32 134.72 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.529 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.35 136.83 53.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.6 p -120.69 134.46 64.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.048 0.451 . . . . 0.0 111.411 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.14 113.07 20.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.563 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.534 HD22 HG23 ' A' ' 123' ' ' THR . 91.3 mt -108.4 133.97 51.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.671 -175.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 52' ' ' ILE . 83.5 mt -111.0 105.65 57.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.918 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -87.01 128.89 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.212 2.608 . . . . 0.0 110.589 166.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.15 -164.36 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.707 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.13 -4.66 1.27 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.633 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.18 -29.16 34.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.02 0.438 . . . . 0.0 109.903 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.6 m -72.04 118.37 14.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.876 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 81.1 mt -77.43 -178.91 5.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.643 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -38.48 65.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -148.8 165.3 31.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -75.42 -32.29 60.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.477 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -82.36 74.62 9.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.375 0.607 . . . . 0.0 110.344 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -91.16 129.49 37.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -97.14 15.59 22.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -168.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.062 175.161 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.599 0.238 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -98.04 118.49 34.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.82 148.25 50.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.474 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -88.37 88.61 7.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -51.61 125.2 14.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.699 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.88 132.49 86.7 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.0 124.69 9.1 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.9 2.4 . . . . 0.0 112.392 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.56 -57.1 14.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 109.814 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -94.2 146.55 23.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.301 171.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.3 93.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 37' ' ' PRO . 54.7 mt -67.84 106.47 2.29 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.915 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.67 95.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.452 . . . . 0.0 109.971 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -91.31 129.19 37.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.502 -173.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.37 107.32 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 m -79.84 -36.88 36.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.003 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.53 130.74 15.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.203 0.525 . . . . 0.0 111.375 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -100.4 106.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 -170.73 34.66 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.116 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.54 -58.68 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.226 0.536 . . . . 0.0 110.59 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.11 38.11 1.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.766 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -151.76 143.87 23.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.906 0.384 . . . . 0.0 110.294 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.28 118.62 59.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.82 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.77 112.0 23.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.733 0.301 . . . . 0.0 110.274 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.51 115.16 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.999 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.42 ' C ' HD22 ' A' ' 25' ' ' ASN . 0.2 OUTLIER 72.12 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.625 0.77 . . . . 0.0 110.428 -178.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -174.88 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.283 0.633 . . . . 0.0 109.364 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.09 126.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.367 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -95.06 121.1 36.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.604 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.7 113.2 26.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.604 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -92.78 19.91 7.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.568 0.699 . . . . 0.0 110.106 175.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -130.59 151.84 50.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.665 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 44' ' ' TRP . . . -58.56 136.8 57.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.7 pt -141.85 154.71 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.097 0.475 . . . . 0.0 111.723 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -132.31 124.04 28.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.327 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -146.24 163.13 36.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.032 0.444 . . . . 0.0 111.529 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -126.65 163.56 40.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -176.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 63.7 Cg_endo -73.4 23.52 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.706 2.27 . . . . 0.0 112.914 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ALA . 38.9 tt0 -173.49 90.3 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.04 -165.04 29.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.878 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.88 167.22 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.2 2.6 . . . . 0.0 113.034 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.1 t -91.84 122.9 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.148 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.12 140.72 29.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.1 p -84.41 119.73 25.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.069 0.461 . . . . 0.0 110.594 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.409 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.3 t90 -98.24 116.4 65.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.737 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.15 35.55 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.267 2.645 . . . . 0.0 114.043 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 51' ' ' ASP . 94.6 t -101.14 133.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.684 0.278 . . . . 0.0 110.577 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -113.84 -43.93 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.477 . . . . 0.0 110.554 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -116.92 151.99 48.09 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.24 -6.66 10.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.746 2.297 . . . . 0.0 112.539 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.39 -3.52 46.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.552 ' HB2' HG13 ' A' ' 46' ' ' VAL . 64.2 m-20 -84.19 -28.16 27.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.555 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.4 mt -55.45 113.73 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.759 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 39.1 p -128.95 175.14 8.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -58.29 -44.92 88.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.043 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 m -60.93 -42.43 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.5 HD13 HG22 ' A' ' 46' ' ' VAL . 80.7 mt -70.51 -28.26 64.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' A' ' 111' ' ' LEU . 83.7 mt -73.45 -30.06 62.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.79 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 95.2 mt-30 -63.75 -43.63 95.86 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 174.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.47 -42.29 92.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.706 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.77 76.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.637 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.48 0.66 25.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.35 82.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.427 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.53 -4.28 29.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.303 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 -5.76 58.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -120.56 158.32 27.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.169 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.02 109.78 29.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.333 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.06 -32.76 55.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.123 0.487 . . . . 0.0 110.553 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -85.84 57.14 4.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.287 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.68 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 20.3 t70 -73.44 -53.35 4.62 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.78 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 69' ' ' ASP . 24.0 Cg_exo -64.88 141.11 69.79 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.136 1.891 . . . . 0.0 112.428 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.07 -9.66 56.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.208 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.5 83.13 8.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.755 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -76.28 -10.06 59.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.613 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.87 -24.53 66.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.341 173.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -83.24 -31.91 26.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.029 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 66.08 86.88 0.13 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.675 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HG3' ' HD2' ' A' ' 70' ' ' PRO . 55.7 Cg_endo -73.91 -20.25 19.81 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.522 2.148 . . . . 0.0 111.201 172.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -107.18 132.76 52.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.433 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.96 70.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.614 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.26 18.43 8.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.028 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HB3' ' HG2' ' A' ' 139' ' ' ARG . . . -93.92 -2.68 52.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.016 0.436 . . . . 0.0 110.704 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.55 101.27 2.36 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.628 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.67 -7.86 57.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.151 0.5 . . . . 0.0 110.912 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.465 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 17.6 mmm180 -102.92 138.81 19.67 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.859 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 32.0 Cg_exo -60.79 -19.89 63.51 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.062 2.508 . . . . 0.0 112.885 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.75 -1.5 38.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.316 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.1 m120 64.08 37.48 9.08 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.516 0.51 . . . . 0.0 110.916 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.501 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -64.98 133.7 95.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.04 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 2.8 Cg_exo -75.54 151.21 36.9 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.041 2.494 . . . . 0.0 112.125 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -67.27 -44.83 78.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.934 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 140' ' ' VAL . 5.4 p -132.4 136.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.484 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 141' ' ' VAL . 62.3 tp -118.07 121.94 41.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.184 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.19 120.85 42.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.5 t -103.31 119.84 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.941 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' A' ' 144' ' ' LEU . . . -98.26 98.81 2.1 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.587 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -126.49 93.0 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.45 -10.21 39.16 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.453 -0.88 . . . . 0.0 114.46 -170.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HD3' ' CG ' ' A' ' 147' ' ' ASP . 41.9 ttp180 -89.51 -26.41 20.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.716 0.758 . . . . 0.0 110.168 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -159.53 94.24 1.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.902 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -65.23 109.5 2.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.29 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -106.13 122.41 46.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.891 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.7 134.07 39.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.134 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.4 mt -94.12 137.12 33.67 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.28 171.08 17.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.075 -171.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.42 -44.06 30.87 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.745 2.963 . . . . 0.0 113.351 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.24 -46.8 69.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.133 0.492 . . . . 0.0 111.404 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 92.8 mt-30 -75.98 -12.55 60.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.581 -173.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.03 14.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.656 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.2 mtm105 -55.84 -54.89 46.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.656 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 24.3 Cg_exo -64.15 -26.71 64.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.842 1.695 . . . . 0.0 111.907 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 57' ' ' LEU . 75.3 mt -78.72 -46.6 18.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.08 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.73 -34.65 74.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.832 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.35 -22.89 65.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.188 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 50.4 mtt -94.3 -7.83 40.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.006 0.432 . . . . 0.0 110.215 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.95 -8.51 55.98 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.561 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.13 122.0 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 0.0 111.004 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.67 109.63 3.78 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.74 110.33 24.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.84 0.352 . . . . 0.0 110.917 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -108.55 116.93 32.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.388 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.95 29.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.495 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 72.1 mtm -137.49 -172.78 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.304 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.9 159.02 29.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.691 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.3 p -59.02 -53.04 62.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.967 0.413 . . . . 0.0 110.973 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -65.33 -36.81 85.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.17 75.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 0.0 110.893 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.46 90.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.668 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.391 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -65.18 -42.69 93.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.979 0.418 . . . . 0.0 110.485 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.0 m -65.3 -34.39 78.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.979 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.413 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 60.6 t80 -61.69 -42.76 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.95 177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -57.2 -45.23 83.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.014 0.435 . . . . 0.0 110.586 175.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.72 -53.34 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.429 ' HB2' HG11 ' A' ' 140' ' ' VAL . 93.1 mt -62.43 -31.23 71.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 37.5 ttm -59.96 -50.23 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.493 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.69 72.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.076 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.78 -23.49 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.11 18.63 58.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.552 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -82.69 144.51 30.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HG2' ' HB3' ' A' ' 81' ' ' ALA . 11.7 mmt180 -70.71 94.09 0.99 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.077 0.465 . . . . 0.0 110.894 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 133' ' ' LEU . 7.4 p -126.37 138.53 54.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.41 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' A' ' 36' ' ' ALA . 44.9 t -118.89 134.92 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.1 p -115.9 128.69 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 0.0 111.002 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.8 109.82 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.521 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.503 HD23 ' HA3' ' A' ' 95' ' ' GLY . 96.1 mt -113.36 136.47 52.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.706 -173.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 91.7 mt -93.72 133.78 27.41 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.245 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 14.9 Cg_exo -68.07 87.6 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.762 2.308 . . . . 0.0 112.804 -178.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.401 ' CG ' ' HD3' ' A' ' 98' ' ' ARG . 7.0 t70 -168.15 -161.77 0.38 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.58 -5.32 0.11 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.511 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -131.19 124.44 30.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.937 0.398 . . . . 0.0 110.596 -176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.1 p -67.13 151.56 47.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.648 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.2 tp -59.53 -46.56 88.51 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.02 106.41 3.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -120.9 99.37 6.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.09 0.471 . . . . 0.0 110.937 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -79.7 148.6 31.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -71.69 -14.0 61.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.805 0.336 . . . . 0.0 110.998 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -66.89 -25.73 66.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.407 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -88.23 122.14 31.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.895 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 59.1 m80 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.801 -178.33 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.75 0.31 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -91.04 -43.3 10.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 109.98 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.0 tp -87.85 146.11 25.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.354 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -126.69 92.88 3.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.56 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -75.67 147.6 39.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.464 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 5.1 p-10 -75.47 133.71 73.9 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.224 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 21.1 Cg_exo -65.86 145.39 80.29 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 123.041 2.494 . . . . 0.0 112.298 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.19 179.08 5.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.972 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -115.83 169.95 8.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . -81.12 129.13 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 0.0 110.965 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.491 HD22 ' HG2' ' A' ' 134' ' ' MET . 71.9 mt -90.62 93.26 9.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.927 -178.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -78.87 98.97 6.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.1 m -108.32 137.05 46.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.091 0.472 . . . . 0.0 111.931 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 24' ' ' VAL . 80.1 t -73.12 126.16 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.479 173.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.9 p -87.63 -34.65 18.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.61 0.243 . . . . 0.0 111.314 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.77 172.96 12.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.754 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.24 -33.33 6.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.95 -118.46 14.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.962 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -157.42 107.19 2.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.857 0.361 . . . . 0.0 110.475 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.09 18.96 48.49 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.213 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.938 ' HE1' ' HB2' ' A' ' 23' ' ' GLU . 44.3 p90 -160.34 176.25 11.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.873 0.337 . . . . 0.0 110.593 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.2 mt -123.85 122.13 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.938 ' HB2' ' HE1' ' A' ' 21' ' ' TYR . 28.5 tt0 -105.44 108.85 20.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -172.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 14' ' ' VAL . 57.7 t -109.91 107.6 23.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.946 177.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 58.3 53.63 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.274 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 72.96 -17.97 0.38 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.619 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 40.3 t -74.72 123.14 29.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.145 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -93.27 102.76 15.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.29 118.05 30.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.563 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -95.14 20.3 9.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.217 0.532 . . . . 0.0 110.133 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -151.08 163.87 37.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.898 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.09 146.62 53.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.197 0.522 . . . . 0.0 112.408 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.73 151.0 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.871 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.47 127.3 40.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -148.31 153.46 38.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.041 0.448 . . . . 0.0 111.397 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.65 159.28 65.91 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 50.0 Cg_exo -55.0 -41.36 79.66 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.608 2.205 . . . . 0.0 112.063 174.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -102.99 94.71 5.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.74 -175.0 23.92 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.815 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -97.89 -178.06 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.365 2.71 . . . . 0.0 112.746 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.21 111.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.14 36.94 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 t -79.2 119.01 21.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.515 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -98.1 126.0 41.75 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -175.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 15.5 Cg_exo -69.58 -7.46 21.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.27 2.647 . . . . 0.0 113.048 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.636 HG11 HG12 ' A' ' 52' ' ' ILE . 48.5 t -86.26 102.6 11.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.413 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -98.23 -7.98 28.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.199 0.523 . . . . 0.0 110.448 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.621 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 12.1 mtm180 -138.57 146.26 50.03 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.917 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.606 ' HG3' ' HB3' ' A' ' 98' ' ' ARG . 33.8 Cg_endo -64.74 -9.79 22.33 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.799 2.333 . . . . 0.0 113.259 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.4 -2.98 47.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.468 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.621 ' OD1' ' HB2' ' A' ' 48' ' ' ARG . 3.6 m-20 -103.39 9.88 37.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.207 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.636 HG12 HG11 ' A' ' 46' ' ' VAL . 58.2 mt -84.7 126.52 40.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.731 0.301 . . . . 0.0 111.578 -175.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.9 p -128.76 166.61 18.67 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.47 -39.38 83.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.473 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 m -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.247 0.546 . . . . 0.0 110.854 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD13 ' CG2' ' A' ' 46' ' ' VAL . 71.1 mt -72.3 -28.86 63.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.75 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.33 -37.79 80.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.252 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.52 -39.62 94.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.231 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -66.21 -41.53 89.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.574 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -20.26 65.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.546 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.74 -7.42 55.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.21 76.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.485 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt -97.48 17.49 17.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.042 0.448 . . . . 0.0 110.837 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.14 95.81 4.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' OE1' ' HD3' ' A' ' 68' ' ' ARG . 48.5 mt-10 -96.62 95.27 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.088 0.471 . . . . 0.0 110.167 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.9 t -59.91 -24.76 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.155 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -73.02 -14.44 16.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.316 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 14.9 mtm-85 -89.64 -42.95 11.08 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.836 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.48 90.57 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.431 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.97 126.44 17.29 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.562 2.175 . . . . 0.0 111.302 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.5 mt -58.73 -41.53 86.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.271 0.558 . . . . 0.0 110.553 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.53 166.76 28.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.556 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -87.51 12.81 11.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.234 0.54 . . . . 0.0 110.026 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.7 mt -129.15 135.59 49.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.064 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.58 73.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.892 0.745 . . . . 0.0 112.647 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 41.8 tt0 -135.99 129.77 18.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 171.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 17.0 Cg_exo -69.44 59.78 1.48 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.287 2.658 . . . . 0.0 113.258 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 43.4 mt-10 67.97 -72.39 0.1 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.714 0.806 . . . . 0.0 112.651 173.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.82 30.82 6.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.065 0.46 . . . . 0.0 110.78 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.2 -69.1 2.55 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -176.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.35 87.29 3.38 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 171.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.8 64.73 4.05 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.695 -170.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.96 -28.54 62.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.604 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 18.8 ptt-85 -124.82 169.05 11.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.521 174.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 84' ' ' ARG . 21.9 Cg_endo -61.86 171.98 4.27 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.197 1.931 . . . . 0.0 112.485 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 78' ' ' GLU . . . -59.82 -26.92 66.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.989 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.516 ' HB3' ' NH2' ' A' ' 139' ' ' ARG . 5.5 m-20 65.48 46.5 2.5 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.078 0.466 . . . . 0.0 110.835 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.25 143.44 79.36 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.112 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.84 164.56 34.17 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.556 2.171 . . . . 0.0 112.414 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 42.0 mt-10 -92.29 -44.13 8.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 140' ' ' VAL . 7.5 p -139.37 136.87 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.073 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.9 tp -113.28 112.03 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.547 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.99 108.6 21.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.404 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.12 106.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.49 98.4 1.39 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 49' ' ' PRO . 5.3 m -65.96 -14.76 62.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -170.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.34 -72.9 2.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.974 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.606 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 39.6 ttm180 -85.81 70.35 10.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.128 0.489 . . . . 0.0 110.074 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 66.28 154.46 0.08 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.726 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 53.7 tt0 -62.53 128.92 38.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.878 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -112.93 138.05 50.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.41 97.12 10.88 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.43 170.74 15.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.321 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.9 144.09 15.78 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.393 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.525 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 48.9 Cg_exo -55.78 -36.47 95.29 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.439 2.759 . . . . 0.0 113.296 -173.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.566 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 10.9 mm-40 -63.66 -28.87 70.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -88.26 -9.88 51.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.371 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.17 5.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 110.9 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.589 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 37.7 mmt180 -53.41 -52.79 63.29 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.292 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 61.7 Cg_exo -53.32 -39.68 80.45 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.153 1.902 . . . . 0.0 112.739 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 87.2 mt -78.72 -42.12 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.024 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.7 -37.06 80.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 110.617 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.75 70.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 65.1 mtt -83.61 -15.34 49.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.97 8.37 42.15 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.177 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 38.2 t -86.54 108.61 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.744 0.307 . . . . 0.0 110.576 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.75 107.23 2.32 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.828 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.5 t -87.09 111.74 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.783 0.325 . . . . 0.0 110.623 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -112.71 117.5 32.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.388 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 100' ' ' GLN . . . -101.98 115.95 31.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.319 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.478 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 65.4 mtm -139.51 -172.81 3.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.052 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.58 157.34 37.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 34.5 m -60.14 -45.83 91.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.241 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -64.39 -41.02 96.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 110.793 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.46 96.43 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.32 86.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.561 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.43 96.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.447 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -62.72 -48.62 78.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.277 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.0 m -62.73 -38.36 90.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.38 -44.04 95.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.75 -46.54 74.34 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 110.711 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.3 mt -60.89 -52.25 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.84 -31.44 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.54 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.491 ' HG2' HD22 ' A' ' 11' ' ' LEU . 48.9 ttp -66.84 -43.23 84.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.825 0.345 . . . . 0.0 110.283 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.98 86.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.16 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.45 36.14 5.22 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.347 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -100.91 161.42 13.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.605 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 55.4 mtp85 -78.57 77.98 5.04 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.368 0.604 . . . . 0.0 111.024 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 91' ' ' VAL . 5.7 p -112.04 132.96 59.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.372 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 36' ' ' ALA . 38.5 t -115.65 134.04 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.5 p -119.04 135.45 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.248 0.546 . . . . 0.0 111.226 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 117.78 30.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.188 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.2 mt -107.37 120.44 42.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.173 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.44 HD21 ' CZ3' ' A' ' 44' ' ' TRP . 71.9 mt -100.96 130.09 25.87 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.278 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 145' ' ' LEU . 1.9 Cg_endo -82.22 105.73 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.995 2.463 . . . . 0.0 110.995 174.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.38 101.61 0.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.19 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.55 -62.93 0.3 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.085 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.4 t70 55.17 53.22 10.42 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.509 1.147 . . . . 0.0 108.473 -169.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.3 m -73.63 -25.02 60.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.032 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.02 109.8 12.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.437 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.503 ' HG2' ' CE1' ' A' ' 158' ' ' HIS . 31.7 mt-10 -76.33 106.46 7.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.215 0.531 . . . . 0.0 109.683 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.406 ' HD2' ' O ' ' A' ' 158' ' ' HIS . 44.0 m-70 -67.41 117.21 9.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.393 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 156' ' ' HIS . 16.2 t-80 -73.58 -19.05 60.99 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 111.007 -174.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -82.96 36.46 0.5 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.256 1.027 . . . . 0.0 108.469 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.434 ' H ' ' C ' ' A' ' 154' ' ' HIS . 4.8 t-80 179.2 -177.47 0.3 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -170.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -90.97 -56.15 3.28 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.503 ' CE1' ' HG2' ' A' ' 152' ' ' GLU . 9.9 t60 . . . . . 0 C--O 1.246 0.902 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 170.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.99 119.4 9.38 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.88 0.372 . . . . 0.0 110.282 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt -71.21 164.26 26.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.497 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -102.68 -28.9 11.85 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.8 p -76.72 -30.63 56.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.56 104.46 52.89 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.622 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.95 129.66 22.53 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 123.136 2.558 . . . . 0.0 112.716 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.51 107.83 15.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.2 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -61.65 129.96 43.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.819 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.51 69.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.029 0.442 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.9 tp -109.71 117.01 32.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.593 HD21 ' HB2' ' A' ' 35' ' ' PHE . 56.8 t30 -75.05 109.75 8.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.339 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -147.06 146.14 29.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.934 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.87 118.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.16 17.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.33 -175.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -147.44 119.31 8.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.083 0.468 . . . . 0.0 111.332 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -113.18 116.54 29.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.416 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.58 -164.1 9.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.831 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.67 109.05 18.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.748 0.309 . . . . 0.0 110.874 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 147' ' ' ASP . . . 91.2 1.0 72.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.437 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -153.43 142.12 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.556 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.0 mt -126.36 111.95 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.254 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -93.69 117.99 30.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.024 0.44 . . . . 0.0 110.436 -176.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.49 113.05 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.741 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 62.32 39.41 12.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 72.19 9.53 5.95 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.773 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.68 107.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 31.0 ptt-85 -81.53 114.85 20.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.323 0.583 . . . . 0.0 110.394 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.39 128.03 43.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.907 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 p -104.55 14.37 30.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.462 0.649 . . . . 0.0 109.717 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -137.68 171.25 14.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.378 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -62.27 141.71 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.555 0.534 . . . . 0.0 111.687 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 pt -142.11 136.41 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.26 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.3 120.87 37.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.308 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.593 ' HB2' HD21 ' A' ' 12' ' ' ASN . 40.2 p90 -149.88 162.78 39.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.165 0.507 . . . . 0.0 111.834 -173.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -130.68 158.62 74.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.747 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.689 ' HB3' ' HG3' ' A' ' 134' ' ' MET . 19.3 Cg_endo -60.1 -32.42 94.68 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.604 2.203 . . . . 0.0 111.702 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -130.44 103.44 6.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.171 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.58 -156.14 26.52 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.923 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.64 162.22 6.43 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.836 2.357 . . . . 0.0 113.091 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -114.27 101.6 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.68 118.99 38.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.954 0.407 . . . . 0.0 111.641 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 65.6 m -66.88 132.66 48.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 170.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.55 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -97.93 129.74 30.42 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -171.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.55 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 41.4 Cg_endo -67.83 -0.93 6.0 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.884 2.389 . . . . 0.0 112.917 -177.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' CG2' HD13 ' A' ' 56' ' ' LEU . 46.8 t -86.22 96.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -89.54 -20.96 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 109.734 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -129.04 130.85 23.44 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.46 12.06 0.26 Allowed 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.058 2.505 . . . . 0.0 113.669 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.47 -2.59 58.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.998 0.428 . . . . 0.0 110.428 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -128.87 69.31 1.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.883 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 101' ' ' HIS . 66.6 mt -115.26 107.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.159 173.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 61.1 p -113.85 174.9 5.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.952 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -62.73 -44.0 97.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.953 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.7 m -59.6 -39.32 83.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.025 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.413 HD13 ' CG2' ' A' ' 46' ' ' VAL . 94.9 mt -70.48 -34.05 71.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 53' ' ' THR . 95.7 mt -68.61 -35.59 77.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 97.1 mt-30 -62.1 -41.91 98.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.46 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -68.62 -38.59 80.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.396 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.8 65.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.57 0.14 35.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 0.0 111.112 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.7 0.1 87.9 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.471 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' HA ' HG22 ' A' ' 66' ' ' VAL . 66.5 mt -85.89 23.81 1.39 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.814 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.68 -30.4 24.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.19 -175.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -112.94 -14.44 13.02 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 63' ' ' LEU . 28.3 m -93.75 140.7 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.956 0.408 . . . . 0.0 110.972 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.464 HG23 ' H ' ' A' ' 69' ' ' ASP . 18.7 m -133.48 -176.27 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.516 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -104.79 27.9 7.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.216 0.531 . . . . 0.0 110.025 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 67' ' ' VAL . 15.7 m-20 -112.1 159.89 32.05 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.278 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.88 152.27 44.06 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.747 2.298 . . . . 0.0 112.312 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.3 mt -87.84 21.86 2.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.167 -176.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.1 179.68 7.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.625 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -78.4 -7.59 57.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.568 0.699 . . . . 0.0 109.786 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.9 mt -107.18 168.05 9.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.122 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -100.96 176.15 5.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.934 0.397 . . . . 0.0 110.907 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -131.16 98.44 18.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.278 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -88.72 -18.9 1.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.912 2.408 . . . . 0.0 113.751 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -96.14 -53.02 3.79 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.266 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.39 97.85 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.929 0.395 . . . . 0.0 110.525 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.19 38.08 3.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.589 -176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.6 91.3 2.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.037 0.446 . . . . 0.0 110.347 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.86 110.12 2.37 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.473 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 67.95 101.39 0.05 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 124.276 0.633 . . . . 0.0 111.036 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 74.3 mtp85 -69.79 133.33 88.45 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.005 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 17.2 Cg_exo -67.91 3.97 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.381 2.72 . . . . 0.0 112.859 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.48 8.02 17.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.086 0.469 . . . . 0.0 110.374 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -95.98 0.37 51.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.237 0.542 . . . . 0.0 109.989 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.13 154.03 38.94 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.832 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.6 ' HB3' HG23 ' A' ' 141' ' ' VAL . 15.8 Cg_endo -58.34 132.22 47.49 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.795 2.33 . . . . 0.0 113.266 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -76.34 -33.98 58.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 140' ' ' VAL . 6.4 p -134.78 134.08 53.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.016 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.407 ' HB3' HG22 ' A' ' 118' ' ' VAL . 64.3 tp -114.12 112.7 23.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.268 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.59 116.01 28.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.36 100.63 11.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -86.04 76.25 2.17 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.353 -174.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 90.48 4.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.041 0.448 . . . . 0.0 109.972 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.33 -30.78 21.28 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.168 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -64.09 -50.39 68.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.304 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -145.32 132.36 20.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -72.41 91.72 1.38 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.403 ' CE1' ' HB ' ' A' ' 52' ' ' ILE . 54.2 t-80 -73.97 108.93 7.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.864 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.8 120.19 9.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.9 mt -80.13 149.02 30.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.54 147.36 16.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.277 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 51.6 Cg_exo -55.9 -32.43 85.29 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.182 2.588 . . . . 0.0 112.51 -177.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.15 -29.35 38.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 98.9 mt-30 -73.82 -41.64 62.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.77 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.6 m -92.07 2.69 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 66.9 ttt180 -59.27 -55.46 45.96 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.292 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 19.0 Cg_endo -57.99 -26.94 77.25 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.026 1.817 . . . . 0.0 112.333 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -83.25 -43.87 15.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.393 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 86.8 mt -61.62 -35.16 77.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.814 0.34 . . . . 0.0 110.583 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.76 68.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.227 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 110' ' ' PRO . 66.0 mtt -83.97 -23.97 30.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.11 0.481 . . . . 0.0 110.175 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.22 3.37 22.88 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.694 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.77 102.94 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.338 . . . . 0.0 110.341 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.23 99.46 1.57 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.103 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 92' ' ' LEU . 21.5 t -84.56 127.51 39.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.625 0.25 . . . . 0.0 110.546 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.92 136.63 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.996 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.12 123.46 35.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.054 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.455 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 38.6 ttm -142.52 160.09 40.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -174.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.62 145.4 54.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.481 HG23 HD22 ' A' ' 144' ' ' LEU . 8.8 m -52.33 -45.66 65.74 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.226 0.329 . . . . 0.0 111.711 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -60.13 -50.14 74.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.65 71.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.294 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.3 88.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.629 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.06 97.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.584 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 132' ' ' ILE . 21.0 ttt180 -58.93 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 28.1 m -62.2 -41.71 98.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.839 0.352 . . . . 0.0 110.69 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.65 ' HE1' ' HD3' ' A' ' 37' ' ' PRO . 53.0 t80 -54.85 -51.6 65.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.103 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.46 -41.75 85.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.084 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 128' ' ' ARG . 80.1 mt -62.46 -54.6 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.62 -32.48 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.174 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.689 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 53.2 ttp -64.42 -43.32 94.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.36 175.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.45 -23.68 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.224 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 132' ' ' ILE . 32.7 mt-10 -88.33 -3.41 58.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.006 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.7 44.17 82.21 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.228 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -117.65 157.31 26.65 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.633 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -73.16 100.39 3.06 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.114 0.483 . . . . 0.0 111.054 -173.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.418 HG23 HG13 ' A' ' 91' ' ' VAL . 7.4 p -131.69 135.24 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.738 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' A' ' 89' ' ' PRO . 66.6 t -128.6 142.15 44.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.0 p -129.6 136.94 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.661 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.73 113.94 22.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.253 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.481 HD22 HG23 ' A' ' 123' ' ' THR . 97.1 mt -100.52 127.89 46.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -172.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' A' ' 32' ' ' ALA . 18.0 mt -117.26 94.5 45.27 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.853 172.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.75 -158.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.272 2.648 . . . . 0.0 112.909 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.44 ' O ' ' HA2' ' A' ' 20' ' ' GLY . 22.4 t70 -117.64 151.89 36.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.377 176.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 177.62 -43.42 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.723 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -93.66 109.2 20.85 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.0 p -73.34 164.75 26.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.611 -175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 98.3 mt -77.25 -25.46 51.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.106 0.479 . . . . 0.0 110.143 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.573 ' HG3' ' HE1' ' A' ' 157' ' ' HIS . 36.9 tt0 -119.86 108.7 14.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.24 176.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -78.2 130.56 36.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -84.34 -73.18 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.08 -171.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 29.1 m170 -78.88 119.88 22.7 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 60.1 m80 75.0 73.26 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.146 0.904 . . . . 0.0 108.704 -167.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.573 ' HE1' ' HG3' ' A' ' 152' ' ' GLU . 83.5 t60 -86.27 -15.32 41.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.544 -176.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.645 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtm . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.594 0.235 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -75.88 -36.5 59.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.2 87.26 0.79 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.03 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -175.92 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.3 m -81.0 -42.04 21.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.32 148.43 90.96 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.652 172.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 30.8 Cg_endo -63.74 147.02 92.69 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.718 2.279 . . . . 0.0 112.916 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.65 0.4 43.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.303 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.9 p -113.08 138.21 50.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.286 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.33 65.03 5.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.101 0.477 . . . . 0.0 110.731 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 71.7 mt -149.92 -35.96 0.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.044 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.569 ' HA ' ' HG3' ' A' ' 7' ' ' PRO . 3.3 m-20 63.74 23.79 13.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.216 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -61.75 139.7 58.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.204 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 22' ' ' ILE . 58.3 t -65.78 103.13 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -70.32 -34.45 72.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.907 -176.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -154.46 149.05 26.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.199 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -120.07 132.22 55.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.02 178.91 17.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.677 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.87 99.26 1.02 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.384 0.274 . . . . 0.0 111.281 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.95 15.65 72.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.314 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -157.55 152.14 25.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.186 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.642 HG12 HD13 ' A' ' 144' ' ' LEU . 3.1 mp -113.41 120.64 63.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 40.1 tt0 -97.33 110.83 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 0.0 110.687 -176.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.453 ' HA ' ' OG1' ' A' ' 15' ' ' THR . 57.5 t -119.99 119.76 61.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.529 176.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t30 63.42 42.5 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.591 0.557 . . . . 0.0 110.22 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 66.79 10.85 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.319 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.5 115.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -82.02 101.99 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.83 89.33 6.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.083 0.468 . . . . 0.0 110.598 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -86.58 52.16 2.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -168.28 156.85 8.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 44' ' ' TRP . . . -56.73 130.5 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.493 0.495 . . . . 0.0 111.262 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.94 136.1 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.298 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -121.03 114.66 21.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.883 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.49 ' HB3' ' HA ' ' A' ' 41' ' ' VAL . 34.7 p90 -138.9 152.78 48.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.115 0.483 . . . . 0.0 111.785 -174.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -139.54 154.62 71.6 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.135 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 -13.7 27.98 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.731 2.287 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -122.45 22.47 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.72 168.91 29.91 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.335 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.62 172.1 15.69 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.581 2.187 . . . . 0.0 112.07 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HA ' ' HB3' ' A' ' 35' ' ' PHE . 46.2 t -87.62 95.97 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.62 109.25 7.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.344 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -85.69 131.27 34.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 27.6 m0 -98.31 145.77 30.41 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.642 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' TRP . 3.4 Cg_exo -81.71 37.01 0.65 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 110.225 168.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.638 HG13 ' HB2' ' A' ' 51' ' ' ASP . 54.3 t -108.85 123.04 64.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -171.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -119.02 -9.84 9.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.911 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 137.77 28.02 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HB3' ' O ' ' A' ' 96' ' ' THR . 28.7 Cg_endo -65.3 -5.45 11.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.477 2.118 . . . . 0.0 112.143 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.31 4.5 53.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.469 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.638 ' HB2' HG13 ' A' ' 46' ' ' VAL . 60.5 m-20 -90.29 -11.24 41.39 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -62.98 105.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.046 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.443 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 67.4 p -111.17 166.13 11.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.34 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -62.88 -32.0 73.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.184 175.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -60.29 -47.97 83.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.604 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.58 -34.39 78.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.843 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HB3' HD11 ' A' ' 111' ' ' LEU . 98.7 mt -65.06 -38.79 91.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.817 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 94.9 mt-30 -65.56 -39.08 91.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 110.43 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -71.83 -39.32 69.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.97 -17.71 63.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.878 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.53 -7.33 56.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.813 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.56 3.15 78.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.163 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt -71.69 -4.0 24.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.025 0.441 . . . . 0.0 110.922 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.3 -25.81 51.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.912 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.65 163.15 17.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.57 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.09 93.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.6 m -89.68 173.74 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.182 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 64.91 38.63 6.36 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -111.74 104.08 55.74 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.021 -174.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.862 ' HB3' ' HB3' ' A' ' 76' ' ' GLU . 91.8 Cg_endo -94.6 15.73 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.242 2.628 . . . . 0.0 112.033 175.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.5 tp -101.77 -41.88 6.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.386 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.02 -24.81 61.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.201 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -126.68 161.15 28.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.444 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.05 -2.99 53.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.027 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -141.82 133.2 26.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.81 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.862 ' HB3' ' HB3' ' A' ' 70' ' ' PRO . 11.2 pt-20 -84.39 119.98 73.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.162 0.506 . . . . 0.0 110.943 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 5.5 Cg_exo -79.96 168.85 18.57 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.38 2.72 . . . . 0.0 112.828 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -92.9 -175.09 3.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.369 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.44 -59.6 2.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.115 0.483 . . . . 0.0 109.761 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.44 -117.96 0.8 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.033 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.33 -10.85 26.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.769 0.319 . . . . 0.0 110.776 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.1 139.79 14.67 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.18 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.67 -27.87 63.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.169 0.509 . . . . 0.0 110.757 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -98.69 155.84 36.28 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.462 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -41.32 126.38 2.81 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.556 2.837 . . . . 0.0 113.431 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.88 76.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.022 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -78.72 62.7 3.31 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.571 0.7 . . . . 0.0 110.388 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -174.4 90.68 0.33 Allowed Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.48 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.54 ' HB3' ' CG2' ' A' ' 141' ' ' VAL . 6.7 Cg_endo -49.41 136.52 32.33 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 123.996 3.131 . . . . 0.0 113.736 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -77.75 -46.6 21.24 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.497 HG11 HD23 ' A' ' 133' ' ' LEU . 7.3 p -132.03 133.85 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.637 173.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.45 119.5 35.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.174 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.56 105.22 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.223 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.15 118.34 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 121' ' ' MET . . . -94.43 118.26 5.75 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -72.13 -5.21 33.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.238 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.23 -80.67 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.537 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 149' ' ' ASP . 38.5 ttm-85 -55.54 -55.72 28.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 110.78 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 99' ' ' ARG . 10.0 ptt180 -172.22 152.44 2.81 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.648 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.579 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 44.4 tt0 -58.4 128.41 37.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.775 0.672 . . . . 0.0 112.375 -168.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.509 ' HB2' HG21 ' A' ' 96' ' ' THR . 32.6 m170 -127.62 148.13 50.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.627 175.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 tp -88.42 126.35 35.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.81 171.54 14.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.423 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.19 156.46 16.33 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.753 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.52 -32.48 88.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.222 2.615 . . . . 0.0 112.973 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 42.7 tt0 -81.96 -25.14 35.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 110.709 -177.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -68.54 -44.73 73.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 35.5 m -97.83 10.64 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.881 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 13.5 ttt180 -54.69 -53.88 55.4 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.503 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 109' ' ' ARG . 31.5 Cg_exo -59.62 -35.24 95.73 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.031 1.821 . . . . 0.0 112.552 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.682 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.7 mt -75.15 -36.62 61.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.08 -176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 89.9 mt -57.96 -42.91 85.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.839 0.352 . . . . 0.0 110.476 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.1 -25.52 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.425 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 66.0 mtt -81.19 -22.53 38.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 110.715 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.25 17.47 10.74 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 46.7 t -93.3 108.87 21.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.426 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.11 86.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.177 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.28 126.02 39.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.736 0.303 . . . . 0.0 111.299 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -127.93 145.75 50.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.028 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.5 128.36 55.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.231 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.525 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 68.4 mtm -147.03 -175.13 4.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.918 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.99 163.03 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.663 0.268 . . . . 0.0 110.633 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.523 HG23 HD22 ' A' ' 144' ' ' LEU . 5.6 m -56.77 -39.12 73.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.667 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.1 -53.32 59.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.095 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.33 76.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.153 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.18 95.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.325 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.78 81.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.233 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.409 ' O ' HG13 ' A' ' 132' ' ' ILE . 78.4 mtp180 -63.39 -45.31 91.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.8 m -65.8 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.85 -49.73 76.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.449 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -58.98 -41.0 86.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.982 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 128' ' ' ARG . 73.2 mt -63.09 -53.3 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.497 HD23 HG11 ' A' ' 91' ' ' VAL . 10.8 mp -69.16 -23.78 63.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.237 -177.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.4 ttp -66.82 -43.2 84.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 109.889 174.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.75 -23.28 64.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.739 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.03 -16.52 63.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.782 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.52 37.84 62.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -115.62 151.96 33.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -80.05 84.39 5.79 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.984 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.73 130.43 54.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.415 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' A' ' 36' ' ' ALA . 22.9 t -115.29 129.43 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -115.95 138.4 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 120.925 0.393 . . . . 0.0 110.843 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.24 105.75 12.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.642 HD13 HG12 ' A' ' 22' ' ' ILE . 77.6 mt -100.43 132.82 45.6 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 32' ' ' ALA . 2.0 tt -119.17 86.95 33.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.228 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -92.35 -159.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.944 2.429 . . . . 0.0 111.439 172.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.2 t0 65.06 27.77 12.47 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.929 0.871 . . . . 0.0 109.877 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.47 -14.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.06 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 9.7 p-10 -61.71 -45.38 94.2 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.327 0.651 . . . . 0.0 111.094 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.7 m -77.73 16.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.888 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.0 tp -83.05 -9.5 59.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.385 0.612 . . . . 0.0 109.412 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.403 ' HG2' ' HG3' ' A' ' 98' ' ' ARG . 15.5 mm-40 -99.72 168.52 9.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.641 174.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -136.33 99.62 4.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.502 0.668 . . . . 0.0 110.407 173.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -112.81 137.51 51.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.496 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -78.9 160.52 27.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.026 0.441 . . . . 0.0 110.988 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -93.26 112.78 24.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.592 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -96.1 159.9 14.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.258 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 . . . . . 0 C--O 1.245 0.858 0 CA-C-O 119.349 -0.357 . . . . 0.0 110.245 -178.751 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -57.7 143.66 40.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.548 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.8 mt -54.61 -41.28 69.78 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -104.57 93.2 4.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m -64.32 104.32 0.75 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.135 0.493 . . . . 0.0 109.817 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -71.16 123.3 89.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.676 -168.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 92.2 Cg_endo -89.61 58.16 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.394 2.729 . . . . 0.0 109.942 169.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 7' ' ' PRO . . . 79.17 -160.31 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.228 -168.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.2 p -59.32 -50.06 75.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 65.65 -68.16 0.12 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.355 0.662 . . . . 0.0 111.286 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.98 104.61 13.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 35.9 t-20 -68.13 105.21 2.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.6 m -119.73 126.12 50.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.474 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.2 120.01 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 p -96.04 -23.36 16.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.738 0.304 . . . . 0.0 111.799 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -143.28 103.23 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.868 0.366 . . . . 0.0 111.309 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HD1' HG12 ' A' ' 22' ' ' ILE . 88.4 t80 -123.96 131.3 53.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.753 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.23 -4.72 33.5 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.29 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -91.34 17.34 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 0.0 110.916 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.01 -42.93 2.09 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 54.0 p90 -111.77 176.28 5.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.45 HG12 ' HD1' ' A' ' 17' ' ' TYR . 48.9 mt -119.49 113.29 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.96 0.409 . . . . 0.0 110.207 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 34.0 tt0 -89.35 118.8 29.28 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.8 t -105.03 104.18 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.161 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 65.69 -80.45 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.935 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -132.22 2.54 3.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.204 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.3 t -125.35 127.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 0.0 111.035 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 66.6 mtt85 -86.99 113.11 22.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 88.8 m-85 -99.24 148.84 23.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.873 0.368 . . . . 0.0 110.836 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -88.72 -67.66 0.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.067 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 147' ' ' ASP . 16.8 p-80 -115.7 -169.14 1.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.927 -172.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 144' ' ' LEU . . . -36.24 128.29 0.74 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 43' ' ' SER . 18.5 pt -143.71 162.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.32 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -137.15 133.64 35.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.812 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.657 ' HB3' HG13 ' A' ' 41' ' ' VAL . 37.1 p90 -157.2 163.01 39.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.291 0.567 . . . . 0.0 112.244 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.95 161.89 58.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 73.5 Cg_exo -49.45 -55.04 4.52 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.132 2.555 . . . . 0.0 112.347 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -131.93 95.12 3.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.09 -153.54 17.15 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.937 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.1 134.69 13.21 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.758 2.305 . . . . 0.0 113.321 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.657 HG13 ' HB3' ' A' ' 35' ' ' PHE . 53.9 t -114.14 121.39 66.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.78 168.16 20.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.127 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.439 ' HA ' HG22 ' A' ' 33' ' ' ILE . 11.6 p -99.94 150.23 22.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.937 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.594 ' CD1' ' HD2' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -98.33 131.64 25.83 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.594 ' HD2' ' CD1' ' A' ' 44' ' ' TRP . 37.7 Cg_endo -67.01 -11.13 31.06 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.842 2.361 . . . . 0.0 112.592 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' CG2' HD13 ' A' ' 56' ' ' LEU . 10.9 t -86.1 146.1 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.94 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -129.11 -1.44 5.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HD2' ' OD2' ' A' ' 51' ' ' ASP . 50.9 mtt85 -134.67 137.17 26.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.46 -7.02 19.08 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.954 2.436 . . . . 0.0 112.377 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.44 -13.94 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.376 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' OD2' ' HD2' ' A' ' 48' ' ' ARG . 27.4 m-20 -96.23 3.88 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.164 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.51 122.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.875 0.369 . . . . 0.0 111.257 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.1 p -121.57 176.3 5.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.373 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -64.29 -37.61 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 0.0 110.199 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -48.41 78.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.506 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD13 ' CG2' ' A' ' 46' ' ' VAL . 44.0 mt -70.63 -30.44 67.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.952 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.505 ' HB3' HD11 ' A' ' 111' ' ' LEU . 81.0 mt -67.23 -39.1 86.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.454 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 54' ' ' ALA . 24.6 mt-30 -58.18 -39.9 80.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.076 0.465 . . . . 0.0 110.214 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -68.41 -42.58 78.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.645 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.68 -13.15 62.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.88 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.1 -13.2 62.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.105 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.99 88.32 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.634 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.2 mt -86.89 2.64 48.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.47 . . . . 0.0 110.809 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.67 74.81 10.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.335 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -90.9 107.06 18.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.957 174.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.4 t -73.26 -38.62 54.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.193 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -82.88 105.84 13.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.316 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -117.02 79.51 1.34 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.572 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.764 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 17.8 m-20 -135.57 -56.8 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.877 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.764 ' HD2' ' H ' ' A' ' 69' ' ' ASP . 34.4 Cg_endo -65.47 -10.91 28.02 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.097 1.865 . . . . 0.0 112.97 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.8 tp -80.01 -16.95 54.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.982 0.42 . . . . 0.0 110.38 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.9 144.22 25.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.549 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -123.46 -176.65 3.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.298 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 27.7 tp -95.52 -1.21 51.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.701 0.762 . . . . 0.0 109.223 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.26 -173.66 4.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.415 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -142.93 143.12 23.95 Favored Pre-proline 0 C--N 1.324 -0.541 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.732 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.25 -3.28 6.04 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.902 2.401 . . . . 0.0 112.274 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 63.9 -74.64 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.667 0.787 . . . . 0.0 112.179 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.15 -27.15 56.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.993 0.425 . . . . 0.0 111.065 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.0 40.85 3.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.342 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.3 -1.92 37.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.779 0.324 . . . . 0.0 111.172 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.03 52.9 2.47 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.953 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.37 -4.57 21.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.234 0.54 . . . . 0.0 110.584 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -111.41 158.98 34.69 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.061 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.09 39.08 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.568 2.845 . . . . 0.0 113.047 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.36 1.78 41.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.26 0.553 . . . . 0.0 110.001 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -118.39 -31.75 4.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.224 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -85.16 132.3 45.82 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 18.1 Cg_exo -66.42 155.73 68.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.947 2.431 . . . . 0.0 112.15 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.34 -44.9 13.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.0 0.429 . . . . 0.0 110.55 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 140' ' ' VAL . 4.9 p -133.02 133.91 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.399 0.618 . . . . 0.0 111.245 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 tp -111.79 110.7 21.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.337 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 119' ' ' GLU . 97.2 mt -90.35 113.12 24.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.58 118.45 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.793 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 123' ' ' THR . . . -92.9 101.49 2.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 p -76.33 56.68 1.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 145' ' ' LEU . . . 76.35 -103.38 1.71 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.614 171.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.59 -35.49 11.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.238 . . . . 0.0 111.262 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -142.55 159.71 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.653 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.737 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 50.7 tt0 -62.79 111.19 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.792 175.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -113.73 116.18 29.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.039 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 143.01 57.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.068 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.27 -164.92 1.16 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.03 147.44 16.24 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.763 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.57 -42.42 65.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.063 2.509 . . . . 0.0 112.658 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.914 0.388 . . . . 0.0 111.697 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.59 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 98.7 mt-30 -96.24 -39.98 9.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 109.858 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.82 -24.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.801 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.53 ' HA ' HD12 ' A' ' 112' ' ' LEU . 7.8 ttp180 -63.4 -38.29 38.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.84 -43.41 23.93 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.803 1.668 . . . . 0.0 112.264 170.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.733 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . 76.4 mt -75.5 -36.21 60.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 109' ' ' ARG . 96.3 mt -61.08 -31.24 70.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 176.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.73 -22.49 63.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -87.9 -30.62 19.98 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 122.47 9.07 6.67 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.155 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.733 ' HB ' ' HB3' ' A' ' 111' ' ' LEU . 17.1 t -98.89 110.13 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 111.023 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.28 122.91 6.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.606 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.28 125.23 46.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.937 0.399 . . . . 0.0 111.491 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' HB2' HD23 ' A' ' 93' ' ' LEU . 51.8 mm-40 -110.01 103.24 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.682 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.43 109.8 21.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.614 0.245 . . . . 0.0 110.355 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.737 ' HA ' ' HG3' ' A' ' 100' ' ' GLN . 63.2 mtm -141.97 -177.24 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 -176.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.63 147.61 36.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.973 172.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.501 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 61.8 m -55.86 -44.46 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.691 0.281 . . . . 0.0 111.323 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -64.0 -44.01 93.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.568 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.07 99.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.003 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.02 79.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.98 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.6 94.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.97 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -61.11 -50.08 74.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.041 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.9 m -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.607 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.548 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 73.2 t80 -61.55 -46.74 88.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.691 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -56.0 -44.55 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.462 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.418 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 62.3 mt -69.29 -54.27 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.237 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.5 HD12 ' HB ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -57.11 -40.31 76.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -175.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 46.7 ttp -58.95 -36.67 75.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.68 -13.11 54.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 132' ' ' ILE . 27.1 mm-40 -88.5 -35.44 16.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 170.42 98.92 0.12 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.06 85.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.409 0.684 . . . . 0.0 112.84 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -144.45 33.79 1.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.5 ' HB ' HD12 ' A' ' 133' ' ' LEU . 7.2 p -127.45 140.42 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.567 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.0 t -124.74 143.84 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 130' ' ' TYR . 9.9 p -120.63 140.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.305 -176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -129.72 109.23 10.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.315 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 84.2 mt -116.58 138.9 51.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.78 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.549 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 5.0 mp -108.76 94.34 14.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 O-C-N 123.239 0.337 . . . . 0.0 110.171 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_endo -91.11 17.45 1.41 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.281 2.654 . . . . 0.0 111.566 177.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.627 ' HB3' ' NE2' ' A' ' 156' ' ' HIS . 1.1 m-20 -48.82 112.52 0.62 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.44 -175.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.61 -6.66 0.13 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.728 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -53.27 -34.65 58.12 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.0 0.92 . . . . 0.0 111.961 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.3 m -79.47 22.79 0.43 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.02 -173.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.2 mt 72.14 -51.77 0.7 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.673 0.789 . . . . 0.0 111.639 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 154' ' ' HIS . 0.9 OUTLIER -74.71 136.61 41.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -97.39 19.86 12.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.769 0.319 . . . . 0.0 111.758 -171.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.434 ' HB2' ' OE1' ' A' ' 152' ' ' GLU . 60.2 m80 -131.66 -51.57 0.99 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -85.62 152.21 23.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.135 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.627 ' NE2' ' HB3' ' A' ' 147' ' ' ASP . 42.5 m80 -138.3 153.7 49.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -119.92 93.36 4.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.187 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.247 0.952 0 O-C-N 124.037 0.835 . . . . 0.0 111.653 174.817 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 79.5 tttt 67.44 83.43 0.17 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.413 0.625 . . . . 0.0 109.722 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.8 mt -130.93 179.09 6.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.016 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -75.28 -42.99 53.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.6 m -124.2 101.33 7.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.816 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.36 164.39 54.44 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.68 95.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.75 2.3 . . . . 0.0 112.792 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.01 96.66 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.196 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -105.39 164.0 12.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.849 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.12 130.05 39.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.966 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.4 117.52 19.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.475 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -76.69 94.69 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 m -109.44 137.76 46.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.658 -171.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.11 127.35 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 p -105.77 -56.33 2.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.657 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -114.89 135.57 54.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.1 0.476 . . . . 0.0 110.877 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.11 167.38 10.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.649 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.07 -172.43 35.05 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.75 -63.51 1.19 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.134 0.492 . . . . 0.0 110.763 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.78 ' HA3' ' HA ' ' A' ' 149' ' ' ASP . . . -92.12 -5.43 65.83 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.907 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 13.0 p90 -139.9 148.72 42.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.858 0.361 . . . . 0.0 110.045 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.66 120.41 58.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 32.5 tt0 -96.37 114.1 25.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.317 0.58 . . . . 0.0 110.566 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.34 125.23 59.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.679 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.04 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -141.54 16.04 2.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.606 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.58 129.73 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.369 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.3 mtp-105 -88.23 114.84 25.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.074 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.17 100.47 9.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.78 0.324 . . . . 0.0 111.123 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 36.2 m -83.81 36.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.439 0.637 . . . . 0.0 109.818 173.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.513 ' HB2' HG23 ' A' ' 33' ' ' ILE . 8.1 m170 -120.22 169.81 9.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.2 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 44' ' ' TRP . . . -85.33 105.26 15.86 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 164.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 31' ' ' HIS . 19.4 pt -112.24 132.31 61.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.419 0.628 . . . . 0.0 112.625 -169.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 142' ' ' VAL . . . -113.6 121.63 44.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.429 174.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -147.88 155.79 41.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.273 0.559 . . . . 0.0 111.773 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' A' ' 141' ' ' VAL . . . -129.23 159.88 66.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.628 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 23.0 Cg_endo -62.71 -25.68 75.08 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.447 2.098 . . . . 0.0 111.628 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -125.63 108.23 11.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.561 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.05 -170.3 23.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.323 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.93 -177.29 1.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.028 2.485 . . . . 0.0 112.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.38 121.86 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.976 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.7 119.46 38.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.962 0.41 . . . . 0.0 110.789 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -94.06 131.8 39.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.345 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 3.9 m0 -98.28 137.1 20.74 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.037 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.53 0.05 9.91 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.017 2.478 . . . . 0.0 111.374 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 56' ' ' LEU . 29.7 t -85.88 113.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.486 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -111.79 7.77 20.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 0.0 110.794 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 54.0 ttp180 -127.02 115.44 21.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 26.8 Cg_exo -63.44 -10.81 22.99 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.4 2.733 . . . . 0.0 113.883 -173.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.37 -2.0 58.35 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.269 -0.269 . . . . 0.0 111.38 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' A' ' 48' ' ' ARG . 42.5 m-20 -98.16 -2.83 39.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.89 118.55 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.206 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 54' ' ' ALA . 1.7 m -129.4 169.16 15.27 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 107' ' ' GLN . . . -49.71 -54.33 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -173.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.9 m -61.7 -33.52 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.655 0.264 . . . . 0.0 111.338 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.436 HD13 HG21 ' A' ' 46' ' ' VAL . 98.3 mt -65.23 -44.54 87.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.498 . . . . 0.0 110.224 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.99 -37.25 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.664 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.522 ' HA ' HD21 ' A' ' 111' ' ' LEU . 48.2 tt0 -62.09 -37.52 85.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.701 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -71.61 -41.3 69.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 110.58 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.11 -4.94 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.875 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 89' ' ' PRO . . . -75.09 -4.42 38.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.531 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.42 35.52 52.01 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.096 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -90.88 13.09 17.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 110.661 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.16 75.88 6.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.417 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -78.37 111.32 14.24 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p -127.37 138.93 53.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.069 0.461 . . . . 0.0 111.622 -171.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.24 148.56 8.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.06 18.37 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -173.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 t70 64.75 96.84 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.368 0 C-N-CA 123.273 0.629 . . . . 0.0 110.434 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.759 ' HB3' ' H ' ' A' ' 75' ' ' ASP . 11.8 Cg_exo -69.92 83.92 0.7 Allowed 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.198 2.599 . . . . 0.0 113.368 -173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.75 -16.63 16.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.334 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.28 -67.76 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.483 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.474 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 77.4 m-85 -123.0 -84.68 0.66 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.666 HD23 ' HB2' ' A' ' 70' ' ' PRO . 6.6 mt 176.92 107.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.849 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.759 ' H ' ' HB3' ' A' ' 70' ' ' PRO . 13.2 m-20 -77.27 100.74 5.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.813 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.04 104.92 5.4 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.187 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 75' ' ' ASP . 86.9 Cg_endo -86.31 -6.25 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.943 2.428 . . . . 0.0 113.509 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.92 -51.93 62.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.095 0.474 . . . . 0.0 110.114 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.44 74.75 9.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.031 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.17 41.76 2.06 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.787 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.45 106.31 3.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.066 0.46 . . . . 0.0 110.65 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.08 -3.01 11.59 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.848 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.41 139.05 42.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.605 0.24 . . . . 0.0 110.479 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -105.55 107.73 59.92 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.979 0.419 . . . . 0.0 110.578 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.84 -39.37 3.39 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.689 2.26 . . . . 0.0 111.654 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.64 43.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.771 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -74.48 -71.69 0.33 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.899 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . 64.57 158.82 0.12 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 124.024 0.827 . . . . 0.0 112.625 176.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 3.5 Cg_exo -77.45 165.86 26.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.695 2.264 . . . . 0.0 111.271 170.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.734 ' HG3' ' HB2' ' A' ' 139' ' ' ARG . 38.2 mt-10 -94.8 -38.01 10.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.769 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.503 HG13 HG23 ' A' ' 140' ' ' VAL . 6.0 p -144.08 137.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 111.179 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.6 tp -113.26 115.39 28.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.702 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.05 116.16 28.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.578 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.51 121.64 52.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.261 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.38 89.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.044 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -101.59 36.91 1.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.227 0.537 . . . . 0.0 109.832 -179.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.577 ' HA3' ' H ' ' A' ' 123' ' ' THR . . . -79.78 63.3 4.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.009 -170.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.473 ' NH2' ' HA ' ' A' ' 147' ' ' ASP . 8.9 ttm180 -161.11 -52.62 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.54 90.3 2.4 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -71.24 93.12 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.7 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -76.09 107.46 8.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.207 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.64 126.04 26.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.16 165.7 15.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.68 157.91 15.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.93 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.94 -33.72 97.46 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.04 2.493 . . . . 0.0 112.594 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.79 -20.5 62.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.952 0.406 . . . . 0.0 111.005 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.556 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 87.9 mt-30 -88.02 -35.11 17.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.448 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 30.2 m -92.48 -21.03 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.741 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.548 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 7.5 tmm_? -59.07 -48.55 96.38 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 8.5 Cg_endo -51.14 -43.42 48.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.323 2.015 . . . . 0.0 112.626 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 58' ' ' GLN . 91.8 mt -75.04 -37.03 61.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 93.9 mt -66.02 -34.71 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.0 -31.22 72.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.213 0.53 . . . . 0.0 110.363 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 65.7 mtt -75.39 -38.28 60.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.79 -12.25 5.91 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.934 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.08 109.66 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.753 0.311 . . . . 0.0 110.871 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.34 115.98 4.79 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.003 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.55 123.53 43.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.621 0.248 . . . . 0.0 110.812 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -129.39 120.2 25.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.476 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.12 122.8 44.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.494 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 70.0 mtm -139.9 -171.82 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.36 150.04 49.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.715 0.293 . . . . 0.0 110.218 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.577 ' H ' ' HA3' ' A' ' 97' ' ' GLY . 8.2 m -56.36 -42.53 77.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.337 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 52.3 tt0 -72.82 -35.98 67.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.18 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.34 -36.46 82.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.126 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.23 95.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.142 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.568 ' O ' HG12 ' A' ' 132' ' ' ILE . 69.5 mtm180 -64.59 -55.85 17.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.412 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -59.71 -32.95 70.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.261 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.44 ' CD1' ' HB ' ' A' ' 142' ' ' VAL . 81.7 t80 -59.03 -54.27 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -61.3 -34.22 74.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.472 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 128' ' ' ARG . 45.0 mm -59.76 -55.31 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.551 177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 72.0 mt -71.89 -31.05 66.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.3 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 ttp -62.12 -49.97 73.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 110.48 178.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.18 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.736 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.42 -16.63 61.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.516 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.46 31.53 24.59 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 138' ' ' ARG . 27.7 ttt180 -106.05 147.4 28.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.012 -175.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.734 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 68.9 mtm180 -81.41 88.81 6.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.274 0.559 . . . . 0.0 110.6 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.503 HG23 HG13 ' A' ' 91' ' ' VAL . 7.4 p -120.19 138.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.958 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 36' ' ' ALA . 40.1 t -121.06 140.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 8.0 p -124.21 138.9 52.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.008 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.84 103.98 9.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.408 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.8 mt -100.63 122.59 43.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.879 0.371 . . . . 0.0 111.165 -173.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.08 109.02 54.89 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.461 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.89 -157.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.311 2.674 . . . . 0.0 110.904 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.473 ' HA ' ' NH2' ' A' ' 98' ' ' ARG . 3.1 p30 -86.84 -55.13 3.99 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.102 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.51 -4.84 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.113 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.78 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 8.2 t0 82.86 65.62 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.3 m -93.59 115.2 27.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.966 -175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.9 mt -81.18 139.81 35.34 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.016 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.95 136.09 50.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.997 0.427 . . . . 0.0 110.515 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -120.56 157.29 29.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -92.2 26.91 2.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.255 0.55 . . . . 0.0 110.823 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -128.99 104.12 7.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.135 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.59 92.52 6.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.072 -174.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -144.84 133.42 22.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.216 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.474 179.471 . . . . . . . . 0 0 . 1 stop_ save_